Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
IGLL1	"14.1, CD179B, IGL5, IGLL, IGVPB"	ENSG00000128322	"Immunoglobulin lambda like polypeptide 1"	P15814	22	23573125-23580308	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"blood: 11.6;bone marrow: 37.7;lymphoid tissue: 29.4;testis: 20.8"	"Cell line enriched"	"Detected in some"	34	"REH: 126.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 11.6;naive B-cell: 9.8"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.6"									"HPA051134, HPA071406"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	100000000000	100000000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA051134: AB_2681356, HPA071406: AB_2686393"	"unprognostic (6.21e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.91e-6)"		"unprognostic (1.08e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.17e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.1	0.1	0.2	37.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	20.8	0.0	29.4	0.0	0.0	1.1	0.0	0.0	11.6	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.4	0.0	0.0	126.8	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.5	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0
CTSG	CG	ENSG00000100448	"Cathepsin G"	P08311	14	24573522-24576260	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"bone marrow: 450.3"	"Cell line enriched"	"Detected in some"	7	"THP-1: 437.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.5;memory CD8 T-cell: 3.5;myeloid DC: 5.1;naive CD8 T-cell: 1.8;neutrophil: 7.1;NK-cell: 5.2;plasmacytoid DC: 5.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"CAB000110, HPA047737"	Enhanced				"Intracellular and membrane"	67000	67000			"CAB000110: , HPA047737: AB_2680140"	"unprognostic (1.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.08e-1)"		"prognostic favourable (1.57e-4)"	"unprognostic (4.05e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (8.91e-4)"	15.1	0.5	0.0	6.0	0.0	450.3	6.0	0.0	0.6	10.0	5.1	0.0	2.8	1.1	6.2	19.7	6.4	0.8	16.7	23.4	0.0	0.0	2.1	2.0	9.2	3.7	0.0	0.0	1.5	3.4	0.8	0.5	3.0	0.0	8.2	3.2	2.6	6.3	6.9	1.1	19.5	8.9	14.9	0.0	10.7	3.2	2.8	0.0	15.6	0.5	12.0	5.1	2.9	3.3	0.0	5.7	7.1	6.5	5.2	3.5	12.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	437.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	64.9	0.0	0.0	6.5	0.0	1.1	1.0	0.0	0.0	1.0	3.5	5.1	0.0	0.0	1.8	7.1	5.2	0.0	5.7	0.0	12.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0
OR10Z1		ENSG00000198967	"Olfactory receptor family 10 subfamily Z member 1"	Q8NGY1	1	158605268-158612514	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	17	"bone marrow: 12.1"	"Cell line enriched"	"Detected in some"	5	"K-562: 4.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058072	Uncertain									"HPA058072: AB_2683595"																		0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.1	0.7	0.1			0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1			0.0		0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.9	0.1	0.2	0.0	0.1	1.0	0.3	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.1	0.2	4.6	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.8	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0										
BX088645.1		ENSG00000283378			9	61330717-61453030	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	16	"blood: 21.7;bone marrow: 14.1"	"Cell line enhanced"	"Detected in some"		"A549: 21.0;SiHa: 4.6;TIME: 6.6;WM-115: 18.5"									"Cell type enriched"	"Detected in some"	13	"neutrophil: 21.7"	"Lineage enriched"	"Detected in single"	182	"granulocytes: 21.7"																																					0.1	0.0		0.0		14.1	0.0		0.5	0.1	0.0			0.0	0.0	0.0	0.2	0.0	0.0	1.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.2		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.1		0.3	0.0	0.5			0.1		0.0	0.0		0.1	0.0	21.7	0.0	0.0	0.0	0.0	0.9	21.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	2.3	0.3	1.6	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.5	1.3	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.6	0.0	0.3	2.4	0.0	0.7	0.3	0.6	4.6	0.1	1.4	0.1	0.1	6.6	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0										
DEFA1B		ENSG00000240247	"Defensin alpha 1B"	P59665	8	6996766-6999195	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"bone marrow: 734.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.8"	"Low lineage specificity"	"Detected in many"											HPA052517	Supported				"Intracellular and membrane"					"HPA052517: AB_2681860"																		0.4	0.0	0.0	0.0	0.0	734.0	0.1	0.0	0.2	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	16.0	0.0	0.0		0.0	0.0	0.0	0.3	0.5		0.0	0.0		1.8	0.0	0.0	0.5	0.0	0.0	0.0	49.1	0.0	0.0			0.2		0.0	0.0	0.0	1.8	1.2	0.8	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	1.8	0.5	1.1	1.2	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0										
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269856-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 315.2"	"Group enriched"	"Detected in some"	93	"HL-60: 212.9;NB-4: 279.1"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0"	"Group enriched"	"Detected in many"	30	"dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	15000000	15000000	Vesicles	Vesicles	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.2	0.1	0.5	0.1	0.8	315.2	0.1	0.4	1.0	0.1	0.1	1.4	0.0	0.1	0.2	0.2	0.1	0.1	0.1	21.5	0.6	0.8	0.1	1.4	6.9	0.8	0.6	0.0	0.6	0.1	0.1	1.0	2.9	0.4	0.2	0.1	0.2	6.3	0.1	0.7	0.5	0.1	0.1	0.4	17.8	0.1	0.4	0.2	19.7	0.6	0.0	0.5	0.1	0.0	0.0	3.2	2.0	7.6	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	279.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	3.8	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	2.0	0.0	0.8	0.0	0.1	7.2	0.5	0.8	0.4	1.0	0.6	0.8	0.6	0.0	0.4	0.2
Z82206.1		ENSG00000225528			22	39960397-39964718	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	14	"blood: 8.1;bone marrow: 4.1;lymphoid tissue: 2.3"	"Cell line enhanced"	"Detected in some"		"HEL: 4.0;K-562: 15.9;MOLT-4: 2.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA047397			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"				Nucleoli	Nucleoli	"HPA047397: AB_2680029"	"unprognostic (8.48e-4)"	"unprognostic (2.95e-6)"	"unprognostic (3.67e-1)"	"unprognostic (5.90e-2)"	"unprognostic (4.27e-1)"	"unprognostic (6.95e-3)"	"unprognostic (3.74e-1)"	"unprognostic (5.41e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.77e-2)"	"unprognostic (6.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.58e-3)"	0.0	0.0		0.5		4.1	0.1		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.3	2.3			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.1		1.0	0.1	0.0			0.0		1.1	0.3		3.6	3.0	5.7	2.2	2.2	8.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.8	4.4	5.2	2.2	4.5	3.6	6.5	5.7	2.7	3.2	6.7	8.1	4.3	2.2	1.9	3.0	4.2	7.6										
OTOF	"DFNB6, DFNB9, FER1L2"	ENSG00000115155	Otoferlin	Q9HC10	2	26457203-26558698	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"bone marrow: 13.8;brain: 26.8"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 26.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"basal ganglia: 26.8"	"Cell type enhanced"	"Detected in some"		"gdTCR: 1.4;memory CD8 T-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012410	Approved									"HPA012410: AB_1854836"	"unprognostic (4.01e-3)"	"unprognostic (7.85e-2)"	"unprognostic (8.95e-2)"	"unprognostic (7.20e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.97e-3)"	"unprognostic (4.85e-14)"	"unprognostic (1.33e-2)"	"unprognostic (5.19e-1)"	"unprognostic (9.65e-2)"	"unprognostic (8.96e-5)"	0.5	0.7	5.5	0.8	26.8	13.8	0.2	0.4	2.2	0.3	0.4	0.3	0.0	1.1	0.2	0.1	0.4	0.3	0.9	0.2	1.6	2.0	0.1	0.2	0.6	0.5	0.6	0.7	0.2	0.1	0.1	0.0	0.2	1.1	0.3	0.3	0.0	0.3	0.2	0.7	0.2	0.7	0.4	0.7	1.2	0.5	1.4	2.6	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.6	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	5.5	26.8	0.4	2.2	1.6	2.0	0.6	0.7	1.1	2.6
SPATC1	"MGC61633, SPATA15, SPERIOLIN"	ENSG00000186583	"Spermatogenesis and centriole associated 1"	Q76KD6	8	144012414-144047085	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"bone marrow: 10.9;testis: 36.6"	"Cell line enriched"	"Detected in some"	9	"U-937: 13.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 30.1"												"unprognostic (2.96e-1)"	"unprognostic (1.41e-3)"	"unprognostic (3.34e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.59e-3)"	"unprognostic (6.96e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.74e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.74e-1)"	0.2	0.1	0.2	2.2	0.3	10.9	0.1	0.2	0.3	0.1	0.1	0.5	0.0	0.1	0.0	0.7	0.5	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.7	0.7	0.1	0.0	0.0	0.1	0.0	0.9	0.3	0.4	0.5	0.0	0.5	0.5	0.0	0.1	0.0	0.6	0.1	0.6	1.8	0.2	36.6	0.0	0.9	0.1	0.3	1.9	0.5	0.1	1.8	1.3	0.8	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.7	0.0	0.0	0.6	0.0	0.2	0.6	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	13.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.5	1.8	0.0	0.0	0.8	0.0	0.0	1.3	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.1	0.1	0.0	0.4	0.0
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228324-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"blood: 10.3;bone marrow: 3.1;lung: 3.1;lymphoid tissue: 9.5"	"Cell line enriched"	"Detected in single"	7	"HEL: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 5.4;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.3"									HPA065044	Uncertain				"Secreted - unknown location"					"HPA065044: AB_2685411"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.3	0.1	0.1	1.2	0.3	3.1	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.6	0.3	0.2	0.1	0.2	0.1	0.2	3.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.4	9.5	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	1.3	0.9	10.3	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.4	0.0	0.5	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	10.3	0.0	0.4	0.9	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0
GATA1	"ERYF1, GATA-1, GF1, NF-E1, NFE1"	ENSG00000102145	"GATA binding protein 1"	P15976	X	48786554-48794311	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"blood: 78.3;bone marrow: 37.0"	"Group enriched"	"Detected in some"	9	"HEL: 49.6;HMC-1: 51.2;K-562: 52.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 78.3"	"Lineage enriched"	"Detected in single"	784	"granulocytes: 78.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000232, HPA000233, CAB009195"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951"	"unprognostic (1.93e-1)"	"unprognostic (7.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.00e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.71e-2)"	0.7	0.2	0.1	2.4	0.7	37.0	0.3	0.0	0.3	0.7	0.3	0.0	0.0	0.6	4.9	2.4	0.4	0.3	0.6	2.3	0.1	0.3	0.4	0.8	5.6	0.2	0.6	0.0	0.1	0.1	0.1	0.5	2.8	0.3	1.4	0.4	1.6	0.3	0.2	0.1	0.6	0.8	2.4	0.3	4.9	0.5	3.1	0.0	1.5	0.6	1.1	0.6	0.9	0.6	0.0	0.0	78.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.6	0.0	0.0	0.0	0.0	51.2	0.0	0.0	0.0	0.0	0.0	52.8	0.1	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	78.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.7	0.0	0.3	0.1	0.3	0.6	0.0	0.3	0.0
MS4A3	"CD20L, HTM4"	ENSG00000149516	"Membrane spanning 4-domains A3"	Q96HJ5	11	60056587-60071128	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"blood: 196.2;bone marrow: 105.4"	"Group enriched"	"Detected in some"	4	"HEL: 36.3;K-562: 30.9;NB-4: 25.1;THP-1: 73.3;U-937: 28.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.6"	"Cell type enriched"	"Detected in single"	1061	"basophil: 196.2"	"Lineage enriched"	"Detected in single"	1963	"granulocytes: 196.2"	"Not detected"	"Not detected"							HPA019210	Supported		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA019210: AB_1854134"					"unprognostic (6.37e-3)"			"unprognostic (1.25e-1)"						"unprognostic (2.67e-1)"	"unprognostic (3.77e-1)"			0.2	0.0	0.1	0.1	0.3	105.4	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	14.7	0.1	0.1	0.1	0.5	6.8	0.0	0.1	0.0	0.1	0.0	0.0	0.4	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.1	8.6	0.0	1.0	0.0	7.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	196.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.0	0.0	9.5	0.9	0.0	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.9	0.0	196.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	1.6	0.1	0.1	0.1	0.0	0.1	0.0
RNASE2	"EDN, RAF3, RNS2"	ENSG00000169385	"Ribonuclease A family member 2"	P10153	14	20955452-20956436	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"blood: 137.2;bone marrow: 236.7"	"Group enriched"	"Detected in some"	318	"HL-60: 53.6;NB-4: 53.6;THP-1: 143.6;U-937: 130.2"	"Cancer enriched"	"Detected in many"	7	"glioma: 14.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 37.8;eosinophil: 137.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 137.2"									HPA044983	Enhanced				"Secreted to blood"	300000000	300000000			"HPA044983: AB_10963689"	"unprognostic (6.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.94e-3)"	"unprognostic (6.77e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavourable (3.28e-13)"	"unprognostic (2.27e-2)"	"unprognostic (7.14e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.50e-1)"	2.7	3.2	4.8	2.0	9.3	236.7	0.5	0.9	3.7	0.9	0.6	1.4	0.1	0.5	0.7	0.5	0.5	3.2	0.9	3.7	3.9	1.8	1.2	1.3	6.6	7.2	4.7	0.1	0.5	2.5	0.5	0.6	0.8	4.9	0.5	0.6	0.1	0.7	0.5	0.9	0.9	0.6	2.1	10.5	19.4	0.9	0.6	3.7	0.1	0.5	0.1	0.6	1.4	0.3	0.0	20.0	137.2	11.5	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	53.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	143.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	130.2	0.0	37.8	11.5	137.2	0.0	2.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	1.0	0.0	0.2	0.2	0.0	3.3	4.8	9.3	0.9	3.7	3.9	1.8	4.7	0.1	4.9	3.7
ADD2	ADDB	ENSG00000075340	"Adducin 2"	P35612	2	70607618-70768225	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"bone marrow: 53.6;brain: 35.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 14.1;K-562: 18.5;NTERA-2: 36.5;RPMI-8226: 17.4;SCLC-21H: 18.1;U-251 MG: 19.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 4.7;non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	20	"B-cells: 4.7;monocytes: 4.4;T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009796, HPA034509, HPA034510"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		66000	66000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB009796: AB_2223572, HPA034509: AB_2674201, HPA034510: "	"unprognostic (3.58e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.01e-4)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.47e-7)"	"unprognostic (2.81e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.31e-3)"	1.9	2.6	14.0	2.6	17.9	53.6	1.5	29.7	35.0	1.3	1.3	1.2	0.0	1.0	1.3	1.2	2.3	1.4	1.2	1.5	14.1	10.7	0.9	0.9	1.8	3.1	6.0	19.7	1.0	2.1	1.3	2.8	1.6	14.0	1.3	1.2	1.7	1.1	1.1	1.6	1.2	1.2	1.9	6.0	1.9	1.1	2.9	2.7	0.0	2.3	0.0	2.9	1.5	0.5	4.7	0.1	0.1	4.4	0.0	1.9	0.6	7.0	8.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.1	0.0	14.1	0.0	0.0	0.0	8.3	0.7	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.1	0.6	36.5	0.2	0.0	0.2	17.4	2.4	0.0	18.1	8.2	8.9	0.0	0.0	0.0	4.3	0.3	0.0	0.4	0.0	19.2	5.9	6.9	0.0	0.3	2.9	3.2	0.1	0.1	0.0	0.0	2.4	0.1	4.7	0.0	0.0	0.1	4.0	1.9	1.0	0.1	0.0	4.4	0.0	0.0	0.6	14.0	17.9	29.7	35.0	14.1	10.7	6.0	19.7	14.0	2.7
GYPA	"CD235a, GPA, MN, MNS"	ENSG00000170180	"Glycophorin A (MNS blood group)"	P02724	4	144109303-144140786	"Blood group antigen proteins, CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 56.9"	"Cell line enriched"	"Detected in some"	4	"HEL: 55.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"											"CAB002658, HPA014811"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"CAB002658: , HPA014811: AB_1849827"					"unprognostic (1.60e-1)"								"unprognostic (2.47e-2)"					0.1	0.0	0.2	0.1	0.4	56.9	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.3	1.7	1.3	3.2	0.1	0.3	0.1	0.1	0.1	0.0	0.3	4.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	6.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.3	0.4	0.2	0.2	0.6	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.2	0.9	0.1	0.2	0.2	1.5	0.2	0.6	0.2	0.2	0.2	0.3	0.0	0.8	0.2	0.4	0.1	0.5	0.2	0.3	0.3	0.1	0.1	0.1
OR52K2		ENSG00000181963	"Olfactory receptor family 52 subfamily K member 2"	Q8NGK3	11	4449295-4450361	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"blood: 6.9;bone marrow: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"classical monocyte: 1.9;neutrophil: 6.9"	"Group enriched"	"Detected in many"	25	"granulocytes: 6.9;monocytes: 1.9"																																					0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0		0.4	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0			0.0		0.0	0.1	0.1	0.0	0.1	6.9	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	0.0	0.8	0.0	0.0	0.3										
OR6N2		ENSG00000188340	"Olfactory receptor family 6 subfamily N member 2"	Q8NGY6	1	158774222-158781204	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	9	"blood: 2.9;bone marrow: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	21	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056637	Uncertain									"HPA056637: AB_2683198"																		0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.4	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0										
PRG3	"MBP2, MBPH"	ENSG00000156575	"Proteoglycan 3, pro eosinophil major basic protein 2"	Q9Y2Y8	11	57376769-57381150	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"bone marrow: 31.6;lymphoid tissue: 8.7"	"Cell line enriched"	"Detected in some"	48	"HMC-1: 66.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA064183	Enhanced				"Secreted in other tissues"	240000	240000			"HPA064183: AB_2685205"																		0.1	0.0	0.0	0.0	0.0	31.6	0.1	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0
RHAG	"CD241, RH50A, SLC42A1"	ENSG00000112077	"Rh associated glycoprotein"	Q02094	6	49605158-49636884	"CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 54.1"	"Group enriched"	"Detected in some"	190	"HEL: 85.7;K-562: 84.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046051, HPA055331"	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA046051: , HPA055331: AB_2682785"					"unprognostic (8.16e-2)"						"unprognostic (6.86e-2)"	"unprognostic (1.25e-3)"		"unprognostic (1.65e-1)"				1.2	0.2	0.0	1.1	0.5	54.1	3.2	0.0	0.1	2.3	1.0	0.5	1.7	0.2	0.4	0.1	2.6	0.5	0.8	5.3	0.0	0.0	0.1	0.7	3.3	0.1	0.0	0.0	0.1	0.2	0.1	0.1	5.8	0.1	1.3	0.2	0.0	0.2	0.5	0.4	0.1	0.9	0.1	0.0	4.5	0.6	0.2	0.0	1.7	1.8	0.0	0.1	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
RNASE3	"ECP, RAF1, RNS3"	ENSG00000169397	"Ribonuclease A family member 3"	P12724	14	20891399-20892348	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"blood: 60.9;bone marrow: 154.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 36.2;NB-4: 12.3;THP-1: 15.6;U-937: 74.0"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	21	"eosinophil: 60.9"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 60.9"									HPA056183	Enhanced				"Secreted to blood"					"HPA056183: AB_2683059"	"unprognostic (2.54e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.21e-2)"		"unprognostic (6.45e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.20e-1)"	"unprognostic (9.21e-2)"		"unprognostic (8.62e-7)"	"unprognostic (6.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.37e-1)"	0.2	0.4	1.0	0.2	3.6	154.1	0.1	1.0	3.1	0.1	0.1	0.8	0.0	0.1	0.1	0.2	0.1	0.3	0.2	0.2	0.8	0.9	0.1	0.5	3.2	0.2	4.4	0.0	0.2	0.1	0.1	0.3	0.6	1.5	0.1	0.1	0.0	0.3	0.1	0.1	0.4	0.1	0.3	2.9	11.8	0.1	1.7	1.9	1.0	0.1	0.0	0.1	0.2	0.0	0.0	2.8	60.9	1.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.0	0.0	1.8	1.8	60.9	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.7	1.0	3.6	1.0	3.1	0.8	0.9	4.4	0.0	1.5	1.9
CLEC12A	"CD371, CLL-1, DCAL-2, MICL"	ENSG00000172322	"C-type lectin domain family 12 member A"	Q5QGZ9	12	9951316-9995694	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 46.5;bone marrow: 35.4;lung: 36.2;lymphoid tissue: 22.4"	"Group enriched"	"Detected in some"	6	"HL-60: 11.8;U-937: 36.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"eosinophil: 46.5"	"Group enriched"	"Detected in many"	38	"dendritic cells: 17.1;granulocytes: 46.5;monocytes: 32.8"									HPA048515	Enhanced									"HPA048515: AB_2680425"	"unprognostic (4.74e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.10e-3)"	"unprognostic (9.67e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.78e-2)"	"prognostic favourable (9.33e-4)"	4.2	1.2	0.3	6.4	1.2	35.4	1.2	0.6	1.1	0.9	1.5	0.3	0.1	0.2	1.9	3.7	0.9	1.3	2.8	3.5	0.3	0.3	1.9	3.4	36.2	9.6	0.5	0.8	1.0	1.4	0.0	0.6	3.4	1.2	1.3	1.3	1.4	1.5	0.1	0.7	1.1	1.9	3.5	1.5	22.4	1.3	0.9	0.3	2.8	0.7	0.1	1.2	2.1	1.0	0.0	17.1	46.5	32.8	0.8	0.1	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	11.8	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	36.9	0.0	4.1	32.8	46.5	0.0	26.4	0.1	0.0	0.0	0.0	17.1	0.0	0.0	0.1	10.2	0.8	28.4	1.5	0.0	12.5	0.3	1.2	0.6	1.1	0.3	0.3	0.5	0.8	1.2	0.3
ELANE	"ELA2, HLE, HNE, NE"	ENSG00000197561	"Elastase, neutrophil expressed"	P08246	19	851014-856247	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 244.3"	"Cell line enriched"	"Detected in some"	65	"THP-1: 193.2"	"Group enriched"	"Detected in some"	7	"pancreatic cancer: 3.5;stomach cancer: 3.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 3.2;neutrophil: 6.9"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.9;monocytes: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB015409, HPA066836"	Enhanced				"Secreted to blood"	59000	59000			"CAB015409: AB_831596, HPA066836: AB_2685733"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.19e-10)"	"unprognostic (6.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.75e-3)"	1.5	0.3	0.1	0.3	0.1	244.3	1.6	0.2	0.6	0.3	0.6	0.7	0.0	0.3	0.3	0.7	0.5	0.6	0.8	31.2	0.0	0.0	0.3	1.5	17.8	1.6	0.0	0.0	0.3	1.8	0.3	0.4	4.7	0.5	1.4	0.3	1.0	0.7	0.3	1.1	2.1	0.5	0.5	0.0	22.5	0.5	0.3	0.0	23.0	2.3	0.9	0.3	1.0	0.2	0.0	0.0	6.9	3.2	0.0	0.5	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	11.2	0.1	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.5	0.0
GFI1B	ZNF163B	ENSG00000165702	"Growth factor independent 1B transcriptional repressor"	Q5VTD9	9	132944000-132991687	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 71.0;bone marrow: 29.2"	"Group enriched"	"Detected in some"	5	"HEL: 54.3;HMC-1: 35.2;K-562: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"basophil: 31.2;eosinophil: 71.0"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 71.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004420, HPA006291"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB004420: AB_2110132, HPA006291: "	"unprognostic (1.79e-2)"	"unprognostic (2.90e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-2)"		"unprognostic (2.53e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.41e-1)"	0.2	0.0	0.2	2.2	0.2	29.2	0.1	0.1	0.2	0.9	4.2	0.2	0.0	0.8	0.4	0.7	0.8	0.2	3.5	0.8	0.2	0.1	0.3	0.4	2.5	0.0	0.1	0.0	0.1	0.2	0.0	0.1	1.2	0.0	4.2	0.3	0.2	0.1	0.1	0.3	0.8	6.3	1.0	0.2	3.3	0.3	4.0	0.0	1.0	0.2	0.0	0.5	0.4	0.2	0.0	0.3	71.0	2.7	0.1	0.1	2.4	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.1	7.6	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	54.3	0.1	0.0	0.0	0.0	35.2	0.0	0.6	0.0	0.1	0.0	16.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	31.2	0.0	71.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.8	0.1	2.7	0.1	0.0	2.4	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.0
H1FX	"H1X, MGC15959, MGC8350"	ENSG00000184897	"H1 histone family member X"	Q92522	3	129314771-129316277	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"bone marrow: 381.6;lymphoid tissue: 238.6"	"Cell line enhanced"	"Detected in all"		"U-266/70: 137.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012235, HPA040099"	Supported		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"CAB012235: , HPA040099: AB_2676846"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.48e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.50e-2)"	23.1	13.1	11.9	19.0	14.5	381.6	33.7	29.0	22.9	30.9	21.0	9.6	13.4	21.1	26.0	19.6	34.5	25.1	24.0	27.5	11.3	11.2	12.9	24.9	30.9	44.2	6.7	16.3	39.0	22.4	18.4	20.5	15.0	6.9	26.2	7.8	18.4	32.3	16.3	30.8	40.5	26.0	19.1	9.6	29.9	29.0	14.2	6.3	238.6	21.9	18.1	20.5	35.6	25.0	5.7	10.8	15.9	5.3	4.8	8.3	2.2	19.6	10.4	19.8	8.5	2.0	2.4	18.8	8.6	6.3	10.3	10.9	6.2	10.8	2.5	9.6	3.0	19.8	8.3	5.5	1.6	18.0	16.1	7.5	8.1	8.5	8.5	8.6	2.0	4.8	7.6	4.1	9.5	5.9	11.5	44.8	1.4	20.6	40.1	17.2	18.5	11.8	28.9	8.4	23.4	3.1	4.1	31.6	36.6	9.1	4.6	26.2	17.9	17.6	5.8	8.0	41.9	7.8	7.2	137.4	52.5	21.2	6.5	8.2	8.7	0.4	5.3	15.9	4.3	3.7	4.0	4.4	6.7	5.1	7.4	5.7	8.3	4.3	1.2	4.8	3.3	10.8	5.1	2.2	11.9	14.5	29.0	22.9	11.3	11.2	6.7	16.3	6.9	6.3
MCEMP1	"C19orf59, MGC132456"	ENSG00000183019	"Mast cell expressed membrane protein 1"	Q8IX19	19	7676628-7679826	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 36.5;bone marrow: 30.9;lung: 66.4;lymphoid tissue: 24.2"	"Group enriched"	"Detected in some"	6	"THP-1: 18.8;U-937: 58.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 2.9"	"Group enriched"	"Detected in some"	5	"classical monocyte: 36.5;neutrophil: 16.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 16.6;monocytes: 36.5"									HPA014731	Enhanced									"HPA014731: AB_1845619"	"unprognostic (4.84e-2)"	"unprognostic (9.81e-4)"	"unprognostic (2.41e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.62e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.15e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	2.2	0.3	0.3	10.0	0.5	30.9	0.5	0.4	0.9	0.1	0.3	0.0	0.0	0.1	0.1	0.2	0.3	1.2	0.2	4.8	0.2	0.2	0.6	1.3	66.4	11.8	2.9	0.0	0.4	0.4	0.0	0.1	0.8	0.6	0.4	0.0	0.1	0.6	0.0	0.2	0.1	0.3	2.4	0.9	24.2	0.6	0.7	0.3	0.3	0.7	0.0	0.1	0.5	2.9	0.0	5.3	16.6	36.5	0.2	0.1	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	36.5	0.9	0.1	2.1	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.1	16.6	0.2	0.1	0.3	0.1	11.6	0.3	0.5	0.4	0.9	0.2	0.2	2.9	0.0	0.6	0.3
ADORA2A	"ADORA2, RDC8"	ENSG00000128271	"Adenosine A2a receptor"	P29274	22	24417879-24442360	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 22.8;bone marrow: 28.1;brain: 43.9;lymphoid tissue: 59.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 15.0;Karpas-707: 20.7;RPMI-8226: 14.6;SK-BR-3: 29.7;U-266/70: 20.8;U-266/84: 27.1;U-698: 21.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	8	"basal ganglia: 43.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in some"	10	"basal ganglia: 357.5"	"Region enriched"	"Detected in single"	95	"basal ganglia: 166.0"	"CAB001943, HPA065566, HPA075997"	Enhanced	Supported								"CAB001943: , HPA065566: , HPA075997: AB_2732298"	"unprognostic (7.30e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.87e-3)"	"unprognostic (6.81e-4)"	"unprognostic (1.50e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.10e-3)"	1.0	2.4	1.9	10.4	43.9	28.1	1.5	3.4	3.8	0.8	2.0	1.7	0.3	5.4	1.4	1.4	1.0	0.9	2.4	3.5	2.4	1.8	3.5	4.3	5.1	14.8	2.6	1.6	1.2	0.8	0.0	2.1	1.4	2.3	1.6	0.8	3.3	2.7	1.5	1.2	0.9	2.6	0.7	1.3	7.5	2.8	2.0	5.7	59.0	1.3	0.9	8.6	3.8	1.3	17.7	1.1	13.7	9.0	2.2	22.8	11.2	0.2	0.3	0.4	0.1	0.2	0.1	0.4	0.2	9.3	0.5	0.9	1.7	0.1	15.0	1.0	0.2	0.3	0.9	0.0	0.0	1.8	2.6	0.2	0.0	2.1	0.1	0.3	7.5	0.1	0.0	2.8	0.0	3.3	0.1	20.7	0.0	0.2	5.2	1.6	0.6	0.0	0.1	0.7	14.6	0.0	0.1	1.5	8.7	0.4	29.7	0.1	0.3	1.4	0.2	0.9	1.4	0.2	0.1	20.8	27.1	21.2	4.7	5.1	0.1	3.0	0.8	4.8	8.6	2.6	20.1	9.6	16.1	16.9	1.1	17.7	22.8	18.3	13.7	2.2	9.0	1.1	21.4	11.2	1.9	43.9	3.4	3.8	2.4	1.8	2.6	1.6	2.3	5.7
AZU1	"AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC"	ENSG00000172232	"Azurocidin 1"	P20160	19	825097-832018	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 238.2"	"Cell line enriched"	"Detected in some"	7	"THP-1: 150.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"classical monocyte: 3.3;neutrophil: 7.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.6;monocytes: 3.3"					"Not detected"	"Not detected"			"HPA055851, HPA075964"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	290000	290000	Vesicles	Vesicles	"HPA055851: AB_2682943, HPA075964: "	"unprognostic (1.12e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-6)"	"unprognostic (1.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.04e-2)"	0.3	0.2	0.4	0.2	0.5	238.2	0.6	0.0	0.6	0.2	0.2	1.0	0.0	0.2	0.2	0.2	0.2	0.8	0.2	34.6	0.4	0.5	0.2	1.5	15.3	0.2	0.2	0.0	0.5	0.1	0.1	0.9	3.8	0.2	0.2	0.2	0.2	0.6	0.2	1.0	0.4	0.2	0.2	0.1	18.6	0.2	1.2	0.0	20.6	1.3	0.0	0.2	0.1	0.4	0.0	0.8	7.6	3.3	0.0	0.3	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	150.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	3.3	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	7.6	0.0	0.5	0.0	0.0	4.1	0.4	0.5	0.0	0.6	0.4	0.5	0.2	0.0	0.2	0.0
C17orf99	"GLPG464, UNQ464"	ENSG00000187997	"Chromosome 17 open reading frame 99"	Q6UX52	17	78146353-78166177	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"bone marrow: 13.5"	"Group enriched"	"Detected in some"	11	"HaCaT: 5.5;HMC-1: 11.3;K-562: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.2;non-classical monocyte: 1.1"	"Low lineage specificity"	"Detected in many"											HPA029655	Uncertain				"Secreted to blood"					"HPA029655: AB_10601691"	"unprognostic (3.55e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (9.77e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.38e-4)"	"unprognostic (6.58e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.78e-3)"	0.2	0.0	0.1	0.1	0.1	13.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.7	0.9	0.1	0.1	0.1	0.0	0.1	0.1	1.6	1.2	0.1	0.1	0.6	0.1	0.0	0.1	1.9	0.1	0.2	0.0	0.1	0.4	0.1	0.1	2.0	0.6	0.1	0.1	1.3	0.0	0.1	0.1	0.1	0.1	0.1	1.1	1.9	0.9	1.2	0.0	0.0	1.1	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	11.3	0.0	0.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CEBPE	CRP1	ENSG00000092067	"CCAAT/enhancer binding protein epsilon"	Q15744	14	23117304-23119616	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 87.1;bone marrow: 29.4"	"Group enriched"	"Detected in some"	4	"HL-60: 58.0;NB-4: 30.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	201	"eosinophil: 87.1"	"Lineage enriched"	"Detected in single"	237	"granulocytes: 87.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002928, CAB005113"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB005113: AB_631240, HPA002928: AB_1078494"	"unprognostic (1.33e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.19e-2)"	0.3	0.0	0.1	0.8	0.2	29.4	0.1	0.1	1.3	0.1	0.1	0.1	0.1	1.4	0.1	0.1	0.1	0.3	0.1	2.2	0.1	0.1	0.1	0.2	2.7	0.2	0.3	0.1	0.1	0.1	0.0	0.1	2.2	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	1.9	0.1	0.3	7.7	0.4	0.1	0.1	2.6	0.1	0.1	0.8	0.2	0.1	0.0	0.1	87.1	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	30.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.3	87.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	1.3	0.1	0.1	0.3	0.1	0.1	0.1
DEFA1	"DEF1, DEFA2, HNP-1, MRS"	ENSG00000206047	"Defensin alpha 1"	P59665	8	6977649-6980080	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"bone marrow: 825.5"	"Cell line enriched"	"Detected in single"	17	"NB-4: 6.6"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"											"CAB032548, HPA052517"	Enhanced				"Intracellular and membrane"					"CAB032548: AB_2277258, HPA052517: AB_2681860"																		1.3	0.1	0.2	0.1	0.6	825.5	0.6	0.0	0.4	0.1	0.1			0.1	0.4	0.1	0.1	0.1	0.1	2.3	0.2	0.2	0.2	6.0	41.9	0.3	0.3		0.1	0.1	0.1	1.0	0.6		0.1	0.1		0.6	0.1	0.5	1.8	0.1	0.1	0.0	115.5	0.1	0.1			0.6		0.1	0.1	0.0	0.1	0.3	0.5	0.7	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.1	0.0	0.2	0.0	0.3	0.7	0.0	0.3	0.0										
DEFA3	"DEF3, HNP-3"	ENSG00000239839	"Defensin alpha 3"	P59666	8	7015869-7018301	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"blood: 235.0;bone marrow: 924.7"	"Cell line enriched"	"Detected in single"	8	"NB-4: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	18	"neutrophil: 51.5"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 51.5"									HPA052517	Supported				"Intracellular and membrane"					"HPA052517: AB_2681860"					"unprognostic (8.21e-2)"													0.7	0.0	0.3	0.3	1.0	924.7	0.3	0.3	0.9	0.3	0.3	0.3	0.3	0.0	0.6	0.3	0.3	0.0	0.3	10.1	0.3	0.2	0.3	3.4	25.6	0.3	0.3	0.3	0.3	0.3	0.0	0.8	2.5	2.3	0.3	0.0	0.6	0.7	0.3	0.3	1.2	0.3	0.3	0.3	81.5	0.0	0.3	0.3	2.0	0.7	0.3	0.3	0.3	0.3	0.1	0.0	51.5	1.6	0.0	2.7	235.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	2.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	51.5	0.0	0.1	0.0	0.0	235.0	0.3	1.0	0.3	0.9	0.3	0.2	0.3	0.3	2.3	0.3
DEFA4	"DEF4, HP-4"	ENSG00000164821	"Defensin alpha 4"	P12838	8	6935822-6938338	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 245.5"	"Cell line enriched"	"Detected in some"	8	"THP-1: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 9.8"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 9.8"									HPA051266	Enhanced				"Secreted to blood"					"HPA051266: AB_2681414"																		0.3	0.0	0.1	0.1	0.2	245.5	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	35.0	0.1	0.1	0.1	1.5	8.9	0.5	0.1	0.0	0.4	0.0	0.0	0.4	3.5	0.4	0.0	0.0	0.1	0.3	0.0	0.2	0.2	0.0	0.2	0.0	26.5	0.0	0.0	0.0	8.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.3	0.0	0.7	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	16.8	0.1	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.0
FAM129C	"BCNP1, FLJ39802"	ENSG00000167483	"Family with sequence similarity 129 member C"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 37.2;bone marrow: 12.1;intestine: 12.3;lymphoid tissue: 37.9;salivary gland: 9.9"	"Group enriched"	"Detected in some"	22	"Daudi: 29.1;REH: 14.6;U-698: 18.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	226	"memory B-cell: 10.9;naive B-cell: 19.5;plasmacytoid DC: 37.2"	"Group enriched"	"Detected in many"	284	"B-cells: 19.5;dendritic cells: 37.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043277	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"	0.5	0.2	0.2	37.9	0.2	12.1	0.2	0.3	0.2	0.2	0.6	0.0	0.0	0.0	0.2	0.0	2.2	0.2	0.5	0.6	0.2	0.2	0.5	0.3	0.9	17.4	0.2	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.5	0.0	0.4	9.9	0.2	0.1	0.2	12.3	0.0	0.3	28.5	0.4	0.5	0.0	2.5	0.5	0.4	35.4	3.0	0.4	19.5	37.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.7	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0
HBB	"beta-globin, CD113t-C"	ENSG00000244734	"Hemoglobin subunit beta"	P68871	11	5225464-5229395	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"bone marrow: 3646.7"	"Cell line enhanced"	"Detected in some"		"HEL: 5.4;SCLC-21H: 4.7;SH-SY5Y: 5.9;U-266/70: 21.8;U-266/84: 3.6"	"Cancer enhanced"	"Detected in all"		"glioma: 244.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"neutrophil: 19.3;plasmacytoid DC: 9.9"	"Group enriched"	"Detected in many"	12	"dendritic cells: 9.9;granulocytes: 19.3"									"CAB009526, HPA043234"	Enhanced					15000000000	15000000000			"CAB009526: AB_2143058, HPA043234: AB_2678378"	"unprognostic (2.41e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.87e-3)"	"unprognostic (6.41e-2)"	32.7	20.0	20.9	10.1	21.0	3646.7	43.4	6.5	10.7	9.2	11.3	7.2	3.4	3.2	7.3	11.1	36.6	28.4	30.4	38.9	17.9	17.4	45.0	37.6	305.8	7.0	31.6	10.8	82.6	28.4	2.9	18.6	236.8	23.7	23.1	7.5	32.0	17.4	12.8	29.5	3.8	3.9	12.0	26.5	216.8	4.0	9.3	3.8	5.6	46.4	20.2	7.6	124.5	256.7	0.6	9.9	19.3	0.6	1.2	1.1	523.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.1	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.3	0.3	0.0	0.0	4.7	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	21.8	3.6	0.0	0.0	0.0	0.0	2.2	0.6	1.9	0.9	0.0	0.1	0.6	0.2	0.0	0.9	0.4	0.4	1.1	19.3	1.2	0.1	9.9	0.0	523.2	20.9	21.0	6.5	10.7	17.9	17.4	31.6	10.8	23.7	3.8
HBD		ENSG00000223609	"Hemoglobin subunit delta"	P02042	11	5232678-5243657	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 233.7"	"Group enriched"	"Detected in some"	5	"HEL: 30.6;U-266/70: 41.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB037087, HPA043234"	Supported					11000000000	11000000000			"CAB037087: AB_260051, HPA043234: AB_2678378"	"unprognostic (1.32e-2)"		"unprognostic (4.87e-2)"		"unprognostic (4.14e-2)"	"unprognostic (2.26e-3)"		"unprognostic (1.52e-1)"		"unprognostic (3.56e-2)"	"unprognostic (1.04e-1)"		"unprognostic (8.67e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.17e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.17e-1)"	1.6	0.2	0.4	0.3	0.6	233.7	0.8	0.1	0.5	0.2	0.2	1.5	0.0	0.2	0.4	0.2	0.9	0.5	0.2	4.3	1.3	0.4	1.4	3.9	22.5	0.2	1.0	0.0	1.1	0.2	0.2	1.3	12.0	0.8	0.5	0.2	1.0	0.9	0.2	1.0	0.2	0.2	0.2	0.4	29.6	0.2	0.2	0.0	1.2	4.4	0.0	0.4	1.7	11.9	0.0	0.5	0.8	0.0	0.0	0.0	31.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	30.6	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.6	7.3	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	31.6	0.4	0.6	0.1	0.5	1.3	0.4	1.0	0.0	0.8	0.0
IPCEF1	"KIAA0403, PIP3-E"	ENSG00000074706	"Interaction protein for cytohesin exchange factors 1"	Q8WWN9	6	154154496-154356792	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9"	"Group enriched"	"Detected in some"	5	"HMC-1: 19.3;THP-1: 9.8;U-937: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA028708, HPA028710"	Enhanced		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"				"Nuclear speckles, Plasma membrane"	"Nuclear speckles, Plasma membrane"	"HPA028708: AB_10601916, HPA028710: AB_2732442"	"unprognostic (1.23e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.51e-4)"	1.3	0.7	5.3	6.9	12.9	15.2	1.9	20.0	26.4	3.4	1.6	5.5	0.0	1.1	1.7	1.8	1.9	2.5	3.2	1.0	3.8	4.6	3.4	2.4	2.0	12.4	3.9	14.1	1.3	1.4	0.4	1.3	2.0	5.5	1.3	1.6	0.0	1.4	0.8	0.7	1.2	2.9	1.3	4.2	6.4	2.6	1.5	4.9	10.0	36.9	0.0	11.7	2.4	1.1	0.0	7.1	30.1	6.3	6.0	13.5	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	19.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.1	1.0	0.4	0.2	0.2	0.5	0.9	2.1	0.3	0.3	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.2	0.0	1.4	6.3	30.1	6.1	2.8	13.1	0.0	7.7	5.8	7.1	0.0	13.5	7.9	19.3	6.0	3.4	0.2	9.9	5.3	5.3	12.9	20.0	26.4	3.8	4.6	3.9	14.1	5.5	4.9
OR6N1		ENSG00000197403	"Olfactory receptor family 6 subfamily N member 1"	Q8NGY5	1	158747814-158772195	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"blood: 7.5;bone marrow: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	18	"basophil: 7.5"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.2	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0										
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821977	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6"	"Group enriched"	"Detected in some"	6	"NB-4: 23.5;THP-1: 49.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA052293: AB_2681787, HPA057034: AB_2683316"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.7	0.7	20.5	1.2	30.0	18.2	2.1	0.1	21.3	0.9	0.7	0.7	0.0	0.7	1.3	0.7	0.7	12.6	1.1	0.7	14.4	13.1	0.7	0.7	2.6	0.9	3.9	14.9	1.0	0.7	0.7	0.1	0.8	4.7	0.9	0.7	0.1	0.7	0.8	0.9	0.8	1.0	0.7	1.1	0.9	0.9	3.0	3.1	0.0	0.7	0.0	0.7	0.8	0.0	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	4.8	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.4	0.0	0.1	0.9	0.0	0.0	0.0	2.0	0.0	0.6	0.0	0.2	1.6	0.1	0.6	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.4	0.0	23.5	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	6.2	0.1	0.0	0.0	2.1	49.8	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	3.8	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	30.0	0.1	21.3	14.4	13.1	3.9	14.9	4.7	3.1
PRSS57	"PRSSL1, UNQ782"	ENSG00000185198	"Serine protease 57"	Q6UWY2	19	685546-695498	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 61.8"	"Group enriched"	"Detected in some"	13	"NB-4: 85.1;THP-1: 42.6"	"Cancer enriched"	"Detected in single"	10	"pancreatic cancer: 2.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 8.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (2.89e-1)"	"unprognostic (1.43e-1)"		"unprognostic (2.10e-1)"		"unprognostic (3.99e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.56e-2)"		0.3	0.2	0.0	0.0	0.0	61.8	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.6	0.0	3.9	0.0	0.1	0.2	0.8	4.0	0.1	0.1	0.0	0.9	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.1	0.0	0.2	0.0	9.3	0.3	0.0	0.9	0.0	0.2	0.0	2.2	8.7	1.6	3.1	4.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	85.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	8.7	1.6	0.0	0.6	0.3	0.0	0.0	0.0	4.5	2.2	0.0	0.0	0.8	1.0	3.1	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
SMIM35	TMPRSS4-AS1	ENSG00000255274	"Small integral membrane protein 35"		11	118003634-118088299	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Group enriched"	"Detected in some"	7	"blood: 4.6;bone marrow: 3.1;kidney: 3.4;lymphoid tissue: 1.7"	"Group enriched"	"Detected in some"	5	"Karpas-707: 14.3;RPMI-8226: 8.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"T-reg: 4.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.1;olfactory region: 4.3"																	"unprognostic (8.83e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.64e-1)"		"unprognostic (1.58e-1)"		"unprognostic (3.04e-4)"		"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"			"unprognostic (1.64e-1)"			"unprognostic (1.88e-1)"	0.0	0.0		1.2		3.1	0.4		0.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.4	0.0			3.4	0.1	0.0	1.7			0.0	0.0	0.0		0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		1.4	0.0	0.0			0.0		1.5	0.0		1.7	0.8	0.1	0.5	1.2	4.6	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	8.9	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.9	0.0	0.0	1.7	0.7	1.1	0.7	0.4	0.0	0.6	0.1	1.2	0.5	0.8	4.6	0.4										
SPN	"CD43, GPL115, LSN"	ENSG00000197471	Sialophorin	P16150	16	29662979-29670876	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 52.1;bone marrow: 33.1;lung: 25.0;lymphoid tissue: 79.7"	"Cell line enhanced"	"Detected in some"		"HEL: 54.9;HL-60: 48.8;HMC-1: 27.5;MOLT-4: 18.9;THP-1: 26.4;U-937: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 52.1"	"Low lineage specificity"	"Detected in all"											"CAB002666, HPA055244"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB002666: , HPA055244: AB_2682756"	"prognostic favourable (1.40e-4)"	"unprognostic (1.63e-3)"	"unprognostic (3.14e-2)"	"prognostic favourable (3.08e-5)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.02e-2)"	"unprognostic (4.17e-2)"	"prognostic favourable (1.88e-4)"	"unprognostic (1.70e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.72e-2)"	5.7	1.0	1.2	12.9	2.7	33.1	1.6	0.7	1.5	1.3	2.8	2.6	0.0	2.3	1.5	0.6	1.9	1.7	2.8	3.9	1.2	1.4	1.8	1.9	25.0	18.3	3.7	0.2	1.0	1.6	0.2	1.0	0.8	2.3	1.6	2.6	1.6	5.0	0.6	0.8	1.6	6.8	1.0	4.6	15.9	2.0	0.6	1.9	79.7	1.6	1.7	17.4	2.6	1.4	1.0	8.8	3.5	52.1	17.5	26.5	10.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.9	0.0	0.4	0.0	48.8	27.5	0.0	0.0	0.0	0.0	0.0	17.1	13.4	0.1	0.0	18.9	12.2	0.0	0.0	17.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.1	0.0	0.0	0.0	0.0	0.0	0.9	7.2	0.0	34.8	0.0	2.4	5.5	3.5	26.5	24.3	14.5	1.0	10.7	18.1	8.8	0.3	7.6	13.2	0.9	17.5	52.1	7.0	9.1	10.7	1.2	2.7	0.7	1.5	1.2	1.4	3.7	0.2	2.3	1.9
SPNS3	MGC29671	ENSG00000182557	"Sphingolipid transporter 3 (putative)"	Q6ZMD2	17	4433688-4488208	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 51.8;bone marrow: 23.1;lymphoid tissue: 15.1"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 4.7;NB-4: 16.0;THP-1: 17.3;U-698: 4.2;U-937: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 51.8;plasmacytoid DC: 25.1"	"Group enriched"	"Detected in many"	24	"dendritic cells: 25.1;granulocytes: 51.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023928	Uncertain									"HPA023928: AB_1844393"	"unprognostic (4.39e-2)"	"unprognostic (8.10e-5)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.94e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (8.09e-4)"	"unprognostic (6.18e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.69e-2)"	0.3	0.5	1.1	2.0	0.9	23.1	0.3	0.5	1.6	0.4	1.3	3.7	0.0	0.6	0.5	0.1	0.4	0.7	0.7	0.7	1.2	1.6	0.4	0.3	1.2	1.3	2.4	0.1	0.2	0.3	0.1	0.5	0.1	2.0	0.5	0.2	0.0	1.3	0.5	0.1	0.5	0.8	0.2	4.2	2.9	0.3	1.3	2.2	15.1	0.2	0.0	1.6	0.3	0.3	0.0	25.1	51.8	1.5	0.0	0.2	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	4.7	16.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	13.3	0.0	0.0	1.5	51.8	0.1	0.3	0.1	0.0	0.0	0.2	11.5	0.0	0.0	0.2	0.2	0.0	0.0	25.1	0.0	1.0	1.1	0.9	0.5	1.6	1.2	1.6	2.4	0.1	2.0	2.2
TSPO2	"BZRPL1, dJ34B21.2"	ENSG00000112212	"Translocator protein 2"	Q5TGU0	6	41042554-41044337	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"bone marrow: 32.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.2;Hep G2: 3.5;U-266/70: 1.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (1.89e-3)"	"unprognostic (8.35e-3)"	"unprognostic (2.57e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.76e-2)"	0.1	0.0	0.1	0.1	0.1	32.4	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.8	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	1.3	2.5	0.4	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.9	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	1.3	0.1	3.3	4.5	1.3	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.3	0.8	0.4	0.0	0.0	3.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.6	0.4	1.2	0.1	0.0	0.9	0.0	0.0	0.7	0.3	1.3	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.9	0.4	1.8	0.6	0.5	0.0	1.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
AC018755.2		ENSG00000268500			19	51612091-51646889	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	6	"blood: 50.4;bone marrow: 20.8"	"Group enriched"	"Detected in some"	11	"HMC-1: 40.3;U-937: 16.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"neutrophil: 50.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 50.4;monocytes: 17.5"									HPA009085	Approved									"HPA009085: AB_1079965"																		1.0	0.4	0.4	5.9	0.1	20.8	0.3	0.0	0.4	0.7	0.3			0.4	0.2	0.0	0.6	1.4	0.6	0.6	0.1	0.1	0.3	0.9	1.9	2.0	0.2		0.1	0.3	0.0	0.2	0.1		0.3	0.0		0.3	0.0	0.3	0.3	0.1	0.2	0.7	3.0	0.3	0.0			0.2		0.1	1.5	0.3	0.8	6.2	50.4	17.5	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	16.3	0.0	2.6	8.9	0.2	0.0	9.1	0.0	0.6	0.0	0.0	6.2	0.8	0.0	0.0	50.4	0.2	17.5	1.3	0.0	3.7										
AHSP	"EDRF, ERAF"	ENSG00000169877	"Alpha hemoglobin stabilizing protein"	Q9NZD4	16	31527864-31528803	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 189.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 7.5;K-562: 3.2;MOLT-4: 2.1;NTERA-2: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA040940	Enhanced					8400000	8400000			"HPA040940: AB_10796231"		"unprognostic (3.00e-1)"			"unprognostic (2.01e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.53e-1)"		"unprognostic (3.10e-1)"	"unprognostic (2.16e-1)"		"unprognostic (3.70e-3)"	"unprognostic (2.04e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.25e-2)"		0.6	0.1	0.3	0.3	0.4	189.3	0.9	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.3	0.1	0.2	0.1	0.1	4.0	0.2	0.2	1.0	3.5	20.0	0.1	0.7	0.0	0.8	1.1	0.1	1.1	30.2	0.2	0.5	0.1	1.0	0.1	0.1	0.7	0.3	0.1	0.1	0.3	18.9	0.1	2.8	0.1	1.1	2.1	0.0	0.1	1.5	0.8	0.3	0.2	0.8	0.1	0.0	0.2	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	9.2	0.3	0.4	0.0	0.1	0.2	0.2	0.7	0.0	0.2	0.1
ARHGDIB	"GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2"	ENSG00000111348	"Rho GDP dissociation inhibitor beta"	P52566	12	14942017-14961728	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"blood: 333.1;bone marrow: 150.7;lymphoid tissue: 221.4"	"Cell line enhanced"	"Detected in many"		"HEL: 101.6;HL-60: 118.9;HMC-1: 134.6;MOLT-4: 140.7;REH: 118.4;U-698: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018584, HPA051235"	Enhanced		Supported	Cytosol		120000000	120000000	Cytosol	Cytosol	"CAB018584: AB_647972, HPA051235: AB_2681398"	"unprognostic (2.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (4.97e-2)"	"prognostic favourable (3.42e-4)"	40.3	13.4	9.0	66.1	18.4	150.7	27.9	1.8	8.9	14.6	14.5	13.9	3.6	8.5	14.7	13.2	16.9	18.2	18.3	20.5	8.3	7.8	24.5	20.0	41.3	93.9	17.0	3.9	11.7	7.1	3.9	8.1	35.6	11.4	18.0	16.1	20.4	22.4	7.6	13.3	14.7	38.3	15.7	17.9	157.8	11.1	11.2	15.8	221.4	22.7	12.4	108.1	31.2	13.5	114.0	95.5	267.1	151.9	96.3	231.1	333.1	9.3	0.3	0.3	20.8	1.4	1.1	0.1	0.3	0.1	0.1	0.1	1.2	10.3	75.4	4.8	1.7	10.3	0.0	16.7	1.1	0.1	0.0	101.6	0.2	0.0	0.3	118.9	134.6	0.1	2.1	0.0	1.5	58.5	0.5	28.9	1.8	0.0	140.7	85.6	0.4	0.1	118.4	1.3	33.7	3.3	52.2	0.1	0.0	0.1	13.5	0.1	0.7	86.6	74.1	0.3	0.7	0.1	2.2	4.8	0.7	108.9	0.3	83.4	0.1	206.0	109.9	267.1	125.6	130.8	123.3	114.0	144.4	140.7	95.5	103.2	141.1	146.5	237.7	96.3	151.9	41.4	231.1	333.1	9.0	18.4	1.8	8.9	8.3	7.8	17.0	3.9	11.4	15.8
BIN2	BRAP-1	ENSG00000110934	"Bridging integrator 2"		12	51281038-51324668	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	6	"blood: 85.3;bone marrow: 38.0;lymphoid tissue: 24.8"	"Cell line enhanced"	"Detected in some"		"HEL: 23.3;HMC-1: 39.7;Karpas-707: 17.3;NB-4: 39.5;RPMI-8226: 15.5;THP-1: 33.5;U-937: 21.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038666, HPA038667"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA038666: AB_2676139, HPA038667: AB_2676140"	"unprognostic (8.44e-3)"	"prognostic favourable (1.33e-4)"	"unprognostic (2.48e-1)"	"prognostic favourable (6.34e-4)"	"unprognostic (4.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.65e-3)"	"unprognostic (4.03e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-1)"	4.6	1.8	3.5	12.3	4.7	38.0	1.7	1.8	2.0	2.3	3.3	3.6	0.7	2.2	1.4	2.8	2.2	1.4	3.6	2.2	3.1	2.1	2.5	3.1	7.7	23.9	4.4	0.9	1.8	2.3	0.0	1.7	8.4	3.2	1.8	3.6	1.5	4.7	0.6	1.9	2.0	3.3	2.3	4.1	18.3	2.6	3.5	3.9	24.8	1.9	0.7	17.5	4.4	1.9	10.5	17.1	85.3	59.9	35.8	47.7	61.4	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	23.3	0.0	0.0	0.0	9.7	39.7	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.1	6.7	39.5	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	9.3	0.0	2.3	0.0	21.9	0.0	85.3	30.9	37.4	47.7	49.0	38.5	8.1	32.4	39.8	17.1	10.5	25.3	33.5	61.0	35.8	59.9	6.3	40.9	61.4	3.5	4.7	1.8	2.0	3.1	2.1	4.4	0.9	3.2	3.9
CA1	Car1	ENSG00000133742	"Carbonic anhydrase 1"	P00915	8	85327608-85379014	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 156.0;intestine: 203.6"	"Cell line enriched"	"Detected in single"	1206	"HEL: 165.2"	"Group enriched"	"Detected in some"	10	"colorectal cancer: 3.4;stomach cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006558, CAB025790"	Enhanced					7800000000	7800000000			"CAB025790: , HPA006558: AB_1845989"	"unprognostic (1.44e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	1.8	0.4	0.5	11.5	0.5	156.0	0.4	0.3	0.4	0.3	95.4	1.5	0.0	0.0	0.3	0.0	0.6	0.7	0.0	17.6	0.5	0.4	0.8	2.9	32.2	0.2	0.9	0.0	0.8	0.5	0.0	1.0	24.0	0.6	1.1	203.6	2.6	0.3	0.1	3.1	0.2	0.4	3.2	0.5	14.3	0.3	0.3	0.0	0.2	7.5	0.0	0.2	4.5	16.0	0.7	0.7	0.0	0.3	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	165.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	7.5	0.5	0.5	0.3	0.4	0.5	0.4	0.9	0.0	0.6	0.0
CCL7	"FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7"	ENSG00000108688	"C-C motif chemokine ligand 7"	P80098	17	34270221-34272242	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adipose tissue: 11.5;bone marrow: 22.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 15.1;BJ hTERT+ SV40 Large T+: 3.2;BJ hTERT+ SV40 Large T+ RasG12V: 3.9;HSkMC: 4.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Low region specificity"	"Detected in many"												"Secreted to blood"						"unprognostic (7.66e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.53e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.54e-2)"	"unprognostic (9.54e-2)"		"unprognostic (4.18e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.99e-8)"	"unprognostic (2.83e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.79e-2)"	11.5	0.6	0.0	2.6	0.0	22.3	0.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.7	0.9	0.1	0.1	0.5	0.2	1.2	0.0	0.1	0.0	1.3	0.4	0.0	0.1	1.7	0.3	0.5	1.0	0.0	0.2	0.0	0.1	0.2	0.2	2.2	0.1	0.1	1.2	0.5	0.0	1.4	0.3	0.0	0.0	0.5	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	2.3	0.0	1.7	15.1	3.2	3.9	0.0	0.0	0.0	0.5	1.0	1.4	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	4.6	0.0	1.3	0.0	1.4	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.0
CIB3	KIP3	ENSG00000141977	"Calcium and integrin binding family member 3"	Q96Q77	19	16161368-16173525	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"blood: 5.4;bone marrow: 4.8;testis: 3.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.0;MCF7: 4.3;NB-4: 2.7;THP-1: 2.5;U-937: 4.0"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 0.9"					"Cell type enhanced"	"Detected in some"		"eosinophil: 5.4"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA043553	Uncertain									"HPA043553: AB_10964566"	"unprognostic (8.43e-2)"	"unprognostic (7.26e-5)"		"unprognostic (3.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.14e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.05e-1)"		"unprognostic (5.68e-2)"	"unprognostic (3.42e-1)"		"unprognostic (1.54e-2)"	0.0	0.0	0.0	0.8	0.0	4.8	0.7	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	3.8			0.0		0.7	0.1	0.0	0.1	0.6	5.4	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	9.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	2.7	0.4	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	4.0	0.0	1.9	0.1	5.4	0.0	0.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.1	0.4	0.0	0.1										
CXCL8	"3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1"	ENSG00000169429	"C-X-C motif chemokine ligand 8"	P10145	4	73740506-73743716	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 79.4;bone marrow: 300.7;lung: 106.1"	"Cell line enriched"	"Detected in many"	7	"BJ hTERT+: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	428	"neutrophil: 79.4"	"Lineage enriched"	"Detected in single"	794	"granulocytes: 79.4"					"Not detected"	"Not detected"			HPA057179	Supported				"Secreted to blood"					"HPA057179: AB_2683362"	"unprognostic (3.42e-1)"	"prognostic unfavourable (1.18e-5)"	"unprognostic (3.91e-3)"	"unprognostic (8.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.03e-3)"	"prognostic unfavourable (1.19e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.19e-1)"	"unprognostic (4.46e-1)"	"unprognostic (7.19e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (3.13e-6)"	"unprognostic (4.73e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.15e-2)"	13.4	1.6	1.8	21.9	1.9	300.7	1.7	0.4	1.5	6.5	1.4	0.8	0.0	0.5	4.5	0.9	6.7	3.9	18.9	17.7	1.3	1.1	2.4	8.4	106.1	2.3	2.4	0.9	4.4	4.3	0.3	1.1	9.6	7.8	4.3	1.0	1.9	7.4	0.3	2.9	0.5	1.6	1.4	5.5	1.6	2.8	13.5	1.1	1.0	1.1	9.3	7.7	27.9	1.5	0.0	0.0	79.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.4	0.0	1.8	288.7	2.6	8.5	0.0	0.9	0.0	39.6	0.0	3.4	0.0	0.0	41.2	0.1	0.0	0.0	0.0	0.4	0.5	2.6	0.1	0.9	0.1	8.6	0.2	8.9	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.4	0.0	0.0	0.0	22.9	1.2	0.0	0.0	0.1	0.0	3.9	0.0	0.3	22.2	4.1	0.3	1.1	3.7	0.0	0.0	0.1	18.6	2.1	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.4	0.0	0.0	0.0	0.0	0.0	1.8	1.9	0.4	1.5	1.3	1.1	2.4	0.9	7.8	1.1
FBXO5	"EMI1, FBX5, Fbxo31"	ENSG00000112029	"F-box protein 5"	Q9UKT4	6	152970519-152983579	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 29.3;lymphoid tissue: 69.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008106, HPA029048"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB008106: AB_828450, HPA029048: AB_10602132"	"unprognostic (1.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.43e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.25e-9)"	"prognostic favourable (8.65e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-1)"	4.2	2.9	2.7	13.7	3.1	29.3	3.5	6.6	3.3	5.3	6.1	1.8	1.8	3.5	5.8	3.7	6.1	4.4	3.0	2.4	2.8	2.3	3.0	4.1	3.8	10.8	4.4	1.6	5.1	3.1	2.0	3.4	8.2	3.5	3.9	4.1	1.6	6.9	2.4	1.6	3.3	5.0	3.9	2.4	10.6	3.5	4.2	3.9	69.0	5.6	4.8	11.2	3.5	4.5	6.8	5.3	0.0	3.5	8.8	7.9	3.2	11.0	5.7	24.2	16.3	1.8	3.8	7.7	26.8	12.1	20.2	22.8	11.8	6.6	27.0	8.2	7.1	10.6	19.1	8.9	24.3	14.4	17.1	27.1	8.5	12.7	3.6	24.1	16.7	2.7	1.7	13.6	10.7	9.2	28.5	25.4	18.3	8.4	27.5	15.6	14.1	8.5	23.3	19.4	17.4	7.1	6.0	15.9	16.5	19.0	10.3	5.0	7.4	22.7	6.9	15.2	19.8	17.5	31.2	8.5	9.4	39.9	11.0	18.0	18.3	0.0	2.4	0.0	3.8	3.0	5.4	6.8	6.3	6.9	4.6	6.0	6.2	6.4	0.0	8.8	3.5	5.3	7.9	3.2	2.7	3.1	6.6	3.3	2.8	2.3	4.4	1.6	3.5	3.9
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635277	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3"	"Group enriched"	"Detected in some"	4	"Daudi: 29.4;U-266/70: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"				"Plasma membrane"	"Plasma membrane"	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	20.8	2.6	2.2	23.6	4.5	73.6	5.6	1.1	4.2	2.9	2.8	1.5	4.2	1.6	4.0	2.3	2.2	6.3	5.3	8.5	2.6	2.3	3.0	4.2	30.9	34.1	6.6	1.7	1.9	2.4	0.4	1.2	3.3	4.2	2.5	1.8	2.1	2.9	2.6	4.4	1.7	3.7	6.4	4.8	54.3	2.5	2.6	4.1	1.9	2.9	2.5	7.8	5.1	6.1	13.3	28.9	40.8	68.0	36.3	29.6	55.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	10.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	54.6	0.7	2.2	0.0	6.7	0.0	3.1	52.4	32.3	29.6	68.0	1.7	7.7	2.6	13.6	28.9	13.3	1.3	12.8	40.8	36.3	55.6	1.3	0.1	55.0	2.2	4.5	1.1	4.2	2.6	2.3	6.6	1.7	4.2	4.1
FUT4	"CD15, ELFT, FCT3A, FUC-TIV"	ENSG00000196371	"Fucosyltransferase 4"	P22083	11	94543840-94549898	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 71.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 20.4;NB-4: 13.2;THP-1: 25.8;U-937: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB000014, CAB016129"	Enhanced		Supported	Vesicles				Vesicles	Vesicles	"CAB000014: , CAB016129: AB_626918"	"unprognostic (6.36e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (3.64e-4)"	"unprognostic (7.26e-2)"	"unprognostic (4.14e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.10e-3)"	5.5	2.4	5.5	6.1	6.2	71.3	6.3	3.0	6.0	4.4	8.3	6.7	4.7	10.9	5.9	2.5	3.0	4.6	7.5	3.7	6.2	2.2	4.1	3.0	6.0	5.4	8.1	2.5	4.9	11.4	1.4	2.9	3.4	4.8	3.4	8.3	3.8	6.3	2.9	1.7	1.9	10.1	5.8	5.7	6.5	9.7	2.9	4.5	10.4	2.9	1.9	3.1	4.4	3.0	0.7	1.9	2.5	3.9	0.8	1.9	0.8	1.6	0.8	1.0	0.0	3.1	2.8	5.1	1.4	0.7	1.3	1.5	6.9	2.2	0.0	3.5	2.4	0.8	1.6	0.1	1.2	10.5	1.6	5.2	1.1	0.1	1.6	20.4	4.6	2.4	0.0	1.7	0.0	2.0	5.2	0.0	1.5	0.7	4.2	13.2	1.9	1.9	3.8	0.0	0.0	1.4	1.1	1.4	0.5	0.8	2.1	0.8	1.2	25.8	1.9	1.0	2.9	0.0	0.5	0.6	0.3	0.0	0.9	18.3	0.6	2.0	3.1	2.5	1.1	1.5	0.7	0.6	1.0	1.3	1.8	0.7	1.1	0.7	1.7	0.8	3.9	1.9	1.9	0.8	5.5	6.2	3.0	6.0	6.2	2.2	8.1	2.5	4.8	4.5
GALR2	GALNR2	ENSG00000182687	"Galanin receptor 2"	O43603	17	76074794-76077541	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.5;intestine: 13.1;lymphoid tissue: 9.8;smooth muscle: 6.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.1;NTERA-2: 4.6;THP-1: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044513	Approved									"HPA044513: AB_10962510"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.32e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.14e-2)"	0.3	0.1	0.0	9.8	0.1	3.5	0.0	0.0	0.3	0.3	13.1	0.0	0.0	0.6	0.0	0.0	1.1	0.1	0.5	0.1	1.4	0.8	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.3	0.0	0.1	0.4	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.3	9.0	6.4	1.4	0.2	0.4	0.3	0.0	0.0	0.0	1.1	1.2	1.0	0.2	0.0	1.1	1.4	0.9	0.5	0.4	0.7	0.2	1.9	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.3	0.0	2.1	0.4	0.6	0.3	0.0	3.1	0.0	0.1	0.0	0.3	2.5	0.0	1.5	2.8	0.3	0.6	0.5	0.0	0.0	0.3	0.0	0.1	0.1	0.5	0.1	1.1	0.2	0.3	4.6	2.9	0.1	0.6	0.8	0.0	0.2	0.2	0.1	1.7	0.7	0.3	0.6	6.8	0.2	0.2	0.6	0.2	0.4	0.7	0.4	2.6	0.0	0.1	0.0	0.0	0.9	0.0	0.4	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.4	0.5	0.4	1.1	0.0	0.7	0.0	0.1	0.0	0.3	1.4	0.8	0.2	0.0	0.6	0.0
HASPIN	GSG2	ENSG00000177602	"Histone H3 associated protein kinase"	Q8TF76	17	3723903-3726699	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 7.5;lymphoid tissue: 26.7;testis: 26.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA027422, HPA030698"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA027422: AB_10601812, HPA030698: AB_2673575"	"unprognostic (1.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.75e-3)"	"unprognostic (3.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.65e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	1.2	0.3	0.3	11.8	0.6	7.5	1.8	0.5	0.3	0.5	1.5	0.2	0.0	2.2	0.3	0.4	2.8	0.6	1.3	0.6	0.2	0.2	0.8	0.4	2.6	5.8	0.4	0.0	0.4	0.5	0.0	0.3	1.3	0.2	0.7	1.5	0.2	1.0	0.0	1.2	0.9	3.6	0.4	1.2	4.9	1.7	26.7	0.3	26.7	0.7	1.7	7.3	0.8	1.0	2.8	1.5	2.1	0.6	0.0	1.2	0.4	7.5	8.2	7.6	8.6	0.5	1.0	6.4	6.9	5.3	13.7	13.5	6.4	3.1	18.5	4.0	3.8	12.3	13.7	6.7	13.1	0.1	11.5	9.2	6.7	3.8	0.3	5.3	9.5	0.6	0.5	10.3	6.4	6.2	8.1	16.3	6.9	3.9	10.7	3.1	6.7	5.7	11.1	9.6	5.0	2.0	5.3	3.1	4.5	6.1	4.2	2.4	4.2	5.0	3.2	6.1	7.0	6.8	12.1	3.1	3.5	9.0	3.6	7.7	7.3	0.4	0.6	2.1	0.2	0.5	0.2	0.7	0.8	0.0	1.1	2.8	1.2	0.2	0.2	0.0	0.0	1.5	0.1	0.4	0.3	0.6	0.5	0.3	0.2	0.2	0.4	0.0	0.2	0.3
HBA2	HBA-T2	ENSG00000188536	"Hemoglobin subunit alpha 2"	P69905	16	172876-173710	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 427.1;bone marrow: 1094.2"	"Group enriched"	"Detected in some"	18	"HEL: 157.4;K-562: 42.2"	"Cancer enhanced"	"Detected in all"		"glioma: 59.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 9.8;neutrophil: 33.6;plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 15.7;granulocytes: 33.6"									"CAB038417, HPA043780"	Enhanced					17000000000	17000000000			"CAB038417: , HPA043780: AB_2678667"	"unprognostic (1.57e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.92e-2)"	15.4	11.8	7.2	6.9	7.3	1094.2	7.6	4.1	4.1	4.1	4.1	4.1	4.1	1.1	4.1	4.1	4.1	7.7	5.8	19.5	5.8	6.2	24.3	17.7	38.4	4.1	11.2	4.1	4.1	4.1	0.5	8.9	128.7	4.1	4.1	1.3	4.1	9.2	5.6	17.7	0.9	4.1	4.1	9.3	98.3	1.9	4.1	4.1	4.1	12.5	4.1	4.1	4.1	20.1	1.4	15.7	33.6	0.9	1.5	3.0	427.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.1	1.6	1.3	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.9	9.8	3.0	0.0	0.1	1.4	0.3	0.2	1.4	0.8	0.8	2.6	33.6	1.5	0.0	15.7	0.0	427.1	7.2	7.3	4.1	4.1	5.8	6.2	11.2	4.1	4.1	4.1
ICAM4	"CD242, LW"	ENSG00000105371	"Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)"	Q14773	19	10286967-10288522	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 53.1;bone marrow: 13.7;lung: 13.5"	"Cell line enhanced"	"Detected in some"		"HEL: 35.3;HMC-1: 8.9;K-562: 18.3;NB-4: 15.2;U-937: 8.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.0;pons and medulla: 2.4"	"Cell type enriched"	"Detected in many"	5	"non-classical monocyte: 53.1"	"Lineage enriched"	"Detected in many"	6	"monocytes: 53.1"														"Intracellular and membrane"																							1.9	0.4	0.4	1.6	0.4	13.7	0.6	0.2	2.0	1.0	2.9	0.2	0.0	1.1	1.1	2.9	2.3	1.1	1.1	1.1	0.5	0.3	1.6	1.7	13.5	3.3	0.4	0.0	1.2	0.4	0.1	0.4	1.9	2.4	2.4	0.5	0.9	2.5	2.7	1.7	0.8	1.4	0.2	0.9	2.8	1.6	0.6	0.3	1.5	0.9	0.0	4.5	3.3	0.7	0.5	8.4	4.5	53.1	0.1	0.6	2.4	0.1	0.1	0.1	0.2	0.0	0.0	3.1	0.3	0.1	0.0	0.0	3.9	0.2	0.4	0.4	0.0	0.3	0.1	0.0	0.0	0.3	0.2	35.3	0.2	5.3	1.0	0.6	8.9	0.2	0.0	0.1	0.1	0.0	18.3	1.6	0.0	0.1	0.9	15.2	0.1	0.1	2.6	1.5	6.7	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.1	1.0	0.3	0.1	0.0	0.3	0.0	0.5	0.9	0.1	0.3	8.5	0.2	4.5	2.6	2.6	0.2	9.7	0.5	0.5	0.3	0.2	8.4	0.4	0.3	0.1	0.7	0.1	53.1	2.7	0.6	2.4	0.4	0.4	0.2	2.0	0.5	0.3	0.4	0.0	2.4	0.3
IFNB1	"IFB, IFF, IFNB"	ENSG00000171855	"Interferon beta 1"	P01574	9	21077105-21077963	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 1.8;bone marrow: 3.7;breast: 5.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 4.8;NB-4: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.8"					"Low region specificity"	"Detected in some"			CAB009386	Uncertain				"Secreted to blood"					"CAB009386: AB_2248817"	"unprognostic (2.38e-1)"									"unprognostic (2.60e-4)"								0.1	0.3	0.0	0.0	0.0	3.7	5.9	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0
KEL	"CD238, ECE3"	ENSG00000197993	"Kell blood group, metallo-endopeptidase"	P23276	7	142941114-142962681	"Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 21.1;testis: 36.4"	"Group enriched"	"Detected in some"	12	"HEL: 14.9;K-562: 12.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA064442			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA064442: "	"unprognostic (5.78e-3)"	"unprognostic (1.08e-5)"	"unprognostic (5.29e-3)"	"unprognostic (4.85e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.25e-3)"	0.2	0.0	0.9	2.5	1.1	21.1	0.2	0.2	0.4	0.4	0.2	0.3	0.2	0.0	0.2	0.2	0.6	0.1	0.2	0.2	1.4	0.7	0.4	0.2	1.4	5.0	2.0	0.2	0.2	0.2	0.0	0.2	1.1	0.3	0.2	0.0	0.3	2.5	0.2	0.2	0.0	0.5	0.2	4.4	3.8	0.0	36.4	0.3	0.4	0.2	0.2	3.7	0.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.1	0.1	0.0	0.0	0.5	0.2	0.3	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.1	0.2	0.4	1.4	0.7	2.0	0.2	0.3	0.3
KIF18B		ENSG00000186185	"Kinesin family member 18B"	Q86Y91	17	44924709-44947711	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 12.3;lymphoid tissue: 34.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024205	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol"				"Nucleoplasm, Microtubule ends"	"Nucleoplasm, Microtubule ends"	"HPA024205: AB_1852472"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.17e-1)"	"unprognostic (7.27e-3)"	"prognostic unfavourable (2.44e-6)"	"unprognostic (3.34e-3)"	"prognostic unfavourable (6.90e-4)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (8.18e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.69e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.68e-2)"	0.7	0.6	0.5	8.2	0.4	12.3	0.4	0.4	0.5	0.9	1.6	0.3	0.7	2.9	0.5	0.6	3.2	0.3	1.3	1.5	0.5	0.5	0.5	0.7	0.8	5.9	0.6	0.1	0.6	0.4	0.0	0.4	1.9	0.2	0.5	1.5	0.1	0.7	0.1	0.4	2.9	2.5	0.8	0.4	1.7	1.5	3.8	0.1	34.7	0.4	2.7	7.6	0.7	1.1	1.1	0.8	2.0	0.6	1.0	1.4	0.4	14.2	18.6	15.9	14.9	0.3	1.3	13.4	12.2	4.6	15.4	12.1	15.4	12.3	12.6	5.3	4.6	15.7	11.0	4.9	7.8	26.0	16.4	16.3	20.9	9.5	0.0	13.4	14.3	0.3	0.2	13.3	5.3	7.8	12.2	21.5	7.9	11.1	24.9	13.3	11.7	12.8	19.1	24.3	8.4	2.5	7.7	12.0	11.7	8.2	7.4	4.5	13.9	9.6	5.1	23.0	22.8	13.6	25.6	6.9	6.8	15.5	7.4	10.2	14.8	1.8	0.6	0.4	0.5	0.3	0.4	0.8	0.7	0.5	0.3	1.1	0.4	0.5	2.0	1.0	0.3	0.8	1.4	0.4	0.5	0.4	0.4	0.4	0.5	0.5	0.6	0.1	0.2	0.1
MMP8	CLG1	ENSG00000118113	"Matrix metallopeptidase 8"	P22894	11	102711795-102727050	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"bone marrow: 119.3"	"Cell line enriched"	"Detected in some"	8	"WM-115: 39.2"	"Cancer enriched"	"Detected in single"	17	"melanoma: 5.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.7"	"Group enriched"	"Detected in some"	32	"neutrophil: 1.4;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	32	"granulocytes: 1.4;monocytes: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021221, HPA022935"	Enhanced				"Secreted to extracellular matrix"	83000	83000			"HPA021221: AB_1854043, HPA022935: AB_1854044"	"unprognostic (3.03e-1)"	"unprognostic (8.49e-5)"	"unprognostic (1.08e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-2)"		"unprognostic (7.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.92e-2)"	"unprognostic (6.64e-3)"		"unprognostic (2.45e-6)"	"unprognostic (2.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.97e-1)"	"unprognostic (2.30e-2)"	1.9	0.1	0.2	0.2	0.4	119.3	0.3	0.1	1.7	0.1	0.2	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.1	9.0	0.2	0.3	0.4	0.8	12.6	2.6	0.3	0.0	0.9	0.9	0.1	0.6	1.4	0.2	0.1	0.1	0.1	0.3	0.1	0.6	0.3	0.1	0.2	0.3	18.7	0.2	0.1	0.1	5.2	1.9	0.0	0.1	0.2	7.6	0.0	0.0	1.4	4.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.9	0.0	0.0	1.7	0.2	0.4	0.1	1.7	0.2	0.3	0.3	0.0	0.2	0.1
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 64.0;blood: 63.2;bone marrow: 89.4;lymphoid tissue: 80.1"	"Cell line enriched"	"Detected in some"	12	"NB-4: 87.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	141	"neutrophil: 63.2"	"Lineage enriched"	"Detected in single"	339	"granulocytes: 63.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	57000000	57000000	Cytosol	Cytosol	"CAB000348: , CAB068199: , CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favourable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	64.0	0.5	0.6	38.6	0.7	89.4	4.3	0.4	0.6	0.8	1.2	0.1	0.0	2.8	0.6	0.2	0.9	1.5	0.6	4.0	0.5	0.6	1.4	2.0	13.3	80.1	0.6	0.0	2.7	1.4	0.0	0.8	2.6	0.5	0.6	0.8	0.5	12.5	0.0	1.3	1.3	4.2	0.3	0.5	53.7	2.5	2.7	0.0	23.6	1.3	2.3	44.5	4.5	2.9	0.0	0.0	63.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	7.3	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	87.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	2.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.6	0.5	0.6	0.6	0.0	0.5	0.0
NME8	"CILD6, NM23-H8, SPTRX2, TXNDC3"	ENSG00000086288	"NME/NM23 family member 8"	Q8N427	7	37848597-37900401	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 7.9;bone marrow: 13.4;testis: 11.3"	"Cell line enhanced"	"Detected in some"		"HEL: 1.6;HMC-1: 2.5;NB-4: 3.7;NTERA-2: 3.4;THP-1: 3.2;U-937: 9.8"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016416, HPA019259"	Enhanced									"CAB016416: , HPA019259: AB_1858475"	"unprognostic (7.44e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-8)"	"unprognostic (5.90e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	0.1	0.0	0.1	0.5	0.1	13.4	0.0	0.0	0.0	0.1	0.1			0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.2	0.2	0.1	0.1	0.5	0.4	0.4		0.0	0.0	0.0	0.0	0.1		0.1	0.0		0.0	0.0	0.0	0.3	0.1	0.0	0.8	1.9	0.1	11.3			0.0		0.2	0.0	0.0	0.0	7.9	3.8	1.9	0.2	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	9.8	0.0	0.0	1.9	1.5	0.7	0.4	0.0	0.0	0.1	1.3	1.5	0.0	0.0	0.7	3.8	0.2	0.0	7.9	0.0	0.8										
RFLNB	"Cfm1, FAM101B, MGC45871, RefilinB"	ENSG00000183688	"Refilin B"	Q8N5W9	17	439978-445939	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 48.4;bone marrow: 40.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.4;HMC-1: 66.0;NB-4: 21.1;U-937: 18.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"basophil: 48.4"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030879, HPA060388"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Actin filaments"	"Actin filaments"	"HPA030879: AB_2673643, HPA060388: AB_2732649"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (3.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-3)"	6.8	1.6	1.9	4.1	2.3	40.9	5.6	1.1	1.5	2.6	4.9			1.8	4.2	2.2	1.1	2.1	2.7	3.7	2.1	1.5	2.7	1.7	5.2	2.9	1.8		1.8	1.0	0.8	1.3	6.3		3.6	1.1		1.2	1.7	2.8	1.9	3.2	3.6	2.3	4.1	3.2	0.9			3.0		2.7	4.5	1.4	0.0	2.5	48.4	2.1	0.5	3.0	1.0	8.6	2.3	1.1	5.5	3.9	2.8	6.1	14.1	6.2	4.7	2.3	0.1	0.3	0.0	0.3	27.4	0.8	3.2	0.3	4.3	0.0	1.9	0.3	0.4	0.6	5.7	3.2	66.0	1.5	0.1	1.4	0.5	4.7	1.3	0.1	5.2	0.1	0.1	21.1	2.5	0.0	0.9	2.5	0.0	0.8	0.0	0.1	12.9	5.7	0.0	5.0	0.1	9.9	0.9	3.7	3.3	2.2	0.0	2.1	2.1	0.0	0.0	18.3	5.7	48.4	2.1	21.6	1.8	1.4	1.8	0.0	1.8	1.5	0.6	0.0	3.0	2.7	10.2	0.5	1.8	2.5	1.1	1.0										
TACC3	ERIC1	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1721490-1745176	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.8"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"				"Mitotic spindle, Centriolar satellite, Cytosol"	"Mitotic spindle, Centriolar satellite, Cytosol"	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	3.8	2.7	1.1	39.1	1.1	26.0	3.4	2.1	1.4	1.9	4.4	1.1	0.8	4.5	1.8	2.7	8.8	1.6	3.5	2.0	1.4	1.3	2.5	2.4	4.3	20.1	1.3	0.7	1.6	1.0	0.5	1.8	5.7	1.1	1.6	4.9	1.6	3.0	1.2	2.0	2.6	7.7	2.5	1.8	15.6	3.4	58.1	0.9	64.3	1.6	7.3	27.9	3.2	3.0	4.0	10.4	54.8	19.9	3.8	17.9	16.1	25.2	21.0	32.2	18.5	1.7	3.6	18.2	28.6	15.3	32.9	21.8	23.2	30.5	32.2	12.2	15.6	17.1	34.0	20.8	33.5	14.1	18.4	27.3	17.4	21.4	1.6	36.9	23.2	1.5	1.4	20.7	12.0	24.9	24.6	25.5	31.2	20.6	48.6	52.8	34.8	27.6	34.4	22.8	12.9	18.7	38.2	25.1	15.8	17.2	10.9	8.0	21.4	21.4	14.6	19.2	23.0	17.3	43.1	17.9	23.6	51.6	11.1	35.7	27.1	24.7	19.9	17.9	5.5	9.0	6.0	4.0	12.3	7.6	10.4	3.8	17.9	9.8	54.8	3.8	5.5	3.1	17.5	16.1	1.1	1.1	2.1	1.4	1.4	1.3	1.3	0.7	1.1	0.9
TBC1D10C	"Carabin, EPI64C, FLJ00332"	ENSG00000175463	"TBC1 domain family member 10C"	Q8IV04	11	67403915-67410089	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 55.4;bone marrow: 16.0;intestine: 14.5;lymphoid tissue: 35.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.8;HEL: 6.2;MOLT-4: 23.1;NB-4: 27.8;U-937: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA069743	Enhanced		Approved	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA069743: AB_2686186"	"prognostic favourable (3.83e-4)"	"prognostic favourable (4.20e-4)"	"unprognostic (9.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.28e-3)"	"prognostic favourable (1.86e-5)"	"unprognostic (6.22e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (4.35e-7)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.81e-2)"	1.3	0.4	0.7	20.8	0.8	16.0	0.7	0.4	0.4	0.9	3.0	0.4	0.7	2.4	0.5	0.6	1.6	1.3	1.5	0.8	1.1	0.3	1.9	1.5	5.2	22.4	0.5	0.8	0.6	0.5	0.0	0.4	0.7	0.4	1.1	0.4	1.4	3.6	0.2	0.4	0.4	14.5	0.2	0.8	35.0	3.1	0.7	0.9	27.1	4.6	1.0	27.8	1.8	1.8	39.1	13.1	52.5	30.6	25.9	55.4	49.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.4	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	23.1	27.8	0.0	0.0	2.6	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	5.0	0.0	11.5	0.0	33.2	10.0	52.5	51.1	23.7	36.2	37.6	44.5	44.7	13.1	39.1	46.8	42.3	49.1	25.9	30.6	11.0	55.4	49.2	0.7	0.8	0.4	0.4	1.1	0.3	0.5	0.8	0.4	0.9
TERT	"EST2, hEST2, TCS1, TP2, TRT"	ENSG00000164362	"Telomerase reverse transcriptase"	O14746	5	1253147-1295069	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.4;lymphoid tissue: 12.0;testis: 5.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 61.2;fHDF/TERT166: 58.1;HBEC3-KT: 118.1;hTEC/SVTERT24-B: 74.6;LHCN-M2: 33.7;TIME: 96.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA054641, HPA065897"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA054641: AB_2682554, HPA065897: AB_2685576"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (9.16e-4)"	"unprognostic (8.84e-11)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-1)"		"unprognostic (3.35e-1)"	0.0	0.0	0.0	7.1	0.9	3.4	0.0	0.0	0.2	0.1	1.1	0.0	0.0	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	1.0	0.4	5.0	0.0	12.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	30.6	61.2	0.5	0.0	23.3	4.2	7.9	0.1	0.1	0.7	0.0	58.1	0.0	0.2	118.1	5.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.2	0.0	3.0	74.6	0.8	0.2	0.6	0.1	33.7	0.0	0.2	1.6	0.4	0.2	0.8	0.0	0.8	3.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	96.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0
TMCC2	"FLJ38497, HUCEP11"	ENSG00000133069	"Transmembrane and coiled-coil domain family 2"	O75069	1	205228176-205273343	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 83.6;brain: 25.9"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.8;WM-115: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014254	Approved									"HPA014254: AB_1851326"	"unprognostic (2.59e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.18e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-5)"	"unprognostic (3.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.99e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.43e-3)"	2.6	4.5	22.2	2.3	17.4	83.6	1.8	22.7	24.0	2.4	2.0	16.5	0.0	2.2	2.8	1.9	2.1	2.5	2.2	2.5	25.9	16.8	2.5	1.8	2.5	2.2	25.4	13.3	4.2	2.0	3.7	3.3	7.9	22.4	2.2	1.9	9.3	2.3	2.3	6.4	2.9	2.5	2.4	24.1	5.6	2.2	3.4	14.2	0.0	2.1	0.0	2.0	2.1	2.2	0.0	0.0	1.1	0.0	0.0	0.3	4.4	1.6	0.8	1.5	3.4	0.6	0.2	0.8	2.0	0.9	2.1	1.6	0.2	0.2	1.5	0.3	0.6	2.8	1.0	0.5	0.6	4.2	3.2	5.5	0.4	0.1	0.3	0.3	2.9	0.3	0.1	1.1	0.0	0.3	3.4	2.2	0.8	0.1	0.0	0.8	3.7	4.7	2.2	3.7	7.7	0.4	0.1	26.8	3.8	0.2	0.0	6.9	0.6	0.4	0.6	1.4	2.2	3.6	2.2	3.8	1.5	1.0	1.2	0.5	8.9	0.0	0.0	1.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	4.4	22.2	17.4	22.7	24.0	25.9	16.8	25.4	13.3	22.4	14.2
AC008763.3		ENSG00000269711			19	7678501-7682854	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"blood: 51.4;bone marrow: 17.2"	"Group enriched"	"Detected in some"	5	"EFO-21: 8.9;HMC-1: 14.3;NB-4: 8.1;THP-1: 21.9;U-937: 16.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"basal ganglia: 2.8"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 51.4;neutrophil: 22.2"	"Low lineage specificity"	"Detected in many"																																							0.4	0.1	0.2	3.8	2.8	17.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	6.5	0.7	0.2	0.2	0.4	1.1	0.2	0.2	0.1	0.2	1.5	6.8	0.2	0.2	0.2	0.2	0.2	0.0	0.2	1.8	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.4	1.5	0.2	0.2	2.9	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	10.6	22.2	51.4	0.1	0.3	23.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	51.4	0.3	0.0	4.5	0.0	0.0	0.1	0.0	10.6	0.0	0.0	0.3	22.2	0.1	0.4	0.4	0.2	23.0	0.2	2.8	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
ARHGAP15	BM046	ENSG00000075884	"Rho GTPase activating protein 15"	Q53QZ3	2	143091362-143768352	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 52.0;bone marrow: 33.5;lymphoid tissue: 94.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.0;HEL: 25.0;HL-60: 35.3;MOLT-4: 23.3;NB-4: 27.3;THP-1: 37.2;U-698: 28.0;U-937: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA032125			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA032125: AB_10671370"	"unprognostic (1.59e-2)"	"unprognostic (2.40e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.62e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (6.95e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.94e-2)"	5.5	2.7	3.6	36.6	4.6	33.5	3.7	0.6	2.9	2.4	4.3	1.5	2.1	2.7	2.1	4.3	3.6	2.4	4.9	5.0	3.8	2.1	4.5	4.8	9.1	36.9	7.8	1.7	1.5	1.2	0.4	1.3	1.6	4.6	3.9	3.3	1.0	8.1	2.2	1.1	1.7	12.2	1.6	11.3	51.8	3.0	3.5	5.9	94.4	4.2	2.2	21.7	6.0	3.9	25.2	14.5	52.0	9.6	28.7	46.0	23.2	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	25.0	0.1	0.0	0.0	35.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	23.3	27.3	0.1	0.0	13.1	0.1	6.6	0.0	0.0	0.1	0.1	0.1	0.0	0.2	1.2	37.2	0.1	0.1	0.8	0.0	0.0	0.3	0.1	28.0	0.2	18.7	1.0	38.6	8.6	34.9	26.6	8.8	42.3	25.2	46.0	33.3	14.5	22.5	33.9	28.4	52.0	28.7	9.6	14.4	36.5	23.2	3.6	4.6	0.6	2.9	3.8	2.1	7.8	1.7	4.6	5.9
ARHGAP45	"HA-1, HMHA1, KIAA0223"	ENSG00000180448	"Rho GTPase activating protein 45"	Q92619	19	1065923-1086628	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 32.1;bone marrow: 35.2;intestine: 23.4;lung: 17.5;lymphoid tissue: 50.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 30.7;THP-1: 27.4;U-266/70: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019816	Enhanced					2200000	2200000			"HPA019816: AB_1853923"	"unprognostic (1.34e-1)"	"unprognostic (5.13e-3)"	"unprognostic (5.17e-3)"	"prognostic favourable (6.02e-4)"	"unprognostic (2.26e-1)"	"prognostic favourable (7.82e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.59e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.33e-2)"	4.9	2.8	2.8	28.3	3.8	35.2	4.3	0.9	2.2	2.1	4.8	3.8	0.6	4.4	2.1	2.6	3.2	3.3	5.4	2.7	3.0	2.2	4.6	3.5	17.5	42.2	5.4	1.2	1.2	1.5	0.5	2.5	5.8	3.9	3.2	1.7	3.2	6.7	1.5	1.2	2.0	23.4	2.0	4.9	50.4	6.1	1.7	4.6	45.0	4.3	1.8	38.4	4.3	4.3	9.3	9.4	15.7	9.2	11.3	32.1	21.0	3.2	0.6	0.0	3.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	8.7	4.2	21.9	0.9	0.0	2.9	0.6	0.1	0.0	16.0	0.3	2.9	6.0	1.0	0.1	14.2	17.3	0.0	0.9	0.0	0.0	0.0	1.9	30.7	0.0	0.2	15.8	12.7	2.3	1.6	15.3	0.1	21.7	0.0	0.0	0.1	0.0	5.0	0.0	1.3	1.0	27.4	1.4	0.0	0.6	0.0	0.0	40.4	17.3	17.5	0.1	21.4	1.6	2.7	9.2	9.8	20.4	9.0	17.8	7.3	23.2	24.2	9.4	9.3	32.1	23.3	15.7	11.3	8.4	5.6	18.2	21.0	2.8	3.8	0.9	2.2	3.0	2.2	5.4	1.2	3.9	4.6
BPI	BPIFD1	ENSG00000101425	"Bactericidal/permeability-increasing protein"	P17213	20	38304123-38337505	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 197.4"	"Cell line enhanced"	"Detected in some"		"BJ: 1.3;BJ hTERT+: 2.1;HL-60: 5.1;RPMI-8226: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"classical monocyte: 13.6;neutrophil: 6.4"	"Group enriched"	"Detected in many"	18	"granulocytes: 6.4;monocytes: 13.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061284	Enhanced				"Secreted to blood"					"HPA061284: AB_2684465"	"unprognostic (9.30e-4)"	"unprognostic (5.49e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.83e-6)"	"unprognostic (2.66e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (9.47e-3)"	0.2	0.1	0.0	0.1	0.1	197.4	0.2	0.1	0.8	1.8	0.1	0.3	0.0	0.1	0.6	0.5	0.1	0.2	0.2	15.3	0.0	0.0	0.6	0.5	6.0	0.1	0.0	0.0	1.7	0.1	0.1	0.5	2.8	0.3	0.2	0.1	0.2	0.3	0.4	0.6	0.3	0.1	0.1	0.1	10.5	0.1	41.7	0.1	5.3	1.3	0.0	0.1	0.1	0.7	0.0	0.5	6.4	13.6	0.0	0.0	6.7	0.0	0.0	0.6	0.0	0.1	0.2	0.0	1.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	13.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.5	0.0	0.0	6.7	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.3	0.1
C12orf71	LOC728858	ENSG00000214700	"Chromosome 12 open reading frame 71"	A8MTZ7	12	27081058-27082514	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 4.1;bone marrow: 3.8;skin 1: 2.5;testis: 7.4"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 5.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	23	"NK-cell: 4.1"	"Lineage enriched"	"Detected in single"	23	"NK-cells: 4.1"									HPA058728	Uncertain									"HPA058728: AB_2683800"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.78e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-8)"	"unprognostic (4.85e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.1	0.0	0.1	0.4	0.1	3.8	0.2	0.8	0.3	0.4	0.1			0.2	0.1	0.0	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.3	0.0		0.1	0.3	0.0	0.1	0.0		0.2	0.0		0.3	0.0	0.5	2.5	0.4	0.0	0.0	0.5	0.1	7.4			0.1		0.0	0.2	0.2	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.3	0.5	0.2	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	5.7	0.0	1.2	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.3	0.9	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.3	0.0	0.4	0.1	0.9	0.0	0.6	0.3	0.1	0.0	0.1	0.0	0.6	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0										
CD300LF	"CD300f, CLM1, IGSF13, IREM1, NKIR"	ENSG00000186074	"CD300 molecule like family member f"	Q8TDQ1	17	74694311-74712978	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 47.8;bone marrow: 18.2;lung: 24.1;lymphoid tissue: 29.1"	"Group enriched"	"Detected in some"	6	"THP-1: 15.6;U-937: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 47.8"	"Group enriched"	"Detected in many"	46	"dendritic cells: 13.5;granulocytes: 47.8;monocytes: 38.1"									HPA013712	Supported									"HPA013712: AB_2668874"	"unprognostic (6.51e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-2)"	"unprognostic (8.51e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.79e-2)"	3.3	1.0	1.2	9.8	3.1	18.2	0.9	1.5	1.3	0.8	2.3	3.1	0.0	2.7	0.7	0.7	0.9	1.1	1.9	2.4	1.3	1.2	1.1	1.5	24.1	15.6	3.8	0.5	0.9	0.9	0.0	1.0	2.1	2.6	1.4	2.6	0.8	1.9	0.3	0.5	0.5	3.4	2.3	5.8	29.1	1.0	0.7	2.4	1.1	0.8	0.0	4.2	2.8	0.8	0.0	13.5	47.8	38.1	0.7	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	30.2	0.0	8.4	20.2	47.8	0.0	34.4	0.1	0.0	0.0	0.0	13.5	0.0	0.0	0.0	15.9	0.7	38.1	1.4	0.0	8.2	1.2	3.1	1.5	1.3	1.3	1.2	3.8	0.5	2.6	2.4
CEACAM4	CGM7	ENSG00000105352	"Carcinoembryonic antigen related cell adhesion molecule 4"	O75871	19	41618971-41627074	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 41.5;bone marrow: 22.5;lymphoid tissue: 30.2"	"Cell line enriched"	"Detected in some"	6	"U-937: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 41.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 41.5"																				"unprognostic (1.10e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-9)"	"unprognostic (3.65e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.34e-1)"	1.8	0.5	0.2	5.5	0.5	22.5	0.5	0.1	1.0	0.4	0.5	0.1	0.2	0.4	0.4	3.3	1.0	1.0	1.6	3.4	0.9	0.3	2.2	1.2	6.4	30.2	1.7	0.1	0.5	1.5	0.0	0.7	1.1	0.9	0.9	0.3	1.6	0.9	0.2	0.3	0.3	1.4	1.2	1.2	27.5	0.8	0.6	0.3	1.0	0.4	0.0	1.4	0.9	0.5	0.1	7.9	41.5	10.3	0.0	3.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	10.3	1.8	0.0	7.5	0.0	0.1	0.4	0.0	7.9	0.0	0.2	0.0	41.5	0.0	3.2	0.0	3.5	3.5	0.2	0.5	0.1	1.0	0.9	0.3	1.7	0.1	0.9	0.3
CEACAM8	"CD66b, CGM6"	ENSG00000124469	"Carcinoembryonic antigen related cell adhesion molecule 8"	P31997	19	42580241-42595055	"CD markers, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 71.0;placenta: 35.6"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 4.2;non-classical monocyte: 3.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.2;monocytes: 3.0"									CAB033676	Approved				"Intracellular and membrane"	15000000	15000000			"CAB033676: AB_1125678"		"unprognostic (2.01e-1)"	"unprognostic (4.52e-2)"		"unprognostic (3.31e-1)"			"unprognostic (6.30e-2)"		"unprognostic (2.68e-1)"	"unprognostic (1.62e-1)"		"unprognostic (1.71e-2)"	"unprognostic (7.77e-2)"		"unprognostic (9.62e-2)"		0.2	0.0	0.1	0.0	0.1	71.0	0.1	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	6.6	0.1	0.1	0.1	0.4	4.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	35.6	0.1	0.0	0.1	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.1	10.1	0.0	0.1	0.1	1.9	0.1	0.0	0.0	0.0	0.7	0.5	0.1	4.2	3.0	0.6	0.4	4.1	0.8	0.2	1.1	2.1	0.0	0.5	0.3	1.3	0.0	0.0	0.1	0.2	0.4	1.2	0.3	0.5	0.5	0.0	0.3	0.0	0.2	0.3	0.5	0.7	0.7	0.1	0.8	0.6	0.0	0.1	0.1	0.1	0.0	0.7	1.5	0.0	0.3	0.4	0.9	0.5	0.1	0.5	0.5	1.3	0.4	0.5	0.7	0.8	0.1	0.3	1.2	1.3	0.9	0.8	1.4	0.3	1.5	0.5	1.5	1.3	0.7	0.8	1.3	0.7	0.6	0.5	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.5	0.3	0.4	4.2	0.6	3.0	0.1	0.1	4.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664588	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 19.5;lymphoid tissue: 67.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	1.6	1.5	1.0	10.7	1.3	19.5	1.1	0.4	0.9	2.1	5.6	0.3	0.0	4.6	1.2	1.7	9.4	0.8	0.4	1.7	0.6	0.6	1.0	0.8	3.2	6.2	0.6	0.5	1.4	0.6	0.0	0.4	6.4	0.8	0.7	4.5	0.4	1.9	0.0	0.5	4.7	6.4	1.6	1.5	3.8	2.3	9.4	0.6	67.5	0.6	7.6	7.6	1.4	2.9	0.3	0.3	0.0	0.0	0.7	1.9	0.2	32.2	18.3	39.5	20.6	1.5	2.0	15.4	20.0	8.2	12.0	11.9	14.5	20.0	30.8	11.9	11.1	20.1	24.3	13.1	20.5	26.8	15.3	25.3	28.1	20.7	0.2	35.7	13.8	0.7	1.0	17.3	20.0	12.6	22.7	18.4	21.5	12.3	21.1	14.3	35.0	8.1	22.5	55.8	10.1	11.8	8.0	18.5	25.2	27.0	18.0	10.4	21.5	13.7	16.5	21.9	25.8	18.1	41.3	14.2	15.3	29.6	9.5	25.8	19.3	0.0	0.0	0.0	0.4	0.0	0.1	0.2	1.4	0.4	0.3	0.3	1.9	0.8	0.0	0.7	0.0	0.3	1.7	0.2	1.0	1.3	0.4	0.9	0.6	0.6	0.6	0.5	0.8	0.6
CORO1A	"coronin-1, HCORO1, p57"	ENSG00000102879	"Coronin 1A"	P31146	16	30182827-30189076	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 204.4;bone marrow: 94.9;lymphoid tissue: 99.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 85.3;HL-60: 59.6;HMC-1: 103.1;MOLT-4: 57.6;NB-4: 68.1;RPMI-8226: 89.9;U-698: 55.7;U-937: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046473, HPA051132"	Enhanced		Approved	Cytosol		130000000	130000000	Cytosol	Cytosol	"CAB046473: AB_10602363, HPA051132: AB_2681355"	"unprognostic (4.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (3.86e-2)"	"prognostic favourable (6.91e-4)"	"unprognostic (2.41e-1)"	"prognostic favourable (4.42e-4)"	"unprognostic (1.99e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.26e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (5.74e-7)"	"unprognostic (2.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	6.4	4.9	12.7	58.9	10.8	94.9	4.4	7.8	13.6	2.9	5.0	6.0	0.2	8.3	3.0	3.0	4.7	5.9	8.6	4.8	10.4	7.8	4.9	3.8	13.7	99.8	9.6	8.2	2.2	2.7	0.6	3.0	4.8	7.3	3.3	2.9	2.2	12.3	1.6	1.3	3.4	28.7	4.1	9.0	92.0	8.5	1.1	7.5	86.0	3.6	3.2	64.8	15.8	3.1	41.6	67.7	204.4	67.5	39.1	66.4	101.2	0.2	0.3	1.0	2.0	0.0	0.0	0.5	0.2	0.0	0.5	0.2	0.0	0.6	85.3	0.5	0.0	0.4	0.4	1.0	0.1	27.3	0.2	9.0	0.0	1.3	0.1	59.6	103.1	0.3	0.0	0.4	0.0	0.1	0.1	43.9	0.3	7.2	57.6	68.1	0.4	0.6	31.3	1.6	89.9	0.1	0.4	1.6	1.2	0.2	10.3	0.2	0.1	34.7	0.1	0.4	0.8	0.2	0.2	34.1	45.0	55.7	0.3	75.5	0.6	52.5	58.3	204.4	53.7	67.5	50.5	41.6	48.4	52.2	67.7	41.6	46.6	48.1	105.8	39.1	66.3	38.2	66.4	101.2	12.7	10.8	7.8	13.6	10.4	7.8	9.6	8.2	7.3	7.5
CST7		ENSG00000077984	"Cystatin F"	O76096	20	24949230-24959928	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 120.9;bone marrow: 160.2;lymphoid tissue: 51.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 15.7;HMC-1: 44.0;NB-4: 43.2;U-937: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"gdTCR: 120.9"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 2.3"	"Low region specificity"	"Detected in all"			HPA040442	Enhanced				"Secreted to blood"	12000	12000			"HPA040442: AB_2676988"	"prognostic favourable (6.55e-4)"	"prognostic favourable (7.90e-4)"	"unprognostic (9.37e-2)"	"prognostic favourable (9.17e-6)"	"unprognostic (2.38e-2)"	"prognostic favourable (5.85e-5)"	"unprognostic (1.00e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.84e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.42e-2)"	"prognostic unfavourable (4.37e-6)"	"unprognostic (7.64e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.45e-1)"	"unprognostic (7.62e-2)"	4.9	0.9	0.8	9.7	0.9	160.2	1.4	0.9	1.0	2.5	1.9	0.1	0.5	1.1	2.2	1.8	2.4	4.6	10.7	6.2	0.9	0.8	1.6	3.5	23.0	30.4	4.0	0.0	2.2	1.1	0.2	0.9	1.6	0.7	3.5	1.0	3.2	1.3	0.7	1.9	1.2	3.7	1.0	1.2	51.3	1.6	1.7	0.2	6.6	1.6	2.5	15.4	6.0	11.8	0.3	2.5	29.8	0.2	53.9	120.9	42.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	15.7	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	43.2	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	77.6	0.0	5.0	0.2	0.8	120.9	0.2	67.5	0.3	18.3	84.3	2.5	0.3	4.0	52.3	29.8	53.9	0.2	0.6	10.5	42.2	0.8	0.9	0.9	1.0	0.9	0.8	4.0	0.0	0.7	0.2
DOK3	FLJ22570	ENSG00000146094	"Docking protein 3"	Q7L591	5	177501907-177511274	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 47.5;bone marrow: 51.8;lymphoid tissue: 50.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 40.5;HMC-1: 33.0;REH: 50.0;U-698: 40.1;U-937: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 47.5"	"Group enriched"	"Detected in many"	6	"B-cells: 12.7;granulocytes: 47.5;monocytes: 23.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA077312	Enhanced					750000	750000			"HPA077312: AB_2732339"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (3.82e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	6.9	2.4	2.7	22.6	7.1	51.8	4.7	2.7	3.3	1.4	2.4	1.5	0.4	3.6	1.4	2.5	2.4	3.3	2.4	2.2	3.6	2.2	2.3	4.0	10.9	26.3	6.1	0.7	2.0	1.8	0.4	1.4	4.0	4.1	2.1	1.8	2.3	4.1	1.0	1.3	1.0	10.8	2.4	7.6	50.0	2.9	3.1	2.9	1.9	1.7	0.6	21.7	4.8	1.5	12.7	4.8	47.5	23.2	0.1	0.1	7.8	1.4	2.2	1.5	1.8	0.9	0.1	3.9	1.2	0.2	3.9	3.6	3.3	0.6	40.5	0.9	1.0	2.5	3.3	2.1	1.9	7.3	4.4	6.6	5.1	0.6	0.3	15.2	33.0	0.5	1.3	4.4	0.4	0.6	4.5	17.8	1.4	3.7	0.7	19.3	3.8	3.9	50.0	3.0	0.3	1.2	1.5	2.1	1.4	0.5	0.6	1.8	3.5	21.7	0.9	3.7	3.5	1.9	1.4	3.6	3.9	40.1	0.7	28.9	0.6	4.7	20.6	19.9	0.1	20.4	0.1	12.7	0.0	0.1	4.8	6.7	0.0	0.0	47.5	0.1	23.2	0.3	0.0	7.8	2.7	7.1	2.7	3.3	3.6	2.2	6.1	0.7	4.1	2.9
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD8 T-cell: 1.5;T-reg: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028016, HPA032023, HPA032031"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	Nucleoplasm	"HPA028016: AB_10611958, HPA032023: AB_2674114, HPA032031: "	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavourable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	1.3	0.7	0.4	5.4	0.6	10.8	1.3	0.4	0.5	1.2	2.8	0.3	0.1	1.7	1.0	0.6	4.0	0.4	1.5	0.6	0.4	0.4	0.8	1.0	1.6	4.4	0.4	0.1	0.6	0.5	0.6	0.7	5.4	0.2	0.6	4.2	0.2	1.1	0.1	0.4	1.6	3.3	1.4	0.4	4.6	1.1	37.2	0.1	41.2	0.9	5.7	7.5	0.9	1.6	0.7	0.3	0.0	0.4	0.6	5.2	0.7	12.5	10.7	18.4	9.2	1.1	2.3	9.0	15.8	9.8	14.9	22.3	6.6	11.1	9.5	5.9	6.0	9.8	24.2	13.3	21.6	11.5	11.6	15.2	14.1	8.1	0.0	19.9	9.5	1.0	0.4	24.2	12.9	6.8	18.1	19.4	17.2	5.0	26.6	9.1	21.2	12.4	21.1	32.4	18.4	4.2	8.7	11.5	18.0	15.0	14.4	6.5	12.2	9.1	3.7	15.0	11.2	15.4	17.7	7.1	11.1	22.0	7.6	13.2	14.5	0.0	0.0	0.0	0.6	0.4	0.0	0.7	0.8	1.5	0.3	0.1	0.0	0.3	0.0	0.6	0.0	0.0	5.2	0.7	0.4	0.6	0.4	0.5	0.4	0.4	0.4	0.1	0.2	0.1
EPB42	"MGC116735, MGC116737, PA"	ENSG00000166947	"Erythrocyte membrane protein band 4.2"	P16452	15	43197227-43221125	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 54.8;placenta: 16.1"	"Cell line enriched"	"Detected in single"	92	"HEL: 42.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040261	Supported		Uncertain	Nucleoplasm,Cytosol		7500000	7500000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA040261: AB_10673441"	"unprognostic (8.45e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.47e-3)"	7.5	0.4	0.4	0.4	0.9	54.8	1.3	4.3	1.0	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.4	0.5	0.6	1.9	0.4	0.9	0.5	0.9	5.5	0.3	0.5	0.3	0.8	0.3	0.3	0.3	16.1	0.7	0.5	0.3	0.3	0.3	0.3	1.3	1.1	1.0	0.3	0.3	5.3	0.5	2.4	0.3	0.5	1.2	0.3	0.5	1.6	4.5	0.0	0.3	0.2	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	4.2	0.4	0.9	4.3	1.0	0.4	0.9	0.5	0.3	0.7	0.3
FCN1	FCNM	ENSG00000085265	"Ficolin 1"	O00602	9	134905890-134917963	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 318.5;bone marrow: 135.4"	"Group enriched"	"Detected in some"	7	"NB-4: 15.3;U-937: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 318.5;intermediate monocyte: 218.1"	"Lineage enhanced"	"Detected in many"		"monocytes: 318.5"									"HPA000685, HPA001295, CAB016760"	Enhanced				"Secreted to blood"	63000000	63000000			"CAB016760: , HPA000685: AB_1078840, HPA001295: AB_1078842"	"unprognostic (1.57e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.66e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (1.73e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.28e-1)"	6.6	0.9	0.6	35.2	0.7	135.4	2.2	0.4	1.0	1.8	2.0	0.4	0.0	0.1	1.6	7.8	1.0	3.6	2.9	7.6	0.5	0.6	2.3	4.6	24.9	23.5	2.3	0.1	3.5	1.6	0.0	0.7	9.2	0.9	1.6	1.0	3.0	1.7	0.3	2.7	0.7	1.3	8.1	1.2	47.3	2.2	1.0	0.5	6.8	1.6	1.1	3.6	8.5	1.6	0.8	93.9	53.7	318.5	0.4	0.6	273.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	15.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.2	0.0	22.8	0.0	1.2	318.5	3.0	0.5	218.1	0.6	0.8	0.2	0.3	93.9	0.2	0.3	0.3	53.7	0.4	99.0	2.5	0.3	273.0	0.6	0.7	0.4	1.0	0.5	0.6	2.3	0.1	0.9	0.5
FOXD4L1	FOXD5	ENSG00000184492	"Forkhead box D4 like 1"	Q9NU39	2	113498665-113501155	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 2.2;bone marrow: 3.0;brain: 3.3;lymphoid tissue: 1.2;testis: 3.1"	"Cell line enhanced"	"Detected in some"		"RH-30: 5.2;THP-1: 3.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	22	"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	22	"B-cells: 2.2"									HPA012836	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA012836: "	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.02e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.41e-4)"	"unprognostic (2.54e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.54e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.18e-8)"	"unprognostic (1.57e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.91e-4)"	0.2	0.5	0.4	1.2	1.2	3.0	0.1	3.3	0.8	0.0	0.0			0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.6	0.6	0.4	0.1	0.4	0.4	0.3		0.0	0.2	0.0	0.4	0.1		0.2	0.1		0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.2	3.1			0.2		0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.6	1.0	0.0	1.5	0.0	0.6	0.0	0.1	0.3	0.0	2.0	0.9	0.1	0.1	0.6	0.0	0.1	1.9	1.3	0.7	1.0	0.9	0.0	2.1	1.6	0.0	0.7	0.2	0.0	0.0	1.2	1.7	0.3	0.1	0.3	0.9	0.0	0.7	0.6	5.2	0.7	0.1	0.6	0.7	0.4	0.5	0.1	0.2	0.4	3.7	0.4	1.7	1.5	0.6	1.3	1.3	1.3	0.7	0.3	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GCA	GCL	ENSG00000115271	Grancalcin	P28676	2	162318840-162371595	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 112.7;bone marrow: 116.0;brain: 30.2;lymphoid tissue: 51.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 41.1;neutrophil: 112.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 112.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035033, HPA035034"	Enhanced		Supported	"Plasma membrane,Cytosol"		890000	890000	Cytosol	Cytosol	"HPA035033: AB_10669854, HPA035034: AB_10669900"	"unprognostic (9.62e-2)"	"unprognostic (9.76e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.32e-2)"	13.1	6.8	13.4	24.8	21.3	116.0	7.8	6.9	15.8	6.0	7.7	15.3	3.2	8.2	4.6	11.0	5.0	7.2	9.7	11.2	15.9	13.0	8.5	7.6	15.6	51.8	26.0	9.7	4.4	11.5	4.8	8.1	10.6	24.6	5.7	8.6	3.7	6.9	4.9	2.2	3.7	7.8	7.7	30.2	50.0	10.3	10.7	20.8	5.8	7.4	2.5	10.3	10.0	6.3	3.1	8.9	112.7	18.2	0.3	1.3	8.4	1.3	2.1	5.8	0.0	1.4	1.2	0.2	2.1	6.1	3.4	6.2	4.8	16.3	1.9	15.0	0.1	0.8	2.2	6.9	4.2	9.1	9.2	17.1	1.5	9.1	1.7	21.4	5.0	1.5	2.4	3.1	0.7	0.4	0.3	6.6	0.2	16.8	0.4	12.4	3.7	8.3	7.4	1.4	9.6	17.9	9.6	3.8	6.5	2.8	12.6	10.6	8.6	9.6	0.4	0.8	6.2	9.7	3.2	6.3	11.7	0.3	5.3	8.4	4.0	4.4	18.2	41.1	0.4	10.7	0.5	3.0	0.6	0.6	8.9	3.1	1.1	0.7	112.7	0.3	8.0	2.2	1.3	8.4	13.4	21.3	6.9	15.8	15.9	13.0	26.0	9.7	24.6	20.8
GMFG		ENSG00000130755	"Glia maturation factor gamma"	O60234	19	39328353-39342372	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 276.5;bone marrow: 80.9;lymphoid tissue: 109.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 77.0;Karpas-707: 59.8;NB-4: 43.6;REH: 49.0;THP-1: 76.8;U-937: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Uncertain	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		1500000	1500000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA002954: AB_1078997"	"unprognostic (1.22e-2)"	"prognostic favourable (7.35e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.93e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (9.11e-6)"	"unprognostic (3.01e-1)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.27e-3)"	22.6	6.1	7.3	29.6	7.4	80.9	16.8	2.2	4.8	6.0	8.8	4.0	1.7	5.3	4.4	9.4	6.4	7.3	8.7	7.5	6.0	4.9	9.4	9.7	28.5	42.2	8.6	2.3	4.7	3.6	1.1	3.1	18.0	5.8	6.1	7.9	4.9	8.1	2.3	5.4	4.2	17.8	6.8	8.2	86.0	5.9	2.9	5.6	109.5	9.8	7.0	37.1	11.1	7.5	39.1	57.2	276.5	79.4	41.6	88.0	106.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.8	33.5	0.3	0.0	0.2	0.0	0.1	0.1	11.3	0.0	36.5	0.0	0.5	0.6	39.0	77.0	0.1	0.0	0.0	0.1	2.0	1.3	59.8	0.3	0.0	35.5	43.6	0.0	0.0	49.0	0.4	21.9	0.0	5.2	0.1	0.0	0.1	0.2	0.2	0.1	76.8	20.0	0.0	0.4	0.1	0.1	3.4	11.6	38.3	0.2	52.7	0.3	185.2	79.4	178.1	37.7	72.3	40.0	39.1	56.7	46.6	57.2	35.0	55.9	46.4	276.5	41.6	78.9	22.2	88.0	106.7	7.3	7.4	2.2	4.8	6.0	4.9	8.6	2.3	5.8	5.6
GYPB	"CD235b, GPB, MNS, SS"	ENSG00000250361	"Glycophorin B (MNS blood group)"	P06028	4	143996104-144019345	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"bone marrow: 37.1"	"Cell line enriched"	"Detected in some"	4	"HEL: 59.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Intracellular and membrane"																							0.2	0.0	0.2	0.1	0.1	37.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.8	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.2	3.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	6.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.2	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1
HBA1	HBA-T3	ENSG00000206172	"Hemoglobin subunit alpha 1"	P69905	16	176680-177522	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 1020.7"	"Group enriched"	"Detected in some"	37	"HEL: 243.0;K-562: 171.3"	"Cancer enhanced"	"Detected in many"		"glioma: 6.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 11.7;plasmacytoid DC: 7.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 7.4;granulocytes: 11.7"									"CAB032534, HPA043780"	Enhanced					17000000000	17000000000			"CAB032534: AB_2294993, HPA043780: AB_2678667"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.87e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.56e-2)"	12.6	8.8	7.1	5.0	6.6	1020.7	5.0	7.9	10.0	2.2	3.2	3.0	2.2	1.3	2.2	4.1	2.8	4.8	4.0	16.9	5.2	5.1	20.6	15.7	30.3	8.1	10.1	5.8	4.9	2.2	0.9	7.5	104.1	3.3	4.8	1.4	4.5	6.7	3.3	9.4	1.9	2.2	5.1	7.9	101.4	1.6	6.7	2.2	2.2	9.3	2.2	2.2	3.4	9.4	0.6	7.4	11.7	0.5	0.9	2.1	186.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	243.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	171.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	3.3	1.9	0.0	0.0	0.6	0.2	0.7	0.7	0.4	0.7	2.1	11.7	0.9	0.0	7.4	0.0	186.1	7.1	6.6	7.9	10.0	5.2	5.1	10.1	5.8	3.3	2.2
HBM	"HBAP2, HBK"	ENSG00000206177	"Hemoglobin subunit mu"	Q6B0K9	16	153892-166768	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 109.8;placenta: 50.2"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									400000	400000								"unprognostic (1.30e-1)"										"unprognostic (7.59e-2)"			0.9	0.2	0.4	0.2	0.5	109.8	0.3	0.1	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.6	0.2	0.2	4.4	0.3	0.4	1.7	2.6	16.5	0.2	0.7	0.0	1.6	0.2	0.2	1.1	50.2	1.2	0.5	0.2	1.2	0.2	0.2	0.4	0.2	0.2	0.2	0.4	17.5	0.2	0.2	0.0	1.0	2.0	0.1	0.3	2.1	4.9	0.1	0.5	0.5	0.0	0.9	0.4	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.0	10.5	0.4	0.5	0.1	0.2	0.3	0.4	0.7	0.0	1.2	0.0
HBQ1	HBQ	ENSG00000086506	"Hemoglobin subunit theta 1"	P09105	16	180453-181181	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 8.0;bone marrow: 29.4;brain: 12.2;vagina: 10.7"	"Group enriched"	"Detected in some"	7	"HEL: 13.1;Hep G2: 9.1;K-562: 32.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"granulocytes: 2.5;T-cells: 2.3"					"Low region specificity"	"Detected in all"			HPA062473	Enhanced		Approved	"Lipid droplets"		47000	47000	"Lipid droplets"	"Lipid droplets"	"HPA062473: AB_2684774"		"unprognostic (4.24e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.02e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.55e-1)"	0.5	0.6	12.2	0.5	10.0	29.4	0.5	0.6	6.3	0.5	0.5	0.2	0.0	0.6	0.5	0.5	0.5	0.5	0.5	0.9	5.6	4.0	0.5	0.5	2.1	0.5	2.2	3.7	0.6	0.5	0.5	0.5	2.6	2.4	0.6	0.5	0.0	0.8	0.5	0.9	0.5	0.5	0.5	0.7	2.8	0.5	1.3	0.3	0.0	0.5	0.0	0.5	0.6	10.7	0.4	0.2	2.5	0.0	0.0	2.3	8.0	0.0	0.7	0.2	2.4	0.0	0.0	0.4	0.1	0.0	0.0	0.1	2.2	0.0	0.0	0.3	0.0	0.1	0.9	0.0	0.0	0.0	0.0	13.1	0.5	9.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	32.4	0.0	0.0	0.1	1.4	0.0	1.8	0.1	0.1	0.0	0.2	0.4	0.0	0.3	1.8	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	2.3	0.4	0.7	1.6	0.1	0.0	0.5	1.2	2.5	0.0	0.0	0.2	0.0	8.0	12.2	10.0	0.6	6.3	5.6	4.0	2.2	3.7	2.4	0.3
HIST1H1E	"H1.4, H1e, H1F4, H1s-4"	ENSG00000168298	"Histone cluster 1 H1 family member e"	P10412	6	26156354-26157107	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 56.4;bone marrow: 102.3;lymphoid tissue: 123.9"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 9.7;U-266/70: 11.8;U-266/84: 13.2;U-87 MG: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011506, HPA055907"	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"CAB011506: AB_470256, HPA055907: AB_2682966"	"unprognostic (6.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.72e-13)"	"unprognostic (4.54e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.18e-2)"	6.7	3.6	3.1	14.3	3.5	102.3	10.3	8.1	9.0	10.7	7.7	4.7	4.2	4.1	6.8	7.5	13.7	4.0	11.3	7.4	4.0	3.5	6.6	6.7	13.1	18.4	3.4	2.4	19.3	17.1	3.7	9.0	7.3	3.5	10.2	4.4	9.8	10.0	4.0	4.1	14.4	9.0	7.4	6.8	14.6	5.3	5.9	0.7	123.9	4.6	10.0	18.4	14.3	10.7	39.6	14.6	56.4	12.9	19.2	24.4	9.4	2.4	0.3	0.4	5.2	0.1	0.0	6.3	0.0	0.4	1.1	0.8	0.1	1.5	1.2	0.7	0.1	1.1	0.3	0.7	0.5	1.7	1.5	0.8	0.5	0.4	0.1	0.7	1.0	0.1	0.3	0.3	0.5	0.5	3.9	6.7	0.1	0.5	7.7	7.1	1.8	0.8	3.6	1.2	9.7	0.3	0.0	3.8	0.9	3.1	0.8	1.1	1.0	2.5	0.4	2.4	3.6	1.4	2.4	11.8	13.2	5.3	12.1	2.1	1.1	56.4	12.7	30.0	21.1	12.9	24.4	21.4	16.7	19.2	14.3	39.6	12.7	11.6	18.6	19.2	10.9	14.6	16.4	9.4	3.1	3.5	8.1	9.0	4.0	3.5	3.4	2.4	3.5	0.7
KCNQ5	Kv7.5	ENSG00000185760	"Potassium voltage-gated channel subfamily Q member 5"	Q9NR82	6	72621792-73198851	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 6.6;brain: 23.0;skeletal muscle: 26.1;thyroid gland: 6.9"	"Cell line enhanced"	"Detected in many"		"BJ: 20.1;HL-60: 17.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016655	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA016655: AB_1855557"	"unprognostic (4.91e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.09e-2)"	"unprognostic (8.55e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.39e-3)"	0.7	2.8	4.2	3.0	14.9	6.6	1.1	0.6	19.6	0.6	0.9	0.0	0.0	0.8	0.7	0.6	1.7	1.0	0.9	0.6	6.9	2.7	0.6	0.8	0.8	3.4	3.0	7.5	0.7	0.6	0.6	0.5	1.0	23.0	2.4	0.9	2.2	2.1	1.9	26.1	0.6	0.9	1.7	0.9	2.0	0.8	2.0	0.7	1.6	6.9	0.4	3.1	1.2	0.7	2.7	0.5	1.2	0.0	2.2	1.7	0.2	2.5	0.6	0.0	0.1	0.0	0.9	0.0	20.1	3.0	3.0	2.6	0.0	0.0	12.0	0.0	6.8	0.4	0.1	1.2	3.6	0.1	4.2	13.1	0.0	0.0	0.5	17.6	0.0	0.2	0.5	8.6	9.0	0.0	0.7	8.3	5.9	0.1	0.0	7.5	0.7	4.2	0.0	0.6	8.2	1.1	0.0	3.4	1.6	0.0	0.0	8.2	2.5	1.3	0.0	12.5	5.5	0.0	13.3	8.7	0.2	5.5	0.1	8.5	0.7	1.2	0.0	0.0	0.2	0.0	1.1	2.7	0.5	1.5	0.5	1.4	1.7	1.2	0.0	2.2	0.0	0.0	0.0	0.2	4.2	14.9	0.6	19.6	6.9	2.7	3.0	7.5	23.0	0.7
KIF14	KIAA0042	ENSG00000118193	"Kinesin family member 14"	Q15058	1	200551497-200620734	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 9.0;lymphoid tissue: 34.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038061, HPA058220"	Uncertain		Supported	"Midbody ring,Cytosol"				Cytosol	Cytosol	"HPA038061: AB_10669515, HPA058220: AB_2683642"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavourable (8.64e-4)"	"unprognostic (8.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-5)"	"unprognostic (2.31e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.28e-3)"	"unprognostic (3.31e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.44e-2)"	0.4	0.6	0.2	2.7	0.4	9.0	2.6	0.3	0.3	0.7	2.0	0.4	0.2	1.8	0.4	0.5	3.8	0.2	0.2	0.5	0.3	0.3	0.4	0.8	1.2	4.7	0.2	0.2	0.3	0.3	0.0	0.2	2.8	0.6	0.6	1.8	0.4	0.9	0.2	0.2	1.4	2.4	0.8	0.6	2.0	1.1	4.5	0.2	34.4	0.3	0.6	4.9	0.8	1.3	0.5	0.1	2.4	0.2	0.7	1.9	0.2	15.5	9.2	14.6	8.1	0.4	1.7	8.1	10.7	6.3	10.3	9.3	5.5	8.1	9.4	3.8	5.1	12.4	11.6	7.1	14.8	11.5	6.1	15.1	13.1	5.4	0.0	23.6	8.6	0.3	0.3	11.4	9.8	7.2	22.6	12.3	12.7	6.3	13.8	7.4	12.3	8.1	12.7	19.3	12.0	3.4	4.4	6.9	7.7	15.1	5.2	6.2	7.0	6.1	5.9	8.1	9.7	8.8	18.6	4.5	4.5	13.8	4.7	12.7	16.5	2.4	0.1	0.1	0.1	0.2	0.1	0.5	0.5	0.4	0.0	0.4	0.2	0.1	0.5	0.7	0.1	0.1	1.9	0.2	0.2	0.4	0.3	0.3	0.3	0.3	0.2	0.2	0.6	0.2
LST1	"B144, D6S49E, LST-1"	ENSG00000204482	"Leukocyte specific transcript 1"	O00453	6	31586124-31588909	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 115.3;bone marrow: 60.9;lymphoid tissue: 72.4"	"Cell line enhanced"	"Detected in some"		"HEL: 11.6;HMC-1: 22.7;MOLT-4: 11.5;NB-4: 23.7;THP-1: 56.8;U-937: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 38.4;eosinophil: 60.8;intermediate monocyte: 95.8;myeloid DC: 34.1;neutrophil: 99.1;non-classical monocyte: 115.3"	"Group enriched"	"Detected in all"	12	"dendritic cells: 34.1;granulocytes: 99.1;monocytes: 115.3"																				"unprognostic (1.08e-2)"	"prognostic favourable (7.89e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.65e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (5.97e-5)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (7.62e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.95e-1)"	4.6	3.1	5.2	14.9	7.3	60.9	2.4	1.0	4.0	1.5	3.3	7.7	0.2	4.2	1.3	3.9	1.9	2.2	2.8	3.2	4.9	5.4	2.8	11.9	16.2	25.7	9.7	1.9	2.3	1.6	0.7	2.2	7.0	6.2	2.7	2.6	2.6	3.0	1.7	1.0	2.3	4.1	4.2	13.6	72.4	2.8	0.9	6.6	12.6	1.5	1.2	5.8	4.1	1.7	1.9	34.1	99.1	115.3	1.6	7.0	35.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.1	0.1	0.1	3.7	0.0	11.6	0.0	0.0	0.2	8.5	22.7	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	11.5	23.7	0.0	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	30.2	0.0	8.6	38.4	60.8	0.8	95.8	7.0	1.9	1.3	1.7	34.1	1.8	0.9	0.8	99.1	1.6	115.3	6.0	0.9	35.7	5.2	7.3	1.0	4.0	4.9	5.4	9.7	1.9	6.2	6.6
MLNR	GPR38	ENSG00000102539	"Motilin receptor"	O43193	13	49220338-49222377	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"bone marrow: 3.9;stomach 1: 2.8;thyroid gland: 5.6"	"Cell line enhanced"	"Detected in some"		"A549: 1.5;NTERA-2: 3.0;THP-1: 9.0"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 2.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"														"unprognostic (9.75e-2)"	"unprognostic (2.13e-2)"		"unprognostic (2.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.03e-2)"		"unprognostic (7.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.38e-1)"		0.1	0.1	0.2	0.0	0.2	3.9	0.0	0.0	0.1	0.3	0.2			0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.5	0.1	0.0	0.0	0.0		0.1	0.1	0.0	0.4	0.0		0.1	0.0		0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.1	2.8	0.4			5.6		0.0	0.0	0.1	0.0	0.0	0.7	0.6	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.8	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0										
MYO1F		ENSG00000142347	"Myosin IF"	O00160	19	8520790-8577577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 64.9;bone marrow: 50.6;lung: 17.1;lymphoid tissue: 56.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 15.2;HL-60: 15.0;HMC-1: 26.5;NB-4: 59.1;THP-1: 44.0;U-937: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 64.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055242	Enhanced					8800	8800			"HPA055242: AB_2682754"	"unprognostic (4.86e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.35e-2)"	7.6	3.7	4.8	22.9	9.1	50.6	3.6	1.0	4.6	2.2	4.3	7.5	0.4	4.6	2.1	4.7	2.7	5.4	6.5	4.0	5.2	3.1	3.7	6.2	17.1	24.8	9.0	1.7	2.5	2.3	0.6	2.3	4.8	6.9	3.3	2.3	3.5	3.3	1.3	1.2	1.8	8.5	3.9	9.9	56.1	3.9	1.3	7.0	4.2	2.7	1.8	11.1	6.8	2.5	1.5	15.4	64.9	23.7	7.5	14.9	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.0	0.0	15.2	0.0	10.9	0.0	0.0	0.0	15.0	26.5	0.1	0.0	0.0	0.0	0.0	0.1	7.1	0.0	0.0	0.0	59.1	0.0	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	44.0	3.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	24.3	0.0	14.4	23.7	24.5	14.9	19.6	11.6	1.5	5.9	10.2	15.4	0.7	0.4	4.6	64.9	7.5	22.4	1.9	8.1	18.6	4.8	9.1	1.0	4.6	5.2	3.1	9.0	1.7	6.9	7.0
NCAPH	"BRRN1, CAP-H, hCAP-H"	ENSG00000121152	"Non-SMC condensin I complex subunit H"	Q15003	2	96335787-96373845	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 17.2;lymphoid tissue: 41.3;testis: 60.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 5.6;T-reg: 8.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.6;T-cells: 8.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA002647, HPA003008"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA002647: AB_1078300, HPA003008: AB_1078301"	"unprognostic (5.52e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"prognostic unfavourable (9.53e-6)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (3.16e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.30e-2)"	1.3	1.1	0.8	13.2	0.9	17.2	1.7	0.7	1.2	1.5	3.9	0.7	0.4	2.9	0.7	1.1	7.4	0.4	1.0	0.8	0.8	0.7	0.9	0.9	1.5	10.6	1.0	0.6	0.8	0.6	0.1	0.5	3.4	1.0	0.7	5.1	0.6	1.9	0.4	0.6	2.7	3.5	1.4	1.2	6.7	2.1	60.4	0.8	41.3	0.6	6.4	12.2	1.7	2.2	1.3	0.5	5.6	1.0	0.1	8.7	0.8	30.9	11.8	29.9	15.5	1.1	1.6	19.8	14.7	10.3	28.4	30.0	21.8	17.4	28.9	10.4	6.4	14.0	25.6	10.0	30.5	25.4	17.0	29.8	12.3	19.6	0.2	27.5	25.5	0.5	1.1	22.0	9.3	11.2	20.6	21.5	13.4	14.6	40.4	28.7	21.4	14.9	31.4	27.2	23.5	5.6	12.0	17.8	13.6	8.5	12.0	5.2	8.8	20.4	6.5	21.0	32.1	19.6	23.7	11.5	16.3	30.8	9.1	27.6	23.7	5.6	0.0	0.3	1.3	1.0	0.2	1.3	1.9	1.5	0.5	0.9	0.0	0.7	0.3	0.1	0.0	0.0	8.7	0.8	0.8	0.9	0.7	1.2	0.8	0.7	1.0	0.6	1.0	0.8
NCF4	"p40phox, SH3PXD4"	ENSG00000100365	"Neutrophil cytosolic factor 4"	Q15080	22	36860988-36878015	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 130.3;bone marrow: 69.0;lymphoid tissue: 66.0"	"Cell line enhanced"	"Detected in some"		"HEL: 18.2;HMC-1: 86.9;NB-4: 30.8;REH: 15.8;RPMI-8226: 30.6;THP-1: 29.0;U-937: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 58.0;eosinophil: 76.4;neutrophil: 130.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 130.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010146, HPA036156, HPA057975"	Enhanced		Enhanced	Cytosol				Cytosol	Cytosol	"CAB010146: AB_627989, HPA036156: AB_2674974, HPA057975: "	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (7.06e-8)"	"unprognostic (3.60e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-1)"	10.4	5.8	4.4	24.8	5.6	69.0	5.6	0.7	2.8	3.4	7.4	2.5	1.2	5.0	2.2	8.1	4.4	5.9	7.2	8.0	3.9	2.2	4.4	4.2	17.5	21.2	8.0	1.0	3.3	2.1	0.6	2.6	10.3	4.6	5.1	5.3	4.2	6.5	2.2	2.6	2.3	16.0	4.3	7.7	66.0	3.9	3.0	5.4	5.0	3.5	2.8	22.2	9.0	7.1	12.6	10.0	130.3	19.5	0.4	10.8	10.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	18.2	0.0	0.0	0.0	2.6	86.9	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.0	30.8	0.0	0.0	15.8	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	16.1	0.0	58.0	19.5	76.4	0.2	9.6	1.1	12.6	3.9	0.8	9.1	8.9	0.2	0.2	130.3	0.4	6.4	10.0	10.8	10.2	4.4	5.6	0.7	2.8	3.9	2.2	8.0	1.0	4.6	5.4
NUSAP1	"ANKT, BM037, FLJ13421, LNP, NuSAP1, PRO0310p1, Q0310, SAPL"	ENSG00000137804	"Nucleolar and spindle associated protein 1"	Q9BXS6	15	41332694-41381050	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 38.3;lymphoid tissue: 123.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.3"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042904, HPA074847"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	Nucleoplasm	"HPA042904: AB_2678220, HPA074847: AB_2732269"	"unprognostic (1.19e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.14e-1)"	"prognostic unfavourable (6.27e-4)"	"unprognostic (8.49e-3)"	"prognostic unfavourable (6.82e-14)"	"unprognostic (4.76e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.22e-1)"	3.2	12.9	0.7	20.3	1.3	38.3	3.8	0.7	0.9	2.9	5.4	1.1	4.4	5.8	1.5	2.8	16.1	0.9	2.5	2.7	0.7	0.7	2.5	4.2	5.7	16.5	0.9	0.5	4.2	3.0	0.0	0.6	9.2	0.9	1.8	6.5	0.8	3.6	5.6	4.4	6.0	6.3	2.2	1.2	7.4	4.1	8.6	0.6	123.4	0.8	9.7	19.4	2.9	5.3	2.7	3.1	6.4	1.4	1.7	16.3	3.1	37.0	12.4	41.3	19.6	2.2	3.6	13.7	29.6	17.5	32.7	31.7	16.8	19.3	19.2	16.5	11.1	35.7	31.8	14.5	31.4	34.4	15.6	48.7	30.9	15.8	0.6	31.0	21.9	1.0	1.7	17.4	13.4	19.6	26.7	65.4	25.3	9.8	38.3	20.8	21.2	15.4	41.4	44.1	20.7	11.7	11.6	29.9	20.5	40.8	24.0	8.5	36.1	23.0	11.8	25.4	31.9	28.7	52.1	24.3	47.1	61.4	13.3	46.6	43.6	6.4	1.4	4.4	0.7	0.9	0.4	2.7	3.5	2.6	3.1	2.1	0.2	1.9	0.8	1.7	1.2	2.9	16.3	3.1	0.7	1.3	0.7	0.9	0.7	0.7	0.9	0.5	0.9	0.6
OR10G3		ENSG00000169208	"Olfactory receptor family 10 subfamily G member 3"	Q8NGC4	14	21568520-21580076	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 3.4;bone marrow: 2.0;pituitary gland: 4.3;skin 1: 1.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA019766	Uncertain									"HPA019766: AB_1854780"																		0.3	0.4	0.0	0.2	0.0	2.0	0.2	0.0	0.2	0.1	0.1			0.0	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0		0.1	0.0	0.1	4.3	0.0		0.0	0.1		0.0	0.0	0.2	1.2	0.6	0.0	0.0	0.1	0.2	0.6			0.1		0.0	0.0	0.0	1.0	0.9	3.4	1.0	0.7	0.7	0.0	0.1	0.0	0.7	0.7	0.0	0.0	0.6	0.5	0.0	0.0	0.0	2.1	0.6	0.8	0.1	0.0	0.4	0.7	0.0	0.3	0.6	0.0	0.0	0.8	0.0	0.0	0.7	0.3	0.0	0.0	0.0	1.0	0.4	0.1	0.4	0.4	0.0	0.6	0.4	0.6	0.5	0.2	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	1.0	1.2	0.0	0.0	0.9	0.6	0.9	0.1	0.2	0.2	0.2	0.6	0.5	0.3	0.9	1.0	0.5	0.6	0.2	0.3	0.4	0.5	0.4	0.2	1.0	0.7	0.5	3.4	0.7	0.3	0.9	0.3	0.0										
OR2W3	"OR2W3P, OR2W8P, OST718"	ENSG00000238243	"Olfactory receptor family 2 subfamily W member 3"	Q7Z3T1	1	247895587-247896531	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"bone marrow: 13.8;thyroid gland: 8.2"	"Cell line enhanced"	"Detected in some"		"HEL: 12.8;PC-3: 12.9;U-2 OS: 8.4;U-937: 6.0;WM-115: 9.2"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"					"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in many"											HPA045594	Uncertain									"HPA045594: AB_10960280"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.57e-5)"	"unprognostic (1.98e-1)"	"unprognostic (5.11e-2)"		"unprognostic (2.79e-6)"	"unprognostic (2.71e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.71e-3)"	"unprognostic (9.05e-3)"	"unprognostic (9.34e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.48e-1)"	0.2	0.7	0.6	0.3	1.6	13.8	0.2	0.0	2.2	0.4	0.7			0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.4	1.7	0.0	0.1	0.5	0.0	1.1		0.0	0.2	0.0	0.3	1.6		0.5	0.6		0.0	0.0	0.0	0.3	0.2	0.4	0.4	0.8	0.1	1.1			8.2		0.0	0.3	0.2	0.6	1.4	1.0	0.6	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	3.8	0.0	0.0	0.0	0.3	12.8	0.0	0.0	0.0	1.6	0.4	0.4	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.1	0.5	12.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	8.4	0.0	0.0	1.4	0.0	0.0	0.0	6.0	9.2	0.0	0.2	1.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.6	0.2	0.0	0.8	0.0	0.5	0.0	0.0	1.5										
OR3A3	"OR17-137, OR17-16, OR17-201, OR3A6, OR3A7, OR3A8P"	ENSG00000159961	"Olfactory receptor family 3 subfamily A member 3"	P47888	17	3411370-3424070	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 10.6;bone marrow: 2.6"	"Cell line enriched"	"Detected in single"	5	"HDLM-2: 4.3"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 10.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 10.6"																																		"unprognostic (2.01e-1)"			0.1	0.0	0.6	0.2	0.9	2.6	0.1	1.2	0.4	0.2	0.2			0.5	0.4	0.1	0.0	0.2	0.5	0.2	0.6	0.5	0.2	0.2	0.1	0.8	1.1		0.1	0.0	0.0	0.3	0.4		0.1	0.0		0.1	0.1	0.5	1.0	0.0	0.0	0.5	0.4	0.4	1.1			0.2		0.4	0.3	0.2	0.3	10.6	0.6	0.2	0.2	0.2	0.0	0.2	0.1	0.3	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.5	0.1	0.3	0.1	0.0	0.2	0.1	0.0	0.0	4.3	0.5	0.4	0.6	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.4	0.0	0.3	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.2	0.1	0.2	0.9	0.3	0.2	0.1	0.0	0.2	0.2	0.3	0.3	0.3	0.2	0.4	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.2	0.6	0.2	0.1	10.6	0.1	0.0										
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73981077-73982124	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 50.5;bone marrow: 46.8;heart muscle: 46.0;lymphoid tissue: 42.6"	"Cell line enriched"	"Detected in some"	10	"HEL: 29.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"basophil: 18.3;neutrophil: 16.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 18.3"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"					"CAB026008: , HPA052485: AB_2681847"		"unprognostic (4.14e-4)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.81e-2)"	0.7	0.4	0.2	0.7	0.9	46.8	0.8	0.2	0.3	0.3	1.1	0.0	0.0	0.1	0.2	0.4	0.2	0.5	0.8	46.0	0.8	0.3	0.5	1.7	9.1	3.3	2.6	0.3	3.0	0.4	0.1	0.4	4.8	1.9	0.2	0.9	1.0	0.4	0.2	1.0	0.2	0.3	0.2	0.9	42.6	0.9	0.6	0.0	0.0	1.8	0.9	0.1	1.0	3.0	0.3	1.9	18.3	1.4	0.0	0.3	50.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.7	0.0	0.0	1.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	1.4	0.4	0.3	0.3	0.3	0.0	0.0	0.0	0.5	0.3	0.2	0.1	16.5	0.0	1.1	1.9	0.2	50.5	0.2	0.9	0.2	0.3	0.8	0.3	2.6	0.3	1.9	0.0
PRTN3	"ACPA, AGP7, C-ANCA, MBT, P29, PR-3"	ENSG00000196415	"Proteinase 3"	P24158	19	840960-848175	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 167.3"	"Cell line enriched"	"Detected in some"	5	"THP-1: 148.0"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.0"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA005938, CAB017558"	Enhanced				"Secreted to blood"	120000	120000			"CAB017558: AB_2172317, HPA005938: AB_1855764"	"unprognostic (2.81e-2)"			"unprognostic (2.10e-1)"	"unprognostic (3.83e-3)"		"unprognostic (4.20e-1)"	"unprognostic (3.31e-2)"		"unprognostic (3.34e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.67e-2)"	"unprognostic (8.62e-6)"	"unprognostic (5.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.14e-2)"		0.3	0.2	0.9	0.2	1.0	167.3	0.2	0.0	2.3	0.2	0.2	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.2	31.0	0.3	0.6	0.2	1.7	8.1	3.5	0.1	0.1	0.4	0.2	0.2	0.8	4.2	0.8	0.2	0.2	0.3	0.3	0.2	0.5	0.3	0.2	0.2	0.0	25.5	0.2	0.2	0.1	35.0	0.9	0.0	0.2	0.2	0.0	0.0	0.0	1.9	0.1	0.0	0.2	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	6.8	0.9	1.0	0.0	2.3	0.3	0.6	0.1	0.1	0.8	0.1
RAC2	EN-7	ENSG00000128340	"Rac family small GTPase 2"	P15153	22	37225261-37244448	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 166.3;bone marrow: 66.3;lymphoid tissue: 169.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 75.8;HMC-1: 155.5;Karpas-707: 73.8;U-87 MG: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022946, HPA047820"	Enhanced					34000000	34000000			"CAB022946: , HPA047820: AB_2680167"	"prognostic favourable (1.03e-5)"	"unprognostic (2.91e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.74e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (8.52e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.81e-1)"	"prognostic unfavourable (1.06e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.50e-2)"	17.4	2.6	2.0	79.2	4.1	66.3	8.3	0.9	2.0	3.3	7.5	1.5	1.2	6.0	3.2	3.5	7.8	4.7	11.2	5.6	1.7	1.9	4.8	5.3	29.6	89.3	3.0	0.2	4.9	2.3	0.0	1.8	3.5	2.2	6.2	5.9	3.3	16.9	2.2	1.4	2.9	29.4	3.2	4.1	102.8	7.0	2.5	2.0	169.1	3.6	3.6	74.2	11.2	4.0	85.3	79.1	166.3	88.3	98.4	121.7	130.9	14.0	0.0	0.0	0.0	1.5	14.5	0.0	1.9	4.4	1.5	3.1	0.0	4.7	17.4	2.1	5.5	3.5	0.1	24.5	1.7	54.2	0.0	21.8	0.4	0.0	3.9	75.8	155.5	10.6	3.5	2.7	9.2	25.6	5.1	73.8	0.2	0.0	22.3	30.0	0.3	9.3	7.5	0.0	19.9	2.4	0.0	0.2	0.0	0.0	2.4	0.3	1.0	40.9	27.5	0.0	2.5	0.1	0.2	33.4	17.2	18.4	67.7	33.0	3.7	115.0	53.8	166.3	111.5	73.2	84.4	85.3	89.3	97.9	53.4	70.9	69.5	88.6	146.6	98.4	88.3	79.1	121.7	130.9	2.0	4.1	0.9	2.0	1.7	1.9	3.0	0.2	2.2	2.0
RGS19	"GAIP, RGSGAIP"	ENSG00000171700	"Regulator of G protein signaling 19"	P49795	20	64073181-64079988	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 95.0;bone marrow: 36.7;lymphoid tissue: 43.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 48.8;NB-4: 38.4;THP-1: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056384, HPA069984"	Enhanced		Supported	"Nucleoli fibrillar center,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA056384: AB_2732602, HPA069984: AB_2732145"	"unprognostic (3.98e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.26e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavourable (2.75e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (2.06e-9)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.66e-3)"	7.0	4.8	6.0	19.0	7.5	36.7	12.7	2.5	5.0	3.3	3.5	6.8	1.9	5.5	2.9	2.9	4.4	4.1	4.5	5.1	5.4	4.9	4.0	7.2	10.4	27.2	9.1	2.6	2.7	3.9	0.8	2.6	5.6	5.7	3.9	1.8	2.2	6.1	2.2	1.6	4.3	10.6	3.2	7.1	43.1	5.7	2.8	7.2	15.2	3.7	1.2	19.5	6.1	3.6	17.3	29.9	95.0	55.5	9.1	13.8	22.0	4.8	7.4	2.1	3.8	0.9	1.6	3.6	3.0	2.1	6.4	2.6	10.9	6.7	8.5	8.5	1.9	4.7	2.1	3.9	1.5	4.1	4.1	12.1	3.8	4.4	1.2	24.7	48.8	1.0	2.4	2.7	0.9	4.1	4.6	4.5	1.9	8.6	18.2	38.4	2.2	9.4	15.3	1.2	6.1	1.8	2.4	4.1	3.8	3.1	1.9	4.0	2.6	32.6	4.3	6.0	3.0	1.0	2.9	2.8	2.2	10.3	3.3	18.9	3.9	33.1	35.5	95.0	13.4	50.4	13.8	17.3	12.7	12.7	29.9	17.1	8.9	9.2	79.6	9.1	55.5	17.1	13.5	22.0	6.0	7.5	2.5	5.0	5.4	4.9	9.1	2.6	5.7	7.2
S100A12	"CAAF1, CAGC, CGRP, ENRAGE, MRP6, p6"	ENSG00000163221	"S100 calcium binding protein A12"	P80511	1	153373706-153375649	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 139.8;bone marrow: 329.6;lymphoid tissue: 94.7"	"Group enriched"	"Detected in some"	7	"hTCEpi: 6.4;SK-BR-3: 2.1;THP-1: 4.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 51.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"classical monocyte: 91.9;neutrophil: 139.8"	"Group enriched"	"Detected in many"	12	"granulocytes: 139.8;monocytes: 91.9"					"Not detected"	"Not detected"			"HPA002881, CAB025872"	Enhanced				"Secreted to blood"	6200000	6200000			"CAB025872: , HPA002881: AB_1848175"	"unprognostic (1.33e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (9.04e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavourable (5.03e-4)"	"unprognostic (3.68e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.70e-2)"	6.7	0.5	0.9	8.9	1.7	329.6	0.8	0.3	1.0	3.5	1.1	0.2	0.0	0.6	0.5	0.4	9.2	3.3	1.1	41.2	0.7	0.8	1.6	4.0	34.4	27.4	3.3	0.0	1.5	5.0	0.4	0.7	3.9	2.8	0.8	0.4	0.7	1.9	0.4	1.3	0.8	0.5	4.4	0.8	94.7	1.4	3.4	0.5	3.9	4.5	15.3	4.9	1.7	36.0	0.2	9.6	139.8	91.9	0.0	0.1	59.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	2.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	91.9	0.3	0.1	3.3	0.0	0.2	0.0	0.1	9.6	0.0	0.0	0.0	139.8	0.0	0.7	0.6	0.1	59.2	0.9	1.7	0.3	1.0	0.7	0.8	3.3	0.0	2.8	0.5
SERPINB10	"bomapin, PI10"	ENSG00000242550	"Serpin family B member 10"	P48595	18	63897174-63936111	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 43.9;tongue: 15.3"	"Cell line enriched"	"Detected in some"	7	"U-937: 47.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"classical monocyte: 4.2;eosinophil: 3.3;neutrophil: 1.8;plasmacytoid DC: 2.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.1;granulocytes: 3.3;monocytes: 4.2"					"Low region specificity"	"Detected in all"			"HPA015480, HPA059582"	Uncertain		Supported	Nucleoplasm,Cytosol		42000	42000	Nucleoplasm	Nucleoplasm	"HPA015480: AB_1855456, HPA059582: AB_2684072"	"unprognostic (4.66e-1)"	"unprognostic (5.11e-2)"			"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"		"unprognostic (9.56e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.64e-1)"			"unprognostic (1.25e-4)"	1.3	0.1	0.0	2.3	0.2	43.9	0.1	0.3	0.1	1.1	0.7	0.0	0.0	0.1	0.2	0.3	3.1	0.1	0.1	5.5	0.0	0.0	0.0	0.2	3.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	4.8	0.2	0.1	0.1	0.0	1.0	0.1	1.3	2.5	0.1	0.1	0.0	2.8	0.1	0.1	0.1	4.0	0.9	15.3	1.5	0.1	1.3	0.3	2.1	3.3	4.2	0.3	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.2	4.2	3.3	0.2	0.1	0.1	0.2	0.1	0.1	0.4	0.3	0.1	0.1	1.8	0.3	0.0	2.1	0.1	0.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.1
SIGLEC14		ENSG00000254415	"Sialic acid binding Ig like lectin 14"	Q08ET2	19	51642553-51646801	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 48.7;bone marrow: 13.3;lymphoid tissue: 21.6"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 46.4"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	6	"classical monocyte: 25.8;intermediate monocyte: 29.7;myeloid DC: 15.9;neutrophil: 48.7;non-classical monocyte: 21.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.9;granulocytes: 48.7;monocytes: 29.7"									HPA014377	Uncertain					18000000	18000000			"HPA014377: AB_2189277"	"unprognostic (3.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	1.6	1.6	0.6	13.0	0.5	13.3	0.5	0.0	0.3	0.6	0.6			0.0	0.4	0.0	0.2	1.7	1.0	0.8	0.6	0.6	0.4	1.4	5.1	6.2	1.3		0.1	0.3	0.0	0.1	0.9		0.4	0.4		0.7	0.1	0.0	0.0	4.0	0.9	1.9	21.6	0.7	1.3			0.2		7.0	2.2	0.2	4.9	15.9	48.7	29.7	0.1	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.7	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	3.6	25.8	0.4	0.0	29.7	0.0	4.9	0.0	0.0	15.9	4.8	0.0	0.0	48.7	0.1	21.3	2.9	0.0	7.6										
SIGLEC5	"CD170, CD33L2, OB-BP2, SIGLEC-5"	ENSG00000105501	"Sialic acid binding Ig like lectin 5"	O15389	19	51611927-51645545	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 46.7;bone marrow: 13.5"	"Group enriched"	"Detected in some"	6	"HMC-1: 34.9;U-937: 14.5"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.7"					"Cell type enhanced"	"Detected in many"		"neutrophil: 46.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 46.7;monocytes: 13.7"									"HPA009085, CAB024900"	Supported									"CAB024900: , HPA009085: AB_1079965"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.95e-1)"	1.2	0.4	0.4	6.4	0.5	13.5	0.2	0.1	0.2	0.1	0.3			0.0	0.2	0.0	0.2	0.1	0.3	0.3	0.3	0.2	0.2	1.2	1.5	2.5	0.5		0.1	0.2	0.0	0.2	0.5		0.2	0.4		0.4	0.0	0.0	0.1	3.4	0.5	0.7	5.9	0.3	0.7			0.2		1.9	0.8	0.1	0.8	4.7	46.7	13.7	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	34.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	3.6	6.4	0.1	0.0	7.5	0.0	0.8	0.0	0.0	4.7	0.7	0.0	0.0	46.7	0.2	13.7	1.5	0.0	2.0										
SNCA	"NACP, PARK1, PARK4, PD1"	ENSG00000145335	"Synuclein alpha"	P37840	4	89724099-89838315	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 31.2;bone marrow: 91.0;brain: 121.3"	"Cell line enhanced"	"Detected in many"		"HEL: 43.3;HUVEC TERT2: 52.7;RT4: 27.8;SK-MEL-30: 51.7;TIME: 60.3"	"Cancer enriched"	"Detected in many"	8	"melanoma: 37.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 25.4;plasmacytoid DC: 31.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 31.2;granulocytes: 10.1;monocytes: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005459, CAB010877"	Enhanced				"Intracellular and membrane"	23000000	23000000			"CAB010877: AB_261518, HPA005459: AB_2667324"	"unprognostic (4.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-4)"	"unprognostic (7.48e-3)"	3.9	5.4	38.9	4.7	26.1	91.0	4.3	41.7	121.3	6.2	4.7	9.0	0.0	2.3	15.5	2.5	4.5	3.2	3.2	9.0	35.2	22.5	4.2	1.9	4.5	1.8	36.2	49.6	13.6	1.6	1.2	5.4	12.1	26.3	4.6	3.9	5.3	4.9	5.3	1.1	7.6	2.9	15.1	21.4	4.0	1.7	2.2	15.1	0.0	5.2	1.2	2.9	4.1	4.4	0.9	31.2	10.1	20.5	4.8	0.6	19.5	0.1	0.1	8.2	0.0	0.1	0.0	0.1	0.0	8.6	0.3	0.6	0.0	0.0	0.0	2.4	0.0	1.8	10.6	19.7	0.3	0.0	4.8	43.3	24.4	0.0	17.7	0.0	0.3	0.4	7.6	0.0	22.3	52.7	0.3	0.1	0.0	0.0	0.3	0.0	2.1	0.9	0.0	3.2	0.0	0.0	27.8	4.6	3.1	0.0	0.0	51.7	0.0	0.0	60.3	0.2	1.6	0.0	0.1	0.0	0.0	0.0	1.7	0.0	17.3	10.1	20.5	0.0	0.0	8.1	0.0	0.9	0.6	0.1	25.4	0.5	0.3	0.2	3.7	4.8	2.3	31.2	0.0	19.5	38.9	26.1	41.7	55.1	35.2	22.5	36.2	49.6	26.3	15.1
SPTA1	EL2	ENSG00000163554	"Spectrin alpha, erythrocytic 1"	P02549	1	158610706-158686715	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 41.0"	"Cell line enriched"	"Detected in some"	4	"K-562: 27.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016193, HPA028048, HPA028253, CAB037246"	Enhanced					45000000	45000000			"CAB016193: AB_669050, CAB037246: AB_261445, HPA028048: AB_10603341, HPA028253: AB_2672537"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.50e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.73e-8)"	"unprognostic (6.08e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.85e-3)"	0.6	0.0	0.0	1.1	0.0	41.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	4.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	8.1	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.6	4.6	0.0	2.2	0.0	0.3	0.9	0.0	0.0	0.0	2.8	0.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7"	"Cell line enriched"	"Detected in single"	166	"HEL: 37.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 19.2"	"Lineage enriched"	"Detected in single"	31	"granulocytes: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced					94000000	94000000			"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	1.2	1.2	2.1	3.7	1.2	10.5	0.6	0.5	1.3	0.4	0.3	0.3	0.3	0.0	0.3	0.6	0.3	0.6	1.3	10.0	2.1	1.6	0.3	0.3	2.9	7.7	3.3	0.3	1.9	0.5	0.2	0.6	1.7	1.2	0.3	1.3	0.6	1.3	0.3	0.8	0.3	0.4	0.3	4.3	26.7	0.2	0.8	0.3	1.4	0.6	0.3	7.1	1.1	0.3	0.1	0.3	19.2	0.6	0.0	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.6	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	3.9	0.0	0.1	0.3	0.0	37.9	2.1	1.2	0.5	0.7	2.1	1.6	3.3	0.3	1.2	0.3
UQCRHL		ENSG00000233954	"Ubiquinol-cytochrome c reductase hinge protein like"	A0A096LP55	1	15807169-15809348	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 5.5;bone marrow: 2.2;epididymis: 1.6;skeletal muscle: 4.4;skin 1: 2.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in all"											HPA042574	Approved									"HPA042574: AB_10960998"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.01e-3)"	"unprognostic (4.83e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-1)"	"unprognostic (9.67e-3)"	"unprognostic (9.76e-3)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.02e-1)"	0.0	0.1		0.2		2.2	0.4		0.4	0.0	0.0			0.2	0.4	1.6	0.1	0.4	0.4	0.1			0.0	0.4	0.2	0.2			0.5	0.0	0.0		0.0		0.1	0.1		0.5	0.0	4.4	2.1	0.4	0.1		0.6	0.0	0.5			0.2		0.0	0.0		1.5	1.2	5.5	1.0	1.3	1.0	0.5	0.7	0.5	3.1	3.2	0.7	0.8	1.2	0.6	0.3	0.1	0.3	0.7	2.5	1.2	0.9	0.5	1.3	0.6	0.5	0.7	2.2	0.3	1.1	1.9	0.5	0.7	0.9	1.4	0.5	1.0	0.3	0.3	0.0	1.1	2.3	0.2	1.9	0.4	1.4	1.5	1.2	1.1	0.7	1.0	0.0	1.7	2.7	1.7	1.0	2.1	0.8	0.9	2.7	0.5	2.0	1.1	1.2	0.8	2.2	0.9	1.3	0.9	2.1	0.9	3.6	1.0	0.9	0.8	0.7	0.6	1.1	0.6	0.8	0.6	1.5	1.0	1.0	5.5	1.3	0.7	1.2	0.5	0.5										
USP29		ENSG00000131864	"Ubiquitin specific peptidase 29"	Q9HBJ7	19	57119138-57131926	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 4.1;bone marrow: 2.7;pancreas: 2.1;skin 1: 2.3;testis: 8.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;HEK 293: 3.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA076515	Enhanced									"HPA076515: "															"unprognostic (1.32e-1)"			0.1	0.1	0.2	0.0	0.2	2.7	0.1	0.1	0.4	0.1	0.1			0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.3	0.2	0.1	0.1	0.1	0.3	0.1		0.2	2.1	0.0	0.1	0.0		0.1	0.0		0.7	0.0	0.2	2.3	0.1	0.0	0.1	0.1	0.4	8.4			0.4		0.0	0.7	0.1	1.1	1.9	4.1	1.1	1.2	0.8	0.6	0.1	0.7	0.8	0.3	0.0	0.0	3.3	0.0	0.0	0.1	0.1	1.7	0.0	0.9	0.0	0.0	2.0	0.0	0.0	0.0	1.0	3.2	0.8	0.0	0.0	1.1	0.0	1.9	0.9	1.0	1.4	0.0	0.0	0.3	0.9	0.0	0.7	0.0	1.2	0.0	1.0	0.9	0.0	1.0	0.0	2.1	2.0	0.7	0.6	0.4	0.2	0.8	1.3	1.5	1.2	0.5	0.0	0.0	1.6	0.5	1.5	0.5	0.8	0.0	3.1	1.1	1.1	0.8	0.7	0.6	0.5	0.7	0.3	0.3	1.1	0.7	0.7	4.1	1.2	0.4	1.9	0.5	0.6										
VSTM1	UNQ3033	ENSG00000189068	"V-set and transmembrane domain containing 1"	Q6UX27	19	54040825-54063953	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 53.5;bone marrow: 39.4"	"Group enriched"	"Detected in some"	7	"EFO-21: 1.0;HMC-1: 2.5;hTERT-HME1: 3.9;U-2 OS: 3.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	15	"eosinophil: 53.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 53.5"									HPA059365			Approved	Vesicles	"Secreted to blood"			Vesicles	Vesicles	"HPA059365: "	"unprognostic (5.13e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.30e-1)"		"unprognostic (1.09e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-5)"	"unprognostic (3.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.67e-2)"	0.9	0.2	0.7	0.1	0.2	39.4	0.1	0.0	0.5	0.2	0.1	1.3	0.0	0.1	0.3	0.1	0.1	0.6	0.1	4.2	0.7	0.2	0.5	1.2	4.0	7.2	0.6	0.0	0.2	1.1	0.1	8.7	2.0	0.2	0.1	0.1	0.2	0.1	0.1	2.1	0.1	0.8	0.3	0.1	7.9	0.1	0.5	0.3	3.0	0.4	0.0	0.1	0.8	0.0	0.0	0.0	53.5	3.6	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	53.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.6	0.0	0.0	2.1	0.7	0.2	0.0	0.5	0.7	0.2	0.6	0.0	0.2	0.3
ZAR1	Z3CXXC6	ENSG00000182223	"Zygote arrest 1"	Q86SH2	4	48490252-48494389	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 2.0;brain: 2.7;salivary gland: 1.3;testis: 4.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.2;HeLa: 1.5;K-562: 1.2;SCLC-21H: 2.4;SH-SY5Y: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in many"	7	"basal ganglia: 1.7;hypothalamus: 1.1;midbrain: 2.7;pons and medulla: 0.5"													"unprognostic (9.71e-2)"	"unprognostic (2.58e-1)"		"unprognostic (4.59e-3)"	"unprognostic (2.47e-2)"		"unprognostic (6.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.54e-1)"				"unprognostic (1.08e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.32e-5)"	"unprognostic (4.51e-1)"	0.0	0.0	0.0	0.0	0.8	2.0	0.0	0.0	0.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.7		0.4	0.0	0.0	0.5	0.0		0.0	0.0		1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.2			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.0	0.4	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.2	1.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	3.1	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ALAS2	ASB	ENSG00000158578	"5'-aminolevulinate synthase 2"	P22557	X	55009055-55031064	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 130.9;placenta: 53.5"	"Group enriched"	"Detected in some"	87	"HEL: 32.0;K-562: 35.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 2.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"								"Intracellular and membrane"						"unprognostic (7.82e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.68e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-1)"	1.7	0.4	0.8	0.4	0.8	130.9	0.5	0.2	0.5	0.3	0.4	0.5	0.0	0.4	0.3	0.3	2.3	1.0	0.5	2.9	0.7	0.7	1.6	2.4	17.3	0.3	1.3	0.7	6.1	2.3	0.3	1.0	53.5	2.3	2.6	0.3	1.0	0.5	0.3	3.7	0.4	0.4	1.1	0.9	22.3	0.3	0.5	0.0	0.4	3.2	0.0	0.3	7.0	6.5	0.3	2.0	0.3	0.1	0.0	0.3	10.7	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	32.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	2.0	0.0	10.7	0.8	0.8	0.2	0.5	0.7	0.7	1.3	0.7	2.3	0.0
ANKRD18A	"FLJ35740, KIAA2015"	ENSG00000180071	"Ankyrin repeat domain 18A"	Q8IVF6	9	38571358-38620660	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"bone marrow: 24.4;brain: 11.1;testis: 19.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 16.9;THP-1: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Nucleoli	"HPA046346: AB_2679631, HPA046695: , HPA049923: , HPA051288: AB_2681421"	"unprognostic (4.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.94e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.14e-1)"	0.5	0.7	1.4	0.8	9.1	24.4	1.1	0.4	4.1	1.0	2.1	8.5	2.4	0.9	0.7	1.1	1.4	1.2	2.7	1.1	3.0	2.2	1.5	1.2	1.5	0.8	4.8	2.3	0.4	4.1	2.5	3.2	0.7	8.7	1.6	1.5	0.4	0.9	3.9	0.4	2.4	1.5	0.7	11.1	0.5	2.0	19.1	6.9	0.0	3.8	0.0	0.5	0.7	0.8	0.4	0.0	1.1	0.0	0.1	1.7	0.1	4.6	3.6	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	2.0	0.0	0.9	3.5	3.3	0.0	0.0	4.8	0.0	4.8	2.8	0.0	16.9	0.4	0.0	2.3	0.0	3.1	0.0	1.6	0.4	0.3	4.3	0.1	0.8	3.7	2.1	0.0	6.4	6.4	2.1	1.9	1.5	3.0	2.3	0.5	0.1	2.5	8.0	4.4	0.0	1.3	0.1	0.0	0.3	0.5	0.0	0.0	0.0	2.0	0.0	0.0	1.1	0.5	0.0	0.7	0.0	1.3	0.8	0.0	0.4	0.7	1.7	0.5	0.1	0.0	0.0	1.0	0.1	1.4	9.1	0.4	4.1	3.0	2.2	4.8	2.3	8.7	6.9
ANKRD61		ENSG00000157999	"Ankyrin repeat domain 61"	A6NGH8	7	6031376-6036386	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"bone marrow: 8.7;testis: 9.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 12.5"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029511, HPA050732"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA029511: AB_10602430, HPA050732: "	"unprognostic (1.40e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-1)"	0.5	0.5	0.0	0.7	0.2	8.7	0.7	0.5	0.9	0.4	0.3			0.6	0.6	0.0	0.4	0.5	0.2	0.6	0.1	0.1	0.3	0.5	0.5	1.1	0.0		0.8	1.0	0.1	0.5	0.4		0.4	0.0		0.9	0.0	0.6	2.1	0.8	0.0	0.2	0.9	0.9	9.1			0.9		0.0	0.5	0.5	0.6	1.5	0.9	1.1	0.0	0.8	0.3	2.1	5.9	1.8	2.7	0.3	0.3	2.5	1.4	0.4	0.6	0.6	2.9	5.5	1.1	0.6	0.2	2.2	1.0	0.0	0.7	0.3	0.7	1.5	12.5	0.3	0.2	1.6	2.5	0.4	1.2	0.5	1.1	0.5	1.9	1.7	0.7	3.7	0.3	1.8	0.9	0.7	1.5	0.5	0.3	0.5	2.8	1.3	2.5	1.4	1.6	0.2	2.9	1.0	1.2	2.3	4.8	2.8	1.7	1.6	1.8	0.9	0.7	1.4	1.4	0.9	1.1	0.0	0.1	1.1	0.0	0.0	0.0	0.8	1.5	0.6	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.3										
C17orf53	MGC3130	ENSG00000125319	"Chromosome 17 open reading frame 53"	Q8N3J3	17	44141906-44162476	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 13.4;lymphoid tissue: 8.2;testis: 32.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA023004, HPA023393, HPA024430"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA023004: AB_1853877, HPA023393: AB_1853878, HPA024430: AB_1853879"	"unprognostic (1.72e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavourable (8.08e-4)"	"unprognostic (1.59e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavourable (3.46e-4)"	"prognostic unfavourable (9.39e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.66e-4)"	"unprognostic (2.86e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.40e-2)"	2.0	0.7	0.5	3.5	0.4	13.4	2.0	2.8	1.4	1.2	1.5	0.6	0.5	1.4	1.3	1.1	4.0	0.9	1.4	1.9	0.8	0.7	0.8	0.8	1.3	2.4	0.5	0.2	1.3	1.2	0.7	0.7	2.3	1.0	1.0	1.7	0.6	1.1	1.1	1.8	2.4	2.2	1.1	0.5	1.9	1.0	32.1	0.4	8.2	0.5	1.5	4.8	0.8	1.7	1.4	3.7	0.9	1.1	0.3	2.0	0.6	7.5	9.5	7.5	6.7	0.6	2.1	8.9	6.0	5.2	11.5	12.7	9.7	4.7	8.1	5.3	5.2	6.6	9.7	9.4	10.2	9.1	12.3	5.2	8.7	6.5	0.3	5.7	6.6	1.8	1.4	14.3	7.1	4.8	11.8	10.7	5.6	5.6	13.5	8.5	5.1	9.4	8.6	12.0	10.0	2.7	6.1	4.7	2.8	3.6	3.6	2.9	7.2	6.6	2.2	11.2	8.8	7.5	8.6	6.1	10.3	7.0	5.2	4.4	6.3	0.0	1.1	0.9	1.1	0.8	0.4	0.8	0.8	0.2	0.4	1.4	0.6	0.4	0.0	0.3	0.4	3.7	2.0	0.6	0.5	0.4	2.8	1.4	0.8	0.7	0.5	0.2	1.0	0.4
CD300LB	"CLM7, TREM5"	ENSG00000178789	"CD300 molecule like family member b"	A8K4G0	17	74521174-74531474	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"adipose tissue: 20.7;blood: 30.7;bone marrow: 8.8;lymphoid tissue: 10.9"	"Group enriched"	"Detected in some"	6	"HL-60: 4.5;NB-4: 5.9;THP-1: 4.6;U-937: 2.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"eosinophil: 30.7"	"Group enriched"	"Detected in many"	52	"dendritic cells: 10.5;granulocytes: 30.7;monocytes: 13.0"																				"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.49e-4)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.01e-2)"	20.7	0.9	0.2	10.9	0.5	8.8	2.0	0.4	0.5	0.6	0.8	0.3	0.1	0.7	0.7	1.0	1.1	1.2	2.8	1.6	1.5	0.4	1.2	1.0	4.4	6.5	1.2	0.1	2.0	2.3	0.0	0.7	1.1	1.0	0.8	1.1	1.6	1.2	0.1	0.3	0.4	2.0	2.2	0.6	6.6	0.7	0.7	0.1	0.9	0.6	0.1	2.2	2.6	0.7	0.0	10.5	30.7	13.0	0.3	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	2.7	0.0	0.6	13.0	30.7	0.0	5.6	0.1	0.0	0.0	0.0	10.5	0.0	0.0	0.1	13.8	0.3	0.7	6.6	0.0	4.2	0.2	0.5	0.4	0.5	1.5	0.4	1.2	0.1	1.0	0.1
CDCA5		ENSG00000146670	"Cell division cycle associated 5"	Q96FF9	11	65066300-65084164	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 27.4;lymphoid tissue: 39.9;testis: 27.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"NK-cell: 5.8;T-reg: 4.2"	"Group enriched"	"Detected in many"	4	"NK-cells: 5.8;T-cells: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023691	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA023691: AB_1846392"	"unprognostic (3.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (2.67e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (8.21e-6)"	"unprognostic (1.41e-3)"	"unprognostic (7.55e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (8.72e-6)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.55e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.97e-2)"	1.3	1.3	1.1	12.3	1.1	27.4	4.3	1.0	2.8	1.6	3.8	0.6	0.0	3.3	0.9	1.4	7.9	0.7	1.4	1.3	1.1	0.9	1.3	1.3	1.9	9.5	1.1	0.5	0.8	0.7	0.2	0.7	5.5	1.3	0.9	4.7	0.1	1.5	0.1	0.7	2.4	3.6	1.7	0.7	5.7	2.1	27.9	0.2	39.9	0.7	6.6	9.9	1.5	2.3	1.2	0.8	0.3	0.5	5.8	4.2	1.4	30.7	17.6	16.9	14.3	1.1	1.8	14.1	22.0	9.2	25.8	20.6	18.0	18.7	28.0	12.7	7.1	21.3	27.3	12.1	25.2	28.0	11.9	25.2	12.8	15.1	0.1	26.8	20.4	0.6	1.1	24.1	11.2	7.8	28.5	51.8	15.7	25.5	37.8	27.7	26.6	21.4	33.2	18.6	26.7	5.3	11.8	22.0	16.5	14.1	20.2	14.9	26.0	13.2	4.9	23.4	24.2	24.6	24.4	26.2	41.5	45.6	9.4	16.5	24.1	0.0	0.2	0.3	0.8	0.0	0.1	0.7	1.1	0.6	0.8	1.2	0.1	0.8	0.1	5.8	0.5	0.7	4.2	1.4	1.1	1.1	1.0	2.8	1.1	0.9	1.1	0.5	1.3	0.2
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692418-37709719	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Cytokinetic bridge"				Nucleoli	Nucleoli	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavourable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavourable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.2	1.4	0.9	12.9	1.7	19.0	1.7	0.8	1.6	1.8	6.0	1.1	0.7	5.3	1.4	1.3	9.6	0.7	2.4	0.8	0.9	0.9	1.3	1.5	2.0	12.2	1.8	1.3	0.9	1.0	0.1	0.8	3.7	1.3	1.0	7.7	0.7	2.1	1.0	0.9	4.0	5.4	1.6	1.2	5.4	3.5	44.7	1.7	51.6	0.9	6.5	14.6	1.6	2.9	2.8	1.8	4.5	5.0	6.3	8.9	2.5	28.0	12.3	23.2	16.7	1.0	2.0	15.6	21.2	10.7	37.5	26.6	19.1	21.1	34.1	8.6	13.5	16.0	26.6	14.1	39.9	22.7	11.9	30.7	13.1	15.1	0.2	29.5	15.9	0.7	1.0	21.1	18.7	16.5	25.9	36.7	27.0	12.5	27.2	18.1	26.8	17.0	26.5	31.7	19.5	8.5	11.8	20.7	9.1	23.3	11.0	14.3	16.1	11.2	9.9	18.5	19.6	10.5	33.1	25.0	32.4	46.5	8.7	27.5	21.1	0.0	1.1	1.8	2.5	2.2	4.5	2.8	5.7	3.3	1.0	2.5	1.9	3.8	4.5	6.3	5.0	1.8	8.9	2.5	0.9	1.7	0.8	1.6	0.9	0.9	1.8	1.3	1.3	1.7
CDT1	"DUP, RIS2"	ENSG00000167513	"Chromatin licensing and DNA replication factor 1"	Q9H211	16	88803213-88809258	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 25.2;esophagus: 7.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017224	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA017224: "	"unprognostic (1.33e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.12e-6)"	"unprognostic (3.44e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.34e-2)"	"prognostic unfavourable (2.69e-6)"	"unprognostic (7.72e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.54e-2)"	0.4	0.4	0.7	2.7	0.9	25.2	0.4	0.0	1.2	1.2	2.5			2.9	0.3	0.0	7.1	0.3	0.0	0.1	0.6	2.2	0.5	0.6	0.9	3.2	1.7		0.0	0.4	0.9	2.1	2.0		0.3	1.0		0.8	0.1	0.0	3.3	3.2	0.3	0.8	3.1	1.7	3.3			0.1		2.1	0.2	1.9	3.7	2.1	3.5	0.9	1.7	4.0	0.7	9.6	10.1	4.4	7.4	0.2	0.9	17.8	6.6	1.8	5.2	3.3	20.6	10.0	14.3	7.3	1.4	12.5	5.5	4.4	1.7	5.1	23.8	13.4	8.9	17.2	0.0	7.6	5.9	0.4	0.3	5.3	1.1	1.6	21.8	4.8	1.9	23.9	31.0	39.3	11.4	8.1	33.3	6.0	12.6	1.1	7.3	10.6	7.9	11.4	3.6	5.0	11.3	15.6	1.7	7.3	11.6	10.9	9.7	17.8	15.4	19.6	5.3	19.4	8.7	0.5	0.9	3.5	2.7	0.5	1.1	1.2	2.7	2.7	1.0	3.7	4.0	2.4	2.1	1.7	0.7	2.1	3.0	0.7										
CLEC4D	"CD368, CLECSF8, Dectin-3, MCL, Mpcl"	ENSG00000166527	"C-type lectin domain family 4 member D"	Q8WXI8	12	8509475-8522366	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 35.0;bone marrow: 38.4;lymphoid tissue: 15.0"	"Group enriched"	"Detected in some"	4	"NB-4: 3.3;NTERA-2: 13.0;U-937: 7.5"	"Cancer enriched"	"Detected in single"	50	"testis cancer: 11.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	18	"classical monocyte: 20.9;neutrophil: 35.0"	"Group enriched"	"Detected in many"	32	"granulocytes: 35.0;monocytes: 20.9"	"Not detected"	"Not detected"							HPA004906	Approved									"HPA004906: AB_1078535"	"unprognostic (1.10e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.81e-1)"	"unprognostic (7.91e-5)"	"unprognostic (1.12e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.18e-1)"	1.7	0.2	0.1	4.8	0.6	38.4	0.4	0.1	1.8	2.2	0.3	0.1	0.0	0.0	0.2	0.3	0.3	1.4	0.3	3.6	1.1	0.2	0.4	0.7	6.7	10.4	0.6	0.0	0.4	0.3	0.0	0.4	0.4	0.7	0.2	0.0	0.1	0.3	0.0	1.3	0.1	0.5	0.5	0.5	15.0	0.5	0.5	0.4	0.1	0.7	0.4	0.4	0.5	4.2	0.1	0.8	35.0	20.9	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	13.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.3	20.9	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	35.0	0.0	0.3	0.2	0.0	4.4	0.1	0.6	0.1	1.8	1.1	0.2	0.6	0.0	0.7	0.4
CLEC7A	"CD369, CLECSF12, dectin-1, hDectin-1, SCARE2"	ENSG00000172243	"C-type lectin domain containing 7A"	Q9BXN2	12	10116777-10130258	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 53.9;bone marrow: 43.9;brain: 18.7;lung: 32.8;lymphoid tissue: 28.8"	"Group enriched"	"Detected in some"	16	"Karpas-707: 59.3;U-266/84: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 53.9"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in some"														"unprognostic (1.79e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (1.83e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.14e-1)"	7.1	5.0	6.3	27.7	7.4	43.9	3.7	0.9	3.4	3.9	4.5	9.5	0.5	3.7	3.2	8.9	8.7	5.3	7.4	5.2	6.2	4.2	8.7	6.9	32.8	24.2	8.9	4.3	2.4	2.8	1.6	2.6	7.8	8.6	2.7	5.0	6.4	6.5	2.4	1.2	3.2	6.5	5.7	18.7	28.8	3.1	1.6	7.3	5.1	2.3	3.2	9.1	5.5	3.8	0.1	13.1	53.9	30.1	0.1	0.1	7.4	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	59.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.3	46.2	0.0	0.1	0.3	0.0	0.2	26.4	0.4	0.0	29.5	0.1	0.0	0.0	0.0	13.1	0.1	0.0	0.0	53.9	0.1	30.1	0.2	0.0	7.4	6.3	7.4	0.9	3.4	6.2	4.2	8.9	4.3	8.6	7.3
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769967	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 12.6;lymphoid tissue: 30.4;testis: 10.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	12	"basal ganglia: 7.0"	"Low region specificity"	"Detected in all"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favourable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	1.5	0.8	0.9	11.5	1.0	12.6	1.7	0.3	3.6	0.9	2.1	0.1	0.0	1.0	0.5	0.9	2.9	0.5	2.8	0.6	1.1	0.6	1.0	0.7	1.9	6.0	0.6	0.1	0.5	0.5	0.3	0.4	4.3	0.7	0.5	2.7	1.9	1.0	0.0	0.4	1.2	3.4	1.0	0.8	4.4	1.1	10.0	0.5	30.4	0.5	4.2	6.6	0.9	1.2	0.9	0.9	3.4	1.1	1.3	1.6	1.1	8.5	7.1	15.7	8.2	1.1	2.0	5.9	17.7	5.0	13.0	17.4	11.4	8.0	18.4	5.8	4.7	8.7	15.2	6.1	20.4	12.6	6.9	25.9	15.7	5.0	0.0	21.2	15.3	0.4	0.2	22.4	1.6	7.0	17.4	12.8	12.4	5.6	22.2	4.8	14.8	5.1	14.2	23.7	5.5	2.7	14.3	5.8	6.8	15.4	4.7	3.1	4.1	8.3	5.0	18.7	14.2	11.5	19.7	4.6	11.3	19.4	5.9	15.2	15.1	1.6	1.1	1.1	1.6	0.5	0.5	0.4	1.0	0.8	0.9	0.9	0.4	0.8	3.4	1.3	0.7	0.8	1.3	1.1	0.9	1.0	0.3	3.6	1.1	0.6	0.6	0.1	0.7	0.5
CSF3R	"CD114, GCSFR"	ENSG00000119535	"Colony stimulating factor 3 receptor"	Q99062	1	36466043-36483278	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 167.3;bone marrow: 88.9;lymphoid tissue: 71.4;placenta: 152.7"	"Group enriched"	"Detected in some"	18	"BEWO: 34.1;NB-4: 9.2;THP-1: 22.4;U-937: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 167.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 167.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017116, HPA048086"	Enhanced				"Intracellular and membrane"					"CAB017116: , HPA048086: AB_2680257"	"unprognostic (5.57e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavourable (5.72e-4)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (3.79e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.31e-2)"	8.5	1.5	2.9	39.5	3.2	88.9	2.4	0.7	2.9	1.1	1.1	4.2	0.4	0.6	0.7	1.1	1.2	6.9	4.3	5.6	2.6	2.0	1.7	4.5	26.9	27.5	7.2	1.1	1.1	1.3	0.3	1.1	152.7	3.8	1.3	0.5	2.1	1.6	0.5	0.6	0.3	1.6	3.1	7.1	71.4	2.2	1.4	3.3	1.1	1.0	0.4	0.9	4.6	3.9	0.0	8.2	167.3	22.1	0.2	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.6	0.0	0.0	22.1	0.6	0.0	4.8	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	167.3	0.2	1.8	0.2	0.0	10.3	2.9	3.2	0.7	2.9	2.6	2.0	7.2	1.1	3.8	3.3
E2F2	E2F-2	ENSG00000007968	"E2F transcription factor 2"	Q14209	1	23506430-23531220	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 22.8;lymphoid tissue: 69.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.6;Karpas-707: 20.3;U-266/84: 18.1;U-698: 19.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 6.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			CAB016313	Uncertain									"CAB016313: AB_2096794"	"unprognostic (3.14e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.18e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.70e-3)"	"unprognostic (6.43e-6)"	"unprognostic (7.83e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.00e-3)"	"unprognostic (2.82e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.84e-1)"	0.4	0.2	0.1	6.1	0.2	22.8	1.0	0.1	0.2	1.1	3.5	0.2	0.0	1.6	0.1	0.2	11.2	0.1	0.2	1.5	0.0	0.0	0.4	0.7	1.2	3.3	0.2	0.0	0.2	0.6	0.0	0.0	2.2	0.2	0.3	2.3	0.3	1.2	0.0	0.0	4.4	3.4	0.4	0.2	6.8	0.9	4.4	0.1	69.7	0.3	3.9	6.1	0.5	2.3	0.9	1.1	6.7	2.0	0.2	2.8	0.4	2.7	2.0	3.3	5.3	0.1	0.1	2.3	1.3	0.6	1.2	1.6	1.2	1.6	23.6	1.6	0.6	5.5	6.7	0.3	1.1	5.9	2.1	3.7	5.0	1.4	0.0	2.7	4.9	0.0	0.0	0.9	0.1	0.4	2.8	20.3	0.5	1.6	12.0	2.5	0.7	1.0	13.3	7.2	8.0	0.5	0.7	4.4	6.1	2.2	2.8	0.6	2.1	2.0	0.2	1.1	3.3	3.6	1.8	15.0	18.1	19.5	1.1	2.9	2.2	6.7	0.6	1.7	0.2	1.5	0.1	0.9	0.7	0.5	1.1	0.6	0.1	0.2	0.4	0.2	2.0	0.9	2.8	0.4	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.1
FCHO1	KIAA0290	ENSG00000130475	"FCH domain only 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 25.7;bone marrow: 18.9;brain: 30.2;lymphoid tissue: 22.6;skin 1: 13.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 27.9;RPMI-8226: 19.2;U-937: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA041653: AB_10795641, HPA062981: AB_2684915"	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	2.3	13.6	13.7	18.9	18.9	1.9	11.4	15.2	1.1	2.7	30.2	0.0	3.7	1.8	1.8	1.5	1.9	4.5	1.1	17.8	11.7	1.0	2.7	3.4	22.6	23.0	10.0	2.2	0.9	0.8	2.6	1.4	10.8	1.4	2.6	0.6	2.7	1.2	0.9	13.4	4.0	2.1	15.9	13.7	3.5	4.3	23.3	16.4	1.2	0.0	17.3	5.1	1.0	9.9	10.4	25.7	9.5	4.1	5.7	4.4	0.4	5.4	3.5	2.5	0.1	0.1	3.5	0.5	0.1	0.1	0.2	0.7	0.6	27.9	8.0	0.2	1.1	1.7	1.0	0.1	12.3	0.9	2.2	0.7	2.8	0.3	6.9	4.7	0.0	0.1	0.1	0.2	0.7	10.9	13.4	0.0	7.7	15.8	12.4	1.7	13.3	13.5	0.1	19.2	0.1	0.5	0.6	1.3	0.1	2.8	0.4	2.7	6.9	0.5	0.1	2.0	0.5	0.2	8.5	3.8	15.1	0.4	17.2	0.3	6.9	6.6	6.5	5.2	9.5	4.5	8.8	5.7	4.5	9.7	9.9	5.5	4.4	25.7	4.1	7.2	10.4	5.2	4.4	13.6	18.9	11.4	15.2	17.8	11.7	23.0	10.0	10.8	23.3
GCNT7	"C20orf105, dJ1153D9.2"	ENSG00000124091	"Glucosaminyl (N-acetyl) transferase family member 7"	Q6ZNI0	20	56491492-56525925	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 3.9;bone marrow: 9.6"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052617	Uncertain									"HPA052617: AB_2681886"	"unprognostic (3.57e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.96e-2)"	"unprognostic (9.08e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.69e-2)"	0.2	0.2	0.0	0.7	0.0	9.6	0.3	0.6	0.3	0.0	0.2			0.3	0.2	0.0	0.3	0.1	0.5	0.1	0.0	0.0	0.1	0.3	0.4	0.4	0.0		0.5	0.5	0.0	0.6	0.1		0.3	0.0		0.4	0.0	0.3	1.0	0.4	0.0	0.1	0.5	0.3	1.6			0.3		0.0	0.6	0.3	1.0	0.9	3.9	0.7	0.3	1.1	0.1	0.6	0.9	0.8	0.5	0.0	0.0	1.1	1.0	0.0	0.0	0.0	2.1	0.5	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.1	1.1	1.7	0.5	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.0	1.3	0.7	1.3	0.5	0.7	0.1	0.4	0.5	0.0	1.8	1.0	0.5	1.2	0.9	0.2	0.8	0.2	0.0	2.2	0.4	0.5	0.5	1.6	0.1	0.5	0.3	0.6	0.5	1.1	0.7	0.9	0.8	0.5	0.8	0.7	0.7	0.5	0.4	1.0	1.1	0.4	3.9	0.3	0.7	0.9	0.9	0.1										
GP9	"CD42a, GPIX"	ENSG00000169704	"Glycoprotein IX platelet"	P14770	3	129060767-129062406	"CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 27.1;bone marrow: 10.0;lymphoid tissue: 24.5"	"Cell line enriched"	"Detected in some"	14	"HEL: 42.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 8.8;neutrophil: 7.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063182	Enhanced					68000000	68000000			"HPA063182: AB_2684956"			"unprognostic (1.70e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.80e-2)"		"unprognostic (2.50e-2)"		"unprognostic (3.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.47e-2)"		"unprognostic (8.70e-2)"		0.2	0.1	0.1	0.1	0.1	10.0	0.1	0.0	0.6	0.4	0.5	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.1	5.0	0.8	0.1	0.1	0.4	4.8	0.0	0.8	0.2	0.5	0.1	0.0	0.3	1.5	0.4	0.1	0.4	0.2	0.0	0.6	0.2	0.0	0.1	0.0	0.1	24.5	0.3	2.2	0.0	0.0	0.6	0.6	0.0	0.6	3.0	0.1	1.5	8.8	0.6	0.0	0.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.6	0.1	0.1	0.3	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	7.5	0.0	0.0	1.5	0.0	27.1	0.1	0.1	0.0	0.6	0.8	0.1	0.8	0.2	0.4	0.0
HIST2H2AC	"H2A, H2A/q, H2AFQ"	ENSG00000184260	"Histone cluster 2 H2A family member c"	Q16777	1	149886975-149887364	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 47.7;bone marrow: 86.5;lymphoid tissue: 80.6"	"Cell line enriched"	"Detected in many"	4	"MCF7: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (5.50e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.34e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavourable (1.20e-10)"	"unprognostic (1.42e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.89e-2)"	"prognostic favourable (7.86e-5)"	10.5	8.5	4.2	6.5	4.2	86.5	8.6	3.1	4.1	13.8	7.5	2.8	5.4	4.6	8.1	6.0	10.9	6.4	8.1	13.2	3.9	3.1	8.2	6.1	10.5	12.5	2.9	3.7	15.3	15.8	3.6	7.6	8.4	2.3	10.6	4.3	13.8	6.0	10.1	7.2	10.1	6.4	9.7	7.6	10.7	5.8	4.9	2.4	80.6	6.0	8.1	10.5	16.2	8.9	15.8	11.6	47.7	15.9	7.9	11.0	10.8	2.5	3.2	3.6	11.0	0.0	0.6	5.3	0.7	0.9	1.8	2.6	1.9	0.7	5.4	0.1	0.2	1.2	0.2	1.2	0.0	0.3	4.3	1.3	0.4	9.2	0.0	3.1	2.8	0.7	0.2	0.1	0.4	1.3	1.1	6.6	0.4	44.3	3.7	3.1	4.7	7.6	1.1	1.5	1.0	0.7	1.9	1.1	5.1	1.5	0.8	2.5	0.4	3.1	1.0	0.8	7.3	1.3	1.9	3.0	1.9	2.8	2.0	4.3	1.6	17.0	15.9	8.1	11.0	10.6	10.0	6.2	9.7	8.7	8.1	15.8	6.8	6.7	47.7	7.9	10.6	11.6	7.3	10.8	4.2	4.2	3.1	4.1	3.9	3.1	2.9	3.7	2.3	2.4
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2"					"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA008436: AB_1850757, HPA027261: AB_2672184"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (3.37e-5)"	"prognostic unfavourable (2.46e-4)"	"prognostic unfavourable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavourable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	1.4	0.9	0.1	12.2	0.4	27.4	2.2	0.1	0.7	1.1	3.7	0.3	0.1	2.6	0.6	1.8	8.0	0.3	0.7	1.1	0.1	0.2	1.0	1.2	2.0	8.1	0.2	0.1	0.6	0.4	0.0	0.2	3.1	0.2	0.7	3.6	0.3	1.5	1.0	0.2	2.6	4.8	1.1	0.4	5.8	2.4	20.9	0.1	51.1	0.4	3.0	11.6	1.0	2.8	0.5	0.3	1.2	1.3	0.5	4.2	1.7	17.0	23.0	22.6	10.6	0.8	1.8	14.1	25.6	12.3	18.3	20.0	16.2	18.6	5.3	2.9	10.1	19.9	18.0	13.2	24.4	12.5	6.7	20.5	18.5	15.7	0.1	16.9	14.2	0.6	0.5	14.9	10.3	11.4	17.4	13.3	33.6	17.2	23.7	18.6	19.2	16.0	18.3	33.8	9.4	9.4	10.3	13.0	8.1	14.7	11.2	10.5	8.4	13.1	8.3	19.8	21.5	14.5	27.6	12.7	10.0	21.4	11.8	12.5	49.2	0.6	0.2	0.2	0.3	0.2	0.2	0.4	0.7	0.6	0.3	0.5	0.3	0.5	1.2	0.5	1.3	0.2	4.2	1.7	0.1	0.4	0.1	0.7	0.1	0.2	0.2	0.1	0.2	0.1
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331695-173335125	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 168.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	380000	380000	Nucleoplasm	Nucleoplasm	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109"	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavourable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	18.8	5.9	10.3	48.9	13.2	325.8	19.9	6.6	9.5	17.1	24.0	8.6	7.9	15.7	18.6	16.2	28.6	15.4	13.8	23.4	9.5	10.2	13.2	6.9	25.4	59.8	12.5	8.2	29.0	5.8	2.9	8.0	18.5	9.3	19.0	21.2	12.2	13.8	8.6	46.2	15.5	21.5	25.3	13.3	36.7	13.0	26.7	10.6	187.1	18.7	23.0	61.6	27.1	18.5	11.6	16.8	95.9	20.5	11.9	39.9	14.3	34.3	8.2	70.9	31.6	8.8	8.8	27.2	25.6	19.5	28.2	25.3	23.3	48.0	116.2	5.8	14.3	13.4	46.5	14.0	44.2	71.1	21.7	127.7	20.9	34.1	8.6	112.9	49.3	8.5	4.3	14.1	32.2	29.0	48.1	163.7	25.9	28.7	168.3	104.8	25.8	14.3	85.1	36.4	43.1	16.3	14.7	61.4	55.4	25.9	15.0	11.5	20.8	82.4	16.6	12.7	37.6	15.7	38.4	52.9	29.6	133.0	10.8	82.6	33.0	95.9	20.5	57.6	15.6	8.5	14.1	11.6	22.7	21.2	16.8	8.8	15.0	14.3	47.8	11.9	6.8	6.8	39.9	14.3	10.3	13.2	6.6	9.5	9.5	10.2	12.5	8.2	9.3	10.6
HYAL3	"LUCA-3, LUCA14, Minna14"	ENSG00000186792	"Hyaluronoglucosaminidase 3"	O43820	3	50292831-50299468	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 26.9;bone marrow: 48.8;brain: 12.5;testis: 31.1"	"Cell line enhanced"	"Detected in many"		"HEL: 21.9;HMC-1: 39.3;THP-1: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 12.1;eosinophil: 26.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 26.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049402	Uncertain				"Secreted to blood"					"HPA049402: AB_2680746"	"unprognostic (1.21e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.45e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.65e-2)"	"unprognostic (7.98e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (2.12e-5)"	3.5	4.2	6.3	3.1	8.8	48.8	3.3	11.4	12.5	4.2	3.6	3.8	6.1	3.8	2.7	5.1	5.6	3.7	5.4	3.4	6.4	5.6	2.9	7.0	3.2	4.2	5.3	5.6	4.3	3.7	2.6	3.1	3.6	11.1	4.9	2.9	3.7	6.7	5.6	3.9	3.0	4.1	4.6	3.4	2.8	6.6	31.1	2.7	3.0	3.3	5.1	3.7	4.8	3.8	1.1	4.2	26.9	2.1	1.0	2.2	1.2	2.2	2.5	1.4	1.6	3.0	1.6	0.9	2.4	2.2	3.1	2.3	3.4	2.3	1.9	1.2	2.8	2.4	2.6	5.7	1.1	4.5	1.3	21.9	6.7	2.8	2.1	2.3	39.3	3.2	4.4	3.1	2.0	3.1	1.6	2.4	1.4	1.3	0.9	13.9	1.1	6.4	0.9	1.9	3.5	3.7	0.9	1.8	2.1	3.5	2.8	1.9	1.9	40.4	4.2	2.6	1.9	8.4	1.4	1.1	2.5	1.5	2.3	8.4	2.2	12.1	2.1	26.9	0.7	1.1	1.2	0.9	2.2	1.0	4.2	1.1	0.6	0.8	0.7	1.0	0.7	1.1	1.3	1.2	6.3	8.8	11.4	12.5	6.4	5.6	5.3	5.6	11.1	2.7
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936748-203961577	"CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 18.4;bone marrow: 13.8;lymphoid tissue: 51.8"	"Group enriched"	"Detected in some"	100	"HEL: 5.9;MOLT-4: 15.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 18.4"	"Lineage enriched"	"Detected in single"	58	"T-cells: 18.4"	"Low region specificity"	"Detected in single"							"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"CAB032575: AB_2122593, HPA034865: "	"unprognostic (2.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.19e-4)"	"unprognostic (2.35e-5)"	"unprognostic (1.07e-1)"	"prognostic favourable (1.80e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.51e-4)"	"unprognostic (7.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.86e-5)"	"unprognostic (7.05e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.82e-3)"	1.5	0.3	0.2	15.6	0.2	13.8	0.7	0.2	0.2	0.8	1.2	0.0	0.2	0.5	1.2	0.5	1.1	1.2	1.6	0.5	0.2	0.2	1.0	0.8	4.0	19.4	0.3	0.0	0.6	0.3	0.0	0.4	0.1	0.1	0.7	1.1	0.7	2.9	0.0	0.2	0.6	6.2	0.3	0.4	6.1	1.0	0.6	0.0	51.8	1.4	2.4	28.9	3.0	0.9	0.0	0.0	0.0	0.0	0.3	18.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	2.9	0.0	10.5	4.6	0.0	0.0	11.0	5.0	0.0	0.3	0.0	0.0	18.4	3.0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.1	0.0
IFIT1B	"bA149I23.6, IFIT1L"	ENSG00000204010	"Interferon induced protein with tetratricopeptide repeats 1B"	Q5T764	10	89378056-89385205	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"bone marrow: 23.2;placenta: 14.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062924	Approved									"HPA062924: AB_2684906"	"unprognostic (2.59e-1)"	"unprognostic (3.13e-1)"			"unprognostic (6.62e-3)"	"unprognostic (4.55e-2)"			"unprognostic (4.11e-2)"	"unprognostic (9.34e-2)"			"unprognostic (1.76e-1)"	"unprognostic (6.86e-2)"				0.4	0.0	0.2	0.0	0.2	23.2	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.2	0.3	0.1	0.2	0.5	4.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	14.6	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.6	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.6	0.0	0.2	0.0	0.9	0.2	0.0	0.1	2.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.1	1.7	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.2	0.0	0.0	2.4	0.2	0.2	0.0	0.1	0.3	0.1	0.2	0.0	0.2	0.0
IRAK1BP1	"AIP70, SIMPL"	ENSG00000146243	"Interleukin 1 receptor associated kinase 1 binding protein 1"	Q5VVH5	6	78867472-78946440	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 79.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035742, HPA035743"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA035742: AB_10670119, HPA035743: AB_2674764"	"unprognostic (2.62e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.93e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.58e-1)"	2.8	4.0	6.9	3.4	12.4	79.6	3.9	8.8	8.1	6.4	4.1	3.4	6.2	3.5	7.2	7.7	3.2	7.3	5.3	3.6	5.6	4.1	7.0	2.6	4.4	6.0	3.0	6.5	7.0	8.1	4.2	17.9	2.8	4.3	5.2	2.7	5.1	4.2	6.5	2.3	5.7	4.7	4.1	3.6	4.7	5.5	15.4	5.7	8.8	7.6	1.9	2.3	4.5	4.0	1.4	1.6	3.9	1.4	1.3	2.0	0.4	1.6	3.2	5.2	4.6	2.2	4.8	4.5	1.1	2.7	1.1	1.9	3.8	3.0	3.1	1.4	2.5	3.0	9.3	4.4	1.9	4.7	3.8	4.0	4.7	2.0	2.8	9.7	3.7	4.2	4.4	2.0	2.5	3.5	5.1	7.7	1.7	0.8	2.9	6.4	2.4	2.7	1.1	2.9	2.2	4.8	6.5	6.9	8.2	1.5	1.7	1.2	3.8	6.5	3.1	2.7	2.6	1.5	4.0	7.8	4.6	4.8	0.8	0.7	3.1	3.9	0.3	0.4	1.5	0.2	1.1	1.4	1.4	0.8	0.6	0.9	1.9	2.0	2.5	1.3	1.4	1.6	1.6	0.4	6.9	12.4	8.8	8.1	5.6	4.1	3.0	6.5	4.3	5.7
IVNS1ABP	"HSPC068, KIAA0850, KLHL39, ND1, NS-1, NS1-BP"	ENSG00000116679	"Influenza virus NS1A binding protein"	Q9Y6Y0	1	185296388-185317329	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 171.2"	"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003405	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA003405: AB_1079141"	"unprognostic (4.11e-3)"	"unprognostic (9.69e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.18e-1)"	"unprognostic (7.04e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.28e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.13e-2)"	23.7	8.7	9.9	19.8	35.8	171.2	29.0	9.9	13.8	12.5	17.0	19.2	28.5	16.2	10.2	12.9	17.1	9.0	15.9	19.3	10.9	8.6	38.7	10.2	26.5	29.9	23.0	7.8	12.7	17.1	11.6	11.9	15.8	16.8	12.6	21.5	9.2	36.2	38.8	13.5	19.5	14.3	7.9	19.3	12.8	18.3	9.0	20.8	13.1	17.3	16.0	16.3	11.5	22.5	4.6	9.1	24.5	8.1	7.4	7.9	8.1	6.8	7.6	22.3	8.9	8.0	2.6	21.0	13.6	4.2	8.6	7.8	8.1	11.0	11.0	11.3	6.6	9.6	8.1	8.9	9.2	8.1	7.8	10.4	11.4	6.5	3.1	7.2	4.1	1.9	10.1	6.5	21.1	11.0	6.9	6.2	15.4	5.2	11.9	5.1	14.0	1.7	7.1	5.9	5.9	73.0	9.2	15.6	13.3	12.0	10.0	8.1	4.5	3.5	7.5	12.0	7.3	3.0	9.6	8.9	7.1	6.5	8.9	7.4	5.3	5.1	8.1	7.7	7.9	5.9	7.0	4.6	6.0	5.7	9.1	3.3	6.7	6.3	24.5	7.4	7.2	2.5	6.1	8.1	9.9	35.8	9.9	13.8	10.9	8.6	23.0	7.8	16.8	20.8
LHFPL5	"DFNB67, dJ510O8.8, MGC33835, Tmhs"	ENSG00000197753	"LHFPL tetraspan subfamily member 5"	Q8TAF8	6	35805293-35833874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"bone marrow: 7.4;brain: 6.7;epididymis: 12.0;pancreas: 12.3"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055110	Uncertain									"HPA055110: AB_2682697"	"unprognostic (2.35e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"		"unprognostic (4.89e-3)"		"unprognostic (2.96e-3)"	"unprognostic (2.46e-2)"		"unprognostic (1.47e-8)"	"unprognostic (5.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.41e-1)"	0.5	0.5	3.9	1.2	4.1	7.4	0.5	0.4	5.8	0.4	0.4	0.2	0.0	0.9	0.9	12.0	0.3	0.3	0.7	0.3	3.5	2.8	0.4	0.4	0.3	1.5	1.2	6.7	0.6	12.3	0.0	2.2	0.6	2.0	0.6	0.3	0.2	1.1	0.1	0.6	2.3	0.8	0.1	0.6	1.0	0.5	0.8	0.0	0.0	0.8	0.0	0.4	0.3	0.4	1.0	0.3	1.0	0.8	0.5	0.9	0.0	1.5	1.9	3.5	2.1	0.6	1.7	3.2	2.5	0.9	0.4	1.1	2.1	2.2	3.5	1.9	1.3	1.9	0.6	1.4	0.9	1.8	2.9	3.8	5.5	1.9	0.1	1.6	2.6	1.4	0.7	0.7	1.0	0.5	2.0	7.1	2.0	1.2	2.3	1.8	2.3	1.5	2.0	1.5	1.0	1.1	3.3	3.3	2.2	1.6	1.8	1.1	2.9	1.3	3.6	2.4	2.1	3.2	1.0	4.0	3.3	2.8	1.1	2.4	1.5	1.0	0.3	0.2	0.9	0.6	0.5	0.5	0.5	0.3	0.0	1.0	0.6	0.8	0.9	0.5	0.8	0.3	0.4	0.0	3.9	4.1	0.4	5.8	3.5	2.8	1.2	6.7	2.0	0.0
LILRA2	"CD85h, ILT1, LIR-7, LIR7"	ENSG00000239998	"Leukocyte immunoglobulin like receptor A2"	Q8N149	19	54572920-54590287	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 21.6;bone marrow: 21.7;lymphoid tissue: 39.9"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.5;REH: 2.9;THP-1: 5.9;U-937: 13.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 21.6;monocytes: 7.1"														"Secreted to blood"	130000000	130000000				"unprognostic (2.04e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.53e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.30e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.59e-2)"	2.8	1.5	1.4	4.7	1.1	21.7	0.9	0.1	2.0	0.6	0.8	3.0	0.0	0.6	0.5	1.0	0.5	2.3	1.0	3.7	1.1	1.1	1.2	3.8	6.8	14.6	2.9	0.4	1.1	0.6	0.5	0.4	1.7	1.4	0.6	0.6	1.1	0.8	0.5	0.6	0.7	0.7	1.0	3.7	39.9	0.7	0.7	2.3	0.7	0.6	0.0	0.8	0.9	1.8	0.2	2.1	21.6	7.1	0.3	0.1	3.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	2.5	0.0	0.0	2.9	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	5.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	13.3	0.1	2.4	4.9	1.8	0.1	7.1	0.0	0.1	0.1	0.1	2.1	0.2	0.1	0.1	21.6	0.3	6.8	0.4	0.0	3.0	1.4	1.1	0.1	2.0	1.1	1.1	2.9	0.4	1.4	2.3
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555563-183590876	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 125.2;bone marrow: 53.0;lung: 39.5;lymphoid tissue: 45.4"	"Cell line enhanced"	"Detected in many"		"A-431: 13.1;HMC-1: 11.4;hTERT-HME1: 27.4;U-2 OS: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 125.2;neutrophil: 80.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Cytosol	"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavourable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	15.3	3.1	2.0	23.0	4.5	53.0	3.9	0.7	2.8	2.9	2.8	3.7	0.2	2.3	1.8	6.1	4.1	5.2	7.2	6.4	2.0	1.8	2.9	5.4	39.5	42.7	6.8	0.4	3.5	4.2	0.6	1.9	11.5	3.8	3.4	3.7	4.2	4.4	0.8	3.5	7.1	3.8	5.8	5.5	45.4	2.6	3.9	3.2	4.2	2.0	5.6	5.5	7.3	3.5	1.4	24.3	125.2	45.7	0.2	1.0	22.7	13.1	0.4	0.0	0.0	0.0	0.0	0.1	1.0	1.2	1.8	0.8	0.1	0.4	1.6	2.3	0.4	7.4	0.0	9.7	1.6	8.2	0.0	0.0	3.3	3.0	0.0	1.0	11.4	0.0	2.1	1.7	27.4	0.0	0.0	2.9	3.0	0.1	0.1	0.5	0.2	0.7	3.5	1.1	9.9	0.4	0.1	0.0	0.0	0.1	0.0	0.4	1.4	4.6	0.6	0.0	26.6	0.0	2.4	0.5	0.7	0.2	0.2	5.2	0.0	15.5	45.7	125.2	0.1	34.4	0.1	1.4	0.4	0.1	24.3	0.8	0.2	0.1	80.6	0.2	29.7	1.3	1.0	22.7	2.0	4.5	0.7	2.8	2.0	1.8	6.8	0.4	3.8	3.2
NFE2	NF-E2	ENSG00000123405	"Nuclear factor, erythroid 2"	Q16621	12	54292111-54301121	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 119.7;bone marrow: 54.3;lymphoid tissue: 32.2"	"Group enriched"	"Detected in some"	4	"HEL: 83.6;K-562: 36.2;NB-4: 25.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 119.7;neutrophil: 80.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 119.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001914	Enhanced		Approved	"Nucleoplasm,Actin filaments"				"Nucleoplasm, Actin filaments"	"Nucleoplasm, Actin filaments"	"HPA001914: AB_1079475"	"unprognostic (2.68e-4)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.90e-6)"	"unprognostic (1.81e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.46e-2)"	2.3	0.3	0.9	3.5	1.5	54.3	0.5	0.4	1.7	0.9	0.4	0.2	0.0	0.5	0.4	0.4	0.7	2.0	0.9	7.8	1.5	0.4	0.9	2.6	9.6	20.9	5.2	0.2	1.2	0.6	1.2	0.8	15.9	1.2	1.0	0.3	1.2	0.5	0.2	1.0	2.9	0.5	1.1	1.0	32.2	0.7	0.9	0.7	1.8	1.7	0.2	0.5	1.2	8.1	0.0	15.2	119.7	23.1	0.0	0.1	12.9	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	1.5	0.1	0.2	1.1	2.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	83.6	0.2	1.9	0.0	1.2	11.0	0.1	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	3.3	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.2	4.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	119.7	23.1	21.7	0.0	6.4	0.1	0.0	0.0	0.0	15.2	0.0	0.1	0.0	80.0	0.0	3.8	0.2	0.0	12.9	0.9	1.5	0.4	1.7	1.5	0.4	5.2	0.2	1.2	0.7
NLRP12	"CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2"	ENSG00000142405	"NLR family pyrin domain containing 12"	P59046	19	53793603-53824394	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 22.8;bone marrow: 11.0;lung: 6.5;lymphoid tissue: 13.5"	"Group enriched"	"Detected in some"	4	"HMC-1: 7.5;THP-1: 6.6;U-87 MG: 7.2;U-937: 6.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 2.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 22.8;neutrophil: 15.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 22.8;monocytes: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042099, HPA042981"	Approved		Uncertain	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	Nucleoplasm	"HPA042099: , HPA042981: AB_10795712"	"unprognostic (6.92e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.66e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.81e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.48e-1)"	1.9	0.3	0.2	4.2	0.6	11.0	0.4	0.2	0.2	0.9	0.3	0.1	0.9	0.3	0.7	0.7	0.6	1.0	0.5	3.3	0.2	0.2	0.5	0.5	6.5	13.5	0.6	0.3	1.0	0.3	0.1	0.2	1.1	0.8	0.3	0.1	0.5	1.7	0.0	0.2	0.2	0.3	1.4	0.5	10.2	0.4	1.0	0.6	0.3	0.3	0.4	0.2	1.1	1.4	0.0	3.6	22.8	8.7	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.6	7.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.2	6.0	0.0	22.8	8.7	11.0	0.0	2.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	15.0	0.0	1.5	0.0	0.0	2.1	0.2	0.6	0.2	0.2	0.2	0.2	0.6	0.3	0.8	0.6
NLRP3	"AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1, FCAS, FCU, MWS, NALP3, PYPAF1"	ENSG00000162711	"NLR family pyrin domain containing 3"	Q96P20	1	247416156-247449108	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 40.3;bone marrow: 38.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 7.1;THP-1: 40.7;U-937: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 40.3"	"Group enriched"	"Detected in many"	20	"dendritic cells: 13.4;granulocytes: 40.3;monocytes: 12.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012878	Uncertain				"Intracellular and membrane"					"HPA012878: AB_1846752"	"unprognostic (3.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.84e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.17e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.10e-2)"	7.4	1.4	2.8	8.3	3.3	38.2	3.2	0.7	3.7	1.8	1.5	6.9	1.5	0.8	4.5	0.9	2.4	3.0	8.9	2.0	3.0	3.1	1.3	1.8	8.2	8.9	3.3	0.8	1.3	1.4	1.1	1.2	3.0	5.2	1.0	1.7	2.4	1.5	0.7	0.9	0.8	2.5	4.1	4.9	8.5	1.6	0.6	3.3	1.0	1.0	3.2	2.8	3.3	0.9	0.0	13.4	40.3	12.5	0.0	1.1	3.9	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.2	1.5	0.2	0.0	0.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.1	0.0	0.2	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	40.7	0.0	1.7	1.3	0.0	0.1	0.0	0.0	0.0	3.9	10.1	1.2	40.3	12.5	0.1	0.2	7.7	0.6	0.0	1.1	0.4	13.4	0.0	0.4	0.2	3.0	0.0	3.6	0.6	0.0	3.9	2.8	3.3	0.7	3.7	3.0	3.1	3.3	0.8	5.2	3.3
NRIP3	C11orf14	ENSG00000175352	"Nuclear receptor interacting protein 3"	Q9NQ35	11	8980576-9004049	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 11.5;blood: 13.8;bone marrow: 12.7;brain: 28.4;testis: 30.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 25.8;SiHa: 16.7;U-87 MG: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"basophil: 13.8"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058827, HPA072961"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA058827: AB_2683829, HPA072961: "	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.03e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.88e-3)"	"unprognostic (1.30e-1)"	2.9	11.5	10.0	2.0	19.7	12.7	4.8	27.6	24.7	1.9	1.0	3.1	0.0	1.0	3.9	3.8	1.4	2.1	2.2	1.4	28.4	9.6	1.2	0.7	1.3	1.3	10.5	6.8	0.8	0.8	2.4	0.7	1.3	11.0	1.2	1.2	3.3	1.1	1.4	0.6	0.9	1.0	2.8	4.5	1.0	1.6	30.3	0.8	0.0	1.4	0.0	1.1	1.0	0.3	0.1	0.2	13.8	0.3	0.1	1.0	0.2	0.0	0.4	0.9	0.1	0.3	1.4	0.0	10.0	3.9	8.1	8.5	1.5	0.8	0.0	1.5	2.9	0.1	2.7	0.2	14.1	0.7	4.0	1.0	0.5	0.1	0.6	12.5	25.8	1.8	0.1	8.3	0.1	6.5	1.9	0.1	7.4	0.0	0.6	4.0	3.2	0.0	0.0	1.4	0.0	0.1	0.6	2.7	0.8	16.7	0.4	2.5	1.7	1.2	8.1	12.4	5.9	0.7	0.0	0.0	0.0	0.0	24.1	1.5	6.0	13.8	0.1	2.0	0.1	0.3	0.2	0.1	0.5	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	1.0	0.2	10.0	19.7	27.6	19.6	28.4	9.6	10.5	6.8	11.0	0.8
OR2AK2	OR2AK1P	ENSG00000187080	"Olfactory receptor family 2 subfamily AK member 2"	Q8NG84	1	247965233-247966386	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"bone marrow: 2.5;testis: 1.3"	"Cell line enhanced"	"Detected in single"		"PC-3: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052544	Uncertain									"HPA052544: AB_2681865"																		0.0	0.2	0.0	0.0	0.3	2.5	0.0	0.1	0.2	0.4	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.3			0.2		0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3										
OR4D1	"OR4D3, TPCR16"	ENSG00000141194	"Olfactory receptor family 4 subfamily D member 1"	Q15615	17	58148449-58159555	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 4.4;bone marrow: 2.2;lymphoid tissue: 1.8;testis: 1.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 2.0;NK-cells: 4.4;T-cells: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.1	0.1	0.1	0.5	0.1	2.2	0.1	0.1	0.6	0.2	0.1			0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	1.8	0.1		0.1	0.1	0.0	0.1	0.0		0.1	0.0		0.2	0.0	0.3	0.3	0.1	0.0	0.1	1.3	0.1	1.5			0.1		0.9	0.5	0.1	0.2	0.4	2.0	0.1	4.4	3.7	0.9	0.2	0.3	0.1	0.7	0.0	0.3	3.7	0.2	0.0	0.1	0.3	0.4	0.6	0.2	0.2	0.1	0.2	0.3	0.1	0.2	0.4	1.1	0.2	0.4	0.3	0.2	0.5	0.3	0.0	0.4	0.4	0.3	0.1	0.5	1.0	0.0	0.4	0.3	0.7	1.9	0.4	0.2	0.1	0.5	0.1	0.5	0.7	0.6	0.3	0.8	0.0	0.3	0.8	0.0	0.4	1.1	0.5	0.3	0.4	0.4	0.5	0.5	1.0	0.5	2.0	0.1	0.8	2.3	0.1	2.4	0.2	2.2	2.1	0.1	0.2	3.4	3.7	0.8	4.4	0.1	0.4	0.5	0.9										
OSCAR		ENSG00000170909	"Osteoclast associated, immunoglobulin-like receptor"	Q8IYS5	19	54094668-54102692	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.3;HHSteC: 9.1;hTERT-HME1: 4.7;NB-4: 5.3;U-937: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	34	"classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2"	"Group enriched"	"Detected in many"	75	"dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073996			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	72000000	72000000	"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA073996: "	"unprognostic (9.09e-2)"	"unprognostic (6.79e-3)"	"unprognostic (8.47e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavourable (2.71e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.28e-2)"	4.5	1.0	1.4	3.8	2.8	18.9	1.4	0.4	1.5	1.3	0.9	3.5	0.0	0.4	0.7	1.3	1.2	2.2	2.3	1.1	3.8	1.9	1.0	1.7	40.4	4.7	3.5	0.4	1.2	0.7	0.3	0.5	2.2	4.0	0.8	0.7	1.0	1.3	0.8	0.7	1.9	1.0	2.8	5.6	20.2	1.3	0.6	2.4	1.7	1.0	0.0	1.2	1.7	3.1	0.0	9.4	18.3	20.6	0.0	0.2	7.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.4	0.0	13.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	9.1	0.7	0.0	0.0	0.2	0.6	4.7	0.0	0.0	0.4	0.1	0.1	0.0	5.3	0.3	1.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	3.8	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.5	0.5	16.5	0.0	0.0	20.6	11.7	0.1	12.8	0.0	0.0	0.1	0.2	9.4	0.0	0.0	0.0	18.3	0.0	11.2	0.4	0.1	7.0	1.4	2.8	0.4	1.4	3.8	1.9	3.5	0.4	4.0	2.4
PADI4	"PAD, PADI5, PDI4, PDI5"	ENSG00000159339	"Peptidyl arginine deiminase 4"	Q9UM07	1	17308195-17364004	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 48.2;bone marrow: 54.8;lymphoid tissue: 24.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;HEL: 4.1;NB-4: 1.6;RPMI-8226: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"basophil: 17.0;classical monocyte: 18.6;eosinophil: 24.6;neutrophil: 48.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 48.2;monocytes: 18.6"	"Not detected"	"Not detected"							"HPA017007, HPA042825"	Enhanced					12000	12000			"HPA017007: AB_1854921, HPA042825: AB_2678189"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.49e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.80e-1)"	1.2	0.2	0.3	0.5	0.2	54.8	0.2	0.1	0.8	0.2	0.2	0.5	0.0	0.2	0.2	0.1	0.4	0.9	0.4	9.8	0.6	0.1	0.3	1.2	9.7	5.2	1.8	0.0	0.9	0.3	0.1	0.6	4.1	0.6	0.1	0.2	0.9	0.5	0.1	0.2	0.2	0.2	0.4	0.2	24.2	0.3	1.0	0.3	2.6	0.6	0.2	0.2	0.4	7.5	0.4	3.6	48.2	18.6	1.1	1.2	8.1	0.2	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	4.1	0.1	0.4	0.0	0.4	0.5	0.0	0.5	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.0	1.6	0.2	0.2	0.2	0.0	4.8	0.0	0.3	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.1	0.0	0.2	0.5	0.1	17.0	18.6	24.6	0.1	1.4	0.0	0.2	0.1	0.2	3.6	0.4	0.7	1.2	48.2	1.1	0.4	1.6	0.1	8.1	0.3	0.2	0.1	0.8	0.6	0.1	1.8	0.0	0.6	0.3
PIK3CG		ENSG00000105851	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma"	P48736	7	106865278-106907145	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 24.5;bone marrow: 27.8;lymphoid tissue: 40.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.2;HMC-1: 15.2;Karpas-707: 12.6;MOLT-4: 23.0;U-266/70: 30.9;U-937: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069976	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA069976: AB_2686224"	"unprognostic (8.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.38e-1)"	"unprognostic (5.24e-2)"	5.0	1.8	2.2	16.0	3.1	27.8	2.3	0.8	1.7	1.7	4.1	2.7	0.0	2.8	1.7	2.0	2.0	1.8	3.5	1.7	1.7	1.5	1.9	1.5	4.3	13.1	3.0	1.0	1.7	1.5	0.6	1.4	2.0	2.5	2.2	2.6	1.9	3.1	0.5	1.1	1.3	6.1	1.9	6.4	17.4	2.5	7.6	3.0	40.8	2.3	0.9	21.2	4.1	1.5	6.2	5.6	14.2	24.5	5.3	5.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.0	0.0	0.0	11.9	15.2	0.0	0.0	0.0	0.0	4.7	8.5	12.6	0.0	0.0	23.0	4.6	0.0	0.0	6.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.2	0.0	0.1	0.0	0.0	30.9	0.0	11.5	0.0	21.8	2.9	4.6	3.4	14.2	5.6	10.6	5.1	4.7	2.6	4.2	5.6	6.2	2.8	3.8	13.9	5.3	24.5	4.9	2.6	3.6	2.2	3.1	0.8	1.7	1.7	1.5	3.0	1.0	2.5	3.0
PKMYT1	"MYT1, PPP1R126"	ENSG00000127564	"Protein kinase, membrane associated tyrosine/threonine 1"	Q99640	16	2968024-2980539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068860			Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA068860: AB_2686050"	"unprognostic (7.82e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (8.33e-4)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.95e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.09e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.91e-2)"	0.9	0.7	0.7	9.4	0.6	19.5	1.3	2.6	0.8	1.3	2.9	0.3	0.5	1.9	0.8	1.5	7.2	0.2	1.5	1.4	0.7	0.7	0.8	1.0	1.3	6.2	0.8	0.2	0.3	1.3	0.0	0.7	4.3	0.4	0.6	0.8	0.3	1.3	0.2	1.6	3.4	3.2	0.6	1.0	4.4	2.7	61.4	0.2	42.8	0.3	9.2	12.7	0.7	2.0	0.8	0.4	0.3	0.5	0.4	4.4	1.0	24.6	17.3	6.8	9.7	0.1	0.3	18.3	19.2	4.6	12.2	11.7	13.4	14.7	15.4	8.6	2.1	31.7	4.7	6.1	2.2	19.8	15.6	7.8	15.6	11.7	0.0	8.7	22.3	0.2	0.5	7.2	1.9	2.5	22.4	27.4	3.9	37.0	24.4	24.2	11.1	9.2	26.6	15.1	29.8	2.3	5.4	12.9	13.6	9.3	24.2	7.2	13.8	17.4	2.3	16.4	20.8	23.9	20.0	20.8	15.4	26.5	6.2	11.7	19.0	0.0	0.4	0.3	0.3	0.3	0.0	0.8	0.5	0.5	0.4	0.0	0.0	0.0	0.1	0.4	0.5	0.1	4.4	1.0	0.7	0.6	2.6	0.8	0.7	0.7	0.8	0.2	0.4	0.2
PRAMEF18		ENSG00000279804	"PRAME family member 18"	Q5VWM3	1	13222705-13226106	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	4	"bone marrow: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA057423	Uncertain									"HPA057423: AB_2683435"																		0.0	0.4		0.0		1.9	0.0		0.0	0.0	0.0			0.0	0.0	0.3	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.1			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.5	0.8	0.0	0.2	0.0	0.1	0.1	0.5	0.0	0.2	0.2	0.4	0.2	0.0	0.1	0.1	0.0	0.6	0.1	0.3	0.1	0.1	0.2	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0										
PRRT4		ENSG00000224940	"Proline rich transmembrane protein 4"	C9JH25	7	128350325-128361685	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 49.0"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 70.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA046373, HPA052681"	Uncertain		Approved	"Nucleoplasm,Peroxisomes,Plasma membrane"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA046373: AB_2679642, HPA052681: AB_2681912"	"unprognostic (1.72e-1)"	"unprognostic (4.55e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.20e-4)"	"unprognostic (2.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.28e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.27e-2)"	12.1	1.9	2.0	5.9	11.3	49.0	6.8	6.5	3.1	1.6	2.7	0.6	0.0	0.6	0.7	0.5	1.9	1.0	1.1	2.4	1.7	6.2	0.5	0.7	0.8	0.6	1.6	2.4	1.0	0.6	0.8	0.0	0.6	2.9	0.8	0.7	3.4	1.9	1.3	4.2	1.5	0.8	1.0	2.8	1.3	1.6	0.7	1.5	0.7	0.7	1.7	1.0	2.0	3.2	0.0	0.4	0.4	0.4	0.0	1.5	0.4	0.0	0.0	0.1	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	13.8	0.3	0.0	3.8	0.2	0.3	0.0	0.0	0.1	70.3	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.0	0.0	1.5	0.7	0.4	0.0	0.0	0.4	0.0	0.4	2.0	11.3	6.5	3.1	1.7	6.2	1.6	2.4	2.9	1.5
RELT	"FLJ14993, TNFRSF19L"	ENSG00000054967	"RELT, TNF receptor"	Q969Z4	11	73376264-73397474	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 92.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062824, HPA071518"			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA062824: AB_2684875, HPA071518: AB_2686408"	"unprognostic (3.49e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.80e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.42e-2)"	"unprognostic (4.13e-2)"	"prognostic unfavourable (4.07e-11)"	"unprognostic (1.64e-1)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.69e-1)"	3.5	2.2	3.5	11.7	8.8	92.2	2.8	3.5	5.7	1.4	2.1	7.4	0.0	2.7	1.9	2.5	3.2	1.6	4.1	5.3	4.0	5.2	2.0	2.0	8.4	18.2	8.3	3.9	1.5	1.6	1.8	3.1	4.1	13.9	1.7	2.0	2.3	4.6	1.3	22.1	2.5	5.6	2.8	14.3	18.1	2.5	3.0	4.6	4.8	1.8	3.9	9.0	3.3	2.1	4.7	6.8	12.1	19.2	0.3	1.1	3.1	5.6	5.7	4.4	4.4	0.5	0.6	5.1	6.3	3.9	7.3	4.4	5.4	2.5	10.4	20.8	4.1	8.4	2.8	3.1	2.6	6.3	5.4	9.9	7.1	2.0	1.2	9.8	17.4	0.7	1.3	7.7	2.0	2.6	7.4	13.9	2.0	5.4	7.0	10.1	4.0	7.1	13.9	7.8	9.1	1.4	2.4	5.9	5.6	5.4	4.9	6.6	2.7	8.4	3.6	9.2	6.5	15.2	11.2	4.9	3.8	11.5	5.6	9.6	9.7	0.4	7.0	12.1	0.5	14.3	1.1	4.7	0.6	1.0	6.8	3.7	0.8	0.4	11.6	0.3	19.2	6.8	0.2	3.1	3.5	8.8	3.5	5.7	4.0	5.2	8.3	3.9	13.9	4.6
RHCE	"CD240CE, RH"	ENSG00000188672	"Rh blood group CcEe antigens"	P18577	1	25362249-25430192	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"bone marrow: 40.5"	"Cell line enriched"	"Detected in some"	5	"HEL: 43.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.4"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA060951: , HPA077385: "	"unprognostic (1.37e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.91e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.77e-5)"	"unprognostic (1.38e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.63e-1)"	0.6	0.8	2.0	0.6	5.1	40.5	0.9	3.3	4.7	0.8	0.7	3.5	1.0	0.7	0.7	5.2	1.4	1.6	0.8	2.1	2.6	1.5	0.8	2.2	0.7	1.0	2.1	2.5	0.9	9.6	0.5	4.0	1.6	5.9	1.6	0.8	2.2	8.4	0.8	1.9	1.1	0.6	0.5	2.9	2.1	0.8	2.6	1.4	1.2	1.1	1.2	0.8	0.5	0.6	0.1	0.2	2.4	0.2	0.1	0.3	0.9	0.1	0.0	0.1	0.2	0.4	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.7	0.3	0.5	0.5	0.1	0.0	0.1	0.1	0.2	0.0	43.6	0.0	0.0	0.5	0.0	0.3	0.9	0.7	0.3	0.2	0.0	8.5	0.2	0.2	0.4	0.0	0.3	0.8	0.2	0.0	0.1	1.2	0.0	0.0	0.3	0.4	0.1	0.1	0.5	0.2	0.0	0.0	0.1	0.0	0.4	0.0	2.6	0.6	0.5	1.4	0.4	0.2	2.4	0.2	0.6	0.3	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.2	0.0	1.0	0.1	0.0	0.1	0.3	0.9	2.0	5.1	3.3	4.7	2.6	1.5	2.1	2.5	5.9	1.4
RNF138	"NARF, STRIN"	ENSG00000134758	"Ring finger protein 138"	Q8WVD3	18	32091855-32131561	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 43.8;bone marrow: 40.4;lymphoid tissue: 28.3;testis: 73.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041101			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA041101: AB_10805837"	"unprognostic (2.37e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.90e-1)"	8.2	5.0	6.5	11.0	7.4	40.4	7.7	9.9	7.1	6.5	11.0	9.0	5.8	8.0	7.5	6.3	7.4	9.7	7.1	5.0	6.8	6.4	5.9	10.1	7.6	17.9	10.6	6.3	9.0	7.8	5.6	8.7	7.2	6.7	6.5	10.0	4.5	6.9	4.9	5.1	5.6	11.2	5.6	9.1	14.3	6.6	73.4	8.1	28.3	7.0	5.7	9.9	6.1	6.8	14.4	24.3	25.7	24.9	16.4	43.8	24.2	8.9	5.3	22.0	10.9	2.8	6.0	12.5	9.2	5.2	11.5	13.4	6.2	6.3	21.6	11.5	6.0	9.4	11.5	10.4	15.7	12.0	19.2	17.0	6.9	7.6	11.3	46.8	15.1	5.8	10.4	12.7	18.1	11.7	23.4	8.9	7.4	8.5	31.6	21.0	24.6	7.4	32.7	13.8	12.4	10.5	6.7	25.0	12.5	12.3	7.1	9.5	4.6	19.8	9.0	13.9	10.2	3.4	10.2	14.8	19.5	37.5	7.6	26.2	13.6	8.0	24.9	24.0	10.5	18.6	13.4	14.0	22.9	14.8	24.3	14.4	43.8	27.9	25.7	16.4	15.3	10.5	16.7	24.2	6.5	7.4	9.9	7.1	6.8	6.4	10.6	6.3	6.7	8.1
RXFP4	"GPCR142, GPR100, RLN3R2, RXFPR4"	ENSG00000173080	"Relaxin/insulin like family peptide receptor 4"	Q8TDU9	1	155941710-155942949	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"blood: 1.8;bone marrow: 1.3;intestine: 5.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.6;NB-4: 2.1;SK-MEL-30: 2.0;T-47d: 2.2"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.4"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (4.90e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.86e-2)"	0.2	0.0	0.0	0.5	0.1	1.3	0.1	0.7	0.0	0.0	5.2			3.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	5.4		0.1	0.1	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.2			0.0		0.0	0.6	0.0	0.6	0.4	1.8	1.4	0.7	0.8	0.2	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.4	1.2	0.0	0.9	0.0	0.3	0.0	0.0	0.3	0.6	0.2	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.1	2.1	0.3	0.0	0.2	0.0	1.0	0.0	0.0	0.1	0.0	0.0	1.0	2.0	2.2	0.0	0.6	0.1	0.0	0.0	0.0	0.1	1.2	0.7	1.2	0.2	0.1	0.0	0.9	1.8	0.0	1.1	0.0	0.0	0.5	0.8	0.4	0.6	0.0	0.1	1.1	0.7	1.4	0.0	0.0	0.2										
S1PR4	EDG6	ENSG00000125910	"Sphingosine-1-phosphate receptor 4"	O95977	19	3172346-3180332	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 44.2;bone marrow: 14.9;lymphoid tissue: 35.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.8;HL-60: 14.4;NB-4: 14.2;REH: 40.1;U-937: 13.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA060601, HPA067232"			Supported	Mitochondria				Mitochondria	Mitochondria	"HPA060601: AB_2797261, HPA067232: AB_2797271"	"prognostic favourable (3.13e-4)"	"prognostic favourable (1.33e-4)"	"unprognostic (2.58e-2)"	"prognostic favourable (2.22e-4)"	"unprognostic (2.98e-2)"	"prognostic favourable (1.45e-6)"	"unprognostic (1.27e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (6.64e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.15e-3)"	2.0	0.5	0.7	8.3	0.3	14.9	1.3	0.6	0.7	0.5	0.9	0.4	0.2	0.8	0.7	0.7	1.2	1.4	0.7	2.1	0.3	0.2	1.2	1.4	6.4	35.9	0.3	0.4	0.7	0.3	0.0	0.2	1.7	0.6	0.7	0.0	1.0	1.3	0.2	1.1	0.4	7.1	0.2	0.5	34.2	3.9	0.3	0.3	10.2	1.5	0.2	10.7	1.9	0.6	14.1	7.3	44.2	15.3	5.4	23.1	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.1	0.0	0.1	0.0	0.0	0.0	10.8	0.0	4.6	0.1	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	40.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	13.7	0.0	16.4	10.4	27.4	11.8	11.6	10.5	11.3	14.7	11.4	7.3	14.1	12.4	11.9	44.2	5.4	15.3	6.6	23.1	7.2	0.7	0.3	0.6	0.7	0.3	0.2	0.3	0.4	0.6	0.3
SMIM3	"C5orf62, MSTP150, NID67"	ENSG00000256235	"Small integral membrane protein 3"	Q9BZL3	5	150777946-150796734	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"adipose tissue: 24.4;blood: 22.3;bone marrow: 11.4;pancreas: 45.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 63.1;ASC TERT1: 30.9;LHCN-M2: 28.6;U-87 MG: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075345			Approved	Vesicles				Vesicles	Vesicles	"HPA075345: AB_2686744"	"unprognostic (2.33e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.45e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.05e-2)"	"unprognostic (9.71e-3)"	"unprognostic (3.46e-3)"	"prognostic unfavourable (1.15e-8)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-3)"	24.4	5.4	6.1	3.3	5.6	11.4	3.9	3.3	6.2	2.2	3.1	1.8	0.7	1.3	3.0	2.9	2.2	3.0	3.3	3.4	2.6	1.2	2.9	1.1	3.6	0.7	3.0	1.0	3.2	45.7	1.2	1.8	6.4	6.2	3.2	2.3	1.3	1.8	3.3	2.5	2.2	3.9	3.7	2.6	1.9	2.9	1.7	4.3	1.8	2.7	0.7	0.7	3.8	1.8	0.3	18.4	22.3	13.3	3.6	7.2	11.6	2.0	0.6	1.1	9.2	63.1	30.9	2.4	7.9	16.9	2.8	11.7	3.1	5.3	0.0	0.4	8.0	1.6	1.8	1.7	4.3	0.0	0.5	2.9	0.4	1.4	11.2	2.8	20.9	25.8	3.5	8.2	3.8	0.9	0.7	0.0	28.6	1.5	4.1	3.9	0.5	1.8	2.2	0.1	0.0	3.1	1.5	0.2	0.7	1.1	0.1	2.3	3.8	17.8	1.5	13.0	2.3	10.1	4.0	0.0	0.0	0.0	46.9	10.9	1.6	17.9	13.3	22.3	7.2	5.3	4.3	0.3	5.1	4.9	6.2	0.0	5.0	4.3	13.9	3.6	4.8	18.4	0.7	11.6	6.1	5.6	3.3	6.2	2.6	1.2	3.0	1.0	6.2	4.3
VNN3	HSA238982	ENSG00000093134	"Vanin 3"	Q9NY84	6	132722787-132734765	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 39.5;bone marrow: 29.8;liver: 29.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.5;EFO-21: 3.7;hTCEpi: 2.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 39.5"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 39.5"														"Secreted to blood"						"unprognostic (3.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.84e-8)"	"unprognostic (1.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	1.1	0.1	0.4	3.3	0.4	29.8	0.2	0.2	0.6	2.4	1.2	0.2	0.2	0.0	0.2	0.8	0.9	2.4	1.3	1.0	0.4	0.0	0.3	29.4	6.1	1.2	0.4	0.2	1.2	0.2	0.0	0.2	5.8	0.3	0.5	0.0	0.4	1.1	0.2	0.2	0.1	0.2	0.2	0.2	7.6	0.4	0.3	0.2	0.2	0.3	2.4	0.7	0.6	0.3	0.0	0.0	39.5	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	2.5	3.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	6.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.2	0.6	0.4	0.0	0.4	0.2	0.3	0.2
ABCA13	"FLJ33876, FLJ33951"	ENSG00000179869	"ATP binding cassette subfamily A member 13"		7	48171458-48647496	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.5;LHCN-M2: 3.6;U-2 OS: 10.2;U-266/84: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063601			Approved	Vesicles,Centrosome,Cytosol				Vesicles	Vesicles	"HPA063601: AB_2685057"	"unprognostic (8.97e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-3)"	"unprognostic (6.03e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.62e-2)"	0.3	0.2	0.1	0.3	1.0	35.4	0.7	0.0	1.1	1.2	0.3	0.4	0.0	0.3	0.3	1.1	10.3	1.8	0.5	3.5	1.8	0.2	1.1	0.7	15.7	0.2	0.1	0.0	0.4	1.2	0.1	8.7	1.2	0.4	0.2	0.4	0.0	1.7	0.4	0.8	1.3	0.3	0.2	0.9	1.3	0.2	4.2	0.0	4.6	7.1	5.4	14.4	0.5	0.3	0.6	0.6	3.2	0.7	1.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.3	1.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.5	1.2	2.1	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.0	0.0	0.1	3.6	0.0	0.0	0.1	0.1	2.1	0.3	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.6	10.2	0.4	1.5	3.0	4.1	0.0	1.3	0.4	0.4	3.2	0.7	0.6	0.3	0.4	0.3	0.4	0.2	0.2	0.1	0.6	0.4	0.4	1.6	1.0	0.3	0.6	0.1	0.2	0.1	1.0	0.0	1.1	1.8	0.2	0.1	0.0	0.4	0.0
ABCA7	ABCX	ENSG00000064687	"ATP binding cassette subfamily A member 7"	Q8IZY2	19	1040101-1065572	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 26.2;HMC-1: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041564	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"				"Golgi apparatus, Plasma membrane"	"Golgi apparatus, Plasma membrane"	"HPA041564: AB_2677550"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (7.26e-4)"	"prognostic favourable (1.12e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.68e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.08e-2)"	"unprognostic (3.66e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.85e-2)"	6.0	3.5	6.2	20.2	4.8	35.2	7.6	13.6	11.1	5.0	5.8	1.9	4.7	4.9	2.1	3.9	7.5	2.8	5.5	2.3	5.3	6.5	5.3	3.6	9.5	17.7	5.2	5.1	1.0	7.0	5.6	34.5	3.1	7.7	4.9	4.2	34.7	9.9	6.5	5.5	11.1	11.1	1.8	6.7	26.6	7.9	1.6	4.3	19.8	7.0	3.9	14.5	5.1	4.9	1.5	9.9	10.8	2.5	1.9	2.6	1.2	5.6	5.3	1.1	3.3	6.5	2.9	5.4	0.8	0.8	0.3	0.6	4.0	2.1	11.0	3.8	0.7	5.6	2.3	5.0	0.3	7.3	2.1	8.5	26.2	4.0	2.5	3.1	31.6	2.7	1.8	1.5	2.8	1.8	8.5	6.8	1.0	1.3	3.1	2.3	0.6	2.5	2.8	0.6	7.9	2.7	10.6	0.7	2.1	6.2	1.9	0.6	3.6	5.1	2.7	0.6	1.3	2.8	0.8	8.0	7.7	6.0	1.4	7.6	1.3	4.3	2.5	7.0	2.6	1.7	1.6	1.0	1.5	1.8	2.8	1.5	1.4	2.1	10.8	1.9	1.6	9.9	0.6	1.2	6.2	4.8	13.6	11.1	5.3	6.5	5.2	5.1	7.7	4.3
AC001226.2		ENSG00000283208			13	76992078-77129589	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"bone marrow: 19.2"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.3;NB-4: 2.9;U-698: 2.7"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																																							3.9	2.7	2.0	2.7	2.3	19.2	4.8	1.8	4.2	3.6	2.4	3.0	2.9	1.7	3.0	6.6	2.7	3.1	4.2	3.5	1.7		10.4	6.0	2.9	3.3	4.1	1.0	5.8	3.4	1.9	5.7	6.1	3.4	3.1	1.8	4.3	2.8	3.8	2.6	4.6	3.2	3.4	2.6	2.9	2.0	2.6	3.2	3.2	12.5	1.0	1.9	3.1	2.6	2.3	0.9	2.8	2.4	0.6	1.3	0.2	0.8	0.5	1.1	0.0	1.7	0.8	0.7	0.1	0.5	0.4	0.2	0.1	1.0	2.0	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.1	0.3	0.5	0.0	0.5	3.3	1.1	0.0	0.0	0.3	0.2	0.0	0.0	1.5	0.3	0.0	0.6	2.9	0.1	0.0	0.7	0.0	0.3	0.0	0.6	0.8	0.4	0.4	0.9	0.2	0.3	2.5	0.0	0.2	0.2	0.2	0.6	1.9	1.2	2.7	0.4	1.9	0.4	2.8	0.7	0.7	0.4	0.5	1.1	0.7	0.9	1.0	0.1	2.3	1.1	1.3	1.4	0.6	2.4	0.9	1.0	0.2										
AC005837.2		ENSG00000267168			17	76732978-76738522	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 2.2;bone marrow: 2.3;testis: 1.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 1.2;hTEC/SVTERT24-B: 1.6;PC-3: 1.7;RT4: 1.4;SCLC-21H: 1.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																																							0.1	0.5	0.5	0.0	0.2	2.3	0.0	0.1	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.2		0.0	0.4	0.0	0.0	0.0		0.0	0.5		0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.4			0.1		0.0	0.0	0.0	1.2	2.2	1.9	0.6	0.5	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	1.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.9	0.1	0.0	0.6	1.2	0.0	0.5	0.5	0.0	1.1	0.4	0.0	0.5	0.2	2.2	0.9	0.1										
AC008878.3		ENSG00000268861			19	7382834-7472477	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 7.7;bone marrow: 7.1;lymphoid tissue: 8.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.9;HL-60: 8.1;MOLT-4: 11.5;REH: 9.4;THP-1: 13.5;U-698: 10.7;U-937: 8.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042689, HPA071867"	Supported		Uncertain	Cytosol				Cytosol	Cytosol	"HPA042689: AB_10794385, HPA071867: AB_2686466"	"unprognostic (1.46e-1)"							"unprognostic (2.47e-2)"			"unprognostic (2.97e-1)"		"unprognostic (1.20e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.45e-4)"			0.0	1.2		4.3		7.1	0.0		0.0	0.0	0.5			0.0	0.9	0.1	1.5	0.0	2.1	0.0			0.2	0.0	1.0	8.6			0.0	0.0	0.0		0.0		0.0	0.7		0.0	0.0	0.0	0.6	0.0	2.3		4.9	0.0	0.0			0.7		4.8	2.4		7.4	1.4	7.7	3.3	0.1	4.2	1.4	0.0	0.2	0.5	0.0	1.3	0.3	0.0	0.0	1.1	0.0	0.3	0.0	0.0	17.9	0.0	4.4	0.0	2.4	0.0	5.7	0.0	0.0	0.2	0.0	0.0	0.3	8.1	7.2	2.7	0.1	0.1	2.2	1.0	0.0	0.0	3.6	0.0	11.5	3.0	0.0	0.0	9.4	0.1	3.7	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.1	0.3	0.1	0.0	0.1	0.0	10.7	0.3	8.4	0.0	0.9	1.7	7.7	2.7	1.9	1.5	7.4	3.6	1.8	1.1	6.7	4.2	1.4	4.3	0.1	3.3	1.4	1.7	1.4										
AC013394.1		ENSG00000279765			15	92883413-92949230	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 28.4;lymphoid tissue: 23.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (7.26e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.84e-2)"	"unprognostic (8.97e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.46e-6)"	"unprognostic (2.74e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.12e-2)"	2.2	2.7	2.7	1.7	4.2	28.4	6.3	3.6	7.3	3.4	3.9	3.1	0.5	1.8	3.3	3.7	2.9	2.8	2.9	5.3	5.8		3.9	2.5	4.6	3.8	2.2	6.2	4.3	6.8	3.5	4.2	3.5	4.8	3.9	3.5	2.4	3.1	3.5	4.9	2.8	4.0	2.9	1.1	23.7	2.1	20.7	3.1	1.0	7.2	2.1	3.6	2.8	0.5	11.4	4.8	8.8	1.5	2.6	4.3	0.8	10.6	8.4	31.8	20.4	9.9	13.0	23.3	10.6	19.1	17.0	12.8	8.5	25.0	11.4	10.6	13.6	16.7	13.3	10.8	17.1	0.0	13.1	19.9	16.7	8.1	20.7	10.5	13.3	13.8	16.1	6.3	32.2	16.0	20.5	33.1	18.7	11.4	12.2	16.4	27.8	7.1	17.5	16.0	24.3	24.0	20.8	16.9	19.3	22.7	16.5	38.3	38.0	24.2	11.0	12.7	9.8	9.8	23.1	24.1	28.6	24.1	9.9	20.2	14.6	8.6	1.1	3.5	3.2	0.9	2.8	11.4	3.4	3.1	1.0	5.0	4.3	3.1	8.8	2.6	1.5	4.8	3.7	0.8										
AC025287.4		ENSG00000284484			16	75660227-75677009	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 1.2;bone marrow: 1.2;skin 1: 1.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;THP-1: 1.4"									"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"																																							0.0	0.0		0.0		1.2	0.0		0.1	0.0	0.0			0.0	0.2	0.0	0.0	0.0	0.0	0.2			0.0	0.0	0.2	0.0			0.5	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.1	1.2	0.0	0.0		0.1	0.2	0.1			0.4		0.0	0.3		0.9	0.0	0.1	0.1	0.0	1.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.8	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.1	0.0	1.2	0.1										
AC091057.5		ENSG00000284906	"Rho GTPase-activating protein 11B "	Q3KRB8	15	30624548-30685606	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 7.1;lymphoid tissue: 14.4;testis: 5.8"	"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA064479	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA064479: AB_2685272"																		0.2	0.1	0.8	10.3	1.8	7.1	0.5	0.7	0.9	0.1	5.1	0.6	0.0	1.1	0.8	0.2	1.8	0.2	0.3	0.2	1.0		0.0	0.1	0.9	2.8	0.1	0.0	0.1	0.0	0.0	0.4	0.7	0.6	0.0	1.2	0.3	0.1	0.1	0.4	0.9	1.5	0.8	1.9	1.4	1.0	5.8	2.1	14.4	0.0	1.4	5.7	0.5	0.0	1.0	1.0	1.6	0.3	0.0	0.8	0.0	4.3	2.9	5.0	2.5	0.1	0.6	2.8	4.6	1.8	3.2	3.7	3.0	3.7	2.8	1.8	1.9	4.0	2.5	1.6	2.8	6.1	3.0	7.4	9.9	1.3	0.0	4.7	5.3	0.2	0.2	2.1	1.6	2.2	4.4	8.6	2.2	2.1	3.6	4.0	1.5	1.5	5.1	5.1	1.3	0.9	2.8	2.4	2.2	5.4	2.0	1.0	2.5	2.4	2.5	5.0	4.2	2.4	3.9	3.0	3.2	6.1	1.7	5.3	4.0	1.6	0.3	0.2	0.4	0.0	0.0	0.6	0.8	0.6	0.1	1.0	0.1	0.1	0.1	0.0	0.1	1.0	0.6	0.0										
AC093525.2		ENSG00000260272			16	2496032-2520218	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 4.5;brain: 5.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.9;RPMI-8226: 3.2;SCLC-21H: 3.4;SH-SY5Y: 4.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"											HPA044712	Uncertain									"HPA044712: AB_10795619"	"unprognostic (4.12e-1)"	"unprognostic (9.64e-2)"			"unprognostic (4.36e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.13e-2)"		"unprognostic (9.83e-2)"	"unprognostic (5.98e-3)"	0.4	0.1	1.1	0.1	1.0	4.5	0.4	5.4	1.8	0.1	0.4			0.1	0.2	0.1	0.3	0.5	0.7	0.1	1.0	0.9	3.2	0.2	1.0	0.7	0.6		0.1	0.3	0.1	1.5	0.1		0.2	0.2		0.6	0.4	1.1	0.4	0.1	0.5	0.1	0.4	0.2	0.6			0.4		0.2	0.6	0.0	0.1	1.7	0.5	0.8	0.7	0.4	0.0	0.5	0.0	0.7	1.8	0.0	0.0	0.0	0.8	1.2	0.0	0.6	0.0	0.8	0.1	0.0	1.7	0.0	0.9	0.0	0.0	0.3	3.9	0.5	0.5	0.4	1.1	1.3	0.0	0.0	0.4	0.5	0.0	0.9	0.1	0.5	0.0	2.2	0.2	1.1	0.2	1.2	0.4	0.0	3.2	0.6	0.2	3.4	4.3	0.0	0.8	0.9	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.7	0.6	1.9	0.7	0.3	0.3	0.0	0.8	0.5	0.4	0.7	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.7	0.3	1.7	0.0	0.0										
ACAP1	"CENTB1, KIAA0050"	ENSG00000072818	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 1"	Q15027	17	7336529-7351478	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.4;bone marrow: 30.3;lymphoid tissue: 51.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.5;HDLM-2: 24.4;Karpas-707: 24.1;NB-4: 29.8;REH: 11.9;U-937: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075570	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA075570: AB_2732295"	"unprognostic (1.20e-2)"	"prognostic favourable (3.66e-4)"	"unprognostic (2.49e-1)"	"prognostic favourable (2.97e-5)"	"unprognostic (4.43e-4)"	"prognostic favourable (4.17e-5)"	"unprognostic (5.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (1.65e-10)"	"unprognostic (1.14e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.61e-3)"	2.6	0.6	0.6	31.4	1.3	30.3	1.1	1.0	1.2	1.4	4.5	0.4	0.4	3.2	0.9	1.5	3.3	2.0	3.1	1.4	0.6	0.6	2.9	2.3	7.3	29.3	2.7	0.1	1.0	0.7	0.0	0.8	0.5	1.2	1.8	1.5	1.7	9.6	1.3	0.5	1.2	19.2	0.8	1.3	44.9	3.7	1.4	0.9	51.5	2.5	1.0	33.9	3.7	1.8	17.8	13.3	22.4	5.9	23.7	29.4	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	18.5	0.1	0.0	0.0	0.0	0.0	0.0	24.4	0.0	7.0	0.1	0.0	0.0	9.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	0.0	11.2	29.8	0.3	0.0	11.9	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	0.0	0.0	7.5	6.3	8.4	0.1	19.7	0.0	17.0	5.9	22.4	24.6	1.8	27.5	16.6	25.8	26.1	10.5	17.8	22.7	22.4	17.7	23.7	0.2	13.3	29.4	16.1	0.6	1.3	1.0	1.2	0.6	0.6	2.7	0.1	1.2	0.9
ADAM8	"CD156, CD156a, MS2"	ENSG00000151651	"ADAM metallopeptidase domain 8"	P78325	10	133262403-133276868	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 56.8;bone marrow: 37.1;lymphoid tissue: 28.3"	"Cell line enhanced"	"Detected in some"		"A-431: 22.3;BEWO: 32.2;CAPAN-2: 27.3;HaCaT: 26.8;HDLM-2: 17.2;U-87 MG: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 20.7;eosinophil: 56.8;neutrophil: 32.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 56.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064637	Approved				"Intracellular and membrane"					"HPA064637: AB_2685306"	"unprognostic (8.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.26e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.37e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavourable (3.99e-10)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.32e-2)"	4.8	1.0	0.7	18.0	1.6	37.1	3.1	1.7	1.2	3.8	4.8	0.9	0.2	3.5	1.8	1.6	2.8	3.6	10.1	4.1	0.8	1.1	2.8	4.3	13.0	25.0	1.0	0.2	1.7	2.4	0.1	2.0	7.5	1.6	2.9	0.9	2.9	5.5	0.7	1.5	1.9	6.0	1.6	1.5	28.3	6.9	2.3	0.5	6.6	2.0	1.8	19.7	12.0	2.8	2.5	8.6	56.8	5.4	5.5	5.5	4.6	22.3	0.6	0.2	0.3	0.1	0.0	32.2	0.2	0.5	0.1	0.1	1.7	27.3	0.4	0.6	0.0	26.8	0.0	4.6	0.0	17.2	0.3	0.3	0.1	0.0	0.2	1.3	6.3	0.1	0.4	0.2	0.4	0.0	1.2	0.9	0.0	1.8	0.0	7.6	0.1	0.6	0.1	0.2	2.4	0.3	0.5	0.0	0.3	0.1	0.1	0.4	0.4	0.7	0.6	0.0	0.6	0.2	0.3	1.3	0.8	0.2	13.7	0.7	0.1	20.7	5.4	56.8	5.5	2.1	4.0	2.5	3.7	5.2	8.6	1.5	1.4	2.0	32.9	5.5	2.0	0.1	3.8	4.6	0.7	1.6	1.7	1.2	0.8	1.1	1.0	0.2	1.6	0.5
ADGRG3	"GPR97, Pb99, PGR26"	ENSG00000182885	"Adhesion G protein-coupled receptor G3"	Q86Y34	16	57668187-57689378	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.8;bone marrow: 62.7;lymphoid tissue: 26.4"	"Group enriched"	"Detected in some"	6	"NB-4: 8.5;SK-MEL-30: 4.7;U-937: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"eosinophil: 33.3;neutrophil: 42.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 42.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040469	Uncertain									"HPA040469: "	"unprognostic (4.41e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-4)"	"unprognostic (5.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.75e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.90e-1)"	4.6	0.4	0.3	7.2	0.9	62.7	1.6	0.2	0.5	1.1	4.1	0.0	0.0	1.4	1.4	2.0	2.9	3.4	1.6	7.7	0.2	0.3	0.7	2.7	11.0	26.4	2.0	0.0	1.7	0.6	0.2	0.3	1.7	0.6	1.6	0.9	1.2	0.4	0.3	2.3	0.7	3.9	1.5	0.3	25.4	1.2	1.7	0.3	1.1	6.5	1.2	0.8	3.4	7.2	0.0	0.0	42.8	0.0	8.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	15.6	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.8	8.8	0.0	0.0	0.0	0.1	0.3	0.9	0.2	0.5	0.2	0.3	2.0	0.0	0.6	0.3
AFF2	"FMR2, FRAXE"	ENSG00000155966	"AF4/FMR2 family member 2"	P51816	X	148500619-149000663	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.6;brain: 13.6;epididymis: 15.1;pituitary gland: 17.4;placenta: 17.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 29.6;HL-60: 12.5;U-698: 43.2;U-937: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"basophil: 1.7;eosinophil: 2.5;neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003139	Approved									"HPA003139: AB_1078107"	"unprognostic (5.68e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.00e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.80e-2)"	"unprognostic (9.78e-5)"	"unprognostic (2.54e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.34e-2)"	1.9	0.6	4.2	5.3	3.7	13.6	1.1	13.6	5.9	4.8	0.4	0.2	1.2	0.2	0.8	15.1	0.5	0.6	2.9	1.3	10.7	5.2	0.7	0.3	3.6	6.3	2.3	5.9	2.0	0.5	0.2	17.4	17.4	3.9	1.0	0.3	0.2	0.8	2.1	0.4	1.3	0.5	0.3	2.4	0.8	0.4	2.8	0.0	5.5	1.1	0.0	7.3	1.0	0.7	0.1	0.0	4.5	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	1.7	0.0	4.6	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	12.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.6	3.8	1.1	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.5	0.0	1.3	0.1	0.1	43.2	0.0	9.2	0.0	1.7	0.1	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	4.2	3.7	13.6	5.9	10.7	5.2	2.3	5.9	3.9	0.0
AGTPBP1	"CCP1, KIAA1035, Nna1"	ENSG00000135049	"ATP/GTP binding protein 1"	Q9UPW5	9	85546539-85742029	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057208	Approved		Approved	Nucleoli,Vesicles				"Nucleoli, Vesicles"	"Nucleoli, Vesicles"	"HPA057208: AB_2683370"	"unprognostic (2.15e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.95e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.26e-3)"	"unprognostic (5.69e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.25e-1)"	7.9	5.7	13.1	8.6	14.6	48.2	6.0	14.2	21.4	5.1	5.0	21.6	1.8	3.8	5.0	4.2	5.4	4.2	5.3	11.2	17.3	13.5	6.8	4.5	11.9	16.0	18.8	14.5	3.5	6.4	8.0	4.8	6.0	23.5	4.9	5.9	7.4	3.9	3.4	13.6	6.0	4.3	6.4	24.1	12.8	5.3	12.5	14.4	8.8	5.8	4.3	7.8	5.7	3.8	1.6	10.7	20.3	9.5	4.5	6.6	5.7	2.9	5.7	16.8	6.7	3.5	3.8	6.4	4.4	3.8	4.5	5.1	3.0	5.1	18.3	3.7	4.5	1.7	7.8	5.6	4.3	19.4	6.9	3.1	6.9	5.4	7.3	14.1	3.7	3.5	6.6	4.2	14.5	7.2	3.9	14.7	2.0	4.6	10.9	8.4	11.7	4.0	10.0	6.2	5.6	7.8	3.2	20.4	14.5	5.0	5.5	9.1	2.1	4.6	7.1	2.9	5.2	18.5	5.2	10.1	8.4	8.4	6.2	13.9	5.9	20.3	9.5	8.3	6.6	5.7	6.4	1.6	3.3	5.1	10.7	1.2	2.7	5.2	14.0	4.5	4.3	1.7	3.4	5.7	13.1	14.6	14.2	21.4	17.3	13.5	18.8	14.5	23.5	14.4
AL662899.1		ENSG00000204422			6	31686962-31714072	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 3.8;brain: 5.3"	"Cell line enriched"	"Detected in single"	25	"HEL: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 2.9;cerebral cortex: 5.3;hippocampal formation: 1.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																								"unprognostic (1.83e-1)"							"unprognostic (2.84e-1)"						"unprognostic (3.49e-1)"		0.1	0.0	2.9	0.1	0.5	3.8	0.1	0.1	5.3	0.4	0.7	0.1	0.1	0.0	0.5	0.7	0.9	0.2	0.4	0.1	1.8	0.2	0.1	0.1	1.1	0.1	0.1	0.1	0.6	0.1	0.3	0.2	0.1	0.7	0.1	0.5	0.1	0.2	0.1	0.1	2.7	0.1	0.1	0.1	1.7	0.0	0.9	0.1	0.6	2.3	0.1	0.1	0.1	0.8	0.8	1.3	2.9	1.5	0.7	0.9	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.6	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.8	1.3	1.7	0.9	1.5	0.6	0.5	0.6	0.6	1.3	0.8	0.4	0.4	2.9	0.7	1.4	1.1	0.6	1.5	2.9	0.5	0.1	5.3	1.8	0.2	0.1	0.1	0.7	0.1
AL662899.2		ENSG00000263020			6	31666102-31673546	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"bone marrow: 83.6"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA005944, HPA048307"	Uncertain									"HPA005944: AB_1847290, HPA048307: AB_2680348"	"unprognostic (7.19e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.09e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-1)"	8.9	7.7	7.6	9.3	9.9	83.6	8.8	16.9	14.5	10.0	9.0	10.0	7.6	7.7	8.0	10.4	10.4	10.9	10.7	9.8	7.4	7.4	11.8	17.2	8.6	10.4	6.8	7.8	12.1	10.7	7.7	8.3	13.3	7.4	10.2	9.4	9.9	10.0	9.8	13.2	15.1	12.9	8.1	6.1	19.1	8.7	11.1	6.4	21.0	11.8	14.4	11.0	9.2	8.3	1.3	2.2	0.4	1.0	1.0	1.1	0.3	1.1	0.8	1.6	2.1	0.0	0.0	0.3	0.0	0.4	1.8	0.7	1.3	1.8	1.6	0.9	1.3	1.3	0.4	3.7	4.2	1.0	3.1	2.8	0.9	0.6	1.6	1.8	0.0	0.0	0.0	0.4	0.0	0.8	1.3	0.5	1.1	2.6	2.9	0.2	1.5	0.0	1.8	0.0	0.0	0.0	0.0	1.3	3.8	0.9	0.8	0.2	0.7	0.8	0.4	2.0	4.2	0.0	0.0	0.0	0.7	3.7	0.4	1.3	1.6	0.3	0.5	0.4	0.2	0.3	1.1	1.3	0.0	0.4	0.1	0.2	0.2	0.8	0.3	1.0	1.0	2.2	0.2	0.3	7.6	9.9	16.9	14.5	7.4	7.4	6.8	7.8	7.4	6.4
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.2;bone marrow: 39.9;lymphoid tissue: 41.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.8;Daudi: 21.8;HMC-1: 15.6;Karpas-707: 6.9;RT4: 10.2;U-266/70: 10.3;U-698: 7.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA071285: AB_2686379"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavourable (1.80e-5)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (7.18e-4)"	7.4	3.9	2.9	18.3	7.4	39.9	5.8	13.2	3.2	3.4	6.5	6.4	1.0	4.5	3.2	4.7	4.9	5.4	8.0	6.1	3.9	2.6	4.8	2.6	34.7	36.9	9.0	1.7	2.6	10.0	1.3	1.7	11.2	6.1	7.8	3.4	3.2	6.6	3.4	1.1	2.9	14.4	7.8	8.4	41.8	4.5	2.0	6.2	2.4	3.0	1.4	16.7	27.2	10.5	14.8	11.1	45.2	21.3	0.0	0.5	9.5	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	6.0	21.8	0.7	0.0	0.3	0.2	0.0	0.0	0.4	0.2	4.2	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.8	0.2	10.2	0.5	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	1.2	0.0	0.0	10.3	1.9	7.2	0.0	0.1	0.0	36.7	21.3	27.0	0.0	20.0	0.1	14.8	0.5	0.2	11.1	10.4	0.0	0.0	45.2	0.0	19.6	0.3	0.1	9.5	2.9	7.4	13.2	3.2	3.9	2.6	9.0	1.7	6.1	6.2
ALOX5AP	FLAP	ENSG00000132965	"Arachidonate 5-lipoxygenase activating protein"	P20292	13	30713478-30764426	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 296.2;bone marrow: 121.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 78.3;HL-60: 41.6;HMC-1: 134.6;THP-1: 52.4;U-937: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 296.2;eosinophil: 148.4;neutrophil: 194.2;plasmacytoid DC: 136.1"	"Group enriched"	"Detected in all"	7	"dendritic cells: 136.1;granulocytes: 296.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026592	Enhanced									"HPA026592: AB_10601115"	"unprognostic (1.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavourable (6.44e-4)"	"unprognostic (7.83e-2)"	"unprognostic (6.63e-2)"	"prognostic unfavourable (5.68e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.59e-1)"	16.7	12.7	9.6	27.9	17.0	121.8	8.3	1.9	10.7	6.3	7.5	17.1	0.0	6.4	7.7	3.3	6.4	11.5	11.7	10.4	8.0	9.0	10.6	5.8	55.8	33.4	22.0	2.7	5.1	7.9	1.7	3.3	10.6	14.2	5.9	6.6	5.1	9.9	4.9	2.4	2.8	10.9	12.1	23.0	57.6	7.8	5.2	15.5	42.2	4.3	3.7	29.2	11.9	6.5	18.4	136.1	296.2	12.6	3.6	33.2	24.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	18.7	0.2	0.0	0.1	0.0	0.5	0.0	78.3	0.0	2.2	0.0	0.1	0.1	41.6	134.6	0.1	0.0	0.0	4.7	0.1	0.0	0.4	0.2	0.0	2.3	1.5	0.0	0.0	0.3	0.4	1.4	0.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	52.4	0.1	0.0	0.4	0.0	0.3	8.3	0.0	12.4	0.1	38.5	0.1	296.2	12.6	148.4	22.3	0.6	33.2	16.9	22.3	18.2	7.6	18.4	11.3	11.1	194.2	3.6	0.4	136.1	30.9	24.1	9.6	17.0	1.9	10.7	8.0	9.0	22.0	2.7	14.2	15.5
AMPD2	SPG63	ENSG00000116337	"Adenosine monophosphate deaminase 2"	Q01433	1	109616104-109632051	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 64.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.8;granulocytes: 29.7;monocytes: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027137, HPA045760, HPA050590"	Approved		Enhanced	Cytosol		380000	380000	Cytosol	Cytosol	"HPA027137: AB_2672129, HPA045760: AB_2679443, HPA050590: AB_2681184"	"unprognostic (2.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.78e-10)"	"unprognostic (9.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	8.1	22.7	20.2	21.7	41.3	64.4	4.9	16.3	26.8	9.5	10.1	9.5	6.3	17.1	9.0	6.0	5.9	11.8	13.2	5.2	21.7	19.4	7.8	13.0	8.2	10.7	14.2	14.2	16.3	9.4	13.0	37.1	10.8	18.3	9.7	5.7	15.7	9.1	12.2	2.1	10.0	11.6	9.1	8.5	15.9	8.3	5.3	12.2	10.3	6.4	3.0	7.5	8.2	8.1	2.8	8.8	29.7	24.5	3.0	4.3	5.4	10.9	12.8	18.8	15.8	16.4	16.4	7.1	15.6	32.0	16.0	15.8	9.7	4.7	5.4	12.0	29.3	8.6	9.8	14.5	9.9	8.8	13.3	28.6	16.8	10.8	15.4	12.1	30.8	18.3	7.7	21.2	16.5	13.8	8.8	14.8	11.4	17.0	17.9	29.0	12.1	13.6	12.8	7.2	8.4	14.7	6.7	14.6	15.3	10.7	13.0	12.7	7.3	11.3	13.2	19.8	23.0	24.2	16.1	29.6	14.3	7.8	29.5	18.9	20.6	0.5	9.2	11.2	3.4	19.6	4.3	2.8	3.3	3.4	8.8	1.7	3.8	2.8	29.7	3.0	24.5	1.4	2.6	5.4	20.2	41.3	16.3	26.8	21.7	19.4	14.2	14.2	18.3	12.2
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.2;skeletal muscle: 61.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.3;CAPAN-2: 19.0;HMC-1: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Enhanced	"Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA038662: AB_2676136, HPA047408: AB_2680034"	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favourable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	2.9	13.7	5.3	13.8	14.0	39.2	2.3	2.3	7.8	3.3	3.4	19.6	0.7	4.7	3.1	4.2	5.2	8.0	4.6	2.1	7.4	7.1	4.2	1.5	4.5	12.7	15.2	5.7	2.3	2.5	24.9	14.5	3.7	11.2	5.5	4.9	4.3	4.7	2.8	61.0	10.8	5.0	3.1	12.8	8.3	4.6	1.4	12.6	14.8	2.7	7.6	14.2	6.1	5.1	7.6	3.9	17.0	6.0	3.3	5.3	2.3	7.4	1.1	0.3	0.1	4.0	2.9	0.4	6.8	24.3	1.7	1.7	3.7	19.0	2.7	0.6	3.1	4.7	0.1	6.4	5.0	6.7	0.2	6.7	0.9	0.5	1.3	9.1	20.2	10.6	10.0	3.3	4.3	0.7	10.1	2.9	5.5	0.2	5.3	11.9	0.9	6.7	2.0	8.8	9.8	0.3	6.3	2.8	1.5	1.5	0.2	0.4	0.2	3.1	1.8	7.7	0.1	5.3	0.2	2.7	1.5	2.9	8.9	9.1	0.2	6.6	6.0	17.0	2.3	3.8	5.3	7.6	3.3	2.5	3.9	5.8	3.7	2.5	8.3	3.3	1.6	2.5	1.9	2.3	5.3	14.0	2.3	7.8	7.4	7.1	15.2	5.7	11.2	12.6
ANKLE1	"ANKRD41, FLJ39369, LEMD6"	ENSG00000160117	"Ankyrin repeat and LEM domain containing 1"	Q8NAG6	19	17281645-17287646	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.6;brain: 8.3;lymphoid tissue: 12.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 30.2;HL-60: 13.3;NB-4: 17.0;U-937: 23.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 8.3"	"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.3"	"Group enriched"	"Detected in many"	4	"B-cells: 3.0;dendritic cells: 2.2;monocytes: 4.3"					"Low region specificity"	"Detected in many"			"HPA026789, HPA073498"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA026789: , HPA073498: AB_2686612"	"unprognostic (5.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.90e-2)"	"prognostic unfavourable (4.86e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.89e-4)"	"unprognostic (5.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.30e-2)"	0.6	0.5	1.0	12.9	3.1	22.6	0.6	8.3	1.4	0.7	0.7	0.6	0.2	0.3	0.9	1.3	0.5	0.8	0.5	0.2	1.0	1.2	0.5	0.5	1.3	3.7	1.6	0.7	1.7	0.2	0.6	0.9	1.1	1.4	1.0	0.5	0.4	0.7	0.6	0.9	1.4	1.2	0.9	1.2	5.7	0.3	1.0	0.5	8.9	0.6	0.2	5.3	1.0	0.7	3.0	2.2	0.7	4.3	0.0	0.4	0.8	0.1	0.3	1.5	0.7	0.0	0.3	1.4	0.5	0.1	0.3	0.2	6.9	0.4	30.2	0.3	0.1	0.6	11.7	0.1	0.2	9.1	1.5	12.3	4.8	0.0	0.1	13.3	5.1	0.1	0.4	1.2	0.0	0.2	1.6	3.6	0.1	0.2	9.1	17.0	3.7	1.0	7.3	0.0	3.1	0.1	0.1	0.4	2.7	2.9	0.2	0.2	0.0	8.7	0.5	0.1	0.5	0.5	0.3	0.3	0.3	10.7	0.1	23.7	0.6	0.0	1.8	0.7	0.0	4.3	0.0	3.0	0.0	0.4	2.2	1.7	0.1	0.0	0.0	0.0	3.1	1.1	0.0	0.8	1.0	3.1	8.3	1.4	1.0	1.2	1.6	0.7	1.4	0.5
ANKRD13D		ENSG00000172932	"Ankyrin repeat domain 13D"	Q6ZTN6	11	67288547-67302485	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.8"	"Cell line enhanced"	"Detected in many"		"NB-4: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039950	Approved		Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Nucleoplasm	"HPA039950: AB_10796337"	"unprognostic (1.10e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.71e-2)"	"prognostic unfavourable (5.73e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.74e-2)"	9.1	9.1	18.2	18.1	17.6	80.8	18.9	20.2	18.7	9.0	7.6	7.7	13.7	8.0	9.0	10.4	14.6	10.2	11.9	8.8	20.2	14.0	8.3	4.5	12.4	20.8	12.4	11.4	9.4	7.7	6.0	17.0	9.2	10.7	12.7	4.5	10.9	17.5	12.0	4.2	28.1	8.6	9.9	9.6	24.1	8.9	6.8	12.0	9.6	6.4	6.2	14.4	14.3	13.4	2.6	8.1	11.4	4.6	3.8	6.7	1.9	6.2	4.4	3.4	7.9	5.1	5.0	6.3	3.8	3.8	4.5	2.8	5.2	6.9	6.7	6.4	4.3	10.4	2.4	4.9	0.7	9.5	2.9	5.7	6.6	2.9	7.9	6.3	23.0	5.4	7.7	4.0	5.1	4.2	4.0	8.3	4.0	10.0	8.4	48.7	3.8	5.6	21.2	3.6	4.7	6.4	8.5	3.9	6.7	3.3	10.0	26.6	10.3	17.9	5.4	7.1	4.6	7.2	5.0	8.4	5.9	4.0	9.4	17.6	4.6	7.2	3.3	11.4	6.7	4.6	4.4	2.6	3.8	5.4	1.9	2.4	2.4	5.8	10.8	3.8	3.8	8.1	2.8	1.9	18.2	17.6	20.2	18.7	20.2	14.0	12.4	11.4	10.7	12.0
ANKRD36B	"FLJ21281, KIAA1641"	ENSG00000196912	"Ankyrin repeat domain 36B"	Q8N2N9	2	97492663-97589965	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 16.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.72e-3)"	"unprognostic (5.03e-2)"	"unprognostic (7.17e-3)"	"unprognostic (4.20e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.13e-6)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.71e-3)"	"unprognostic (6.98e-2)"	1.0	1.5	2.0	2.8	7.0	16.4	3.3	6.8	6.7	1.4	1.7	1.6	0.2	1.3	3.8	2.0	0.5	2.0	2.1	0.8	3.1		1.1	0.4	2.2	2.3	4.3	6.2	3.8	1.7	1.8	3.3	0.7	3.9	1.8	2.7	1.0	2.6	3.0	0.7	3.6	2.1	1.9	1.9	1.7	1.7	7.5	4.0	4.2	1.3	2.8	2.1	1.2	0.8	3.5	2.6	3.4	0.7	2.6	3.0	0.3	4.0	2.5	2.9	2.5	1.7	3.9	1.9	2.8	1.8	1.8	2.1	2.4	4.9	5.6	1.5	2.3	1.8	1.8	1.3	1.9	1.6	4.5	4.4	5.1	1.8	1.3	3.5	2.6	2.6	2.3	2.3	3.8	2.4	6.0	4.8	2.2	1.0	4.4	6.3	1.4	3.0	5.4	1.4	1.9	2.0	2.5	3.3	4.7	2.1	1.8	1.5	2.8	3.3	3.5	3.3	3.8	3.8	3.7	6.6	8.4	5.3	2.0	4.7	1.7	3.4	0.7	0.9	2.2	0.3	2.0	2.2	2.6	1.8	0.3	3.5	3.0	2.3	0.5	2.6	0.2	2.6	1.3	0.3										
ANXA3	ANX3	ENSG00000138772	"Annexin A3"	P12429	4	78551519-78610451	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 83.0"	"Cell line enhanced"	"Detected in many"		"A-431: 52.0;CACO-2: 53.3;CAPAN-2: 72.2;EFO-21: 44.2;hTERT-HME1: 73.6;RPTEC TERT1: 62.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	319	"neutrophil: 51.3"	"Lineage enriched"	"Detected in single"	319	"granulocytes: 51.3"	"Low region specificity"	"Detected in all"							"HPA013398, HPA013431"	Enhanced		Enhanced	Cytosol		7400000	7400000	Cytosol	Cytosol	"HPA013398: AB_1844861, HPA013431: AB_1844862"	"unprognostic (2.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.92e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavourable (1.28e-4)"	"unprognostic (4.82e-2)"	"prognostic favourable (8.48e-6)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.30e-2)"	20.3	1.1	4.0	7.1	7.4	83.0	16.2	2.4	6.8	7.0	8.5	2.3	0.9	4.2	3.4	4.2	25.0	4.6	11.7	20.5	5.2	5.2	19.8	1.6	46.0	5.7	6.6	5.6	2.8	14.7	6.5	5.8	33.7	10.4	18.8	7.4	2.6	50.8	3.6	14.2	4.1	9.3	5.3	4.0	11.0	23.4	1.8	5.0	2.0	45.3	13.6	7.4	2.8	5.9	0.1	0.0	51.3	0.1	0.0	0.0	0.5	52.0	9.9	0.1	0.1	0.1	0.2	0.0	0.6	0.0	1.5	1.4	53.3	72.2	0.0	44.2	1.8	20.6	0.0	38.1	2.3	0.2	0.4	4.6	21.3	3.2	6.1	0.6	0.0	0.3	33.8	0.5	73.6	15.1	0.1	0.0	0.2	2.0	0.2	0.0	1.6	7.3	0.0	0.1	0.0	62.0	6.0	0.0	0.0	30.7	7.6	2.2	1.3	0.6	19.1	0.1	6.9	0.0	11.7	0.4	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	51.3	0.0	0.1	0.0	0.0	0.5	4.0	7.4	2.4	6.8	5.2	5.2	6.6	5.6	10.4	5.0
AP000781.2		ENSG00000254979			11	57387365-57424059	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 11.8;liver: 8.1"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 63.9"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	7	"basophil: 6.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.3"									HPA038515	Supported									"HPA038515: AB_10675800"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.55e-4)"	"unprognostic (2.16e-1)"	"unprognostic (4.01e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.51e-10)"	"unprognostic (4.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.10e-1)"	7.3	0.0	0.0	0.3	0.0	11.8	3.0	0.0	0.5	0.5	0.5			0.5	0.4	0.0	1.2	0.0	0.9	0.6	0.0	0.0	0.1	8.1	1.0	0.7	0.0		0.2	3.0	0.0	0.1	7.9		0.1	0.2		1.6	0.0	0.9	6.6	0.4	0.0	0.0	0.4	0.3	0.0			1.4		0.7	0.8	0.6	0.7	0.9	6.3	0.6	0.0	0.7	0.7	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.3	9.4	63.9	0.6	0.0	0.2	0.0	0.1	0.1	0.5	0.0	0.0	0.3	2.9	0.1	0.0	1.3	0.0	2.8	0.0	0.0	0.3	0.1	0.0	0.1	1.0	0.0	0.3	0.0	0.0	0.1	1.1	0.0	0.1	0.0	0.3	0.3	0.3	0.4	6.3	0.6	0.6	0.7	0.3	0.0	0.0	0.5	0.2	0.0	0.7	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.7										
AP000812.4		ENSG00000284844			11	72105924-72109329	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 1.1;cervix, uterine: 1.1;testis: 2.0"	"Cell line enhanced"	"Detected in some"		"HSkMC: 1.4;RH-30: 1.2;SK-MEL-30: 2.9;WM-115: 1.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		1.1	0.0		0.9	1.1	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.2	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.1	0.6	0.0	0.0	0.0		0.0	0.0	2.0			0.0		0.0	0.0		0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.2	0.5	0.4	0.0	0.0	0.0	0.9	0.5	0.2	0.1	0.4	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	2.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0										
AP002512.3		ENSG00000284732			11	56459221-56473352	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 1.3;bone marrow: 1.9;skin 1: 1.2"	"Cell line enhanced"	"Detected in some"		"K-562: 1.9"									"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"																																							0.0	0.0		0.1		1.9	0.1		0.1	0.0	0.0			0.2	0.1	0.0	0.0	0.0	0.0	0.0			0.0	0.1	0.3	0.2			0.0	0.1	0.0		0.0		0.0	0.0		0.1	0.0	0.3	1.2	0.0	0.0		0.1	0.2	0.3			0.2		0.0	0.0		0.7	0.3	1.3	0.3	0.8	0.5	0.0	0.3	0.5	0.2	0.3	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.1	0.3	0.4	0.2	0.4	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.1	1.9	0.6	0.0	0.0	0.4	0.7	0.6	1.2	0.0	0.5	0.6	0.1	0.4	0.6	0.8	0.1	0.2	0.1	0.8	1.1	0.5	0.6	0.7	0.5	0.3	0.7	0.5	0.2	1.0	0.2	0.4	1.2	0.3	0.3	0.3	0.1	0.2	0.4	0.3	0.2	0.1	0.7	0.3	0.5	1.3	0.8	0.2	0.3	0.2	0.0										
AP5B1	"AP-5, DKFZp761E198, PP1030"	ENSG00000254470	"Adaptor related protein complex 5 beta 1 subunit"	Q2VPB7	11	65775893-65780802	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	16	"neutrophil: 22.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065739, HPA067880"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA065739: AB_2685550, HPA067880: AB_2685914"	"unprognostic (3.64e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.15e-1)"	"prognostic favourable (2.31e-5)"	"unprognostic (2.03e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.67e-1)"	11.2	6.8	5.3	10.2	8.2	48.6	10.3	10.7	9.1	6.3	6.7	4.0	6.9	9.6	9.8	6.8	13.2	7.2	8.2	6.6	5.7	3.5	7.7	9.3	11.3	13.3	6.0	5.5	4.5	16.1	9.9	5.5	14.8	5.3	6.4	4.2	8.0	10.9	10.7	11.9	10.3	9.5	5.1	5.6	13.0	7.9	3.1	6.2	9.2	7.9	7.4	7.8	11.0	6.5	0.2	0.3	22.5	1.3	0.3	0.4	0.5	10.0	7.8	1.8	10.2	4.9	2.5	14.7	4.3	4.1	4.5	3.6	6.7	4.7	5.7	8.3	3.7	12.0	5.0	3.2	1.4	9.1	8.7	5.2	8.8	3.3	3.9	6.8	11.1	4.8	6.2	3.1	1.6	3.5	11.8	7.6	2.3	7.0	4.3	6.7	3.6	8.9	13.8	0.3	12.6	3.3	11.4	2.4	4.2	3.1	2.0	19.2	3.9	9.9	5.5	8.3	7.5	10.5	4.3	7.8	7.8	5.8	5.8	5.8	7.9	0.6	1.3	0.5	0.4	0.8	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.2	22.5	0.3	1.0	0.2	0.1	0.5	5.3	8.2	10.7	9.1	5.7	3.5	6.0	5.5	5.3	6.2
APOBEC3A	"ARP3, PHRBN"	ENSG00000128383	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3A"	P31941	22	38952741-38992778	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 113.5;bone marrow: 42.7;lymphoid tissue: 31.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 113.5"	"Lineage enriched"	"Detected in many"	7	"monocytes: 113.5"									"HPA043237, HPA056980, HPA066719"	Approved		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: "	"unprognostic (6.45e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-3)"	"unprognostic (9.01e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.91e-1)"	4.3	0.2	0.3	11.0	0.4	42.7	0.5	0.2	0.7	1.7	0.8	0.2	0.0	0.6	1.3	1.4	7.2	3.3	3.4	0.9	0.2	0.3	0.7	1.3	16.0	15.8	1.9	0.5	0.7	0.7	0.1	0.3	4.9	0.7	0.3	0.2	2.0	5.9	0.0	1.2	0.3	0.8	0.8	1.7	31.5	0.8	0.4	0.2	1.4	0.7	22.3	29.0	2.7	6.4	0.2	1.2	15.3	113.5	0.1	0.1	15.2	0.7	0.3	0.5	2.5	0.2	0.4	1.1	0.3	0.0	0.0	0.1	0.2	1.6	0.5	1.7	0.2	2.1	0.6	0.4	0.0	0.8	0.2	0.2	1.6	0.2	0.2	0.3	1.1	0.2	0.8	0.3	0.2	0.1	0.3	3.4	0.1	1.2	0.5	0.5	1.1	0.2	0.8	0.5	0.6	0.6	1.3	1.2	0.5	0.4	1.4	0.2	1.1	0.1	1.5	1.0	0.9	0.3	0.4	0.5	0.8	1.0	1.4	2.5	1.2	3.5	26.8	0.9	0.0	113.5	0.1	0.2	0.0	0.0	1.2	0.1	0.0	0.0	15.3	0.1	31.1	0.1	0.1	15.2	0.3	0.4	0.2	0.7	0.2	0.3	1.9	0.5	0.7	0.2
APOBEC3B	"FLJ21201, PHRBNL"	ENSG00000179750	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3B"	Q9UH17	22	38982347-38992804	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.1"	"Cell line enhanced"	"Detected in many"		"A-431: 59.6;Karpas-707: 67.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 10.2"	"Low lineage specificity"	"Detected in many"											"HPA056980, HPA066719"			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA056980: AB_2683298, HPA066719: AB_2685711"	"unprognostic (2.92e-2)"	"prognostic favourable (2.58e-5)"	"unprognostic (4.29e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (8.47e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.04e-1)"	1.6	2.3	0.3	4.4	2.2	20.1	1.4	0.3	1.2	2.3	9.9	0.7	0.3	5.8	2.0	2.4	4.6	1.2	2.2	1.6	0.6	0.2	3.6	0.9	2.5	4.3	0.3	0.3	1.7	5.7	0.4	0.3	6.4	0.8	2.1	10.0	1.3	4.8	0.3	4.1	1.9	8.8	1.0	0.7	10.4	3.8	2.0	0.3	5.9	3.3	0.3	12.0	2.0	2.4	10.2	0.8	1.7	5.8	2.2	3.8	5.9	59.6	6.7	2.6	16.1	0.3	1.5	4.5	5.5	4.8	10.6	13.9	12.8	10.9	0.6	5.0	5.5	25.6	0.3	1.1	10.7	21.6	0.6	17.2	1.4	3.3	0.1	14.2	10.4	0.5	0.1	11.0	0.5	4.1	9.6	67.6	16.4	1.6	0.0	8.0	0.0	6.0	0.4	25.8	21.5	2.1	10.1	0.4	0.0	0.0	0.0	3.7	7.9	4.1	2.5	11.7	20.4	1.8	0.1	15.0	4.1	0.0	8.3	15.9	23.7	0.5	1.3	0.0	0.3	5.8	0.0	10.2	0.8	0.5	0.8	3.2	0.0	0.4	1.7	2.2	1.8	0.1	3.8	5.9	0.3	2.2	0.3	1.2	0.6	0.2	0.3	0.3	0.8	0.3
ARAP2	"CENTD1, PARX"	ENSG00000047365	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2"	Q8WZ64	4	35948221-36244509	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 12.1;hTCEpi: 11.4;MOLT-4: 10.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035925	Approved		Approved	"Actin filaments,Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA035925: AB_10672075"	"unprognostic (2.97e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-2)"	5.2	2.5	16.3	9.1	27.5	32.5	5.2	4.8	20.8	4.2	5.1	18.3	0.3	8.5	3.5	4.1	12.7	3.5	9.2	2.5	16.0	9.5	3.9	8.8	12.7	13.7	24.4	12.1	1.9	6.8	8.2	5.1	3.5	18.4	2.9	5.8	0.7	5.8	3.3	1.4	16.1	8.2	4.4	15.3	10.4	5.8	5.9	32.0	26.4	22.4	4.0	10.2	6.2	7.2	2.4	1.7	0.6	5.8	8.6	5.7	0.7	7.3	0.6	0.7	0.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.6	12.1	3.5	2.9	0.3	2.8	1.1	5.8	0.0	0.0	6.7	0.1	2.5	0.2	1.5	4.7	0.0	0.4	11.4	0.0	2.5	0.0	0.2	0.6	0.0	3.1	10.8	3.8	0.8	2.3	5.6	0.0	4.0	8.3	7.5	6.5	0.0	0.4	1.9	2.4	5.0	1.4	0.0	2.0	6.8	0.0	1.0	0.0	0.0	6.8	0.8	5.3	1.7	0.0	0.8	0.0	5.7	2.7	5.3	2.4	3.2	3.9	0.4	1.4	1.1	2.9	0.6	8.6	5.8	1.7	1.5	0.7	16.3	27.5	4.8	20.8	16.0	9.5	24.4	12.1	18.4	32.0
ARHGAP11A	KIAA0013	ENSG00000198826	"Rho GTPase activating protein 11A"	Q6P4F7	15	32615144-32639949	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.4;lymphoid tissue: 35.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA040419, HPA040830"	Enhanced		Approved	Nucleoli,Cytosol				Cytosol	Cytosol	"HPA040419: AB_10796121, HPA040830: AB_10805830"	"unprognostic (5.00e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavourable (2.05e-4)"	"prognostic unfavourable (8.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (7.71e-2)"	"prognostic unfavourable (2.92e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.07e-12)"	"unprognostic (7.37e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.64e-2)"	1.9	1.5	2.0	17.2	2.9	16.4	3.3	1.1	3.9	1.6	5.4	1.6	0.5	4.3	2.3	0.5	7.5	0.5	4.1	1.4	2.2	1.9	0.8	1.2	2.0	9.4	4.4	0.8	0.8	3.1	0.9	1.0	4.7	2.0	1.2	6.7	0.8	2.0	0.5	1.7	3.2	9.6	3.3	8.9	5.0	2.6	6.4	1.9	35.0	1.0	5.3	10.3	2.6	2.7	0.9	1.7	2.6	1.8	0.5	3.8	1.1	23.3	25.1	20.2	13.3	1.4	3.7	12.0	23.7	13.7	22.6	17.5	17.3	11.9	13.5	7.5	13.9	17.4	14.2	12.4	30.5	26.7	8.2	43.0	22.7	8.8	0.5	31.9	17.3	1.2	1.5	18.2	14.4	16.6	29.8	32.3	26.1	9.5	16.8	10.7	12.6	14.8	19.9	45.1	10.6	8.0	12.4	19.4	13.4	24.8	12.9	5.4	18.3	30.7	12.8	30.5	22.6	12.8	25.2	11.8	18.6	37.4	13.1	38.1	26.6	0.1	1.1	2.6	2.3	1.8	0.9	0.9	3.8	3.3	1.7	0.7	1.5	2.0	0.0	0.5	0.3	0.6	2.8	1.1	2.0	2.9	1.1	3.9	2.2	1.9	4.4	0.8	2.0	1.9
ARHGAP4	"C1, KIAA0131, p115, RhoGAP4, SrGAP4"	ENSG00000089820	"Rho GTPase activating protein 4"	P98171	X	153907367-153934999	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.8;lymphoid tissue: 48.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 25.7;Karpas-707: 26.4;MOLT-4: 24.8;RPMI-8226: 48.8;THP-1: 23.8;U-698: 22.7;U-937: 21.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001012, HPA001083"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA001012: AB_1078201, HPA001083: AB_1078199"	"unprognostic (3.54e-2)"	"prognostic favourable (3.94e-5)"	"prognostic unfavourable (1.97e-5)"	"unprognostic (5.79e-2)"	"unprognostic (9.42e-2)"	"prognostic favourable (3.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.81e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (8.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	7.0	4.8	5.3	24.3	5.8	44.8	5.0	4.5	3.2	3.1	6.5	5.2	2.1	6.0	3.9	7.0	4.4	5.2	6.5	4.2	4.5	3.2	7.4	4.9	13.4	29.1	5.2	0.9	2.6	2.3	0.9	3.5	9.0	4.8	4.2	3.0	5.7	7.5	1.8	1.6	1.8	18.0	3.9	5.9	48.4	4.9	3.6	4.2	43.2	4.2	1.6	29.0	7.1	3.6	10.8	17.7	18.7	30.5	8.5	15.7	12.6	0.4	0.1	0.2	1.7	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.1	12.3	25.7	1.5	0.0	0.2	1.3	0.0	0.0	6.9	1.0	9.9	0.1	0.4	1.0	18.2	16.9	0.0	0.1	0.0	0.1	2.6	0.0	26.4	0.1	1.3	24.8	0.3	0.8	0.0	11.8	3.5	48.8	0.1	0.2	2.4	3.5	0.2	0.6	0.2	5.7	23.8	0.5	0.1	0.3	0.2	0.1	16.0	13.6	22.7	0.2	21.3	0.0	5.1	14.1	18.7	15.7	23.1	10.9	10.8	11.2	12.4	14.1	10.4	10.1	10.1	12.0	8.5	30.5	17.7	12.6	12.6	5.3	5.8	4.5	3.2	4.5	3.2	5.2	0.9	4.8	4.2
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472255-57488814	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.9;bone marrow: 48.1;lymphoid tissue: 50.4"	"Cell line enhanced"	"Detected in some"		"HEL: 11.0;HMC-1: 49.0;THP-1: 14.1;U-937: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 76.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 76.9"					"Low region specificity"	"Detected in many"														"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favourable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	5.1	2.5	5.1	33.0	8.0	48.1	4.4	3.7	4.8	1.8	5.4	2.5	0.5	3.6	1.6	1.7	2.7	4.4	4.8	2.4	4.2	1.8	3.5	3.8	11.2	24.1	8.1	0.6	1.2	2.2	0.3	1.5	2.3	5.8	2.5	5.1	2.4	6.0	1.3	0.9	1.4	18.6	2.6	8.5	50.4	3.9	8.8	6.4	19.0	2.6	3.2	28.5	4.7	2.2	8.9	18.9	76.9	17.0	13.1	13.3	11.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	5.8	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	11.0	0.0	0.0	0.4	6.4	49.0	0.2	0.0	0.0	0.1	0.0	0.2	3.2	0.0	0.0	8.7	8.7	0.4	0.0	3.6	4.2	1.7	0.0	0.0	1.6	1.3	0.0	0.0	0.1	0.0	14.1	0.3	0.0	0.1	0.0	0.0	4.0	2.6	5.3	0.1	11.1	0.2	8.4	16.6	45.1	9.0	17.0	6.2	7.1	9.9	8.1	13.9	8.9	13.3	9.6	76.9	13.1	12.8	18.9	12.1	11.8	5.1	8.0	3.7	4.8	4.2	1.8	8.1	0.6	5.8	6.4
ARRB2	"ARR2, BARR2, DKFZp686L0365"	ENSG00000141480	"Arrestin beta 2"	P32121	17	4710489-4721499	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 102.8;lymphoid tissue: 66.6"	"Cell line enhanced"	"Detected in all"		"HMC-1: 70.2;NB-4: 42.1;U-937: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065681			Supported	Vesicles				Vesicles	Vesicles	"HPA065681: AB_2685529"	"unprognostic (1.12e-1)"	"prognostic favourable (2.93e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavourable (2.61e-5)"	"unprognostic (1.32e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.88e-1)"	21.6	15.6	23.7	47.8	18.3	102.8	10.0	28.1	26.3	8.7	16.1	20.4	1.9	23.0	7.4	7.8	7.1	10.8	14.8	10.2	27.3	20.9	10.5	15.6	35.0	31.3	20.1	19.6	8.7	8.3	6.6	10.2	16.0	19.7	7.4	13.2	10.7	8.7	6.2	5.5	5.8	21.0	13.7	21.7	66.6	12.5	5.0	18.3	23.5	6.4	3.2	17.0	15.7	7.1	2.2	18.0	52.9	32.8	5.9	11.4	16.0	3.6	19.5	7.7	7.3	1.5	2.1	4.0	2.9	3.9	8.6	10.7	6.7	3.1	10.2	2.6	2.2	6.2	12.7	4.0	8.9	24.3	18.4	41.5	9.9	11.8	2.3	18.5	70.2	2.0	5.2	10.5	4.2	6.5	2.7	10.3	1.9	6.5	18.5	42.1	4.1	4.1	21.7	6.8	11.3	2.9	2.0	8.0	11.0	6.5	11.2	5.0	5.4	8.7	5.6	3.2	6.4	5.5	10.9	4.3	5.8	5.8	8.5	60.1	4.7	22.6	30.4	52.5	11.0	31.5	7.8	2.2	7.1	11.4	18.0	1.9	6.8	9.0	52.9	5.9	32.8	4.4	6.0	16.0	23.7	18.3	28.1	26.3	27.3	20.9	20.1	19.6	19.7	18.3
ASTL	"ovastacin, SAS1B"	ENSG00000188886	"Astacin like metalloendopeptidase"	Q6HA08	2	96123850-96138436	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;fHDF/TERT166: 2.1;RT4: 3.8"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015620	Uncertain				"Secreted in female reproductive system"					"HPA015620: AB_1845121"	"unprognostic (3.21e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.03e-2)"		"unprognostic (3.53e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.61e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	0.2	0.1	0.2	0.6	0.4	8.5	0.1	1.3	0.8	0.0	0.5			0.1	0.3	0.4	0.5	0.0	0.4	0.0	0.8	0.0	0.1	0.0	0.5	1.1	0.0		0.2	0.0	0.0	0.8	0.0		0.9	0.2		0.6	2.7	0.0	2.3	1.1	0.0	0.0	2.3	0.2	0.7			0.0		0.7	3.2	0.0	0.3	0.0	0.0	0.0	1.9	1.8	0.3	0.0	0.0	0.0	0.1	0.0	0.4	3.1	0.0	0.0	0.0	0.1	1.2	0.1	0.1	1.2	2.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	1.1	0.9	0.7	0.0	0.0	0.0	0.4	0.0	3.8	0.8	0.0	0.0	0.3	0.3	1.4	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	1.2	0.3	1.8	1.8	0.0	0.0	0.3	0.6	0.0	1.9	0.0	0.0	0.0	0.3										
ATAD5	"C17orf41, ELG1, FLJ12735, FRAG1"	ENSG00000176208	"ATPase family, AAA domain containing 5"	Q96QE3	17	30831970-30895869	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.0;lymphoid tissue: 29.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066823			Approved	"Nucleoplasm,Cytokinetic bridge,Centriolar satellite,Cytosol"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA066823: "	"unprognostic (3.12e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.28e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.19e-3)"	"unprognostic (6.30e-10)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.38e-1)"	2.0	1.2	1.1	8.1	3.8	19.0	2.4	9.6	3.2	2.7	3.3	1.2	0.7	2.8	2.1	2.5	4.0	2.0	1.7	1.4	1.8	1.3	1.9	1.4	2.3	6.4	1.9	2.7	3.0	1.7	1.3	3.1	5.3	2.3	1.8	3.1	0.6	2.1	1.2	1.3	4.5	3.4	1.5	1.5	6.3	2.2	4.0	2.6	29.9	1.8	2.7	5.3	1.8	2.7	2.3	2.1	3.1	1.3	3.0	1.6	0.3	4.8	4.0	9.5	9.0	0.2	1.0	3.8	4.2	2.1	4.7	6.8	4.4	3.4	12.9	4.1	1.9	8.8	6.1	3.2	8.6	2.9	5.3	7.8	5.2	3.0	0.1	15.1	6.3	0.4	0.4	6.9	2.4	2.4	12.1	10.8	3.1	2.8	16.8	7.5	5.6	1.9	11.6	18.1	6.1	1.2	5.1	5.6	5.0	4.7	2.7	2.5	5.1	6.7	1.9	5.9	7.9	8.2	7.5	3.6	3.7	16.2	2.5	7.2	5.7	1.2	1.0	1.4	1.6	1.3	0.9	1.2	0.9	1.2	0.7	2.3	1.1	1.2	3.1	3.0	0.6	2.1	1.4	0.3	1.1	3.8	9.6	3.2	1.8	1.3	1.9	2.7	2.3	2.6
ATG16L2	"ATG16B, FLJ00012, WDR80"	ENSG00000168010	"Autophagy related 16 like 2"	Q8NAA4	11	72814308-72843674	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.9;lymphoid tissue: 52.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 28.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045444, HPA050312"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA045444: AB_2679324, HPA050312: AB_2681082"	"unprognostic (7.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	"prognostic favourable (7.06e-4)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.83e-2)"	7.8	6.6	7.1	20.7	8.0	60.9	7.2	7.4	6.2	9.5	9.7	10.5	7.6	5.5	11.9	7.5	10.2	8.3	11.6	5.8	7.4	4.8	7.2	6.5	16.3	16.4	10.7	7.0	10.1	8.0	5.7	11.5	5.2	8.6	7.3	8.9	11.3	10.1	5.5	3.6	35.7	13.1	10.4	7.9	52.0	6.6	2.6	8.3	3.2	6.5	8.0	19.6	8.5	8.5	2.0	4.7	28.5	7.1	2.4	2.6	1.4	1.5	1.4	4.3	3.3	5.0	4.2	2.6	3.3	3.3	1.6	2.5	1.7	3.6	9.9	2.2	4.2	3.0	0.5	11.1	2.8	7.8	1.7	7.7	7.0	2.7	3.7	10.1	32.2	4.0	1.5	3.7	4.6	5.0	1.0	13.6	1.9	4.9	11.6	17.4	0.6	1.6	5.7	3.0	4.3	5.4	5.0	3.1	2.5	1.4	7.4	3.0	3.7	13.9	7.0	4.5	1.7	8.2	2.5	6.1	1.5	4.3	2.0	9.0	2.5	2.4	7.1	18.1	1.3	3.9	1.3	1.2	1.9	2.6	4.7	2.0	1.0	1.2	28.5	2.4	4.7	0.8	1.7	1.4	7.1	8.0	7.4	6.2	7.4	4.8	10.7	7.0	8.6	8.3
ATG2A	KIAA0404	ENSG00000110046	"Autophagy related 2A"	Q2TAZ0	11	64894546-64917248	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 16.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038715	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"			Cytosol	Cytosol	"HPA038715: AB_10673474"	"unprognostic (3.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"prognostic favourable (4.79e-5)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	8.4	8.3	6.0	8.4	10.4	63.7	7.1	12.2	14.3	7.2	9.2	11.6	8.2	10.0	9.5	5.5	6.1	7.7	8.9	6.4	7.0	6.4	9.0	33.2	9.3	7.7	7.5	7.5	11.8	11.7	7.6	8.7	8.9	9.0	8.5	4.3	12.1	9.3	8.4	12.4	15.9	11.4	9.7	6.7	11.1	9.2	8.0	8.2	13.2	8.4	7.8	9.4	7.9	6.2	1.0	2.3	16.5	2.0	1.5	2.6	0.9	9.9	9.6	3.6	9.6	4.7	3.3	9.5	5.5	8.3	7.6	5.6	8.6	7.9	7.1	11.7	4.7	8.6	3.6	6.6	2.0	6.6	12.4	6.4	14.4	7.7	6.6	5.0	14.9	9.1	5.8	9.5	5.1	6.3	12.0	5.8	3.3	16.2	6.0	17.0	4.1	10.8	6.7	5.6	10.4	4.1	8.5	13.0	5.1	8.0	11.7	10.1	11.3	6.4	7.9	7.2	7.1	14.2	4.1	11.5	4.0	5.1	10.6	4.0	4.5	2.8	2.0	2.0	2.6	1.9	2.2	0.8	1.7	2.2	1.3	1.0	1.4	2.5	16.5	1.5	1.5	2.3	0.9	0.9	6.0	10.4	12.2	14.3	7.0	6.4	7.5	7.5	9.0	8.2
ATP5MGL	"ATP5K2, ATP5L2, dJ222E13.5"	ENSG00000249222	"ATP synthase membrane subunit g like"	Q7Z4Y8	22	42639803-42640601	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 3.9;bone marrow: 4.5"	"Cell line enhanced"	"Detected in some"		"RT4: 2.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA044629	Uncertain		Supported	Mitochondria				Mitochondria	Mitochondria	"HPA044629: AB_2679028"	"unprognostic (4.53e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.74e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-3)"	0.4	0.7	0.4	0.0	0.4	4.5	0.3	0.6	0.5	0.0	0.2			0.4	0.4	2.4	0.3	0.4	0.4	1.2	0.3	0.4	0.4	0.7	0.2	1.0	0.3		0.5	0.4	0.0	0.4	0.0		0.3	0.0		0.9	0.1	0.7	3.1	0.5	0.0	0.3	0.4	1.0	0.3			0.5		0.1	0.5	0.2	1.2	1.0	3.9	1.2	0.6	1.0	1.1	0.2	0.0	0.4	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.3	1.6	0.3	1.0	0.2	0.6	0.2	0.0	0.0	0.8	0.6	1.2	0.0	2.0	0.7	0.0	0.0	1.2	0.0	0.0	0.9	0.5	0.8	0.0	1.3	0.0	0.5	0.8	1.7	1.5	0.0	0.2	0.0	0.6	0.0	2.4	0.2	0.1	0.0	0.7	0.2	0.2	0.0	0.0	1.2	0.8	0.8	0.6	0.6	1.1	0.1	0.3	0.7	0.9	2.3	1.2	0.7	0.6	0.6	0.5	1.2	0.9	0.6	0.5	1.2	1.0	0.7	3.9	0.6	0.7	1.0	0.7	1.1										
ATP8B4	"ATPIM, KIAA1939"	ENSG00000104043	"ATPase phospholipid transporting 8B4 (putative)"	Q8TF62	15	49858238-50182817	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 18.6;NB-4: 7.1;THP-1: 12.0;U-937: 37.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 6.9;NK-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040254	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA040254: AB_10673028"	"unprognostic (6.45e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.08e-1)"	2.3	1.2	1.6	1.5	2.1	28.1	1.0	0.6	0.9	26.0	1.5	1.7	1.6	0.4	18.2	3.5	0.6	9.5	3.1	0.8	2.5	0.9	1.0	1.2	3.2	0.7	2.7	0.1	3.9	0.4	0.2	1.1	2.9	2.1	0.7	1.2	0.8	0.9	0.6	0.4	0.5	1.1	2.7	3.1	2.3	0.6	0.9	4.6	0.8	0.5	0.8	2.1	1.3	1.5	0.0	2.2	6.9	1.7	10.6	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.1	0.0	3.0	0.6	0.0	0.0	5.2	18.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	12.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.4	37.6	0.0	6.9	1.7	2.4	0.5	0.8	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.8	10.6	0.3	0.0	0.0	0.8	1.6	2.1	0.6	0.9	2.5	0.9	2.7	0.1	2.1	4.6
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;lymphoid tissue: 59.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 10.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"	"Nucleoplasm, Midbody"	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.2	1.3	0.4	22.1	0.6	19.7	2.0	0.6	0.6	2.6	5.8	0.5	0.9	5.9	0.9	1.3	17.1	0.3	2.2	1.0	0.4	0.2	1.4	1.8	2.4	17.8	0.4	0.4	0.8	0.6	0.0	0.4	3.8	0.8	0.9	5.5	0.7	2.7	0.4	2.1	5.0	8.1	1.3	0.7	11.2	4.2	1.2	0.4	59.9	0.5	8.0	19.1	2.1	5.0	2.3	0.8	1.2	0.6	0.5	10.9	1.4	41.0	28.2	42.0	20.2	0.9	1.4	16.1	19.7	10.6	40.8	37.7	36.5	12.4	41.0	10.2	7.8	30.2	30.5	13.5	33.8	18.0	50.1	24.4	16.1	30.8	0.1	12.9	24.0	0.7	0.6	23.9	15.0	18.8	15.2	15.9	17.9	19.5	46.8	18.3	26.1	12.6	31.7	38.7	17.0	8.9	8.1	9.1	13.0	17.5	7.9	13.4	13.8	8.7	7.3	16.4	16.9	14.7	51.2	11.6	7.7	30.8	7.9	19.6	33.1	0.0	0.6	0.9	0.6	0.4	0.2	1.6	1.9	3.1	0.8	2.3	0.2	1.0	1.2	0.5	0.3	0.2	10.9	1.4	0.4	0.6	0.6	0.6	0.4	0.2	0.4	0.4	0.8	0.4
BCL2A1	"ACC-1, ACC-2, ACC1, ACC2, BCL2L5, BFL1, GRS, HBPA1"	ENSG00000140379	"BCL2 related protein A1"	Q16548	15	79960889-79971446	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 72.7;bone marrow: 105.7;lung: 45.6"	"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 94.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 39.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"eosinophil: 37.1;intermediate monocyte: 25.3;neutrophil: 72.7;non-classical monocyte: 47.2"	"Group enriched"	"Detected in all"	6	"granulocytes: 72.7;monocytes: 47.2"																				"unprognostic (3.19e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.54e-3)"	"unprognostic (9.65e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (2.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.87e-1)"	21.6	0.9	1.9	22.6	4.0	105.7	1.8	0.5	1.8	1.0	2.0	0.4	0.0	1.0	0.7	1.0	3.0	4.9	3.6	9.8	2.2	1.3	1.8	5.2	45.6	24.9	11.8	0.0	3.7	1.0	0.2	2.2	3.8	3.8	1.6	1.3	0.8	2.3	0.3	1.4	0.6	4.4	2.7	8.2	32.8	1.9	4.6	4.0	4.3	2.3	1.4	11.1	4.8	7.1	9.3	3.4	72.7	47.2	2.8	5.7	5.8	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.6	0.7	0.2	0.0	0.0	0.0	0.2	0.4	0.5	20.1	0.2	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	94.5	0.0	0.9	0.0	10.3	0.8	0.0	0.1	0.1	0.0	0.7	0.4	6.4	4.8	3.3	5.6	37.1	3.6	25.3	2.0	9.3	4.7	4.7	3.4	5.9	5.7	5.3	72.7	2.8	47.2	0.6	1.0	5.8	1.9	4.0	0.5	1.8	2.2	1.3	11.8	0.0	3.8	4.0
BID		ENSG00000015475	"BH3 interacting domain death agonist"	P55957	22	17734138-17774770	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 96.5;bone marrow: 55.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 44.3;eosinophil: 68.5;intermediate monocyte: 75.7;myeloid DC: 36.3;neutrophil: 96.5;non-classical monocyte: 92.8;plasmacytoid DC: 25.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 36.3;granulocytes: 96.5;monocytes: 92.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000722, CAB003771"	Enhanced		Supported	Cytosol		2400000	2400000	Cytosol	Cytosol	"CAB003771: AB_365478, HPA000722: AB_1078283"	"unprognostic (1.59e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (3.50e-13)"	"unprognostic (4.66e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.18e-2)"	13.0	5.2	16.8	21.7	18.7	55.0	8.5	17.1	23.0	3.9	12.2	9.3	1.0	11.2	4.3	7.1	6.7	4.9	11.3	9.6	17.8	12.8	6.1	31.9	13.7	22.5	16.5	6.3	3.7	8.9	4.3	3.5	6.9	8.1	7.1	8.3	4.5	8.0	3.8	11.3	4.7	13.0	5.3	10.9	29.1	9.5	2.4	9.2	21.0	5.5	5.9	12.8	16.2	9.4	5.5	36.3	96.5	92.8	11.6	10.1	37.0	28.5	22.7	3.9	11.6	3.9	7.7	5.1	14.1	11.5	11.4	9.8	13.2	17.1	4.8	11.1	6.1	24.4	3.4	3.4	6.3	9.2	16.9	22.9	9.0	23.9	4.7	23.5	26.7	7.1	8.3	11.2	2.7	11.4	17.2	6.8	5.7	56.4	40.1	33.4	11.9	12.6	18.5	8.4	7.3	3.1	37.1	23.2	17.1	2.8	10.1	9.7	20.1	32.9	19.6	6.5	9.4	10.9	11.0	10.1	15.7	17.9	20.0	26.8	8.7	13.8	44.3	68.5	8.8	75.7	8.2	5.5	8.1	9.6	36.3	3.2	6.4	7.5	96.5	11.6	92.8	25.3	10.1	37.0	16.8	18.7	17.1	23.0	17.8	12.8	16.5	6.3	8.1	9.2
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465840	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 137.6"	"Cell line enhanced"	"Detected in many"		"A549: 82.6;K-562: 75.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 73.4"	"Group enriched"	"Detected in all"	7	"dendritic cells: 54.8;monocytes: 73.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		440000000	440000000	Cytosol	Cytosol	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (1.86e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (3.90e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	36.9	17.9	10.9	12.8	12.2	137.6	28.9	3.5	10.9	17.0	26.7	7.7	18.5	20.9	14.1	19.6	45.3	14.6	19.0	31.0	8.2	8.6	31.8	72.4	37.3	30.0	11.7	9.6	21.3	19.4	5.7	5.6	32.2	13.8	22.9	7.7	17.5	27.1	22.1	43.4	16.7	26.4	22.1	9.7	47.1	31.1	7.6	7.9	6.6	24.3	42.9	24.4	29.9	22.1	8.6	54.8	9.1	73.4	4.0	5.3	34.4	34.8	82.6	1.1	12.3	11.5	11.1	9.8	4.4	12.9	6.0	11.7	16.2	31.7	11.7	34.0	7.9	11.1	4.2	9.6	1.2	19.8	3.6	17.8	12.5	9.8	26.5	0.2	5.2	10.8	18.2	8.0	4.4	6.3	75.0	21.3	7.0	54.2	0.9	1.0	0.3	23.1	8.2	3.9	18.9	7.5	23.5	0.0	1.8	13.4	35.2	13.5	34.3	2.7	6.8	16.0	17.2	24.6	2.3	11.6	13.6	4.4	41.8	7.0	6.2	5.0	73.4	2.6	4.6	33.7	4.4	8.6	4.0	4.0	54.8	5.4	4.2	3.3	9.1	4.0	16.9	11.5	5.3	34.4	10.9	12.2	3.5	10.9	8.2	8.6	11.7	9.6	13.8	7.9
BST1	CD157	ENSG00000109743	"Bone marrow stromal cell antigen 1"	Q10588	4	15702950-15738313	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.5;bone marrow: 54.9;intestine: 61.3"	"Cell line enhanced"	"Detected in many"		"THP-1: 36.3;TIME: 20.0;U-937: 23.7;WM-115: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 52.7;neutrophil: 59.5"	"Group enriched"	"Detected in many"	105	"dendritic cells: 16.6;granulocytes: 59.5;monocytes: 52.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050121	Uncertain				"Intracellular and membrane"	170000000	170000000			"HPA050121: AB_2681025"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.95e-1)"	14.3	2.0	1.1	5.6	2.0	54.9	6.6	0.8	1.5	7.2	33.8	1.5	2.1	20.4	6.4	7.0	4.6	5.6	10.3	14.5	1.8	0.8	6.6	3.7	9.4	9.6	1.3	1.9	5.5	1.0	0.4	1.3	8.0	1.3	7.5	4.0	5.4	2.8	2.2	3.4	3.5	61.3	7.9	1.5	13.6	2.4	2.4	1.2	2.8	3.5	2.9	1.8	7.5	16.1	0.4	16.6	59.5	52.7	0.1	0.3	19.6	0.2	5.4	0.5	0.4	13.2	3.1	0.7	10.3	0.9	9.4	10.6	0.1	5.6	0.3	0.9	5.2	0.1	1.5	0.2	8.0	0.3	0.2	2.4	0.3	0.2	3.4	3.2	7.1	2.7	0.7	6.0	0.5	1.4	0.3	0.2	5.5	0.1	1.0	1.9	1.2	1.1	0.3	0.7	0.2	0.3	0.3	0.7	2.0	0.2	0.3	6.8	0.2	36.3	20.0	0.3	0.4	3.7	0.4	0.2	0.0	0.2	1.3	23.7	21.6	7.6	52.7	3.9	0.2	19.8	0.3	0.4	0.1	0.1	16.6	0.2	0.2	0.1	59.5	0.1	13.6	5.5	0.2	19.6	1.1	2.0	0.8	1.5	1.8	0.8	1.3	1.9	1.3	1.2
C11orf21		ENSG00000110665	"Chromosome 11 open reading frame 21"	Q9P2W6	11	2295645-2303049	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.5;bone marrow: 30.4;lymphoid tissue: 16.0"	"Cell line enhanced"	"Detected in some"		"HEL: 30.1;HL-60: 11.4;NB-4: 10.4;THP-1: 7.3;U-937: 12.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA037607	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA037607: AB_10672909"	"unprognostic (5.25e-3)"	"unprognostic (2.65e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.58e-4)"	"unprognostic (8.98e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.84e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.07e-2)"	1.5	0.4	0.7	8.7	0.5	30.4	0.7	0.2	0.7	1.5	0.8	1.7	0.8	0.2	1.6	1.3	0.7	1.0	5.4	15.6	0.4	0.4	1.0	1.3	5.2	8.5	2.2	0.9	0.7	0.6	0.0	0.8	0.8	1.0	0.8	0.8	1.4	9.3	0.1	0.4	0.8	3.3	0.6	1.4	16.0	2.0	0.9	1.0	6.4	1.1	2.7	11.5	1.0	0.9	2.6	7.3	29.5	23.2	9.5	10.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	30.1	0.0	0.1	0.3	11.4	0.5	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	12.8	0.0	29.5	6.3	18.7	10.6	13.1	7.3	2.0	3.6	8.4	7.3	2.6	5.4	7.5	5.5	9.5	23.2	0.7	2.6	6.4	0.7	0.5	0.2	0.7	0.4	0.4	2.2	0.9	1.0	1.0
C19orf38	HIDE1	ENSG00000214212	"Chromosome 19 open reading frame 38"	A8MVS5	19	10836575-10869790	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.7;bone marrow: 54.4"	"Cell line enriched"	"Detected in some"	4	"U-937: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"classical monocyte: 44.3;eosinophil: 26.1;intermediate monocyte: 48.7;myeloid DC: 26.2;neutrophil: 37.3;non-classical monocyte: 58.7"	"Group enriched"	"Detected in many"	19	"dendritic cells: 26.2;granulocytes: 37.3;monocytes: 58.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA012150, HPA055027"			Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA012150: , HPA055027: "	"unprognostic (6.65e-3)"	"prognostic favourable (2.43e-4)"	"unprognostic (6.44e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.56e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (1.75e-7)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.11e-2)"	2.7	1.2	2.1	6.9	4.0	54.4	1.8	0.7	3.1	2.0	1.3	4.8	0.0	1.3	0.9	4.0	0.9	2.6	2.1	5.6	2.4	2.1	1.4	2.3	12.8	19.6	4.2	0.6	1.6	1.3	0.3	1.0	1.9	3.8	1.6	1.0	1.5	1.0	0.8	2.3	0.6	1.7	2.3	6.3	22.3	1.2	15.0	3.7	4.1	0.7	0.5	2.0	2.8	3.5	2.1	26.2	37.3	58.7	1.2	0.8	20.7	1.5	0.0	0.1	0.3	1.4	0.8	0.1	0.2	0.0	0.2	0.6	0.1	0.2	3.7	0.3	0.0	0.1	0.2	0.2	0.2	1.7	0.4	0.2	0.0	0.0	1.1	2.4	0.4	4.0	0.4	0.7	0.2	0.1	0.2	7.9	0.1	1.3	0.1	5.7	0.3	0.2	2.8	0.0	1.9	0.0	0.1	0.2	0.1	0.7	0.0	0.5	0.1	5.5	0.0	0.0	0.0	0.7	0.0	4.8	2.2	1.1	0.0	32.0	0.0	1.2	44.3	26.1	0.1	48.7	0.2	2.1	0.1	0.1	26.2	1.2	0.8	0.2	37.3	1.2	58.7	0.5	0.3	20.7	2.1	4.0	0.7	3.1	2.4	2.1	4.2	0.6	3.8	3.7
CAMP	"CAP18, FALL-39, FALL39, LL37"	ENSG00000164047	"Cathelicidin antimicrobial peptide"		3	48223347-48225491	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 63.7;bone marrow: 201.8;epididymis: 275.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 13.3;hTCEpi: 9.3;U-698: 38.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 63.7"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 63.7"	"Low region specificity"	"Detected in single"							"CAB015949, CAB016522, HPA029874"	Enhanced				"Secreted to blood"					"CAB015949: , CAB016522: , HPA029874: AB_10600859"	"unprognostic (2.14e-2)"	"prognostic favourable (5.73e-4)"	"unprognostic (4.59e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.57e-5)"	"unprognostic (3.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.08e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-2)"	0.2	0.1	0.1	0.1	0.2	201.8	0.2	0.1	0.1	0.1	0.1	0.0	14.7	0.0	0.0	275.0	0.1	0.2	0.0	0.5	0.1	0.1	0.1	0.2	1.5	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.2	0.0	0.1	1.1	0.1	0.1	0.1	2.6	0.0	0.1	10.1	0.1	4.0	0.0	0.4	0.4	0.1	0.2	0.4	0.1	0.5	1.5	63.7	5.2	0.5	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	38.5	0.0	1.4	0.0	5.5	1.1	15.8	0.0	1.7	0.0	0.5	0.0	0.0	1.5	0.3	0.0	0.0	63.7	0.5	5.2	0.8	0.0	10.9	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CARD9		ENSG00000187796	"Caspase recruitment domain family member 9"	Q9H257	9	136361903-136373681	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.5;bone marrow: 19.4;lymphoid tissue: 15.9"	"Cell line enhanced"	"Detected in some"		"HEL: 9.6;HMC-1: 32.5;NB-4: 23.6;THP-1: 28.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 24.5;non-classical monocyte: 20.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059502	Enhanced									"HPA059502: AB_2684042"	"unprognostic (7.03e-2)"	"unprognostic (5.61e-2)"	"unprognostic (8.62e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.89e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.68e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.02e-6)"	"unprognostic (2.52e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-1)"	1.7	2.4	3.6	8.8	10.4	19.4	2.2	2.7	6.4	2.1	1.9	5.5	0.3	2.7	1.4	1.9	1.7	3.3	4.2	1.7	4.0	2.4	2.0	2.3	4.8	6.6	8.1	2.0	1.6	1.0	0.6	1.5	2.3	5.0	2.7	1.0	1.5	2.9	2.2	0.8	4.8	3.8	2.0	4.8	15.9	1.7	0.8	6.9	0.9	0.8	1.5	4.6	2.5	1.8	0.0	11.3	4.6	24.5	0.3	0.4	5.1	0.0	0.0	0.3	0.0	0.0	0.0	2.7	4.9	0.1	0.1	0.0	0.5	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.2	9.6	0.1	3.1	2.3	6.0	32.5	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	23.6	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.2	7.2	0.0	7.7	0.0	2.3	28.7	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	7.2	0.1	2.3	14.6	4.6	0.0	24.5	0.4	0.0	0.0	0.0	11.3	0.0	0.0	0.0	1.1	0.3	20.5	0.1	0.3	5.1	3.6	10.4	2.7	6.4	4.0	2.4	8.1	2.0	5.0	6.9
CBX4	"hPC2, NBP16, PC2"	ENSG00000141582	"Chromobox 4"	O00257	17	79833156-79839429	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 109.1"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 38.4;SK-MEL-30: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008228, HPA012021"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA008228: AB_1078413, HPA012021: AB_2668603"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (8.72e-8)"	"unprognostic (7.49e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-1)"	7.1	9.9	11.6	11.3	14.8	109.1	7.0	9.0	22.5	5.9	6.2	20.4	6.3	8.3	5.9	6.3	14.8	6.7	10.3	12.0	12.9	12.9	6.5	15.3	9.0	13.9	15.4	10.8	9.3	16.8	16.2	14.8	17.0	13.9	8.9	4.8	14.5	12.9	6.9	3.8	20.6	8.5	5.2	12.6	16.3	10.8	5.5	13.1	29.2	8.3	6.7	19.2	8.6	7.1	3.6	4.2	5.2	1.7	1.0	3.8	1.3	10.6	9.6	2.9	12.5	1.8	1.7	8.2	4.8	2.9	1.8	1.9	6.9	6.0	4.1	6.9	1.9	5.5	3.2	3.2	1.3	4.4	6.1	2.3	9.1	12.8	9.0	12.2	18.3	2.3	19.0	1.6	2.9	1.5	7.1	23.3	1.9	7.6	16.7	12.5	1.6	9.7	17.4	2.9	18.5	2.5	5.1	3.0	5.8	7.3	38.4	42.7	9.1	19.6	3.8	10.4	9.2	6.4	6.2	20.2	10.3	11.6	6.5	10.6	13.8	3.9	1.4	4.1	2.4	1.5	1.8	3.3	3.1	3.3	0.9	3.6	3.8	3.5	5.2	1.0	1.7	4.2	0.5	1.3	11.6	14.8	9.0	22.5	12.9	12.9	15.4	10.8	13.9	13.1
CCDC88B	"BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3"	ENSG00000168071	"Coiled-coil domain containing 88B"	A6NC98	11	64340223-64357534	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;brain: 23.7;lymphoid tissue: 29.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 39.8;Karpas-707: 10.4;THP-1: 15.8;U-937: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA026652	Approved		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"			Centrosome	Centrosome	"HPA026652: AB_1846168"	"unprognostic (1.18e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favourable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavourable (7.65e-5)"	"unprognostic (3.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.83e-2)"	3.5	2.5	5.2	29.5	5.4	32.5	2.7	23.7	2.8	2.6	6.1	4.5	6.9	3.2	2.0	1.3	4.2	2.5	8.5	2.3	4.1	2.6	2.0	1.6	11.4	18.6	8.6	2.2	1.3	2.1	0.7	1.6	1.4	6.5	2.9	2.9	1.7	7.5	8.9	0.8	1.9	11.1	1.3	7.2	26.6	3.3	7.3	6.5	16.8	1.9	2.7	20.8	4.1	2.8	3.0	3.5	11.3	6.5	7.1	4.6	1.6	0.1	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	1.5	9.0	1.4	0.5	0.7	0.0	0.2	0.0	9.8	0.0	6.8	1.8	0.5	0.4	4.2	39.8	0.0	0.0	0.1	0.0	0.2	0.2	10.4	0.3	0.4	5.7	3.5	0.3	0.2	5.4	0.1	8.4	0.1	0.1	2.2	0.0	0.0	0.2	0.4	1.2	15.8	0.0	0.0	0.3	0.0	0.1	2.2	0.7	7.3	0.5	11.5	0.2	3.6	6.5	7.6	4.6	4.7	1.4	2.2	2.7	3.8	2.1	3.0	2.6	3.2	11.3	7.1	3.1	3.5	0.8	1.6	5.2	5.4	23.7	2.8	4.1	2.6	8.6	2.2	6.5	6.5
CCL3	"G0S19-1, LD78ALPHA, MIP-1-alpha, SCYA3"	ENSG00000277632	"C-C motif chemokine ligand 3"	P10147	17	36088256-36090169	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.7;lymphoid tissue: 18.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 26.7;U-266/70: 45.9;U-266/84: 116.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"gdTCR: 10.2"	"Group enriched"	"Detected in many"	5	"B-cells: 4.5;granulocytes: 4.0;T-cells: 10.2"														"Secreted to blood"						"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.54e-1)"	"unprognostic (8.90e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.00e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.23e-2)"	5.3	4.3	0.0	5.7	1.6	35.7	2.4	0.5	6.0	0.9	0.9	11.6	0.0	0.8	0.7	1.4	0.4	0.4	3.5	3.4	0.0		0.5	7.9	15.1	5.8	0.0	0.0	2.0	0.4	1.8	0.0	5.7	3.7	0.5	0.9	1.7	1.0	0.2	1.2	0.0	0.8	1.1	0.0	18.0	0.2	3.7	0.0	1.8	0.8	0.5	1.8	2.3	0.0	4.5	0.2	4.0	0.8	1.1	10.2	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	26.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.1	45.9	116.1	0.0	0.2	0.0	0.0	0.1	0.8	4.0	10.2	0.5	0.3	1.4	0.3	2.8	0.2	4.5	0.0	3.0	4.0	1.1	0.5	0.0	0.0	4.6										
CCL3L1	"CCL3L3, D17S1718, G0S19-2, LD78BETA, MGC12815, SCYA3L, SCYA3L1"	ENSG00000276085	"C-C motif chemokine ligand 3 like 1"	P16619	17	36194869-36196758	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 17.7;brain: 16.5"	"Group enriched"	"Detected in some"	38	"U-266/70: 22.3;U-266/84: 44.3"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"eosinophil: 7.7;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.7"														"Secreted to blood"						"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.58e-2)"	0.4	0.1	0.0	3.5	2.2	17.7	0.2	0.0	9.0	0.7	0.4	16.5	0.0	0.4	0.6	0.6	0.1	0.2	1.9	0.1	0.0		0.6	2.7	4.0	0.9	0.0	0.1	1.2	0.3	0.1	0.0	3.0	4.4	0.9	0.3	1.9	2.3	0.4	0.1	0.1	0.6	0.3	0.2	2.7	0.3	2.5	0.0	1.3	0.3	0.6	0.7	0.9	0.0	0.0	0.1	7.7	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	22.3	44.3	0.5	0.0	0.0	0.0	0.3	0.1	7.7	0.9	0.0	0.6	0.0	0.0	0.6	0.1	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.1										
CCL4L2		ENSG00000276070	"C-C motif chemokine ligand 4 like 2"	Q8NHW4	17	36210924-36212878	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 41.8;bone marrow: 18.7;lung: 15.2"	"Group enriched"	"Detected in some"	4	"Daudi: 5.6;HMC-1: 8.0;U-266/70: 12.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in many"	7	"eosinophil: 41.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 41.8"														"Secreted to blood"						"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.99e-3)"	0.8	2.4	0.0	4.5	0.6	18.7	8.0	0.3	4.6	0.9	0.4	2.3	0.0	0.6	0.3	0.3	0.1	0.0	4.5	2.1	0.0		0.7	5.0	15.2	8.1	0.6	0.3	0.1	0.1	1.0	0.0	1.0	0.5	0.7	0.8	1.0	1.6	0.0	0.0	0.0	0.5	0.5	0.0	2.6	0.0	0.4	0.4	0.3	0.0	0.9	1.8	1.9	0.0	0.0	0.0	41.8	0.1	0.3	5.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.4	1.9	1.0	0.0	0.1	0.0	0.2	0.1	41.8	5.6	0.0	1.3	0.0	0.2	3.2	0.0	0.0	0.0	3.3	6.3	0.3	0.0	0.0	0.0	1.5										
CCNDBP1	"DIP1, GCIP, HHM"	ENSG00000166946	"Cyclin D1 binding protein 1"	O95273	15	43185118-43197176	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.4"	"Cell line enriched"	"Detected in many"	8	"HEL: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020664, HPA041065"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"CAB020664: , HPA041065: AB_2677282"	"unprognostic (4.48e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"prognostic favourable (2.06e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.68e-2)"	15.6	10.9	3.4	12.6	5.3	55.4	17.5	10.8	9.5	8.8	9.4	5.6	11.5	7.6	11.3	10.7	18.3	10.4	9.6	14.1	3.9	6.9	8.2	8.4	11.6	23.6	6.1	5.6	5.6	13.4	5.2	9.6	24.1	9.3	8.8	9.0	7.7	11.3	12.8	21.1	12.0	12.9	8.2	6.0	12.8	11.8	5.9	5.4	8.3	15.6	5.9	11.0	15.9	11.7	5.4	2.9	16.9	8.0	4.6	7.6	1.6	0.3	0.3	0.6	0.3	1.6	1.1	0.6	0.4	2.0	0.4	0.4	0.5	0.4	0.6	0.5	1.3	0.6	1.4	0.6	0.2	0.9	1.4	16.6	0.8	0.6	1.2	0.8	1.0	1.9	1.6	0.2	0.6	1.2	1.0	0.6	0.5	0.0	0.5	1.9	1.2	0.4	0.5	0.6	1.4	2.1	0.7	0.8	1.3	0.6	0.5	0.4	0.1	1.6	1.6	0.5	0.2	1.2	0.3	1.9	0.7	0.3	1.7	1.8	0.5	16.9	1.9	4.9	5.2	3.3	5.4	4.4	5.6	5.1	1.6	5.4	5.9	6.1	6.1	4.6	8.0	2.9	7.6	1.6	3.4	5.3	10.8	9.5	3.9	6.9	6.1	5.6	9.3	5.4
CCNE1	CCNE	ENSG00000105173	"Cyclin E1"	P24864	19	29811898-29824308	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.3;placenta: 46.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB000308, CAB016682, HPA018169"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384"	"unprognostic (2.90e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavourable (6.35e-6)"	"unprognostic (5.78e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavourable (3.89e-5)"	"unprognostic (1.26e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavourable (2.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.11e-16)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	1.6	6.8	2.4	4.5	2.9	23.3	0.6	6.3	3.3	0.8	3.0	1.7	1.1	2.3	1.2	0.6	4.7	0.7	2.2	4.4	2.3	2.8	1.2	0.7	1.1	4.6	1.9	1.9	0.9	1.4	1.7	1.0	46.7	2.8	1.1	3.8	1.5	3.2	1.2	2.2	4.4	2.5	3.0	1.7	4.6	2.0	12.3	1.6	4.1	1.6	2.1	5.9	2.7	2.5	2.7	1.6	1.6	1.9	0.0	1.4	0.5	4.0	8.4	6.5	9.2	1.4	1.6	79.9	6.5	1.4	2.9	3.5	8.5	8.2	3.4	15.3	2.8	1.2	7.6	3.3	4.1	10.8	4.7	2.9	8.2	8.9	1.1	11.3	7.7	1.6	1.8	3.9	0.5	3.5	11.6	1.5	4.3	6.0	6.2	3.2	10.8	2.0	9.3	7.6	2.6	2.2	6.5	5.5	4.6	9.3	11.5	1.0	2.5	8.4	2.0	6.7	25.4	4.0	4.3	6.5	4.5	23.4	3.8	1.4	3.6	0.0	0.1	0.0	0.6	1.9	1.1	2.7	0.5	0.4	1.6	0.2	0.1	0.9	1.6	0.0	1.9	0.0	1.4	0.5	2.4	2.9	6.3	3.3	2.3	2.8	1.9	1.9	2.8	1.6
CCNE2	CYCE2	ENSG00000175305	"Cyclin E2"	O96020	8	94879770-94896678	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.2;brain: 22.2;testis: 18.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 39.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 8.8"	"Group enriched"	"Detected in many"	4	"NK-cells: 2.2;T-cells: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007825, CAB019374"	Enhanced									"CAB007825: AB_598148, CAB019374: "	"unprognostic (1.80e-2)"	"unprognostic (4.81e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.36e-1)"	"prognostic favourable (5.87e-4)"	"unprognostic (8.37e-4)"	"prognostic unfavourable (8.77e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.01e-12)"	"unprognostic (1.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.03e-1)"	1.3	0.9	3.1	4.9	11.3	24.2	1.5	3.3	6.3	1.7	4.0	10.4	0.0	2.6	1.3	0.1	3.6	1.0	1.7	0.9	5.7	3.5	0.9	1.6	1.7	7.9	8.0	6.5	1.4	2.3	0.5	1.1	3.1	11.8	1.3	4.3	0.6	1.5	0.0	0.8	4.4	3.1	1.4	22.2	1.9	2.9	18.9	4.9	12.7	1.1	2.4	7.0	1.9	1.9	1.1	1.3	1.1	0.3	2.2	8.8	1.1	17.7	2.4	9.5	5.9	1.1	2.1	6.5	18.3	6.4	11.5	11.3	4.2	8.0	9.3	12.5	7.7	9.4	7.3	6.7	15.6	6.5	6.8	18.8	10.0	1.6	0.1	7.5	11.5	0.6	0.4	8.3	0.8	5.9	8.0	39.3	16.3	5.1	28.7	3.5	3.2	5.5	20.5	16.4	4.4	3.2	10.0	13.8	5.8	12.3	3.3	2.3	16.5	8.0	5.0	12.2	8.0	9.0	16.3	7.5	7.8	22.7	9.9	13.8	8.9	0.0	0.3	0.2	1.6	0.3	0.5	0.7	2.0	2.3	1.3	1.1	0.6	1.3	1.1	2.2	0.3	0.1	8.8	1.1	3.1	11.3	3.3	5.7	5.7	3.5	8.0	6.5	11.8	4.9
CD177	"HNA2A, NB1, PRV1"	ENSG00000204936	"CD177 molecule"		19	43353659-43363172	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 67.6;intestine: 43.5;lymphoid tissue: 33.9;vagina: 30.8"	"Cell line enriched"	"Detected in some"	24	"RPMI-8226: 44.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 27.6"					"Cell type enriched"	"Detected in some"	7	"neutrophil: 11.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 11.3"									"HPA041820, HPA046601"	Enhanced				"Intracellular and membrane"					"HPA041820: AB_2677691, HPA046601: AB_2679716"	"unprognostic (4.32e-2)"	"prognostic favourable (3.66e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.24e-1)"	1.0	0.0	0.0	8.3	0.0	67.6	0.7	0.0	0.9	2.3	39.5	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	17.3	0.0		0.0	2.1	16.6	26.6	0.1	0.0	2.0	1.0	0.0	0.0	0.4	1.9	17.3	43.5	0.9	0.0	0.0	0.0	0.0	0.0	0.6	4.8	33.9	0.0	1.1	0.0	2.0	1.3	7.2	2.3	0.8	30.8	0.0	0.0	11.3	1.6	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.3	0.3	0.0	0.0	0.0	1.2	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.0	44.9	0.7	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	1.6	0.0	0.9	0.0										
CD300E	"CD300LE, CLM2, IREM2"	ENSG00000186407	"CD300e molecule"	Q496F6	17	74609887-74623738	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.5;bone marrow: 22.5;lymphoid tissue: 21.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;SCLC-21H: 1.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"classical monocyte: 22.7;intermediate monocyte: 36.5;non-classical monocyte: 36.3"	"Lineage enriched"	"Detected in many"	6	"monocytes: 36.5"	"Low region specificity"	"Detected in single"							HPA015570	Uncertain									"HPA015570: AB_1846294"	"unprognostic (1.70e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.80e-3)"	"unprognostic (4.51e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.19e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.00e-4)"	"unprognostic (7.38e-3)"	"unprognostic (1.19e-1)"	8.5	0.7	0.5	21.0	0.6	22.5	0.7	1.2	1.0	0.5	1.2	0.3	0.0	0.0	0.7	3.0	0.9	1.5	1.9	2.0	0.5	0.5	2.5	1.1	14.3	9.4	0.5	0.2	1.0	0.8	0.0	0.5	1.7	0.7	0.6	0.2	1.1	0.6	1.6	1.6	0.6	0.7	5.3	0.9	14.3	0.8	0.7	0.3	0.2	1.2	0.8	0.8	1.8	0.6	0.0	5.9	0.5	36.5	0.0	0.0	11.6	0.2	0.0	1.1	0.1	0.0	0.1	0.2	0.2	0.2	0.0	0.1	1.1	0.0	0.5	0.2	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.0	1.7	0.8	0.0	0.9	0.3	0.1	0.3	0.0	0.0	0.0	0.2	0.5	0.0	0.9	0.2	0.8	0.5	0.4	0.2	0.0	0.2	0.1	0.6	1.5	0.5	0.3	0.0	0.1	0.6	0.0	0.0	0.5	0.7	0.7	0.2	0.9	0.0	0.1	0.0	0.6	0.5	0.0	22.7	0.1	0.0	36.5	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.5	0.0	36.3	0.1	0.0	11.6	0.5	0.6	1.2	1.0	0.5	0.5	0.5	0.2	0.7	0.3
CD300LD	"CD300D, CMRF35A4"	ENSG00000204345	"CD300 molecule like family member d"	Q6UXZ3	17	74579365-74592283	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 8.5;bone marrow: 3.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.4;RPMI-8226: 2.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	7	"neutrophil: 8.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.5"									HPA027756	Uncertain									"HPA027756: AB_10601097"			"unprognostic (8.03e-2)"											"unprognostic (3.30e-1)"				0.3	0.2	0.1	2.2	0.1	3.2	0.2	0.2	0.3	0.4	0.2			0.0	0.2	0.0	0.2	0.4	0.3	0.3	0.1	0.1	0.1	0.2	0.9	0.7	0.1		0.1	0.1	0.0	0.1	0.1		0.1	0.0		1.1	0.0	0.1	1.6	0.9	0.1	0.1	1.4	0.2	1.7			0.1		0.6	0.4	0.1	0.5	0.7	8.5	0.7	0.8	1.3	0.2	0.4	0.3	0.5	1.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.4	0.5	0.3	0.5	0.5	0.3	0.5	0.0	0.5	0.2	0.2	1.5	0.7	0.0	1.1	4.4	0.6	0.4	0.3	0.5	0.0	0.5	1.7	0.2	1.4	0.2	0.6	0.5	0.6	0.4	0.6	2.7	0.5	0.8	0.5	0.5	0.7	0.4	0.0	0.6	0.1	0.5	0.6	0.5	1.1	0.0	0.8	0.3	0.6	0.2	0.3	0.3	0.8	0.4	0.4	0.4	0.7	0.2	0.3	0.3	0.2	0.7	0.5	0.5	0.4	8.5	0.8	0.4	0.5	1.3	0.2										
CD69	CLEC2C	ENSG00000110848	"CD69 molecule"	Q07108	12	9752486-9760901	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.1;lymphoid tissue: 56.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 12.4;K-562: 24.0;MOLT-4: 8.6;U-266/70: 9.8;U-698: 11.1;U-937: 41.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cells: 14.8;T-cells: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002503, HPA050525"	Enhanced									"CAB002503: AB_563625, HPA050525: AB_2681157"	"prognostic favourable (3.31e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.10e-3)"	"unprognostic (4.76e-3)"	"unprognostic (9.53e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (7.87e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"	10.1	2.2	1.3	19.9	1.4	52.1	7.0	0.5	0.9	9.0	9.6	4.6	0.8	2.8	5.1	5.1	10.6	6.4	13.6	3.1	2.0	2.2	4.7	6.2	27.0	31.6	4.5	0.6	3.4	1.4	0.9	3.4	1.9	3.5	7.4	8.0	3.3	6.0	2.0	1.5	3.3	14.3	5.0	8.3	43.3	4.3	4.5	1.6	56.4	5.5	6.1	26.7	27.4	5.9	3.9	0.0	3.1	0.1	14.8	18.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	12.4	0.5	0.0	0.0	0.0	0.0	0.2	24.0	0.0	0.0	0.0	8.6	2.5	0.0	0.0	0.0	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	1.1	11.1	0.0	41.1	0.0	0.7	0.1	3.1	13.7	0.0	18.3	3.3	8.7	9.9	0.0	3.9	12.6	9.2	0.2	14.8	0.0	0.0	4.3	3.8	1.3	1.4	0.5	0.9	2.0	2.2	4.5	0.6	3.5	1.6
CD83	"BL11, HB15"	ENSG00000112149	"CD83 molecule"	Q01151	6	14117256-14136918	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 70.0;lymphoid tissue: 64.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 28.6;HDLM-2: 25.7;U-698: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002509, HPA041454"	Enhanced									"CAB002509: AB_563641, HPA041454: AB_2677489"	"unprognostic (2.22e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.05e-3)"	"unprognostic (9.05e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.68e-2)"	"prognostic favourable (3.49e-4)"	"unprognostic (2.30e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.46e-2)"	14.0	8.3	6.1	64.5	5.7	70.0	7.5	14.2	11.8	17.0	2.0	24.7	3.4	1.8	3.7	8.3	3.6	1.8	9.9	2.6	7.3	12.7	9.7	6.0	29.0	19.5	7.8	2.2	9.7	1.6	2.2	4.1	3.4	10.8	5.2	3.8	3.5	16.4	7.8	1.8	2.6	6.9	2.7	11.1	16.5	2.2	4.0	2.8	33.8	2.3	6.2	57.5	16.4	9.8	19.1	5.2	1.3	15.4	2.6	3.6	2.3	6.5	0.3	4.9	6.8	7.2	1.6	0.1	1.8	6.7	3.2	5.6	0.5	4.3	28.6	5.5	0.5	0.7	1.8	2.0	10.6	25.7	2.7	3.9	8.5	0.7	0.2	5.7	6.3	1.9	0.9	3.0	1.0	0.1	0.8	0.0	0.3	2.4	4.5	10.8	2.0	1.3	4.4	10.7	4.0	2.3	6.5	1.0	1.9	0.4	0.2	4.9	1.1	4.6	0.1	4.9	3.1	0.7	4.4	0.3	0.0	44.0	1.0	7.8	7.4	0.0	1.7	1.1	2.7	10.7	2.9	11.5	2.5	2.2	5.2	19.1	1.8	2.1	1.3	2.6	15.4	1.8	3.6	2.3	6.1	5.7	14.2	11.8	7.3	12.7	7.8	2.2	10.8	2.8
CDA	CDD	ENSG00000158825	"Cytidine deaminase"	P32320	1	20588948-20618908	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 126.5;bone marrow: 68.0"	"Cell line enhanced"	"Detected in many"		"A-431: 41.9;CAPAN-2: 28.0;HeLa: 39.7;PC-3: 20.0;SiHa: 49.8;U-937: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 126.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 126.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA064202	Enhanced		Approved	Nucleoplasm		3700000	3700000	Nucleoplasm	Nucleoplasm	"HPA064202: AB_2685211"	"unprognostic (2.38e-1)"	"prognostic unfavourable (5.05e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavourable (8.56e-5)"	"unprognostic (2.94e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.89e-3)"	4.0	1.4	1.5	4.0	1.5	68.0	2.2	1.1	2.4	19.0	8.6	1.7	2.0	2.6	6.7	3.5	38.3	2.9	1.8	5.9	1.7	1.6	12.5	42.1	8.4	9.1	2.0	1.3	2.9	0.8	1.2	0.7	30.8	3.5	4.2	10.2	4.5	6.9	1.5	3.2	7.0	24.7	4.3	1.9	11.8	1.2	2.9	0.9	0.9	3.0	23.3	10.5	3.1	16.5	0.0	1.3	126.5	21.7	0.0	0.1	7.1	41.9	4.1	0.0	0.0	0.0	1.2	0.0	3.2	0.8	0.8	3.3	0.2	28.0	0.0	1.6	6.7	14.7	0.8	11.0	2.2	0.0	0.8	0.0	39.7	5.3	0.3	0.0	0.0	1.8	1.8	7.9	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	20.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	49.8	0.0	0.0	0.0	1.2	0.7	0.0	1.7	3.8	0.2	0.0	0.0	0.0	0.5	17.6	0.0	16.3	21.7	43.3	0.0	11.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	126.5	0.0	9.3	0.2	0.0	7.1	1.5	1.5	1.1	2.4	1.7	1.6	2.0	1.3	3.5	0.9
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188402	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005855			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA005855: AB_1846364"	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.8	1.2	1.1	5.5	1.1	13.0	0.8	0.7	1.2	1.1	3.3	0.6	1.0	1.8	0.6	0.9	3.9	0.4	2.2	0.7	1.3	2.4	1.2	0.9	0.7	4.1	1.4	0.2	2.1	3.6	0.4	2.3	4.2	1.2	1.0	4.0	1.5	1.8	0.5	0.7	0.8	2.1	0.8	0.7	3.6	1.3	19.4	0.2	23.0	1.6	8.8	7.4	0.8	1.3	1.7	0.9	0.5	0.1	0.0	1.0	0.1	7.5	3.7	17.8	9.6	0.6	1.2	12.3	10.5	4.0	13.2	10.7	16.1	3.9	22.4	4.1	2.7	5.7	30.5	7.2	13.9	7.3	16.0	28.7	6.8	7.9	0.6	20.2	8.3	0.6	1.1	16.4	7.1	5.0	22.8	11.9	7.1	4.0	25.2	15.7	26.0	8.5	11.3	11.7	12.2	3.3	7.1	8.4	10.4	6.5	7.6	3.3	4.0	14.3	2.5	6.5	10.0	7.2	14.2	6.0	17.9	35.2	4.8	22.5	5.4	0.0	0.0	0.5	0.4	0.0	0.0	1.7	0.6	0.2	0.9	0.0	0.0	1.0	0.0	0.0	0.1	0.5	0.0	0.1	1.1	1.1	0.7	1.2	1.3	2.4	1.4	0.2	1.2	0.2
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479459-19520612	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5"	"Cell line enhanced"	"Detected in many"		"K-562: 86.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	Nucleoplasm	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavourable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.9	0.9	0.3	8.4	0.5	15.7	0.9	0.3	0.6	1.3	3.4	0.3	0.2	2.2	0.6	1.4	6.2	0.4	0.8	1.6	0.7	0.3	0.8	1.4	1.3	7.5	0.4	0.2	0.7	0.5	0.1	0.4	3.5	0.4	0.7	4.3	0.2	1.3	0.2	0.4	2.1	3.1	1.1	0.4	4.2	1.8	43.5	0.2	25.4	0.5	7.2	10.2	1.3	1.9	0.7	0.9	1.6	0.5	1.8	3.2	1.9	13.1	11.0	13.7	10.7	0.6	1.3	5.8	16.2	7.6	18.7	18.6	8.4	7.3	14.6	5.7	4.8	12.6	14.6	10.7	16.8	17.8	24.7	19.5	12.4	9.2	0.7	28.3	10.7	0.4	0.5	14.3	6.4	9.4	86.6	18.4	10.9	17.5	22.9	13.4	4.1	8.3	19.1	22.8	6.4	4.3	12.6	17.7	9.3	8.8	9.7	2.8	6.3	12.6	3.6	14.6	23.4	11.0	14.7	6.3	11.6	17.0	7.7	14.2	19.5	0.0	0.2	0.0	2.2	0.0	0.0	0.7	1.4	2.3	0.6	0.0	1.0	0.7	1.6	1.8	0.5	0.9	3.2	1.9	0.3	0.5	0.3	0.6	0.7	0.3	0.4	0.2	0.4	0.2
CDCA4	"FLJ20764, Hepp"	ENSG00000170779	"Cell division cycle associated 4"	Q9BXL8	14	105009573-105021148	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059416, HPA064971"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA059416: AB_2684008, HPA064971: AB_2685395"	"unprognostic (2.22e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavourable (4.19e-4)"	"prognostic unfavourable (7.94e-4)"	"unprognostic (4.20e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavourable (6.67e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavourable (1.47e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.24e-2)"	4.5	2.6	1.7	11.5	2.6	38.3	4.1	8.3	3.2	8.7	3.7	2.6	4.5	4.1	5.6	4.0	16.6	4.1	4.2	2.4	1.5	1.3	2.8	3.0	5.1	9.1	2.7	1.4	5.0	6.2	1.6	1.9	12.4	3.3	4.6	2.7	3.3	5.3	2.2	1.3	21.8	4.4	3.1	2.3	6.7	3.6	12.8	2.3	24.9	5.1	11.2	15.0	3.7	8.8	7.4	4.2	8.3	4.3	10.6	14.7	5.5	15.0	15.7	18.2	13.7	3.1	5.2	23.8	22.5	6.9	17.7	15.5	19.2	19.3	19.8	12.3	7.9	24.2	12.7	25.9	10.4	21.6	10.0	12.5	13.4	16.0	3.8	22.1	10.5	3.7	8.1	13.6	12.8	11.9	13.7	20.5	12.2	36.9	20.6	14.9	13.5	36.0	20.0	26.5	7.3	6.0	17.5	10.6	13.1	21.5	8.6	17.3	17.0	14.9	18.5	15.7	19.9	21.5	29.9	7.6	9.4	20.2	13.1	11.2	25.9	0.9	3.6	8.3	10.9	3.9	13.3	7.4	11.4	14.7	3.9	5.2	6.8	8.0	1.3	10.6	4.3	4.2	8.9	5.5	1.7	2.6	8.3	3.2	1.5	1.3	2.7	1.4	3.3	2.3
CDKN2D	"INK4D, p19"	ENSG00000129355	"Cyclin dependent kinase inhibitor 2D"	P55273	19	10566462-10569059	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.1;bone marrow: 119.4"	"Cell line enhanced"	"Detected in many"		"HEL: 32.4;MOLT-4: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011201, HPA043546"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB011201: AB_261049, HPA043546: AB_2678545"	"unprognostic (3.08e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.55e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.90e-2)"	"unprognostic (4.52e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	5.5	4.7	27.9	6.8	24.2	119.4	4.1	14.3	28.7	2.6	3.9	4.2	0.5	3.9	2.4	2.5	3.8	3.0	4.0	8.4	22.9	17.9	2.7	2.1	6.6	11.1	14.3	14.3	2.8	2.8	2.6	3.4	4.8	11.8	2.5	3.6	2.4	3.2	3.0	6.3	6.0	3.5	4.6	5.7	9.7	2.8	10.9	3.6	18.6	1.8	2.8	8.4	4.2	2.4	17.3	16.0	44.1	10.7	11.9	11.3	9.5	10.9	1.7	5.6	3.7	3.0	4.7	1.4	7.2	8.5	8.0	7.0	2.2	2.6	3.0	2.4	7.6	2.3	1.9	1.8	2.9	12.2	4.6	32.4	2.0	3.6	3.5	3.2	26.3	1.9	6.0	4.1	3.0	2.2	1.3	26.7	7.9	1.5	39.9	17.1	1.1	8.4	6.5	5.5	1.8	3.6	0.9	7.9	4.2	5.1	3.8	5.5	3.4	8.6	1.7	9.5	4.9	15.6	10.7	16.8	5.7	5.6	10.0	5.5	6.7	35.9	5.6	23.5	10.0	6.8	8.0	17.3	8.3	11.3	5.4	15.9	7.9	9.4	44.1	11.9	10.7	16.0	6.7	9.5	27.9	24.2	14.3	28.7	22.9	17.9	14.3	14.3	11.8	3.6
CEACAM21	"FLJ13540, R29124_1"	ENSG00000007129	"Carcinoembryonic antigen related cell adhesion molecule 21"	Q3KPI0	19	41549518-41586844	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 19.1;bone marrow: 21.1;lymphoid tissue: 22.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.5;Karpas-707: 7.6;U-266/70: 8.4;U-937: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043411	Uncertain									"HPA043411: AB_10794886"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.73e-2)"	"prognostic favourable (1.89e-5)"	"unprognostic (2.57e-1)"	"unprognostic (8.02e-4)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.37e-6)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.37e-1)"	1.8	1.2	1.6	18.5	1.7	21.1	1.3	1.0	1.4	3.5	3.8	2.4	0.0	1.2	3.9	1.4	1.5	1.4	1.1	2.1	2.0	7.2	1.4	1.8	7.2	19.2	8.4	0.5	1.1	0.7	0.3	1.0	2.4	1.9	1.2	1.2	2.0	4.3	6.2	0.5	0.6	5.0	0.9	3.3	22.7	1.4	1.5	1.6	11.1	1.2	0.7	22.4	2.9	0.8	6.9	7.0	13.0	4.6	10.3	19.1	10.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	8.4	1.5	1.6	0.0	6.4	0.0	0.0	2.6	10.8	19.1	4.6	12.8	6.7	16.5	13.1	2.8	6.9	14.2	13.8	13.0	10.3	2.8	7.0	14.6	10.1	1.6	1.7	1.0	1.4	2.0	7.2	8.4	0.5	1.9	1.6
CEACAM3	"CD66d, CGM1"	ENSG00000170956	"Carcinoembryonic antigen related cell adhesion molecule 3"	P40198	19	41796437-41811553	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 60.0;bone marrow: 35.4"	"Cell line enhanced"	"Detected in single"		"PC-3: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 60.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 60.0"									HPA011041	Approved									"HPA011041: AB_1078481"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.68e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.83e-1)"	0.9	0.3	0.3	3.6	0.8	35.4	0.7	0.2	0.8	0.6	1.0	0.0	0.0	0.2	0.4	0.2	1.2	0.7	0.4	5.1	0.4	0.3	0.4	1.1	14.0	11.5	1.8	0.1	0.7	1.0	0.2	0.3	4.6	0.5	0.3	0.3	1.4	0.8	0.2	1.5	0.2	0.6	0.4	0.3	10.7	0.4	0.9	0.2	1.6	0.5	0.3	2.7	0.8	0.6	0.0	0.8	60.0	8.9	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.8	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	60.0	0.0	8.9	0.0	0.0	0.6	0.3	0.8	0.2	0.8	0.4	0.3	1.8	0.1	0.5	0.2
CENPE	"KIF10, PPP1R61"	ENSG00000138778	"Centromere protein E"	Q02224	4	103105806-103198409	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.3;lymphoid tissue: 25.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA042294	Enhanced		Approved	Nucleoplasm,Microtubules,Cytosol				"Microtubules, Cytosol"	"Microtubules, Cytosol"	"HPA042294: AB_10797386"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.40e-8)"	"unprognostic (2.49e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.15e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-1)"	2.7	0.9	0.6	9.4	1.5	11.3	0.7	0.2	1.3	1.0	2.1	0.5	0.0	1.9	0.7	1.9	5.9	0.5	0.8	2.5	2.0	0.8	1.3	0.6	1.4	7.3	1.9	0.6	0.7	0.5	0.1	0.4	3.1	1.4	0.7	2.7	0.2	2.2	0.8	0.4	2.2	2.4	1.4	1.3	3.3	1.6	6.6	0.6	25.1	0.6	5.9	6.4	1.5	1.9	0.6	0.5	5.7	3.0	0.8	1.4	0.2	20.6	5.9	21.6	10.4	1.5	3.3	4.2	18.8	9.4	14.0	9.4	9.3	11.2	14.0	4.8	6.9	9.2	15.4	7.6	22.2	17.5	5.7	16.5	12.4	6.7	0.2	19.5	9.6	1.0	0.5	11.3	9.5	11.8	17.0	16.8	18.1	7.5	15.3	8.8	6.9	9.3	10.3	20.2	4.6	3.9	4.1	10.0	5.9	16.7	11.6	4.5	6.6	6.9	12.8	13.6	14.3	14.1	19.2	8.2	14.0	14.5	7.5	10.9	14.4	5.7	0.1	0.7	0.2	0.6	0.0	0.6	0.4	0.4	0.2	0.2	0.1	0.3	0.1	0.8	3.0	0.5	1.4	0.2	0.6	1.5	0.2	1.3	2.0	0.8	1.9	0.6	1.4	0.6
CENPU	"CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1"	ENSG00000151725	"Centromere protein U"	Q71F23	4	184694618-184734133	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.7;lymphoid tissue: 30.0;testis: 50.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 14.1;eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA022048			Supported	"Nucleoplasm,Centriolar satellite"				"Nucleoplasm, Centriolar satellite"	"Nucleoplasm, Centriolar satellite"	"HPA022048: AB_1853985"	"unprognostic (1.47e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.39e-3)"	"prognostic unfavourable (7.51e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.34e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavourable (1.11e-9)"	"unprognostic (2.19e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.46e-2)"	"unprognostic (2.74e-1)"	2.7	1.7	1.4	7.8	1.0	30.7	3.1	1.2	1.3	2.8	4.4	1.2	2.9	2.8	1.4	3.2	11.2	0.9	1.7	1.0	1.2	0.6	1.4	2.3	2.0	9.5	1.3	0.2	1.1	1.3	0.7	0.6	7.0	1.0	2.0	5.1	0.9	3.5	0.5	1.2	7.1	5.2	1.5	1.0	5.8	2.3	50.2	0.6	30.0	0.9	7.3	9.1	1.6	4.5	0.8	1.7	14.3	2.8	3.0	2.5	0.7	23.0	6.5	28.0	14.1	1.5	2.4	14.8	13.9	6.2	11.4	7.9	7.7	13.3	19.2	1.3	6.5	9.2	23.0	14.2	11.7	9.3	9.2	16.5	5.9	3.9	0.2	29.1	11.5	1.2	0.7	14.0	2.6	11.9	18.1	57.7	21.3	15.3	37.4	18.6	14.8	8.7	29.7	9.1	5.6	6.3	8.9	19.8	21.1	10.1	12.9	10.5	17.7	16.0	7.1	10.2	13.3	10.5	16.0	8.5	8.6	15.7	14.3	22.6	33.4	14.1	0.7	14.3	0.6	1.9	0.4	0.8	1.0	1.0	0.5	0.8	0.6	0.8	0.1	3.0	2.8	1.7	2.5	0.7	1.4	1.0	1.2	1.3	1.2	0.6	1.3	0.2	1.0	0.6
CFP	PFC	ENSG00000126759	"Complement factor properdin"	P27918	X	47623172-47630305	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 106.7;bone marrow: 39.4;lymphoid tissue: 41.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.7;HEL: 4.5;HMC-1: 5.1;NB-4: 9.9;U-937: 6.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"classical monocyte: 102.4;intermediate monocyte: 106.7;myeloid DC: 86.2;neutrophil: 64.3;non-classical monocyte: 70.6"	"Group enriched"	"Detected in many"	40	"dendritic cells: 86.2;granulocytes: 64.3;monocytes: 106.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	8500000000	8500000000				"unprognostic (2.77e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.66e-5)"	"unprognostic (9.90e-3)"	"unprognostic (1.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.17e-1)"	3.3	1.0	0.7	10.3	0.9	39.4	1.6	0.7	0.6	0.6	2.0	0.2	0.6	0.5	0.7	3.1	1.8	2.5	2.1	4.3	0.6	0.6	1.3	21.6	8.7	41.3	0.4	0.0	0.7	0.4	0.0	0.7	1.6	0.3	0.8	0.4	1.2	3.1	0.6	1.4	1.0	2.1	2.6	0.4	39.3	1.1	0.8	0.0	6.0	0.9	1.3	5.6	2.1	0.9	0.4	86.2	64.3	106.7	1.1	2.1	70.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.7	0.0	0.1	0.1	0.0	0.0	0.0	0.2	4.5	0.1	0.0	0.1	1.1	5.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	9.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.5	0.1	0.4	0.3	0.1	0.1	6.9	0.0	9.0	102.4	3.2	0.2	106.7	0.2	0.4	1.4	0.1	86.2	0.1	2.1	0.7	64.3	1.1	70.6	2.7	1.1	70.7	0.7	0.9	0.7	0.6	0.6	0.6	0.4	0.0	0.3	0.0
CHRFAM7A	"CHRNA7-DR1, D-10"	ENSG00000166664	"CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion"	Q494W8	15	30357766-30393849	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 6.2;parathyroid gland: 6.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.2;HEK 293: 3.6;HEL: 5.9;RH-30: 4.8;SH-SY5Y: 6.1;U-937: 6.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"eosinophil: 5.2"	"Low lineage specificity"	"Detected in many"																						"unprognostic (3.61e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.53e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.71e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	0.9	3.5	1.3	1.1	1.3	6.2	0.4	0.0	2.5	0.6	0.4			0.7	0.3	0.2	0.1	0.8	0.4	2.4	0.9	1.6	0.2	0.0	1.2	0.5	2.8		0.6	0.9	6.3	1.0	0.0		1.0	0.6		0.2	0.5	0.1	0.4	1.8	0.6	1.6	0.8	0.9	5.5			3.2		0.2	0.8	0.5	0.2	2.8	5.2	2.1	1.0	0.3	0.4	0.0	0.5	1.9	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	6.2	0.0	0.0	0.0	3.6	5.9	0.2	0.6	0.1	1.2	2.0	0.4	0.0	0.2	0.0	0.6	0.6	0.0	1.8	0.0	0.0	0.6	0.6	0.0	0.0	4.8	0.0	1.5	1.9	0.3	6.1	0.0	0.0	0.0	0.1	1.3	2.6	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	2.1	5.2	0.3	0.7	0.1	0.2	0.0	0.0	2.8	0.1	0.0	0.3	0.0	1.0	0.1	0.6	0.1	0.4										
CIT	"CITK, CRIK, KIAA0949, STK21"	ENSG00000122966	"Citron rho-interacting serine/threonine kinase"	O14578	12	119685790-119877291	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3;brain: 35.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA019082, HPA048812, HPA075506"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA019082: AB_1846803, HPA048812: AB_2680528, HPA075506: "	"unprognostic (5.64e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.61e-6)"	"unprognostic (6.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.30e-1)"	1.4	4.4	14.7	3.3	14.0	15.3	1.6	12.7	35.0	1.6	4.6	2.9	0.0	4.0	1.3	1.5	3.2	0.9	1.6	1.0	9.8	5.7	5.7	1.4	3.0	3.4	3.2	21.9	0.7	0.7	1.2	2.9	2.6	7.4	1.0	5.3	0.6	1.3	1.0	1.3	5.1	3.5	2.6	5.0	5.6	3.5	8.3	9.5	5.9	1.5	0.1	4.9	1.7	1.7	0.4	0.0	0.0	0.1	0.0	1.2	0.8	15.0	13.5	11.9	11.2	1.1	3.3	7.0	11.5	9.6	12.1	9.1	8.6	6.2	10.8	6.2	8.9	9.4	8.1	6.7	16.7	7.7	5.9	13.7	8.7	5.3	0.1	7.2	12.6	0.7	0.7	14.4	8.9	9.2	8.7	9.2	11.3	7.5	13.0	11.0	6.4	9.1	11.9	21.6	3.6	2.4	6.6	8.5	4.7	19.1	3.7	9.1	13.5	5.2	7.0	15.1	13.9	10.3	12.5	6.3	7.0	7.4	10.0	7.9	23.3	0.0	0.0	0.0	0.4	0.1	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	14.7	14.0	12.7	35.0	9.8	5.7	3.2	21.9	7.4	9.5
CKAP2	"FLJ10749, LB1, se20-10, TMAP"	ENSG00000136108	"Cytoskeleton associated protein 2"	Q8WWK9	13	52455429-52476628	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 42.3;lymphoid tissue: 49.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA008410, HPA027821"	Enhanced		Approved	Microtubules,Cytosol				"Microtubules, Cytosol"	"Microtubules, Cytosol"	"HPA008410: AB_1846832, HPA027821: AB_10602208"	"unprognostic (1.85e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (3.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.60e-3)"	"prognostic unfavourable (1.90e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	4.6	9.2	7.1	12.1	12.2	42.3	4.4	16.4	9.9	4.3	6.7	1.9	2.3	9.0	4.2	5.2	14.7	3.0	4.1	5.3	5.8	7.8	5.0	3.2	5.0	13.5	5.9	5.8	3.5	2.4	3.4	10.9	10.2	16.1	4.6	7.4	1.4	6.7	3.6	5.8	10.4	7.0	6.5	5.5	12.4	4.2	22.1	5.2	49.2	5.0	10.3	14.8	8.1	6.6	15.2	16.1	30.4	12.8	2.5	15.7	4.2	19.2	10.4	41.8	20.6	5.4	5.4	10.5	31.7	18.7	37.0	23.9	15.0	24.4	36.9	5.1	23.6	22.6	28.8	16.1	51.7	25.0	23.7	33.3	11.7	10.6	2.3	33.1	13.6	3.9	6.7	17.3	22.8	22.4	14.0	15.3	40.8	9.0	22.7	16.3	24.7	11.0	21.9	23.9	16.1	11.3	10.5	12.8	16.7	17.9	13.2	9.8	14.5	15.9	14.7	10.7	16.6	16.7	31.7	9.0	13.3	45.6	7.5	17.3	28.2	30.4	7.2	10.4	5.4	10.4	4.8	12.2	8.2	6.4	7.5	15.2	6.5	5.5	2.2	2.5	12.8	16.1	15.7	4.2	7.1	12.2	16.4	9.9	5.8	7.8	5.9	5.8	16.1	5.2
CKAP2L	"FLJ40629, radmis"	ENSG00000169607	"Cytoskeleton associated protein 2 like"	Q8IYA6	2	112736607-112764677	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.4;lymphoid tissue: 38.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039407, HPA040057, HPA070737"	Uncertain		Supported	"Mitotic spindle,Cytosol"				"Mitotic spindle"	"Mitotic spindle"	"HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303"	"unprognostic (2.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.59e-2)"	"unprognostic (5.75e-5)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.57e-6)"	"unprognostic (2.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.37e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	1.5	0.7	0.6	9.2	0.6	13.4	1.3	0.7	0.6	0.6	1.8	0.0	0.3	1.5	0.5	1.4	3.8	0.7	0.1	2.3	0.6	0.5	0.7	0.7	1.2	5.3	0.6	0.2	0.6	0.6	0.0	0.5	3.2	0.2	0.6	2.4	0.0	1.0	0.0	0.6	1.5	2.4	0.9	0.6	2.2	0.9	9.0	0.1	38.3	0.6	5.9	6.0	0.9	0.7	1.0	0.8	1.8	0.7	1.6	1.8	0.4	19.9	4.0	15.8	7.1	0.9	1.5	3.2	16.5	13.7	17.2	16.4	3.7	5.8	13.7	6.9	6.5	7.7	9.1	8.7	29.0	19.0	4.0	22.8	5.6	3.2	0.0	10.7	13.7	0.4	0.8	21.6	12.3	7.8	6.0	20.0	14.0	2.9	12.9	4.1	6.7	13.0	9.4	16.6	3.6	2.9	7.8	8.7	5.5	6.7	5.6	5.7	5.4	5.0	5.5	19.1	14.9	15.2	12.1	4.3	8.3	11.7	8.2	7.7	29.9	0.8	0.5	0.7	0.5	0.7	0.4	0.9	1.2	1.1	0.5	1.0	0.5	0.7	1.8	1.6	0.7	0.8	1.8	0.4	0.6	0.6	0.7	0.6	0.6	0.5	0.6	0.2	0.2	0.1
CLEC11A	"CLECSF3, LSLCL, P47, SCGF"	ENSG00000105472	"C-type lectin domain containing 11A"	Q9Y240	19	50723329-50725718	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.1"	"Group enriched"	"Detected in many"	4	"HEL: 44.4;HMC-1: 82.3;NB-4: 109.3;THP-1: 88.3;U-937: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.0;monocytes: 17.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042690	Approved		Approved	Centrosome	"Secreted in other tissues"	45000	45000	Centrosome	Centrosome	"HPA042690: AB_10795511"	"unprognostic (9.33e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.40e-2)"	"prognostic favourable (6.91e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (6.09e-2)"	"unprognostic (8.66e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.57e-2)"	5.5	5.4	3.0	5.6	3.1	77.1	4.5	4.5	3.6	33.6	6.5	1.2	6.7	3.9	26.6	27.8	6.7	13.5	10.7	5.6	2.6	3.4	7.4	5.4	7.5	3.5	2.9	1.3	16.1	2.6	2.0	7.5	6.9	4.0	18.9	2.1	8.9	2.9	10.2	3.4	5.0	5.2	8.5	3.4	4.9	3.1	4.9	0.8	4.0	3.8	4.5	2.6	8.4	10.1	0.3	12.0	1.2	17.2	3.4	3.2	6.7	0.3	0.4	0.0	0.3	4.3	5.9	10.1	17.3	4.7	2.0	1.9	0.0	0.0	0.0	0.2	8.6	0.2	0.0	0.0	1.3	0.0	2.8	44.4	0.0	0.0	2.7	0.0	82.3	4.3	0.0	0.2	0.2	2.2	0.5	0.2	3.7	0.3	0.3	109.3	0.2	0.5	3.8	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.0	6.7	0.1	88.3	12.4	0.1	5.4	0.0	0.1	0.2	0.2	0.0	6.3	45.8	5.7	1.0	17.2	0.2	0.6	7.2	0.0	0.3	0.2	0.1	12.0	0.3	1.5	3.2	1.2	3.4	3.3	3.2	0.1	6.7	3.0	3.1	4.5	3.6	2.6	3.4	2.9	1.3	4.0	0.8
CLEC4E	"CLECSF9, mincle"	ENSG00000166523	"C-type lectin domain family 4 member E"	Q9ULY5	12	8533305-8540963	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.7;bone marrow: 37.7;lymphoid tissue: 41.2"	"Group enriched"	"Detected in some"	4	"NB-4: 5.7;RPTEC TERT1: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"classical monocyte: 22.8;neutrophil: 81.7"	"Group enriched"	"Detected in many"	17	"granulocytes: 81.7;monocytes: 22.8"	"Not detected"	"Not detected"							HPA004935	Uncertain		Uncertain	Cytosol				Cytosol	Cytosol	"HPA004935: AB_2667299"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.29e-1)"	8.4	3.0	1.1	20.9	2.4	37.7	17.5	1.2	2.2	3.4	1.4	0.0	1.1	0.1	1.2	1.6	1.7	4.2	6.7	5.9	1.3	1.2	6.2	3.5	25.6	41.2	2.8	0.6	1.0	3.3	0.0	1.7	1.7	9.0	1.6	0.5	1.1	1.2	0.6	2.7	0.7	1.9	3.2	5.3	34.2	1.8	3.3	0.8	0.7	12.8	0.9	1.1	2.2	2.2	0.0	2.9	81.7	22.8	0.0	0.0	4.5	0.1	0.6	0.4	0.0	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.1	1.9	0.1	2.6	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.3	0.3	0.0	0.7	0.1	0.0	1.7	0.1	0.7	0.2	0.1	0.0	0.1	0.0	5.7	0.5	0.1	0.1	0.2	0.1	16.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.5	1.2	0.6	0.1	1.1	0.1	0.2	0.1	0.1	1.6	0.4	0.1	0.0	22.8	0.0	0.0	3.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	81.7	0.0	0.1	0.1	0.0	4.5	1.1	2.4	1.2	2.2	1.3	1.2	2.8	0.6	9.0	0.8
CLEC5A	"CLECSF5, MDL-1"	ENSG00000258227	"C-type lectin domain containing 5A"	Q9NY25	7	141927357-141947007	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.8"	"Group enriched"	"Detected in some"	23	"HL-60: 14.8;U-937: 57.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"classical monocyte: 11.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA054137			Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA054137: AB_2732582"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.33e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (6.58e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.64e-1)"	1.4	3.2	1.8	7.3	2.4	35.8	0.8	0.8	2.5	1.7	0.4	1.9	0.6	0.4	0.8	0.5	1.4	1.2	2.0	3.8	7.6	3.1	2.9	2.1	13.9	0.3	2.4	0.5	2.7	2.6	1.4	1.1	2.7	8.2	0.9	0.5	0.8	2.7	0.8	0.3	2.7	0.3	1.5	4.8	2.1	0.4	0.9	4.8	1.1	1.4	4.9	1.4	1.9	1.1	0.0	0.5	1.4	11.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.3	0.0	0.0	11.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	1.9	1.8	2.4	0.8	2.5	7.6	3.1	2.4	0.5	8.2	4.8
CORO7	FLJ22021	ENSG00000262246	"Coronin 7"	P57737	16	4354542-4425705	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.5;RPMI-8226: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA041657, HPA053586"	Uncertain					17000	17000			"HPA041657: AB_10796351, HPA053586: AB_2682201"	"unprognostic (4.75e-3)"	"prognostic favourable (8.68e-4)"	"unprognostic (2.18e-1)"	"prognostic favourable (4.25e-4)"	"unprognostic (3.80e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.54e-4)"	"unprognostic (3.32e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.76e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.06e-3)"	9.7	8.4	14.8	15.7	19.2	53.9	6.8	7.0	16.1	5.9	9.3	25.2	4.0	14.7	7.7	7.9	5.6	8.9	9.5	5.8	13.5	7.4	8.7	4.8	14.1	27.9	27.3	9.7	4.3	8.4	6.5	7.3	9.6	11.9	9.0	6.4	5.0	7.1	7.8	4.0	5.8	15.8	7.1	12.2	30.9	10.7	13.2	24.9	13.1	7.6	5.3	11.8	7.8	5.9	5.6	9.3	17.3	16.3	4.1	9.4	9.7	2.4	3.7	2.1	2.3	0.5	0.8	4.4	1.7	1.4	2.4	2.5	2.0	5.1	5.8	2.0	1.8	3.7	1.5	2.8	1.0	5.4	10.3	2.0	5.4	3.1	2.0	5.8	11.9	2.1	0.7	1.6	0.4	3.9	5.6	19.5	1.0	7.6	4.0	14.7	2.4	1.4	13.1	7.8	36.3	1.3	4.0	4.2	5.1	1.6	1.7	4.1	1.2	8.1	4.9	1.8	3.0	4.9	2.1	10.5	5.3	12.8	1.4	7.8	1.8	8.9	12.4	17.3	8.7	16.3	9.4	5.6	7.3	9.2	9.3	2.7	3.8	5.4	12.4	4.1	13.2	3.7	8.4	9.7	14.8	19.2	7.0	16.1	13.5	7.4	27.3	9.7	11.9	24.9
CR1L		ENSG00000197721	"Complement C3b/C4b receptor 1 like"	Q2VPA4	1	207645113-207738416	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.1;brain: 4.3"	"Group enriched"	"Detected in some"	8	"HEL: 3.0;HMC-1: 7.6;K-562: 3.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049348	Approved				"Intracellular and membrane"					"HPA049348: AB_2680723"	"unprognostic (2.35e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.45e-2)"	"unprognostic (5.27e-2)"	"unprognostic (8.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.31e-2)"	"unprognostic (9.68e-2)"	0.4	0.3	0.2	1.3	2.5	6.1	0.2	0.2	4.0	0.7	0.3	0.9	0.9	0.1	0.2	0.1	0.2	1.3	0.1	0.2	0.8	0.2	3.2	0.8	2.8	1.3	1.0	1.7	0.9	0.2	0.1	0.2	2.6	1.1	0.3	0.2	0.0	0.9	1.0	0.2	0.2	0.6	0.1	4.3	1.0	0.2	0.2	3.3	0.0	0.3	0.0	0.8	0.2	0.2	0.4	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.2	4.0	0.8	0.2	1.0	1.7	1.1	3.3
CRYBA1	CRYB1	ENSG00000108255	"Crystallin beta A1"	P05813	17	29246863-29254494	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.4;bone marrow: 1.4;brain: 2.8;lymphoid tissue: 1.5"	"Group enriched"	"Detected in some"	8	"AF22: 6.7;BEWO: 8.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebral cortex: 2.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022016	Supported									"HPA022016: AB_2732426"	"unprognostic (2.89e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.60e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.09e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.84e-3)"	0.0	0.0	0.2	1.5	0.3	1.4	0.0	0.0	2.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.4	0.6	0.0	0.0	0.0	1.3	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.4	1.4	0.0	0.7	0.1	0.0	0.0	6.7	0.1	0.0	0.0	8.7	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.3	1.4	0.4	0.4	0.7	0.1	0.8	1.0	0.3	0.1	0.4	0.0	0.0	0.4	0.0	0.1	0.2	0.3	0.0	2.8	0.2	0.2	0.5	0.0	0.0	0.0
CSGALNACT2	"GALNACT-2, GALNACT2, MGC40204, PRO0082"	ENSG00000169826	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2"	Q8N6G5	10	43138486-43185308	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031540	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA031540: AB_10599943"	"unprognostic (1.65e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.85e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.43e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (3.53e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.05e-3)"	18.3	8.2	9.0	16.4	13.0	80.6	11.5	10.0	10.9	11.4	12.5	17.6	4.8	6.8	14.7	7.5	9.8	12.8	18.4	11.5	10.0	9.0	8.2	11.3	24.0	25.7	11.0	6.2	16.2	6.3	7.8	15.0	18.3	11.5	10.4	8.9	19.8	7.9	8.6	12.5	8.1	9.6	15.7	14.4	21.1	8.7	6.7	9.6	24.3	9.2	6.6	12.2	17.8	11.0	2.5	11.6	15.2	16.3	8.7	6.3	5.1	4.8	3.2	6.1	5.8	9.5	16.1	1.5	17.8	24.0	7.9	12.4	1.1	5.1	8.1	4.4	16.0	4.5	5.0	6.7	12.9	9.7	3.7	4.2	3.1	3.3	20.9	9.7	8.9	16.0	7.4	17.5	36.8	10.0	1.7	24.3	16.1	2.5	7.3	5.8	2.6	4.3	4.6	6.1	3.4	6.9	2.6	5.5	10.9	4.6	4.8	11.1	6.3	8.0	14.8	6.8	10.8	21.2	11.9	6.3	8.8	4.3	14.4	23.9	3.1	10.7	9.8	15.2	6.3	11.4	5.5	2.5	4.9	4.9	11.6	2.2	5.8	4.8	9.0	8.7	16.3	3.4	5.6	5.1	9.0	13.0	10.0	10.9	10.0	9.0	11.0	6.2	11.5	9.6
CTSW		ENSG00000172543	"Cathepsin W"	P56202	11	65879809-65883741	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.2;bone marrow: 41.4"	"Group enriched"	"Detected in some"	23	"HEL: 37.9;NB-4: 86.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"gdTCR: 106.6;MAIT T-cell: 67.7;memory CD8 T-cell: 68.3;naive CD8 T-cell: 51.4;NK-cell: 157.2"	"Group enriched"	"Detected in many"	48	"NK-cells: 157.2;T-cells: 106.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB016345	Enhanced				"Secreted to blood"	340000	340000			"CAB016345: AB_626813"	"prognostic favourable (3.06e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.71e-2)"	"prognostic favourable (8.36e-6)"	"unprognostic (1.21e-1)"	"prognostic favourable (9.89e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (8.84e-6)"	"unprognostic (3.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.01e-3)"	5.2	1.2	0.9	4.9	1.0	41.4	2.3	0.6	0.7	3.9	4.9	0.8	0.5	2.4	8.4	4.0	2.1	2.1	2.5	9.0	0.9	1.0	2.5	6.8	12.7	36.0	1.1	0.6	3.0	1.1	0.0	1.4	10.7	1.4	7.4	2.5	6.3	10.9	1.5	1.9	1.5	5.9	1.7	2.1	33.1	3.3	3.4	0.4	11.1	3.1	1.3	18.2	4.5	2.6	0.4	2.7	2.3	0.3	157.2	106.6	45.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	37.9	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.4	86.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	2.3	0.0	2.3	0.2	0.3	106.6	0.2	67.7	0.4	11.7	68.3	2.7	0.3	7.0	51.4	2.0	157.2	0.3	1.7	1.6	45.7	0.9	1.0	0.6	0.7	0.9	1.0	1.1	0.6	1.4	0.4
CWC25	"CCDC49, FLJ20291"	ENSG00000273559	"CWC25 spliceosome associated protein homolog"	Q9NXE8	17	38800434-38825481	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 29.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014874, HPA062997"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"CAB014874: , HPA062997: AB_2684917"	"unprognostic (2.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.79e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.68e-3)"	6.0	4.4	5.1	5.5	5.8	29.7	4.6	6.6	6.2	5.5	4.8	4.4	5.4	5.4	6.0	3.6	3.9	3.1	4.5	3.0	4.3		4.6	4.8	4.6	6.5	5.0	3.7	5.0	4.3	4.0	7.8	7.5	4.4	5.1	4.1	4.4	4.5	6.3	7.6	8.6	5.6	4.3	6.5	5.2	4.0	10.4	5.8	7.8	4.6	4.4	6.4	5.4	5.6	4.5	4.8	18.0	5.2	3.4	4.4	2.5	5.8	7.3	5.2	7.3	6.3	5.2	4.6	6.1	4.8	8.7	6.5	6.1	6.1	7.8	4.5	5.8	13.4	5.8	4.6	9.4	6.8	8.1	5.5	7.4	6.4	6.3	13.5	9.0	5.4	7.4	7.0	6.1	5.3	8.5	7.9	5.6	3.8	14.1	14.2	4.6	4.4	10.3	7.1	6.2	7.6	5.9	5.0	4.6	6.0	4.0	7.2	6.2	10.8	5.7	6.0	5.2	7.8	9.9	7.1	5.7	10.1	6.5	7.3	5.9	7.6	5.2	5.8	3.9	3.0	3.3	4.2	3.6	3.7	3.6	4.5	4.4	3.3	18.0	3.4	4.1	4.8	3.1	2.5										
CXCR4	"CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R"	ENSG00000121966	"C-X-C motif chemokine receptor 4"	P61073	2	136114349-136118165	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 149.9;lymphoid tissue: 186.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 75.5;Karpas-707: 40.5;MOLT-4: 68.5;REH: 36.3;U-266/70: 87.9;U-698: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.19e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.99e-2)"	"unprognostic (9.25e-2)"	"unprognostic (6.06e-2)"	"prognostic favourable (2.05e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (1.41e-7)"	"prognostic unfavourable (5.67e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	"unprognostic (9.33e-2)"	15.4	26.5	3.0	39.1	3.4	149.9	9.7	0.8	2.1	7.7	8.7	6.8	1.5	1.6	8.3	3.8	16.4	9.1	12.0	5.4	4.1	4.7	8.2	7.1	29.3	94.5	6.5	1.3	6.3	3.1	0.7	8.1	7.8	6.1	6.8	7.0	10.0	10.6	2.2	3.2	2.3	57.8	3.8	22.9	82.4	8.0	7.2	3.4	186.3	9.2	4.6	97.5	50.0	6.6	47.3	16.8	37.8	7.2	4.0	32.0	11.9	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	75.5	0.2	0.0	0.0	0.2	0.0	0.0	3.8	0.9	4.5	12.0	0.0	0.0	10.4	8.2	0.0	0.0	0.0	0.0	7.2	0.1	40.5	0.0	0.2	68.5	9.3	1.2	0.3	36.3	8.4	13.2	0.6	0.0	4.2	3.5	0.0	0.2	0.0	0.0	20.5	1.0	0.0	0.2	0.0	0.0	87.9	14.8	88.4	0.0	17.2	0.0	17.9	7.2	29.6	22.9	3.8	18.7	30.1	21.1	21.7	6.6	47.3	32.0	30.1	37.8	4.0	2.1	16.8	18.9	11.9	3.0	3.4	0.8	2.1	4.1	4.7	6.5	1.3	6.1	3.4
CXorf21	FLJ11577	ENSG00000120280	"Chromosome X open reading frame 21"	Q9HAI6	X	30558824-30577844	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.9;bone marrow: 16.0;lymphoid tissue: 16.7"	"Cell line enriched"	"Detected in some"	7	"THP-1: 57.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001185	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"	6.5	2.1	4.6	9.8	4.0	16.0	2.0	0.8	4.4	1.4	3.0	2.3	0.2	4.3	1.2	2.4	1.4	1.5	3.6	1.5	5.0	2.1	1.9	2.8	6.1	12.9	6.3	0.0	1.0	2.0	0.7	1.5	2.7	5.1	1.5	3.1	1.1	3.3	0.5	0.8	1.1	5.3	1.8	9.9	16.7	3.1	0.8	5.2	9.1	1.4	1.2	9.3	4.8	1.4	11.1	21.9	14.9	18.9	3.2	1.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	7.4	0.0	0.0	7.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.8	0.0	0.0	0.0	0.0	0.0	5.4	0.5	2.6	0.0	8.3	0.0	3.4	10.3	11.4	0.8	9.6	0.1	11.1	1.0	0.5	12.0	10.8	1.0	0.7	14.9	3.2	18.9	21.9	1.6	3.5	4.6	4.0	0.8	4.4	5.0	2.1	6.3	0.0	5.1	5.2
CYBA	p22-PHOX	ENSG00000051523	"Cytochrome b-245 alpha chain"	P13498	16	88643283-88651152	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.7;lymphoid tissue: 129.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 138.7;THP-1: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 94.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009492	Enhanced									"CAB009492: AB_2090309"	"prognostic favourable (8.19e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.32e-2)"	"prognostic favourable (4.75e-5)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (1.83e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.63e-2)"	31.4	12.6	9.7	60.1	14.9	116.7	16.5	2.0	8.6	16.1	40.5	11.5	25.8	35.7	11.4	20.0	19.6	19.2	43.6	18.0	7.8	8.0	49.3	19.8	46.7	120.1	15.7	3.4	14.8	37.4	0.9	8.2	19.3	11.8	14.7	15.2	15.1	21.7	22.5	6.7	7.1	41.0	9.0	16.7	129.2	41.1	7.4	12.7	31.0	25.6	14.0	60.4	27.0	13.6	15.3	28.4	94.1	20.7	5.2	11.9	5.7	0.2	54.2	0.2	0.1	0.1	0.0	29.3	13.3	7.2	3.8	2.2	36.1	77.3	41.5	39.4	5.5	22.6	2.1	0.0	0.5	13.2	44.8	8.1	20.3	57.7	7.2	13.8	36.8	7.7	0.0	0.1	0.0	2.0	23.3	56.7	0.3	84.1	13.3	65.5	9.9	0.1	39.0	0.1	138.7	31.6	45.5	7.7	6.9	39.7	7.8	12.5	0.1	115.8	11.0	0.1	0.5	0.1	0.2	33.9	40.6	45.7	18.8	39.4	5.0	15.9	14.7	94.1	11.9	20.7	8.7	14.5	5.8	11.0	15.7	15.3	4.6	5.7	28.5	5.2	19.3	28.4	5.8	5.7	9.7	14.9	2.0	8.6	7.8	8.0	15.7	3.4	11.8	12.7
DENND3	KIAA0870	ENSG00000105339	"DENN domain containing 3"	A2RUS2	8	141117278-141195808	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.8;HeLa: 33.1;U-937: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 18.0;neutrophil: 22.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 22.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024491, HPA041668"		Approved	Approved	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA024491: AB_2671581, HPA041668: "	"unprognostic (2.27e-1)"	"unprognostic (9.62e-2)"	"unprognostic (9.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.25e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.42e-2)"	21.8	6.2	12.2	21.7	15.2	75.9	17.6	1.7	12.3	10.4	17.0	11.5	2.3	5.5	10.3	6.1	6.8	8.3	12.0	8.8	12.1	8.5	12.2	3.9	30.1	27.8	15.9	7.7	8.9	4.7	4.5	5.8	13.0	13.7	9.0	7.4	7.1	10.2	8.3	12.9	8.3	12.7	7.8	21.9	24.7	9.1	4.6	11.8	3.4	11.4	3.5	20.6	9.5	9.8	2.4	2.2	22.2	5.4	1.4	0.4	1.6	6.8	6.2	0.4	1.3	1.9	2.8	1.0	3.9	11.5	1.6	1.3	1.9	6.4	1.8	10.2	7.3	3.5	1.7	4.2	1.1	26.8	1.6	7.1	33.1	0.6	1.7	7.0	1.1	0.2	2.1	1.8	2.3	9.0	0.0	17.3	1.2	2.1	1.0	9.8	0.4	8.1	1.2	0.3	6.7	6.4	2.3	2.0	1.2	0.7	0.5	0.4	2.8	11.3	7.1	0.3	3.1	4.5	0.1	3.5	15.4	0.5	1.1	24.3	0.4	9.3	2.9	18.0	0.4	4.5	0.4	2.4	0.3	0.1	2.2	2.3	0.0	0.1	22.2	1.4	5.4	0.0	0.1	1.6	12.2	15.2	1.7	12.3	12.1	8.5	15.9	7.7	13.7	11.8
DNAJC9	"JDD1, SB73"	ENSG00000213551	"DnaJ heat shock protein family (Hsp40) member C9"	Q8WXX5	10	73183362-73248862	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035215, HPA035216"	Supported		Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA035215: AB_10603663, HPA035216: AB_2674522"	"unprognostic (4.18e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.45e-1)"	"unprognostic (6.83e-3)"	"unprognostic (2.43e-3)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavourable (7.07e-5)"	"unprognostic (5.61e-2)"	"unprognostic (3.08e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	3.1	4.0	4.0	5.0	4.3	24.2	4.6	12.9	5.8	3.0	4.6			4.2	4.0	3.9	6.8	2.9	1.7	2.7	4.2	5.2	2.8	3.5	2.9	7.7	3.5		5.2	2.6	3.6	4.3	5.4		3.6	5.8		3.6	3.9	3.4	5.3	4.1	3.8	3.1	5.9	3.4	4.3			2.9		9.9	3.1	4.4	15.6	9.4	13.2	4.9	10.6	16.5	8.8	26.2	16.3	21.0	17.4	5.0	4.9	9.2	21.3	12.6	21.5	22.5	27.8	18.4	18.2	7.0	9.4	17.9	21.0	14.2	24.3	21.0	14.5	38.6	16.6	18.4	3.5	33.9	15.6	4.0	7.8	22.5	19.7	14.1	34.5	21.2	16.9	24.4	32.8	25.7	7.7	45.5	24.4	18.4	9.9	10.6	12.7	10.1	17.0	15.6	25.7	11.2	13.4	15.9	10.3	14.4	25.5	15.3	32.6	9.9	14.9	29.2	14.4	33.8	9.2	7.3	1.8	13.2	13.0	4.9	14.4	15.6	15.9	14.1	3.0	12.7	15.6	13.8	2.1	10.6	4.7	9.4	16.5	8.8										
DOCK2	KIAA0209	ENSG00000134516	"Dedicator of cytokinesis 2"	Q92608	5	169637247-170083382	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.0;bone marrow: 29.8;lymphoid tissue: 50.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.9;HDLM-2: 40.1;HL-60: 31.8;HMC-1: 37.0;MOLT-4: 24.2;U-698: 28.2;U-937: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036469	Enhanced									"HPA036469: AB_2675140"	"unprognostic (3.45e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.92e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.24e-2)"	7.3	3.1	2.9	30.7	4.8	29.8	4.1	1.0	2.7	2.2	3.5	5.8	1.2	2.6	2.9	2.7	2.4	2.9	4.9	2.7	3.4	2.5	3.1	2.9	12.6	22.6	4.8	1.3	1.9	1.9	0.7	2.2	3.8	4.1	3.3	4.5	2.6	6.6	1.2	1.3	2.0	13.7	3.6	8.5	28.0	3.6	1.8	3.7	50.3	2.8	1.7	31.5	6.2	2.5	6.4	14.0	12.7	31.0	6.6	6.6	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	3.2	0.0	0.0	31.9	0.6	2.5	0.0	0.0	0.0	4.0	40.1	0.0	17.7	0.3	0.0	0.0	31.8	37.0	0.0	0.0	0.7	0.0	0.0	0.3	16.0	0.8	0.0	24.2	8.2	0.0	0.0	15.1	0.5	12.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.1	0.3	1.0	0.4	0.7	5.0	7.8	28.2	0.6	22.1	0.0	6.2	12.7	10.0	6.4	23.0	6.6	6.4	5.9	6.3	14.0	5.3	4.3	5.0	12.7	6.6	31.0	4.8	5.3	9.4	2.9	4.8	1.0	2.7	3.4	2.5	4.8	1.3	4.1	3.7
DUXB		ENSG00000282757	"Double homeobox B"		16	75693929-75701459	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 1.3;retina: 1.8;testis: 1.2;thyroid gland: 1.4"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;MCF7: 1.8;NTERA-2: 1.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0		0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	1.2	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DYTN		ENSG00000232125	Dystrotelin	A2CJ06	2	206651621-206718396	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.5;bone marrow: 1.5"	"Cell line enriched"	"Detected in single"	10	"HEL: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (3.23e-3)"		"unprognostic (8.52e-2)"						0.0	0.0	0.0	0.0	0.3	1.5	0.1	0.0	0.0	0.0	0.0			0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5										
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675683-33686404	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;lymphoid tissue: 21.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Enhanced	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: "	"unprognostic (7.46e-2)"	"prognostic favourable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavourable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favourable (1.62e-4)"	"unprognostic (1.91e-1)"	2.4	5.3	6.8	12.7	9.7	32.5	2.1	1.1	6.4	1.2	4.4	5.1	0.7	3.9	1.4	0.8	5.1	1.5	4.1	2.0	7.1	3.6	0.9	1.7	8.1	9.3	6.2	2.9	3.4	1.2	2.3	0.3	3.3	5.9	1.7	4.8	0.3	1.6	1.4	1.4	5.4	4.9	3.3	6.2	4.8	3.4	12.1	6.0	21.9	1.0	4.9	7.7	1.9	3.1	2.2	0.6	0.7	3.7	1.4	1.2	0.6	15.9	15.5	18.0	14.0	1.8	1.3	13.7	15.3	7.4	19.6	16.5	27.4	16.5	29.4	15.5	6.8	12.0	8.7	8.1	8.8	8.8	12.5	24.0	23.1	15.9	0.1	11.2	15.2	1.0	0.5	10.7	1.9	5.0	6.3	20.8	12.1	14.1	23.8	23.8	5.4	22.3	23.8	49.1	12.1	3.3	9.8	26.9	18.9	18.6	13.0	7.6	16.3	14.2	2.7	22.9	13.4	15.8	21.7	20.3	13.7	24.2	19.0	6.7	13.5	0.0	0.0	0.7	0.1	0.9	0.0	2.2	0.6	0.4	0.2	0.2	0.2	1.2	0.3	1.4	3.7	0.6	0.8	0.6	6.8	9.7	1.1	6.4	7.1	3.6	6.2	2.9	5.9	6.0
EAF1		ENSG00000144597	"ELL associated factor 1"	Q96JC9	3	15427355-15450635	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.7"	"Cell line enhanced"	"Detected in all"		"BEWO: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059516, HPA060569, HPA069538"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles,Cytokinetic bridge"				"Nucleoplasm, Nuclear bodies, Vesicles"	"Nucleoplasm, Nuclear bodies, Vesicles"	"HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	15.6	11.5	13.9	12.2	20.0	55.7	11.4	18.1	19.1	9.8	11.7	13.3	11.5	12.7	10.1	9.9	13.1	9.4	12.9	7.6	14.3	18.1	13.7	22.2	12.0	12.4	14.7	13.0	8.0	11.8	13.0	17.6	18.9	18.6	12.7	12.4	9.6	9.5	15.4	8.6	15.9	12.5	10.4	13.7	15.1	13.7	9.7	10.1	14.0	13.0	9.1	12.9	11.9	9.0	5.1	9.9	7.1	7.4	8.1	15.4	4.3	3.9	6.4	6.8	7.0	4.0	3.4	55.0	5.8	4.1	6.7	6.5	8.8	4.4	11.0	3.7	4.2	3.3	8.9	5.1	7.7	9.0	6.4	9.5	5.8	8.0	9.0	8.9	7.7	4.5	9.1	9.6	6.5	6.6	10.1	8.2	5.5	8.1	8.8	5.0	12.2	6.7	8.1	5.6	6.1	5.8	6.9	7.0	12.3	7.1	6.6	6.7	9.9	7.1	6.4	7.0	5.2	6.2	8.3	10.8	21.6	11.6	6.8	10.7	8.3	7.1	7.4	4.5	12.0	5.4	15.4	5.1	10.1	9.3	4.3	3.8	6.0	9.8	6.7	8.1	6.5	9.9	10.5	4.3	13.9	20.0	18.1	19.1	14.3	18.1	14.7	13.0	18.6	10.1
EAF2	"BM040, TRAITS, U19"	ENSG00000145088	"ELL associated factor 2"	Q96CJ1	3	121835183-121886526	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 40.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 25.2;HL-60: 38.6;THP-1: 20.6;U-698: 31.9;U-937: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 32.1;naive B-cell: 30.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA008411	Enhanced									"HPA008411: AB_1847950"	"unprognostic (3.43e-1)"	"prognostic favourable (2.25e-9)"	"unprognostic (1.48e-1)"	"prognostic favourable (2.66e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.04e-2)"	"unprognostic (8.34e-2)"	3.4	3.7	7.2	21.3	6.1	40.1	6.5	9.3	5.7	3.8	6.4	1.7	20.7	5.5	2.0	3.4	4.1	3.3	3.3	3.0	8.2	3.9	18.4	4.1	4.5	30.7	4.5	4.7	1.9	6.9	2.8	19.8	2.0	4.6	13.6	7.6	1.9	8.3	29.7	1.9	1.8	8.2	2.4	7.8	26.0	5.0	5.7	6.5	6.1	2.6	1.0	25.5	7.9	3.6	32.1	9.8	13.1	16.1	0.5	1.0	4.3	1.1	1.0	0.6	0.8	0.2	0.6	2.1	0.4	0.2	0.8	1.6	2.0	0.7	25.2	0.5	0.1	1.9	1.7	0.9	2.1	12.3	1.0	14.4	1.0	3.8	0.3	38.6	16.0	0.3	2.5	1.0	0.9	0.8	1.6	5.0	0.4	0.3	5.5	5.1	1.0	0.9	5.8	2.3	3.7	0.9	1.5	0.8	0.2	0.7	0.7	1.9	0.6	20.6	0.2	0.5	0.8	0.5	1.2	9.1	4.0	31.9	1.0	22.1	1.6	3.2	6.2	13.1	0.4	12.8	0.9	32.1	0.7	0.5	6.9	30.8	1.0	0.5	1.1	0.5	16.1	9.8	0.8	4.3	7.2	6.1	9.3	5.7	8.2	3.9	4.5	4.7	4.6	6.5
EBLN2		ENSG00000255423	"Endogenous Bornavirus like nucleoprotein 2"	Q6P2I7	3	73061659-73063337	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA062510, HPA068795"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA062510: AB_2684787, HPA068795: AB_2686038"	"unprognostic (1.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.38e-6)"	"unprognostic (1.54e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.12e-1)"	2.2	1.2	0.0	2.1	0.0	15.3	2.6	0.5	0.3	2.4	1.5			1.0	2.6	2.5	1.8	3.1	1.1	2.1	0.1	0.0	0.8	1.8	3.1	1.7	0.1		5.1	2.6	1.2	1.2	1.9		1.6	2.4		3.1	0.5	1.3	2.2	2.1	1.4	1.0	2.1	1.8	0.9			2.4		1.5	2.4	2.9	2.6	2.2	6.3	1.5	1.1	3.8	0.2	1.3	0.9	5.2	4.6	1.4	2.9	3.9	2.1	0.4	1.3	1.0	2.6	4.3	3.2	0.8	2.7	1.8	2.0	2.2	2.6	1.3	1.2	2.2	5.0	2.2	0.8	4.1	4.8	2.9	1.6	2.6	2.6	1.8	1.6	5.0	1.4	2.8	2.0	5.8	3.3	1.4	5.2	1.3	2.0	1.4	5.4	1.2	2.5	1.3	2.3	0.7	3.5	1.6	3.4	1.5	2.9	4.0	3.1	5.0	2.4	2.6	1.5	4.6	2.5	0.3	1.5	6.3	3.6	0.5	3.0	1.5	3.2	3.1	0.5	2.6	2.7	3.8	3.3	1.1	0.6	2.2	3.7	0.2										
EMB	MGC71745	ENSG00000170571	Embigin	Q6PCB8	5	50396192-50443248	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;intestine: 42.2;lymphoid tissue: 44.1"	"Cell line enhanced"	"Detected in many"		"THP-1: 68.9;U-937: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.01e-3)"	"unprognostic (8.65e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (2.76e-5)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.86e-3)"	15.0	16.4	1.7	21.7	2.0	43.3	8.4	1.1	2.9	2.7	18.9	1.4	0.5	21.7	1.6	5.6	6.5	4.7	6.1	16.7	2.2	4.7	4.2	1.9	10.6	44.1	3.8	1.4	2.7	1.8	15.2	8.0	6.6	4.5	9.5	3.6	4.0	7.4	6.9	2.7	15.9	42.2	2.5	3.3	20.6	3.7	10.5	1.8	15.9	13.7	3.6	17.0	5.3	2.9	9.9	11.4	16.4	14.7	16.4	26.1	16.1	8.4	0.7	1.6	0.0	0.7	2.3	0.1	0.4	0.0	0.7	0.0	0.0	22.3	16.9	0.4	0.8	12.9	3.8	10.9	0.1	5.2	8.6	8.0	2.7	0.0	0.1	16.0	0.0	0.1	6.0	1.8	7.3	0.0	0.0	22.6	13.3	9.8	9.9	9.5	6.4	4.3	15.8	0.0	22.1	0.0	7.6	5.1	4.6	0.0	2.5	0.2	1.0	68.9	0.0	0.0	8.2	0.0	0.0	0.2	0.0	14.0	0.0	29.9	2.0	3.7	14.7	16.4	21.5	1.9	26.1	9.9	19.4	19.3	9.7	6.5	11.5	15.5	13.7	16.4	0.6	11.4	23.4	16.1	1.7	2.0	1.1	2.9	2.2	4.7	3.8	1.4	4.5	1.8
EPX	"EPO, EPP, EPX-PEN"	ENSG00000121053	"Eosinophil peroxidase"	P11678	17	58192737-58205174	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 27.2;lymphoid tissue: 15.5"	"Cell line enriched"	"Detected in some"	69	"NB-4: 72.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	41	"eosinophil: 5.5"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 5.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA076792	Enhanced									"HPA076792: "	"unprognostic (5.67e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.36e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.34e-3)"	"unprognostic (4.83e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.71e-4)"	"unprognostic (7.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.73e-1)"	0.1	0.1	0.3	0.2	0.8	27.2	0.1	2.0	0.6	0.1	0.1	0.5	0.1	0.1	0.4	0.1	0.1	0.2	0.1	1.4	0.3	0.3	0.1	0.2	4.2	0.4	0.2	0.1	0.2	0.1	0.0	0.3	0.2	0.6	0.1	0.0	0.1	0.3	0.1	0.1	0.5	0.1	0.1	0.2	4.5	0.1	0.1	0.1	15.5	0.1	0.1	0.1	0.1	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	2.0	0.6	0.3	0.3	0.2	0.1	0.6	0.1
EREG	ER	ENSG00000124882	Epiregulin	O14944	4	74365143-74388751	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.1;tongue: 44.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 58.9;hTEC/SVTERT24-B: 18.5;U-2197: 40.1;U-87 MG: 68.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054373			Approved	Vesicles	"Secreted to blood"			Vesicles	Vesicles	"HPA054373: "	"unprognostic (1.26e-2)"	"prognostic unfavourable (1.67e-7)"	"unprognostic (4.56e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (1.45e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (6.57e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.70e-6)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.59e-3)"	"unprognostic (3.16e-3)"	2.2	0.0	0.1	4.6	0.3	52.1	1.2	0.0	0.1	5.0	1.2	0.1	0.0	0.0	0.1	0.5	15.3	1.2	7.3	0.8	0.0	0.0	0.4	0.2	6.7	1.1	0.0	0.2	0.5	0.1	0.0	0.0	2.0	0.3	0.2	1.6	0.1	1.6	0.0	0.5	10.7	1.0	1.3	0.1	1.9	0.3	0.3	0.0	0.2	0.0	44.0	7.2	4.1	4.6	0.6	1.3	2.6	1.2	0.4	0.3	0.3	0.3	8.9	0.0	0.0	0.8	1.5	0.0	2.0	58.9	0.5	0.3	6.9	16.7	0.0	9.8	0.0	0.5	0.0	12.8	0.6	0.0	0.0	0.2	0.3	0.2	0.2	0.0	0.0	0.9	4.5	18.5	9.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	40.1	0.0	0.0	0.0	0.0	68.9	0.0	0.0	1.9	1.2	2.6	0.3	1.0	0.2	0.2	0.2	0.2	1.3	0.6	0.3	0.2	1.0	0.4	0.2	0.4	0.2	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0
ETDC		ENSG00000283644	"Embryonic testis differentiation homolog C"		X	135309480-135309659	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 2.2;seminal vesicle: 2.9;skin 1: 3.9"	"Group enriched"	"Detected in some"	30	"HeLa: 3.6;SK-MEL-30: 3.6;U-937: 1.7"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		2.2	0.0		0.0	0.0	0.9			0.0	0.0	0.0	0.5	0.0	0.0	0.0			0.0	1.2	0.0	0.3			0.6	0.0	0.0		0.0		0.1	0.0		0.0	2.9	0.0	3.9	0.0	0.0		0.2	0.2	0.0			1.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9										
EXO1	"HEX1, hExoI"	ENSG00000174371	"Exonuclease 1"	Q9UQ84	1	241847967-241895148	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.6;lymphoid tissue: 31.3;testis: 14.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA053079, HPA069738"			Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA053079: AB_2682037, HPA069738: AB_2732140"	"unprognostic (6.33e-3)"	"unprognostic (8.54e-3)"	"unprognostic (9.47e-3)"	"prognostic unfavourable (8.21e-4)"	"unprognostic (2.43e-1)"	"unprognostic (6.34e-2)"	"prognostic unfavourable (6.94e-7)"	"unprognostic (1.84e-3)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (2.40e-2)"	"unprognostic (4.81e-3)"	"unprognostic (9.40e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.57e-1)"	2.1	1.0	0.9	10.3	1.0	15.6	1.0	0.3	1.3	1.3	3.1	0.3	0.1	2.9	0.7	0.8	6.2	0.4	1.3	1.5	0.7	0.6	0.9	1.3	1.5	5.6	0.6	0.3	1.3	1.3	1.8	0.4	4.6	0.7	0.7	3.9	0.3	1.4	0.1	1.0	1.7	4.2	1.0	0.6	5.7	1.5	14.8	0.1	31.3	0.6	4.0	8.1	1.6	2.0	1.4	0.6	2.9	0.7	0.9	3.3	1.0	15.0	10.0	16.5	10.9	1.0	2.7	14.0	20.0	6.7	17.9	19.6	12.5	8.5	16.4	9.8	4.6	15.0	20.9	8.3	21.3	25.4	18.3	15.2	10.7	6.3	0.3	21.7	11.3	0.6	0.4	17.9	4.8	5.5	30.5	21.7	14.3	6.9	23.4	12.3	22.6	9.9	17.0	15.5	17.5	3.7	9.6	18.5	23.5	13.1	10.6	7.1	9.8	13.5	2.0	17.4	15.3	16.3	27.0	16.0	21.1	26.4	6.0	17.7	20.8	2.9	0.7	0.0	1.1	0.0	0.0	1.4	1.1	1.1	0.6	1.3	0.6	0.2	0.3	0.9	0.0	0.1	3.3	1.0	0.9	1.0	0.3	1.3	0.7	0.6	0.6	0.3	0.7	0.1
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.5;lymphoid tissue: 44.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009589	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB009589: "	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavourable (8.18e-12)"	"prognostic favourable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	2.0	1.7	1.8	10.6	1.6	25.5	1.4	4.9	2.7	2.6	4.8	1.1	0.1	3.8	1.7	2.8	11.0	0.9	3.0	0.9	0.8	0.6	1.7	3.3	2.3	12.6	1.3	0.3	2.2	3.8	0.6	1.7	3.4	1.4	1.4	5.1	1.8	3.2	1.6	3.7	6.4	4.8	1.5	1.2	5.8	2.7	19.6	1.3	44.1	0.9	5.5	12.4	2.6	3.5	1.5	4.7	1.3	3.9	8.5	10.3	1.7	16.9	7.9	27.1	18.0	0.8	1.4	14.8	13.2	5.3	10.9	11.0	11.9	19.6	29.9	6.4	4.9	10.4	13.9	4.5	13.9	42.8	13.9	12.7	9.8	9.2	2.2	28.4	10.5	1.2	2.6	8.1	4.3	6.4	27.1	19.9	9.7	19.2	55.1	23.7	21.5	10.7	34.1	15.2	18.5	5.0	8.1	25.9	16.5	16.6	12.6	4.3	9.2	12.2	3.9	11.6	5.4	23.1	23.6	17.9	19.4	30.1	10.6	19.4	22.7	0.5	2.2	1.3	1.7	1.5	1.3	1.5	3.4	2.9	4.7	0.8	1.9	1.2	0.2	8.5	3.9	1.0	10.3	1.7	1.8	1.6	4.9	2.7	0.8	0.6	1.3	0.3	1.4	1.3
FAM105A	"FLJ11127, NET20"	ENSG00000145569	"Family with sequence similarity 105 member A"	Q9NUU6	5	14581775-14615007	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 13.8;HMC-1: 43.3;THP-1: 12.0;U-937: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046638	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"HPA046638: AB_2679731"	"unprognostic (1.47e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.42e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (7.62e-4)"	"unprognostic (3.14e-1)"	"unprognostic (8.79e-3)"	5.1	3.5	4.0	7.9	4.9	35.4	5.2	3.1	5.1	6.3	15.4	9.0	4.5	8.3	3.0	5.6	2.9	3.1	4.1	3.0	3.9	4.3	5.2	1.9	28.8	16.7	6.1	3.8	4.0	13.3	1.9	8.7	6.7	7.9	12.6	17.3	10.3	3.1	13.5	1.3	2.6	13.7	3.3	10.8	13.2	5.4	4.4	4.1	3.5	27.2	3.0	6.2	7.1	5.8	0.1	26.7	6.9	26.2	14.1	9.6	16.2	0.0	0.6	1.2	0.0	0.2	0.0	5.2	1.5	1.4	0.4	0.7	1.9	1.3	0.0	0.8	0.7	0.1	2.6	1.2	0.6	0.8	3.6	3.4	13.8	0.3	1.3	0.0	43.3	0.1	0.3	0.2	0.0	0.0	0.0	5.4	0.1	1.0	0.0	1.2	1.9	9.2	0.3	0.5	1.5	0.0	10.4	4.5	5.0	0.7	0.4	0.0	0.4	12.0	0.0	0.6	3.4	0.2	1.1	0.0	0.0	0.0	0.7	20.5	0.2	0.0	26.2	0.1	4.5	12.4	6.0	0.1	5.7	6.1	26.7	0.1	7.8	7.5	6.9	14.1	9.4	19.7	9.6	16.2	4.0	4.9	3.1	5.1	3.9	4.3	6.1	3.8	7.9	4.1
FAM178B	LOC51252	ENSG00000168754	"Family with sequence similarity 178 member B"	Q8IXR5	2	96875882-96986592	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2;lymphoid tissue: 13.3;testis: 29.5"	"Cell line enhanced"	"Detected in some"		"K-562: 17.1;RH-30: 4.7;RPMI-8226: 18.7;WM-115: 18.8"	"Cancer enriched"	"Detected in many"	5	"melanoma: 8.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.2;naive CD4 T-cell: 2.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042516, HPA062110"	Uncertain		Uncertain	"Nuclear speckles,Golgi apparatus"				"Nuclear speckles"	"Nuclear speckles"	"HPA042516: AB_10806241, HPA062110: "	"unprognostic (2.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.02e-4)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.82e-11)"	"unprognostic (6.93e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.63e-3)"	"unprognostic (1.08e-1)"	0.8	0.0	2.4	0.6	3.8	18.2	0.6	1.0	1.5	0.6	1.0	0.6	0.6	0.1	0.7	6.8	0.6	1.5	0.6	0.6	3.4	1.9	0.6	0.6	0.6	0.6	5.3	0.6	0.6	0.6	0.0	0.6	1.1	0.6	0.6	0.2	1.0	0.6	1.0	0.6	1.2	0.6	0.6	8.5	13.3	0.0	29.5	0.6	0.6	0.6	0.6	0.6	1.0	0.6	0.0	0.8	0.0	0.0	0.1	2.6	0.6	4.1	0.0	0.0	1.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.4	1.7	0.0	0.0	0.1	0.0	0.0	4.7	18.7	0.0	0.0	0.6	0.0	0.0	3.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	18.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	1.7	0.0	0.1	0.0	0.8	0.0	0.6	2.4	3.8	1.0	1.5	3.4	1.9	5.3	0.6	0.6	0.6
FAM49B	BM-009	ENSG00000153310	"Family with sequence similarity 49 member B"	Q9NUQ9	8	129839593-130017129	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.5;bone marrow: 80.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA009076	Approved		Approved	Nucleoplasm,Cytosol		990000	990000	Nucleoplasm	Nucleoplasm	"HPA009076: AB_1848402"	"unprognostic (4.35e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (2.80e-2)"	"unprognostic (9.61e-3)"	"prognostic unfavourable (3.02e-6)"	"unprognostic (4.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-1)"	"prognostic unfavourable (3.09e-10)"	"unprognostic (3.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.46e-1)"	19.2	14.5	23.2	42.8	33.1	80.1	20.6	28.0	36.9	7.2	14.3	18.2	5.5	14.2	8.0	10.6	17.9	7.9	14.9	9.8	25.5	25.2	11.8	12.3	19.1	49.6	28.5	19.6	6.4	10.0	7.5	16.1	19.4	21.2	7.6	17.4	7.3	12.0	7.9	16.8	9.0	19.3	13.5	38.8	41.3	12.9	13.6	21.2	28.2	13.8	9.7	46.4	20.6	8.4	21.0	47.3	93.5	42.2	30.8	29.3	43.4	31.6	17.0	18.5	10.4	1.6	2.4	24.7	9.6	9.3	13.4	14.3	9.7	21.8	31.6	21.2	6.3	15.8	15.3	25.4	20.1	66.2	10.7	31.7	9.5	10.9	6.5	20.5	27.3	3.9	11.9	9.0	18.8	11.8	22.7	36.7	14.6	14.1	69.6	15.2	15.7	23.5	30.4	12.5	53.1	27.4	13.0	12.4	16.2	19.3	12.2	28.5	14.2	26.6	7.2	4.9	31.8	10.4	20.4	12.2	36.0	52.5	7.8	44.7	12.7	45.5	35.3	65.6	29.3	42.2	22.4	21.0	16.7	23.9	47.3	15.1	15.0	24.6	93.5	30.8	36.5	30.4	22.5	43.4	23.2	33.1	28.0	36.9	25.5	25.2	28.5	19.6	21.2	21.2
FAM72B	RP11-439A17.6	ENSG00000188610	"Family with sequence similarity 72 member B"	Q86X60	1	121167646-121185539	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 6.5;lymphoid tissue: 9.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.3"	"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	Vesicles	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (8.53e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.25e-3)"	"unprognostic (4.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-4)"	"unprognostic (8.22e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.46e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.30e-2)"	1.0	0.8	1.3	4.1	1.0	6.5	0.6	5.1	1.0	0.5	1.0			1.3	0.4	0.2	3.0	0.5	1.0	0.2	1.6	0.9	0.3	0.4	0.8	9.3	1.4		0.4	0.1	1.5	0.1	1.4		0.2	1.3		0.5	0.0	0.0	2.1	1.3	0.7	1.4	3.2	0.9	3.6			0.2		7.9	0.9	0.9	0.8	3.3	0.1	2.4	0.8	1.4	1.1	11.9	4.4	7.4	3.6	0.7	1.1	5.8	6.4	2.7	7.5	6.3	0.1	6.3	26.6	8.9	1.2	7.5	10.1	3.6	11.6	17.6	7.5	11.5	4.9	5.3	0.4	19.9	10.3	0.6	0.4	5.9	12.0	4.5	15.0	16.4	5.4	5.0	10.0	16.4	13.9	9.1	15.0	15.8	12.1	2.9	1.4	8.0	4.6	4.8	3.7	3.7	5.0	15.6	1.5	6.2	10.5	12.0	11.2	14.6	18.1	26.3	5.5	21.7	14.3	0.0	2.4	0.0	0.0	0.9	0.0	0.8	0.4	0.5	3.3	0.3	0.0	0.1	0.1	0.8	1.1	0.4	1.4	1.1										
FAM72C	RP5-998N21.9	ENSG00000263513	"Family with sequence similarity 72 member C"	H0Y354	1	143955364-143971965	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.6;lymphoid tissue: 6.4"	"Cell line enhanced"	"Detected in many"		"U-266/84: 29.0"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in some"		"T-reg: 2.2"	"Low lineage specificity"	"Detected in many"											"HPA043271, HPA067321"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	Vesicles	"HPA043271: AB_2678402, HPA067321: "	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.98e-3)"	"unprognostic (9.46e-5)"	"unprognostic (1.23e-3)"	"unprognostic (4.36e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.47e-2)"	0.1	0.0		1.6		3.6	0.0		0.0	0.0	0.2			0.5	0.0	0.0	0.5	0.0	0.0	0.0			0.0	0.0	0.0	6.1			0.0	0.0	0.0		0.3		0.0	0.6		0.0	0.0	0.0	1.5	0.0	0.1		0.5	0.1	1.9			0.0		6.4	0.4		1.1	0.4	0.0	1.0	1.7	2.2	0.6	8.5	5.0	6.1	2.7	0.3	0.8	5.8	4.3	1.4	5.7	4.4	0.7	10.3	20.4	5.6	0.5	8.3	8.1	2.6	6.3	7.0	4.8	8.8	4.4	1.5	0.3	17.9	8.0	0.1	0.0	4.5	11.8	2.5	15.4	9.6	0.3	0.6	10.6	13.9	4.8	3.2	13.5	4.3	14.5	1.0	1.1	3.0	5.5	4.1	2.4	2.3	5.9	15.4	1.7	4.6	7.6	6.0	9.3	20.1	29.0	12.1	2.4	11.2	2.9	0.0	1.0	0.0	0.1	0.3	0.0	1.1	0.4	0.5	0.4	0.0	0.1	0.0	0.0	1.7	0.6	0.1	2.2	0.6										
FANCB	"FAAP95, FAB, FLJ34064"	ENSG00000181544	"Fanconi anemia complementation group B"	Q8NB91	X	14835961-14873069	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA003124	Uncertain									"HPA003124: AB_1078813"	"unprognostic (3.49e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (8.42e-3)"	"unprognostic (7.99e-2)"	"unprognostic (2.42e-2)"	"unprognostic (4.05e-5)"	"unprognostic (6.93e-3)"	"unprognostic (1.77e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.76e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-11)"	"unprognostic (4.46e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.96e-2)"	1.6	0.9	2.7	3.2	8.2	10.9	2.0	3.5	4.6	2.4	1.5	4.7	0.0	1.1	1.7	1.0	3.3	1.5	0.9	1.2	3.9	1.2	1.1	0.9	1.5	6.2	7.7	1.3	2.1	1.2	1.2	0.7	3.2	5.5	1.2	2.1	0.3	1.7	0.7	0.9	1.7	2.0	1.7	4.3	2.9	1.4	1.4	7.9	7.5	1.2	1.4	4.5	1.8	2.2	3.0	1.0	1.8	1.2	1.6	1.9	1.1	6.2	4.2	4.2	3.4	0.3	0.7	1.4	9.6	2.6	7.7	9.1	3.2	4.3	9.1	1.7	3.4	6.0	9.5	3.4	12.0	4.4	4.5	3.7	6.3	1.5	0.1	4.8	2.9	0.1	0.3	7.4	1.7	3.5	5.7	6.6	4.3	3.0	4.5	2.7	5.2	6.3	4.3	9.6	4.0	0.7	2.3	2.8	3.0	5.1	1.9	3.0	3.3	1.7	1.7	5.9	3.4	12.8	5.5	1.6	3.4	6.2	2.6	3.5	11.9	1.5	1.2	0.9	1.3	0.8	0.9	3.0	0.8	1.7	0.9	2.8	0.9	0.8	1.8	1.6	0.5	1.0	1.9	1.1	2.7	8.2	3.5	4.6	3.9	1.2	7.7	1.3	5.5	7.9
FBXO33	Fbx33	ENSG00000165355	"F-box protein 33"	Q7Z6M2	14	39397669-39432500	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 49.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046657	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA046657: AB_10960398"	"unprognostic (8.84e-3)"	"unprognostic (6.72e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-1)"	"prognostic favourable (4.94e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"prognostic favourable (4.58e-4)"	"unprognostic (9.61e-2)"	"unprognostic (4.54e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.58e-3)"	8.9	13.3	8.9	8.9	12.1	49.1	8.4	12.3	19.7	10.1	7.0	7.1	10.0	8.2	8.5	12.0	7.5	8.8	8.6	6.1	10.4	11.7	8.5	8.8	9.0	12.8	9.1	11.0	9.4	7.8	18.4	19.0	8.8	9.3	9.1	6.9	9.4	10.8	12.0	4.4	6.7	8.0	7.7	7.2	10.4	8.2	12.8	7.5	16.6	14.9	5.7	10.6	8.6	8.7	2.5	1.6	7.8	2.2	5.5	4.8	1.3	9.5	6.0	5.5	8.4	19.9	9.3	9.1	9.6	13.1	5.4	6.4	3.5	8.6	10.8	12.0	15.0	5.0	14.1	9.5	9.8	10.3	9.1	4.3	8.8	9.2	5.6	16.1	16.4	8.6	10.4	9.2	3.0	4.5	3.7	9.8	10.6	10.2	14.3	10.1	5.6	9.0	12.5	8.9	9.8	10.3	12.3	9.5	4.3	8.7	9.2	10.5	6.7	10.4	5.7	9.2	8.3	13.6	7.6	13.4	15.7	17.0	7.1	7.7	6.8	1.6	1.7	3.7	3.4	2.1	3.2	2.5	3.4	3.7	1.6	2.3	4.8	4.5	7.8	5.5	2.2	1.5	3.4	1.3	8.9	12.1	12.3	19.7	10.4	11.7	9.1	11.0	9.3	7.5
FCAR	CD89	ENSG00000186431	"Fc fragment of IgA receptor"	P24071	19	54874248-54890472	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;lung: 19.5;lymphoid tissue: 15.9"	"Cell line enhanced"	"Detected in single"		"THP-1: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.6;neutrophil: 6.1"	"Group enriched"	"Detected in many"	44	"granulocytes: 6.1;monocytes: 2.6"					"Low region specificity"	"Detected in many"			HPA014050	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA014050: AB_1846338"	"unprognostic (1.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.19e-6)"	"unprognostic (9.23e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.04e-3)"	"unprognostic (9.81e-2)"	4.0	0.6	0.4	1.5	4.4	28.1	0.8	0.1	1.0	0.6	0.6	0.7	0.0	0.6	0.6	0.6	0.6	3.8	0.6	8.2	2.0	0.4	0.6	1.8	19.5	15.9	1.2	0.0	2.2	0.6	0.6	0.3	1.5	4.3	0.6	0.6	0.9	0.6	0.6	0.6	0.6	0.6	0.7	2.7	14.9	0.9	2.1	0.0	1.0	0.6	0.3	0.6	4.4	4.8	0.0	0.0	6.1	2.6	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.7	0.4	4.4	0.1	1.0	2.0	0.4	1.2	0.0	4.3	0.0
FECH		ENSG00000066926	Ferrochelatase	P22830	18	57548283-57586772	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 87.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044100, HPA048177"	Approved									"HPA044100: AB_2678809, HPA048177: AB_2680300"	"unprognostic (2.30e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.85e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.36e-1)"	"prognostic favourable (2.38e-10)"	"unprognostic (1.10e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.05e-3)"	"unprognostic (3.58e-2)"	10.0	18.0	9.9	6.5	14.1	87.9	9.9	7.9	17.4	7.9	9.5	23.1	8.0	7.6	10.5	7.9	13.6	8.5	6.9	17.6	10.4	9.7	28.2	28.3	7.2	9.8	12.0	13.9	9.1	9.5	11.4	8.8	14.8	15.6	14.5	9.3	12.1	10.1	11.1	36.2	8.6	7.2	12.3	11.7	10.6	8.5	5.8	13.1	18.4	11.6	10.8	7.1	12.1	8.8	4.2	12.4	14.9	10.9	13.8	9.3	9.1	7.3	20.0	7.4	11.9	4.7	10.8	13.0	10.5	10.7	15.2	13.6	5.3	6.7	3.3	10.8	14.4	9.4	10.9	8.8	12.3	19.2	11.6	24.3	13.9	11.0	12.1	16.9	44.4	11.2	9.4	9.4	4.3	11.4	34.5	13.9	8.5	8.7	17.6	3.5	5.6	8.7	12.6	10.3	19.8	15.1	13.9	7.4	11.2	13.6	14.6	6.2	13.9	7.1	9.0	5.3	7.0	2.1	7.6	40.6	17.4	7.1	8.6	8.3	8.9	14.0	9.6	14.9	9.3	10.9	6.7	4.2	5.7	8.3	12.4	2.6	4.2	5.9	0.7	13.8	10.2	9.5	5.9	9.1	9.9	14.1	7.9	17.4	10.4	9.7	12.0	13.9	15.6	13.1
FEM1C	"EUROIMAGE686608, EUROIMAGE783647, FEM1A, KIAA1785"	ENSG00000145780	"Fem-1 homolog C"	Q96JP0	5	115520908-115544894	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059919, HPA060977"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA059919: AB_2684161, HPA060977: AB_2684402"	"unprognostic (1.14e-2)"	"unprognostic (3.02e-1)"	"prognostic favourable (1.83e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.99e-2)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.05e-2)"	18.2	6.8	15.9	8.6	19.4	58.5	14.6	21.1	19.6	15.1	14.2	12.2	10.7	12.1	11.3	7.5	16.4	8.7	13.8	28.6	13.9	8.6	8.7	16.8	15.3	7.3	12.9	17.1	10.7	12.1	6.9	8.2	7.2	14.9	11.5	13.7	6.4	8.5	9.9	24.3	13.1	17.4	12.2	15.3	9.0	14.2	14.1	14.5	4.1	9.5	15.4	7.4	16.5	10.2	3.3	6.1	6.4	10.9	3.0	5.5	3.6	8.2	5.0	7.2	11.1	13.0	18.2	5.8	13.1	10.5	9.9	11.5	5.5	7.4	8.5	9.0	9.6	6.5	5.7	10.9	14.6	13.0	5.5	4.4	7.1	4.1	8.6	2.9	6.0	11.9	9.2	12.3	11.2	9.6	2.8	11.2	14.8	3.6	7.6	4.9	5.0	6.3	6.5	13.1	9.1	11.0	15.7	5.9	4.8	8.4	5.9	14.1	7.7	5.9	16.9	17.0	8.9	15.5	11.6	8.8	6.4	6.8	9.9	8.2	6.8	2.5	6.1	6.4	3.8	9.4	5.5	3.3	4.0	2.8	6.1	1.9	4.6	3.7	6.4	3.0	10.9	1.6	4.4	3.6	15.9	19.4	21.1	19.6	13.9	8.6	12.9	17.1	14.9	14.5
FERMT3	"KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2"	ENSG00000149781	"Fermitin family member 3"	Q86UX7	11	64206678-64223886	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.4;bone marrow: 57.6;lymphoid tissue: 52.7"	"Cell line enhanced"	"Detected in many"		"HEL: 61.5;HL-60: 26.9;HMC-1: 65.8;Karpas-707: 26.5;NB-4: 34.6;U-937: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065231			Approved	Vesicles		450000000	450000000	Vesicles	Vesicles	"HPA065231: AB_2685439"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.38e-3)"	"prognostic favourable (9.89e-4)"	"unprognostic (8.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (2.12e-5)"	"unprognostic (3.08e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.75e-1)"	20.0	5.6	3.1	29.4	5.5	57.6	5.6	0.9	3.2	3.4	8.8	3.4	0.7	8.1	3.4	6.0	3.6	5.8	6.5	7.2	2.2	2.4	5.3	5.5	17.8	39.1	6.3	0.8	4.9	2.8	0.2	2.6	7.5	3.7	4.2	3.0	5.6	8.9	2.9	3.2	2.8	12.4	3.3	4.8	52.7	10.6	2.5	4.3	51.2	4.0	2.4	29.6	6.2	2.9	13.7	47.3	54.7	49.5	22.6	30.6	59.4	0.2	0.3	0.1	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.5	0.4	6.5	0.6	1.2	0.5	0.2	0.1	0.1	16.7	0.1	61.5	0.2	0.0	2.3	26.9	65.8	0.2	0.2	1.0	0.0	16.7	1.4	26.5	1.7	0.7	23.9	34.6	0.2	0.4	14.5	1.8	0.1	0.0	0.1	0.3	0.1	0.1	0.9	0.3	0.4	18.7	1.5	0.2	0.5	0.3	0.1	0.3	0.6	11.8	4.1	27.9	17.7	40.6	49.5	54.7	30.6	46.3	29.4	13.7	24.4	28.4	39.0	13.4	16.1	21.1	45.0	22.6	33.5	47.3	28.3	59.4	3.1	5.5	0.9	3.2	2.2	2.4	6.3	0.8	3.7	4.3
FFAR1	"FFA1R, GPR40"	ENSG00000126266	"Free fatty acid receptor 1"	O14842	19	35351552-35353862	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 5.7;brain: 4.1;ovary: 4.8;pancreas: 9.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;U-698: 5.4;WM-115: 2.0"	"Cancer enriched"	"Detected in single"	13	"pancreatic cancer: 2.2"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"																		"unprognostic (9.49e-2)"				"unprognostic (2.08e-1)"			"unprognostic (1.59e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.51e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.19e-2)"	"unprognostic (9.56e-3)"		0.0	0.0	1.2	0.2	1.6	5.7	0.0	0.0	0.6	0.0	0.0			0.8	0.1	0.0	0.0	0.8	0.0	0.0	1.9	0.9	0.0	0.0	0.1	0.7	1.7		4.8	9.6	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.1	0.2	0.5	0.0	4.1	0.3	1.6	0.1			0.0		0.2	0.0	0.0	1.2	0.5	1.9	0.3	0.7	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	2.8	0.4	0.1	0.4	0.0	0.0	0.1	0.3	0.3	0.8	0.2	0.0	0.1	0.4	1.4	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.6	0.1	0.0	1.1	0.2	0.0	0.0	0.3	0.1	0.4	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	5.4	0.1	0.2	2.0	1.6	0.3	0.7	0.4	0.2	0.4	0.3	0.3	0.2	0.0	1.2	0.3	0.4	1.9	0.7	0.2	0.5	0.2	0.0										
FMNL1	"C17orf1, C17orf1B, FMNL"	ENSG00000184922	"Formin like 1"	O95466	17	45221444-45247320	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 107.4;lymphoid tissue: 56.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 49.5;MOLT-4: 33.9;U-266/70: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008129, HPA028288"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA008129: AB_1848963, HPA028288: AB_10612110"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"prognostic unfavourable (4.23e-8)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.16e-1)"	8.6	3.8	10.7	29.7	9.6	107.4	7.5	8.1	16.1	4.6	5.2	4.2	0.8	5.8	2.6	5.8	4.5	6.1	9.1	5.8	13.4	6.0	4.2	3.6	22.2	38.1	6.1	6.4	3.1	3.6	3.6	7.4	7.4	7.2	4.3	4.1	3.3	8.4	2.3	2.5	4.2	14.9	4.3	6.2	45.9	6.6	2.7	3.3	56.6	3.9	4.1	22.8	11.3	4.6	3.5	4.3	22.3	5.6	5.4	7.6	3.5	4.1	8.1	0.0	0.4	0.0	1.8	0.4	0.5	1.1	3.1	2.3	0.3	1.8	12.8	4.2	0.1	0.7	0.0	0.1	1.0	22.5	1.1	7.4	12.1	0.6	8.7	19.3	26.3	1.4	0.3	4.0	1.7	0.0	0.6	49.5	2.2	2.7	33.9	20.0	0.4	0.2	21.5	2.9	22.9	0.8	0.5	2.6	1.2	2.5	0.4	0.9	2.3	15.8	1.0	0.1	2.9	0.4	18.2	41.3	18.2	13.1	0.3	15.8	0.6	6.8	5.1	8.2	7.0	5.6	4.7	3.5	5.5	7.6	4.3	3.3	3.6	4.8	22.3	5.4	4.2	2.5	6.0	3.5	10.7	9.6	8.1	16.1	13.4	6.0	6.1	6.4	7.2	3.3
FOLR3	FR-G	ENSG00000110203	"Folate receptor 3"	P41439	11	72114869-72139892	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 73.4;bone marrow: 43.4;lymphoid tissue: 22.6"	"Group enriched"	"Detected in some"	5	"hTERT-HME1: 34.8;U-2197: 30.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 5.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	12	"classical monocyte: 52.9;neutrophil: 73.4"	"Group enriched"	"Detected in many"	12	"granulocytes: 73.4;monocytes: 52.9"														"Secreted to blood"	9600000	9600000				"unprognostic (1.47e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.72e-3)"	"unprognostic (6.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.90e-2)"	"unprognostic (8.39e-2)"	"unprognostic (9.99e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.03e-6)"	"unprognostic (4.17e-1)"	2.9	0.3	0.1	4.8	0.2	43.4	4.2	0.1	0.8	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.4	1.0	0.1	1.7	0.2	0.1	2.7	0.6	14.4	8.2	0.2	0.0	0.1	1.7	0.0	0.1	4.5	0.2	0.1	0.0	0.2	0.2	0.0	0.1	0.3	0.2	0.2	0.1	22.6	0.4	0.7	0.2	0.3	0.9	0.4	0.4	0.2	7.5	0.0	5.1	73.4	52.9	0.0	0.2	29.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.8	6.1	1.8	4.4	0.0	0.0	0.0	0.6	0.9	0.4	0.0	3.3	4.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	2.5	34.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.1	30.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.2	52.9	4.3	0.0	3.5	0.2	0.0	0.0	0.0	5.1	0.0	0.0	0.0	73.4	0.0	0.1	0.9	0.0	29.5	0.1	0.2	0.1	0.8	0.2	0.1	0.2	0.0	0.2	0.2
FOXN2	HTLF	ENSG00000170802	"Forkhead box N2"	P32314	2	48314637-48379294	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 45.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003485	Supported		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA003485: AB_1078905"	"unprognostic (5.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.65e-3)"	"prognostic favourable (3.85e-4)"	"unprognostic (4.00e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (2.81e-5)"	"unprognostic (2.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.12e-2)"	17.7	6.2	12.7	13.9	17.4	45.5	13.6	23.6	13.8	8.1	7.4	25.0	3.2	8.2	8.2	4.6	9.1	6.5	9.8	8.3	16.1	9.5	6.8	18.7	10.6	17.4	23.3	12.8	6.2	8.4	9.8	7.0	12.6	19.0	6.2	8.0	2.9	7.1	4.7	8.0	5.9	10.1	9.5	23.6	17.2	7.4	6.1	26.0	17.8	7.9	6.9	15.7	10.9	8.2	7.6	11.3	42.3	11.3	8.3	9.9	5.6	6.9	10.6	12.2	10.8	9.7	7.2	13.5	7.7	8.5	6.5	7.4	9.3	8.7	15.1	10.4	9.1	8.8	7.4	8.8	9.6	11.7	6.5	29.6	7.6	9.3	17.0	16.2	23.5	6.4	3.8	7.0	12.4	6.9	14.0	18.1	10.6	5.3	17.9	10.7	9.3	5.5	9.0	25.6	12.4	5.7	8.8	6.9	7.0	3.8	7.2	13.7	3.2	9.6	8.0	9.0	9.0	8.5	8.2	9.8	7.3	21.9	7.9	14.9	12.1	35.1	11.1	42.3	8.7	8.9	9.9	7.5	8.3	7.9	11.3	7.6	6.4	6.4	14.1	8.3	11.3	7.0	9.5	5.6	12.7	17.4	23.6	13.8	16.1	9.5	23.3	12.8	19.0	26.0
FUT5	FUC-TV	ENSG00000130383	"Fucosyltransferase 5"	Q11128	19	5865826-5870540	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.8;SH-SY5Y: 2.9;U-266/70: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046966	Uncertain									"HPA046966: AB_2679879"				"unprognostic (7.72e-2)"	"unprognostic (3.59e-1)"		"unprognostic (5.03e-2)"			"unprognostic (1.20e-1)"								0.2	0.1	1.0	0.1	0.5	3.6	0.1	0.0	0.4	0.1	0.1			0.1	0.1	0.1	0.5	0.3	0.3	1.1	0.4	0.3	0.2	1.1	0.1	0.2	0.9		0.2	0.5	0.1	0.3	0.1		0.1	0.1		0.4	0.1	1.2	0.5	0.1	0.1	0.8	0.2	0.1	1.6			0.1		0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.0	0.7	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
G0S2		ENSG00000123689	"G0/G1 switch 2"	P27469	1	209675420-209676388	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 203.9;liver: 154.7"	"Group enriched"	"Detected in some"	6	"ASC diff: 75.4;HBEC3-KT: 113.8;PC-3: 28.6;RPMI-8226: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	62	"neutrophil: 89.5"	"Lineage enriched"	"Detected in single"	197	"granulocytes: 89.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.67e-3)"	"unprognostic (1.99e-3)"	"prognostic unfavourable (7.72e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (7.57e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.64e-1)"	130.1	23.3	1.1	18.5	1.1	203.9	85.2	2.0	0.9	2.0	11.3	1.4	29.9	1.6	6.1	9.3	2.0	4.0	13.5	43.7	1.1	0.8	22.2	154.7	51.6	6.4	1.8	0.0	18.4	5.3	0.5	1.2	2.6	1.3	8.7	1.1	3.1	49.2	73.5	97.9	3.0	3.5	3.8	1.5	6.3	7.1	5.3	1.1	0.0	3.1	14.3	6.1	12.6	13.1	0.0	0.0	89.5	0.1	0.0	0.4	0.0	0.0	0.6	0.0	0.0	75.4	2.6	0.0	0.1	0.2	0.3	0.3	2.9	2.3	0.0	0.6	0.5	0.0	0.0	113.8	0.7	0.1	0.2	0.0	0.2	0.0	6.1	0.0	0.0	7.8	0.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	28.6	0.0	0.0	36.3	0.2	0.0	0.1	0.2	2.5	0.0	0.6	0.0	8.7	11.4	0.0	0.7	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	1.1	1.1	2.0	0.9	1.1	0.8	1.8	0.0	1.3	1.1
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902852	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.8;liver: 58.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.6;Daudi: 13.2;SH-SY5Y: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 15.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favourable (8.69e-4)"	"prognostic favourable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (6.67e-4)"	4.8	5.2	1.3	5.7	4.5	26.8	2.1	0.6	1.1	2.2	5.5	1.2	1.5	7.5	1.8	1.9	3.8	1.3	1.6	1.5	1.6	4.3	7.9	58.2	11.6	6.7	2.9	0.7	1.4	3.2	0.3	2.5	2.5	2.8	2.9	4.0	5.2	2.5	4.7	1.4	2.5	9.1	2.0	1.7	10.0	4.2	3.6	1.1	13.0	2.3	2.0	8.5	2.9	2.5	1.6	3.0	0.4	11.5	2.3	3.2	1.3	1.9	0.6	0.7	3.5	0.0	0.0	11.6	0.0	1.2	0.8	2.2	0.9	0.6	13.2	3.3	0.1	2.0	5.7	0.9	0.0	5.1	4.9	0.3	0.2	1.9	5.6	0.0	1.2	1.4	1.6	1.9	0.0	0.4	0.8	0.0	0.0	6.8	7.1	0.2	1.1	4.5	5.8	1.4	0.0	1.6	2.7	5.8	29.3	2.4	1.5	0.7	5.6	1.6	0.2	0.1	1.9	3.7	2.3	5.6	4.2	3.2	2.4	4.5	0.0	0.0	3.0	0.2	3.0	6.3	2.5	0.8	1.6	2.1	3.0	1.6	3.2	1.8	0.4	2.3	11.5	0.1	2.3	1.3	1.3	4.5	0.6	1.1	1.6	4.3	2.9	0.7	2.8	1.1
GFI1	"GFI-1, GFI1A, ZNF163"	ENSG00000162676	"Growth factor independent 1 transcriptional repressor"	Q99684	1	92474762-92486876	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.9;lymphoid tissue: 56.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 16.3;HMC-1: 13.1;NB-4: 16.9;THP-1: 34.0;U-937: 70.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"gdTCR: 4.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB011197	Uncertain									"CAB011197: AB_532302"	"unprognostic (5.67e-4)"	"unprognostic (8.67e-3)"	"prognostic favourable (5.68e-5)"	"unprognostic (4.88e-3)"	"unprognostic (3.57e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.26e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.80e-6)"	"unprognostic (2.63e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.37e-2)"	1.2	0.4	0.1	3.6	0.3	31.9	0.7	0.2	0.3	1.1	3.9	0.1	0.1	3.0	0.7	0.7	1.2	1.0	2.6	0.6	0.2	0.1	1.0	0.9	3.4	5.4	0.5	0.3	0.5	12.4	0.0	0.7	0.7	0.5	1.1	3.1	0.9	1.2	1.3	0.7	0.4	6.8	0.6	0.8	8.9	1.8	1.1	0.2	56.1	1.2	0.5	5.0	1.9	0.8	0.0	1.6	0.8	0.0	0.3	4.9	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.7	0.4	0.0	1.3	0.0	16.3	13.1	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.0	0.5	10.2	16.9	0.0	0.0	2.0	0.7	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	34.0	0.0	0.0	0.4	0.0	0.0	6.1	0.4	1.1	0.0	70.3	0.0	0.0	0.0	0.8	4.9	0.0	2.2	0.0	2.1	3.0	0.0	0.0	0.8	4.5	0.1	0.3	0.0	1.6	0.7	0.5	0.1	0.3	0.2	0.3	0.2	0.1	0.5	0.3	0.5	0.2
GJB6	"CX30, DFNA3, ED2, EDH, HED"	ENSG00000121742	"Gap junction protein beta 6"	O95452	13	20221962-20232395	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 50.5;esophagus: 97.1;tongue: 43.6"	"Cell line enriched"	"Detected in some"	9	"RT4: 63.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 145.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Lineage enhanced"	"Detected in many"		"T-cells: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014846			Supported	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA014846: "	"unprognostic (5.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"unprognostic (7.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.96e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.14e-11)"	"unprognostic (8.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.35e-3)"	"unprognostic (5.04e-2)"	1.2	1.0	15.3	1.1	17.0	50.5	3.3	9.0	15.9	16.9	1.0	1.9	0.0	1.0	1.6	1.1	97.1	1.2	1.8	1.0	16.3	7.9	1.0	1.0	1.1	1.4	11.1	11.3	1.0	1.0	1.0	0.7	1.0	9.2	1.1	1.1	0.0	8.7	1.0	1.0	18.7	1.0	1.0	3.7	1.1	1.2	1.7	6.0	7.9	4.1	43.6	15.7	6.3	30.9	1.4	0.0	1.2	0.0	0.0	5.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	63.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	1.4	2.7	1.5	1.2	0.0	0.0	0.0	5.7	0.6	15.3	17.0	9.0	15.9	16.3	7.9	11.1	11.3	9.2	6.0
GLT1D1	FLJ31978	ENSG00000151948	"Glycosyltransferase 1 domain containing 1"	Q96MS3	12	128853427-128984968	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.1;bone marrow: 25.4;liver: 24.7"	"Group enriched"	"Detected in some"	7	"MOLT-4: 12.2;NTERA-2: 17.6;SCLC-21H: 8.3"	"Group enriched"	"Detected in some"	6	"liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 23.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039051, HPA039052"			Enhanced	Cytosol	"Secreted - unknown location"			Cytosol	Cytosol	"HPA039051: , HPA039052: "	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.41e-1)"	3.0	0.6	7.0	7.0	12.4	25.4	0.6	7.1	15.5	1.8	0.6	1.2	0.2	0.5	4.1	1.4	0.9	2.1	2.1	1.2	6.3	10.5	1.2	24.7	2.2	4.5	5.8	6.4	0.6	1.2	0.4	1.0	1.0	7.6	1.3	0.7	2.6	0.4	1.9	8.2	1.3	0.6	3.6	1.6	9.2	0.6	14.7	1.3	0.1	2.0	0.0	0.8	1.7	0.6	0.0	1.4	23.1	3.8	0.0	0.3	0.8	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.1	0.0	1.1	1.4	0.0	0.8	7.0	12.4	7.1	15.5	6.3	10.5	5.8	6.4	7.6	1.3
GMIP	ARHGAP46	ENSG00000089639	"GEM interacting protein"	Q9P107	19	19629476-19643667	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 32.7;bone marrow: 31.0;lymphoid tissue: 40.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042484, HPA045481"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA042484: AB_2678018, HPA045481: AB_2679343"	"unprognostic (7.54e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavourable (3.97e-5)"	"prognostic favourable (3.03e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (5.15e-4)"	6.1	2.8	3.5	20.3	4.9	31.0	4.0	0.9	4.1	2.9	6.9	4.3	2.7	7.0	2.7	3.2	6.2	4.4	7.9	3.3	4.3	3.4	4.2	3.9	11.7	28.0	4.2	2.5	2.4	4.6	10.6	3.0	3.9	3.4	4.1	4.6	2.7	6.0	4.5	1.5	4.9	15.3	2.9	4.9	40.0	11.1	2.2	3.1	26.8	6.2	2.7	23.2	6.1	4.5	6.6	6.7	32.7	13.9	4.2	6.4	4.6	4.4	2.0	2.7	3.0	3.0	1.6	11.0	2.8	2.4	1.7	1.6	1.6	5.9	10.8	5.7	1.9	5.3	1.7	3.0	1.1	3.7	2.8	3.4	3.2	1.7	0.9	9.6	43.0	2.0	2.1	1.8	0.9	3.8	2.3	3.9	1.8	6.5	6.0	15.9	1.6	3.7	10.4	1.2	6.2	3.2	10.5	2.3	7.1	3.8	4.0	1.6	3.7	13.8	6.8	3.1	1.8	3.5	2.0	2.0	0.8	8.9	2.0	12.6	2.1	2.9	8.3	21.5	6.4	10.6	5.9	5.9	4.0	5.7	6.7	6.6	4.5	4.6	32.7	4.2	13.9	6.1	4.5	4.6	3.5	4.9	0.9	4.1	4.3	3.4	4.2	2.5	3.4	3.1
GNA13	"G13, MGC46138"	ENSG00000120063	"G protein subunit alpha 13"	Q14344	17	65010715-65056839	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010087	Approved		Supported	Cytosol		4000000	4000000	Cytosol	Cytosol	"HPA010087: AB_10601478"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.21e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	28.2	17.4	16.4	25.3	17.5	75.6	15.1	15.1	15.0	14.2	19.1	23.0	13.0	14.0	12.9	12.1	13.2	12.1	17.7	15.4	16.8	13.3	12.4	17.4	27.6	27.5	18.5	9.4	16.3	10.0	12.1	10.0	25.0	14.8	16.8	17.3	10.7	10.5	13.9	35.0	11.4	17.5	15.9	32.1	22.5	13.6	11.3	20.4	34.9	11.9	9.0	27.5	28.3	26.0	5.7	5.5	15.8	13.4	7.8	11.2	4.4	11.6	13.2	12.1	8.2	12.6	11.4	12.5	9.1	10.6	12.5	14.3	7.4	7.8	47.6	6.0	9.8	8.1	12.9	11.1	19.3	12.3	7.5	24.8	8.0	14.5	18.2	18.5	16.5	9.6	17.0	12.0	16.6	18.8	10.0	29.7	14.4	11.0	28.4	6.7	7.5	9.8	16.5	24.3	17.3	12.6	19.1	8.9	18.8	6.6	13.8	15.6	14.2	18.1	13.4	20.8	18.3	8.9	11.9	22.0	26.1	54.0	7.6	12.0	11.0	7.1	6.4	8.5	7.2	13.4	7.3	5.7	8.9	8.5	5.5	4.8	5.2	5.7	15.8	7.8	8.3	2.5	11.2	4.4	16.4	17.5	15.1	15.0	16.8	13.3	18.5	9.4	14.8	20.4
GNA15	GNA16	ENSG00000060558	"G protein subunit alpha 15"	P30679	19	3136193-3163769	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.4;esophagus: 46.0;lymphoid tissue: 42.2"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 19.4;HMC-1: 45.9;MOLT-4: 45.9;NB-4: 17.2;REH: 34.3;THP-1: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 31.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043113	Approved									"HPA043113: AB_10967343"	"prognostic favourable (7.57e-5)"	"unprognostic (6.06e-2)"	"unprognostic (3.43e-1)"	"prognostic favourable (2.01e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (4.26e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.07e-1)"	4.9	1.7	1.6	7.2	2.3	37.4	3.9	1.1	2.0	7.9	1.3	1.6	1.0	1.0	0.8	1.8	46.0	1.3	2.8	2.6	1.6	1.1	1.3	1.2	7.6	3.7	3.1	1.3	1.0	0.7	0.2	0.8	4.5	2.7	5.9	1.1	1.3	9.2	1.7	0.8	20.0	1.1	1.8	2.8	5.6	2.5	1.1	2.2	42.2	0.7	29.0	25.3	10.4	16.2	0.0	31.0	6.2	12.6	2.1	3.9	5.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	10.7	0.0	19.4	0.0	0.0	0.0	5.5	0.0	0.0	0.0	7.8	45.9	0.0	12.1	0.0	8.0	0.0	0.0	0.1	0.0	0.0	45.9	17.2	0.0	0.0	34.3	0.0	0.0	0.0	6.9	0.0	0.0	1.3	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	5.8	12.6	6.2	0.0	9.7	0.5	0.0	1.0	0.1	13.0	0.0	0.0	0.0	3.1	2.1	6.5	31.0	3.9	5.1	1.6	2.3	1.1	2.0	1.6	1.1	3.1	1.3	2.7	2.2
GPR141	PGR13	ENSG00000187037	"G protein-coupled receptor 141"	Q7Z602	7	37683796-37833788	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 27.6;brain: 18.1"	"Cell line enhanced"	"Detected in some"		"HEL: 7.6;HMC-1: 30.1;NTERA-2: 16.2;U-937: 12.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 11.4;eosinophil: 8.1;gdTCR: 4.8;memory CD8 T-cell: 4.5;myeloid DC: 5.8;naive CD8 T-cell: 3.3;neutrophil: 10.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (4.91e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.26e-4)"	"unprognostic (4.70e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.39e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.60e-1)"	1.7	0.9	2.5	4.4	3.3	27.6	0.9	1.0	3.2	1.9	1.4	0.6	0.0	1.0	1.9	2.0	1.8	1.5	3.7	1.7	3.2	1.4	1.2	1.3	4.3	10.0	5.3	0.7	0.6	1.5	0.3	1.0	2.8	5.8	2.0	2.0	2.7	1.7	0.5	0.6	1.2	1.8	1.8	18.1	10.0	1.2	1.5	5.1	2.9	1.1	1.0	2.1	4.8	2.3	0.0	5.8	10.7	11.4	0.6	4.8	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.6	0.6	0.0	0.0	0.1	30.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	12.7	0.0	0.0	11.4	8.1	4.8	0.9	0.0	0.0	1.2	4.5	5.8	0.0	0.5	3.3	10.7	0.6	0.1	0.2	0.0	3.4	2.5	3.3	1.0	3.2	3.2	1.4	5.3	0.7	5.8	5.1
GPR84	EX33	ENSG00000139572	"G protein-coupled receptor 84"	Q9NQS5	12	54362445-54364487	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.2"	"Group enriched"	"Detected in some"	5	"HL-60: 9.1;NB-4: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"basophil: 6.0;classical monocyte: 8.7;myeloid DC: 12.9;neutrophil: 5.3"	"Group enriched"	"Detected in many"	53	"dendritic cells: 12.9;granulocytes: 6.0;monocytes: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027603	Enhanced									"HPA027603: AB_10612115"	"unprognostic (5.40e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.16e-3)"	"unprognostic (7.43e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.36e-9)"	"unprognostic (1.27e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.44e-2)"	7.2	2.3	2.7	11.2	6.8	27.2	0.7	0.4	3.3	1.0	0.9	5.0	0.0	0.8	0.6	0.9	1.1	1.7	1.8	3.2	1.6	2.1	2.4	0.8	5.3	2.7	4.4	0.0	2.7	1.0	0.7	2.3	6.7	5.0	1.2	1.3	0.7	1.2	0.7	1.1	1.4	0.8	2.8	6.7	8.0	1.2	2.1	7.5	0.9	2.1	0.0	2.8	3.0	2.1	0.0	12.9	6.0	8.7	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.1	1.6	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.7	0.0	6.0	8.7	0.0	0.0	0.3	0.0	0.0	0.0	0.1	12.9	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.8	2.7	6.8	0.4	3.3	1.6	2.1	4.4	0.0	5.0	7.5
GRK2	"ADRBK1, BARK1"	ENSG00000173020	"G protein-coupled receptor kinase 2"	P25098	11	67266410-67286556	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 78.2"	"Cell line enhanced"	"Detected in all"		"NB-4: 55.2;REH: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005021, CAB037248, HPA048330"	Approved		Approved	Vesicles				Vesicles	Vesicles	"CAB005021: AB_562360, CAB037248: AB_1078280, HPA048330: AB_2680361"	"unprognostic (5.58e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.31e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.19e-3)"	13.1	10.7	24.5	35.8	17.0	78.2	17.0	32.9	35.3	12.8	17.2	12.2	12.6	17.5	11.4	9.9	20.2	12.6	17.6	13.6	21.9	17.4	13.0	14.1	19.1	42.8	13.4	19.0	9.8	10.4	9.7	12.2	12.7	15.7	17.8	16.2	9.3	17.4	20.8	20.8	23.5	26.3	12.2	12.5	59.6	17.4	6.8	11.1	35.9	10.1	13.6	37.5	17.1	15.5	4.1	6.0	21.0	18.3	3.8	5.3	7.4	7.5	5.3	5.2	8.8	4.2	3.8	5.2	4.5	4.3	6.2	5.1	11.8	12.5	38.8	7.3	4.2	10.2	7.6	6.1	3.2	47.2	4.7	22.0	6.1	5.3	5.2	46.1	44.2	3.4	7.1	4.9	6.6	7.9	7.9	19.9	5.3	14.0	25.6	55.2	6.5	8.0	73.3	10.3	11.5	6.3	9.9	10.5	5.7	6.7	9.8	16.0	9.1	50.2	4.3	4.9	6.5	6.2	5.0	12.7	11.6	34.8	6.4	27.3	4.5	6.9	10.3	10.5	5.3	15.9	4.0	3.8	4.0	4.3	6.0	4.1	3.2	3.1	21.0	3.8	18.3	5.3	2.6	7.4	24.5	17.0	32.9	35.3	21.9	17.4	13.4	19.0	15.7	11.1
GRK6	GPRK6	ENSG00000198055	"G protein-coupled receptor kinase 6"	P43250	5	177403204-177442901	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015327, HPA018903"	Approved		Approved	Mitochondria		7500	7500	Mitochondria	Mitochondria	"HPA015327: AB_1850334, HPA018903: AB_1850335"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (5.66e-6)"	"unprognostic (2.63e-1)"	"unprognostic (6.45e-2)"	"unprognostic (8.96e-2)"	"prognostic favourable (1.22e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.47e-1)"	6.8	5.5	7.8	26.8	7.3	68.1	10.2	7.7	10.9	5.9	9.2	6.6	5.0	10.9	8.0	6.0	11.0	6.6	9.3	6.2	8.0	7.3	5.7	6.6	11.1	37.6	7.1	10.7	6.1	12.1	3.5	5.6	4.9	6.7	8.1	5.5	5.0	10.8	5.2	7.4	7.7	14.5	7.8	5.4	34.3	9.1	10.5	5.1	32.3	5.3	6.4	26.5	11.4	6.5	9.2	5.7	32.1	22.6	17.4	11.7	9.1	12.1	13.2	4.8	21.1	1.4	2.4	20.7	8.9	4.7	11.3	11.2	30.8	10.4	14.4	13.7	4.7	8.9	7.5	20.4	4.4	39.6	23.4	12.8	10.8	10.4	7.8	17.2	16.3	3.8	5.1	11.2	6.6	6.3	13.3	52.2	3.4	34.7	17.7	18.0	8.3	14.6	17.0	7.8	20.8	3.3	9.9	11.2	15.2	7.4	13.1	17.2	10.3	19.0	8.0	9.1	13.8	9.7	22.3	15.1	18.2	11.7	6.2	28.2	8.9	4.5	9.5	32.1	11.7	16.5	8.4	9.2	9.8	10.7	5.5	9.2	10.4	9.0	23.2	17.4	22.6	5.7	11.7	9.1	7.8	7.3	7.7	10.9	8.0	7.3	7.1	10.7	6.7	5.1
GVQW2		ENSG00000279968	"GVQW motif containing 2"	A0A096LPI5	6	138725211-138773652	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 5.4;bone marrow: 3.7;gallbladder: 2.2"	"Cell line enhanced"	"Detected in some"		"HSkMC: 6.3;MCF7: 2.2;U-266/70: 1.8"	"Low cancer specificity"	"Detected in single"							"Group enriched"	"Detected in some"	4	"basophil: 5.4;eosinophil: 1.7;memory B-cell: 1.6;naive B-cell: 2.2;neutrophil: 2.3"	"Group enriched"	"Detected in many"	6	"B-cells: 2.2;granulocytes: 5.4"																				"unprognostic (2.47e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.65e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.11e-1)"	"unprognostic (5.42e-4)"	0.5	0.9		0.7		3.7	0.0		0.0	0.5	0.4			0.0	0.4	0.0	0.0	0.0	2.2	0.0			0.0	0.1	0.0	0.0			0.0	0.0	0.8		0.1		0.0	1.6		0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0			0.1		0.3	0.0		2.2	0.4	5.4	0.4	0.3	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	1.1	0.0	0.2	6.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	2.2	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.1	0.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	5.4	0.4	1.7	0.0	0.3	0.2	1.6	0.6	0.1	0.2	2.2	0.3	0.3	2.3	0.3	0.4	0.4	0.1	0.5										
GYPE	"GPE, MNS"	ENSG00000197465	"Glycophorin E (MNS blood group)"	P15421	4	143870867-143905563	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 14.5;lymphoid tissue: 6.9"	"Group enriched"	"Detected in some"	11	"HEL: 49.7;K-562: 16.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.5"	"Group enriched"	"Detected in many"	12	"B-cells: 3.5;NK-cells: 2.1;T-cells: 1.3"																				"unprognostic (2.17e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.09e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.10e-4)"	"unprognostic (7.81e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.49e-2)"	2.7	0.2	1.2	1.5	0.5	14.5	1.2	0.5	1.2	0.9	0.5	0.5	0.5	0.0	0.5	0.8	0.5	0.1	0.7	2.6	1.1	0.3	0.7	0.5	3.7	1.0	0.5	0.5	1.5	0.5	0.0	0.5	5.7	1.1	0.5	0.4	0.5	0.5	0.6	0.5	0.5	1.7	0.5	0.7	6.9	0.4	0.8	0.5	1.5	1.4	0.5	3.1	0.9	0.5	3.5	0.1	0.0	0.0	2.1	1.3	0.0	0.0	0.0	0.0	0.0	2.9	2.9	0.0	1.2	2.7	0.6	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	49.7	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.5	0.0	0.0	0.0	1.1	0.8	0.6	0.0	2.1	0.0	0.1	0.0	0.0	1.2	0.5	0.5	1.2	1.1	0.3	0.5	0.5	1.1	0.5
H1F0	"H10, H1FV"	ENSG00000189060	"H1 histone family member 0"	P07305	22	37805093-37807436	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 158.1"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000843	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA000843: AB_1079062"	"unprognostic (1.29e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.86e-3)"	"prognostic favourable (7.68e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	21.7	13.6	27.5	14.7	24.9	158.1	32.3	35.7	41.7	48.2	37.9	20.4	11.3	35.8	42.7	18.5	66.0	31.7	38.5	30.3	23.5	17.6	33.2	90.6	22.8	15.0	16.0	23.8	48.5	43.5	20.2	25.6	33.6	23.5	43.7	34.0	28.3	43.2	12.4	53.5	53.2	59.2	28.0	18.6	16.3	34.6	15.2	18.8	56.3	36.1	33.4	32.0	24.9	45.2	0.1	6.3	12.5	9.0	0.1	2.4	4.7	20.7	9.0	28.0	12.4	7.4	6.8	39.8	16.9	35.3	49.5	70.7	36.6	33.1	0.0	4.2	14.0	40.6	0.0	11.6	35.3	0.1	2.0	35.1	3.3	24.4	25.9	0.0	0.1	6.3	20.8	24.8	28.0	13.1	0.0	0.0	3.8	34.3	5.8	3.4	10.8	44.5	9.7	16.7	7.1	7.8	5.6	6.4	36.1	46.6	31.8	61.5	24.8	21.9	8.7	3.7	113.0	16.6	3.4	0.0	2.3	0.1	4.6	12.6	10.7	12.5	7.6	11.3	0.1	9.0	0.1	0.0	0.8	0.2	6.3	0.1	2.4	0.3	4.2	0.1	7.7	5.7	0.2	4.7	27.5	24.9	35.7	41.7	23.5	17.6	16.0	23.8	23.5	18.8
H3F3B	H3.3B	ENSG00000132475	"H3 histone family member 3B"	P84243	17	75776434-75785893	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 570.8;bone marrow: 441.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 570.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 570.8"									"CAB037166, CAB037187, CAB037221, HPA042570"	Supported		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: "	"unprognostic (1.66e-1)"	"unprognostic (8.42e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.99e-1)"	57.2	41.2	38.1	58.9	48.6	441.9	71.4	60.2	47.0	86.6	44.6	65.9	42.7	37.9	60.5	77.7	93.2	70.2	75.8	35.1	38.5	33.9	42.8	48.1	64.2	62.3	50.4	41.2	141.0	90.9	33.0	41.5	58.5	42.7	60.5	26.6	65.8	58.4	55.4	71.1	114.0	58.0	63.7	51.8	65.9	45.1	66.9	46.2	78.6	58.9	69.1	55.7	78.5	71.9	78.9	88.1	570.8	98.4	80.0	77.2	203.5	118.3	105.1	43.9	43.3	25.1	39.4	60.7	56.1	49.7	68.9	55.3	112.5	84.2	59.3	53.6	32.6	46.6	34.7	77.5	39.3	32.3	78.2	52.9	56.1	95.2	56.7	87.8	68.1	42.9	48.0	70.6	91.1	51.7	74.8	106.6	35.4	174.1	126.0	73.7	35.2	117.5	93.8	80.4	64.6	54.4	70.3	89.1	99.0	56.9	83.5	120.3	65.4	94.8	48.2	123.7	109.4	53.3	148.4	129.0	76.3	71.2	65.4	83.8	67.4	182.8	98.4	259.3	74.4	86.9	70.2	78.9	71.8	70.5	86.7	65.3	77.2	64.5	570.8	80.0	78.9	88.1	76.0	203.5	38.1	48.6	60.2	47.0	38.5	33.9	50.4	41.2	42.7	46.2
HBZ	"HBZ-T1, HBZ1"	ENSG00000130656	"Hemoglobin subunit zeta"	P02008	16	152687-154503	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.9;placenta: 5.0;testis: 9.9"	"Cell line enriched"	"Detected in some"	79	"K-562: 222.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA063268, HPA064073, HPA071726"	Approved		Approved	Nucleoplasm,Cytosol		160000000	160000000	Cytosol	Cytosol	"HPA063268: , HPA064073: , HPA071726: AB_2732184"					"unprognostic (3.56e-1)"				"unprognostic (1.32e-1)"									0.8	0.0	0.8	0.1	0.5	8.9	0.6	0.6	0.6	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	1.6	3.3	0.7	0.3	0.1	1.1	0.6	0.1	1.1	0.1	0.7	0.1	0.0	0.1	5.0	0.1	1.2	0.0	0.1	0.1	0.1	0.9	0.5	0.1	0.1	0.1	0.8	0.1	9.9	0.1	0.1	0.1	0.1	0.1	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	222.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.5	0.6	0.6	0.7	0.3	1.1	0.1	0.1	0.1
HCST	"DAP10, DKFZP586C1522, KAP10, PIK3AP"	ENSG00000126264	"Hematopoietic cell signal transducer"	Q9UBK5	19	35902480-35904377	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 134.0;bone marrow: 84.0;lymphoid tissue: 79.1"	"Cell line enhanced"	"Detected in some"		"HEL: 51.7;HL-60: 29.8;HMC-1: 34.5;THP-1: 39.1;U-937: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034435, HPA063026"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"				"Plasma membrane"	"Plasma membrane"	"CAB034435: AB_2117803, HPA063026: "	"unprognostic (1.40e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.54e-1)"	"prognostic favourable (6.70e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (1.59e-10)"	"unprognostic (3.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.56e-1)"	29.4	4.0	6.5	19.9	5.2	84.0	5.9	1.4	3.1	3.9	4.9	4.8	0.5	4.5	5.4	6.0	3.0	4.5	6.3	7.3	5.7	5.9	5.6	6.9	38.4	79.1	7.7	2.2	3.4	2.9	0.7	4.3	10.6	4.9	5.5	3.6	7.1	6.2	3.7	2.4	2.8	10.9	4.5	12.7	49.5	5.6	1.7	4.4	56.8	3.4	3.3	26.7	5.2	3.6	6.1	66.6	15.9	57.0	96.4	134.0	89.5	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.2	5.6	0.3	0.4	0.2	0.0	0.0	0.0	0.1	0.0	51.7	0.1	0.1	0.1	29.8	34.5	0.3	0.0	0.0	0.0	0.0	0.4	7.4	0.1	0.0	3.4	11.6	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.1	39.1	0.1	0.3	0.4	0.0	0.0	0.3	0.2	8.5	0.3	58.7	0.0	7.3	57.0	7.9	134.0	42.0	99.3	6.1	57.4	108.5	32.6	3.7	48.3	96.4	15.9	96.4	23.0	66.6	48.5	89.5	6.5	5.2	1.4	3.1	5.7	5.9	7.7	2.2	4.9	4.4
HEMGN	"CT155, EDAG, NDR"	ENSG00000136929	Hemogen	Q9BXL5	9	97926791-97944856	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 71.1;placenta: 20.2;testis: 32.5"	"Cell line enriched"	"Detected in some"	4	"K-562: 75.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.2"	"Group enriched"	"Detected in many"	27	"granulocytes: 2.1;NK-cells: 2.9;T-cells: 8.2"					"Region enriched"	"Detected in all"	5	"cerebellum: 55.9"	"HPA019572, HPA019604, HPA019606"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591"	"unprognostic (1.94e-1)"				"unprognostic (3.15e-3)"			"unprognostic (2.50e-2)"		"unprognostic (9.00e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-4)"	"unprognostic (2.77e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.25e-1)"		0.3	0.2	0.2	0.4	0.2	71.1	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.3	1.0	0.2	0.2	0.3	0.9	5.4	0.5	0.2	0.0	0.6	0.2	0.0	0.3	20.2	1.1	0.2	0.0	0.1	0.2	0.0	0.2	0.2	0.2	0.0	0.3	2.8	0.2	32.5	0.0	17.1	0.3	0.2	0.5	1.4	4.8	0.0	0.1	2.1	0.1	2.9	8.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	2.1	0.1	0.0	0.4	0.1	0.8	0.0	2.3	1.1	0.1	0.0	8.2	3.3	1.0	2.9	0.0	0.0	1.2	4.4	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.0	1.1	0.0
HIPK1	"KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2"	ENSG00000163349	"Homeodomain interacting protein kinase 1"	Q86Z02	1	113929192-113977869	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 90.1"	"Cell line enhanced"	"Detected in all"		"MCF7: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016664	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome, Cytosol"	"Nucleoplasm, Centrosome, Cytosol"	"HPA016664: AB_1850725"	"unprognostic (2.98e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.22e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.99e-2)"	15.1	16.8	21.2	14.7	23.0	90.1	13.6	38.1	20.4	20.4	14.4	20.7	14.5	10.2	15.5	14.2	18.7	27.3	17.5	27.9	22.9	17.2	14.8	13.8	19.3	14.7	15.0	16.4	18.7	16.8	20.7	23.8	13.8	21.3	14.4	15.2	20.7	13.0	14.9	19.7	18.5	13.4	15.1	18.3	15.9	14.8	33.5	21.3	47.2	23.3	13.1	15.5	17.3	26.7	2.3	6.2	9.8	4.2	4.3	6.0	2.3	8.1	6.6	9.2	7.0	10.8	5.7	6.2	5.6	6.8	8.0	7.7	7.6	3.1	10.9	7.7	8.9	5.5	11.8	6.6	11.6	7.9	6.0	15.9	8.3	8.0	9.0	12.7	19.7	6.1	9.6	10.2	10.5	11.8	10.8	11.8	11.5	61.5	16.6	7.2	9.4	5.9	10.1	27.0	3.8	7.2	7.0	4.1	5.4	10.2	11.0	7.2	6.4	18.3	11.5	7.9	10.7	12.8	8.5	7.4	5.8	9.5	8.8	10.3	17.9	3.4	4.2	8.2	5.5	3.7	5.2	1.7	4.9	4.9	3.1	2.3	5.0	6.0	9.8	4.3	2.6	6.2	3.6	2.3	21.2	23.0	38.1	20.4	22.9	17.2	15.0	16.4	21.3	21.3
HIST2H2AA3	"H2A.2, H2A/q, H2AFO, HIST2H2AA"	ENSG00000203812	"Histone cluster 2 H2A family member a3"	Q6FI13	1	149842188-149842736	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 67.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.4;U-266/70: 94.8;U-266/84: 52.6"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041189	Supported									"HPA041189: AB_2677357"	"unprognostic (2.41e-2)"				"unprognostic (3.79e-1)"					"unprognostic (1.53e-1)"		"unprognostic (2.89e-1)"		"unprognostic (2.20e-1)"				6.1	2.7	3.7	6.8	3.7	67.4	7.8	3.7	5.4	10.1	4.0	3.7	3.7	4.2	3.7	3.7	6.5	5.4	5.0	4.5	3.7	1.6	5.6	9.9	14.6	4.4	3.7	3.7	5.1	3.7	0.4	3.7	8.9	3.7	35.8	1.7	3.7	22.4	3.7	4.5	11.7	3.7	3.7	8.0	12.8	9.6	11.2	3.7	18.9	3.7	3.7	5.4	3.7	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.6	0.0	5.2	2.5	3.5	3.0	0.0	1.0	1.5	3.8	2.3	0.9	0.3	1.1	0.4	2.5	0.0	0.7	6.8	0.9	2.4	0.0	0.7	11.5	2.0	0.8	1.0	0.9	7.6	19.4	1.2	0.0	0.0	5.7	0.0	4.1	0.7	0.0	7.3	1.4	1.7	0.0	0.0	6.6	0.0	0.2	5.0	1.9	2.0	0.7	8.7	0.0	0.5	94.8	52.6	2.1	5.5	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.7	3.7	5.4	3.7	1.6	3.7	3.7	3.7	3.7
HIST2H3C	"H3, H3.2, H3/m, H3F2, H3FM, MGC9629"	ENSG00000203811	"Histone cluster 2 H3 family member c"	Q71DI3	1	149839538-149841193	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.8;brain: 5.1;prostate: 3.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 5.5;SiHa: 8.3;U-266/70: 7.3;U-266/84: 7.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"											"HPA042570, CAB069990"	Approved									"CAB069990: AB_10804539, HPA042570: AB_2678056"					"unprognostic (1.78e-1)"			"unprognostic (2.25e-1)"		"unprognostic (2.42e-1)"				"unprognostic (1.36e-2)"				0.4	0.5	0.7	0.4	1.4	3.8	0.0	5.1	2.9	0.1	0.3			0.8	0.2	0.0	0.4	1.0	0.0	1.4	0.7	0.2	0.1	0.6	0.3	0.5	0.3		0.0	1.9	0.0	0.1	0.3		3.6	0.0		0.9	0.0	0.2	0.5	0.6	0.0	0.4	0.4	1.1	1.4			0.1		0.0	0.4	0.6	0.4	0.6	1.6	0.2	0.2	0.1	0.2	0.5	3.2	0.6	0.4	0.1	0.0	1.1	0.5	0.1	0.7	0.1	0.5	0.6	0.3	0.5	0.0	2.6	0.0	0.1	0.2	0.8	5.5	0.5	2.5	0.1	0.0	0.4	1.5	0.0	0.0	0.1	0.2	0.1	2.5	3.1	0.1	2.2	1.5	2.0	1.7	1.3	1.3	0.3	1.5	0.0	0.3	4.9	1.1	8.3	2.3	0.4	1.4	1.8	0.0	0.6	4.7	0.3	0.4	7.3	7.2	1.7	0.5	0.6	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.1	1.6	0.2	0.2	0.6	0.0	0.2										
HIST2H3D		ENSG00000183598	"Histone cluster 2 H3 family member d"	Q71DI3	1	149813271-149813681	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 12.6;bone marrow: 9.3;lymphoid tissue: 10.2"	"Cell line enriched"	"Detected in many"	4	"U-266/70: 21.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.6"	"Low lineage specificity"	"Detected in many"											HPA042570	Approved									"HPA042570: AB_2678056"	"unprognostic (3.35e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.27e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.93e-4)"	"unprognostic (6.95e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.48e-3)"	1.1	1.2	1.5	1.7	1.4	9.3	5.7	2.6	2.0	1.1	0.9	0.6	0.6	0.5	0.6	0.6	3.8	1.2	3.1	1.9	0.6	0.5	0.6	1.4	1.9	2.9	0.6	0.6	2.4	1.1	0.0	0.6	0.6	1.2	1.9	0.1	0.6	0.6	0.6	0.6	1.1	1.6	0.6	2.3	2.2	2.6	2.3	1.3	10.2	0.7	2.2	1.1	2.7	1.3	6.9	2.7	12.6	1.8	0.4	2.4	0.5	0.8	0.0	0.2	2.3	0.4	0.0	0.5	1.3	0.0	0.0	0.1	0.4	0.2	0.6	0.2	0.0	1.1	0.0	0.0	0.0	1.3	0.7	0.2	3.4	0.1	0.4	0.0	1.9	0.8	0.0	0.5	0.3	0.0	1.8	2.0	0.0	1.5	2.2	5.4	2.1	4.0	1.2	0.4	1.6	0.0	1.1	0.5	0.3	1.3	0.0	0.1	0.4	0.6	0.5	1.2	0.0	1.0	0.0	21.7	2.2	1.4	0.2	0.4	0.8	0.0	1.3	0.5	1.2	1.8	2.4	1.3	1.6	1.8	1.2	6.9	0.6	0.4	12.6	0.4	0.6	2.7	0.2	0.5	1.5	1.4	2.6	1.1	0.6	0.5	0.6	0.6	1.2	1.3
HK3		ENSG00000160883	"Hexokinase 3"	P52790	5	176880869-176899332	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.2;bone marrow: 55.0;lymphoid tissue: 40.6"	"Cell line enriched"	"Detected in some"	4	"U-937: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 76.2"	"Group enriched"	"Detected in many"	11	"granulocytes: 76.2;monocytes: 31.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056743	Enhanced					1700000	1700000			"HPA056743: AB_2683222"	"unprognostic (4.22e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.82e-1)"	"prognostic unfavourable (3.84e-8)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.42e-2)"	9.2	2.6	0.6	8.5	1.0	55.0	1.3	0.3	1.2	0.4	1.7	0.3	0.0	0.9	0.8	2.6	1.9	3.0	0.9	5.4	0.6	0.3	1.6	4.1	16.3	24.1	1.2	0.5	1.2	1.0	0.0	0.4	2.9	0.5	0.9	0.6	0.9	0.9	0.1	0.8	0.3	1.6	3.4	0.6	40.6	1.2	0.6	0.2	1.3	1.5	0.2	1.2	1.8	5.3	0.0	5.1	76.2	31.4	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.6	0.1	0.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	20.8	0.0	76.2	15.4	32.9	0.0	29.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	5.4	0.0	31.4	0.2	0.0	6.0	0.6	1.0	0.3	1.2	0.6	0.3	1.2	0.5	0.5	0.2
HLX	"HB24, HLX1"	ENSG00000136630	"H2.0 like homeobox"	Q14774	1	220879400-220885059	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 54.0"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 13.2;THP-1: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 25.8;neutrophil: 28.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 28.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA005968	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA005968: AB_1079066"	"unprognostic (6.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (7.28e-6)"	"unprognostic (8.44e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	27.7	3.0	2.7	8.8	3.0	54.0	18.4	0.9	2.3	5.7	24.3	2.0	3.8	4.5	7.4	3.6	8.7	5.0	7.5	15.2	3.3	0.9	4.0	11.5	14.3	10.5	6.2	0.3	4.9	4.9	1.8	2.0	14.0	2.5	6.9	2.4	4.2	2.3	3.8	10.4	5.7	11.1	4.2	6.4	10.9	3.1	3.9	3.1	1.4	6.3	3.0	3.2	10.4	12.9	2.2	5.5	28.5	6.3	0.2	0.1	1.8	0.0	1.8	0.0	1.4	4.2	6.8	3.5	5.1	8.5	5.8	4.9	0.4	0.1	0.0	0.1	3.2	0.0	1.1	0.0	2.4	1.3	3.7	0.0	2.1	0.2	7.4	1.7	0.3	7.8	0.2	6.6	0.3	2.5	2.2	0.0	0.8	0.0	0.0	6.1	0.2	3.5	0.1	4.0	0.0	0.6	0.0	0.0	2.0	0.7	0.1	13.2	0.0	46.4	0.7	4.0	0.0	0.6	4.0	0.0	0.0	0.0	6.4	5.3	1.6	25.8	6.3	10.7	0.0	1.8	0.0	2.2	0.0	0.0	5.5	1.1	0.0	0.0	28.5	0.2	0.3	3.5	0.1	1.8	2.7	3.0	0.9	2.3	3.3	0.9	6.2	0.3	2.5	3.1
HMBS	"PBGD, PORC, UPS"	ENSG00000256269	"Hydroxymethylbilane synthase"	P08397	11	119084866-119093549	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006114, HPA050659"	Supported		Approved	"Lipid droplets"		28000000	28000000	"Lipid droplets"	"Lipid droplets"	"HPA006114: AB_1079067, HPA050659: AB_2681206"	"unprognostic (6.24e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.91e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	5.5	11.0	5.3	6.2	9.3	75.2	8.6	5.2	8.0	5.5	8.3	6.0	6.0	7.9	6.9	7.9	9.4	5.5	6.4	11.5	5.9	5.5	9.9	22.2	5.8	14.5	8.8	4.5	3.7	21.2	7.9	5.9	9.7	8.4	5.5	9.2	4.1	10.1	7.2	17.4	6.0	7.9	6.8	9.7	10.4	7.1	7.4	7.5	6.0	8.4	13.0	9.3	5.7	4.8	7.7	19.1	12.0	14.0	3.8	7.4	9.4	9.1	14.0	6.7	11.9	5.4	6.7	10.1	7.3	8.3	10.8	9.3	17.3	14.5	14.2	16.4	9.3	13.0	10.0	14.2	6.9	9.7	10.2	23.3	5.6	12.6	9.9	8.7	7.6	7.3	9.1	17.0	13.0	5.0	34.5	6.3	8.5	36.8	8.4	16.8	7.5	8.9	9.7	6.6	13.8	10.8	8.4	7.4	10.1	5.9	9.2	6.4	15.7	12.1	4.6	8.2	6.2	8.0	8.5	3.4	4.0	8.4	5.4	11.5	9.7	12.0	14.0	1.4	5.1	12.2	6.7	7.7	4.8	5.7	19.1	7.2	7.4	5.6	0.4	3.8	7.3	12.3	4.9	9.4	5.3	9.3	5.2	8.0	5.9	5.5	8.8	4.5	8.4	7.5
HRH2		ENSG00000113749	"Histamine receptor H2"	P25021	5	175658030-175710756	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 45.7;bone marrow: 30.1"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 35.4;SK-MEL-30: 10.6;THP-1: 9.8;U-937: 11.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 4.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 45.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 45.7;monocytes: 13.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013770	Approved									"HPA013770: AB_1851086"	"unprognostic (8.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.77e-2)"	7.9	1.5	5.9	11.1	11.6	30.1	2.8	1.0	12.1	3.9	2.8	0.9	0.5	5.9	2.3	1.3	1.6	2.7	2.6	18.6	3.4	1.7	2.4	1.2	5.4	12.3	2.3	4.9	1.6	1.6	0.3	1.3	9.5	2.4	3.0	1.3	0.6	1.7	4.8	1.2	2.1	7.2	3.5	4.4	9.9	10.3	1.2	5.6	9.9	1.8	0.2	3.0	2.8	2.0	0.0	6.4	45.7	13.1	0.6	2.3	3.7	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.7	1.6	0.0	3.8	0.0	35.4	0.0	0.2	0.2	0.0	0.0	0.0	10.6	0.0	9.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.8	2.4	28.9	12.9	13.6	0.0	12.0	0.1	0.0	1.1	0.2	6.4	0.0	2.3	1.4	45.7	0.6	13.1	5.0	0.8	3.7	5.9	11.6	1.0	12.1	3.4	1.7	2.3	4.9	2.4	5.6
ICAM3	"CD50, CDW50, ICAM-R"	ENSG00000076662	"Intercellular adhesion molecule 3"	P32942	19	10333776-10339823	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 64.3;NB-4: 41.4;RPMI-8226: 48.2;U-266/84: 34.1;U-937: 33.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 172.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 172.3"									"CAB002498, HPA049820"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		370000000	370000000	Mitochondria	Mitochondria	"CAB002498: AB_563593, HPA049820: AB_2680897"	"unprognostic (6.85e-4)"	"unprognostic (5.28e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.34e-3)"	"unprognostic (5.79e-6)"	"unprognostic (5.05e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.62e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.84e-1)"	6.8	2.8	1.7	23.5	1.9	51.5	5.5	0.6	1.5	3.0	6.8	1.1	1.2	4.3	1.7	3.0	4.0	2.9	7.2	6.4	1.1	0.9	5.1	28.7	13.2	68.5	1.8	1.4	1.7	6.8	0.2	0.4	4.8	1.5	2.8	3.3	2.4	10.3	1.3	5.0	1.6	11.9	1.8	1.0	39.4	5.4	1.4	1.0	47.6	3.0	5.7	38.4	4.5	4.9	25.5	28.4	172.3	33.5	31.0	41.0	43.1	2.6	1.3	0.9	2.9	1.6	1.3	1.6	1.6	1.1	1.4	1.2	1.1	1.8	0.0	5.7	1.4	1.1	0.0	1.2	0.4	19.8	0.8	5.0	1.2	5.0	0.8	18.3	20.7	1.1	1.0	1.6	0.5	0.6	2.7	64.3	1.5	5.4	2.4	41.4	0.7	9.0	1.5	0.6	48.2	1.4	2.3	0.3	1.2	1.4	4.5	3.6	3.9	5.2	1.1	6.3	0.5	7.0	1.6	3.1	34.1	7.6	4.5	33.8	4.9	15.3	33.1	72.0	33.8	24.4	41.0	25.5	32.7	31.2	28.4	23.9	29.3	27.4	172.3	31.0	33.5	4.8	36.9	43.1	1.7	1.9	0.6	1.5	1.1	0.9	1.8	1.4	1.5	1.0
ICOSLG	"B7-H2, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653"	ENSG00000160223	"Inducible T cell costimulator ligand"	O75144	21	44217014-44240966	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.5"	"Low lineage specificity"	"Detected in many"											"CAB026037, HPA029179"	Uncertain		Approved	"Plasma membrane,Cytoplasmic bodies"		150000000	150000000	"Plasma membrane, Cytoplasmic bodies"	"Plasma membrane, Cytoplasmic bodies"	"CAB026037: , HPA029179: AB_2732445"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-4)"	"unprognostic (3.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.40e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.84e-1)"	2.3	3.0	5.3	3.9	7.1	14.1	2.3	2.3	5.9	2.9	2.3	2.3	2.3	1.8	2.3	2.3	4.0	2.7	3.5	3.7	8.8	3.7	5.3	2.7	2.3	6.5	6.5	2.3	2.3	2.3	0.0	2.3	2.3	2.3	2.3	1.2	2.3	2.3	2.3	2.3	5.5	2.9	2.3	8.4	3.2	4.2	2.3	2.3	2.3	2.3	2.3	4.5	2.4	2.6	6.5	1.6	1.0	0.8	0.5	1.1	0.4	0.3	3.3	0.1	2.8	0.8	1.1	7.7	0.7	0.6	0.4	0.2	5.6	0.4	14.0	2.1	0.3	4.2	1.9	1.3	0.2	1.4	1.4	0.4	2.7	1.6	0.7	6.0	10.3	1.1	1.9	0.9	0.9	0.8	2.3	1.3	0.2	3.6	0.3	7.9	2.0	3.5	11.9	0.9	8.2	0.6	7.4	1.4	0.0	9.3	13.2	0.3	3.8	8.6	0.8	0.4	3.3	0.3	0.2	12.1	8.2	11.7	4.3	5.6	1.8	0.6	0.8	0.4	0.3	0.8	0.3	3.7	0.8	0.5	0.5	6.5	0.8	1.1	1.0	0.5	0.5	1.6	0.4	0.4	5.3	7.1	2.3	2.3	8.8	3.7	6.5	2.3	2.3	2.3
IFNG		ENSG00000111537	"Interferon gamma"	P01579	12	68154768-68159747	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.4;lung: 14.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.2;U-266/70: 2.2;U-698: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"gdTCR: 7.3;memory CD4 T-cell: 3.3;memory CD8 T-cell: 8.6;naive CD8 T-cell: 5.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 8.6"					"Low region specificity"	"Detected in single"			CAB010344	Approved				"Secreted to blood"					"CAB010344: AB_2123447"	"unprognostic (2.16e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-4)"	"unprognostic (5.14e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-4)"	"unprognostic (7.79e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.62e-9)"	"unprognostic (3.54e-2)"	"unprognostic (5.36e-1)"	"unprognostic (6.32e-2)"	"unprognostic (7.38e-3)"	2.4	0.9	0.3	4.5	0.3	14.4	0.5	0.1	1.0	1.4	0.9	0.5	0.0	0.2	0.6	1.4	1.3	0.2	0.6	1.0	0.3	0.3	0.7	4.1	14.5	8.5	1.5	0.4	0.4	0.2	0.0	0.5	0.8	0.6	1.2	0.4	1.1	1.4	0.2	1.7	0.3	0.7	0.7	1.3	4.1	0.8	0.2	0.0	0.8	1.3	3.1	4.7	2.2	0.6	0.5	0.0	0.2	0.0	1.2	8.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	3.3	8.6	0.0	0.5	0.8	5.2	0.2	1.2	0.0	0.0	0.2	1.1	0.3	0.3	0.1	1.0	0.3	0.3	1.5	0.4	0.6	0.0
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.7;bone marrow: 55.2;lymphoid tissue: 86.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 26.6;HDLM-2: 45.2;HMC-1: 42.4;MOLT-4: 33.1;REH: 35.8;U-698: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009247, HPA035221, HPA035222"	Enhanced									"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favourable (4.28e-4)"	"prognostic favourable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favourable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"	3.5	1.5	2.9	25.5	3.8	55.2	2.3	0.7	1.8	1.6	3.6	2.8	0.8	2.4	1.6	2.1	2.2	2.4	2.9	1.6	3.4	1.8	2.5	2.3	8.3	44.4	5.9	1.1	1.1	1.3	0.2	1.2	1.2	3.4	2.2	2.5	1.5	5.2	0.7	0.9	1.9	14.5	1.4	5.1	31.0	3.7	1.1	4.1	86.7	2.4	1.2	26.3	4.5	2.9	24.0	12.6	12.8	23.6	12.8	28.7	12.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	45.2	0.0	9.1	0.0	0.0	0.0	16.1	42.4	0.0	0.0	0.0	0.0	0.0	11.7	3.1	0.0	0.0	33.1	16.0	0.4	0.0	35.8	0.0	7.5	0.0	0.0	0.3	0.3	0.1	0.2	0.1	0.0	22.2	0.0	0.0	0.3	0.0	0.0	14.5	7.4	68.0	0.1	17.5	0.1	10.2	7.7	12.8	20.4	23.6	17.0	24.0	21.2	19.9	8.2	21.3	28.7	20.7	11.2	12.8	22.3	12.6	17.1	12.7	2.9	3.8	0.7	1.8	3.4	1.8	5.9	1.1	3.4	4.1
IL18RAP	"AcPL, CD218b"	ENSG00000115607	"Interleukin 18 receptor accessory protein"	O95256	2	102418689-102452565	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 34.6;bone marrow: 50.2;lymphoid tissue: 29.8"	"Cell line enriched"	"Detected in some"	10	"U-937: 34.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 34.6"	"Group enriched"	"Detected in many"	108	"granulocytes: 22.5;NK-cells: 34.6;T-cells: 22.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025270	Enhanced									"CAB025270: "	"unprognostic (1.73e-3)"	"unprognostic (6.27e-3)"	"unprognostic (5.07e-3)"	"unprognostic (4.64e-6)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.86e-5)"	"unprognostic (5.09e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.73e-2)"	3.6	0.3	0.2	6.1	0.5	50.2	0.9	0.3	0.4	1.2	4.8	0.5	0.0	1.2	1.2	2.1	0.8	3.8	3.0	2.1	0.2	0.2	0.9	2.6	9.6	16.4	0.9	0.0	1.1	0.4	0.0	0.9	0.8	0.2	0.6	0.9	1.5	0.8	0.3	0.6	0.2	8.1	1.0	1.0	29.8	1.5	1.3	0.0	1.3	0.8	0.9	3.5	2.5	1.3	0.0	0.2	22.5	0.0	34.6	22.1	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	1.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	0.2	0.0	0.0	6.1	15.7	0.0	22.1	0.0	2.0	4.2	0.1	0.0	0.0	0.5	22.5	34.6	0.0	0.2	0.1	2.0	0.2	0.5	0.3	0.4	0.2	0.2	0.9	0.0	0.2	0.0
IL1B	"IL-1B, IL1-BETA, IL1F2"	ENSG00000125538	"Interleukin 1 beta"	P01584	2	112829751-112836903	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.3;lymphoid tissue: 35.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 92.5;HBEC3-KT: 42.0;HMC-1: 34.3;hTEC/SVTERT24-B: 46.3;U-87 MG: 84.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 34.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 34.4"	"Low region specificity"	"Detected in some"												"Secreted to blood"						"unprognostic (1.55e-3)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.57e-2)"	"prognostic unfavourable (7.49e-5)"	"unprognostic (1.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.01e-2)"	19.6	3.3	4.2	20.4	15.3	62.3	0.8	1.1	10.8	1.6	3.2	12.7	0.2	1.2	3.0	1.5	3.5	3.4	7.5	3.7	19.0	3.6	1.7	4.0	17.3	5.0	5.9	0.3	3.4	2.4	2.4	3.0	10.3	24.9	2.6	2.6	1.0	2.2	0.8	0.4	0.9	3.7	3.5	29.7	35.4	20.9	1.6	5.8	0.8	1.1	13.5	14.0	10.4	1.2	0.0	6.9	34.4	7.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	92.5	0.4	1.0	0.0	0.0	0.0	2.6	0.0	2.1	0.0	42.0	5.7	0.0	0.0	4.1	0.0	0.0	0.3	0.0	34.3	0.1	1.3	46.3	15.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	3.5	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	84.5	1.9	3.2	0.5	4.2	1.5	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	34.4	0.0	2.7	0.0	0.0	1.0	4.2	15.3	1.1	10.8	19.0	3.6	5.9	0.3	24.9	5.8
IL3	"IL-3, MCGF, MGC79398, MGC79399, MULTI-CSF"	ENSG00000164399	"Interleukin 3"	P08700	5	132060529-132063204	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 1.8;lymphoid tissue: 2.8"	"Cell line enriched"	"Detected in single"	16	"HMC-1: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"																				"unprognostic (9.74e-2)"			0.1	0.1	0.0	0.3	0.0	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.9	0.0	2.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
ING3	"Eaf4, FLJ20089, MEAF4, p47ING3"	ENSG00000071243	"Inhibitor of growth family member 3"	Q9NXR8	7	120950749-120977216	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004762, HPA067388, HPA067575"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA004762: , HPA067388: AB_2685831, HPA067575: "	"unprognostic (1.35e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.09e-3)"	"unprognostic (4.07e-2)"	"unprognostic (5.18e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.64e-2)"	9.6	9.1	7.4	8.8	9.9	57.7	9.6	21.5	13.8	9.0	9.6	5.5	11.1	7.3	11.1	9.7	8.0	9.7	7.7	7.6	7.3	7.3	8.8	8.4	12.3	11.9	7.6	12.2	11.9	12.1	7.9	17.7	13.0	11.1	9.5	10.6	6.7	10.0	11.5	7.7	6.1	12.9	11.4	8.8	16.4	10.4	8.6	9.6	19.0	12.6	10.4	11.2	8.3	8.4	15.8	15.0	32.7	19.5	18.5	16.9	9.8	9.2	2.7	12.5	7.0	4.7	3.8	4.2	6.3	5.0	9.2	10.7	3.6	10.7	14.9	2.9	5.5	4.5	12.0	4.9	10.5	10.4	21.0	10.8	10.4	2.0	6.5	20.8	12.9	2.7	2.6	8.0	5.7	14.3	24.1	24.2	8.7	3.2	17.0	12.5	15.0	5.1	8.4	8.9	12.4	9.2	9.5	11.3	12.2	6.5	13.5	6.7	3.0	8.2	5.0	9.3	3.5	20.0	11.4	11.1	7.1	22.5	4.7	14.0	7.7	22.3	19.1	16.5	13.9	19.5	13.4	14.4	14.1	12.6	15.0	15.8	14.4	13.1	32.7	18.5	19.1	11.2	16.9	9.8	7.4	9.9	21.5	13.8	7.3	7.3	7.6	12.2	11.1	9.6
IQGAP3		ENSG00000183856	"IQ motif containing GTPase activating protein 3"	Q86VI3	1	156525405-156572604	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.8;intestine: 13.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA030142, HPA030143"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA030142: AB_10600108, HPA030143: AB_10601104"	"unprognostic (9.99e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-3)"	"prognostic unfavourable (8.94e-6)"	"unprognostic (1.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.81e-2)"	3.2	1.2	0.3	5.4	0.3	14.8	0.6	0.3	0.8	1.4	10.1	0.4	1.3	7.0	1.1	3.7	9.8	0.3	1.8	1.8	0.4	0.2	1.5	1.1	2.6	1.4	0.3	0.3	0.5	0.4	0.0	0.3	6.5	0.8	0.8	5.5	0.4	1.8	0.3	0.5	3.8	13.0	2.9	1.5	1.5	5.1	6.8	0.3	12.2	0.4	3.1	7.3	0.9	3.1	0.2	0.9	0.5	0.3	0.6	2.6	0.0	23.5	11.3	10.7	7.5	0.6	1.7	5.2	17.5	11.7	17.2	15.4	13.0	21.7	2.1	6.5	10.2	22.4	7.2	9.0	15.4	0.0	6.5	3.1	22.4	6.4	0.1	3.8	0.0	0.5	1.0	14.4	21.2	9.9	6.3	3.4	12.5	12.3	2.2	5.5	7.7	11.4	7.5	12.0	2.4	4.3	8.0	6.7	10.5	15.9	18.7	6.4	14.9	10.3	6.5	15.6	18.6	12.7	20.5	1.6	0.8	1.0	5.2	6.1	17.6	0.5	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.6	0.1	0.1	0.1	0.2	0.6	0.3	0.9	2.6	0.0	0.3	0.3	0.3	0.8	0.4	0.2	0.3	0.3	0.8	0.3
IRAK2		ENSG00000134070	"Interleukin 1 receptor associated kinase 2"	O43187	3	10164865-10243743	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;BJ hTERT+: 18.4;CAPAN-2: 18.7;RT4: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013483, HPA050520"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"CAB013483: , HPA050520: AB_2681154"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavourable (8.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.91e-2)"	"prognostic favourable (6.60e-5)"	12.1	5.8	3.6	8.6	5.9	28.7	5.4	4.5	7.0	3.3	4.0	12.2	2.3	3.3	3.5	2.6	8.4	2.4	6.8	2.7	3.6	5.2	4.3	15.4	12.7	5.3	10.4	3.7	1.9	3.2	2.4	1.8	3.5	7.8	6.4	3.1	2.1	4.8	3.4	19.6	6.2	6.7	3.4	6.1	5.9	5.2	1.7	8.6	3.9	4.1	2.7	16.7	14.3	7.2	5.0	1.3	2.5	1.2	8.4	7.9	2.5	1.4	4.0	0.1	0.5	4.4	3.7	17.7	1.5	18.4	2.5	2.4	1.9	18.7	0.0	0.5	2.2	0.4	0.4	4.7	3.4	1.1	1.3	0.4	0.9	5.1	2.1	0.0	0.6	2.2	0.8	9.2	12.1	5.1	0.9	5.7	3.0	0.0	0.0	0.9	0.1	3.9	0.8	0.0	0.3	5.5	25.5	0.2	0.1	1.7	0.1	0.2	0.4	0.8	5.3	5.7	0.5	3.5	3.6	1.9	5.6	1.0	12.3	2.4	1.0	0.2	1.2	0.1	7.5	0.7	7.9	5.0	2.2	4.1	1.3	4.5	1.6	3.9	2.5	8.4	0.2	0.1	0.9	2.5	3.6	5.9	4.5	7.0	3.6	5.2	10.4	3.7	7.8	8.6
IRAK3	IRAK-M	ENSG00000090376	"Interleukin 1 receptor associated kinase 3"	Q9Y616	12	66188879-66254622	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.7;ASC TERT1: 12.2;HEL: 12.6;HL-60: 16.7;NB-4: 13.3;THP-1: 20.2;U-937: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 5.6;classical monocyte: 13.1;intermediate monocyte: 13.2;myeloid DC: 6.2;neutrophil: 7.2;non-classical monocyte: 20.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 6.2;granulocytes: 7.2;monocytes: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043097	Approved		Approved	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"HPA043097: AB_10795612"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavourable (6.23e-4)"	"unprognostic (5.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.23e-2)"	21.8	3.7	2.1	10.6	3.6	58.0	13.4	1.0	2.4	8.7	6.5	2.3	5.5	1.7	6.2	8.6	4.9	7.0	7.6	16.0	2.9	2.1	3.6	2.9	22.1	25.6	4.6	0.3	5.9	2.7	1.3	17.9	6.1	3.7	7.0	3.0	5.5	6.0	5.5	5.5	3.3	4.9	6.4	5.9	25.3	6.2	5.1	2.8	1.0	4.9	4.5	5.4	9.5	11.4	0.4	6.2	7.2	20.6	0.9	0.3	3.6	0.0	0.0	0.2	0.0	14.7	12.2	0.0	1.6	0.0	0.9	1.3	0.0	1.2	0.0	0.8	3.0	0.0	1.8	0.0	0.7	0.0	0.0	12.6	0.7	0.0	7.7	16.7	2.3	7.7	0.0	0.7	0.0	4.3	0.0	0.0	0.5	0.0	0.0	13.3	0.7	0.0	0.0	3.6	0.0	0.1	1.8	0.1	0.0	6.5	0.0	0.7	0.0	20.2	4.6	0.0	0.0	0.0	0.0	0.5	0.1	1.2	0.0	14.7	0.0	5.6	13.1	2.2	0.0	13.2	0.0	0.0	0.0	0.0	6.2	0.4	0.0	0.0	7.2	0.9	20.6	0.0	0.3	3.6	2.1	3.6	1.0	2.4	2.9	2.1	4.6	0.3	3.7	2.8
IRS2		ENSG00000185950	"Insulin receptor substrate 2"	Q9Y4H2	13	109752698-109786568	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 70.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 18.0;SH-SY5Y: 18.9;THP-1: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016944, HPA054664"	Approved		Supported	Aggresome,Cytosol				Cytosol	Cytosol	"CAB016944: , HPA054664: AB_2682563"	"unprognostic (2.87e-3)"	"unprognostic (5.73e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.24e-1)"	38.9	24.3	27.6	10.9	25.2	70.1	33.5	19.6	30.6	13.5	10.9	13.0	6.7	8.7	14.4	12.2	7.1	7.7	8.4	13.5	23.6	14.6	7.7	24.6	11.6	5.3	24.2	22.1	27.1	7.9	6.1	23.0	13.6	19.5	20.0	7.5	9.3	11.5	12.2	20.9	15.3	9.7	9.7	25.1	9.0	8.3	6.3	21.3	2.0	10.7	4.7	5.3	8.4	17.8	0.5	0.1	6.9	1.4	0.2	0.5	0.2	2.6	3.0	1.9	0.0	16.5	3.3	1.0	2.9	3.4	1.7	1.5	0.2	3.2	0.0	1.8	2.0	1.2	1.0	2.6	2.2	1.0	13.6	1.2	4.3	0.0	16.7	4.7	1.5	6.9	13.9	0.5	18.0	0.6	0.8	0.0	17.0	1.3	0.0	13.9	2.1	0.6	5.9	1.8	1.2	4.9	0.7	2.9	18.9	1.5	0.0	11.6	0.3	28.3	0.0	3.7	0.0	0.2	3.8	0.0	1.3	0.9	2.7	4.6	6.3	2.7	1.4	1.9	0.2	0.3	0.3	0.1	0.4	0.1	0.1	0.5	0.5	0.4	6.9	0.2	0.4	0.1	0.5	0.2	27.6	25.2	19.6	30.6	23.6	14.6	24.2	22.1	19.5	21.3
ITGAM	"CD11b, CR3A, MAC-1"	ENSG00000169896	"Integrin subunit alpha M"	P11215	16	31259990-31332892	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 93.7"	"Group enriched"	"Detected in some"	4	"HMC-1: 32.7;NB-4: 11.6;U-937: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 29.4;classical monocyte: 19.1;eosinophil: 23.8;gdTCR: 12.2;intermediate monocyte: 7.6;neutrophil: 21.0;NK-cell: 18.8"	"Low lineage specificity"	"Detected in all"											"HPA002274, CAB025091, CAB072870"	Enhanced					900000	900000			"CAB025091: , CAB072870: AB_2665722, HPA002274: AB_1078435"	"unprognostic (1.82e-2)"	"unprognostic (1.70e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (6.93e-5)"	"unprognostic (9.89e-2)"	"prognostic unfavourable (6.93e-4)"	"unprognostic (3.99e-2)"	"unprognostic (5.03e-2)"	19.7	5.0	6.0	14.0	7.2	93.7	6.0	2.0	4.5	2.9	3.2	9.4	0.5	1.8	2.5	3.5	2.2	4.8	4.0	6.5	4.3	3.9	3.0	3.3	14.6	22.8	10.5	1.6	2.5	2.9	1.6	1.8	4.9	5.3	3.6	2.7	3.3	3.2	2.0	1.6	1.5	4.4	6.9	8.6	29.9	2.8	1.5	7.4	2.3	2.1	1.7	6.6	4.9	4.5	1.9	3.4	29.4	19.1	18.8	12.2	8.0	0.5	1.1	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.3	0.4	0.8	0.5	0.0	0.1	0.0	0.2	0.0	4.7	0.0	0.6	0.0	0.0	0.0	1.1	32.7	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	11.6	0.0	0.0	0.1	0.0	0.6	0.0	1.3	0.0	0.0	0.0	0.3	0.2	0.1	2.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	14.0	0.0	29.4	19.1	23.8	12.2	7.6	0.7	1.9	1.3	3.6	3.4	0.3	0.3	3.0	21.0	18.8	1.1	0.2	0.5	8.0	6.0	7.2	2.0	4.5	4.3	3.9	10.5	1.6	5.3	7.4
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 159.7;bone marrow: 91.4;lymphoid tissue: 75.6"	"Group enriched"	"Detected in some"	5	"THP-1: 114.8;U-937: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"		2500000	2500000	"Plasma membrane"	"Plasma membrane"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	59.1	9.8	9.0	47.5	16.8	91.4	8.4	1.7	8.0	5.6	7.4	12.2	1.2	6.3	4.9	9.0	4.8	10.7	10.3	9.7	7.2	6.4	8.1	7.0	32.9	73.8	14.3	2.9	6.6	5.1	1.1	3.3	12.7	12.1	6.9	4.2	5.2	8.8	2.7	3.0	4.1	13.2	12.3	18.3	75.6	7.6	4.2	12.2	53.5	4.5	2.2	29.0	15.7	4.2	9.5	76.0	104.6	122.9	41.0	57.4	159.7	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	2.4	19.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.3	0.0	0.4	0.0	15.0	3.9	0.2	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.5	17.0	18.0	0.0	0.3	0.2	3.5	9.3	0.7	0.0	0.0	0.2	0.5	0.3	0.3	0.0	114.8	0.3	0.0	1.0	0.0	0.5	0.1	0.8	0.4	0.0	85.3	0.1	10.5	122.9	85.7	57.4	84.1	25.8	6.7	28.4	39.5	76.0	9.5	19.1	32.0	104.6	41.0	81.0	11.6	20.7	159.7	9.0	16.8	1.7	8.0	7.2	6.4	14.3	2.9	12.1	12.2
ITPRIP	"bA127L20.2, DANGER, KIAA1754"	ENSG00000148841	"Inositol 1,4,5-trisphosphate receptor interacting protein"	Q8IWB1	10	104309698-104338404	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 81.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 24.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 24.1"					"Low region specificity"	"Detected in all"			HPA043626			Uncertain	Vesicles				Vesicles	Vesicles	"HPA043626: "	"unprognostic (2.45e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.20e-1)"	"unprognostic (7.87e-2)"	"prognostic unfavourable (3.59e-4)"	"unprognostic (9.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.11e-3)"	23.7	5.8	3.5	7.4	3.8	81.5	20.8	0.5	4.3	13.5	5.5	4.5	6.8	1.6	8.5	6.0	29.5	5.6	9.8	33.8	3.0	1.5	6.9	7.2	20.2	9.8	4.4	1.5	19.9	4.4	4.4	7.3	24.4	4.7	8.6	2.5	21.7	6.7	7.3	7.6	26.4	3.8	8.4	3.4	8.8	5.6	8.4	5.2	12.9	14.0	14.6	14.2	13.6	17.3	2.4	4.4	24.1	5.7	3.2	3.4	9.7	2.3	5.8	7.0	3.1	12.3	11.9	4.0	13.0	27.6	9.5	11.9	0.4	1.0	4.1	2.9	8.0	7.6	2.3	6.3	9.9	3.5	2.9	2.4	9.2	1.7	24.3	5.4	4.6	11.0	38.2	19.8	15.9	17.7	10.2	7.8	11.6	0.9	1.1	6.0	5.2	6.8	5.1	3.7	2.4	3.9	1.0	4.0	2.6	2.4	2.8	5.7	0.2	4.1	30.6	19.3	5.1	12.7	12.3	3.0	3.5	2.7	14.1	9.9	9.0	3.5	5.7	9.9	3.4	4.1	3.3	1.9	1.9	1.9	4.4	2.4	2.3	2.0	24.1	3.2	3.7	3.1	1.5	9.7	3.5	3.8	0.5	4.3	3.0	1.5	4.4	1.5	4.7	5.2
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246296-15522040	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 40.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	10.2	5.3	6.9	11.5	8.8	53.3	7.2	40.6	9.3	6.3	8.3	11.4	9.4	6.9	8.8	8.4	15.4	5.0	7.9	5.9	6.8	7.1	4.6	4.4	8.2	12.8	6.8	3.8	7.2	4.4	6.1	8.2	8.4	8.4	5.5	5.9	15.1	10.7	11.9	12.5	14.9	12.5	5.3	6.6	14.2	8.2	17.5	6.5	41.3	5.0	8.9	19.2	6.5	7.7	4.2	4.6	14.4	4.0	4.9	3.9	2.0	6.2	4.3	17.9	10.3	2.2	2.2	17.7	1.8	4.3	2.3	3.0	4.5	4.9	3.3	6.5	3.6	3.2	4.1	10.4	2.2	6.4	6.4	11.7	5.1	5.8	2.4	11.8	13.8	3.1	6.6	3.5	14.0	2.5	15.2	5.6	1.4	6.2	23.5	22.3	19.1	2.0	10.5	5.4	9.3	2.2	6.6	13.8	7.9	3.7	13.0	16.3	4.5	12.8	4.3	11.0	6.1	6.0	6.2	3.6	8.6	5.9	3.7	11.1	13.8	9.6	4.0	3.2	3.9	2.6	3.3	2.6	1.9	2.3	3.3	4.2	2.4	3.3	14.4	4.9	2.7	4.6	1.5	2.0	6.9	8.8	40.6	7.9	6.8	7.1	6.8	3.8	8.4	6.5
JMJD6	"KIAA0585, PTDSR, PTDSR1"	ENSG00000070495	"Arginine demethylase and lysine hydroxylase"	Q6NYC1	17	76712832-76726799	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004548, HPA059156"	Supported		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB004548: AB_628185, HPA059156: AB_2683934"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.06e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.14e-3)"	"prognostic unfavourable (5.75e-6)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-2)"	"prognostic favourable (5.71e-4)"	"unprognostic (5.66e-2)"	"prognostic unfavourable (7.59e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.86e-2)"	"unprognostic (3.82e-1)"	14.9	15.9	10.7	12.6	14.9	80.6	14.3	20.5	18.7	9.9	17.5	8.5	10.5	11.7	12.2	6.6	12.2	11.5	14.7	26.0	11.9	7.3	9.7	11.1	14.6	11.0	17.8	7.8	16.7	13.7	10.6	13.3	12.3	16.9	11.9	8.6	8.3	9.7	10.2	19.6	8.6	10.5	13.7	13.8	12.7	14.7	11.2	18.6	5.4	11.0	8.6	10.0	16.1	57.5	13.4	17.3	25.2	24.8	8.6	20.4	12.8	16.7	23.0	8.1	10.6	10.5	9.1	7.9	15.4	11.9	22.4	21.9	23.3	8.4	10.9	6.8	16.6	12.8	25.6	7.6	21.7	7.9	20.4	16.3	16.2	23.5	16.9	8.5	25.0	10.8	12.0	24.6	8.4	18.6	24.2	20.5	16.6	10.4	14.7	12.2	7.1	27.9	11.6	15.3	16.9	7.6	5.2	14.1	13.9	13.4	19.8	18.4	17.8	12.7	12.0	26.2	15.4	13.5	28.5	22.7	12.1	10.1	25.3	7.5	14.5	25.1	19.4	25.2	17.6	24.8	17.0	13.4	20.4	19.5	17.3	9.2	17.0	15.8	15.4	8.6	23.7	14.9	19.5	12.8	10.7	14.9	20.5	18.7	11.9	7.3	17.8	7.8	16.9	18.6
JUND	AP-1	ENSG00000130522	"JunD proto-oncogene, AP-1 transcription factor subunit"	P17535	19	18279760-18281622	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 204.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005268, HPA063029"	Supported		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB005268: AB_2130177, HPA063029: AB_2684925"	"prognostic favourable (6.15e-5)"	"unprognostic (4.18e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.99e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.49e-1)"	75.7	52.7	35.4	38.9	32.4	204.7	51.5	34.7	56.5	42.4	49.5	42.6	21.1	35.7	43.4	31.0	31.7	55.7	43.5	35.9	31.5	32.1	26.9	66.5	55.7	17.2	21.6	22.6	78.1	64.3	21.7	47.8	80.3	27.0	45.5	21.0	35.2	39.0	33.3	29.2	44.5	61.8	34.4	31.5	39.3	46.2	34.9	19.2	32.0	27.2	33.7	23.1	41.7	30.8	8.6	10.7	19.0	7.8	4.5	6.3	1.7	22.0	9.3	9.3	10.5	7.4	8.3	41.2	9.2	11.1	5.2	7.1	10.1	19.9	11.4	10.9	9.4	12.0	2.2	2.1	2.7	22.6	20.2	16.8	7.6	21.8	16.5	7.8	22.0	8.0	9.4	5.6	7.3	4.2	22.9	33.3	1.4	29.3	23.1	24.5	19.3	13.4	8.5	5.8	23.9	7.6	3.4	50.7	20.8	11.4	12.6	30.0	10.5	11.8	14.4	3.2	15.2	20.3	5.6	46.6	18.5	9.2	11.3	11.9	7.4	8.0	6.4	5.8	4.9	7.8	3.8	7.4	6.3	4.4	4.6	8.6	4.7	4.9	19.0	4.5	7.4	10.7	5.1	1.7	35.4	32.4	34.7	56.5	31.5	32.1	21.6	22.6	27.0	19.2
KCNAB2	"AKR6A5, HKvbeta2.1, HKvbeta2.2, KCNA2B"	ENSG00000069424	"Potassium voltage-gated channel subfamily A regulatory beta subunit 2"	Q13303	1	5991466-6101193	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 57.5;brain: 54.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 67.1;U-937: 71.5"	"Cancer enriched"	"Detected in all"	7	"melanoma: 29.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001975	Enhanced									"CAB001975: "	"unprognostic (6.60e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.71e-3)"	"unprognostic (8.83e-3)"	"prognostic unfavourable (3.50e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.24e-2)"	6.9	4.8	37.8	21.5	34.7	57.5	2.7	13.5	54.3	2.7	4.2	4.2	0.5	3.7	3.4	2.1	4.1	6.2	8.1	8.1	44.6	13.1	10.9	3.8	13.9	31.2	16.1	24.7	3.2	2.2	1.3	6.1	4.5	28.7	2.7	4.1	10.8	3.1	2.5	4.0	9.0	7.4	5.0	5.8	21.9	5.3	3.1	4.7	13.9	2.4	0.5	17.0	9.0	1.7	6.8	19.6	11.4	21.1	9.2	19.8	22.8	2.5	7.0	0.6	0.8	0.3	1.2	2.3	1.3	8.5	1.4	1.7	2.5	1.1	14.9	4.3	0.9	0.9	0.5	0.1	0.8	17.3	2.3	18.2	7.0	4.2	1.3	67.1	0.5	1.3	0.3	0.9	1.7	1.1	0.5	28.2	0.7	2.2	12.9	28.9	0.4	3.1	2.6	2.1	17.6	0.2	0.0	4.3	1.5	1.0	1.2	22.1	1.0	25.9	0.2	0.3	2.5	2.5	1.4	21.4	25.0	21.1	2.6	71.5	0.5	2.1	21.1	11.4	19.8	17.6	18.7	6.0	13.0	19.1	19.6	6.8	13.8	14.5	9.0	9.2	15.4	8.1	13.6	22.8	37.8	34.7	13.5	54.3	44.6	13.1	16.1	24.7	28.7	4.7
KCNH2	"erg1, HERG, Kv11.1, LQT2"	ENSG00000055118	"Potassium voltage-gated channel subfamily H member 2"	Q12809	7	150944961-150978315	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9"	"Group enriched"	"Detected in some"	7	"K-562: 58.4;NB-4: 29.1;SH-SY5Y: 24.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (6.06e-5)"	"unprognostic (9.79e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.52e-1)"	"prognostic favourable (5.61e-4)"	"unprognostic (6.08e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.02e-2)"	1.1	4.9	5.0	3.2	8.3	37.9	0.7	19.3	8.0	4.3	17.3	2.8	3.1	3.5	9.3	4.6	3.4	4.1	28.5	24.9	4.8	9.3	0.8	0.7	1.7	0.9	4.7	3.9	6.6	5.1	10.5	23.8	2.2	14.1	6.8	1.8	8.0	1.8	10.2	0.8	0.7	6.9	9.4	2.2	1.6	6.8	18.0	1.6	0.1	0.7	0.0	0.7	7.5	2.4	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.9	0.0	0.0	1.1	0.0	0.0	0.2	0.1	5.5	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	0.3	0.5	29.1	0.4	0.0	0.0	0.0	3.0	0.0	0.0	1.2	24.5	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.4	0.0	0.0	1.7	0.0	0.6	0.0	3.6	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	8.3	19.3	8.0	4.8	9.3	4.7	3.9	14.1	1.6
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023700	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3;brain: 20.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 16.4;HMC-1: 17.5;Karpas-707: 20.7;RPMI-8226: 17.6;U-266/70: 37.8;U-266/84: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	2.2	1.6	19.8	10.0	12.9	34.3	1.5	3.7	20.4	1.5	2.8	6.0	1.0	2.7	1.4	1.0	1.5	1.4	2.9	1.5	15.1	12.5	1.4	1.7	4.3	15.7	8.3	12.7	1.4	1.5	11.3	0.9	1.6	7.1	1.2	2.6	8.6	2.1	1.7	0.9	1.3	6.1	1.5	4.3	11.5	3.2	11.1	4.9	10.8	1.2	0.0	9.1	3.7	1.1	0.9	0.2	8.0	0.5	2.4	1.7	0.6	0.5	0.6	4.9	0.2	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.1	16.4	0.2	0.0	0.1	0.5	0.1	0.1	0.8	0.1	3.9	0.1	0.1	0.4	12.0	17.5	0.4	1.7	0.1	0.3	0.6	1.8	20.7	0.0	0.0	9.5	4.3	2.1	0.0	3.3	0.0	17.6	0.1	0.0	3.4	0.4	0.2	0.2	0.2	0.0	3.6	1.1	0.0	1.5	0.0	0.1	37.8	17.5	8.2	1.7	5.2	0.1	8.0	0.1	1.0	1.6	0.4	1.7	0.9	1.2	1.7	0.1	0.7	1.0	1.1	2.0	2.4	0.5	0.2	1.0	0.6	19.8	12.9	3.7	20.0	15.1	12.5	8.3	12.7	7.1	4.9
KIF4A	"FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100"	ENSG00000090889	"Kinesin family member 4A"	O95239	X	70290090-70420832	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.1;lymphoid tissue: 19.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"									"HPA034745, HPA034746, HPA061583"	Approved		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"	"Nucleoplasm, Midbody"	"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (8.17e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (7.37e-6)"	"unprognostic (2.18e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (9.44e-6)"	"unprognostic (3.79e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	0.9	0.6	0.8	3.3	1.0	11.1	0.5	0.4	3.4	1.2	4.1	0.4	0.4	3.4	0.8	0.4	7.4	1.5	2.5	2.0	0.8	1.3	0.7	0.7	1.5	5.8	0.5	0.9	0.4	0.4	0.0	1.3	2.4	0.8	0.7	5.2	0.4	1.2	0.4	0.8	2.3	3.6	1.2	0.5	4.9	2.1	7.5	1.1	19.3	0.4	0.4	7.2	1.1	2.0	0.7	0.0	0.0	0.2	0.2	3.2	0.3	22.4	15.7	23.8	11.7	1.1	2.0	9.4	17.1	9.2	23.4	20.4	17.6	13.2	13.8	10.8	8.4	13.5	25.7	9.3	26.4	15.8	12.9	15.6	19.2	12.5	0.2	17.3	10.9	0.6	0.5	19.4	11.1	14.3	19.8	30.8	22.0	14.4	15.8	8.6	24.0	16.7	17.6	32.1	13.0	5.6	8.9	15.7	13.1	27.9	11.8	7.3	9.5	6.8	9.9	15.5	20.2	16.6	20.3	8.9	15.2	20.0	8.2	19.1	23.3	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	3.2	0.3	0.8	1.0	0.4	3.4	0.8	1.3	0.5	0.9	0.8	1.1
KIR3DL1	"AMB11, CD158E1, CD158e1/2, CD158e2, cl-11, cl-2, KIR, nkat3, NKB1, NKB1B"	ENSG00000167633	"Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1"	P43629	19	54816468-54830778	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 5.4;bone marrow: 2.0;lymphoid tissue: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	4	"gdTCR: 5.4"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.4"																				"unprognostic (3.18e-1)"	"unprognostic (8.01e-2)"		"unprognostic (3.53e-2)"	"unprognostic (4.85e-1)"	"unprognostic (5.18e-3)"	"unprognostic (6.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.28e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.19e-2)"	0.1	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0			0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.1	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.0			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	5.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.5										
KLF1	EKLF	ENSG00000105610	"Kruppel like factor 1"	Q13351	19	12884422-12887199	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 30.6;lymphoid tissue: 7.0;placenta: 9.0"	"Group enriched"	"Detected in some"	28	"HEL: 22.6;K-562: 54.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.7;intermediate monocyte: 4.7;non-classical monocyte: 2.9"	"Lineage enriched"	"Detected in single"	8	"monocytes: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051850	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA051850: AB_2616460"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.13e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.44e-1)"	0.0	0.0	0.5	0.0	0.3	30.6	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	1.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.2	9.0	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	7.0	0.0	0.1	0.0	0.0	0.8	1.2	0.0	0.6	0.0	0.3	0.5	0.5	4.7	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	22.6	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.3	0.0	0.0	1.7	0.0	0.2	4.7	0.0	0.3	0.0	0.1	0.5	0.1	0.1	0.2	0.5	0.0	2.9	0.0	0.0	1.6	0.5	0.3	0.1	0.4	0.2	0.1	0.2	0.0	0.3	0.0
KLHL15	KIAA1677	ENSG00000174010	"Kelch like family member 15"	Q96M94	X	23983720-24027186	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 25.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065730	Uncertain		Approved	Aggresome,Cytosol				Cytosol	Cytosol	"HPA065730: AB_2685547"	"unprognostic (5.89e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.13e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.37e-3)"	"unprognostic (7.42e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.40e-2)"	2.9	6.1	1.7	1.3	2.3	25.1	1.3	2.8	1.8	1.9	2.0			1.0	2.3	4.0	4.3	3.8	1.9	2.1	1.6	1.9	2.2	6.4	1.6	1.4	1.3		4.6	2.9	4.3	2.6	1.2		2.8	1.2		1.3	1.8	2.6	1.0	1.5	2.2	1.6	1.5	3.4	9.0			2.3		1.2	1.3	1.1	1.4	2.1	2.8	2.6	1.6	2.8	1.3	4.2	4.1	4.6	6.8	6.9	4.9	4.8	6.9	6.0	3.2	3.9	3.7	3.8	11.2	2.5	4.4	3.2	7.3	3.7	7.8	4.3	15.0	7.1	11.1	2.0	4.3	9.2	5.0	5.1	1.9	5.4	5.4	2.3	4.5	15.8	5.9	1.5	8.3	9.0	8.7	5.1	6.6	8.4	6.9	2.9	3.8	12.2	5.7	9.6	2.3	7.9	3.2	8.3	2.9	4.9	3.0	9.7	4.4	8.8	8.8	12.9	3.9	6.0	3.8	1.5	1.1	2.8	2.0	2.6	2.8	1.0	1.8	2.3	2.1	1.4	2.4	2.4	1.5	1.6	2.6	1.7	1.8	1.3										
KRTAP19-8		ENSG00000206102	"Keratin associated protein 19-8"	Q3LI54	21	31038159-31038476	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 1.4;skin 1: 1.4;testis: 2.7"	"Group enriched"	"Detected in some"	23	"NTERA-2: 1.7;U-937: 2.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																				"unprognostic (1.94e-1)"			0.0	0.0	0.1	0.0	0.0	1.4	0.4	0.1	0.0	0.8	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.2	0.0		0.0	0.0		0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.7			0.0		0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LAPTM5		ENSG00000162511	"Lysosomal protein transmembrane 5"	Q13571	1	30732469-30757820	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 166.6;bone marrow: 157.5;lymphoid tissue: 144.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 46.0;HEL: 87.3;HL-60: 55.3;HMC-1: 206.8;REH: 64.8;U-698: 75.1;U-937: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051293	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA051293: AB_2681424"	"unprognostic (3.12e-2)"	"prognostic favourable (3.40e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (5.89e-5)"	"unprognostic (9.47e-2)"	"unprognostic (8.18e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.94e-2)"	56.0	15.5	11.5	59.1	17.8	157.5	15.0	2.2	10.4	8.2	11.2	20.7	1.8	9.5	7.5	6.8	8.3	13.7	19.9	9.2	11.2	12.7	14.0	18.2	60.8	144.5	19.0	3.3	7.7	6.3	2.0	6.8	20.1	14.6	8.2	13.2	7.4	11.7	4.7	4.0	5.5	37.1	12.9	33.8	130.9	9.5	6.7	15.8	75.2	10.1	5.2	91.2	21.4	6.4	98.2	69.1	145.1	109.3	26.0	55.4	166.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	46.0	4.8	0.1	0.1	0.0	0.0	0.0	5.1	0.0	87.3	0.0	0.1	0.0	55.3	206.8	0.0	0.1	0.0	0.3	10.5	1.1	2.9	0.7	0.0	9.5	11.6	0.0	0.0	64.8	8.6	32.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	35.2	12.2	0.0	0.2	0.0	0.2	0.2	0.0	75.1	0.2	45.2	0.1	73.5	109.3	115.3	47.7	87.9	55.4	70.2	43.7	44.6	69.1	98.2	44.2	43.1	145.1	26.0	83.9	33.2	53.7	166.6	11.5	17.8	2.2	10.1	11.2	12.7	19.0	3.3	14.6	15.8
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153455	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 199.7;gallbladder: 173.3;lymphoid tissue: 178.1;salivary gland: 168.7"	"Group enriched"	"Detected in some"	11	"CAPAN-2: 271.0;EFO-21: 111.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"basophil: 5.4;neutrophil: 11.4;non-classical monocyte: 4.5"	"Group enriched"	"Detected in many"	72	"granulocytes: 11.4;monocytes: 4.5"									"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	870000000	870000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favourable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	0.3	0.5	0.2	24.6	0.3	199.7	2.7	0.2	0.5	78.7	19.4	1.0	0.5	2.4	7.9	9.1	77.0	4.0	173.3	20.4	0.2	0.2	12.7	12.8	32.6	0.2	0.2	0.1	6.7	17.4	0.0	5.4	7.1	0.8	17.0	10.5	1.0	168.7	0.9	1.0	3.1	17.0	0.7	0.2	8.1	35.1	5.8	0.1	5.0	3.8	142.0	178.1	68.9	48.5	0.0	0.0	11.4	4.5	0.0	0.1	9.6	8.5	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	271.0	0.0	111.0	0.0	17.7	0.0	0.5	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	4.9	0.0	0.6	0.1	0.0	0.2	1.2	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	4.5	0.0	0.0	9.6	0.2	0.3	0.2	0.5	0.2	0.2	0.2	0.1	0.8	0.1
LCP2	"SLP-76, SLP76"	ENSG00000043462	"Lymphocyte cytosolic protein 2"	Q13094	5	170246237-170298227	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.1;lymphoid tissue: 95.2"	"Cell line enhanced"	"Detected in some"		"HEL: 33.6;HL-60: 34.5;HMC-1: 89.1;Karpas-707: 19.1;MOLT-4: 20.7;THP-1: 18.4;U-937: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004574, HPA036396, HPA036397"	Enhanced					3600000	3600000			"CAB004574: AB_628259, HPA036396: AB_10671840, HPA036397: AB_10670436"	"unprognostic (1.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.52e-3)"	"prognostic favourable (5.08e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.10e-1)"	"prognostic unfavourable (6.22e-5)"	"unprognostic (1.87e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.07e-1)"	18.9	5.8	4.6	26.6	5.8	51.1	6.8	1.2	6.3	5.4	7.5	5.2	0.7	5.7	4.2	5.0	3.6	5.4	10.8	4.3	3.7	3.6	5.4	9.4	22.0	25.3	8.4	1.7	3.6	3.0	0.9	3.3	8.0	5.6	7.3	6.1	4.6	5.3	2.3	2.7	4.0	14.3	5.9	7.9	46.8	6.1	4.0	6.7	95.2	4.6	2.4	25.8	9.7	4.3	1.3	11.3	31.1	26.1	18.0	18.4	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	33.6	0.0	0.0	0.0	34.5	89.1	0.0	0.0	0.0	0.0	0.0	0.2	19.1	0.0	0.0	20.7	11.8	0.1	0.0	3.2	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.3	3.1	0.0	0.0	22.7	0.4	23.2	8.6	31.1	18.3	18.4	18.4	1.3	15.0	17.5	11.3	0.4	14.2	14.5	30.6	18.0	26.1	2.3	16.8	8.7	4.6	5.8	1.2	6.3	3.7	3.6	8.4	1.7	5.6	6.7
LILRB2	"CD85d, ILT4, LIR-2, LIR2, MIR-10, MIR10"	ENSG00000131042	"Leukocyte immunoglobulin like receptor B2"	Q8N423	19	54273821-54281184	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 37.9;bone marrow: 30.3;lymphoid tissue: 31.9"	"Cell line enhanced"	"Detected in single"		"THP-1: 1.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.9;intermediate monocyte: 33.8;neutrophil: 16.7;non-classical monocyte: 37.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 16.7;monocytes: 37.9"															52000000	52000000				"unprognostic (1.23e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (5.45e-7)"	"unprognostic (1.90e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.72e-1)"	"unprognostic (9.73e-2)"	3.2	1.4	0.4	6.8	0.6	30.3	1.0	0.3	1.9	0.5	1.1	0.6	0.4	3.3	0.6	0.9	0.5	2.3	6.6	1.5	1.6	0.4	1.5	3.6	18.4	4.9	2.6	0.0	0.4	0.7	0.2	0.7	0.7	1.8	0.9	1.0	1.1	7.4	2.6	0.5	0.4	1.5	0.6	3.4	31.9	1.0	0.3	0.8	0.8	0.6	5.0	0.7	0.6	1.9	0.0	5.3	16.7	37.9	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	15.9	4.2	0.0	33.8	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	16.7	0.0	37.9	2.2	0.1	8.1	0.4	0.6	0.3	1.9	1.6	0.4	2.6	0.0	1.8	0.8
LILRB3	"CD85a, HL9, ILT5, LIR-3, LIR3, PIR-B, PIRB"	ENSG00000204577	"Leukocyte immunoglobulin like receptor B3"	O75022	19	54216278-54223506	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.4;bone marrow: 15.3;lymphoid tissue: 23.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.8;HEK 293: 2.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 24.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 24.4;monocytes: 9.4"																				"unprognostic (7.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.83e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.92e-8)"	"unprognostic (2.18e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-1)"	5.1	0.8	0.4	8.9	1.0	15.3	0.8	0.4	0.5	0.7	1.6	0.0	0.2	0.2	0.6	2.5	0.7	1.3	1.1	7.8	1.5	0.6	0.7	1.5	10.9	19.7	0.5	0.0	3.0	1.7	0.0	0.5	2.0	0.6	0.9	0.0	1.0	0.8	0.0	1.7	0.6	0.9	0.9	2.2	23.4	0.8	0.7	0.0	0.3	1.5	0.0	0.1	6.4	1.1	0.1	4.0	24.4	9.4	0.0	0.1	4.5	1.5	0.6	0.4	0.8	0.0	0.0	0.5	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.4	2.5	1.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	1.1	0.5	0.6	0.2	0.0	0.0	0.9	1.6	0.0	0.0	0.6	0.1	1.5	0.0	0.0	0.7	0.8	0.0	0.0	0.5	0.3	0.0	0.3	0.9	0.0	0.4	9.4	0.3	0.0	7.5	0.1	0.1	0.1	0.0	4.0	0.1	0.0	0.0	24.4	0.0	3.3	0.4	0.0	4.5	0.4	1.0	0.4	0.5	1.5	0.6	0.5	0.0	0.6	0.0
LTF	HLF2	ENSG00000012223	Lactotransferrin	P02788	3	46435645-46485234	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 277.8;salivary gland: 181.9;seminal vesicle: 177.1"	"Group enriched"	"Detected in some"	10	"RPMI-8226: 29.1;TIME: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	27	"neutrophil: 4.0;non-classical monocyte: 13.5"	"Group enriched"	"Detected in many"	27	"granulocytes: 4.0;monocytes: 13.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB008646, CAB016201, HPA057177, HPA059976"	Enhanced				"Secreted in other tissues"	600000000	600000000			"CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185"	"unprognostic (7.24e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.45e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.04e-1)"	"prognostic favourable (6.30e-5)"	"unprognostic (1.66e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.09e-3)"	1.0	0.3	0.4	8.8	0.5	277.8	23.0	0.3	0.3	53.1	0.3	3.2	108.0	0.0	0.7	39.3	3.8	0.9	2.2	2.5	0.6	0.6	20.8	0.6	10.8	1.3	0.6	0.0	0.3	2.7	0.0	1.2	0.8	1.5	13.0	0.0	0.2	181.9	177.1	0.4	1.2	0.9	0.1	0.7	9.1	22.6	2.8	0.1	4.0	1.6	13.4	30.7	2.3	1.0	0.0	0.3	4.0	13.5	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.1	0.0	0.0	1.4	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.5	29.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.2	0.8	0.1	0.4	0.0	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	13.5	0.3	0.0	14.7	0.4	0.5	0.3	0.3	0.6	0.6	0.6	0.0	1.5	0.1
LY6G6E	"C6orf22, G6e"	ENSG00000255552	"Lymphocyte antigen 6 family member G6E"		6	31711771-31714065	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 4.3;brain: 5.2;lung: 3.9;skin 1: 4.0"	"Cell line enriched"	"Detected in single"	111	"HEL: 22.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 2.9;cerebral cortex: 5.2;hippocampal formation: 1.7"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA056234			Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA056234: AB_2732601"			"unprognostic (1.77e-1)"							"unprognostic (1.58e-2)"				"unprognostic (2.25e-1)"		"unprognostic (6.88e-2)"		0.3	0.0	2.9	0.0	0.5	4.3	0.0	0.0	5.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.3	0.2	1.7	0.1	0.0	0.3	3.9	0.0	0.0	0.0	0.6	0.0	0.2	0.2	0.6	0.7	0.2	0.0	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.6	2.2	0.0	0.1	0.2	0.4	0.4	0.8	1.1	0.4	0.1	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.6	0.2	0.4	0.4	0.4	0.7	0.4	0.0	0.2	0.3	0.4	1.1	0.1	0.3	0.8	0.7	1.0	2.9	0.5	0.0	5.2	1.7	0.1	0.0	0.0	0.7	0.0
LY6G6F	"C6orf21, G6f, LY6G6D, NG32"	ENSG00000204424	"Lymphocyte antigen 6 family member G6F"	Q5SQ64	6	31706885-31710595	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.0;bone marrow: 4.0;lung: 3.3;lymphoid tissue: 4.3"	"Cell line enriched"	"Detected in single"	138	"HEL: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"									HPA008053	Uncertain					12000000	12000000			"HPA008053: AB_1840160"			"unprognostic (3.77e-1)"							"unprognostic (7.01e-2)"						"unprognostic (2.66e-3)"		0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	1.1	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	4.3	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
LYL1	bHLHa18	ENSG00000104903	"LYL1, basic helix-loop-helix family member"	P12980	19	13099033-13103161	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.4;lymphoid tissue: 25.4"	"Cell line enhanced"	"Detected in some"		"HEL: 32.3;HL-60: 22.6;HMC-1: 54.5;K-562: 25.3;NB-4: 33.1;REH: 24.3;THP-1: 21.9;U-937: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA075004			Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA075004: AB_2686728"	"unprognostic (8.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.76e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (3.89e-4)"	"unprognostic (1.18e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.28e-1)"	6.3	3.0	3.4	19.9	5.8	37.4	8.0	1.1	3.8	4.0	3.7	5.5	1.3	3.0	5.3	3.9	5.9	3.8	3.5	4.9	4.5	2.9	3.9	2.0	8.1	24.0	7.1	1.6	3.2	1.6	0.8	1.7	8.0	5.1	6.2	1.4	4.4	6.4	2.4	3.5	2.0	8.8	3.3	6.0	25.4	4.2	11.9	4.1	3.6	3.5	1.4	18.9	3.3	7.0	4.6	1.4	8.8	3.6	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	6.3	2.2	0.0	0.0	0.1	0.0	0.0	3.7	0.0	32.3	0.0	0.3	0.3	22.6	54.5	0.1	0.0	0.0	0.0	8.3	25.3	1.1	0.0	0.0	0.1	33.1	0.0	0.8	24.3	0.0	2.7	0.0	0.0	0.0	2.4	0.7	0.0	1.5	0.0	21.9	13.3	0.0	0.0	0.9	0.0	0.0	0.0	5.1	0.0	21.8	0.0	2.5	2.3	8.8	0.1	2.9	0.2	2.8	0.3	0.2	1.4	4.6	0.2	0.2	3.6	0.0	3.6	0.4	0.5	0.6	3.4	5.8	1.1	3.7	4.5	2.9	7.1	1.6	5.1	4.1
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	"Mitogen-activated protein kinase kinase kinase 8"	P41279	10	30433937-30461833	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 104.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005120, HPA017962"	Supported		Supported	Cytosol				Cytosol	Cytosol	"CAB005120: AB_2140669, HPA017962: AB_1853776"	"unprognostic (1.91e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.04e-3)"	"unprognostic (8.23e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (8.76e-7)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.98e-3)"	28.0	7.6	3.6	15.6	4.1	104.6	26.1	1.5	2.6	8.2	8.4	2.7	11.3	3.4	11.5	16.5	13.8	19.5	15.3	20.1	4.3	2.9	6.3	7.6	29.0	33.7	4.3	2.0	9.8	3.6	2.8	4.1	27.5	8.3	7.9	6.8	9.4	6.1	18.4	8.6	15.3	9.6	23.4	9.7	25.6	10.7	6.7	3.6	2.4	7.0	13.2	17.2	13.2	15.6	19.6	13.8	23.7	16.8	12.4	7.8	4.0	7.9	7.1	1.9	4.1	10.3	8.7	9.1	2.0	11.9	4.4	5.3	4.9	18.5	5.2	5.1	4.2	14.9	4.5	1.9	1.6	12.0	2.3	9.7	12.1	15.7	8.7	3.0	24.0	10.8	1.1	4.4	0.8	1.9	4.3	7.8	0.7	4.5	0.1	11.6	0.7	2.5	0.6	1.6	3.0	4.4	16.1	0.2	0.8	7.1	6.1	0.9	2.0	6.4	0.1	2.7	2.3	9.7	0.3	11.9	11.1	1.5	3.9	13.2	0.1	17.9	7.0	23.7	7.8	12.0	4.3	9.6	1.7	4.9	6.6	19.6	0.1	3.0	16.7	12.4	16.8	13.8	0.4	4.0	3.6	4.1	1.5	2.6	4.3	2.9	4.3	2.0	8.3	3.6
MATK	"CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101"	ENSG00000007264	"Megakaryocyte-associated tyrosine kinase"	P42679	19	3777970-3802129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.3;bone marrow: 19.1;brain: 27.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 40.7;HMC-1: 12.5;K-562: 18.1;MCF7: 13.2;NB-4: 28.4;SCLC-21H: 12.4;THP-1: 10.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdTCR: 19.4;NK-cell: 29.3"	"Group enriched"	"Detected in many"	54	"NK-cells: 29.3;T-cells: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004847, HPA066547"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol"				Microtubules	Microtubules	"HPA004847: AB_1079316, HPA066547: "	"prognostic favourable (5.27e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-2)"	11.2	1.6	22.1	6.8	18.1	19.1	2.2	1.5	27.4	1.5	2.3	1.7	0.0	7.0	1.2	0.4	1.1	4.7	5.1	1.7	25.1	10.0	1.1	2.8	7.3	9.6	7.0	11.0	1.0	1.6	0.1	1.4	1.4	6.1	1.2	1.4	0.6	3.8	1.0	0.8	1.6	6.7	1.1	2.8	14.8	4.1	2.1	1.3	3.5	0.9	0.0	4.5	2.4	0.7	0.4	0.3	0.4	0.0	29.3	19.4	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	4.1	5.4	0.1	0.0	0.0	7.0	4.5	0.5	1.1	0.0	40.7	12.5	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	13.2	0.1	28.4	3.3	0.1	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	10.7	1.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	13.2	0.0	2.5	12.2	0.3	0.4	1.2	7.1	0.4	29.3	0.0	0.1	0.1	2.7	22.1	18.1	1.5	27.4	25.1	10.0	7.0	11.0	6.1	1.3
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161554-13211104	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.8;lymphoid tissue: 31.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA045899: AB_10960529, HPA071952: AB_2686477"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	3.0	0.5	0.3	5.6	0.3	10.8	2.1	0.3	0.5	1.4	2.6	0.4	0.3	1.8	1.1	0.6	5.9	0.2	0.7	0.7	0.3	0.3	0.6	0.9	1.4	6.0	0.3	0.6	0.7	0.3	0.3	0.4	3.6	0.5	0.6	2.9	0.4	1.1	0.3	1.5	1.3	1.8	0.9	0.7	2.9	1.1	4.3	0.3	31.4	0.9	3.3	6.9	0.9	1.8	0.5	1.0	1.5	0.4	0.8	3.4	1.5	13.5	15.3	18.2	13.7	0.6	1.1	7.9	14.2	2.2	16.0	16.7	14.9	9.7	20.4	6.5	3.6	15.9	25.5	8.3	14.8	10.6	12.1	25.5	6.8	9.9	0.0	13.0	11.6	0.2	0.3	16.2	1.5	5.2	30.0	14.0	8.6	12.2	30.9	5.6	10.7	3.8	24.5	16.1	12.6	3.6	5.0	3.6	13.8	11.5	8.2	2.1	10.3	9.0	3.1	10.2	19.2	15.3	15.3	4.4	16.9	26.9	6.5	14.4	7.9	0.2	0.3	0.2	1.1	0.1	0.2	0.5	1.6	3.4	1.0	0.4	0.4	2.8	1.5	0.8	0.4	0.2	1.6	1.5	0.3	0.3	0.3	0.5	0.3	0.3	0.3	0.6	0.5	0.3
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400063-35425430	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.0;lymphoid tissue: 60.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979"	"unprognostic (6.71e-2)"	"prognostic favourable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (1.78e-4)"	"prognostic unfavourable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavourable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	12.1	4.9	6.1	27.5	9.0	57.0	9.1	6.7	5.7	10.4	11.5	12.3	5.0	9.5	10.8	10.8	15.8	8.7	9.4	5.2	4.4	3.4	6.8	8.0	9.3	31.1	8.8	3.7	17.9	10.8	6.2	3.6	19.3	5.8	7.2	8.3	6.5	8.9	5.1	8.8	10.3	16.7	6.0	7.8	31.2	8.4	16.4	8.8	60.6	9.0	17.7	33.0	8.7	9.6	46.8	30.9	19.0	26.0	21.3	32.9	24.0	38.9	28.3	22.4	22.8	2.1	4.4	19.6	26.0	13.8	38.9	37.0	18.8	19.4	25.8	15.1	13.2	19.4	22.3	20.6	12.5	20.8	41.0	36.8	28.4	37.5	0.7	75.9	33.3	2.4	1.9	23.2	6.3	17.2	22.7	38.6	14.7	32.1	61.8	25.3	29.7	16.8	70.0	31.7	32.5	7.7	22.6	17.3	18.4	35.8	14.4	8.0	15.0	29.0	10.1	39.3	29.9	24.4	26.8	21.5	26.4	48.5	25.4	28.7	30.0	19.0	20.7	14.5	18.4	24.1	13.1	46.8	16.1	19.4	27.1	37.0	13.1	14.8	9.9	21.3	26.0	30.9	32.9	24.0	6.1	9.0	6.7	5.7	4.4	3.4	8.8	3.7	5.8	8.8
MFSD2B		ENSG00000205639	"Major facilitator superfamily domain containing 2B"	A6NFX1	2	24010081-24063321	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 17.4;brain: 7.5;placenta: 7.5"	"Group enriched"	"Detected in some"	14	"HEL: 12.8;K-562: 5.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"basal ganglia: 7.5"	"Cell type enriched"	"Detected in some"	4	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA044145	Enhanced									"HPA044145: AB_2678833"	"unprognostic (5.67e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.84e-1)"	"unprognostic (5.35e-5)"	"unprognostic (2.82e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.90e-2)"	"unprognostic (6.87e-6)"	"unprognostic (7.76e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.72e-1)"	0.2	0.1	0.1	0.6	7.5	17.4	0.2	0.1	0.3	0.3	0.4	0.0	1.1	0.3	0.5	0.3	0.1	0.2	0.2	0.5	0.1	0.4	0.1	0.4	3.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	7.5	0.3	1.2	0.2	0.2	1.0	0.1	0.5	0.2	0.2	0.1	0.3	2.3	0.2	2.0	0.0	0.1	0.1	0.0	0.4	0.8	1.8	0.0	0.2	5.5	0.0	0.2	0.0	3.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	5.5	0.0	0.6	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.0	3.4	0.1	7.5	0.1	0.3	0.1	0.4	0.3	0.0	0.3	0.0
MGAT4A	"GnT-4a, GnT-Iva"	ENSG00000071073	"Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A"	Q9UM21	2	98619106-98731126	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 49.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 47.2;HUVEC TERT2: 17.6;TIME: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007608	Enhanced		Approved	"Golgi apparatus"	"Secreted in other tissues"			"Golgi apparatus"	"Golgi apparatus"	"HPA007608: AB_10602008"	"prognostic unfavourable (4.30e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (6.48e-8)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.76e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.04e-1)"	8.1	5.1	11.3	11.9	15.6	49.2	8.2	28.5	14.3	6.1	14.6	8.3	6.8	17.6	5.2	4.1	4.1	6.2	8.0	5.1	11.3	10.4	17.1	6.0	13.7	16.7	9.9	8.3	2.9	26.7	33.3	14.1	11.9	10.4	6.6	15.8	5.6	14.5	4.4	3.3	3.4	38.5	7.2	16.1	7.0	8.4	3.9	14.3	20.3	6.4	3.1	11.6	8.3	5.0	2.0	9.3	7.6	2.9	7.7	19.7	7.4	3.1	0.6	1.2	2.6	0.0	0.0	47.2	0.0	0.0	0.3	0.0	7.5	3.8	0.0	7.1	0.0	0.1	2.6	0.3	0.0	3.7	2.8	0.2	0.0	13.0	0.0	6.2	2.3	0.0	1.7	0.0	0.2	17.6	0.5	3.4	0.0	6.1	13.7	10.9	0.4	0.5	3.4	0.0	3.7	9.2	6.3	3.8	1.2	0.9	11.8	1.7	2.8	8.5	28.5	0.0	1.5	0.0	0.9	1.2	2.6	0.8	0.0	9.5	0.2	3.3	2.9	6.6	12.3	0.5	15.9	2.0	14.9	13.7	2.0	1.1	19.7	16.1	7.6	7.7	1.1	9.3	8.4	7.4	11.3	15.6	28.5	14.3	11.3	10.4	9.9	8.3	10.4	14.3
MKI67	"MIB-, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126385	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.2;lymphoid tissue: 81.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.4;T-reg: 1.3"	"Group enriched"	"Detected in many"	13	"NK-cells: 1.1;T-cells: 1.4"									"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavourable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	1.8	1.2	0.2	9.9	0.5	25.2	1.8	0.3	0.5	1.5	5.0	0.6	0.2	3.6	0.7	1.4	13.4	0.3	1.2	1.3	0.2	0.2	1.2	1.0	1.9	8.8	0.2	0.2	0.5	0.4	0.0	0.4	2.9	0.5	0.7	5.8	0.5	2.2	0.6	0.5	3.9	6.2	1.3	0.8	6.5	3.5	2.5	0.2	81.5	0.4	5.2	10.0	1.3	3.5	0.0	0.0	0.0	0.0	1.1	1.4	0.4	47.3	24.1	25.1	17.8	1.0	2.1	7.8	18.0	13.3	17.1	15.3	19.7	19.7	35.7	5.2	12.3	28.9	26.3	13.5	25.8	37.6	12.7	30.6	17.8	12.3	0.0	43.0	16.6	0.5	0.6	17.6	18.0	16.7	14.0	34.4	16.9	18.8	25.6	13.1	10.0	11.0	19.1	32.9	4.7	6.2	13.3	8.7	9.5	25.5	9.2	4.4	7.5	9.2	15.4	9.1	18.2	12.8	48.6	15.7	12.4	43.3	7.5	19.7	7.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.4	1.0	0.0	1.1	0.0	0.0	1.3	0.4	0.2	0.5	0.3	0.5	0.2	0.2	0.2	0.2	0.5	0.2
MLC1	"KIAA0027, LVM, MLC, VL"	ENSG00000100427	"Megalencephalic leukoencephalopathy with subcortical cysts 1"	Q15049	22	50059391-50085902	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.0;brain: 95.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 45.7;NB-4: 42.4;THP-1: 80.2;U-266/70: 28.0;U-266/84: 23.9"	"Cancer enriched"	"Detected in some"	69	"glioma: 122.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003040	Enhanced									"HPA003040: AB_1079387"	"unprognostic (2.68e-2)"	"unprognostic (5.46e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.54e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.51e-3)"	"unprognostic (8.39e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.92e-1)"	1.6	1.4	42.3	1.9	45.4	27.0	1.4	17.6	95.3	2.5	1.5	25.9	0.0	1.8	1.5	2.3	1.4	2.8	2.1	1.6	30.9	19.6	1.4	1.6	2.3	1.6	22.5	28.9	1.4	1.4	1.4	0.1	3.2	18.4	2.9	1.4	0.0	1.5	2.6	1.4	2.2	1.5	1.6	18.9	2.8	1.5	2.8	17.3	0.0	1.4	0.0	1.8	1.8	2.6	0.1	0.7	0.1	7.1	15.8	3.3	2.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	45.7	14.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	42.4	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.2	0.0	0.0	0.0	0.0	0.0	28.0	23.9	0.0	0.0	7.0	0.4	0.0	0.7	0.0	3.3	5.7	0.1	0.1	0.2	1.4	0.7	0.0	0.1	1.6	0.1	15.8	7.1	0.1	0.1	2.7	42.3	45.4	17.6	29.8	30.9	19.6	22.5	28.9	18.4	17.3
MMP25	"MMP20, MMPL1, MT6-MMP"	ENSG00000008516	"Matrix metallopeptidase 25"	Q9NPA2	16	3046681-3060726	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.6;bone marrow: 25.6;lymphoid tissue: 54.1"	"Cell line enriched"	"Detected in some"	12	"HMC-1: 49.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"basophil: 10.2;eosinophil: 6.0;neutrophil: 17.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 17.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB025177	Uncertain				"Secreted to blood"					"CAB025177: "	"unprognostic (4.51e-3)"	"unprognostic (9.28e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.26e-1)"	"prognostic favourable (1.09e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	4.0	0.3	0.6	12.3	0.4	25.6	0.8	0.5	0.6	0.8	1.1	0.2	0.0	1.0	0.4	0.5	0.8	3.8	1.1	2.8	0.5	0.4	0.7	2.5	10.7	54.1	1.8	0.0	0.6	0.8	0.0	0.5	2.0	1.1	0.6	1.0	1.0	0.9	0.0	2.4	0.6	1.8	0.5	0.4	43.9	1.1	0.7	0.5	4.1	0.7	0.9	4.2	1.5	2.5	0.0	0.3	17.6	0.2	1.7	0.5	0.1	0.2	0.1	0.6	1.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.6	0.3	0.0	0.0	3.9	0.8	0.1	0.1	0.0	0.0	0.1	49.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	3.0	1.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	3.5	0.1	0.1	0.4	0.1	0.0	1.2	0.1	0.1	0.0	0.9	0.1	10.2	0.2	6.0	0.3	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.3	0.2	17.6	1.7	0.0	0.3	0.3	0.1	0.6	0.4	0.5	0.6	0.5	0.4	1.8	0.0	1.1	0.5
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831317-158849506	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 289.8;bone marrow: 83.3"	"Group enriched"	"Detected in some"	15	"NB-4: 35.9;THP-1: 67.7;U-937: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 289.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 289.8"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	Nucleoplasm,Nucleoli		110000	110000	"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA034532: AB_10669677, HPA073215: AB_2686582"	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	17.6	6.3	5.4	24.4	7.9	83.3	3.0	1.4	5.8	2.1	2.1	3.2	0.2	1.1	1.7	3.4	2.3	4.7	8.4	6.3	4.9	3.2	3.9	4.2	31.3	32.2	10.7	2.6	3.4	2.4	1.1	2.2	9.9	6.8	2.6	2.5	5.0	3.6	1.2	2.0	1.9	3.6	6.2	18.6	57.3	2.6	4.0	6.3	5.5	2.1	1.4	4.2	9.1	4.9	1.6	29.7	289.8	60.9	0.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.4	0.0	7.1	60.9	11.1	0.1	25.4	0.1	1.6	0.0	0.1	29.7	0.6	0.0	0.0	289.8	0.1	12.0	0.4	0.0	40.2	5.4	7.9	1.4	5.8	4.9	3.2	10.7	2.6	6.8	6.3
MTFR2	"DUFD1, FAM54A"	ENSG00000146410	"Mitochondrial fission regulator 2"	Q6P444	6	136231024-136250335	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.2;lymphoid tissue: 16.8;testis: 13.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029792, HPA029794"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA029792: AB_10600210, HPA029794: AB_10600535"	"unprognostic (6.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (9.64e-4)"	"unprognostic (3.93e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.60e-6)"	"prognostic unfavourable (8.28e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.82e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.64e-2)"	1.7	0.9	0.6	5.1	1.5	15.2	0.9	0.9	1.1	0.8	2.9	0.8	0.4	2.8	0.7	0.9	4.5	0.5	1.7	1.0	0.6	0.6	2.5	0.7	1.5	6.4	0.8	0.4	0.9	0.7	0.0	0.7	3.2	1.2	0.7	4.1	0.6	1.3	0.4	1.4	1.9	3.2	0.9	1.1	3.8	1.9	13.5	0.4	16.8	0.4	3.2	5.8	1.1	1.4	1.6	3.0	0.1	2.9	0.0	2.6	1.1	7.1	5.6	4.8	8.9	0.8	1.4	8.6	9.5	6.6	11.3	15.9	9.9	5.9	18.7	5.8	3.8	11.2	10.8	7.0	16.9	10.4	8.3	14.7	4.1	9.0	0.5	26.9	13.9	1.1	1.5	12.6	8.1	6.1	15.8	14.6	8.4	9.6	15.1	22.6	4.8	6.9	13.9	7.7	9.4	4.8	5.6	3.8	3.8	6.0	10.6	5.4	4.4	18.6	3.3	5.6	5.9	19.8	14.5	5.5	13.0	12.4	3.2	18.4	8.6	0.0	0.6	0.0	1.2	2.9	0.4	1.6	1.6	2.6	3.0	1.3	0.2	1.3	0.1	0.0	2.3	2.2	2.2	1.1	0.6	1.5	0.9	1.1	0.6	0.6	0.8	0.4	1.2	0.4
MXD1	"bHLHc58, MAD, MAD1"	ENSG00000059728	"MAX dimerization protein 1"	Q05195	2	69897688-69942945	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.1;bone marrow: 72.8;esophagus: 64.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 81.1"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001599	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA001599: AB_1079434"	"unprognostic (1.59e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavourable (8.14e-6)"	"unprognostic (1.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (8.50e-4)"	"unprognostic (8.72e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.77e-2)"	6.9	2.2	2.7	18.7	3.8	72.8	3.7	5.7	4.1	15.8	19.6	4.7	0.9	13.6	2.9	2.6	64.8	3.8	4.9	10.8	3.0	2.9	3.0	5.5	17.0	14.3	5.9	2.4	3.3	2.5	3.6	4.0	15.8	3.1	3.3	14.0	5.1	8.8	1.4	3.1	5.9	50.2	4.6	4.3	15.8	8.2	3.6	3.7	9.4	4.0	20.8	34.0	6.3	21.6	0.2	0.8	81.1	1.6	0.4	0.4	0.6	3.4	1.5	2.2	1.6	4.9	2.4	8.2	3.8	2.2	1.9	1.3	4.9	2.7	2.0	2.0	1.5	12.3	4.2	7.7	2.0	1.1	5.0	4.1	4.4	4.8	16.4	4.9	4.1	2.8	13.0	4.3	20.0	2.4	7.1	7.9	1.2	2.8	2.4	9.9	0.6	2.5	1.1	2.2	4.9	2.5	4.1	7.1	3.0	5.1	6.8	2.7	1.0	2.9	9.4	2.7	0.7	2.9	3.6	5.4	9.1	0.7	2.8	8.7	1.0	17.0	1.6	16.8	0.3	1.0	0.4	0.1	0.2	0.2	0.8	0.2	0.2	0.3	81.1	0.4	0.8	0.2	0.2	0.6	2.7	3.8	5.7	4.1	3.0	2.9	5.9	2.4	3.1	3.7
MXD3	"bHLHc13, MAD3"	ENSG00000213347	"MAX dimerization protein 3"	Q9BW11	5	177301461-177312757	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.1;lymphoid tissue: 59.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 14.1;monocytes: 8.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA070111			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA070111: AB_2686228"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-1)"	"unprognostic (8.26e-2)"	"unprognostic (6.18e-3)"	"prognostic unfavourable (3.60e-4)"	"unprognostic (3.32e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.33e-16)"	"unprognostic (8.55e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-3)"	2.5	1.8	1.3	28.2	1.9	32.1	5.4	1.2	3.4	2.4	6.8	1.2	2.8	6.9	2.7	6.2	6.6	3.6	2.8	2.4	1.6	0.8	2.7	6.6	5.4	7.3	2.2	1.2	2.6	5.8	0.7	4.3	4.5	2.1	5.0	0.9	1.1	4.7	2.1	3.6	10.3	5.6	1.4	1.3	10.3	3.8	3.1	2.9	59.4	3.5	3.7	13.5	2.7	3.6	2.0	1.6	14.1	8.7	0.7	0.8	1.1	8.0	5.6	3.4	9.4	0.2	0.4	5.7	10.6	3.5	4.8	4.6	3.6	8.4	4.3	4.4	1.4	4.0	0.4	1.2	0.2	58.7	7.1	2.4	8.0	5.3	0.5	2.3	7.4	0.3	0.6	0.3	0.2	4.4	1.4	13.5	0.9	10.3	21.4	6.4	1.2	9.7	10.5	10.7	6.1	1.0	1.1	8.5	7.0	6.8	6.9	3.6	10.8	6.1	3.2	5.8	14.9	4.5	5.6	17.9	5.9	4.7	4.5	8.1	3.3	3.5	2.6	7.7	0.7	7.2	0.0	1.6	0.1	0.1	1.6	2.0	0.0	0.3	14.1	0.7	8.7	1.0	0.8	1.1	1.3	1.9	1.2	3.4	1.6	0.8	2.2	1.2	2.1	2.9
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716496	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;bone marrow: 33.0;lymphoid tissue: 49.2"	"Cell line enhanced"	"Detected in many"		"MCF7: 101.9"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	30	"plasmacytoid DC: 35.9"	"Lineage enriched"	"Detected in many"	30	"dendritic cells: 35.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB017114: , HPA030530: AB_2673515, HPA055416: "	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavourable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.7	0.7	0.2	48.3	0.2	33.0	1.0	0.2	0.2	1.0	4.4	0.2	0.1	2.7	1.1	1.1	8.4	0.3	1.7	0.9	0.2	0.2	1.0	1.2	1.8	22.3	0.3	0.1	0.8	9.4	0.0	0.4	4.0	0.2	0.7	2.7	0.3	2.9	0.1	0.3	1.8	6.4	0.6	0.3	43.9	2.9	12.6	0.1	49.2	0.6	6.4	33.8	1.9	2.1	1.1	35.9	0.0	0.0	0.0	0.4	0.3	25.8	16.5	14.6	15.1	0.1	0.5	19.0	11.7	4.0	37.1	27.4	80.9	16.3	52.3	6.8	5.1	15.8	26.4	8.1	13.9	9.8	16.9	24.5	16.5	21.8	0.0	22.3	17.0	0.3	0.7	14.1	3.2	9.9	24.4	65.1	3.2	101.9	45.3	31.4	16.8	14.5	31.6	30.1	30.0	6.8	5.3	13.5	19.6	34.8	35.0	3.5	23.1	24.5	4.6	2.3	37.4	16.4	20.1	22.6	46.5	82.3	4.8	19.1	14.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	35.9	0.4	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.1
MYO1G	HA-2	ENSG00000136286	"Myosin IG"	B0I1T2	7	44962662-44979098	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 37.9;bone marrow: 27.4;lymphoid tissue: 46.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.9;HEL: 25.3;HL-60: 14.4;MOLT-4: 32.0;NB-4: 13.5;THP-1: 28.4;U-937: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021252	Enhanced					120000	120000			"HPA021252: AB_1854254"	"unprognostic (2.74e-2)"	"prognostic favourable (8.26e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.47e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavourable (8.71e-8)"	"unprognostic (3.20e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.92e-2)"	2.5	1.2	1.6	11.0	3.0	27.4	1.5	0.4	2.0	1.0	1.9	0.7	0.0	1.8	1.2	2.1	2.4	1.9	3.6	3.2	1.0	0.9	1.9	1.9	13.0	18.6	4.5	0.0	0.9	0.8	0.0	0.9	1.5	2.7	1.5	1.1	1.5	5.8	0.5	0.6	1.2	8.3	1.9	2.6	22.3	2.1	0.9	1.8	46.8	2.1	2.2	26.6	4.7	1.3	9.9	14.0	9.4	37.9	6.7	24.4	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	25.3	0.8	0.0	0.0	14.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	13.5	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	20.9	0.0	9.4	17.0	5.2	19.9	29.6	12.6	9.9	12.7	17.4	14.0	6.6	4.6	9.0	1.7	6.7	37.9	1.2	24.4	19.3	1.6	3.0	0.4	2.0	1.0	0.9	4.5	0.0	2.7	1.8
NBEAL2	KIAA0540	ENSG00000160796	"Neurobeachin like 2"	Q6ZNJ1	3	46979683-47009703	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.4"	"Cell line enhanced"	"Detected in many"		"HEL: 31.1;SK-BR-3: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 8.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051969	Approved					490000	490000			"HPA051969: "	"unprognostic (3.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.37e-2)"	"unprognostic (5.99e-3)"	"prognostic favourable (4.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.17e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.75e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.34e-2)"	7.6	5.5	3.5	14.8	4.2	53.4	7.0	5.5	3.9	11.6	10.5	2.8	17.0	7.5	7.1	5.7	36.2	5.6	20.9	3.8	3.7	1.8	11.4	3.9	19.4	10.7	5.6	2.4	3.0	15.0	4.2	4.8	3.3	4.2	7.6	6.6	5.2	14.2	10.3	2.7	26.5	14.2	6.9	3.8	26.3	16.2	2.7	3.8	11.5	5.4	22.1	39.0	6.7	18.7	0.1	0.2	8.1	1.2	0.7	1.1	0.4	8.5	9.3	2.1	5.0	1.3	0.4	5.5	1.1	0.7	1.7	1.2	8.4	6.1	7.4	3.4	1.2	5.9	3.8	4.1	1.0	6.6	5.7	31.1	11.3	5.1	0.9	5.2	22.4	0.8	7.1	1.7	3.4	15.6	6.3	12.9	0.7	13.3	8.5	14.1	4.8	4.5	9.4	0.2	9.4	4.4	18.1	2.8	4.4	1.1	28.4	2.4	13.8	8.5	11.4	0.1	5.3	2.3	3.8	9.0	8.4	7.1	2.2	24.7	1.2	0.4	1.2	0.6	1.1	1.1	0.3	0.1	0.4	1.1	0.2	0.1	0.2	0.2	8.1	0.7	0.8	0.2	0.5	0.4	3.5	4.2	5.5	3.9	3.7	1.8	5.6	2.4	4.2	3.8
NFAM1	CNAIP	ENSG00000235568	"NFAT activating protein with ITAM motif 1"	Q8NET5	22	42380410-42432395	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 34.0;bone marrow: 28.0;lymphoid tissue: 35.2"	"Cell line enriched"	"Detected in some"	4	"THP-1: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 34.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 34.0;monocytes: 17.5"					"Group enriched"	"Detected in many"	4	"basal ganglia: 2.9;hypothalamus: 3.7;midbrain: 7.4;pons and medulla: 7.8;thalamus: 8.3"	HPA031812	Uncertain									"HPA031812: AB_10603121"	"unprognostic (9.77e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.21e-2)"	"prognostic favourable (6.16e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.12e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	10.9	3.1	1.7	12.3	3.1	28.0	2.0	0.9	1.9	2.2	1.8	4.0	0.7	1.5	1.4	4.2	2.0	3.3	2.8	4.8	1.8	2.2	2.5	9.9	12.1	35.2	2.4	0.6	1.5	1.7	0.4	1.3	4.4	2.7	2.5	1.4	2.4	2.0	1.8	1.1	1.6	3.3	3.0	4.8	27.7	1.7	1.4	2.5	2.8	1.5	1.2	3.7	3.1	1.5	0.0	6.1	34.0	17.5	0.0	0.1	7.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.4	0.2	0.0	0.1	0.0	0.0	0.3	0.1	4.4	0.0	0.0	0.1	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.1	17.5	0.9	0.0	12.2	0.1	0.0	0.0	0.0	6.1	0.0	0.0	0.0	34.0	0.0	10.6	0.1	0.0	7.3	1.7	3.1	0.9	1.9	1.8	2.2	2.4	0.6	2.7	2.5
NFKBIA	"IkappaBalpha, IKBA, MAD-3, NFKBI"	ENSG00000100906	"NFKB inhibitor alpha"	P25963	14	35401511-35404749	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 209.1"	"Cell line enhanced"	"Detected in all"		"RT4: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003815, HPA029207"	Approved		Enhanced	Cytosol				Cytosol	Cytosol	"CAB003815: AB_344886, HPA029207: AB_10603122"	"prognostic favourable (1.33e-5)"	"unprognostic (3.39e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.80e-2)"	49.0	38.5	14.9	63.7	25.7	209.1	60.8	16.1	27.8	33.8	32.8	10.3	36.7	13.5	21.3	15.6	50.4	30.5	34.3	30.9	18.8	10.5	30.6	45.1	73.0	47.7	29.7	7.8	57.4	22.1	6.5	25.3	25.5	21.8	28.7	18.6	19.5	44.2	64.6	33.1	48.2	42.3	24.9	23.0	47.4	26.1	19.6	23.9	35.0	27.8	46.2	38.1	41.8	45.2	45.3	55.0	118.2	58.3	33.2	37.3	51.7	12.9	11.5	4.3	3.9	25.7	17.1	15.6	5.4	52.0	11.7	10.5	3.6	7.8	7.8	14.5	8.5	17.1	8.2	22.4	16.9	47.8	3.2	3.9	8.3	21.2	15.4	6.1	3.2	18.6	22.7	7.9	20.4	10.5	3.2	12.7	8.3	15.2	8.0	14.8	4.0	7.1	18.3	5.0	6.5	20.1	83.5	3.9	6.8	14.4	25.3	6.0	14.3	13.1	19.6	16.1	5.8	4.6	8.6	15.5	15.7	13.4	13.4	4.6	3.3	35.8	58.3	36.6	24.2	33.4	37.3	34.0	29.3	25.4	55.0	45.3	25.6	21.7	118.2	33.2	22.1	29.7	19.5	51.7	14.9	25.7	16.1	27.8	18.8	10.5	29.7	7.8	21.8	23.9
NFKBID	"IkappaBNS, TA-NFKBH"	ENSG00000167604	"NFKB inhibitor delta"	Q8NI38	19	35887653-35902303	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 21.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043573			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA043573: "	"prognostic favourable (6.01e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-2)"	"prognostic favourable (5.43e-4)"	"unprognostic (4.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.64e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.71e-2)"	"prognostic favourable (8.34e-6)"	4.1	2.8	0.9	13.5	2.5	21.0	7.0	4.5	2.4	1.9	2.1	4.4	0.9	1.9	2.3	2.7	3.0	3.7	6.9	2.1	0.7	1.1	3.4	1.8	11.4	9.1	2.3	0.4	4.3	3.5	1.9	5.5	1.6	2.0	2.6	1.5	2.7	2.3	3.4	0.9	3.6	4.8	5.1	2.4	6.8	2.8	1.5	1.1	14.4	5.1	1.0	14.7	2.8	7.4	9.4	1.9	4.8	1.6	2.0	2.3	0.6	4.7	4.4	0.9	3.0	0.6	0.7	2.1	2.9	3.5	3.2	2.3	1.0	3.8	5.7	2.3	3.0	2.5	3.1	2.3	1.3	3.3	0.6	3.4	6.1	1.0	0.8	2.9	10.3	1.0	1.6	5.8	1.4	1.1	0.7	3.6	0.6	3.7	2.4	3.5	1.3	0.9	1.3	0.7	1.2	2.8	2.0	1.6	1.2	3.9	3.0	0.3	1.3	3.0	1.2	4.9	4.5	2.2	2.0	2.5	0.9	6.7	2.7	7.0	0.7	0.0	1.4	2.5	2.3	0.9	1.7	5.4	1.0	1.8	1.4	9.4	1.7	1.0	4.8	2.0	1.6	1.9	2.2	0.6	0.9	2.5	4.5	2.4	0.7	1.1	2.3	0.4	2.0	1.1
NFKBIZ	"FLJ34463, INAP, MAIL"	ENSG00000144802	"NFKB inhibitor zeta"	Q9BYH8	3	101827991-101861022	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 116.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 31.3;RPTEC TERT1: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 20.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 15.8;monocytes: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010547, HPA075363"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Nuclear speckles"	"HPA010547: AB_1854442, HPA075363: AB_2686745"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	"prognostic unfavourable (4.30e-8)"	"unprognostic (2.69e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.30e-1)"	"unprognostic (8.52e-3)"	26.4	4.4	2.2	35.5	3.4	116.9	46.9	2.4	2.0	17.4	23.7	3.6	5.5	16.8	21.3	13.0	22.1	39.5	31.5	17.3	2.8	1.9	13.8	26.8	29.6	21.3	4.4	0.3	18.2	15.7	2.4	7.2	18.8	5.0	16.3	10.4	10.9	37.4	8.1	9.8	21.0	18.5	17.9	5.2	21.5	16.8	7.1	3.3	3.3	26.5	30.8	23.8	18.7	20.0	3.2	3.8	15.8	20.0	0.5	4.1	1.1	2.7	2.2	1.5	1.9	4.4	7.6	2.4	11.3	31.3	5.0	4.8	2.6	3.4	5.2	14.5	3.0	8.9	1.1	4.9	13.1	15.2	1.0	4.9	3.9	1.4	6.8	0.3	0.3	5.2	7.7	13.4	6.2	3.7	0.8	10.8	7.1	3.5	0.1	2.9	2.6	6.7	0.6	6.9	0.7	31.4	18.3	0.7	0.9	1.9	2.3	12.2	2.7	2.1	4.6	8.1	8.2	3.0	3.6	9.1	3.1	3.6	14.8	1.0	1.1	4.9	3.6	1.0	1.0	8.3	1.1	1.9	1.4	1.0	2.4	3.2	4.1	2.7	15.8	0.5	20.0	3.8	0.7	1.1	2.2	3.4	2.4	2.0	2.8	1.9	4.4	0.3	5.0	3.3
NKG7	"GIG1, GMP-17"	ENSG00000105374	"Natural killer cell granule protein 7"	Q16617	19	51371606-51372715	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 270.6;bone marrow: 108.2"	"Group enriched"	"Detected in some"	5	"NB-4: 58.8;THP-1: 17.5;U-937: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdTCR: 270.6;MAIT T-cell: 113.5;memory CD8 T-cell: 168.7;naive CD8 T-cell: 130.3;NK-cell: 166.7"	"Group enriched"	"Detected in all"	46	"NK-cells: 166.7;T-cells: 270.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071454			Approved	Vesicles				Vesicles	Vesicles	"HPA071454: AB_2686399"	"unprognostic (1.56e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.54e-2)"	"prognostic favourable (7.42e-6)"	"unprognostic (1.27e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.89e-3)"	"unprognostic (3.39e-1)"	"unprognostic (9.93e-2)"	"prognostic unfavourable (3.32e-6)"	"unprognostic (7.62e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.44e-3)"	7.4	1.8	1.3	11.2	1.7	108.2	3.3	0.7	1.0	2.9	2.2	0.8	0.4	2.2	5.4	6.3	3.8	1.8	10.6	6.0	1.2	1.2	3.2	9.4	26.1	31.0	2.3	0.7	4.1	2.6	0.0	1.8	9.3	1.3	6.8	1.6	6.2	3.5	0.9	5.6	1.0	7.6	2.5	2.8	63.3	2.5	1.9	0.2	7.3	3.1	2.0	16.0	5.1	2.3	1.1	3.2	4.5	4.7	166.7	270.6	141.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.6	0.2	0.0	0.0	6.2	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.7	58.8	0.0	0.1	1.4	3.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.5	0.1	0.0	0.0	0.2	0.0	0.8	0.2	0.3	0.0	15.3	0.0	2.2	1.3	0.5	270.6	4.7	113.5	1.1	34.1	168.7	3.2	0.5	11.5	130.3	4.5	166.7	3.6	2.5	0.6	141.5	1.3	1.7	0.7	1.0	1.2	1.2	2.3	0.7	1.3	0.2
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015789-139045939	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nuclear bodies"	"HPA012287: AB_2668640, HPA053714: AB_2682238"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavourable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavourable (6.23e-4)"	17.5	3.9	3.3	4.9	8.0	38.7	7.4	3.2	7.3	2.7	3.1	2.7	0.0	2.2	2.8	1.5	4.0	2.5	7.9	5.4	4.9	3.7	6.9	25.8	5.1	3.1	3.0	3.1	1.7	4.4	4.0	4.7	9.3	3.7	2.0	2.8	1.8	10.8	1.4	12.0	3.9	10.5	4.5	2.3	3.2	3.0	4.9	2.6	3.7	2.9	11.8	3.9	3.7	4.6	1.9	1.5	6.3	3.1	1.4	2.4	0.2	4.8	5.6	2.2	4.2	5.0	2.1	13.7	7.2	5.2	10.3	7.4	7.5	2.0	16.0	5.8	5.3	3.5	11.5	6.3	9.7	7.2	4.7	7.4	3.4	6.5	4.6	10.8	4.4	2.4	3.1	11.4	7.8	4.5	13.3	5.3	4.5	5.5	7.4	5.7	7.1	6.0	6.1	6.5	5.6	6.9	3.1	8.3	5.5	4.5	5.2	4.1	3.8	8.4	6.7	5.5	7.2	5.2	8.6	4.3	4.0	10.1	5.1	21.5	7.0	1.5	1.4	0.8	2.4	1.5	1.4	1.1	1.1	1.3	0.6	1.9	0.8	1.6	6.3	1.4	3.1	1.5	0.7	0.2	3.3	8.0	3.2	7.3	4.9	3.7	3.0	3.1	3.7	2.6
NRROS	"ELLP3030, GARPL1, LRRC33, MGC50789, UNQ3030"	ENSG00000174004	"Negative regulator of reactive oxygen species"	Q86YC3	3	196639686-196662004	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 30.4"	"Cell line enhanced"	"Detected in some"		"HMC-1: 34.1;Karpas-707: 21.1;MOLT-4: 17.9;NB-4: 42.0;RPMI-8226: 20.8;THP-1: 18.5;U-937: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 7.4;classical monocyte: 1.9;eosinophil: 3.3;intermediate monocyte: 2.0;myeloid DC: 2.5;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.5;granulocytes: 7.4;monocytes: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031586	Uncertain									"HPA031586: AB_10601543"	"unprognostic (5.28e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.20e-2)"	"prognostic unfavourable (9.63e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	17.0	3.6	3.8	9.3	4.4	30.4	12.4	1.6	3.1	4.7	3.3	4.0	1.0	3.0	7.6	7.1	2.7	4.2	5.8	8.5	3.1	2.7	4.3	3.4	13.4	23.0	4.3	1.3	2.6	2.6	1.2	2.3	12.4	3.4	4.5	2.2	5.7	3.8	2.2	3.1	3.1	6.9	4.9	5.2	22.5	3.4	2.8	4.8	15.6	3.5	2.4	8.8	6.3	3.5	0.6	2.5	7.4	2.0	0.6	0.7	1.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	2.2	0.1	0.0	0.3	0.0	0.0	1.2	0.0	16.2	0.0	0.0	0.1	13.2	34.1	0.1	0.0	0.5	0.2	1.3	1.6	21.1	0.3	0.0	17.9	42.0	1.4	0.0	4.8	0.0	20.8	0.0	0.1	0.1	0.0	0.0	0.0	8.5	0.0	18.5	0.1	0.1	0.0	0.6	0.0	8.5	12.7	3.7	1.1	23.4	0.2	7.4	1.9	3.3	0.7	2.0	0.2	0.6	0.5	0.4	2.5	0.5	0.2	0.4	0.0	0.6	1.9	0.3	0.5	1.2	3.8	4.4	1.6	3.1	3.1	2.7	4.3	1.3	3.4	4.8
NTNG2	"KIAA1857, Lmnt2, NTNG1"	ENSG00000196358	"Netrin G2"	Q96CW9	9	132161676-132244534	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.9;brain: 32.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.7;HMC-1: 11.9;NB-4: 27.0;U-937: 7.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 4.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA065089, HPA071290"	Approved		Approved	"Plasma membrane,Cytokinetic bridge,Midbody ring"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA065089: AB_2732730, HPA071290: AB_2686381"	"unprognostic (5.01e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.62e-2)"	"prognostic favourable (6.06e-4)"	"unprognostic (9.30e-12)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	1.2	1.4	11.9	1.6	10.9	38.9	0.6	4.4	32.0	1.0	0.8	11.5	0.2	1.8	0.7	0.9	0.8	0.7	1.4	4.6	11.4	3.1	0.8	0.8	2.0	1.9	4.4	7.4	0.6	1.8	11.9	1.0	1.1	11.7	7.4	0.7	10.7	1.3	1.8	0.9	0.8	1.1	0.8	5.3	2.8	1.2	1.8	2.8	0.0	0.7	0.0	1.0	1.1	0.9	0.1	0.1	4.0	0.2	0.0	0.4	0.0	0.0	0.3	0.2	0.4	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.6	4.7	11.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.2	27.0	1.0	0.1	0.3	0.3	0.1	0.0	0.0	3.3	3.0	0.1	0.0	0.0	0.0	0.4	0.1	0.6	2.1	2.6	0.1	0.1	0.0	0.0	0.9	7.0	0.7	0.6	0.2	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.0	0.0	0.1	0.1	0.1	0.0	11.9	10.9	4.4	32.0	11.4	3.1	4.4	7.4	11.7	2.8
NUP210	"FLJ22389, GP210, KIAA0906, POM210"	ENSG00000132182	"Nucleoporin 210"	Q8TEM1	3	13316235-13420309	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.0;lymphoid tissue: 44.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 46.4;U-266/84: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066888	Approved					28000	28000			"HPA066888: AB_2685741"	"unprognostic (3.17e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.72e-3)"	"prognostic unfavourable (6.03e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.63e-2)"	1.6	4.1	4.0	25.6	5.2	31.0	3.7	12.6	6.7	1.7	4.2	8.0	3.3	4.9	1.8	7.0	5.6	2.9	4.0	2.0	4.1	5.3	6.8	13.8	5.3	25.6	4.9	3.5	1.4	11.4	7.2	10.9	4.3	4.5	4.2	3.9	6.3	6.8	4.4	7.2	3.8	16.4	1.6	3.6	25.3	5.6	6.6	6.1	44.2	6.5	3.1	23.1	5.6	1.8	6.7	6.8	1.0	3.9	6.2	9.3	3.6	8.3	14.7	7.3	18.9	0.0	0.0	29.1	0.1	0.0	1.8	0.0	7.5	13.7	33.9	11.7	0.0	4.9	16.1	0.0	0.6	27.2	12.0	13.1	16.7	7.9	0.0	42.0	4.8	0.0	0.0	0.0	0.0	0.0	20.3	36.5	0.0	20.9	22.3	16.7	8.4	3.0	0.0	0.0	46.4	3.5	7.8	8.4	8.4	10.5	14.1	4.4	13.5	35.0	0.1	0.0	2.5	0.0	6.4	37.1	51.4	29.6	0.0	23.5	0.0	0.0	2.9	1.0	9.3	3.9	7.4	6.7	6.7	9.0	6.4	4.5	5.6	7.3	0.1	6.2	2.4	6.8	5.6	3.6	4.0	5.2	12.6	6.7	4.1	5.3	4.9	3.5	4.5	6.1
OASL	"OASL1, p59OASL, TRIP14"	ENSG00000135114	"2'-5'-oligoadenylate synthetase like"	Q15646	12	121019111-121039242	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.5;bone marrow: 33.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 51.5;BJ hTERT+ SV40 Large T+ RasG12V: 26.5;hTEC/SVTERT24-B: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA001474	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA001474: AB_1079518"	"unprognostic (2.39e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.93e-3)"	"prognostic unfavourable (9.20e-4)"	"unprognostic (4.61e-1)"	"prognostic unfavourable (3.70e-9)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.17e-2)"	20.5	0.5	1.0	8.3	1.4	33.1	2.7	0.4	1.9	3.6	5.9	1.7	0.1	1.6	1.7	1.3	4.7	0.6	3.1	2.2	0.7	0.9	4.0	22.6	16.5	1.9	1.3	1.2	1.4	0.4	0.2	0.8	3.6	2.3	2.5	3.0	2.3	3.4	0.3	1.1	0.8	2.0	1.1	1.9	5.2	15.7	2.1	0.6	6.0	3.2	3.7	7.6	2.9	1.5	0.8	3.2	44.5	10.8	6.9	23.6	10.8	1.0	0.2	0.0	0.3	0.3	0.9	0.0	0.1	0.5	51.5	26.5	0.0	4.9	0.3	1.5	0.0	2.7	0.0	0.3	3.8	9.1	0.0	0.0	5.2	0.0	0.3	0.0	0.7	0.3	0.2	20.6	0.0	0.1	0.0	1.8	0.2	0.4	0.0	2.6	0.0	1.1	0.0	0.1	0.6	0.2	4.8	0.0	0.0	0.4	0.2	8.1	0.1	0.8	0.0	0.2	0.4	0.6	0.1	1.9	3.7	0.0	7.7	0.4	0.1	4.2	10.3	22.4	20.4	10.8	5.3	0.8	14.1	23.6	3.2	0.3	4.0	15.7	44.5	6.9	7.4	0.1	9.9	10.8	1.0	1.4	0.4	1.9	0.7	0.9	1.3	1.2	2.3	0.6
OR10A3	"HSHTPCRX12, HTPCRX12"	ENSG00000170683	"Olfactory receptor family 10 subfamily A member 3"	P58181	11	7937171-7941708	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.2;bone marrow: 1.4;skin 1: 1.8"	"Cell line enhanced"	"Detected in some"		"A-431: 2.1;HMC-1: 2.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 2.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.2"																																		"unprognostic (2.53e-2)"		"unprognostic (3.24e-3)"	0.1	0.1	0.0	0.2	0.0	1.4	0.4	0.0	0.1	0.2	0.0			0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0		0.2	0.1	0.0	0.0	0.0		0.3	0.1		0.2	0.0	0.0	1.8	0.2	0.0	0.0	0.4	0.3	0.2			0.1		0.0	0.9	0.1	0.5	0.4	2.2	0.3	0.2	0.3	0.1	2.1	0.2	0.0	0.4	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.8	0.2	0.0	0.2	0.0	0.1	0.2	0.8	0.3	0.4	0.2	0.5	0.2	0.2	0.3	0.2	0.1	0.0	0.3	0.3	0.2	0.6	0.5	0.0	0.1	0.0	0.3	0.1	0.2	0.3	0.3	0.0	0.1	0.1	0.1	0.3	0.1	2.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.3	1.7	0.2	0.1	0.4	0.2	0.1										
OR10G4		ENSG00000254737	"Olfactory receptor family 10 subfamily G member 4"	Q8NGN3	11	124012997-124018732	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 2.7;pancreas: 3.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																																							0.1	0.2	0.1	0.1	0.1	2.7	0.1	0.1	0.1	0.1	0.3			0.3	0.1	0.5	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.8	0.1	0.1	0.1		0.2	3.7	0.1	0.1	0.1		0.1	0.5		0.1	0.0	0.5	0.7	0.4	0.0	0.1	0.4	0.1	0.6			0.2		0.0	0.2	0.1	1.2	0.5	1.6	0.6	0.5	0.5	0.1	0.3	0.1	0.3	0.3	0.5	0.1	0.4	0.4	0.0	0.1	0.0	0.4	0.3	0.0	0.4	0.2	0.2	0.1	0.0	0.1	0.6	0.9	1.4	1.6	0.9	0.1	0.6	3.0	0.0	0.5	0.0	0.1	0.3	0.3	1.4	0.0	1.1	0.2	1.6	1.2	1.0	0.1	0.4	0.4	0.0	1.1	0.5	0.2	0.2	0.3	0.2	0.2	0.5	0.5	0.6	0.3	0.8	0.1	0.7	0.5	0.2	0.2	1.4	0.2	0.7	0.5	0.8	0.5	0.2	0.3	0.5	0.5	0.5	0.3	1.2	0.5	0.5	1.6	0.5	0.6	0.5	0.3	0.1										
OR10X1	OR10X1P	ENSG00000279111	"Olfactory receptor family 10 subfamily X member 1 (gene/pseudogene)"	Q8NGY0	1	158578919-158579899	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"bone marrow: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		1.4	0.1		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.5			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0										
OR1A1	OR17-7	ENSG00000172146	"Olfactory receptor family 1 subfamily A member 1"	Q9P1Q5	17	3207539-3218896	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 4.1;bone marrow: 3.2;salivary gland: 4.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 7.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																																							0.3	0.3	0.4	0.6	0.5	3.2	0.3	0.4	0.6	1.2	0.4			0.8	0.3	0.9	0.4	0.3	0.1	0.5	0.4	0.3	0.4	0.4	0.3	0.5	0.3		0.4	0.5	0.0	0.3	0.0		0.3	0.0		4.2	0.0	0.5	1.5	0.3	0.0	0.4	0.5	0.4	1.2			0.3		0.1	0.6	0.4	2.2	1.4	4.1	1.3	1.5	1.6	0.3	1.5	0.9	0.8	1.4	0.4	0.3	1.6	0.8	0.3	0.2	0.3	0.6	1.1	1.8	1.5	0.4	0.9	0.1	0.2	0.3	2.1	0.6	1.2	2.8	0.7	0.1	1.4	4.2	0.4	0.3	0.3	0.4	0.3	0.8	7.7	0.0	0.9	1.6	1.5	1.9	1.0	2.0	1.3	2.3	0.2	1.8	1.5	1.1	0.6	1.0	0.9	1.6	1.5	0.8	1.4	2.6	1.4	1.5	3.2	2.0	1.4	1.0	1.5	1.2	4.1	1.2	1.0	1.4	1.2	1.2	1.3	1.2	1.0	0.8	2.2	1.6	1.5	2.0	1.5	1.3	1.4	0.9	0.3										
OR1B1	OR9-B	ENSG00000280094	"Olfactory receptor family 1 subfamily B member 1 (gene/pseudogene)"	Q8NGR6	9	122628579-122629573	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"bone marrow: 1.2"	"Cell line enriched"	"Detected in single"	8	"RT4: 4.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.2	0.0		0.0		1.2	0.7		0.6	0.0	0.0			0.0	0.5	0.0	0.3	0.0	0.1	0.0			0.0	0.1	0.0	0.3			0.0	0.0	0.0		0.1		0.0	0.0		0.0	0.0	0.4	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.3	0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	4.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR1I1	"OR19-20, OR1I1P, OR1I1Q"	ENSG00000094661	"Olfactory receptor family 1 subfamily I member 1"	O60431	19	15082211-15092970	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 4.5;bone marrow: 3.1"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																															0.3	0.6	0.4	0.7	0.4	3.1	0.3	0.4	0.4	0.3	0.3			0.4	0.4	0.9	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.7	0.4		0.4	0.8	0.0	0.3	0.8		0.4	0.1		0.3	0.0	0.7	2.2	0.3	0.0	0.3	0.5	0.4	0.7			0.7		0.0	0.3	0.4	2.0	1.7	4.5	1.3	3.2	1.5	0.9	0.9	1.3	1.0	1.1	0.6	0.7	1.5	0.7	0.4	0.3	0.3	0.9	1.5	1.7	0.6	0.9	1.9	0.6	0.2	0.5	1.5	0.9	1.6	3.7	1.3	0.4	0.9	3.1	0.6	0.8	0.3	0.4	0.3	1.4	2.2	0.6	1.2	1.0	1.7	1.4	1.3	0.7	0.8	0.9	0.3	2.2	1.2	1.0	0.7	0.8	0.4	1.2	0.7	0.7	1.7	1.1	1.5	0.7	1.4	0.7	1.1	0.7	0.9	0.9	3.1	1.2	1.0	1.2	0.9	1.4	1.3	1.0	1.2	0.5	2.0	1.3	1.5	4.5	3.2	1.3	1.7	1.1	0.9										
OR2AG2	OR2AG2P	ENSG00000188124	"Olfactory receptor family 2 subfamily AG member 2"	A6NM03	11	6765626-6771976	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 1.7"	"Cell line enhanced"	"Detected in some"		"K-562: 2.6;U-698: 2.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"																								"unprognostic (6.24e-3)"								"unprognostic (7.69e-2)"			"unprognostic (1.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.30e-2)"		0.0	0.1	0.3	0.4	1.1	1.7	0.0	0.1	0.8	0.4	0.3			0.6	0.1	0.3	0.1	0.4	0.0	0.1	0.2	0.5	0.1	0.2	0.1	0.5	0.2		0.5	0.3	0.0	0.1	0.0		0.3	0.5		0.1	0.0	0.3	0.2	0.3	0.2	0.0	0.1	0.0	1.0			0.2		0.3	0.5	0.1	0.6	0.4	1.0	0.4	0.5	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.8	1.0	1.3	0.4	1.4	0.1	0.0	0.6	0.2	1.0	0.3	0.3	1.1	1.3	0.0	0.7	0.0	0.2	0.0	0.6	1.9	0.0	0.4	0.2	0.0	1.6	1.4	2.6	0.9	0.4	0.0	0.0	0.0	0.5	0.4	0.1	0.0	0.2	0.0	1.8	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.3	1.0	0.9	0.2	0.0	0.3	0.0	2.5	1.2	0.2	0.7	0.9	0.4	0.1	0.2	0.2	0.1	0.6	0.5	0.2	0.0	0.6	0.6	0.3	1.0	0.5	0.2	0.4	0.1	0.0										
OR2AT4		ENSG00000171561	"Olfactory receptor family 2 subfamily AT member 4"	A6NND4	11	75081753-75096876	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.6;bone marrow: 3.5"	"Cell line enhanced"	"Detected in many"		"K-562: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"																																			0.4	0.5	0.4	0.4	0.6	3.5	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.2	0.4	1.7	0.4	0.3	0.5	0.4	0.4	0.4	0.4	1.7	0.5	0.7	0.4	0.4	0.8	0.4	0.3	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.5	1.9	0.6	0.4	0.4	0.6	0.4	1.5	0.4	0.4	0.6	0.4	0.4	0.4	0.4	1.2	0.8	3.6	0.8	0.7	0.7	0.1	1.1	0.8	1.5	1.3	0.7	0.8	1.2	0.7	0.4	0.3	0.4	1.3	1.3	2.1	0.7	0.6	1.1	0.7	0.5	0.8	1.0	0.9	2.2	2.2	1.2	0.4	1.6	1.6	0.6	0.6	0.7	0.7	0.5	6.6	3.1	0.3	1.3	0.8	1.7	2.0	0.8	1.1	1.6	1.9	0.4	1.8	1.7	1.1	0.7	1.0	1.0	1.0	0.9	1.6	1.2	1.2	1.2	0.7	1.7	1.4	1.3	1.0	1.1	1.2	1.7	0.8	0.5	0.7	0.5	0.6	0.6	0.6	0.5	0.3	1.2	0.7	0.7	3.6	0.7	0.7	0.8	0.5	0.1	0.4	0.6	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4
OR2B11		ENSG00000177535	"Olfactory receptor family 2 subfamily B member 11"	Q5JQS5	1	247449118-247458105	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.1"	"Cell line enriched"	"Detected in single"	5	"THP-1: 5.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047459	Uncertain									"HPA047459: AB_10963692"					"unprognostic (1.83e-1)"													1.5	0.1	0.1	1.2	0.1	3.1	0.1	0.0	0.2	0.3	0.1			0.0	0.0	0.1	0.1	0.7	1.0	0.2	0.1	0.1	0.0	0.1	0.4	0.3	0.1		0.1	1.1	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.7	0.1	0.2			0.3		0.0	0.3	0.0	0.0	0.0	0.5	1.5	0.0	0.3	0.0	0.1	0.2	0.6	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	5.0	0.6	0.1	0.4	0.1	0.1	0.1	0.1	0.4	0.9	0.6	0.1	0.5	0.8	0.0	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0										
OR2G6		ENSG00000188558	"Olfactory receptor family 2 subfamily G member 6"	Q5TZ20	1	248508073-248527337	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																																							0.2	0.2	0.2	0.2	0.2	3.2	0.2	0.2	0.2	0.3	0.2			0.6	0.2	1.1	0.2	0.2	0.1	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2		0.2	1.1	0.0	0.2	0.1		0.8	0.0		0.6	0.0	0.3	0.9	0.3	0.0	0.2	0.5	1.1	1.9			0.2		0.3	0.4	0.2	1.4	0.7	1.8	0.8	0.6	0.6	0.1	0.7	0.5	0.6	0.7	0.1	0.3	1.0	1.0	0.1	0.1	0.2	0.7	0.9	0.8	1.0	0.0	0.7	0.3	0.1	0.4	0.9	0.7	0.7	1.3	0.4	0.0	1.0	0.9	0.1	0.4	0.1	0.4	0.3	0.7	3.1	0.1	0.6	0.7	0.8	1.2	0.7	0.9	0.6	0.4	0.2	1.3	0.6	0.8	0.8	0.7	0.7	1.9	0.8	2.4	0.9	1.2	1.2	0.8	1.3	0.9	1.0	0.5	0.9	0.7	1.7	0.5	0.5	0.5	0.3	0.4	0.4	0.4	0.4	0.2	1.4	0.5	0.6	1.8	0.6	0.8	0.7	0.3	0.1										
OR2J2	"dJ80I19.4, hs6M1-6, OR6-8"	ENSG00000204700	"Olfactory receptor family 2 subfamily J member 2"	O76002	6	29170907-29175811	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.6;bone marrow: 1.5;testis: 3.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.0;Karpas-707: 2.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																																							0.0	0.0	0.3	0.4	0.7	1.5	0.0	0.0	0.0	0.2	0.0			0.2	0.0	0.5	0.0	0.6	0.2	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0		0.2	0.1	0.0	0.0	0.1		0.0	0.1		0.0	0.0	0.3	0.8	0.1	0.0	0.0	0.0	0.3	3.0			0.5		0.0	0.1	0.0	1.0	0.7	1.6	0.4	0.3	0.5	0.0	0.1	0.3	0.1	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.4	0.2	0.2	0.3	1.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.4	0.1	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.4	0.3	0.0	0.0	0.4	0.1	0.6	0.4	0.7	0.5	0.2	0.3	0.4	0.3	0.3	0.1	1.0	0.4	0.3	1.6	0.3	0.4	0.7	0.4	0.0										
OR2L3		ENSG00000198128	"Olfactory receptor family 2 subfamily L member 3"	Q8NG85	1	248046836-248063407	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.0;prostate: 4.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.8;Karpas-707: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.3	0.2	0.4	1.0	0.4	3.0	0.6	1.3	0.5	0.4	0.0			0.1	0.2	0.1	0.0	0.4	0.3	0.0	0.6	0.8	0.0	0.0	0.1	0.4	0.8		0.0	0.0	0.0	0.9	0.2		4.1	0.0		0.1	0.1	0.0	0.3	0.1	0.0	1.5	0.8	0.0	0.2			0.4		0.0	0.3	0.0	0.1	0.0	0.5	0.2	0.1	0.3	0.0	0.5	0.4	0.8	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.3	0.1	0.5	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.3	0.0	1.8	0.1	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.7	0.4	0.4	0.5	0.7	0.1	0.8	0.2	0.1	0.5	0.2	0.1	0.4	0.0	0.0	0.1	1.0	0.0	0.8	0.5	0.3	0.4	0.9	0.5	0.7	1.1	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0										
OR2L5	"OR2L11, OR2L5P"	ENSG00000197454	"Olfactory receptor family 2 subfamily L member 5"	Q8NG80	1	248013660-248024276	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"bone marrow: 1.7"	"Cell line enhanced"	"Detected in single"		"PC-3: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.1	0.1	0.3	0.2	0.6	1.7	0.0	0.7	0.6	0.5	0.1			0.0	0.1	0.5	0.0	0.2	0.2	0.0	0.5	0.5	0.0	0.0	0.1	0.3	0.5		0.0	0.0	0.0	0.3	0.2		0.4	0.0		0.0	0.2	0.6	0.5	0.0	0.1	0.5	0.6	0.0	0.5			0.3		0.5	0.2	0.0	0.6	0.2	0.7	0.3	0.1	0.4	0.0	0.1	0.4	0.0	0.1	0.4	0.3	0.6	0.5	0.1	0.0	0.1	0.4	0.5	0.1	0.1	0.6	0.4	0.0	0.6	0.0	0.0	0.0	0.3	0.9	0.6	0.0	0.2	0.5	0.0	0.0	0.2	0.3	0.0	0.0	0.5	0.0	0.3	0.1	0.1	0.1	1.2	0.4	0.2	0.2	0.0	0.2	0.1	0.0	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.4	0.7	0.1	0.0	0.1	0.0	0.0										
OR2M4	"HSHTPCRX18, HTPCRX18, OST710, TPCR100"	ENSG00000171180	"Olfactory receptor family 2 subfamily M member 4"	Q96R27	1	248231417-248244679	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 2.6"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA051308	Uncertain									"HPA051308: AB_2681435"																		0.4	0.1	0.5	0.0	0.6	2.6	0.5	0.4	1.3	0.3	0.2			0.2	0.3	1.1	0.1	0.5	0.5	0.1	0.7	1.3	0.1	1.5	0.1	0.2	1.1		0.8	1.4	0.6	0.3	0.0		0.2	0.0		0.7	0.0	0.1	1.0	0.2	0.0	1.0	0.2	0.2	0.4			0.4		0.0	0.2	0.2	1.0	0.6	2.1	0.6	1.3	0.7	0.3	0.7	0.2	0.5	0.7	1.2	2.3	0.4	0.4	0.2	0.1	0.0	0.8	0.4	0.7	0.3	0.3	0.4	0.5	0.7	0.1	0.1	0.3	1.0	1.6	0.7	0.1	1.1	0.7	1.6	0.1	0.3	0.2	0.8	0.9	1.8	0.2	0.9	0.3	0.9	0.8	0.8	1.9	0.4	0.8	0.2	1.3	1.3	1.0	0.4	0.5	0.7	0.6	0.1	1.7	0.8	0.8	0.9	0.3	1.3	0.7	0.3	0.6	1.0	1.0	1.9	0.6	0.4	0.6	0.5	0.4	0.5	0.5	0.4	0.1	1.0	0.5	0.7	2.1	1.3	0.6	0.6	0.4	0.3										
OR2T11	OR2T11Q	ENSG00000279301	"Olfactory receptor family 2 subfamily T member 11 (gene/pseudogene)"	Q8NH01	1	248623557-248635091	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.4;bone marrow: 1.1"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"																																							0.1	0.0		0.0		1.1	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.6	0.0	0.0	0.1			0.0	0.0	0.0		0.0		0.0	0.0		0.5	0.0	0.2	0.5	0.1	0.0		0.0	0.2	0.5			0.0		0.0	0.0		1.1	0.4	1.4	0.3	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.3	0.7	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.2	0.4	0.0	0.2	0.3	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.0	1.1	0.0	0.1	1.4	0.3	0.2	0.4	0.1	0.0										
OR2T33		ENSG00000177212	"Olfactory receptor family 2 subfamily T member 33"	Q8NG76	1	248269917-248277976	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 2.2;thyroid gland: 2.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.1;PC-3: 1.8;U-2197: 1.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"																															"unprognostic (5.79e-2)"						"unprognostic (2.22e-1)"		0.1	0.2	0.4	0.2	1.0	2.2	0.1	0.0	0.8	0.5	0.1			0.5	0.0	0.5	0.1	0.2	0.3	0.0	0.2	1.1	0.1	0.2	0.0	0.2	0.8		0.5	0.0	0.0	0.1	0.1		0.5	0.0		1.5	0.0	0.7	0.3	0.6	0.0	0.1	0.3	0.7	1.7			2.4		0.1	0.6	0.0	0.6	0.9	1.3	0.3	0.4	0.7	0.0	0.6	0.0	0.3	0.4	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.4	2.1	0.5	0.0	0.6	0.0	0.0	0.0	0.6	0.1	1.7	0.7	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.6	0.5	0.7	0.4	1.8	0.3	0.5	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.3	0.1	0.4	0.6	0.7	0.9	1.8	0.1	0.8	0.3	0.8	0.2	1.2	0.5	1.3	0.2	0.3	0.5	0.3	0.3	0.6	0.4	0.4	0.2	0.6	0.7	0.7	0.7	0.4	0.3	0.9	0.2	0.0										
OR2T8	OR2T8P	ENSG00000177462	"Olfactory receptor family 2 subfamily T member 8"	A6NH00	1	247920252-247921956	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 2.4;thyroid gland: 3.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;HEL: 3.0;PC-3: 2.1;U-2 OS: 1.3;U-937: 2.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (7.26e-2)"									"unprognostic (4.16e-1)"		"unprognostic (2.88e-1)"			"unprognostic (1.06e-1)"	"unprognostic (2.83e-2)"		0.1	0.0	0.3	0.1	1.1	2.4	0.2	0.0	0.7	0.2	0.1			0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.6		0.0	0.0	0.0	0.0	0.3		0.5	0.4		0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	1.4			3.8		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.4	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0										
OR2V2	"OR2V3, OST713"	ENSG00000182613	"Olfactory receptor family 2 subfamily V member 2"	Q96R30	5	181147586-181159285	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 2.8;bone marrow: 2.5;fallopian tube: 2.2"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 2.8"	"Low lineage specificity"	"Detected in single"											HPA049953	Uncertain									"HPA049953: AB_2680971"																		0.3	0.2	0.2	0.3	0.2	2.5	0.1	0.3	0.3	0.3	0.1			0.1	0.2	0.0	0.2	2.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.5	0.2		0.2	0.7	0.0	0.1	0.0		0.1	0.0		0.2	0.0	0.2	0.9	0.3	0.0	0.1	0.3	0.4	0.7			0.4		0.0	0.2	0.1	0.7	0.4	2.8	0.3	0.5	0.3	0.1	0.4	0.8	0.5	0.8	0.2	0.0	0.4	0.2	0.1	0.0	0.3	0.4	1.0	0.2	0.2	0.0	0.6	0.2	0.1	0.1	0.1	0.7	0.8	1.9	0.7	0.0	0.6	1.0	0.1	0.1	0.0	0.0	0.0	0.5	1.1	0.0	1.5	0.6	0.4	0.4	0.6	0.4	0.2	0.4	0.0	0.8	0.6	0.5	0.5	1.7	0.4	0.7	1.4	0.4	0.4	0.7	0.7	0.2	0.8	0.3	0.2	0.5	0.7	0.1	2.8	0.3	0.6	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.7	0.3	0.3	1.6	0.5	0.3	0.4	0.2	0.1										
OR4D9		ENSG00000172742	"Olfactory receptor family 4 subfamily D member 9"	Q8NGE8	11	59511368-59520703	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 4.6;bone marrow: 3.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																																							0.2	0.2	0.2	0.5	0.2	3.4	0.2	0.2	0.3	0.5	0.3			1.4	0.4	0.3	0.2	0.4	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2		0.2	0.3	0.0	0.2	0.1		0.2	0.4		0.5	0.0	0.3	1.4	0.7	0.0	0.2	0.5	0.3	0.5			0.2		0.0	0.7	0.3	1.6	1.0	4.6	1.1	1.6	0.8	0.5	0.8	0.8	0.5	1.2	0.0	0.6	1.0	0.7	0.0	0.3	0.5	1.2	1.4	1.0	0.5	0.4	1.4	0.5	0.5	0.4	0.7	0.7	1.2	3.1	0.9	0.1	0.8	1.2	0.2	0.3	0.5	0.4	0.3	1.3	2.8	0.2	1.2	0.6	1.8	1.0	1.0	1.2	0.6	0.3	0.2	1.2	1.3	0.7	0.7	1.0	1.9	1.0	0.9	1.0	1.6	1.0	1.5	0.9	1.2	0.6	1.1	0.9	1.2	1.0	3.4	1.1	0.9	0.7	0.6	0.5	0.9	0.6	0.6	0.5	1.6	0.7	0.8	4.6	1.6	0.5	1.0	0.4	0.5										
OR4E1	OR4E1P	ENSG00000276240	"Olfactory receptor family 4 subfamily E member 1 (gene/pseudogene)"		14	21667940-21673818	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 2.9;bone marrow: 1.4"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"																															0.0	0.0		0.8		1.4	0.0		0.2	0.0	0.0			0.0	0.2	0.1	0.0	0.0	0.1	0.0			0.0	0.0	0.2	1.0			0.0	0.0	0.1		0.0		0.4	0.1		0.0	0.0	0.4	0.9	0.0	0.0		0.8	0.1	0.4			0.2		0.1	0.0		1.3	0.4	2.9	0.5	0.9	1.1	0.0	0.3	0.2	0.3	0.5	0.2	0.0	0.2	0.7	0.0	0.3	0.0	0.4	0.6	0.2	0.4	0.0	0.5	0.0	0.0	0.6	0.3	0.0	0.8	1.2	0.5	0.0	0.0	0.3	0.8	0.7	0.3	0.1	0.1	0.1	0.3	0.5	0.4	0.1	0.5	0.3	0.5	0.1	0.0	0.2	0.3	0.2	0.8	0.0	0.6	0.6	0.3	0.5	0.0	0.7	1.1	0.4	0.6	0.4	0.6	0.3	0.0	0.0	0.8	0.2	2.0	0.5	0.3	0.5	0.3	0.8	0.7	0.5	0.4	0.1	1.3	1.1	1.1	2.9	0.9	0.2	0.4	0.3	0.0										
OR4K17		ENSG00000176230	"Olfactory receptor family 4 subfamily K member 17"	Q8NGC6	14	20110739-20122199	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.5;liver: 7.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																																							0.2	0.2	0.2	0.4	0.2	3.5	0.2	0.2	0.3	1.0	0.3			0.7	0.4	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.4	7.7	0.2	0.5	0.3		0.2	0.3	0.0	0.2	0.0		0.3	0.0		0.4	0.0	1.3	0.9	0.2	0.0	0.2	0.3	0.3	0.4			0.3		0.0	0.4	0.3	1.3	1.2	3.0	1.3	1.4	1.3	0.5	1.3	1.3	1.5	1.5	0.2	0.2	1.8	0.4	0.0	0.1	0.2	1.3	1.8	2.1	1.1	0.2	1.2	0.2	0.6	0.2	1.9	1.1	2.5	2.0	0.8	0.3	2.5	1.9	0.4	0.4	0.5	0.4	0.3	2.3	2.3	0.1	1.9	1.1	2.8	1.9	1.0	1.0	1.5	1.4	0.2	2.0	1.3	1.5	2.0	1.4	0.6	1.4	1.2	1.0	1.4	0.8	1.2	1.0	2.5	1.2	2.4	1.4	1.4	0.6	3.0	1.0	1.4	0.8	1.0	0.9	1.0	1.0	0.9	0.6	1.3	1.3	1.2	2.7	1.4	1.3	1.2	0.9	0.5										
OR4P4	OR4P3P	ENSG00000181927	"Olfactory receptor family 4 subfamily P member 4"	Q8NGL7	11	55635113-55640309	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 1.6;bone marrow: 2.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;MOLT-4: 1.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA059458	Uncertain									"HPA059458: AB_2684027"																		0.1	0.3	0.1	0.0	0.1	2.2	0.1	0.1	0.3	0.4	0.1			0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1		0.5	0.1	0.0	0.1	0.0		0.1	0.0		0.1	0.0	0.7	1.3	0.2	0.0	0.1	0.2	0.1	0.2			0.1		0.0	0.3	0.1	0.7	0.4	1.6	0.2	1.3	0.4	0.2	0.1	0.7	0.2	0.7	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	0.2	0.2	0.2	0.1	0.7	0.8	0.2	1.7	0.5	0.0	0.5	0.7	0.0	0.0	0.2	0.8	0.1	0.0	0.4	0.0	0.0	1.6	1.1	0.6	0.0	0.2	0.2	1.1	0.0	0.8	0.3	0.6	0.2	0.3	0.7	0.7	0.1	0.0	0.7	0.0	0.0	0.2	0.4	0.3	0.3	0.4	0.4	0.4	0.9	0.1	0.4	0.4	0.2	0.3	0.4	0.2	0.3	0.1	0.7	0.3	0.3	1.6	1.3	0.2	0.4	0.0	0.2										
OR4X2		ENSG00000172208	"Olfactory receptor family 4 subfamily X member 2 (gene/pseudogene)"	Q8NGF9	11	48245056-48246080	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"bone marrow: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0			0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0										
OR51V1	OR51A12	ENSG00000176742	"Olfactory receptor family 51 subfamily V member 1"	Q9H2C8	11	5199735-5200700	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"bone marrow: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	9	"olfactory region: 0.3"																													0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.2	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR52A5		ENSG00000171944	"Olfactory receptor family 52 subfamily A member 5"	Q9H2C5	11	5128776-5138356	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"bone marrow: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.8	0.5	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR52K1		ENSG00000196778	"Olfactory receptor family 52 subfamily K member 1"	Q8NGK4	11	4482646-4493497	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.1;bone marrow: 3.9"	"Cell line enhanced"	"Detected in many"		"RT4: 7.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in many"																																							0.3	0.3	0.3	0.8	0.3	3.9	0.2	0.2	0.3	0.3	0.3			0.5	0.3	0.5	0.3	0.3	0.2	0.2	0.3	0.2	0.9	0.8	0.5	0.9	0.4		1.2	0.3	0.0	0.2	1.4		0.3	0.1		0.3	0.0	0.4	1.2	1.8	0.0	0.5	0.9	0.2	1.1			0.3		0.6	0.4	0.4	0.6	0.6	3.1	1.4	0.3	0.5	0.3	0.9	1.8	1.4	1.5	0.3	0.2	0.9	1.3	0.3	0.8	0.8	1.8	1.4	1.1	1.2	0.7	1.7	1.3	0.7	1.0	0.6	0.8	1.4	5.0	1.9	0.1	0.7	2.0	0.4	0.3	0.8	0.7	0.6	0.8	2.6	2.1	1.0	0.5	1.5	0.7	1.1	1.8	1.0	0.8	0.5	7.4	1.6	0.7	0.4	0.6	0.3	1.1	0.5	0.3	2.5	0.7	0.8	2.6	1.4	0.7	0.7	0.6	2.4	1.6	0.7	1.4	0.4	0.4	1.2	0.2	0.3	0.3	0.5	0.6	0.6	0.4	0.5	3.1	0.3	1.3	0.3	0.3	0.3										
OR52N1		ENSG00000181001	"Olfactory receptor family 52 subfamily N member 1"	Q8NH53	11	5786471-5791265	"Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.8;bone marrow: 1.4"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA054028	Uncertain									"HPA054028: AB_2682348"																		1.8	0.0	0.0	0.3	0.0	1.4	0.3	0.0	0.2	0.0	0.1			0.0	0.4	0.1	0.1	0.2	0.9	0.2	0.0	0.0	0.1	0.1	0.2	0.2	0.1		0.1	0.1	0.0	0.1	0.1		0.3	0.0		0.1	0.0	0.3	0.1	0.6	0.0	0.0	0.2	0.1	0.4			0.0		0.0	0.1	0.0	0.5	0.7	1.2	0.6	1.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.3	0.0	0.1	0.7	0.5	0.0	0.2	0.3	0.0	0.1	0.0	0.7	0.8	0.7	0.2	0.1	0.2	0.0	0.1	0.4	0.6	1.2	0.6	0.2	0.5	0.4	0.6	0.5	0.7	0.6	0.0	0.5	0.7	0.7	0.5	1.0	0.5	0.7	0.1	0.0										
OR52W1	OR52W1P	ENSG00000175485	"Olfactory receptor family 52 subfamily W member 1"	Q6IF63	11	6199146-6200259	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"bone marrow: 1.9"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.33e-1)"				"unprognostic (1.91e-1)"				0.0	0.0	0.1	0.2	0.7	1.9	0.0	0.8	0.4	0.0	0.3			0.5	0.3	0.0	0.2	0.2	0.1	0.0	0.2	0.1	0.2	0.2	0.3	0.1	0.0		0.0	0.2	0.0	0.0	0.1		0.0	0.0		0.5	0.0	0.0	0.7	0.3	0.0	0.0	0.3	0.2	0.2			0.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.4	0.4	0.0	0.3	0.9	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR56A1		ENSG00000180934	"Olfactory receptor family 56 subfamily A member 1"	Q8NGH5	11	6019336-6034338	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 1.8;testis: 2.7"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"																																							0.1	0.1	0.1	0.2	0.1	1.8	0.1	0.1	0.2	0.1	0.4			0.0	0.2	0.8	0.1	0.2	0.5	0.1	0.1	0.2	0.3	0.8	0.1	0.6	0.1		0.2	0.1	0.1	0.1	0.2		0.2	0.1		0.4	0.0	0.1	0.3	0.1	0.0	0.1	0.3	0.1	2.7			0.3		0.0	0.2	0.1	0.8	0.4	0.8	0.1	0.6	1.2	0.1	0.5	0.1	0.9	0.6	0.1	0.6	0.3	0.7	0.6	0.5	0.2	0.2	1.1	1.0	1.2	0.2	0.7	0.1	0.0	1.0	0.4	0.4	0.6	0.7	0.8	0.2	1.0	0.8	0.3	1.3	0.6	0.2	0.2	0.9	0.9	0.2	1.0	0.2	0.6	1.3	0.4	0.6	0.8	0.1	0.5	0.9	0.6	0.9	0.1	0.6	0.5	0.6	0.6	0.6	1.0	1.0	0.5	0.3	1.1	0.7	0.5	0.5	0.5	0.6	0.7	0.1	0.4	0.6	0.0	1.0	0.5	1.0	0.8	0.1	0.8	1.2	0.9	0.8	0.6	0.1	0.4	0.5	0.1										
OR56A4		ENSG00000183389	"Olfactory receptor family 56 subfamily A member 4"	Q8NGH8	11	5999445-6006946	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.2;bone marrow: 1.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"																																							0.3	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.1	0.4	0.1			0.1	0.0	0.4	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1		0.1	0.1	0.0	0.1	0.0		0.1	0.0		1.3	0.0	0.4	0.6	0.4	0.0	0.1	0.1	0.1	1.0			0.1		0.0	0.0	0.1	0.5	0.4	2.2	0.5	0.4	0.4	0.0	0.7	0.2	0.2	0.3	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.6	0.9	0.5	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.5	1.2	0.1	0.0	0.8	0.7	0.1	0.0	0.1	0.0	0.0	0.2	2.1	0.1	0.5	0.0	0.5	0.9	0.4	0.1	0.1	0.0	0.0	0.5	0.4	0.7	0.5	0.2	0.3	0.5	0.0	1.3	0.4	1.3	0.2	0.4	0.8	0.6	0.4	0.5	0.2	0.4	0.6	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.2	0.5	0.4	0.4	2.2	0.4	0.5	0.4	0.2	0.0										
OR5A1	"OR5A1P, OST181"	ENSG00000172320	"Olfactory receptor family 5 subfamily A member 1"	Q8NGJ0	11	59436469-59451380	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.4;bone marrow: 2.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"																																	"unprognostic (1.73e-2)"		0.2	0.4	0.2	0.4	0.2	2.4	0.2	0.2	0.3	0.7	0.3			0.1	0.3	1.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.5	0.2		0.5	0.3	0.0	0.2	0.1		0.2	0.0		0.4	0.0	0.5	2.0	0.4	0.0	0.2	0.5	0.3	1.6			0.4		0.0	0.3	0.2	0.8	0.4	2.4	0.3	0.3	0.5	0.0	0.7	0.3	0.8	1.2	0.5	0.3	0.8	0.6	0.1	0.1	0.1	0.8	0.7	1.3	0.6	0.1	0.7	0.3	0.0	0.1	0.7	0.9	0.9	2.5	0.6	0.1	0.7	1.7	0.0	0.3	0.1	0.1	0.1	1.0	3.4	0.3	0.7	0.8	1.0	1.3	0.7	0.7	0.7	1.3	0.2	1.5	1.0	0.8	0.7	0.4	0.4	1.2	0.7	0.6	0.9	1.0	0.9	0.7	1.2	1.0	0.8	1.1	1.0	0.8	0.9	0.3	0.2	0.5	0.2	0.3	0.4	0.3	0.3	0.1	0.8	0.4	0.4	2.4	0.3	0.2	0.4	0.1	0.0										
OR5AN1		ENSG00000176495	"Olfactory receptor family 5 subfamily AN member 1"	Q8NGI8	11	59358895-59371714	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.5;bone marrow: 2.2"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 2.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in single"																																							0.1	0.0	0.0	0.0	0.1	2.2	0.1	0.1	0.1	0.8	0.1			0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.0		0.3	0.8	0.0	0.0	0.0		0.1	0.0		0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.2	0.1	0.2			0.1		0.0	0.4	0.1	0.1	1.5	0.7	0.4	0.0	0.1	0.0	0.4	0.1	0.2	0.5	0.0	0.5	0.2	0.7	0.5	0.1	0.1	0.2	0.1	1.0	0.2	1.4	0.2	0.2	0.8	0.4	0.4	0.3	0.6	0.7	0.7	0.0	0.3	0.4	0.0	0.0	0.5	2.5	0.1	0.7	1.2	0.7	1.1	0.1	0.4	0.3	1.5	0.6	0.4	0.0	0.0	0.3	0.4	0.0	0.3	0.0	0.2	0.2	0.2	1.4	0.4	1.3	0.8	0.3	0.4	0.5	0.7	0.7	0.2	0.3	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.7	0.0	0.0	1.5	0.0	0.0										
OR5AU1		ENSG00000169327	"Olfactory receptor family 5 subfamily AU member 1"	Q8NGC0	14	21148370-21159060	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.3;bone marrow: 2.4"	"Cell line enhanced"	"Detected in some"		"U-2197: 4.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																															0.1	0.1	0.2	0.1	0.3	2.4	0.6	0.1	0.3	0.4	0.2			0.4	0.2	0.5	0.2	0.1	0.2	0.1	0.2	0.3	0.1	0.1	0.2	0.4	0.2		0.2	0.1	0.0	0.1	0.1		0.2	0.0		0.4	0.9	1.7	0.6	0.4	0.0	0.1	0.4	0.2	0.9			0.3		0.0	0.1	0.5	0.8	0.8	2.3	0.7	0.7	0.4	0.0	0.3	0.4	0.3	0.3	0.2	0.1	0.5	0.4	0.0	0.0	0.0	0.7	0.6	0.3	0.3	0.2	0.7	0.1	0.0	0.1	0.3	0.2	0.7	0.9	0.7	0.3	0.6	0.6	0.1	0.0	0.1	0.2	0.1	0.7	1.0	0.1	0.5	0.3	0.9	0.4	0.1	0.5	0.7	0.3	0.1	0.7	0.7	0.6	0.6	1.6	0.1	0.3	0.1	0.1	0.6	0.4	4.4	0.3	0.6	0.3	0.4	0.4	1.0	0.5	1.1	0.7	0.4	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.8	0.4	0.3	2.3	0.7	0.3	0.8	0.2	0.0										
OR5B2	OST073	ENSG00000172365	"Olfactory receptor family 5 subfamily B member 2"	Q96R09	11	58421264-58428121	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 1.8"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.2	0.6	0.0	0.0	0.1	1.8	0.5	0.4	0.3	0.5	0.1			0.0	0.2	0.2	0.3	0.4	0.4	0.1	0.1	0.1	0.4	0.3	0.3	0.6	0.0		0.6	0.1	0.3	0.2	0.3		0.4	0.3		0.2	0.3	0.3	0.5	0.5	0.0	0.1	0.5	0.2	1.0			0.2		0.1	0.7	0.2	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.6	0.3	0.5	0.2	0.0	0.6	0.0	0.8	0.4	0.2	0.0	0.2	0.3	1.4	0.3	0.8	0.3	0.1	0.2	0.6	0.9	0.2	1.3	1.0	0.0	0.0	0.4	1.2	1.1	0.5	0.4	0.4	0.0	0.3	1.3	0.7	0.5	1.7	0.7	0.3	0.2	1.0	0.3	0.3	0.0	0.1	0.1	0.0	0.0	0.6	0.7	1.0	0.5	0.0	0.3	0.1	0.2	0.8	0.4	0.1	0.4	0.2	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0										
OR6J1	"OR6J1P, OR6J2"	ENSG00000255804	"Olfactory receptor family 6 subfamily J member 1 (gene/pseudogene)"	Q8NGC5	14	22630929-22644352	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 3.3;bone marrow: 3.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in single"																															0.3	0.2	0.7	0.7	0.6	3.4	0.3	0.3	1.0	0.3	0.2			0.3	0.5	0.9	0.3	0.2	0.3	0.2	0.5	0.3	0.3	0.3	0.4	0.4	0.7		0.4	0.5	0.0	0.3	0.0		0.3	0.1		0.7	0.0	1.0	1.5	0.6	0.0	0.4	0.6	0.6	0.6			0.4		0.0	0.1	0.4	0.9	0.8	3.3	0.8	1.1	0.9	0.4	1.1	0.6	1.3	1.3	0.2	0.4	2.1	0.3	0.0	0.2	0.1	1.5	1.0	0.9	0.6	0.0	1.0	0.2	0.2	0.2	1.9	0.8	0.6	2.8	1.6	0.0	1.2	1.8	0.1	0.6	0.3	0.3	0.1	0.6	2.4	0.6	1.2	1.2	1.0	1.1	0.8	1.0	0.7	0.6	0.2	1.8	1.7	1.4	1.4	1.1	0.7	1.2	0.5	1.6	1.0	1.1	1.1	0.4	1.1	0.7	1.3	0.7	1.2	0.6	3.1	0.8	1.1	0.7	0.6	0.7	0.5	0.7	0.5	0.2	0.9	0.7	0.9	3.3	1.1	0.6	0.8	0.6	0.4										
OR6K3		ENSG00000203757	"Olfactory receptor family 6 subfamily K member 3"	Q8NGY3	1	158716327-158720720	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 10.4;bone marrow: 4.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in many"	6	"basophil: 10.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055949	Uncertain									"HPA055949: AB_2682982"																		0.1	0.1	0.0	0.0	0.1	4.8	0.1	0.1	0.1	0.2	0.1			0.3	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	2.2	0.3	0.1		0.2	0.1	0.1	0.1	0.1		0.1	0.0		0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.5	0.1	0.4			0.1		0.0	0.2	0.1	1.3	1.0	10.4	0.9	0.9	1.5	0.3	0.2	0.3	0.1	0.9	0.6	0.2	0.5	0.2	0.4	0.4	0.2	0.6	0.7	1.1	0.3	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.5	0.2	0.8	0.3	0.8	0.6	0.3	1.8	0.3	0.5	2.7	0.1	0.6	0.3	1.0	0.1	0.0	0.4	0.2	0.4	0.2	0.6	0.4	0.0	0.0	0.3	0.1	0.2	0.0	1.6	0.6	0.5	0.4	0.1	0.6	0.6	0.6	0.0	0.6	0.7	10.4	0.9	0.9	1.3	0.8	1.4	1.1	1.3	1.0	0.4	1.3	1.4	1.5	1.7	0.9	0.7	1.0	0.9	0.3										
OR8H2		ENSG00000181767	"Olfactory receptor family 8 subfamily H member 2"	Q8N162	11	56103687-56107658	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 3.1;bone marrow: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"basophil: 3.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 3.1"																																					0.3	0.1	0.0	0.1	0.0	1.3	0.0	0.0	0.3	0.5	0.1			0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0		0.1	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.3			0.0		0.0	0.7	0.1	0.2	0.1	3.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.5	0.0	0.2	0.0	0.1	0.9	0.0	0.5	0.3	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.1	3.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.9	0.2	0.0	0.1	0.0	0.0										
OR9A4		ENSG00000258083	"Olfactory receptor family 9 subfamily A member 4"	Q8NGU2	7	141916399-141920625	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 1.9;epididymis: 1.0;testis: 1.0"	"Cell line enriched"	"Detected in single"	6	"U-937: 5.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																												"unprognostic (2.77e-1)"			0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.1	0.2	0.0			0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.6	0.0	0.0	0.4	0.1	0.0	1.0			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1										
ORC1	"HSORC1, ORC1L, PARC1"	ENSG00000085840	"Origin recognition complex subunit 1"	Q13415	1	52372829-52404459	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.9;lymphoid tissue: 29.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"NK-cell: 7.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA027439, HPA027450"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA027439: , HPA027450: AB_10602041"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-3)"	"prognostic favourable (1.74e-5)"	"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (3.22e-5)"	"unprognostic (3.77e-3)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.70e-3)"	"unprognostic (8.39e-2)"	"unprognostic (1.25e-10)"	"unprognostic (4.56e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.57e-2)"	0.9	1.2	0.2	9.9	0.4	22.9	0.8	1.4	1.1	1.1	3.4	0.4	0.1	1.4	0.6	1.5	5.3	0.5	0.8	0.9	0.3	0.4	1.0	1.1	1.4	5.7	0.3	0.4	1.0	0.7	0.2	0.9	1.6	0.9	0.8	3.8	0.5	1.4	0.8	0.9	2.0	3.0	0.7	0.4	4.2	1.2	8.7	0.5	29.1	0.5	8.0	11.3	1.0	1.7	1.0	1.3	0.7	0.4	7.5	2.3	0.7	7.3	8.1	13.1	8.6	0.3	1.1	12.7	5.3	4.8	15.5	16.1	9.9	4.2	16.9	4.6	3.3	10.2	19.2	6.6	13.6	7.2	11.0	20.3	12.0	9.8	0.0	27.2	11.7	0.6	0.3	15.2	1.7	4.6	23.6	8.3	5.0	5.5	21.3	12.9	29.0	11.6	23.0	20.4	16.6	2.7	9.7	7.4	6.2	12.1	7.4	4.1	4.0	11.0	2.1	6.3	9.1	9.9	13.0	4.3	11.5	21.0	6.3	20.3	7.6	0.1	0.2	0.0	0.5	0.3	0.6	0.4	0.8	0.8	1.3	1.0	0.3	0.7	0.7	7.5	0.4	0.1	2.3	0.7	0.2	0.4	1.4	1.1	0.3	0.4	0.3	0.4	0.9	0.5
ORC6	ORC6L	ENSG00000091651	"Origin recognition complex subunit 6"	Q9Y5N6	16	46689643-46698394	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;lymphoid tissue: 12.8;testis: 23.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016330, HPA072587"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	Nucleoplasm	"CAB016330: AB_670295, HPA072587: AB_2686537"	"unprognostic (3.47e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.15e-6)"	"unprognostic (1.36e-2)"	"prognostic unfavourable (3.53e-4)"	"prognostic favourable (1.48e-4)"	"unprognostic (1.50e-4)"	"unprognostic (3.97e-2)"	"unprognostic (3.90e-14)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.98e-2)"	0.8	1.4	4.1	8.9	7.0	14.2	1.1	3.8	6.1	1.3	2.8	1.2	1.4	2.7	1.5	1.9	6.7	0.9	1.2	2.3	4.4	3.5	0.8	1.6	1.5	10.6	3.1	4.5	0.9	0.6	0.3	1.2	5.2	2.4	0.8	3.1	0.5	1.4	0.6	0.4	1.9	2.7	1.7	2.9	4.1	1.5	23.1	1.4	12.8	0.9	4.2	10.7	2.6	2.0	4.1	3.4	1.0	2.6	2.8	4.1	2.5	10.7	10.0	15.9	12.4	2.0	2.5	11.8	19.3	7.2	21.3	11.2	14.0	6.6	12.5	10.1	3.6	11.0	20.4	5.3	18.1	6.4	16.5	10.4	5.3	14.1	2.4	16.9	10.9	0.7	0.9	11.6	6.1	7.0	12.5	6.4	12.9	9.5	22.7	21.2	17.6	27.4	27.4	29.2	12.7	5.2	3.7	19.1	11.3	9.8	10.9	6.7	5.8	13.4	4.2	19.7	13.3	12.4	18.1	4.9	6.6	43.6	8.3	11.1	15.2	0.0	1.1	1.0	3.5	2.6	1.4	2.7	2.0	2.0	2.2	4.1	2.9	1.4	0.5	2.8	2.5	3.4	4.1	2.5	4.1	7.0	3.8	6.1	4.4	3.5	3.1	4.5	2.4	1.4
OSBP2	"KIAA1664, ORP-4, ORP4, OSBPL1"	ENSG00000184792	"Oxysterol binding protein 2"	Q969R2	22	30693782-30907824	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.1;retina: 45.7"	"Cell line enhanced"	"Detected in many"		"HEL: 15.2;HeLa: 54.7;hTERT-HME1: 14.6;SiHa: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021514	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA021514: AB_1854813"	"unprognostic (2.89e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.31e-1)"	"prognostic favourable (3.79e-6)"	"unprognostic (9.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	1.0	8.5	5.7	2.3	11.6	36.1	1.2	17.0	14.4	1.4	1.6	8.5	1.3	6.3	1.9	13.0	3.3	2.0	2.7	10.0	7.7	5.6	2.1	0.7	1.8	1.9	7.1	6.2	1.7	4.9	8.8	14.1	4.0	7.3	2.2	1.7	45.7	2.5	2.4	2.3	4.6	4.6	1.2	6.4	3.4	3.2	19.6	5.5	0.0	2.9	0.3	1.3	4.3	2.2	1.9	1.6	2.5	3.1	2.7	3.2	6.2	2.6	5.7	0.5	2.5	0.3	2.2	0.6	0.5	1.2	1.8	1.8	5.1	1.4	4.5	2.2	0.7	1.5	2.3	0.2	1.3	2.4	0.7	15.2	54.7	0.9	0.3	0.1	0.9	0.1	6.3	4.5	14.6	4.5	9.5	0.2	4.1	2.8	0.4	1.6	1.4	5.2	1.3	0.2	0.2	0.2	0.9	6.4	2.6	14.6	1.5	0.1	1.8	0.8	3.2	1.3	6.9	1.2	2.5	1.2	1.6	0.8	5.1	0.0	1.0	0.6	1.8	1.1	1.5	3.1	3.1	1.7	2.9	1.4	1.6	1.9	3.0	3.2	2.5	2.7	2.3	0.7	1.9	6.2	5.7	11.6	17.0	14.4	7.7	5.6	7.1	6.2	7.3	5.5
OSM	MGC20461	ENSG00000099985	"Oncostatin M"	P13725	22	30262829-30266840	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 24.9;bone marrow: 63.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 15.9;HL-60: 3.9;HMC-1: 11.7;Karpas-707: 3.6;NB-4: 6.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 24.9;neutrophil: 17.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 24.9"					"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (5.15e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.02e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (1.03e-5)"	"unprognostic (4.00e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.82e-1)"	5.3	2.6	0.9	8.5	2.5	63.0	3.7	0.7	1.7	1.6	1.0	5.3	0.4	0.6	1.2	1.9	0.8	3.8	4.1	2.2	3.8	1.7	1.9	1.8	11.4	9.4	2.0	0.0	3.0	1.0	1.0	2.5	6.4	5.9	1.2	0.7	1.8	1.4	0.5	1.7	0.4	1.0	2.1	7.8	6.9	1.4	2.3	1.2	0.6	1.1	0.5	2.2	6.8	0.9	0.1	0.4	24.9	0.2	1.9	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.3	0.0	0.0	0.0	3.9	11.7	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.5	6.7	0.0	0.0	0.6	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.4	0.0	24.9	0.2	0.9	1.0	0.1	3.4	0.0	2.5	1.3	0.4	0.1	0.5	1.2	17.5	1.9	0.0	0.1	0.7	0.8	0.9	2.5	0.7	1.7	3.8	1.7	2.0	0.0	5.9	1.2
PABPN1L	ePABP2	ENSG00000205022	"Poly(A) binding protein nuclear 1 like, cytoplasmic"	A6NDY0	16	88863333-88866660	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 3.6;bone marrow: 3.0;brain: 5.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.9;NB-4: 3.4;SCLC-21H: 9.3;T-47d: 2.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 3.6"	HPA043415	Uncertain									"HPA043415: AB_10981610"	"unprognostic (2.19e-1)"							"unprognostic (1.50e-2)"			"unprognostic (1.40e-3)"	"unprognostic (8.96e-3)"		"unprognostic (1.57e-1)"	"unprognostic (3.19e-1)"			0.5	3.6	0.0	0.2	1.1	3.0	0.1	5.3	0.5	0.0	0.1			0.1	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.1	0.0	0.3	0.2	1.1	0.0		0.1	1.8	0.0	0.3	0.0		0.8	0.0		0.3	0.0	0.6	0.0	0.4	0.0	0.0	1.1	0.0	0.5			0.0		0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.9	0.6	3.4	0.0	0.0	0.2	0.4	0.3	0.0	0.0	9.3	0.2	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0										
PARVG		ENSG00000138964	"Parvin gamma"	Q9HBI0	22	44172956-44219533	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.4;bone marrow: 31.2;lymphoid tissue: 27.7"	"Group enriched"	"Detected in some"	4	"HL-60: 43.8;NB-4: 16.9;THP-1: 24.8;U-937: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031833, HPA031834"	Uncertain									"HPA031833: AB_2674063, HPA031834: AB_10601242"	"unprognostic (9.83e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.06e-1)"	"prognostic favourable (4.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavourable (3.43e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.89e-2)"	8.0	2.9	3.5	22.2	6.9	31.2	2.7	1.2	3.1	3.5	3.5	4.9	0.8	2.7	1.9	2.7	1.9	3.1	4.5	3.5	4.2	3.3	3.1	3.1	13.1	20.3	8.9	1.5	1.6	2.0	0.5	2.1	2.3	5.4	2.6	2.7	2.5	5.2	1.0	1.0	1.7	10.1	2.2	10.8	27.7	3.1	1.7	5.6	19.7	2.4	0.0	18.8	4.5	5.9	8.4	18.5	27.4	23.6	4.8	6.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	43.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	16.9	0.0	0.0	3.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	24.8	0.0	0.0	4.7	0.1	0.0	0.1	0.0	0.1	0.0	20.6	0.7	3.6	23.6	25.3	5.5	21.3	5.5	8.3	3.3	6.0	18.5	8.4	3.7	4.2	27.4	4.8	22.6	12.6	4.4	14.2	3.5	6.9	1.2	3.1	4.2	3.3	8.9	1.5	5.4	5.6
PBOV1	"UC28, UROC28"	ENSG00000254440	"Prostate and breast cancer overexpressed 1"	Q9GZY1	6	138215986-138218491	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.5;bone marrow: 1.9;brain: 1.9"	"Cell line enhanced"	"Detected in single"		"MCF7: 1.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"											HPA063021	Uncertain									"HPA063021: AB_2684923"	"unprognostic (3.32e-3)"							"unprognostic (8.23e-2)"		"unprognostic (9.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.77e-2)"		"unprognostic (2.51e-1)"			"unprognostic (1.35e-4)"	0.0	0.0	0.2	0.0	0.3	1.9	0.2	1.9	0.2	0.0	0.0			0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.3	0.2	1.1	0.1	0.1	0.0	0.1		0.0	0.8	0.7	0.3	0.0		0.5	0.0		0.5	0.0	0.2	0.5	0.2	0.1	0.2	0.2	0.3	0.2			0.2		0.0	0.0	0.0	0.8	0.4	2.5	0.4	1.1	0.4	0.1	0.0	0.5	0.1	0.8	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.8	0.3	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.2	1.0	0.4	0.8	0.4	0.0	0.3	0.1	0.3	0.0	0.4	0.3	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.2	0.9	0.1	0.0	0.4	0.1	0.0	2.5	0.4	0.3	0.2	0.2	0.1	0.4	0.2	0.3	0.1	0.8	0.4	0.4	2.0	1.1	0.2	0.4	0.1	0.1										
PCLAF	"KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15"	ENSG00000166803	"PCNA clamp associated factor"	Q15004	15	64364311-64387687	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 42.1;lymphoid tissue: 78.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"T-reg: 24.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 24.2"									HPA047929			Supported	Centrosome				Centrosome	Centrosome	"HPA047929: AB_2680215"	"unprognostic (5.34e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (4.38e-3)"	"unprognostic (1.91e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.56e-3)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (9.77e-15)"	"unprognostic (5.59e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.22e-1)"	2.1	1.8	0.7	24.5	0.8	42.1	2.6	0.4	0.8	1.8	7.7	0.6	1.0	4.6	1.6	2.8	18.8	0.6	4.0	2.2	0.8	1.0	2.5	3.0	4.0	21.8	1.4	0.4	0.9	1.4	0.1	0.6	5.1	0.7	1.6	10.1	0.5	3.1	0.4	0.9	2.8	8.1	1.6	1.9	10.9	4.9	3.0	0.5	78.3	1.2	18.0	20.7	4.3	5.7	2.2	3.2	2.0	0.4	5.2	24.2	2.7	30.4	35.2	30.0	19.1	3.1	11.3	21.9	23.5	20.9	45.3	65.8	39.5	29.0	58.5	8.4	11.9	22.9	74.7	18.2	51.3	37.1	26.8	57.3	37.1	34.0	0.3	37.7	21.2	3.8	1.9	35.8	7.2	34.4	35.2	21.5	52.1	35.1	45.6	84.6	11.1	15.3	59.6	56.8	38.4	21.5	31.5	2.9	15.4	18.6	14.8	10.8	20.9	52.4	4.8	22.5	47.2	27.2	62.7	11.7	40.6	36.6	9.3	83.2	15.1	2.0	0.2	1.2	1.6	0.1	0.2	2.2	4.8	4.5	3.2	0.5	0.4	0.8	1.6	5.2	0.4	0.2	24.2	2.7	0.7	0.8	0.4	0.8	0.8	1.0	1.4	0.4	0.7	0.5
PDE4B	DPDE4	ENSG00000184588	"Phosphodiesterase 4B"	Q07343	1	65792514-66374579	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.9;HUVEC TERT2: 35.9;NTERA-2: 21.8;SK-MEL-30: 21.6;TIME: 20.0;U-266/84: 18.8"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 36.6"	"Group enriched"	"Detected in all"	5	"B-cells: 16.1;granulocytes: 36.6;T-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003005	Uncertain		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA003005: AB_1079587"	"unprognostic (7.86e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (2.89e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.33e-3)"	14.9	2.9	21.5	28.4	29.0	48.2	15.0	12.7	31.9	6.4	6.6	39.2	0.7	3.9	6.7	2.1	3.9	3.5	8.1	16.1	20.7	18.8	3.7	8.7	10.0	15.9	36.3	14.2	2.0	1.7	1.7	3.4	13.1	32.2	18.3	8.6	6.6	15.9	10.3	28.2	6.2	8.5	9.5	37.4	18.5	4.2	3.2	36.9	2.3	5.5	5.5	14.7	16.1	3.9	16.1	2.6	36.6	2.8	4.4	13.3	3.7	0.0	6.8	13.5	23.9	0.7	0.7	0.0	4.4	5.2	4.2	5.5	0.0	0.0	2.0	0.1	8.2	0.0	0.1	0.0	4.1	5.8	0.0	0.1	1.9	0.0	0.5	4.8	0.0	1.4	0.2	2.1	0.1	35.9	0.0	1.3	1.8	0.1	0.0	2.8	21.8	0.3	0.9	2.4	1.3	3.3	0.0	0.1	10.4	0.0	1.1	21.6	0.1	1.7	20.0	3.3	0.8	1.8	0.7	0.6	18.8	7.3	3.4	5.0	1.4	2.7	2.8	8.4	4.4	2.4	8.4	15.4	8.3	6.2	2.4	16.1	9.4	6.5	36.6	4.4	2.1	2.6	13.3	3.7	21.5	29.0	12.7	24.6	20.7	18.8	36.3	14.2	32.2	36.9
PDZD8	"bA129M16.2, FLJ34427, PDZK8"	ENSG00000165650	"PDZ domain containing 8"	Q8NEN9	10	117277274-117375467	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 61.7"	"Cell line enhanced"	"Detected in all"		"HEL: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015716, HPA051610"	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane"	"Intracellular and membrane"			"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA015716: AB_1855162, HPA051610: AB_2681549"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.75e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavourable (6.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.01e-2)"	8.1	7.8	12.2	5.1	13.3	61.7	8.2	8.7	12.9	9.1	14.8	11.4	32.8	14.0	10.7	15.1	11.4	7.7	10.3	7.0	12.0	10.4	13.5	21.1	7.4	3.7	14.7	7.4	10.1	20.1	18.9	8.6	6.0	12.9	7.3	12.0	6.3	12.4	21.3	6.7	6.6	13.7	7.6	14.8	5.0	10.6	23.2	12.4	8.9	7.5	5.4	4.2	8.0	15.3	1.0	1.7	5.7	2.0	2.5	2.5	0.5	5.1	8.8	3.2	6.2	5.6	5.0	1.8	4.9	4.3	2.2	1.8	4.4	6.9	6.0	4.5	7.5	7.7	5.6	5.3	4.4	3.8	4.9	51.0	3.6	4.3	4.1	21.2	4.8	4.9	6.3	4.0	12.0	3.9	4.6	6.3	5.5	2.0	4.1	2.7	2.5	7.9	3.3	12.4	2.6	6.6	3.7	2.5	4.1	5.3	2.2	3.9	1.5	3.1	6.3	3.7	4.1	6.7	8.4	3.4	2.9	4.4	4.6	9.7	3.2	2.7	1.4	5.7	2.2	1.1	2.5	0.9	1.8	1.8	1.7	1.0	1.5	2.0	5.6	2.5	2.0	1.3	0.8	0.5	12.2	13.3	8.7	12.9	12.0	10.4	14.7	7.4	12.9	12.4
PELI1		ENSG00000197329	"Pellino E3 ubiquitin protein ligase 1"	Q96FA3	2	64092652-64144454	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.3;U-698: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 33.9"	"Group enriched"	"Detected in all"	4	"granulocytes: 33.9;monocytes: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"				"Nucleoplasm, Nucleoli, Intermediate filaments"	"Nucleoplasm, Nucleoli, Intermediate filaments"	"HPA053182: AB_2682072"	"unprognostic (3.33e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavourable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-3)"	"unprognostic (5.99e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavourable (5.67e-6)"	"unprognostic (6.72e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.03e-1)"	15.7	5.1	10.0	15.1	20.5	105.7	22.3	15.1	8.9	9.9	14.5	11.0	3.3	9.9	14.5	7.1	26.4	8.0	14.9	11.6	11.3	6.8	6.7	8.6	20.1	16.8	15.6	5.2	4.8	6.2	11.0	14.8	13.7	10.8	7.6	11.8	6.0	12.3	8.5	4.5	17.5	17.3	8.4	15.0	17.8	10.2	7.8	12.8	19.9	6.3	10.2	19.3	14.1	14.8	3.9	2.3	33.9	9.2	1.3	5.0	2.5	1.2	1.0	13.7	9.1	1.6	1.2	3.1	1.7	2.0	1.6	2.6	21.3	1.5	17.5	4.3	0.6	2.1	4.1	3.8	3.2	4.3	3.3	1.6	0.6	3.4	4.8	1.7	3.1	1.6	3.0	2.4	8.2	9.0	0.9	4.4	1.3	0.1	3.7	2.5	8.9	0.6	4.7	4.7	9.9	6.6	3.9	6.3	8.8	1.3	2.0	4.7	1.1	1.2	6.4	1.5	2.2	1.5	2.5	10.1	0.9	53.0	0.8	1.5	4.0	5.1	6.5	6.3	0.4	6.1	0.7	3.9	2.2	0.9	2.3	2.4	2.7	1.1	33.9	1.3	9.2	0.2	5.0	2.5	10.0	20.5	15.1	8.8	11.3	6.8	15.6	5.2	10.8	12.8
PGLYRP1	"PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L"	ENSG00000008438	"Peptidoglycan recognition protein 1"	O75594	19	46019153-46023065	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 73.7;bone marrow: 130.1"	"Cell line enhanced"	"Detected in some"		"A549: 7.1;HEK 293: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	190	"eosinophil: 63.0;neutrophil: 73.7"	"Lineage enriched"	"Detected in single"	205	"granulocytes: 73.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045702	Enhanced				"Secreted to blood"	47000000	47000000			"HPA045702: AB_10960204"	"unprognostic (2.87e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.20e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.37e-3)"	0.7	0.1	0.2	0.5	0.4	130.1	0.2	0.4	0.2	0.1	0.3	0.3	0.0	0.2	0.1	0.1	0.2	0.4	0.1	10.9	0.2	0.2	0.2	1.5	10.9	1.0	0.2	0.0	0.7	0.2	0.1	1.4	4.1	0.1	0.1	0.1	0.5	0.7	0.1	1.3	0.3	0.2	0.1	0.1	26.9	0.2	0.9	0.0	7.5	1.3	0.0	0.5	0.1	5.5	0.0	0.0	73.7	0.3	0.0	0.0	0.4	0.6	7.1	1.1	0.7	0.0	0.0	1.9	0.6	0.0	0.0	0.0	1.1	0.6	1.9	0.2	0.0	2.6	0.0	0.0	0.0	1.8	4.0	0.8	3.4	0.2	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.5	0.4	2.2	0.4	2.7	1.5	0.2	0.1	0.0	2.6	0.8	0.1	0.5	0.1	0.0	0.3	0.1	0.0	0.1	0.3	0.7	1.1	1.5	1.3	0.8	1.1	1.6	0.1	0.0	0.0	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.7	0.0	0.3	0.0	0.0	0.4	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.0	0.1	0.0
PIK3CD	p110D	ENSG00000171608	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"	O00329	1	9651732-9729114	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.0;bone marrow: 32.8;lymphoid tissue: 40.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.5;NB-4: 21.8;REH: 22.7;THP-1: 22.0;U-937: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015420, HPA044953"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"				Vesicles	Vesicles	"CAB015420: AB_831654, HPA044953: AB_2679153"	"unprognostic (5.73e-3)"	"unprognostic (2.75e-3)"	"unprognostic (8.93e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.78e-2)"	4.5	2.1	3.4	34.8	7.1	32.8	2.9	3.3	4.3	3.2	3.3	5.5	0.7	3.1	3.7	3.4	3.5	4.0	6.5	2.9	4.2	3.1	4.6	3.3	8.2	40.3	7.4	1.8	5.3	2.2	2.3	2.2	3.3	4.6	3.2	2.1	3.1	11.2	1.8	0.9	2.0	11.4	2.9	5.3	35.5	3.3	3.0	5.7	23.5	4.1	2.3	36.0	5.8	3.6	8.4	14.5	35.0	15.0	14.5	13.7	16.6	2.6	1.7	0.1	0.5	0.4	0.4	0.2	4.1	8.4	9.0	7.4	0.1	1.1	7.1	1.7	3.3	0.8	0.7	3.7	5.7	50.5	0.1	0.8	0.4	3.0	1.8	18.4	6.4	1.5	1.5	10.1	3.4	1.3	2.6	0.0	5.1	0.2	1.7	21.8	0.7	0.5	22.7	4.5	0.2	3.8	0.0	0.5	0.5	0.9	1.7	4.0	0.2	22.0	3.3	2.7	2.8	0.0	3.8	1.6	1.6	10.0	5.8	26.3	1.5	9.6	11.8	21.1	12.9	13.1	13.7	7.8	9.8	11.8	12.5	8.4	12.9	13.4	35.0	14.5	15.0	14.5	7.4	16.6	3.4	7.1	3.3	4.3	4.2	3.1	7.4	1.8	4.6	5.7
PIK3R5	"p101, P101-PI3K"	ENSG00000141506	"Phosphoinositide-3-kinase regulatory subunit 5"	Q8WYR1	17	8878911-8965712	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.0"	"Group enriched"	"Detected in some"	4	"HDLM-2: 28.0;U-937: 8.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044505, HPA052247, HPA052412"	Uncertain		Supported	"Centriolar satellite,Cytosol"				Cytosol	Cytosol	"HPA044505: AB_2678964, HPA052247: AB_2681772, HPA052412: AB_2681823"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.24e-1)"	13.8	4.1	2.0	13.0	3.4	51.0	7.2	0.6	1.8	2.1	5.6	3.6	0.0	2.5	1.9	3.1	3.1	3.8	5.7	3.1	3.4	1.6	2.7	2.4	16.4	22.9	5.0	0.6	2.5	1.8	0.7	1.3	2.3	3.0	2.7	2.1	2.4	3.1	1.0	1.0	1.8	10.4	2.9	5.3	23.8	2.6	4.0	2.5	17.6	2.2	1.9	12.4	4.5	2.8	3.6	8.0	23.8	12.1	5.7	13.6	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.3	1.0	0.0	0.0	0.0	0.4	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.8	0.4	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	4.9	10.6	3.7	13.6	10.0	8.8	3.2	7.5	11.4	8.0	3.6	5.8	8.9	23.8	5.7	12.1	6.4	9.2	9.5	2.0	3.4	0.6	1.8	3.4	1.6	5.0	0.6	3.0	2.5
PIWIL4	"FLJ36156, HIWI2, Miwi2"	ENSG00000134627	"Piwi like RNA-mediated gene silencing 4"	Q7Z3Z4	11	94543840-94621421	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8;testis: 30.9"	"Cell line enriched"	"Detected in some"	5	"NB-4: 43.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036587, HPA036588, HPA057508"	Enhanced		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.80e-2)"	1.9	0.6	1.9	1.9	3.1	17.8	2.7	4.1	1.7	2.2	3.8	1.7	1.7	4.5	2.5	1.7	1.7	2.0	3.6	1.7	1.9	1.7	1.7	1.7	1.7	2.5	1.7	1.7	2.2	8.2	0.2	1.7	2.3	1.7	1.7	5.0	1.7	7.6	2.0	1.7	0.8	4.3	1.7	2.5	2.3	3.6	30.9	1.7	1.7	1.7	1.7	1.8	1.7	1.7	0.0	0.8	0.5	2.4	0.3	1.3	1.0	0.1	0.0	0.2	0.0	3.2	2.2	0.2	0.2	0.1	0.1	0.4	0.3	0.3	0.0	0.2	1.3	0.0	0.4	0.0	0.1	1.2	0.1	0.1	0.3	0.0	1.3	3.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.2	0.1	43.9	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	9.6	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	2.4	0.5	1.0	1.0	0.0	0.0	0.1	0.6	0.8	0.0	1.3	0.4	0.0	0.3	1.0	0.0	0.4	1.0	1.9	3.1	4.1	1.7	1.9	1.7	1.7	1.7	1.7	1.7
PLAUR	"CD87, UPAR, URKR"	ENSG00000011422	"Plasminogen activator, urokinase receptor"	Q03405	19	43646095-43670547	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 118.0;bone marrow: 165.0"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 49.4;U-251 MG: 70.2;U-87 MG: 61.3;WM-115: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 118.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050843, CAB073533"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	760000	760000	"Plasma membrane"	"Plasma membrane"	"CAB073533: , HPA050843: AB_2681255"	"unprognostic (9.28e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.59e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.18e-3)"	"prognostic unfavourable (2.33e-5)"	"unprognostic (8.08e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.30e-2)"	"prognostic unfavourable (7.83e-9)"	"unprognostic (4.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.33e-2)"	25.2	3.6	3.0	23.6	4.8	165.0	6.3	2.2	6.1	10.7	7.5	4.4	1.8	3.3	9.5	6.0	8.6	10.6	23.0	11.5	4.5	3.2	5.1	6.1	39.4	8.1	6.0	1.1	11.9	4.3	2.5	4.4	12.2	6.9	6.1	6.0	4.6	11.0	3.7	7.9	3.5	7.3	7.2	7.1	12.6	12.0	6.3	6.3	2.5	4.4	7.7	7.0	22.7	14.9	0.2	21.3	118.0	50.5	0.6	0.9	21.0	14.0	4.9	4.5	0.3	4.0	14.4	2.7	29.6	30.1	18.7	23.5	0.4	16.6	0.5	7.5	18.3	6.0	1.2	7.3	20.9	0.9	0.9	2.6	7.4	0.6	5.1	3.1	34.3	14.8	1.4	49.4	7.4	20.6	2.7	0.6	17.9	1.0	3.4	8.4	1.4	10.6	3.9	3.0	1.0	5.8	0.7	0.2	3.9	13.2	3.0	3.9	0.6	9.8	21.1	41.3	21.2	18.9	70.2	0.6	1.4	0.1	61.3	5.8	59.7	7.2	48.9	72.4	0.7	41.5	0.8	0.2	0.9	0.6	21.3	0.1	0.3	0.4	118.0	0.6	50.5	6.8	0.3	21.0	3.0	4.8	2.2	6.1	4.5	3.2	6.0	1.1	6.9	6.3
PLBD1	FLJ22662	ENSG00000121316	"Phospholipase B domain containing 1"	Q6P4A8	12	14503661-14568349	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.8;bone marrow: 54.7;pancreas: 51.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.6;BEWO: 25.2;CAPAN-2: 65.3;MCF7: 10.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 76.8;intermediate monocyte: 24.0;myeloid DC: 43.0;neutrophil: 53.2"	"Group enriched"	"Detected in many"	148	"dendritic cells: 43.0;granulocytes: 53.2;monocytes: 76.8"	"Not detected"	"Not detected"							HPA040303	Enhanced				"Intracellular and membrane"					"HPA040303: AB_2676922"	"unprognostic (9.13e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (2.81e-5)"	"unprognostic (4.80e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.99e-2)"	"unprognostic (5.44e-2)"	9.6	1.2	2.0	6.3	2.5	54.7	12.4	1.2	1.8	8.4	10.7	2.2	5.7	5.4	5.5	3.4	22.0	5.0	7.6	11.8	1.0	0.5	8.8	6.0	11.9	7.2	2.4	1.6	4.7	51.9	0.4	1.7	10.9	4.7	4.8	14.5	4.8	6.1	3.5	6.6	10.8	9.1	4.7	2.4	13.5	6.7	11.3	2.0	1.9	3.2	5.0	5.1	15.5	14.2	0.3	43.0	53.2	76.8	0.2	0.1	38.5	1.6	1.1	0.1	11.6	0.0	0.0	25.2	0.0	0.0	0.7	0.6	3.3	65.3	0.0	0.3	0.3	2.4	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	5.0	0.0	0.3	10.8	0.0	0.0	4.2	0.0	0.0	0.0	0.1	0.1	6.9	0.0	0.1	8.6	3.7	0.6	2.3	2.2	0.0	0.1	0.1	0.0	0.1	2.1	6.4	0.0	0.0	0.0	0.0	0.0	76.8	0.6	0.1	24.0	0.0	0.3	0.0	0.0	43.0	0.1	0.0	0.0	53.2	0.2	8.0	0.5	0.1	38.5	2.0	2.5	1.2	1.8	1.0	0.5	2.4	1.6	4.7	2.0
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 30.5;lymphoid tissue: 36.3"	"Cell line enhanced"	"Detected in some"		"HEL: 30.8;HMC-1: 38.5;THP-1: 11.1;U-937: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298"	Approved		Approved	Cytosol				Cytosol	Cytosol	"CAB009443: AB_632197, HPA041298: AB_2677395"	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favourable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	6.3	3.6	8.1	17.6	11.6	30.5	2.9	1.1	7.5	2.9	3.3	16.2	1.7	4.0	2.8	3.2	2.4	4.6	6.5	3.3	6.9	5.1	3.3	4.2	12.5	17.2	12.7	2.4	1.6	2.0	1.3	2.9	4.6	9.3	3.2	5.5	4.1	5.2	2.9	1.3	1.5	10.2	4.8	17.9	36.3	3.6	1.4	10.9	12.2	2.8	1.8	17.6	6.9	2.5	1.0	4.5	8.5	4.3	1.8	3.1	2.0	0.1	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	7.7	0.6	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	6.5	38.5	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	1.8	3.5	0.4	0.1	5.4	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	11.1	4.0	0.0	3.7	0.0	0.0	0.0	0.0	1.4	0.0	21.1	0.0	2.7	4.2	8.5	3.1	4.3	2.0	0.7	1.6	1.6	4.5	1.0	1.6	1.8	6.9	1.8	4.2	1.6	2.9	2.0	8.1	11.6	1.1	7.5	6.9	5.1	12.7	2.4	9.3	10.9
PLEK	P47	ENSG00000115956	Pleckstrin	P08567	2	68365173-68397453	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 80.4;bone marrow: 120.1;lymphoid tissue: 51.0"	"Cell line enhanced"	"Detected in some"		"HEL: 91.5;HMC-1: 35.0;NB-4: 30.8;THP-1: 35.8;U-266/84: 23.8;U-698: 24.4;U-937: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031838, HPA057341"	Enhanced		Approved	Nucleoli		970000000	970000000	Nucleoli	Nucleoli	"HPA031838: AB_10602146, HPA057341: AB_2732609"	"unprognostic (2.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	27.8	3.6	3.0	21.7	7.7	120.1	4.6	1.0	3.0	1.8	4.2	7.0	0.4	2.4	2.4	7.5	3.5	5.5	4.9	4.9	2.6	2.4	3.8	6.5	17.0	36.6	6.4	0.8	4.3	2.8	0.7	2.0	8.5	5.0	4.0	4.5	2.7	3.5	0.8	2.3	1.7	8.0	5.0	8.6	51.0	3.2	5.7	3.7	8.2	3.8	2.7	25.7	7.3	2.0	22.9	66.9	80.4	50.8	33.2	44.7	65.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.5	0.0	0.0	0.0	20.6	35.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	30.8	0.0	0.0	0.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	1.3	23.8	24.4	0.0	56.8	0.0	24.8	39.7	57.2	44.7	49.2	23.5	22.9	8.2	32.2	32.1	13.5	2.3	25.3	80.4	33.2	50.8	66.9	0.8	65.9	3.0	7.7	1.0	3.0	2.6	2.4	6.4	0.8	5.0	3.7
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880861-127899195	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol				"Centrosome, Cytosol"	"Centrosome, Cytosol"	"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: "	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favourable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.4	1.3	1.5	4.7	2.4	16.5	2.2	0.5	2.2	2.0	3.2	0.3	0.6	2.3	1.3	1.3	5.4	1.1	1.2	2.0	1.2	1.3	1.5	0.9	1.5	5.9	1.2	1.4	1.5	0.9	0.3	0.6	5.0	2.6	1.4	3.7	0.8	1.7	0.7	0.4	2.7	3.2	1.9	1.8	2.7	1.6	21.7	1.0	21.7	1.0	2.1	6.0	1.5	2.2	0.7	0.7	1.5	0.8	1.4	4.0	0.8	11.6	5.5	20.7	10.6	0.7	2.0	9.4	11.4	8.1	15.2	15.8	7.7	12.0	15.7	4.2	6.3	7.7	14.6	9.1	23.5	12.2	6.0	14.2	8.8	7.2	0.2	20.0	16.9	0.6	0.9	13.9	6.4	11.7	16.5	21.0	12.8	8.1	30.8	9.0	9.6	6.3	16.1	14.5	5.4	5.0	7.4	11.5	9.4	7.2	6.6	3.5	5.3	8.7	5.0	12.0	11.6	8.1	14.2	10.9	11.9	22.4	6.1	15.3	13.2	0.0	0.4	1.5	1.6	0.8	1.1	0.3	1.8	1.7	0.7	0.7	0.6	2.3	0.0	1.4	0.3	0.4	4.0	0.8	1.5	2.4	0.5	2.2	1.2	1.3	1.2	1.4	2.6	1.0
PMAIP1	"APR, NOXA"	ENSG00000141682	"Phorbol-12-myristate-13-acetate-induced protein 1"	Q13794	18	59899948-59904306	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.3;bone marrow: 45.5"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"basophil: 42.3"	"Low lineage specificity"	"Detected in all"											HPA051063	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA051063: AB_2681330"	"unprognostic (1.35e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.88e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.12e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.56e-2)"	"prognostic unfavourable (3.15e-6)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.09e-1)"	1.9	0.4	2.2	9.4	2.4	45.5	3.1	0.9	2.5	6.0	2.8	1.6	0.1	2.2	3.3	1.7	12.4	1.7	4.8	1.3	3.3	2.3	1.3	1.3	10.9	7.8	2.6	0.8	1.6	1.3	5.6	27.3	14.7	3.3	3.0	2.0	0.6	3.9	0.8	1.8	20.2	6.4	1.1	2.3	7.6	1.7	1.7	0.8	12.7	1.3	11.7	18.7	7.3	6.8	10.6	3.7	42.3	9.2	1.9	7.4	4.1	6.4	4.3	1.3	0.4	2.2	18.0	5.0	31.2	21.2	18.3	18.3	0.4	8.1	25.6	4.3	5.8	9.7	5.2	2.9	18.0	8.2	38.7	4.7	6.5	1.1	22.7	16.1	7.2	7.4	7.8	23.9	12.5	6.0	6.3	4.4	6.0	0.6	12.9	4.8	38.3	8.1	13.2	7.3	9.3	10.5	6.0	10.1	8.3	1.5	0.8	17.3	1.3	13.3	22.5	51.9	13.8	2.6	34.6	0.7	0.0	22.4	4.3	9.2	12.1	42.3	5.1	30.5	3.5	7.8	3.1	10.6	1.6	2.2	3.7	7.8	1.4	1.9	16.3	1.9	9.2	3.0	7.4	4.1	2.2	2.4	0.9	2.5	3.3	2.3	2.6	0.8	3.3	0.8
POLE2	DPE2	ENSG00000100479	"DNA polymerase epsilon 2, accessory subunit"	P56282	14	49643555-49688422	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.6;lymphoid tissue: 17.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA027555	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA027555: AB_10610282"	"unprognostic (1.42e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.53e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (5.13e-11)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-3)"	3.3	2.2	1.5	11.6	2.8	17.6	3.4	1.7	1.6	4.4	4.2	1.1	1.5	2.6	2.8	3.5	9.0	2.4	2.3	1.6	1.0	1.2	2.5	5.1	2.2	5.3	1.1	0.3	2.7	5.0	1.4	2.5	4.1	1.4	2.1	5.2	2.6	2.6	0.7	1.1	3.7	7.7	2.9	2.7	5.4	3.0	5.3	2.4	17.6	1.6	10.3	8.4	2.1	4.2	1.2	0.9	0.7	0.0	3.2	2.7	0.5	17.1	8.8	16.7	7.7	0.8	4.9	8.5	9.8	5.0	15.6	18.1	8.8	13.5	10.7	5.6	5.5	10.6	16.7	6.0	18.5	12.5	9.2	15.9	9.7	10.9	0.4	18.9	6.9	1.4	0.4	8.5	1.4	9.0	13.9	6.9	15.6	15.0	19.2	12.4	9.8	20.6	16.4	15.4	9.7	5.6	9.7	12.0	6.9	9.9	5.8	3.1	11.7	6.7	3.2	2.5	18.6	10.4	7.7	5.0	10.2	24.7	4.7	14.0	10.0	0.0	0.0	0.7	0.9	0.0	0.7	1.2	0.9	1.7	0.6	1.2	0.1	0.8	0.0	3.2	0.0	0.9	2.7	0.5	1.5	2.8	1.7	1.6	1.0	1.2	1.1	0.3	1.4	2.4
POLQ	POLH	ENSG00000051341	"DNA polymerase theta"	O75417	3	121431427-121546641	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.5;lymphoid tissue: 21.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.2"	"HPA048931, HPA053359"			Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus, Cytosol"	"Nucleoplasm, Golgi apparatus, Cytosol"	"HPA048931: , HPA053359: "	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (5.46e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.09e-5)"	"unprognostic (8.55e-3)"	"unprognostic (1.09e-4)"	"unprognostic (2.86e-1)"	"unprognostic (5.59e-5)"	"unprognostic (2.06e-3)"	"unprognostic (0.00e+0)"	"prognostic favourable (1.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.76e-2)"	0.5	0.8	0.2	8.2	0.7	9.5	0.6	0.6	0.4	0.9	3.5	0.2	0.8	2.0	0.9	0.6	6.0	0.3	0.4	0.8	0.3	0.2	0.4	0.6	0.9	4.7	0.3	0.0	0.4	0.4	0.0	0.2	2.8	0.3	0.4	3.7	0.1	1.1	0.8	1.2	2.4	3.9	0.5	0.4	2.6	1.1	5.8	0.6	21.4	0.3	5.6	7.5	0.6	1.7	0.5	1.1	1.6	0.4	0.0	0.4	0.0	13.3	9.1	7.8	5.5	0.7	0.9	7.1	6.3	2.4	7.5	10.1	7.2	5.0	15.9	2.9	3.4	10.6	9.2	4.1	12.8	4.6	5.0	10.2	5.6	4.5	0.0	11.0	9.3	0.1	0.3	6.8	4.2	3.7	6.7	12.1	7.8	5.2	9.9	6.4	7.4	4.4	8.4	9.4	5.6	2.4	7.7	4.3	3.8	7.3	4.0	2.6	3.7	10.9	2.8	6.6	8.7	2.6	8.2	6.1	4.9	16.5	3.2	8.2	4.9	1.6	0.2	0.0	0.3	0.2	0.0	0.3	0.4	0.3	0.4	0.5	0.0	0.2	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.7	0.6	0.4	0.3	0.2	0.3	0.0	0.3	0.6
PPBP	"b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1"	ENSG00000163736	"Pro-platelet basic protein"	P02775	4	73987038-73988197	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 206.7;bone marrow: 67.0;lymphoid tissue: 60.0"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 4.0;HEL: 11.7;RPTEC TERT1: 2.7"	"Cancer enriched"	"Detected in many"	7	"colorectal cancer: 86.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"basophil: 30.0;neutrophil: 18.4"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 30.0"					"Low region specificity"	"Detected in all"			"HPA008354, CAB017624"	Supported				"Secreted to blood"	3500000000	3500000000			"CAB017624: AB_1127132, HPA008354: AB_1847353"	"unprognostic (2.13e-1)"	"prognostic unfavourable (6.17e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.59e-2)"	1.4	0.6	0.4	0.6	1.7	67.0	0.6	0.2	0.4	0.5	0.2	0.1	0.0	0.1	0.3	0.5	0.5	0.8	0.9	35.7	0.3	0.3	0.5	1.9	13.3	0.1	1.6	0.0	6.0	0.4	0.1	0.5	8.7	1.3	0.6	0.2	0.4	0.5	0.1	1.0	0.3	0.2	0.2	1.3	60.0	0.3	0.5	0.0	0.0	2.2	0.9	0.1	1.7	11.0	0.3	2.6	30.0	1.8	0.2	0.5	206.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	30.0	1.8	1.1	0.2	0.6	0.3	0.1	0.1	0.0	1.0	0.3	0.5	0.1	18.4	0.2	0.5	2.6	0.2	206.7	0.4	1.7	0.2	0.4	0.3	0.3	1.6	0.0	1.3	0.0
PPIAL4E		ENSG00000271567	"Peptidylprolyl isomerase A like 4E"	A0A075B759	1	144372875-144373659	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 3.4;bone marrow: 2.7;skeletal muscle: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;HL-60: 1.3;NB-4: 1.4;SK-BR-3: 2.1;TIME: 2.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA058345	Uncertain									"HPA058345: AB_2683685"					"unprognostic (6.97e-2)"					"unprognostic (5.22e-2)"				"unprognostic (2.28e-1)"				0.0	0.4		0.0		2.7	0.0		0.0	0.0	0.0			0.6	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0			0.0	0.7	0.0		0.0		0.0	0.0		0.0	0.0	1.8	1.1	0.4	0.0		0.0	0.0	0.0			0.0		0.0	0.0		1.7	0.6	1.9	2.0	3.4	2.9	0.6	0.6	0.5	0.5	0.1	0.0	0.0	0.4	0.2	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	2.0	0.1	0.6	0.3	0.0	0.6	0.4	0.2	0.0	0.2	0.0	0.0	2.0	1.0	2.9	0.5	1.9	1.3	1.6	1.3	0.5	1.7	0.5	0.5	1.9	3.4	1.5	0.6	0.8	0.6										
PPP1R15A	GADD34	ENSG00000087074	"Protein phosphatase 1 regulatory subunit 15A"	O75807	19	48872392-48876057	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 156.9"	"Cell line enhanced"	"Detected in all"		"HHSteC: 54.6;hTERT-HME1: 94.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 69.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.8;granulocytes: 69.8"					"Low region specificity"	"Detected in all"			"CAB018395, HPA020240"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"CAB018395: AB_2237473, HPA020240: AB_1849404"	"unprognostic (2.43e-3)"	"unprognostic (3.21e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.43e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.94e-2)"	39.8	29.1	16.2	33.6	12.9	156.9	56.3	12.1	12.8	26.3	19.7	13.6	12.0	12.0	37.8	19.5	28.2	34.0	32.3	42.0	14.6	13.9	18.6	18.6	56.5	10.6	29.5	6.3	24.5	10.9	9.8	16.2	44.7	31.5	28.2	15.6	12.4	9.2	23.6	35.2	40.0	16.0	36.2	17.7	13.3	19.8	14.5	17.8	3.4	18.6	46.7	19.0	41.1	114.7	8.1	23.8	69.8	10.3	2.5	6.1	6.6	9.9	4.3	4.7	3.8	13.7	7.8	7.4	17.5	27.5	20.1	18.2	6.6	5.1	3.4	4.7	12.6	7.2	1.7	9.1	15.2	1.9	2.6	15.6	2.5	3.2	54.6	3.6	22.5	10.6	25.5	27.7	94.1	10.4	20.9	29.1	12.9	1.1	1.9	5.0	1.1	7.9	2.2	4.3	1.1	4.1	11.7	2.6	4.6	9.0	6.2	39.6	2.2	6.5	11.1	24.0	6.0	16.8	10.7	15.7	12.4	3.3	8.8	2.5	28.7	27.4	10.3	17.7	4.9	6.3	4.3	8.1	4.8	4.0	7.3	5.5	2.7	2.4	69.8	2.5	7.1	23.8	6.1	6.6	16.2	12.9	12.1	12.8	14.6	13.9	29.5	6.3	31.5	17.8
PRAM1	PML-RAR	ENSG00000133246	"PML-RARA regulated adaptor molecule 1"	Q96QH2	19	8490056-8503112	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.8;bone marrow: 70.7;brain: 25.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 9.1;NB-4: 7.2;THP-1: 15.8;U-937: 50.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 23.6;intermediate monocyte: 28.1;myeloid DC: 16.1;neutrophil: 14.9;non-classical monocyte: 30.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 16.1;granulocytes: 14.9;monocytes: 30.8"					"Low region specificity"	"Detected in all"			"HPA045236, HPA050161"	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA045236: AB_2679267, HPA050161: AB_2681036"	"unprognostic (1.68e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.54e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (8.08e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.12e-3)"	4.0	1.5	7.1	9.2	15.5	70.7	1.3	2.7	8.3	2.7	1.2	14.4	0.0	3.0	1.7	1.2	1.4	2.3	2.4	1.5	6.8	3.7	1.3	2.4	12.3	10.2	10.9	3.5	1.7	1.5	1.2	2.1	1.6	10.1	3.7	1.3	1.5	1.5	1.2	1.2	1.9	3.1	2.5	25.1	12.8	1.7	1.3	12.0	1.8	2.0	0.0	1.2	2.3	1.4	0.0	16.1	14.9	30.8	3.1	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	50.6	0.0	0.8	23.6	0.8	0.0	28.1	0.1	0.0	0.0	0.0	16.1	0.0	0.0	0.1	14.9	3.1	30.8	0.9	0.0	8.9	7.1	15.5	2.7	8.3	6.8	3.7	10.9	3.5	10.1	12.0
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966038-90995629	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 18.9;T-reg: 5.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 18.9;T-cells: 5.8"	"Low region specificity"	"Detected in single"							"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"				"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	3.2	2.8	3.5	13.0	3.8	43.3	3.6	12.5	5.8	3.4	9.3	1.6	0.2	6.1	3.5	4.7	15.0	2.6	2.8	3.5	5.1	4.9	2.3	1.9	5.8	9.2	3.4	4.7	3.6	3.8	1.6	1.5	10.4	5.2	2.4	9.9	2.7	3.9	1.0	2.5	9.9	6.6	5.4	3.5	5.8	5.0	44.3	0.8	44.5	1.8	15.3	16.5	3.5	4.9	0.9	2.0	18.9	0.4	2.0	5.8	0.7	32.4	39.7	33.2	22.6	3.5	6.0	17.8	46.8	27.7	51.9	39.7	26.5	31.7	12.4	18.6	29.8	44.3	37.8	20.0	49.1	22.9	41.9	25.6	51.9	24.3	0.8	12.6	22.2	1.5	2.6	29.4	30.2	29.0	21.3	26.6	48.2	28.2	12.9	19.3	13.0	17.0	13.6	41.5	16.6	23.1	24.7	30.3	24.0	44.5	24.8	16.1	29.7	25.0	17.3	34.3	30.3	28.3	67.4	8.6	22.8	15.3	15.0	31.4	52.3	18.9	0.4	2.0	0.5	0.0	0.3	0.9	1.0	1.0	1.8	0.4	0.9	0.4	0.2	2.0	0.2	2.0	5.8	0.7	3.5	3.8	12.5	5.8	5.1	4.9	3.4	4.7	5.2	0.8
PREX1	"KIAA1415, P-REX1"	ENSG00000124126	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1"	Q8TCU6	20	48624252-48827883	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.7;brain: 35.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 43.2;SK-BR-3: 45.3;T-47d: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001927	Supported		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA001927: AB_1079674"	"unprognostic (8.07e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.47e-2)"	"prognostic favourable (8.56e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.86e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-2)"	10.8	8.1	20.5	25.1	24.9	32.7	12.4	11.4	25.0	9.6	5.1	35.5	0.2	4.6	3.2	2.7	4.8	3.7	9.5	4.9	21.8	15.5	4.1	4.0	17.7	28.3	26.2	12.1	2.2	3.9	5.2	5.8	8.4	17.4	3.9	4.6	7.7	4.0	2.8	4.6	2.7	8.6	5.6	27.6	28.7	6.1	4.5	23.9	2.8	6.7	1.0	15.1	10.3	2.5	2.0	2.1	11.7	2.7	2.1	9.3	2.2	0.6	1.6	22.0	0.0	0.3	1.6	7.7	0.7	0.9	3.1	0.8	0.1	0.0	4.4	14.0	1.9	0.2	1.1	0.0	2.1	1.0	0.5	0.6	2.5	0.0	1.3	2.3	14.4	1.8	0.0	7.2	0.0	19.0	0.0	0.1	4.1	43.2	0.0	6.8	0.8	1.8	6.4	6.4	2.6	0.1	0.0	4.6	0.7	4.0	45.3	5.0	40.5	18.5	21.2	1.2	4.5	0.0	1.2	0.2	0.9	5.4	20.6	4.8	6.7	5.2	2.3	2.5	5.0	2.7	3.0	2.0	2.7	4.2	2.1	1.7	0.4	1.5	11.7	2.1	2.3	1.7	9.3	2.2	20.5	24.9	11.4	17.7	21.8	15.5	26.2	12.1	17.4	23.9
PROK2	"BV8, KAL4, MIT1, PK2"	ENSG00000163421	"Prokineticin 2"	Q9HC23	3	71771656-71785206	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 82.6;bone marrow: 42.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 8.8;NB-4: 7.6;NTERA-2: 5.4;U-266/70: 12.1;U-266/84: 19.7;U-937: 8.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.1"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	49	"neutrophil: 82.6"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 82.6"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.7;hypothalamus: 1.3;olfactory region: 4.3"	"Region enhanced"	"Detected in many"		"olfactory region: 11.4"	HPA041408	Approved				"Secreted to blood"					"HPA041408: AB_10964057"	"unprognostic (5.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.51e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.91e-3)"	"unprognostic (6.89e-2)"	"unprognostic (5.73e-1)"	"unprognostic (1.59e-4)"	"unprognostic (2.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	5.7	0.2	0.8	12.6	0.9	42.8	0.3	0.5	2.1	0.3	0.4	0.6	0.0	0.2	0.2	0.1	0.5	2.7	0.9	9.0	0.8	0.8	0.5	2.0	10.7	21.9	3.7	0.0	0.7	0.7	0.0	0.5	2.2	0.8	0.8	0.1	0.9	0.2	0.0	0.6	0.2	0.7	1.0	1.3	20.8	0.6	22.1	1.1	0.4	1.4	0.1	0.3	2.0	4.3	0.0	0.1	82.6	1.6	0.0	1.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	7.6	5.4	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	19.7	0.0	0.0	8.1	0.0	0.0	1.6	0.6	0.7	0.1	0.0	0.0	0.6	0.6	0.1	0.0	0.2	1.1	82.6	0.0	0.0	0.0	0.3	0.5	0.8	0.9	0.5	2.1	0.8	0.8	3.7	0.0	0.8	1.1
PROKR2	"dJ680N4.3, GPR73b, GPR73L1, GPRg2, KAL3, PKR2"	ENSG00000101292	"Prokineticin receptor 2"	Q8NFJ6	20	5302040-5314369	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.7;brain: 5.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.6;NTERA-2: 3.2;SCLC-21H: 1.1;SH-SY5Y: 6.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"memory CD8 T-cell: 1.6;neutrophil: 1.1"	"Group enriched"	"Detected in many"	8	"granulocytes: 1.1;T-cells: 1.6"	"Region enhanced"	"Detected in many"		"olfactory region: 20.9"	"Low region specificity"	"Detected in all"			HPA047281	Uncertain									"HPA047281: AB_10960057"										"unprognostic (1.36e-1)"					"unprognostic (1.69e-1)"			0.0	0.0	0.4	0.0	0.5	3.7	0.1	0.1	5.9	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.4	0.0	0.0	0.0	1.8	0.1		0.0	0.1	0.0	0.1	0.0		0.0	0.0		0.5	1.4	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.7			0.0		0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0										
PSTPIP1	"CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PSTPIP"	ENSG00000140368	"Proline-serine-threonine phosphatase interacting protein 1"	O43586	15	76993359-77037332	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 34.2;bone marrow: 41.0;lymphoid tissue: 29.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 28.9;HL-60: 6.8;NB-4: 11.5;THP-1: 7.8;U-937: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA010600	Enhanced									"HPA010600: AB_1855870"	"unprognostic (4.42e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.56e-2)"	"prognostic favourable (4.74e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavourable (7.36e-9)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.42e-2)"	6.0	1.9	1.7	29.3	1.7	41.0	2.7	0.4	0.9	2.4	3.8	0.6	0.1	2.0	3.6	4.1	3.3	2.2	7.2	3.8	2.0	1.4	2.8	2.2	10.6	28.1	1.8	0.0	1.8	1.2	0.4	1.1	2.3	1.0	2.5	0.9	2.1	7.6	2.6	2.3	1.2	6.6	1.9	2.4	24.5	2.5	2.3	0.9	15.7	2.1	2.4	18.6	2.8	2.0	6.4	23.0	34.2	27.9	15.4	17.3	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	28.9	0.0	0.0	0.0	1.7	0.0	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	11.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	31.2	0.0	1.8	27.9	26.7	17.3	12.7	13.3	5.5	11.6	14.2	23.0	6.4	6.4	9.9	34.2	15.4	13.0	1.9	10.3	14.8	1.7	1.7	0.4	0.9	2.0	1.4	1.8	0.0	1.0	0.9
PSTPIP2		ENSG00000152229	"Proline-serine-threonine phosphatase interacting protein 2"	Q9H939	18	45983536-46072272	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7"	"Cell line enhanced"	"Detected in many"		"HEL: 37.1;HMC-1: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 38.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040923, HPA040944"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		7100000	7100000	"Plasma membrane, Mitochondria"	"Plasma membrane, Mitochondria"	"HPA040923: , HPA040944: AB_10795485"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavourable (2.39e-7)"	"unprognostic (5.21e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.93e-1)"	4.6	3.3	1.8	6.1	3.1	36.9	4.9	0.6	2.1	3.4	3.4	0.9	2.7	2.0	2.7	2.8	4.4	2.9	4.4	4.0	4.5	1.2	3.3	8.6	7.4	11.5	3.4	0.4	3.1	3.9	2.2	3.9	11.6	3.5	5.8	3.0	3.5	4.5	8.8	16.6	5.9	3.1	4.1	4.6	46.7	4.3	1.9	3.2	3.0	1.8	6.5	5.6	4.6	3.0	0.0	8.9	38.1	12.4	0.9	3.9	6.3	1.0	0.0	1.4	0.0	0.3	2.6	7.8	5.5	2.7	2.0	1.7	4.2	1.5	0.0	0.3	1.8	13.5	7.6	10.4	2.5	0.0	1.2	37.1	1.8	0.0	2.2	2.1	41.2	1.9	13.0	1.9	6.2	3.9	8.8	0.0	8.6	1.3	0.3	0.0	0.8	0.0	0.0	2.8	1.8	4.2	13.6	0.1	0.8	0.9	3.8	0.1	12.2	4.3	2.8	0.2	3.1	0.3	0.0	0.0	0.1	0.0	0.5	0.0	0.1	20.7	9.0	38.1	3.9	12.4	1.3	0.0	2.3	2.8	8.9	0.0	2.8	3.3	4.9	0.9	11.9	0.3	1.4	6.3	1.8	3.1	0.6	2.1	4.5	1.2	3.4	0.4	3.5	3.2
PTH2R	PTHR2	ENSG00000144407	"Parathyroid hormone 2 receptor"	P49190	2	208359714-208854503	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 8.6;brain: 8.9;salivary gland: 8.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 11.4;HEL: 16.2;HL-60: 4.0;SH-SY5Y: 6.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010655	Approved									"HPA010655: AB_2668333"	"unprognostic (4.76e-3)"	"unprognostic (1.39e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.77e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.54e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.37e-2)"	2.5	0.9	6.0	0.6	3.5	8.6	2.1	0.2	8.6	0.2	0.2	0.0	0.0	0.0	1.6	4.9	0.2	0.2	0.2	0.2	8.9	4.3	0.5	1.4	0.3	0.3	0.5	4.3	0.1	1.4	0.0	1.0	2.7	0.1	1.2	0.1	0.0	8.2	1.4	0.1	0.3	0.2	1.2	0.4	0.4	0.1	1.7	0.0	0.0	0.2	0.1	0.2	0.2	0.2	1.4	0.6	0.9	1.3	0.0	0.8	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.7	1.3	0.8	1.4	0.0	0.0	0.0	1.0	0.4	0.0	0.9	0.0	0.9	0.6	0.0	0.4	6.0	3.5	0.2	8.6	8.9	4.3	0.5	4.3	0.1	0.0
PTK2B	"CADTK, CAKB, FAK2, PTK, PYK2, RAFTK"	ENSG00000120899	"Protein tyrosine kinase 2 beta"	Q14289	8	27311482-27459391	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 46.7;brain: 65.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.0;REH: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 202.9;basal ganglia: 236.9;cerebral cortex: 189.7;hippocampal formation: 443.3;olfactory region: 185.5"	"Low region specificity"	"Detected in many"			"CAB003850, HPA026091, HPA026276"	Approved		Supported	"Plasma membrane,Cytosol"		84000	84000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234"	"unprognostic (2.36e-2)"	"prognostic favourable (3.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (5.11e-4)"	"unprognostic (3.33e-3)"	7.2	4.7	20.4	24.3	30.0	46.7	4.9	65.2	48.3	5.4	14.5	7.8	5.0	16.6	4.3	4.7	7.9	6.8	6.4	4.7	30.5	7.0	6.8	5.0	11.5	35.6	4.3	25.4	2.4	5.4	5.2	5.3	4.1	3.9	10.1	11.9	8.3	12.6	6.7	2.2	15.1	18.4	5.5	4.8	32.0	10.8	4.3	3.7	37.8	5.6	2.9	35.4	13.0	6.0	26.9	18.7	24.0	25.8	14.7	19.0	21.5	10.9	3.0	0.8	0.9	23.5	1.7	6.4	0.8	0.5	0.6	0.8	2.9	6.3	37.0	1.2	1.7	10.1	0.3	9.2	0.3	2.5	0.2	7.6	2.9	0.5	4.8	8.2	13.8	12.7	13.8	0.8	5.3	0.3	8.9	25.7	0.6	1.1	14.0	16.5	0.6	0.8	41.0	0.2	25.3	2.6	8.6	5.8	1.0	3.9	2.7	1.4	3.3	21.2	5.2	0.4	0.8	0.7	0.3	20.7	8.9	20.0	1.6	17.8	0.7	22.3	23.7	18.0	19.0	22.4	12.5	25.5	9.6	13.3	18.7	26.9	12.1	14.2	24.0	14.7	25.8	6.2	9.5	21.5	20.4	30.0	65.2	48.3	30.5	7.0	4.3	25.4	3.9	3.7
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase, non-receptor type 22"	Q9Y2R2	1	113813811-113871759	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.6;lymphoid tissue: 46.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 32.9;HL-60: 13.0;U-266/70: 14.2;U-698: 17.6;U-937: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	10	"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"				Nucleoplasm	Nucleoplasm	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	4.2	1.4	0.5	17.1	0.8	23.6	1.9	1.0	0.5	2.4	3.3	0.3	1.0	4.1	2.0	2.2	2.0	1.7	3.2	2.5	0.6	0.7	3.4	1.8	9.0	14.9	0.7	0.4	1.5	2.4	0.0	0.9	0.9	1.0	1.7	2.8	1.3	2.7	3.0	0.6	1.0	9.9	0.9	2.1	19.0	3.1	1.1	0.4	46.0	1.5	2.4	12.8	4.8	1.7	7.2	6.2	17.2	3.5	7.5	14.9	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.3	0.0	0.2	32.9	0.0	0.1	0.0	0.0	0.0	0.2	3.1	0.0	4.6	0.0	0.0	0.1	13.0	10.3	2.9	0.0	1.4	0.1	5.1	0.0	7.5	5.0	0.1	9.2	7.4	0.0	0.0	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	2.3	7.8	0.1	0.1	0.2	14.2	3.0	17.6	5.4	13.4	0.0	10.2	3.5	17.2	12.8	0.9	14.9	7.2	6.5	10.1	6.2	4.7	3.9	9.4	1.7	7.5	0.4	3.7	10.0	4.6	0.5	0.8	1.0	0.5	0.6	0.7	0.7	0.4	1.0	0.4
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase, non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.5;lymphoid tissue: 63.7"	"Cell line enhanced"	"Detected in some"		"HEL: 16.4;HL-60: 35.6;HMC-1: 48.1;NB-4: 15.5;THP-1: 16.4;U-937: 25.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basal ganglia: 9.4;thalamus: 2.9"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 17.0;NK-cells: 9.9;T-cells: 10.6"	"Region enriched"	"Detected in single"	10	"basal ganglia: 5.5"	"Region enriched"	"Detected in all"	4	"basal ganglia: 10.9"	"CAB009530, HPA019118"	Approved									"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favourable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	2.6	3.1	0.5	27.1	9.4	24.5	0.6	0.4	0.5	0.6	2.3	0.6	0.0	3.0	0.7	0.6	1.7	0.8	2.9	0.5	0.6	0.8	1.1	0.9	3.2	16.5	1.2	0.2	0.6	0.6	0.0	0.7	0.4	0.8	1.3	1.9	0.7	5.3	0.3	0.4	0.6	3.7	0.9	1.6	15.4	1.4	12.7	2.9	63.7	0.9	0.6	24.8	2.9	0.8	2.6	2.6	17.0	1.1	9.9	10.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	16.4	0.0	0.0	0.0	35.6	48.1	0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	4.8	15.5	0.0	0.0	0.7	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.4	0.0	0.0	0.1	0.0	0.0	7.2	1.8	10.3	0.0	25.7	0.0	11.5	1.1	17.0	10.6	1.1	9.5	1.9	7.1	10.5	2.0	2.6	5.3	6.4	7.1	9.9	0.4	2.6	9.0	2.8	0.5	9.4	0.4	0.5	0.6	0.8	1.2	0.2	0.8	2.9
PTX4	C16orf38	ENSG00000251692	"Pentraxin 4"	Q96A99	16	1485886-1488981	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.0;bone marrow: 4.0;testis: 3.9"	"Group enriched"	"Detected in some"	6	"HL-60: 19.0;NB-4: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	21	"intermediate monocyte: 1.1;non-classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	31	"monocytes: 3.0"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Low region specificity"	"Detected in all"			HPA073694	Supported				"Secreted - unknown location"					"HPA073694: AB_2732237"	"unprognostic (1.04e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.84e-4)"	"unprognostic (3.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.23e-3)"	"unprognostic (4.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.03e-1)"	0.2	1.0	0.6	0.2	0.8	4.0	0.2	0.8	0.5	0.4	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.4	0.3	0.2	0.8	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.4	0.0	0.4	0.4	0.2	0.9	0.1	3.9	0.2	1.5	0.2	0.2	0.2	0.4	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	14.1	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.6	0.8	0.8	0.3	0.8	1.0	0.2	0.2	0.2	0.2
RAB32		ENSG00000118508	"RAB32, member RAS oncogene family"	Q13637	6	146543693-146554965	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 26.5"	"Group enriched"	"Detected in many"	40	"dendritic cells: 16.0;granulocytes: 26.5;monocytes: 17.3"	"Low region specificity"	"Detected in all"							HPA025731	Approved		Approved	Cytosol		330000	330000	Cytosol	Cytosol	"HPA025731: AB_1856001"	"unprognostic (3.07e-1)"	"unprognostic (5.32e-2)"	"prognostic favourable (1.56e-4)"	"prognostic unfavourable (6.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (1.08e-7)"	"unprognostic (2.64e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (8.62e-4)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	18.4	9.0	5.2	11.0	4.9	57.8	29.9	1.1	4.4	8.4	14.6	6.6	6.3	6.7	14.8	12.8	10.2	10.2	11.2	15.3	5.2	3.0	10.7	23.0	16.5	26.4	6.2	3.5	11.0	7.4	1.5	2.8	5.9	7.4	12.5	14.9	11.3	10.1	6.9	6.3	10.2	9.0	28.2	7.5	29.4	10.6	20.8	5.5	10.4	5.8	7.0	5.6	15.6	15.2	0.0	16.0	26.5	17.3	0.5	0.0	4.9	12.0	6.4	7.5	12.5	11.3	19.4	0.0	23.4	26.1	32.2	53.6	3.9	6.0	0.0	8.6	24.6	16.0	0.4	15.1	43.5	0.0	5.8	15.3	16.1	14.1	49.6	21.0	22.7	17.1	25.4	18.4	26.2	20.8	2.9	0.0	17.5	2.8	9.5	11.5	0.9	12.3	0.0	8.0	0.1	12.6	8.4	0.0	9.9	27.4	3.3	40.5	6.4	17.1	16.6	9.8	13.4	25.7	28.5	0.0	1.7	0.0	22.5	15.9	13.2	26.5	17.3	2.9	0.0	7.7	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	6.3	0.5	5.3	0.8	0.0	4.9	5.2	4.9	1.1	4.4	5.2	3.0	6.2	3.5	7.4	5.5
RAB44	"dJ431A14.3, RASD3, RASL13"	ENSG00000255587	"RAB44, member RAS oncogene family"		6	36697810-36733183	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 10.0;bone marrow: 36.0"	"Cell line enhanced"	"Detected in some"		"HEL: 8.5;HL-60: 11.9;HMC-1: 36.3;NB-4: 29.9;THP-1: 11.8;U-937: 23.9"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	9	"basophil: 10.0;eosinophil: 7.8"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 10.0"					"Not detected"	"Not detected"														"unprognostic (8.86e-2)"	"unprognostic (5.58e-3)"	"unprognostic (5.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.56e-2)"	"unprognostic (6.35e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.03e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.79e-2)"	1.4	0.0	0.0	1.2	0.1	36.0	0.2	0.0	0.0	1.9	1.0	0.0	0.9	0.4	3.5	0.7	0.6	0.3	7.2	2.6	0.0		0.0	0.2	6.6	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	2.4	0.2	1.1	0.0	1.0	0.0	0.3	0.5	0.5	0.0	0.9	0.4	0.5	0.0	0.9	0.0	1.8	0.3	1.5	0.0	0.0	0.8	10.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	11.9	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	10.0	0.9	7.8	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
RASGEF1A	"CG4853, FLJ37817"	ENSG00000198915	"RasGEF domain family member 1A"	Q8N9B8	10	43194535-43266919	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.6;brain: 18.3"	"Cell line enhanced"	"Detected in some"		"K-562: 13.0;SCLC-21H: 12.6;SK-BR-3: 11.4;T-47d: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035593	Enhanced		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA035593: AB_10602083"	"prognostic favourable (1.86e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (4.28e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.73e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.52e-1)"	"prognostic unfavourable (4.11e-7)"	"unprognostic (2.88e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.83e-2)"	1.1	2.3	13.1	1.6	16.2	16.6	4.4	11.0	18.3	2.1	0.9	4.0	0.0	1.2	1.6	0.7	1.5	3.4	3.0	1.5	12.3	10.6	1.4	0.4	1.8	6.0	7.2	8.7	1.8	4.8	10.7	3.3	1.1	7.2	1.7	0.7	2.3	4.6	2.6	1.1	0.9	0.8	1.7	3.5	3.5	1.0	3.1	4.1	0.0	1.2	0.2	4.6	2.2	1.9	2.1	5.8	10.4	0.6	7.1	3.6	1.1	7.4	6.4	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	0.0	0.2	4.1	6.5	7.0	0.6	0.1	1.0	6.1	0.0	0.0	5.0	0.0	0.1	0.3	3.1	0.0	2.4	1.6	7.0	0.6	0.0	0.0	13.0	0.0	0.0	1.5	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.5	3.5	12.6	0.0	0.0	11.4	0.1	12.5	0.1	0.0	0.0	2.9	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	6.6	3.6	0.6	1.3	0.2	0.9	2.6	3.3	2.1	0.3	1.8	10.4	7.1	0.4	5.8	0.0	1.1	13.1	16.2	11.0	17.8	12.3	10.6	7.2	8.7	7.2	4.1
RASGRP2	CALDAG-GEFI	ENSG00000068831	"RAS guanyl releasing protein 2"	Q7LDG7	11	64726911-64745456	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.6;bone marrow: 63.9;lymphoid tissue: 47.6"	"Cell line enhanced"	"Detected in some"		"HEL: 22.5;HL-60: 40.7;NB-4: 77.3;REH: 23.1;THP-1: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015667	Approved					1900000	1900000			"HPA015667: AB_1856090"	"unprognostic (5.96e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.52e-2)"	"unprognostic (4.74e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (1.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.23e-1)"	7.6	4.2	4.6	26.8	26.4	63.9	4.5	4.3	8.2	5.6	9.9	3.2	4.5	3.6	8.8	4.9	4.5	8.9	4.7	13.7	5.5	4.7	5.5	3.1	8.5	47.6	4.7	5.7	2.7	1.2	0.7	1.5	8.1	4.1	6.9	3.2	5.3	7.4	10.4	5.8	1.5	25.6	8.1	2.7	43.9	5.4	3.1	8.2	9.7	2.9	2.5	30.1	7.0	4.8	51.6	29.1	24.5	32.2	16.7	32.8	22.2	0.0	0.0	0.7	0.0	0.0	0.0	2.0	0.3	0.0	0.3	0.2	0.3	0.0	14.0	0.6	0.0	0.1	1.2	0.2	0.0	0.0	0.4	22.5	0.0	0.0	0.0	40.7	8.3	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.3	9.6	77.3	0.5	0.0	23.1	0.0	0.9	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	24.2	0.1	0.0	0.4	0.3	0.0	0.1	0.0	12.9	0.0	12.9	0.0	16.5	11.8	19.1	24.4	28.6	13.2	51.6	25.3	19.3	11.6	32.0	32.8	29.0	24.5	16.7	32.2	29.1	29.9	22.2	4.6	26.4	4.3	8.2	5.5	4.7	4.7	5.7	4.1	8.2
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.4;bone marrow: 23.3;lymphoid tissue: 23.1"	"Group enriched"	"Detected in some"	5	"HEL: 18.9;HMC-1: 18.9;U-937: 4.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA041929: "	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	4.5	1.8	2.4	8.0	3.3	23.3	5.4	0.7	1.8	1.8	1.7	2.8	0.1	1.4	1.6	2.9	1.6	2.6	3.4	6.2	2.0	1.3	1.5	1.8	11.8	23.1	3.4	0.2	1.1	1.6	0.5	0.9	3.0	1.8	1.7	1.2	1.7	1.6	0.8	1.5	1.4	2.4	2.7	4.2	19.2	1.9	0.8	2.4	0.5	1.0	0.2	1.0	2.6	3.1	0.1	5.2	22.4	9.5	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	18.9	0.0	0.0	0.0	0.1	18.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	6.0	7.1	10.6	0.0	8.5	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.0	22.4	0.0	9.5	0.4	0.7	2.1	2.4	3.3	0.7	1.8	2.0	1.3	3.4	0.2	1.8	2.4
RBM15	"OTT, OTT1"	ENSG00000162775	"RNA binding motif protein 15"	Q96T37	1	110338506-110346681	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015201, HPA019824, HPA049642"	Supported		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB015201: , HPA019824: AB_1856113, HPA049642: AB_2680839"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.57e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (7.61e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (1.37e-4)"	"prognostic favourable (7.97e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-1)"	8.5	7.6	6.3	12.2	7.6	48.7	7.9	18.6	8.3	6.6	8.8	7.6	8.3	7.3	8.5	7.2	8.0	7.3	6.6	8.8	5.2	4.3	6.3	11.0	10.5	13.7	8.3	6.0	8.6	7.5	7.1	8.1	7.1	5.9	5.7	5.7	8.1	7.4	6.4	17.2	7.2	11.3	5.5	5.0	12.5	8.3	14.0	7.9	21.8	7.0	5.3	13.4	6.5	8.6	10.5	4.8	9.8	6.9	5.0	9.9	5.5	7.0	7.7	6.9	7.1	4.4	4.6	10.9	3.7	4.9	5.9	7.8	9.4	6.5	13.3	6.0	4.2	10.0	10.8	9.4	8.8	13.8	10.0	10.8	11.7	6.8	6.2	11.7	11.5	4.2	6.6	8.2	7.7	6.3	15.2	23.4	5.9	7.2	10.5	9.2	14.8	4.3	12.5	10.5	9.1	4.8	7.1	8.4	4.2	8.2	10.3	7.9	7.2	14.1	4.3	5.7	10.2	6.1	6.8	18.0	9.1	28.9	8.5	11.8	7.0	8.2	6.9	9.4	7.0	6.0	9.9	10.5	7.7	6.0	4.8	10.0	6.8	8.2	9.8	5.0	6.4	4.7	7.5	5.5	6.3	7.6	18.6	8.3	5.2	4.3	8.3	6.0	5.9	7.9
RBM38	"dJ800J21.2, HSRNASEB, RNPC1, seb4B, SEB4D"	ENSG00000132819	"RNA binding motif protein 38"	Q9H0Z9	20	57391407-57409333	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 64.3;skeletal muscle: 107.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 38.8;U-698: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			CAB017036	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB017036: "	"unprognostic (1.03e-1)"	"prognostic favourable (3.64e-7)"	"unprognostic (3.71e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.04e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (2.13e-2)"	"unprognostic (2.29e-1)"	"prognostic favourable (1.63e-4)"	"unprognostic (1.83e-1)"	4.4	3.5	4.5	22.8	4.9	64.3	4.3	10.0	5.2	9.2	28.1	6.4	7.1	5.9	13.0	6.7	16.3	10.4	6.5	24.4	4.2	3.9	5.3	6.7	9.8	23.3	4.7	2.3	17.2	5.9	1.9	4.4	9.9	5.0	12.2	3.4	10.9	11.6	8.3	107.9	2.7	12.9	27.4	3.4	22.0	8.1	16.7	4.1	26.8	4.1	18.9	28.0	25.1	11.4	6.4	2.2	3.5	2.9	5.5	7.6	3.4	5.4	5.6	2.8	7.1	0.0	0.4	16.1	1.8	0.4	3.9	1.0	23.0	5.9	38.8	15.4	0.5	5.0	2.3	2.2	0.6	7.8	9.6	32.9	2.1	14.5	1.7	15.8	15.5	0.5	1.1	1.6	0.3	2.6	26.8	7.1	0.4	23.6	11.4	16.3	10.4	7.1	22.2	7.0	31.5	2.9	2.5	11.7	7.5	4.3	14.3	7.2	7.9	22.3	4.6	1.3	12.4	1.6	7.5	17.0	22.5	40.8	0.3	11.4	1.2	0.0	1.0	3.5	5.4	2.9	3.5	5.6	4.5	3.7	1.8	6.4	5.7	5.0	1.3	5.5	2.7	2.2	7.6	3.4	4.5	4.9	10.0	5.2	4.2	3.9	4.7	2.3	5.0	4.1
RECQL4	RecQ4	ENSG00000160957	"RecQ like helicase 4"		8	144511288-144517845	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 21.0;lymphoid tissue: 18.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	14	"B-cells: 1.9;monocytes: 1.0;T-cells: 1.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB017800, HPA025821"	Supported		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB017800: , HPA025821: AB_1856168"	"unprognostic (5.92e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (1.91e-4)"	"unprognostic (1.12e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	2.0	1.6	2.6	12.3	5.6	21.0	2.8	11.5	3.7	1.8	4.3	1.5	1.6	5.6	2.5	4.9	9.4	1.5	1.9	1.9	2.3	1.7	1.6	1.9	1.6	5.9	1.5	2.2	1.9	3.5	0.3	2.4	2.7	2.2	7.7	1.5	1.4	5.4	0.9	2.1	9.4	4.8	1.1	1.7	4.7	3.0	18.1	1.8	18.9	2.5	5.3	8.0	1.6	1.8	1.9	0.1	0.0	1.0	0.0	1.6	0.2	10.3	18.5	8.7	18.2	0.5	0.8	15.2	10.5	1.9	7.8	6.6	18.2	15.3	7.1	7.0	1.7	12.6	5.7	4.5	2.1	12.4	21.8	25.5	31.7	13.5	0.1	6.4	21.2	1.1	0.6	8.7	1.7	2.1	25.3	9.2	2.6	32.0	23.5	17.5	6.0	22.2	24.6	6.8	11.8	2.1	11.2	17.1	10.3	14.2	11.9	3.7	14.5	14.2	2.9	12.6	38.3	15.1	19.3	5.1	5.4	11.9	7.3	20.0	12.6	0.0	0.1	0.0	1.1	1.0	0.0	1.9	0.5	1.1	0.1	0.0	0.9	1.6	0.0	0.0	0.0	0.1	0.0	0.2	2.6	5.6	11.5	3.7	2.3	1.7	1.5	2.2	2.2	1.8
REM2	FLJ38964	ENSG00000139890	"RRAD and GEM like GTPase 2"	Q8IYK8	14	22883165-22887686	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.4;brain: 23.9"	"Cell line enhanced"	"Detected in some"		"AF22: 7.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	8	"basal ganglia: 23.9"	"Cell type enriched"	"Detected in some"	4	"neutrophil: 7.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 7.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.1"	"Low region specificity"	"Detected in all"														"unprognostic (4.56e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.49e-5)"	"unprognostic (9.40e-2)"	"unprognostic (4.63e-5)"	"unprognostic (3.56e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.49e-2)"	0.6	1.0	0.4	1.6	23.9	15.4	0.6	2.7	2.5	0.5	0.7	0.9	0.4	0.7	0.9	0.9	0.4	2.4	0.7	0.4	1.2	1.5	0.7	0.4	1.6	1.6	0.4	1.1	1.3	1.0	5.7	5.4	0.4	1.5	1.0	0.4	0.4	1.0	0.7	0.7	1.5	1.4	0.6	0.9	5.2	1.0	3.8	2.9	0.6	0.7	0.4	1.0	0.6	0.4	1.7	0.4	7.5	0.7	0.0	1.0	0.2	1.6	0.8	7.2	0.3	0.7	1.0	1.1	0.1	0.5	0.1	0.6	0.8	2.4	0.6	0.3	0.1	3.0	0.1	0.2	0.6	1.1	1.7	0.3	2.9	0.0	0.6	0.3	0.5	0.4	0.2	0.2	0.1	0.3	0.2	3.0	0.4	2.3	0.0	0.7	0.4	1.3	0.1	0.2	0.7	0.3	0.2	0.9	3.4	0.6	1.1	1.2	1.3	0.6	0.0	0.0	1.6	0.1	0.2	2.9	1.1	1.8	0.3	0.1	0.0	0.4	0.0	0.8	0.2	0.0	0.7	1.1	0.5	0.6	0.0	1.7	1.0	1.0	7.5	0.0	0.7	0.4	0.4	0.2	0.4	23.9	2.7	2.5	1.2	1.5	0.4	1.1	1.5	2.9
RETN	"ADSF, FIZZ3, RETN1"	ENSG00000104918	Resistin	Q9HD89	19	7669044-7670454	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.5;bone marrow: 79.5;lymphoid tissue: 27.6"	"Group enriched"	"Detected in some"	11	"NB-4: 100.1;U-937: 46.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 4.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.5;myeloid DC: 30.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 30.3;monocytes: 45.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	350000	350000				"unprognostic (5.61e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.19e-4)"	"unprognostic (1.53e-4)"	"unprognostic (7.34e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.16e-5)"	"unprognostic (4.23e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.20e-1)"	1.3	0.4	0.0	1.9	0.6	79.5	0.6	0.4	0.9	0.1	0.2	0.1	0.7	2.3	0.3	0.1	0.2	1.3	0.2	21.9	0.0	0.0	0.9	1.6	17.3	7.5	1.3	0.0	0.8	1.6	0.1	0.4	1.1	0.2	0.2	0.1	0.7	0.7	0.1	0.6	0.2	0.3	1.5	0.4	27.6	0.4	0.4	0.5	2.7	0.8	0.0	0.4	0.2	2.3	0.0	30.3	3.4	45.5	0.0	2.4	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	100.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.0	45.5	0.0	0.1	21.7	0.3	0.0	0.5	0.4	30.3	0.0	1.1	2.4	3.4	0.0	11.1	1.2	0.0	14.0	0.0	0.6	0.4	0.9	0.0	0.0	1.3	0.0	0.2	0.5
RFESD		ENSG00000175449	"Rieske Fe-S domain containing"	Q8TAC1	5	95646754-95684773	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.3"	"Cell line enhanced"	"Detected in many"		"HEL: 20.8;K-562: 38.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 3.7;NK-cells: 5.0;T-cells: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016546	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB016546: AB_630417"	"unprognostic (1.15e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.83e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.03e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.09e-1)"	2.4	3.8	2.8	2.8	5.5	28.3	8.6	4.9	5.1	3.5	2.6	3.1	3.3	1.8	3.1	6.2	3.4	2.8	1.9	5.4	3.8	3.1	3.4	4.4	3.7	3.8	4.5	4.1	4.2	10.7	6.9	9.7	2.9	5.5	4.5	2.2	2.8	8.1	4.9	6.8	9.7	2.3	2.1	8.6	3.7	3.4	16.0	3.9	8.6	4.5	1.4	4.1	3.3	2.9	3.7	1.6	0.3	0.9	5.0	12.7	2.8	1.8	2.8	0.5	1.8	1.8	3.3	0.0	0.9	1.5	1.6	1.6	2.2	1.9	2.9	2.0	0.8	2.6	1.9	1.5	1.7	4.4	1.7	20.8	2.8	0.8	2.3	1.9	2.2	1.5	2.9	2.1	1.9	1.6	38.7	2.3	2.5	1.2	6.1	8.2	2.3	2.7	3.0	0.3	1.2	0.6	1.0	2.8	2.0	2.8	1.2	0.0	1.4	1.0	0.8	2.0	1.6	1.5	1.7	2.1	4.9	2.3	1.8	2.3	1.0	0.0	0.7	0.3	3.5	0.9	9.4	3.7	8.5	6.0	1.5	2.9	12.7	7.2	0.0	5.0	0.8	1.6	4.9	2.8	2.8	5.5	4.9	5.1	3.8	3.1	4.5	4.1	5.5	3.9
RFX8	FLJ42986	ENSG00000196460	"RFX family member 8, lacking RFX DNA binding domain"	Q6ZV50	2	101397361-101474703	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;breast: 7.5;lymphoid tissue: 7.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.9;hTEC/SVTERT24-B: 15.4;LHCN-M2: 7.3;U-87 MG: 10.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	12	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059745			Approved	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA059745: AB_2684120"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.56e-3)"	"unprognostic (8.14e-2)"	"unprognostic (3.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.73e-5)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-2)"	2.1	0.6	0.4	0.8	0.7	10.0	7.5	0.2	2.3	0.9	0.5	0.8	1.3	0.4	0.7	1.7	0.7	0.2	1.0	0.8	0.4	0.9	0.6	0.7	0.7	0.9	0.7	1.6	0.7	0.6	1.0	2.2	0.9	1.6	0.5	0.1	0.8	0.9	0.1	0.5	1.4	0.3	0.8	0.8	0.4	0.4	2.6	0.0	7.8	1.5	0.0	0.3	0.6	2.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	2.0	1.4	1.3	1.4	0.0	3.1	0.0	0.0	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	2.0	0.0	15.4	0.1	0.0	0.0	0.0	7.3	0.0	0.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	3.8	0.2	0.0	0.0	1.9	2.8	0.0	0.0	0.0	10.1	4.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.2	2.3	0.4	0.9	0.7	1.6	1.6	0.0
RGCC	"bA157L14.2, C13orf15, RGC-32, RGC32"	ENSG00000102760	"Regulator of cell cycle"	Q9H4X1	13	41457559-41470882	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 109.9;lung: 120.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 15.0;BJ hTERT+: 78.9;Daudi: 25.7;U-698: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 46.2"	"Lineage enriched"	"Detected in many"	26	"T-cells: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035638, HPA063701"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	390000	390000	Nucleoplasm	Nucleoplasm	"HPA035638: AB_10670152, HPA063701: AB_2685096"	"unprognostic (1.39e-3)"	"unprognostic (4.61e-2)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-3)"	58.6	6.7	26.7	8.8	33.1	109.9	27.7	21.6	22.7	12.8	5.6	36.1	4.2	5.7	8.7	3.1	5.4	7.6	14.3	15.1	32.1	16.8	11.0	8.3	120.1	10.8	41.7	15.2	1.8	13.4	8.7	7.1	70.6	21.1	10.7	3.6	16.1	33.2	6.8	12.7	10.8	4.9	11.3	22.2	7.3	8.0	7.1	34.8	15.2	26.9	5.8	6.9	9.5	8.7	1.7	1.7	0.2	0.2	0.1	46.2	2.8	0.2	0.1	8.8	0.0	1.7	15.0	0.3	0.2	78.9	0.0	0.3	10.9	0.1	25.7	0.2	1.0	0.2	0.3	0.5	0.1	2.6	1.2	0.0	1.9	0.8	0.8	0.9	0.3	1.1	1.7	0.3	11.0	9.0	1.9	0.0	0.2	0.0	5.7	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.2	4.9	6.0	0.0	0.9	0.5	0.1	0.0	0.0	27.0	0.0	0.6	0.2	0.0	0.2	0.0	1.6	0.1	1.6	1.2	13.8	4.4	1.7	1.7	46.2	10.5	0.2	0.1	0.0	0.5	23.1	2.8	26.7	33.1	21.6	21.7	32.1	16.8	41.7	15.2	21.1	34.8
RGL4	Rgr	ENSG00000159496	"Ral guanine nucleotide dissociation stimulator like 4"	Q8IZJ4	22	23688136-23699176	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 81.3;bone marrow: 55.8"	"Group enriched"	"Detected in many"	5	"MOLT-4: 14.8;U-937: 34.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"neutrophil: 81.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 81.3"									HPA035979	Uncertain		Approved	Centrosome	"Intracellular and membrane"			Centrosome	Centrosome	"HPA035979: AB_10673227"	"unprognostic (1.48e-4)"	"unprognostic (2.75e-4)"	"unprognostic (4.44e-2)"	"unprognostic (1.11e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.93e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.11e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-3)"	1.6	1.0	0.5	9.8	0.6	55.8	0.6	1.0	0.8	0.4	1.0	0.2	0.0	1.3	1.0	1.0	1.1	1.2	1.8	10.8	0.5	0.5	0.8	1.5	6.7	19.9	0.6	0.0	1.4	1.0	0.0	0.7	0.8	0.5	0.5	0.2	0.4	2.2	0.0	0.8	1.9	4.1	0.0	0.6	21.6	0.9	18.4	0.3	11.1	1.0	0.3	8.9	1.1	3.6	0.9	0.8	81.3	12.0	4.8	17.8	5.8	0.9	0.3	3.4	1.5	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.7	0.6	1.1	0.2	0.0	1.6	0.0	0.0	0.0	1.1	2.1	0.5	1.2	0.2	0.0	1.9	2.3	0.0	0.0	0.0	0.0	0.0	1.2	1.8	0.0	0.5	14.8	2.1	0.2	0.4	5.3	1.2	0.8	0.0	1.0	1.0	1.6	1.0	2.2	0.3	0.7	1.1	1.4	1.9	1.2	1.3	0.6	3.1	0.5	0.7	1.1	34.8	0.9	11.8	0.4	58.6	9.5	2.9	9.8	0.9	12.4	10.9	0.8	0.7	17.8	15.9	81.3	4.8	12.0	0.1	17.0	5.8	0.5	0.6	1.0	0.5	0.5	0.5	0.6	0.0	0.5	0.3
RHD	"CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI"	ENSG00000187010	"Rh blood group D antigen"	Q02161	1	25272393-25330445	"Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 10.0;bone marrow: 16.5;salivary gland: 7.1"	"Group enriched"	"Detected in some"	6	"HEL: 27.6;K-562: 8.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.0"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA060951: , HPA077385: "	"unprognostic (4.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.92e-3)"	0.3	0.3	0.3	0.5	0.5	16.5	0.3	1.5	1.4	0.6	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.4	0.9	0.3	0.2	0.3	0.3	2.5	0.8	0.3	0.3	0.9	0.3	0.1	0.4	0.3	1.1	0.5	0.0	0.3	7.1	0.3	4.1	2.5	0.4	0.3	0.4	1.8	0.3	0.5	0.3	0.3	0.4	2.3	0.3	0.3	0.3	2.0	0.6	10.0	1.4	1.4	1.4	1.2	0.1	0.0	0.2	0.2	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.1	27.6	0.6	0.2	0.0	0.3	0.2	0.1	0.1	0.1	0.1	0.1	8.5	0.7	0.0	0.1	0.2	0.2	3.1	0.1	0.2	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.2	0.1	0.2	0.4	0.4	0.5	0.2	0.4	0.1	0.3	0.1	0.1	0.4	0.2	0.1	4.9	1.4	2.8	1.0	0.6	1.1	1.3	1.3	0.8	0.2	2.0	1.4	1.3	10.0	1.4	0.8	0.6	0.9	1.2	0.3	0.5	1.5	1.4	0.3	0.2	0.3	0.3	1.1	0.3
RHOG	"ARHG, MGC125835, MGC125836, RhoG"	ENSG00000177105	"Ras homolog family member G"	P84095	11	3826978-3840983	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 112.3;bone marrow: 109.5"	"Cell line enhanced"	"Detected in all"		"HMC-1: 117.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA039871	Enhanced					2300000	2300000			"HPA039871: AB_10673428"	"unprognostic (2.39e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (1.81e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.27e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavourable (9.49e-8)"	"unprognostic (9.38e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	22.9	14.0	14.5	36.6	24.4	109.5	22.0	4.9	21.4	14.6	15.9	49.7	9.2	21.0	17.8	10.1	28.2	15.8	16.5	12.6	19.8	13.5	13.7	17.3	30.2	65.1	34.8	11.6	15.6	12.2	8.8	9.9	22.3	23.3	13.2	14.0	9.3	14.4	14.9	17.9	17.3	27.0	18.6	44.5	63.8	15.1	9.4	26.5	38.6	11.0	15.9	30.4	19.6	18.6	9.6	35.3	112.3	58.4	10.3	22.6	31.4	13.1	18.0	3.6	6.3	14.2	16.1	4.0	8.8	11.0	13.8	14.6	11.1	14.4	13.4	4.7	16.1	15.6	5.7	12.4	8.9	11.8	13.8	30.5	8.8	10.2	14.4	26.6	117.6	15.6	11.4	8.6	8.3	15.8	17.8	15.0	11.2	15.4	22.2	36.8	5.8	14.5	11.4	3.9	7.9	9.8	9.2	1.9	5.0	6.2	14.4	7.0	7.6	20.1	12.2	16.7	8.4	17.7	10.2	8.4	11.4	7.5	15.3	24.3	9.3	40.8	38.9	80.1	14.0	51.7	12.2	9.6	15.3	15.4	35.3	9.2	10.9	12.5	112.3	10.3	58.4	8.8	22.6	31.4	14.5	24.4	4.9	21.4	19.8	13.5	34.8	11.6	23.3	26.5
RNF166	"MGC14381, MGC2647"	ENSG00000158717	"Ring finger protein 166"	Q96A37	16	88696495-88706421	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.9"	"Cell line enhanced"	"Detected in all"		"NB-4: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042970			Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA042970: AB_10796682"	"unprognostic (3.01e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.96e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.38e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (9.45e-6)"	"unprognostic (1.54e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-2)"	9.2	8.1	9.2	22.8	8.9	63.9	10.5	13.7	15.3	6.7	7.2	11.2	3.7	12.0	8.1	8.3	6.4	9.1	12.3	10.0	8.6	7.3	9.6	9.7	20.8	30.5	8.9	6.5	9.7	11.4	5.3	8.5	7.5	8.4	8.9	4.9	11.0	12.1	6.0	14.8	8.2	16.0	8.3	11.1	47.2	10.9	9.2	9.1	21.6	8.8	7.8	23.8	9.7	6.7	2.0	11.8	28.7	12.5	5.5	17.1	9.7	4.1	6.7	5.2	8.2	2.5	2.2	9.9	4.2	2.7	5.0	2.3	4.5	2.7	5.0	5.5	2.4	4.6	3.0	2.8	2.0	2.6	9.0	6.8	4.9	7.6	6.8	6.7	8.7	2.6	2.7	4.0	3.2	5.2	11.3	3.7	2.0	8.2	15.6	43.8	8.5	9.0	14.7	3.3	13.0	2.2	1.9	4.8	5.4	9.6	2.0	5.2	5.7	22.9	7.2	3.8	5.6	5.6	5.1	8.4	4.9	12.2	3.3	25.5	5.2	3.0	12.5	28.7	17.1	9.1	14.8	2.0	10.4	14.8	11.8	1.9	8.7	12.5	20.4	5.5	10.5	7.3	10.5	9.7	9.2	8.9	13.7	15.3	8.6	7.3	8.9	6.5	8.4	9.1
RNF182	MGC33993	ENSG00000180537	"Ring finger protein 182"	Q8N6D2	6	13924446-13980302	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 12.9;brain: 17.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 36.3;RPTEC TERT1: 29.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012309	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA012309: AB_1856349"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (4.66e-5)"	"unprognostic (6.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.33e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.26e-1)"	1.2	0.7	7.6	0.6	6.2	12.9	1.2	16.6	17.6	1.2	0.7	7.5	2.0	0.8	1.6	2.5	1.0	2.7	0.9	1.0	11.0	7.3	2.6	0.5	5.7	0.8	6.8	8.5	1.1	3.6	0.5	2.0	2.9	14.3	0.9	0.6	2.2	1.9	4.7	0.9	0.8	1.1	1.0	5.1	0.5	0.6	7.0	2.9	0.0	3.0	0.0	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.7	5.2	0.0	1.8	2.2	0.3	2.6	3.6	7.4	7.1	0.1	0.0	0.0	0.0	2.8	0.0	6.1	0.0	13.5	0.0	2.0	0.1	36.3	0.0	0.0	0.0	0.0	1.2	0.0	11.3	0.1	0.1	0.2	0.0	5.1	0.0	0.0	0.9	2.9	10.1	1.5	1.2	0.4	29.1	0.0	6.3	6.0	0.2	0.0	10.2	0.0	1.0	2.7	9.0	1.9	0.1	6.0	0.0	0.0	0.0	6.1	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	6.2	16.6	12.1	11.0	7.3	6.8	8.5	14.3	2.9
RNF24	G1L	ENSG00000101236	"Ring finger protein 24"	Q9Y225	20	3927309-4015582	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 59.0;bone marrow: 59.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 59.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 59.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011900	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA011900: AB_10671089"	"unprognostic (6.61e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavourable (3.81e-5)"	"unprognostic (2.65e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.19e-3)"	"unprognostic (3.42e-1)"	"prognostic unfavourable (2.67e-7)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.24e-1)"	9.1	9.3	13.1	11.6	13.0	59.4	14.8	12.3	16.2	9.2	6.6	8.4	17.0	4.7	9.1	20.6	8.1	8.0	9.3	7.4	13.0	10.5	9.5	3.2	14.5	14.1	10.5	9.9	9.3	5.9	5.3	8.2	5.6	9.4	9.9	5.8	5.4	9.8	14.9	3.2	11.4	5.3	9.0	12.8	14.8	7.6	6.3	7.6	6.3	8.8	4.5	6.0	9.4	15.5	1.1	4.6	59.0	5.8	1.7	1.8	2.4	8.0	3.7	5.4	4.8	20.7	35.3	1.9	6.7	14.4	6.8	9.8	2.4	7.9	1.7	1.5	13.6	5.4	2.1	7.5	11.5	1.2	1.7	14.9	6.5	1.9	18.2	29.7	5.9	11.8	2.4	18.1	15.5	6.3	18.8	4.1	11.0	2.2	4.9	7.3	8.2	5.2	5.6	4.7	1.4	3.8	4.4	5.2	4.2	18.9	11.5	5.0	4.0	10.7	9.7	17.0	5.6	11.5	8.0	3.5	3.6	0.7	8.8	10.4	5.3	20.7	5.8	11.8	0.9	2.1	0.9	0.3	1.8	1.4	4.6	1.1	1.2	1.4	59.0	1.7	2.8	0.2	0.8	2.4	13.1	13.0	12.3	13.5	13.0	10.5	10.5	9.9	9.4	7.6
RPH3A	"exophilin-1, KIAA0985, rabphilin"	ENSG00000089169	"Rabphilin 3A"	Q9Y2J0	12	112570380-112898881	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.9;brain: 51.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 8.1;SH-SY5Y: 18.6"	"Cancer enriched"	"Detected in some"	5	"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 9.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002475	Enhanced									"HPA002475: AB_1079837"	"unprognostic (5.50e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-3)"	"unprognostic (5.90e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.46e-2)"	0.9	3.5	15.5	1.6	27.4	15.9	1.2	32.9	51.2	0.7	1.2	3.6	0.0	1.2	1.6	2.7	1.3	1.1	2.2	1.0	14.0	13.2	1.0	1.2	1.0	3.2	6.4	19.9	1.4	2.5	0.9	0.2	1.5	9.9	1.2	1.6	0.2	1.3	0.9	1.0	2.5	1.4	1.6	5.0	1.9	1.0	1.6	5.9	0.0	1.8	0.0	2.1	1.7	0.2	1.8	0.9	3.5	9.2	0.9	0.8	2.3	0.9	0.9	0.9	1.6	0.3	0.6	2.7	0.0	0.5	0.5	0.0	0.6	1.3	1.3	0.5	0.0	2.3	0.4	0.6	1.2	0.4	1.3	2.3	3.3	2.2	0.5	1.4	2.1	0.6	0.2	1.4	1.7	0.0	0.1	3.5	2.0	1.4	0.6	1.7	1.3	1.2	0.0	1.0	8.1	0.0	1.8	1.6	18.6	0.2	0.1	0.1	0.8	0.1	0.1	1.8	1.4	1.7	1.0	1.7	0.3	1.3	1.2	0.8	0.6	1.3	9.2	0.5	0.7	4.2	0.4	0.8	0.4	0.6	0.9	1.8	0.5	0.8	3.5	0.9	5.7	0.5	0.1	2.3	15.5	27.4	32.9	51.2	14.0	13.2	6.4	19.9	9.9	5.9
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				Nucleoli	Nucleoli	"HPA049945: AB_2680965, HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	7.1	8.4	5.9	7.4	11.9	62.6	4.6	3.8	15.7	4.1	4.0	5.4	2.9	5.2	6.4	3.9	7.1	6.4	6.4	8.4	4.4	7.2	4.4	9.3	5.6	6.0	5.9	6.1	6.0	16.4	9.6	10.6	3.9	9.6	5.5	3.6	4.1	6.6	3.9	31.7	8.2	3.8	5.3	3.2	7.1	5.3	13.9	6.1	4.6	4.9	7.2	5.4	4.2	4.3	3.4	4.3	19.3	11.1	1.2	2.4	3.7	15.8	21.1	5.6	12.1	4.3	5.1	12.4	10.0	6.0	10.4	8.1	22.9	14.7	17.4	13.0	6.3	20.4	15.4	11.6	7.0	9.4	18.5	13.4	7.9	17.8	7.2	20.9	17.7	5.3	16.4	25.6	23.7	5.8	19.2	11.7	5.9	20.5	14.1	13.5	24.2	14.3	15.6	7.7	17.2	7.2	8.8	7.6	16.2	8.0	7.7	10.0	18.6	10.9	7.6	7.0	12.0	15.6	31.5	23.9	20.8	20.5	10.0	26.9	7.4	0.2	7.3	4.6	2.0	9.3	2.4	2.9	1.2	1.6	4.3	3.4	1.9	2.1	19.3	1.2	11.1	3.6	0.8	3.7	5.9	11.9	3.8	15.7	4.4	7.2	5.9	6.1	9.6	6.1
RUNX3	"AML2, CBFA3, PEBP2A3"	ENSG00000020633	"Runt related transcription factor 3"	Q13761	1	24899511-24965121	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.5;lymphoid tissue: 47.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 38.7;Karpas-707: 52.1;SK-MEL-30: 28.9;U-266/70: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004195, CAB025416, HPA059006"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	Nucleoplasm	"CAB025416: , HPA004195: , HPA059006: AB_2683877"	"unprognostic (7.75e-3)"	"unprognostic (6.51e-3)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"prognostic unfavourable (5.59e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	3.0	1.1	0.9	25.4	1.1	31.5	3.4	0.5	1.0	11.9	8.0	1.2	0.3	2.5	1.7	1.4	3.5	1.7	6.2	1.3	0.9	1.1	2.2	2.3	11.7	28.8	2.8	0.7	1.3	1.0	0.0	1.0	1.3	1.8	2.3	2.3	2.8	6.5	2.2	2.2	9.5	13.7	1.3	1.8	30.6	2.7	2.1	0.8	14.2	1.8	3.1	47.6	8.9	2.2	4.5	1.0	4.3	4.6	18.1	15.1	3.1	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	6.2	6.1	5.3	0.1	3.6	0.0	0.2	38.7	0.6	0.1	0.6	0.0	0.0	1.4	13.4	0.0	0.0	0.0	0.3	0.0	0.0	52.1	0.0	0.0	0.4	12.0	0.2	1.0	0.0	0.0	7.3	0.0	0.1	1.2	0.0	2.4	0.0	28.9	0.0	8.3	0.0	0.0	0.5	0.0	0.1	18.1	12.5	5.9	0.0	13.5	1.4	0.4	0.7	4.3	15.1	3.0	8.1	4.5	5.7	13.2	0.9	3.8	2.8	10.3	0.9	18.1	4.6	1.0	5.7	3.1	0.9	1.1	0.5	1.0	0.9	1.1	2.8	0.7	1.8	0.8
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391188	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 720.9;bone marrow: 718.8;esophagus: 532.3;tongue: 597.1"	"Group enriched"	"Detected in some"	28	"hTCEpi: 27.5;SK-BR-3: 100.9;THP-1: 53.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 320.7;neutrophil: 720.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 720.9;monocytes: 320.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	530000000	530000000	"Intermediate filaments"	"Intermediate filaments"	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	14.0	0.8	0.8	30.5	2.6	718.8	1.1	0.5	1.6	123.0	2.8	0.7	0.4	0.4	12.0	1.2	532.3	5.5	2.1	36.7	1.5	0.5	1.4	4.3	26.2	37.3	3.3	0.4	2.1	2.7	0.1	0.9	4.7	3.3	1.4	0.4	1.3	92.4	0.3	2.5	6.2	1.0	9.0	1.8	72.4	2.0	1.9	0.9	2.6	4.6	597.1	257.6	5.0	224.1	0.6	63.7	720.9	320.7	0.3	0.6	244.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	1.6	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	27.5	0.0	0.9	0.0	1.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.4	100.9	0.0	0.6	53.6	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	1.6	0.0	8.2	320.7	38.9	0.4	26.5	0.6	0.6	0.3	0.2	63.7	0.3	0.3	0.3	720.9	0.3	6.4	2.5	0.4	244.7	0.8	2.6	0.5	1.6	1.5	0.5	3.3	0.4	3.3	0.9
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6"	"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 227.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 381.5;neutrophil: 638.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 638.3;monocytes: 381.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	1400000000	1400000000	"Nucleoplasm, Cell Junctions, Cytosol"	"Nucleoplasm, Cell Junctions, Cytosol"	"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavourable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	19.5	2.1	1.3	41.9	4.2	820.1	4.1	0.9	2.1	143.6	4.4	0.7	0.4	0.7	4.9	4.0	642.6	9.9	4.4	51.2	2.5	0.4	2.8	4.8	29.2	169.0	5.3	0.6	3.4	4.4	0.1	0.9	10.4	5.2	2.2	0.7	2.0	109.6	0.5	3.4	7.5	1.4	13.1	2.1	103.2	3.5	2.9	1.4	3.8	6.7	477.6	228.0	24.3	237.0	0.5	87.5	638.3	381.5	0.3	1.0	323.2	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	35.7	0.0	2.1	0.0	14.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	12.4	0.0	0.8	0.0	0.6	0.3	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.4	7.5	0.0	9.2	0.1	0.0	0.3	227.6	0.1	3.6	28.9	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	6.5	0.0	5.3	381.5	46.4	0.5	31.6	1.0	0.4	0.4	0.3	87.5	0.5	0.3	0.3	638.3	0.3	15.0	2.9	0.5	323.2	1.3	4.2	0.9	2.1	2.5	0.4	5.3	0.6	5.2	1.4
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693069-6697170	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 89.9;bone marrow: 42.8;stomach 1: 70.0;urinary bladder: 47.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 37.2;Hep G2: 39.1;hTCEpi: 43.6;RT4: 80.0;SK-BR-3: 44.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"					"Group enriched"	"Detected in some"	41	"basophil: 47.8;eosinophil: 24.8;neutrophil: 89.9"	"Lineage enriched"	"Detected in many"	68	"granulocytes: 89.9"									HPA019502	Enhanced		Supported	"Nuclear bodies"		1200000	1200000	"Nuclear bodies"	"Nuclear bodies"	"HPA019502: AB_1856530"	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.0	1.1	0.0	42.8	0.0	0.0	0.0	0.3	5.2			0.1	0.0	0.0	23.3	0.3	1.0	0.0	0.0	0.0	0.0	1.9	2.4	0.0	0.0		0.0	0.0	0.0	0.0	16.4		4.8	5.4		1.1	0.0	0.0	3.9	0.5	0.1	0.0	4.4	70.0	0.0			0.0		2.5	47.6	5.1	0.0	0.0	89.9	1.3	0.0	0.0	0.4	5.0	3.2	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	0.1	0.7	0.0	1.8	0.0	6.2	0.0	0.0	0.0	2.4	0.0	0.1	3.6	39.1	0.0	2.3	0.1	0.0	43.6	0.0	0.0	0.0	0.1	0.0	0.0	7.1	0.0	4.5	0.0	5.7	0.0	0.0	0.0	0.0	80.0	0.0	0.0	7.3	44.8	0.0	1.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	47.8	1.3	24.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.1	0.0	0.0	0.4										
SAMSN1	"HACS1, NASH1, SASH2, SH3D6B, SLy2"	ENSG00000155307	"SAM domain, SH3 domain and nuclear localization signals 1"	Q9NSI8	21	14485228-14658821	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.6;bone marrow: 72.1;lymphoid tissue: 43.6"	"Group enriched"	"Detected in some"	4	"HEL: 59.5;K-562: 70.8;Karpas-707: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 53.6;eosinophil: 49.9"	"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in some"	7	"olfactory region: 25.4"	"Low region specificity"	"Detected in all"			"HPA010645, HPA017055, HPA046639"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732"	"unprognostic (7.62e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (4.52e-6)"	"unprognostic (9.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.68e-2)"	14.4	3.9	5.8	33.0	10.4	72.1	4.2	1.1	5.1	2.9	4.7	4.9	0.0	3.1	3.4	4.6	4.1	6.8	10.1	5.1	4.4	3.4	5.9	7.2	27.9	28.3	11.1	1.4	3.3	2.3	1.0	2.7	6.7	6.7	4.1	7.0	3.4	3.4	1.2	1.6	1.9	13.6	4.7	17.5	43.6	5.0	2.4	7.1	12.6	2.6	2.8	16.7	11.8	4.5	6.5	5.6	53.6	17.3	3.7	12.9	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	59.5	0.0	0.0	0.0	7.0	2.9	0.0	0.0	0.0	8.8	0.8	70.8	30.9	0.0	0.0	3.3	8.5	0.0	0.0	5.8	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	7.7	0.0	0.0	0.0	0.0	13.3	0.1	0.0	0.3	4.5	0.0	53.6	8.8	49.9	5.3	11.6	3.6	6.5	10.3	7.8	5.6	2.6	6.6	4.6	11.0	3.7	17.3	0.2	12.9	6.8	5.8	10.4	1.1	5.1	4.4	3.4	11.1	1.4	6.7	7.1
SASH3	"753P9, CXorf9, HACS2, SH3D6C, SLY"	ENSG00000122122	"SAM and SH3 domain containing 3"	O75995	X	129779979-129795201	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.8;bone marrow: 33.2;lymphoid tissue: 85.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 43.9;HL-60: 15.4;MOLT-4: 31.3;NB-4: 23.8;REH: 23.5;U-698: 40.0;U-937: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001085	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA001085: AB_2184289"	"unprognostic (1.88e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.49e-3)"	"prognostic favourable (3.15e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.23e-3)"	"unprognostic (7.92e-3)"	"unprognostic (3.45e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (6.51e-5)"	"unprognostic (3.30e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.53e-1)"	7.8	3.4	2.8	34.6	5.2	33.2	2.7	0.7	2.2	2.0	3.3	4.0	0.2	3.9	1.9	2.1	2.9	3.4	3.6	2.0	3.3	2.4	3.3	3.0	10.6	38.2	5.2	1.1	1.3	1.8	0.2	1.8	2.5	4.2	2.7	3.5	1.6	7.8	0.8	0.9	1.1	18.8	2.4	6.2	55.7	4.2	0.8	4.0	85.3	2.5	2.0	38.6	7.0	2.0	22.0	27.6	53.7	44.2	33.4	46.9	61.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	31.3	23.8	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.1	0.0	0.0	0.0	8.9	40.0	0.0	31.1	0.0	7.9	29.4	53.7	46.9	44.1	38.7	19.1	26.7	43.1	27.6	22.0	19.3	30.0	29.1	33.4	44.2	12.7	32.3	61.8	2.8	5.2	0.7	2.2	3.3	2.4	5.2	1.1	4.2	4.0
SCO2		ENSG00000284194	"SCO2, cytochrome c oxidase assembly protein"		22	50523568-50526439	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 17.6;bone marrow: 13.0"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 13.5"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA046943, HPA056254"	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA046943: AB_2732536, HPA056254: AB_2683080"																		2.4	1.1	0.7	6.3	0.6	13.0	6.7	0.6	1.2	1.5	2.3	0.0	1.1	0.6	0.6	0.7	4.6	0.8	2.4	4.3	0.1		2.8	4.2	3.7	9.3	0.4	0.0	1.2	0.8	0.0	0.0	0.9	0.6	1.6	0.5	0.1	4.2	0.2	0.7	1.8	3.5	1.6	1.7	5.7	1.9	0.4	0.6	10.6	1.0	1.4	2.6	1.6	0.7	10.3	17.6	10.4	12.6	4.0	10.3	10.7	4.0	2.7	0.1	2.6	0.0	0.5	2.3	2.8	1.9	2.4	1.9	0.4	3.7	6.9	2.0	0.9	2.5	1.0	0.0	0.0	1.3	10.6	3.5	0.7	0.4	4.9	9.3	2.8	3.3	1.2	1.2	0.5	0.4	4.4	9.4	1.4	1.5	1.1	9.8	1.4	4.1	6.4	0.7	13.5	1.8	1.1	0.6	2.3	1.2	0.4	9.5	1.4	7.2	3.1	1.7	3.7	2.9	2.4	8.0	2.5	9.6	3.9	2.1	1.6	8.4	12.6	8.7	7.2	7.3	8.7	10.3	9.4	7.8	17.6	8.9	6.9	5.5	10.4	4.0	6.8	12.6	10.3	10.7										
SEC14L3	TAP2	ENSG00000100012	"SEC14 like lipid binding 3"	Q9UDX4	22	30447959-30472049	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 6.8;liver: 6.0;thyroid gland: 3.5"	"Cell line enhanced"	"Detected in some"		"WM-115: 3.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059450	Uncertain									"HPA059450: AB_2684024"		"unprognostic (2.42e-1)"		"unprognostic (2.56e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.00e-4)"	"unprognostic (3.62e-3)"		"unprognostic (6.68e-2)"	"unprognostic (3.19e-1)"		"unprognostic (2.41e-10)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.10e-1)"		0.0	0.1	0.0	0.0	0.3	6.8	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	6.0	2.4	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.4			3.5		0.0	0.0	0.0	0.5	0.3	1.3	0.1	0.1	0.3	0.0	0.2	0.2	0.1	1.0	0.6	0.0	0.9	0.3	0.0	0.1	0.2	0.0	0.8	0.2	0.3	0.0	0.6	0.3	0.0	0.2	0.3	1.5	0.1	0.6	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.6	1.2	0.4	0.6	0.1	0.3	0.3	0.2	0.3	0.3	0.4	0.4	0.3	0.6	1.0	0.1	0.3	0.0	0.3	0.7	0.0	0.9	0.4	0.7	0.1	0.2	0.2	0.3	0.0	0.9	3.1	1.3	0.1	0.1	0.2	0.0	0.1	0.2	0.3	0.1	0.0	0.5	0.1	0.1	0.7	0.1	0.1	0.3	0.2	0.0										
SH2D4B		ENSG00000178217	"SH2 domain containing 4B"	Q5SQS7	10	80537902-80646560	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.8;bone marrow: 2.5;epididymis: 2.4"	"Cell line enriched"	"Detected in single"	87	"REH: 24.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA040022	Uncertain									"HPA040022: AB_10805601"	"unprognostic (1.19e-2)"	"unprognostic (4.51e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.65e-6)"	"unprognostic (9.37e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.81e-1)"	0.6	0.0	0.2	0.2	0.3	2.5	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0.3	0.2	2.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.2	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.0	1.3	0.1	0.1	0.5	0.1	0.2	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1
SHCBP1	"FLJ22009, PAL"	ENSG00000171241	"SHC binding and spindle associated 1"	Q8NEM2	16	46580554-46621626	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.9;lymphoid tissue: 22.9;testis: 14.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA048876	Uncertain		Uncertain	"Nuclear bodies,Microtubules,Midbody,Mitotic spindle"				"Nuclear bodies"	"Nuclear bodies"	"HPA048876: AB_2680542"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.96e-4)"	"unprognostic (2.26e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (4.47e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.22e-16)"	"unprognostic (3.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.66e-1)"	1.5	0.8	1.0	17.3	3.0	18.9	0.9	2.4	1.3	0.8	2.2	0.6	0.3	1.3	1.5	2.0	5.7	0.4	1.1	1.5	1.0	0.7	5.0	0.3	1.7	11.2	0.7	0.7	1.2	0.3	0.2	0.8	2.8	0.7	0.9	2.5	0.3	2.6	0.3	1.4	3.8	2.3	1.9	1.1	9.9	1.4	14.1	0.9	22.9	0.6	3.0	12.9	2.0	1.6	4.6	2.0	1.8	5.4	0.3	3.4	2.1	15.2	16.2	6.1	7.4	1.3	3.1	8.5	31.0	12.2	30.4	14.1	7.7	10.0	13.3	14.0	14.1	10.1	13.4	10.1	37.6	8.5	9.0	14.6	12.2	13.1	0.0	12.8	18.7	0.6	0.6	22.3	9.0	15.9	6.0	14.1	32.9	10.1	11.5	10.7	4.8	17.3	21.0	41.1	21.3	6.2	4.7	2.6	3.3	21.4	11.4	4.9	6.2	10.5	9.1	22.3	14.4	21.4	24.6	11.2	14.8	21.4	10.2	13.9	22.4	0.3	0.8	1.8	0.5	1.3	0.1	4.6	0.8	0.4	1.2	1.9	0.1	0.3	0.8	0.3	5.4	2.0	3.4	2.1	1.0	3.0	2.4	1.3	1.0	0.7	0.7	0.7	0.7	0.9
SLC22A15	FLIPT1	ENSG00000163393	"Solute carrier family 22 member 15"	Q8IZD6	1	115976498-116070054	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.6;brain: 27.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.6;hTERT-HME1: 27.4;NB-4: 14.9;THP-1: 16.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.9;monocytes: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019785	Approved									"HPA019785: AB_1857011"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.85e-5)"	"unprognostic (8.91e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.29e-3)"	"unprognostic (8.78e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.97e-4)"	"unprognostic (1.30e-1)"	2.9	4.5	7.0	3.2	14.1	34.6	2.3	8.6	11.1	2.6	2.1	27.8	0.7	1.7	1.9	2.2	5.5	2.4	2.9	6.1	9.9	8.0	4.9	1.3	6.3	1.7	20.0	8.1	2.0	4.2	7.5	4.5	2.9	15.1	2.8	2.7	2.5	4.6	2.7	0.8	11.8	1.7	1.7	14.1	3.5	4.8	1.8	17.6	0.0	4.0	0.8	1.9	2.5	4.6	0.5	0.3	3.9	2.9	0.2	0.0	0.3	1.6	0.1	1.2	0.0	2.1	2.6	0.8	2.6	3.9	1.6	2.9	0.0	0.3	1.8	2.9	1.3	2.5	2.0	5.4	1.6	0.0	1.3	1.7	1.8	0.2	7.2	2.7	2.4	2.6	20.6	0.0	27.4	0.0	0.1	0.0	2.6	1.4	0.0	14.9	1.7	1.3	0.0	0.0	0.0	2.2	0.9	1.2	1.1	4.5	0.9	7.6	0.2	16.2	0.0	2.9	1.6	0.5	0.6	2.7	2.5	0.2	3.0	4.4	4.5	1.0	2.5	0.9	0.0	0.7	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	3.9	0.2	2.9	0.0	0.0	0.3	7.0	14.1	8.6	11.1	9.9	8.0	20.0	8.1	15.1	17.6
SLC22A16	"CT2, FLIPT2, OAT6, OKB1"	ENSG00000004809	"Solute carrier family 22 member 16"	Q86VW1	6	110424687-110476641	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 9.5;bone marrow: 16.0;parathyroid gland: 9.6;testis: 26.4"	"Group enriched"	"Detected in some"	18	"NB-4: 9.5;REH: 8.8;THP-1: 30.6;U-937: 18.0"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 9.5"	"Group enriched"	"Detected in many"	66	"dendritic cells: 5.1;granulocytes: 5.0;monocytes: 9.5"					"Low region specificity"	"Detected in all"			HPA036902	Uncertain									"HPA036902: AB_10672274"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.19e-3)"	"unprognostic (2.70e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.61e-6)"	"unprognostic (5.78e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.65e-2)"	3.5	0.2	0.2	0.4	0.2	16.0	0.2	0.1	0.2	0.1	0.7	0.0	0.0	0.0	4.9	0.8	0.1	0.3	0.7	0.1	0.2	0.1	1.1	0.3	1.6	0.0	0.2	0.0	0.9	0.1	9.6	0.1	0.3	0.2	0.2	0.0	0.0	0.6	0.0	0.2	0.3	0.1	1.6	0.2	0.8	0.2	26.4	0.0	2.2	0.1	0.8	0.1	0.1	0.1	0.0	5.1	5.0	9.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	18.0	0.0	5.0	9.5	1.6	0.0	2.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.2	0.0
SLC25A37	"HT015, MFRN, MFRN1, MSCP"	ENSG00000147454	"Solute carrier family 25 member 37"	Q9NYZ2	8	23528805-23575463	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.8"	"Cell line enriched"	"Detected in all"	4	"HEL: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 28.9"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 28.9"	"Low region specificity"	"Detected in all"							HPA045680	Uncertain		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"	"Mitochondria, Cytosol"	"HPA045680: AB_10963693"	"unprognostic (6.15e-3)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (4.37e-6)"	"unprognostic (8.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	8.2	18.3	5.8	13.7	8.3	88.8	13.1	4.2	8.2	13.4	16.4	6.5	11.7	39.7	10.3	6.8	8.2	9.5	8.5	16.8	6.2	5.2	9.4	11.8	25.7	18.5	12.2	5.1	17.2	14.8	15.6	8.8	23.9	10.3	17.1	5.8	7.9	21.1	17.4	13.8	7.6	17.6	7.9	10.2	28.7	8.0	15.0	8.6	1.9	9.0	5.9	5.7	13.9	33.0	1.2	1.4	28.9	1.6	0.7	1.2	0.8	3.9	4.3	4.6	4.2	6.1	7.5	6.9	3.1	4.1	2.3	2.6	4.3	8.5	6.4	3.8	2.6	5.1	4.2	8.5	3.2	1.0	2.2	49.4	7.2	1.5	5.1	2.7	1.9	6.4	8.3	5.0	5.0	3.6	10.8	3.2	3.6	1.7	3.3	11.7	2.4	3.4	3.5	2.3	2.5	7.1	2.2	1.4	2.0	4.3	6.6	3.1	1.8	4.3	5.7	11.2	1.7	6.6	6.0	2.6	1.0	4.0	10.6	6.8	7.0	0.6	1.6	1.4	0.6	0.6	0.6	1.2	0.4	0.3	1.4	0.8	1.2	0.7	28.9	0.7	0.8	0.4	0.7	0.8	5.8	8.3	4.2	8.2	6.2	5.2	12.2	5.1	10.3	8.6
SLC2A3	GLUT3	ENSG00000059804	"Solute carrier family 2 member 3"	P11169	12	7919230-7936275	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 166.3"	"Group enriched"	"Detected in many"	5	"BEWO: 148.6;CACO-2: 159.4"	"Cancer enriched"	"Detected in all"	7	"testis cancer: 107.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 30.2;neutrophil: 55.6"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 55.6"									"CAB002763, HPA006539"	Approved		Approved	"Plasma membrane"		33000000	33000000	"Plasma membrane"	"Plasma membrane"	"CAB002763: , HPA006539: AB_1078984"	"unprognostic (9.20e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavourable (8.58e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.40e-2)"	"prognostic unfavourable (6.36e-8)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.91e-3)"	48.8	10.0	9.5	25.2	10.5	166.3	26.4	13.1	24.3	9.4	10.0	6.8	1.8	4.2	10.3	8.2	13.2	8.0	25.6	22.8	10.8	13.6	10.3	14.1	32.4	12.8	13.3	3.3	18.8	6.1	6.9	10.9	43.9	13.7	15.0	6.9	14.8	3.8	3.9	13.6	7.4	5.8	18.7	15.4	16.4	7.0	10.6	12.5	3.3	15.7	7.0	13.6	51.8	10.5	1.8	2.4	55.6	4.6	3.6	6.4	3.5	0.0	0.7	6.8	2.6	2.5	8.9	148.6	2.4	2.6	2.4	5.6	159.4	1.0	0.1	0.0	1.6	0.0	0.2	0.3	4.3	4.6	0.2	9.2	0.6	21.0	6.9	3.3	13.5	3.6	0.2	6.3	2.9	2.2	4.2	2.2	2.1	0.0	0.2	3.6	30.1	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.1	0.0	0.4	2.2	3.0	1.6	5.8	0.2	0.0	6.4	0.5	8.8	1.5	1.6	30.2	4.6	7.0	6.4	0.5	5.3	1.8	4.4	4.9	2.4	1.7	2.8	3.8	55.6	3.6	0.2	0.1	5.8	3.5	9.5	10.5	13.1	13.3	10.8	13.6	13.3	3.3	13.7	12.5
SLC2A5	GLUT5	ENSG00000142583	"Solute carrier family 2 member 5"	P22732	1	9035107-9088478	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.7;intestine: 84.1"	"Group enriched"	"Detected in some"	5	"Daudi: 50.1;THP-1: 12.8;U-266/70: 40.4;U-698: 47.1;U-937: 18.1"	"Group enriched"	"Detected in many"	6	"glioma: 11.0;renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"naive B-cell: 19.7"	"Lineage enriched"	"Detected in many"	7	"B-cells: 19.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005449	Enhanced									"HPA005449: AB_1078985"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.18e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (5.44e-5)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.61e-2)"	5.2	2.2	10.3	4.1	15.0	36.7	3.7	1.1	9.9	2.4	50.4	9.2	0.7	44.8	0.8	4.9	2.5	1.5	0.6	1.4	8.6	6.0	16.2	0.6	0.9	8.1	14.1	2.4	1.6	0.6	0.5	1.9	2.1	10.4	6.7	1.6	0.8	1.8	2.4	25.1	3.1	84.1	1.9	17.8	3.1	0.7	30.2	15.4	0.0	0.8	3.7	7.3	1.8	2.5	19.7	0.7	3.0	2.1	0.6	0.3	0.8	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.2	0.0	0.1	0.3	0.0	50.1	0.0	0.1	0.1	0.4	0.0	0.1	6.5	0.0	0.0	0.9	0.0	0.1	0.8	0.5	0.7	0.7	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.3	2.8	0.0	0.0	1.3	0.0	1.5	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.0	12.8	0.0	0.8	0.2	0.1	0.0	40.4	0.0	47.1	0.0	18.1	0.1	3.0	2.1	0.2	0.2	0.5	0.1	3.4	0.2	0.2	0.7	19.7	0.3	0.2	2.2	0.6	0.1	0.4	0.1	0.8	10.3	15.0	1.1	9.9	8.6	6.0	14.1	2.4	10.4	15.4
SLC4A1	"AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR"	ENSG00000004939	"Solute carrier family 4 member 1 (Diego blood group)"	P02730	17	44248385-44268141	"Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 95.7;placenta: 32.7"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	91	"renal cancer: 16.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebellum: 0.4"	"Low region specificity"	"Detected in all"			"HPA015584, CAB034438, HPA063911"	Enhanced					160000000	160000000			"CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.13e-1)"	0.9	0.1	0.3	0.2	0.4	95.7	0.2	0.8	0.2	0.1	0.1	0.6	0.0	0.2	0.1	0.4	0.6	0.2	0.2	2.6	0.2	0.3	18.6	1.3	12.9	0.8	0.6	0.1	2.8	0.1	0.0	0.6	32.7	0.9	0.6	0.1	1.2	0.1	0.1	1.2	0.2	0.1	0.0	1.0	8.4	0.1	0.3	0.0	0.7	1.9	0.0	0.2	3.9	11.8	1.8	1.4	6.3	1.2	2.9	1.5	0.7	1.3	0.4	1.4	1.7	0.6	0.7	1.0	0.2	0.4	0.3	0.8	1.3	3.2	0.7	0.6	0.3	1.4	0.5	0.5	1.0	1.3	1.3	1.6	1.5	2.2	0.0	0.8	2.3	0.8	0.5	0.8	0.8	0.2	4.7	3.4	0.4	0.6	0.9	3.5	0.9	0.5	2.5	0.7	1.8	0.3	0.8	2.2	1.0	1.3	1.4	0.5	2.5	1.8	1.0	2.3	2.0	1.4	1.4	1.0	2.3	1.1	1.6	2.1	1.1	6.1	1.0	2.0	1.1	0.9	1.0	1.1	1.0	0.9	0.5	1.8	1.5	1.2	6.3	2.9	1.2	1.4	0.7	0.7	0.3	0.4	0.8	0.2	0.2	0.3	0.6	0.1	0.9	0.0
SLC7A5	"CD98, D16S469E, E16, LAT1, MPE16"	ENSG00000103257	"Solute carrier family 7 member 5"	Q01650	16	87830023-87869488	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 71.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 106.7;hTCEpi: 183.4;MCF7: 99.4;SiHa: 150.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"plasmacytoid DC: 15.9"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052673, HPA056077"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA052673: AB_2681909, HPA056077: AB_2683031"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (5.93e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.19e-3)"	8.2	3.2	18.3	14.7	24.5	71.2	4.3	15.9	45.8	7.9	4.6	16.7	8.9	6.2	5.3	30.4	38.7	3.3	6.4	8.2	19.8	22.1	3.6	9.7	3.8	11.1	23.9	9.6	5.1	12.1	1.5	9.0	28.4	23.4	4.3	3.4	34.9	11.5	15.4	11.2	10.7	5.7	4.8	17.7	6.4	12.7	34.9	19.8	3.7	4.2	16.7	15.0	11.5	7.7	0.5	15.9	0.6	0.0	0.2	1.4	0.4	14.6	55.6	1.0	15.6	0.4	0.9	40.1	11.8	4.3	7.2	4.6	36.2	21.0	13.4	10.5	15.0	66.2	11.5	106.7	5.0	14.1	5.8	11.0	52.2	25.9	16.8	10.2	20.3	3.0	183.4	8.8	65.7	1.4	16.4	15.1	5.7	99.4	12.3	15.1	5.1	13.5	11.9	4.3	20.6	8.0	1.2	9.0	3.5	150.7	30.1	32.3	13.8	13.6	1.1	2.5	16.8	10.4	9.1	19.6	16.0	58.1	9.9	25.5	24.0	0.6	0.0	0.0	1.0	0.0	1.2	0.5	0.5	0.8	0.3	0.0	0.1	0.4	0.1	0.2	0.0	15.9	1.4	0.4	18.3	24.5	15.9	28.1	19.8	22.1	23.9	9.6	23.4	19.8
SLFN14		ENSG00000236320	"Schlafen family member 14"	P0C7P3	17	35548125-35558098	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.0;lymphoid tissue: 3.0"	"Cell line enriched"	"Detected in some"	6	"HEL: 21.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022994, HPA023065"	Uncertain					13000	13000			"HPA022994: AB_10670035, HPA023065: AB_2671055"	"unprognostic (4.27e-3)"	"unprognostic (4.72e-4)"		"unprognostic (1.21e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.79e-1)"	"unprognostic (7.59e-8)"	"unprognostic (1.21e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-3)"	0.2	0.0	0.0	0.5	0.0	9.0	0.1	0.0	0.0	0.1	0.1			0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.2	1.5	1.3	0.0		0.0	0.0	0.0	0.0	0.9		0.1	0.0		0.2	0.0	0.0	0.0	1.9	0.0	0.0	3.0	0.3	0.3			0.2		0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	21.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	2.2										
SOD2		ENSG00000285441	"Superoxide dismutase 2"	P04179	6	159679119-159762529	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 3.2;bone marrow: 4.9;seminal vesicle: 3.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.0"									"Cell type enhanced"	"Detected in single"		"memory B-cell: 3.2"	"Low lineage specificity"	"Detected in single"																	140000000	140000000																					0.0	0.0	0.0	0.2	0.4	4.9	0.3	0.0	1.7	0.0	0.1	1.6	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0		0.3	1.0	0.6	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	1.6	0.5	0.2	1.0	0.1	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.4	0.9	0.4	0.2	0.8	0.2	0.0	0.3	0.4	0.4	1.4	1.3	0.5	0.1	2.0	0.8	1.4	0.5	0.2	0.1	0.4	0.4	0.3	1.0	1.8	0.5	0.2	0.0	0.2	0.4	0.7	0.6	0.1	0.1	1.0	1.4	1.6	0.0	0.1	0.2	0.6	0.4	0.0	0.7	0.1	0.1	0.0	0.5	0.3	0.4	0.4	0.0	0.7	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.3	0.0	0.6	0.6	0.2	0.2	0.2	0.1	0.6	0.4	0.4	0.7	0.2	0.1	3.2	0.6	0.4	0.4	0.9	0.8	0.4	0.9	0.2	0.4	0.2	0.5	0.2										
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378576	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 100.3;lymphoid tissue: 70.2"	"Cell line enhanced"	"Detected in some"		"HEL: 18.7;HL-60: 32.9;HMC-1: 61.4;NB-4: 55.5;THP-1: 43.2;U-937: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 45.4;neutrophil: 24.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 45.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB004079: AB_10692379, HPA044653: AB_2679036"	"unprognostic (4.45e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.07e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.92e-2)"	24.4	8.1	6.7	35.7	15.2	100.3	9.0	1.5	6.6	3.6	5.2	8.6	0.0	7.6	3.2	6.2	4.0	8.5	7.7	15.7	5.6	5.1	5.8	11.9	37.2	51.1	12.6	1.6	6.1	3.5	0.9	3.6	10.1	9.6	4.5	3.9	3.9	6.4	2.6	3.3	5.0	10.5	7.6	12.1	70.2	5.8	5.4	10.5	9.6	3.7	2.7	16.8	9.1	5.7	1.0	4.6	45.4	9.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	32.9	61.4	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	55.5	0.0	0.0	10.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	43.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	17.5	0.0	24.4	0.0	3.6	5.4	45.4	0.0	7.8	0.0	1.0	0.0	0.0	4.6	0.8	0.0	0.0	24.8	0.0	9.1	0.2	0.0	1.5	6.7	15.2	1.5	6.6	5.6	5.1	12.6	1.6	9.6	10.5
SPTB		ENSG00000070182	"Spectrin beta, erythrocytic"	P11277	14	64746283-64879907	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.2;brain: 25.2;skeletal muscle: 67.6"	"Group enriched"	"Detected in some"	5	"HEL: 23.0;K-562: 27.5;U-937: 8.3"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"basal ganglia: 11.6;cerebellum: 25.2;cerebral cortex: 10.4;pons and medulla: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003394, HPA003398, CAB015169, CAB016232"	Enhanced		Approved	Cytosol		43000000	43000000	Cytosol	Cytosol	"CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074"	"unprognostic (2.69e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.18e-2)"	1.9	1.6	3.2	0.7	11.6	32.2	0.7	25.2	10.4	0.8	0.7	0.8	0.3	0.6	0.7	5.2	1.8	0.8	0.8	14.7	3.1	3.2	1.2	0.6	0.9	0.6	2.8	3.5	0.7	2.2	6.5	4.7	4.7	16.4	1.5	0.7	1.1	1.9	1.3	67.6	0.7	0.7	1.0	1.7	1.1	0.7	1.0	1.4	0.0	0.7	17.4	0.6	0.8	0.5	0.0	0.6	0.9	0.0	0.0	0.2	1.5	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	1.4	3.8	0.1	0.0	0.2	2.2	23.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	27.5	0.0	0.0	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.1	3.7	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.2	4.2	0.0	0.4	0.9	4.3	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	1.5	3.2	11.6	25.2	10.4	3.1	3.2	2.8	3.5	16.4	1.4
SRGN	"PPG, PRG, PRG1"	ENSG00000122862	Serglycin	P10124	10	69088106-69104811	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 259.2;bone marrow: 657.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 229.4;NB-4: 133.3;THP-1: 229.8;TIME: 138.6;U-937: 185.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 259.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 259.2"					"Low region specificity"	"Detected in many"			HPA000759	Enhanced		Supported	"Golgi apparatus"	"Intracellular and membrane"	50000000	50000000	"Golgi apparatus"	"Golgi apparatus"	"HPA000759: AB_1079675"	"unprognostic (3.61e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.82e-2)"	"prognostic unfavourable (3.18e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.08e-2)"	51.3	12.3	11.0	74.4	18.7	657.4	27.0	5.7	11.8	11.6	13.8	9.7	3.4	8.1	11.6	10.5	13.3	19.6	31.6	31.9	21.0	14.0	29.1	23.2	107.8	87.1	18.4	3.0	11.9	7.4	6.5	13.2	33.0	32.9	12.7	12.6	15.7	8.4	6.8	15.1	3.7	16.8	21.1	42.4	129.8	11.7	10.7	12.6	28.2	15.2	6.5	31.1	46.1	16.2	3.3	28.4	259.2	46.1	40.8	22.7	53.1	0.2	2.1	0.0	0.0	42.8	41.9	0.0	5.0	3.3	12.6	15.4	0.0	0.9	0.4	6.3	0.2	0.0	0.0	1.0	43.7	27.2	0.0	4.4	1.8	0.0	17.5	229.4	50.2	17.0	0.0	34.9	2.1	65.3	4.0	22.6	66.3	0.0	0.9	133.3	0.0	4.3	0.1	0.1	23.0	0.0	0.3	0.0	0.0	0.1	0.0	0.8	0.1	229.8	138.6	10.4	0.6	0.2	1.0	26.5	25.5	2.9	6.2	185.8	0.0	82.5	46.1	116.7	22.7	34.3	14.8	3.3	11.0	16.9	26.1	1.6	6.2	13.2	259.2	40.8	29.7	28.4	17.1	53.1	11.0	18.7	5.7	11.8	21.0	14.0	18.4	3.0	32.9	12.6
STK17B	DRAK2	ENSG00000081320	"Serine/threonine kinase 17b"	O94768	2	196133566-196176503	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 35.5;HMC-1: 36.0;Karpas-707: 33.4;U-698: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebellum: 71.1"	"Low region specificity"	"Detected in all"			HPA034858	Enhanced		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA034858: AB_10670981"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.72e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.80e-2)"	21.0	4.1	3.2	42.8	3.8	103.4	10.1	3.2	3.3	8.2	18.8	1.1	3.8	8.5	3.4	3.9	8.9	6.3	8.6	5.7	3.3	2.2	7.2	2.9	26.2	53.7	2.3	1.8	3.1	5.0	0.7	3.8	6.5	1.7	6.8	5.7	3.5	16.7	6.1	3.4	10.9	31.8	5.3	2.7	59.3	6.0	4.6	1.4	72.2	7.5	7.0	56.2	11.3	6.0	16.9	13.6	62.0	27.0	10.3	28.4	19.0	3.1	2.2	3.3	1.2	14.7	5.6	3.7	7.6	11.4	8.3	8.7	6.6	1.1	35.5	7.0	4.3	2.2	1.4	3.2	10.2	6.2	3.8	3.3	2.8	0.6	4.4	13.4	36.0	7.1	3.2	10.3	5.4	3.4	2.6	33.4	20.6	1.7	17.4	30.4	1.9	5.1	2.9	20.3	10.7	4.9	7.5	1.2	1.3	1.9	1.9	1.6	1.3	7.0	4.1	8.1	4.0	5.8	4.2	13.7	22.2	38.7	6.1	4.6	3.6	35.9	19.7	40.2	12.0	20.7	15.3	13.3	21.5	14.5	13.6	16.9	28.4	23.1	62.0	10.3	27.0	9.7	18.5	19.0	3.2	3.8	3.2	3.3	3.3	2.2	2.3	1.8	1.7	1.4
STX11		ENSG00000135604	"Syntaxin 11"	O75558	6	144150526-144188370	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.5;bone marrow: 68.1;breast: 41.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 25.0;Karpas-707: 13.6;RH-30: 8.7;TIME: 11.0;U-266/70: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 13.4;granulocytes: 45.5;monocytes: 40.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA007992	Approved					19000000	19000000			"HPA007992: AB_1857620"	"unprognostic (1.30e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.07e-1)"	20.0	3.6	0.7	7.0	1.2	68.1	41.9	0.3	0.8	1.4	3.1	0.6	0.0	1.1	1.1	2.2	4.4	2.0	2.4	8.8	1.8	0.9	2.0	5.4	26.3	14.5	1.2	0.0	2.5	0.9	0.6	2.4	15.5	1.8	1.9	1.0	1.6	1.6	0.6	5.3	5.6	2.5	1.9	2.0	20.6	1.4	0.9	1.0	2.8	8.2	4.0	6.8	2.6	6.1	0.8	13.4	45.5	40.8	1.5	4.1	18.9	0.5	0.2	0.0	5.8	0.2	0.2	0.9	0.6	0.5	0.6	1.1	0.2	0.5	0.0	0.6	0.9	0.9	0.1	0.2	0.2	25.0	0.9	3.7	0.7	0.0	1.6	0.9	0.4	0.0	0.0	0.3	0.1	6.2	0.1	13.6	0.8	0.3	0.5	1.1	0.0	0.5	0.0	8.7	0.9	0.0	2.7	0.2	0.0	1.6	0.1	2.6	0.0	4.5	11.0	0.1	1.6	0.4	0.4	16.0	6.1	0.0	0.1	2.8	0.5	9.2	35.0	21.6	3.1	40.2	1.9	0.7	1.4	2.6	13.4	0.8	0.5	1.6	45.5	1.5	40.8	1.4	4.1	18.9	0.7	1.2	0.3	0.8	1.8	0.9	1.2	0.0	1.8	1.0
SYNE3	"C14orf139, C14orf49, FLJ25605, LINC00341, NCRNA00341, Nesp3, Nesprin-3, NET53"	ENSG00000176438	"Spectrin repeat containing nuclear envelope family member 3"	Q6ZMZ3	14	95407266-95475836	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.2;bone marrow: 10.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.8;ASC TERT1: 19.4;Karpas-707: 21.9;REH: 17.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055227, HPA077140"	Approved		Supported	"Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA055227: AB_2682747, HPA077140: AB_2686826"	"unprognostic (4.63e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.92e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.41e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.19e-2)"	12.2	2.4	1.2	2.7	1.3	10.0	6.5	0.3	1.2	2.1	1.0			0.6	1.2	0.6	1.1	2.0	1.2	2.8	1.6	1.1	0.4	1.0	2.7	4.0	1.6		3.0	0.1	0.0	0.5	2.1		0.6	1.6		1.9	0.4	1.1	2.8	1.5	1.2	2.6	2.7	0.9	1.6			1.7		4.3	1.6	2.8	3.4	2.6	5.4	5.1	0.9	3.7	2.2	0.6	0.0	0.3	0.5	24.8	19.4	7.4	2.7	4.8	2.6	2.1	3.9	0.6	3.1	0.4	1.3	0.1	0.6	2.0	1.2	10.4	0.4	2.1	0.5	1.0	3.2	3.3	5.5	5.4	0.7	3.3	1.9	4.6	0.1	21.9	2.0	0.7	1.9	3.6	0.1	1.3	17.3	12.1	6.7	0.3	0.3	0.5	2.7	0.1	0.0	1.3	1.0	4.8	4.2	1.9	1.2	2.6	0.3	2.6	5.3	3.0	3.9	7.4	14.5	5.4	5.1	0.4	2.2	4.0	2.8	3.4	2.9	2.3	2.1	3.3	3.7	3.0	2.4	0.9	4.1	2.6	2.3	2.2										
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.9;bone marrow: 55.6;lymphoid tissue: 32.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.1;HMC-1: 20.6;Karpas-707: 21.4;U-266/84: 9.6;U-698: 19.8;U-937: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Uncertain	Cytosol				Cytosol	Cytosol	"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"	4.4	2.3	1.5	16.9	2.1	55.6	2.5	0.9	2.0	1.9	2.5	7.9	1.3	1.7	9.7	1.8	2.7	2.1	4.1	2.0	1.9	3.7	2.2	2.4	8.4	32.7	5.0	1.1	1.9	1.0	0.4	1.4	2.8	3.9	1.9	3.6	3.2	3.2	1.8	0.8	1.4	11.8	12.2	9.2	22.1	2.7	1.7	3.0	32.6	2.2	4.0	32.1	6.8	1.9	14.9	7.8	47.9	7.7	12.0	22.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.1	0.0	0.0	0.0	7.3	20.6	0.1	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	1.9	3.8	5.8	0.0	0.6	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	2.3	9.6	19.8	0.0	15.8	0.0	38.7	7.7	23.6	16.4	5.5	18.5	13.9	22.0	19.0	7.8	14.9	17.4	12.1	47.9	12.0	7.0	2.6	15.5	14.4	1.5	2.1	0.9	2.0	1.9	3.7	5.0	1.1	3.9	3.0
TAL1	"bHLHa17, SCL, TCL5"	ENSG00000162367	"TAL bHLH transcription factor 1, erythroid differentiation factor"	P17542	1	47216290-47232220	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.1"	"Cell line enhanced"	"Detected in some"		"HEL: 52.8;HMC-1: 25.4;HUVEC TERT2: 11.0;K-562: 16.5;MOLT-4: 8.8;TIME: 12.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.2;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.2"	"Region enriched"	"Detected in some"	5	"midbrain: 17.1"	"Low region specificity"	"Detected in many"			"CAB017805, HPA047866, HPA073983"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB017805: , HPA047866: AB_2680192, HPA073983: "	"unprognostic (2.63e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-2)"	9.1	2.7	7.0	1.8	5.7	33.1	7.1	1.6	6.9	3.3	2.4	12.0	2.3	1.6	3.7	3.3	2.5	4.1	4.2	3.9	8.8	3.5	4.5	2.4	14.6	2.2	11.1	4.4	1.5	1.3	2.2	2.1	9.8	7.3	2.4	2.4	2.1	1.4	3.0	3.1	2.0	3.3	4.4	9.4	8.5	2.1	1.8	9.2	0.0	6.7	4.1	1.5	2.5	5.5	0.3	0.1	3.2	0.3	0.4	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	52.8	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	11.0	16.5	0.0	0.0	0.0	8.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.4	0.1	1.2	0.4	0.1	0.1	0.1	2.2	7.0	5.7	1.6	6.9	8.8	3.5	11.1	4.4	7.3	9.2
TBC1D3C	MGC44903	ENSG00000278299	"TBC1 domain family member 3C"	Q6IPX1	17	38057693-38068592	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.3;skin 1: 3.5;testis: 3.4"	"Cell line enriched"	"Detected in some"	5	"CAPAN-2: 26.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "																		0.0	0.0		0.6		3.3	0.0		0.0	0.0	0.0			0.9	0.2	0.0	0.0	0.5	1.2	0.5			0.1	0.0	1.8	1.0			0.7	0.0	0.0		0.0		0.0	0.0		0.8	0.0	1.3	3.5	0.0	0.1		0.0	1.5	3.4			0.0		0.9	0.0		0.0	0.0	0.8	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.2	0.1	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.5	0.2	0.0	1.0	0.0	0.0	5.4	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0										
TBC1D3E		ENSG00000278599	"TBC1 domain family member 3E"	A0A087X179	17	38127951-38138862	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.9;gallbladder: 3.0;pancreas: 4.3;testis: 4.1"	"Cell line enriched"	"Detected in some"	4	"HHSteC: 9.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "	"unprognostic (1.18e-1)"	"unprognostic (3.35e-1)"			"unprognostic (3.51e-1)"					"unprognostic (4.22e-2)"	"unprognostic (6.28e-2)"		"unprognostic (1.87e-2)"	"unprognostic (5.07e-3)"			"unprognostic (1.32e-3)"	0.0	0.0		0.0		3.9	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	3.0	0.0			0.0	0.0	0.0	1.7			0.0	4.3	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.1			0.0		0.0	0.0		0.0	0.5	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	9.5	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0										
TBX21	"T-bet, TBLYM"	ENSG00000073861	"T-box 21"	Q9UL17	17	47733244-47746119	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.5;bone marrow: 12.2;lymphoid tissue: 17.7"	"Cell line enriched"	"Detected in single"	113	"HDLM-2: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"gdTCR: 13.5;NK-cell: 10.8"	"Group enriched"	"Detected in many"	8	"NK-cells: 10.8;T-cells: 13.5"	"Region enriched"	"Detected in single"	27	"olfactory region: 27.1"	"Low region specificity"	"Detected in all"			"CAB009524, CAB030043"	Enhanced									"CAB009524: AB_2200557, CAB030043: AB_1595503"	"unprognostic (3.31e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.17e-2)"	"unprognostic (5.35e-6)"	"unprognostic (3.93e-1)"	"unprognostic (2.56e-4)"	"unprognostic (5.86e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.26e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.04e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.19e-3)"	"unprognostic (4.43e-3)"	2.9	0.6	0.5	5.7	0.5	12.2	0.9	0.4	0.4	2.3	4.3	0.9	0.4	1.3	2.0	1.7	1.4	1.0	1.8	0.9	0.5	0.5	1.3	1.9	11.1	9.3	2.6	0.3	1.2	0.6	0.0	0.6	0.2	0.7	3.3	0.7	2.2	3.0	0.4	1.5	0.5	2.7	1.4	0.8	17.7	1.6	0.7	0.4	4.1	1.4	1.6	8.1	2.6	1.8	1.5	0.0	0.2	0.0	10.8	13.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	3.1	1.5	2.8	7.4	0.0	0.4	0.4	7.1	0.2	10.8	0.0	0.0	0.1	1.6	0.5	0.5	0.4	0.4	0.5	0.5	2.6	0.3	0.7	0.4
THEMIS2	"C1orf38, ICB-1"	ENSG00000130775	"Thymocyte selection associated family member 2"	Q5TEJ8	1	27872543-27886685	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 72.0;bone marrow: 72.3;lymphoid tissue: 73.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 47.2;U-266/70: 36.7;U-937: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 43.6;granulocytes: 72.0;monocytes: 62.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027513, HPA031096"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA027513: , HPA031096: AB_10599254"	"unprognostic (7.38e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.56e-3)"	"unprognostic (4.13e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.52e-3)"	13.4	5.2	4.3	27.2	7.2	72.3	5.8	0.9	4.6	3.6	7.2	10.7	0.3	4.1	3.0	6.6	4.6	5.4	9.5	6.5	7.1	4.6	5.9	7.5	22.1	39.0	11.5	2.7	3.8	2.7	1.0	2.7	7.1	7.8	2.8	4.2	6.0	6.0	1.8	2.3	2.3	12.7	6.0	16.4	73.0	4.8	9.9	6.7	12.5	5.3	1.1	25.2	7.8	3.3	6.5	43.6	72.0	62.6	8.5	11.3	40.5	3.1	0.1	1.2	0.2	4.0	5.6	0.5	0.6	6.9	10.1	14.3	0.4	0.8	4.4	0.4	2.2	0.4	1.8	0.4	1.6	0.6	0.4	6.2	0.1	0.9	8.0	7.6	10.1	2.8	0.1	5.2	0.0	3.8	8.6	47.2	0.7	2.1	0.3	6.7	4.1	0.7	1.3	4.5	7.7	3.0	0.1	0.0	1.8	0.0	0.2	8.8	0.1	6.8	2.4	0.6	0.0	1.9	0.1	36.7	2.1	0.3	11.4	21.4	0.1	4.4	54.1	47.1	11.3	62.6	10.3	6.5	8.2	9.1	43.6	2.9	7.1	7.3	72.0	8.5	60.9	17.7	7.9	40.5	4.3	7.2	0.9	4.6	7.1	4.6	11.5	2.7	7.8	6.7
TK1		ENSG00000167900	"Thymidine kinase 1"	P04183	17	78174075-78187233	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.8;lymphoid tissue: 41.8;tongue: 33.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 21.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB004683	Enhanced									"CAB004683: AB_437067"	"unprognostic (7.09e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (6.87e-4)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (4.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (6.50e-11)"	"unprognostic (5.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.94e-2)"	5.3	2.0	2.1	21.4	4.5	32.8	4.8	1.1	1.9	3.7	11.4	2.2	1.9	8.5	2.4	4.8	18.9	2.2	7.0	4.3	1.6	0.7	7.9	6.2	9.3	15.7	3.1	1.6	2.1	3.6	0.1	1.3	8.6	2.1	2.3	7.9	0.5	4.6	2.0	2.0	6.2	8.5	4.4	1.7	9.0	9.4	3.6	1.6	41.8	1.3	33.0	20.5	3.1	5.8	4.0	2.1	1.1	1.2	6.2	21.2	3.5	65.1	54.2	10.8	13.6	1.0	4.3	7.1	32.4	17.0	48.2	66.9	47.8	27.5	21.2	11.4	19.4	29.7	9.8	28.9	25.0	7.3	36.2	37.4	19.4	31.3	0.3	15.8	24.2	2.1	0.9	25.1	3.4	19.6	23.0	47.0	18.5	48.7	7.9	8.9	5.6	37.8	21.4	43.8	47.3	12.8	21.2	4.9	14.3	24.8	68.2	9.1	46.0	21.3	9.0	47.4	46.6	33.8	41.6	19.8	10.3	27.3	23.3	10.7	21.3	0.0	0.7	0.0	1.1	1.2	0.5	4.0	5.3	2.7	2.1	1.2	0.3	1.4	1.1	6.2	1.0	0.7	21.2	3.5	2.1	4.5	1.1	1.9	1.6	0.7	3.1	1.6	2.1	1.6
TKT		ENSG00000163931	Transketolase	P29401	3	53224707-53256052	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 216.3"	"Cell line enhanced"	"Detected in all"		"A549: 161.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 63.0;eosinophil: 41.5;intermediate monocyte: 31.0;myeloid DC: 32.5;neutrophil: 60.1;non-classical monocyte: 35.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 32.5;granulocytes: 60.1;monocytes: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029480, HPA029481"	Enhanced		Enhanced	Nucleoplasm		190000000	190000000	Nucleoplasm	Nucleoplasm	"HPA029480: AB_10599307, HPA029481: AB_10601895"	"unprognostic (5.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (7.21e-6)"	"unprognostic (6.78e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.90e-3)"	53.6	37.0	21.2	24.1	26.0	216.3	70.1	18.1	24.3	19.0	24.3	21.1	9.9	31.8	16.9	9.5	60.4	21.8	36.5	15.3	19.4	23.0	51.9	27.4	50.1	45.6	33.4	16.0	35.2	69.9	22.5	16.9	29.8	28.7	25.2	19.6	17.5	21.0	21.6	5.2	16.8	22.5	34.5	28.2	45.6	24.5	10.8	23.3	44.8	67.7	37.9	25.1	58.2	57.3	6.8	32.5	60.1	63.0	4.7	5.7	37.6	31.8	161.2	23.1	25.6	51.5	63.0	47.1	21.6	37.5	37.4	35.8	44.5	82.0	40.1	10.4	31.5	46.2	40.0	81.3	11.1	13.3	22.2	26.7	112.8	66.8	63.0	32.6	18.1	45.5	46.8	44.8	23.1	47.1	19.0	17.5	15.2	38.9	34.0	36.5	78.3	38.9	20.6	10.5	74.5	58.5	54.2	15.0	11.1	40.2	64.4	38.8	20.0	45.2	35.2	11.6	17.9	34.1	41.2	10.1	18.9	24.0	25.3	33.0	21.5	7.0	63.0	41.5	3.0	31.0	3.8	6.8	4.4	3.4	32.5	3.5	4.6	3.4	60.1	4.7	35.5	5.5	5.7	37.6	21.2	26.0	18.1	24.3	19.4	23.0	33.4	16.0	28.7	23.3
TMC6	"EVER1, EVIN1, LAK-4P"	ENSG00000141524	"Transmembrane channel like 6"	Q7Z403	17	78110458-78132407	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.6;brain: 43.1;lymphoid tissue: 41.4"	"Cell line enhanced"	"Detected in many"		"K-562: 33.7;SK-BR-3: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051430	Uncertain									"HPA051430: AB_2681483"	"unprognostic (6.34e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.16e-2)"	"prognostic favourable (1.82e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-2)"	"prognostic favourable (3.20e-4)"	10.5	3.5	7.5	26.1	25.5	39.6	8.3	2.1	12.8	4.1	8.8	33.5	5.6	13.5	3.1	1.7	9.5	5.6	6.5	8.1	12.5	8.1	6.9	3.7	14.4	39.2	43.1	4.6	1.7	6.4	1.8	2.4	6.6	20.3	7.5	4.7	3.6	12.7	7.2	2.3	6.5	17.5	2.7	31.4	41.4	9.1	1.6	31.2	12.1	5.0	2.7	24.8	7.3	6.5	13.5	8.3	9.8	26.7	15.6	27.2	13.2	5.4	4.3	2.4	1.9	0.0	0.0	4.9	0.0	0.0	0.0	0.0	7.8	6.2	6.2	7.7	0.0	9.7	0.3	1.8	0.0	0.6	3.5	12.8	1.1	9.6	0.6	11.7	21.9	0.3	5.2	0.0	0.4	4.7	33.7	23.4	0.0	11.0	5.7	20.0	1.9	1.6	2.6	0.2	18.1	3.6	20.3	0.6	1.5	1.8	38.5	10.4	21.9	17.8	1.6	0.0	3.0	0.0	0.1	18.5	8.1	3.9	0.0	19.0	0.3	6.4	4.9	9.8	27.2	16.9	23.7	13.5	20.1	21.9	8.3	10.2	18.1	18.7	6.9	15.6	26.7	2.5	17.0	13.2	7.5	25.5	2.1	12.8	12.5	8.1	43.1	4.6	20.3	31.2
TMC8	"EVER2, EVIN2"	ENSG00000167895	"Transmembrane channel like 8"	Q8IU68	17	78130770-78142968	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.6;intestine: 23.2;lymphoid tissue: 52.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.4;HL-60: 20.4;HMC-1: 41.5;Karpas-707: 35.2;RPMI-8226: 21.8;U-266/70: 17.1;U-937: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047387, HPA054429"	Uncertain		Uncertain	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA047387: , HPA054429: AB_2682485"	"unprognostic (8.54e-3)"	"prognostic favourable (8.45e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.59e-1)"	"prognostic favourable (4.19e-5)"	"unprognostic (6.38e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavourable (1.96e-7)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	3.6	1.6	2.3	30.1	4.6	33.6	1.9	0.7	2.3	1.7	4.4	3.5	0.1	4.2	2.5	2.1	2.5	2.1	6.2	1.5	2.3	1.7	3.4	3.1	10.7	38.7	4.0	0.8	0.9	1.2	0.1	1.3	1.5	2.8	2.4	1.9	2.6	10.2	1.0	0.6	1.7	23.2	1.0	5.1	52.9	4.1	0.7	3.7	49.7	3.1	1.8	36.6	3.9	2.5	5.0	2.1	5.5	6.6	6.7	13.1	4.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	15.4	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	20.4	41.5	0.0	0.0	0.0	0.0	0.0	1.3	35.2	0.0	0.4	7.0	0.9	0.0	0.1	0.4	0.1	21.8	0.0	0.0	0.0	0.0	0.0	0.7	0.2	2.3	4.2	0.0	0.0	0.0	0.0	0.0	17.1	0.7	1.5	0.0	17.3	0.0	2.3	1.8	5.5	13.1	3.1	9.4	5.0	10.5	12.9	2.1	5.0	9.4	8.4	3.0	6.7	6.6	1.9	5.7	4.2	2.3	4.6	0.7	2.3	2.3	1.7	4.0	0.8	2.8	3.7
TMEM170B		ENSG00000205269	"Transmembrane protein 170B"	Q5T4T1	6	11538278-11583524	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"bone marrow: 31.1"	"Cell line enhanced"	"Detected in many"		"THP-1: 18.3;U-937: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"dendritic cells: 3.2;granulocytes: 2.4;monocytes: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055134	Uncertain		Approved	Centrosome				Centrosome	Centrosome	"HPA055134: AB_2682709"	"unprognostic (1.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.45e-5)"	"unprognostic (3.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-4)"	"unprognostic (3.97e-2)"	10.1	4.8	11.7	6.4	9.6	31.1	6.1	13.5	18.6	3.1	3.3	4.9	2.0	1.6	4.1	5.2	2.5	2.8	3.0	4.5	10.1	8.8	5.9	12.8	8.8	3.5	8.3	8.7	3.9	3.3	5.8	4.2	4.0	8.4	3.4	2.2	4.2	2.5	3.7	8.3	1.8	2.0	4.7	8.2	5.7	2.4	5.2	6.0	4.2	4.4	1.2	2.2	2.7	3.1	0.2	3.2	2.4	2.9	0.1	0.3	0.5	0.7	1.2	7.5	6.7	1.4	0.1	1.5	0.6	1.7	1.0	1.2	0.4	0.4	5.9	3.4	0.4	0.0	8.5	0.5	2.7	1.6	4.3	3.3	0.8	1.0	0.5	5.3	3.5	0.5	0.1	1.1	0.0	0.7	0.2	0.1	1.5	1.1	6.3	9.2	2.1	1.0	3.2	7.2	0.9	0.8	1.5	5.1	4.4	0.4	2.4	2.7	2.4	18.3	0.1	1.4	1.6	2.8	1.7	5.2	10.4	5.3	1.2	13.6	1.8	2.4	2.9	1.5	0.2	1.6	0.1	0.0	0.1	0.1	1.8	0.2	0.3	0.2	1.1	0.1	0.6	3.2	0.0	0.5	11.7	9.6	13.5	13.5	10.1	8.8	8.3	8.7	8.4	6.0
TMEM78	FLJ40168	ENSG00000177800	"Transmembrane protein 78"	Q5T7P6	1	229249636-229251810	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 5.3;bone marrow: 2.5"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 5.3"	"Low lineage specificity"	"Detected in many"											HPA042351	Uncertain									"HPA042351: AB_10961259"	"unprognostic (2.45e-2)"		"unprognostic (3.07e-1)"		"unprognostic (1.23e-1)"			"unprognostic (1.51e-1)"		"unprognostic (3.33e-1)"		"unprognostic (9.45e-2)"		"unprognostic (5.59e-2)"	"unprognostic (1.29e-1)"			0.1	0.4	0.5	0.2	0.5	2.5	0.4	0.7	0.7	0.1	0.1			0.1	0.5	0.6	0.1	0.3	0.2	0.1	0.4	0.3	0.1	0.6	0.0	0.7	0.3		0.2	0.7	0.5	0.2	0.0		0.4	0.3		0.7	0.0	1.8	1.2	0.2	0.0	0.3	0.6	0.1	0.7			0.3		0.2	0.1	0.1	1.3	2.6	5.3	0.5	1.3	0.9	0.1	0.4	1.3	0.7	2.1	0.2	0.0	0.6	0.4	0.0	0.1	0.1	0.2	1.9	0.4	0.5	0.4	1.0	0.0	0.0	0.3	0.6	0.6	0.7	1.8	0.3	0.0	0.5	0.5	0.2	0.0	0.1	0.0	0.1	0.3	0.7	0.0	0.3	0.6	1.5	0.6	0.6	0.4	0.4	0.2	0.2	1.0	0.4	0.5	0.5	0.2	0.0	0.5	0.1	0.0	0.6	0.5	0.5	0.3	0.9	0.6	0.8	0.5	0.6	0.8	5.3	0.5	0.7	0.7	0.3	0.5	0.8	0.6	0.5	0.1	1.3	0.9	0.8	2.6	1.3	0.5	2.6	0.4	0.1										
TNF	"DIF, TNF-alpha, TNFA, TNFSF2"	ENSG00000232810	"Tumor necrosis factor"	P01375	6	31575567-31578336	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.6;lymphoid tissue: 28.0"	"Group enriched"	"Detected in some"	5	"HDLM-2: 10.0;HMC-1: 9.6;NB-4: 28.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 10.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.5;monocytes: 10.8;T-cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (1.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-1)"	2.3	1.2	0.6	15.6	1.0	14.6	1.2	0.4	1.8	1.7	1.3	3.7	0.3	1.3	1.1	0.4	1.5	0.9	2.3	2.0	0.5	0.3	2.6	1.9	9.5	8.0	0.8	0.0	0.6	0.7	0.5	0.5	3.2	2.0	0.7	0.7	0.4	2.2	0.8	0.4	2.7	4.1	0.7	1.0	28.0	1.0	0.4	0.5	2.1	0.6	5.3	14.7	1.2	0.4	1.3	1.2	3.5	10.8	0.5	6.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	10.0	0.0	1.8	0.0	0.0	0.0	0.8	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	1.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	4.1	6.5	6.6	1.3	3.1	2.4	1.2	1.3	0.9	1.0	3.5	0.5	10.8	0.7	2.2	2.1	0.6	1.0	0.4	1.8	0.5	0.3	0.8	0.0	2.0	0.5
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867188-137883312	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 48.4;REH: 42.0;U-266/84: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA002116, HPA067479"	Approved		Supported	Vesicles				Vesicles	Vesicles	"HPA002116: AB_1858162, HPA067479: AB_2732767"	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	27.4	6.0	1.5	58.6	1.8	112.4	17.2	0.4	1.5	7.7	15.7	3.2	2.6	5.1	9.7	7.3	12.7	12.1	17.0	11.7	2.1	1.3	6.8	8.1	45.1	38.8	2.1	2.6	37.5	7.2	2.1	3.7	14.5	4.6	13.8	6.3	7.2	8.2	3.5	10.7	20.5	17.2	8.2	3.8	25.9	8.0	9.3	2.1	38.6	5.7	9.2	31.4	23.3	9.5	7.1	18.6	10.0	9.7	7.5	20.5	9.0	8.9	1.5	0.5	0.8	3.0	5.1	2.1	5.1	20.0	1.4	1.8	9.9	3.0	2.0	13.2	5.9	6.8	0.3	14.8	2.6	14.6	0.5	2.0	5.2	5.8	3.3	2.7	3.7	4.7	2.1	16.9	16.1	0.8	4.1	48.4	2.4	0.5	14.7	11.5	0.3	0.4	42.0	10.4	1.4	4.4	4.3	0.2	0.0	1.0	1.5	4.4	1.0	3.4	4.0	14.5	1.7	12.9	2.9	15.6	36.1	4.1	5.3	3.5	1.8	5.6	9.7	5.5	14.8	7.1	20.5	6.2	15.1	13.3	10.3	7.1	10.0	7.4	10.0	7.5	3.7	18.6	14.7	9.0	1.5	1.8	0.4	1.5	2.1	1.3	2.1	2.6	4.6	2.1
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286719	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 96.9;bone marrow: 38.5;lung: 34.2"	"Cell line enriched"	"Detected in some"	7	"U-87 MG: 23.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 96.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 96.9"									HPA005563	Uncertain				"Intracellular and membrane"					"HPA005563: "	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	10.2	0.6	0.7	21.1	1.5	38.5	1.0	0.6	2.1	0.7	0.9	0.7	0.5	0.1	1.0	1.5	0.6	4.2	5.1	3.7	1.2	0.9	1.1	3.7	34.2	8.0	2.7	0.1	2.1	1.8	0.2	2.7	31.2	2.3	0.9	0.0	2.5	1.3	0.1	2.4	0.4	1.1	3.8	3.9	12.1	1.0	2.6	0.6	0.3	2.2	1.9	1.0	3.9	0.7	0.2	5.0	96.9	12.8	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.6	0.0	0.0	0.3	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	1.5	0.0	0.0	12.8	0.3	0.0	3.1	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.0	96.9	0.0	1.4	0.1	0.0	4.1	0.7	1.5	0.6	2.1	1.2	0.9	2.7	0.1	2.3	0.6
TREML2	"C6orf76, dJ238O23.1, FLJ13693, TLT2"	ENSG00000112195	"Triggering receptor expressed on myeloid cells like 2"	Q5T2D2	6	41190277-41201194	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 20.8;bone marrow: 13.6;placenta: 54.3"	"Cell line enhanced"	"Detected in some"		"HEL: 24.4;HL-60: 5.7;U-698: 6.9;U-937: 4.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 16.1;neutrophil: 20.8"	"Group enriched"	"Detected in many"	15	"B-cells: 16.1;dendritic cells: 5.5;granulocytes: 20.8"					"Low region specificity"	"Detected in some"									2300000	2300000				"unprognostic (3.76e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.23e-2)"	"unprognostic (6.71e-2)"	1.7	0.2	0.2	6.3	0.2	13.6	0.2	0.2	0.2	0.2	0.4	0.1	0.1	0.1	0.2	0.1	0.4	0.9	0.3	0.5	0.2	0.2	0.3	0.4	1.5	9.2	0.2	0.1	0.2	0.2	0.0	0.2	54.3	0.3	0.2	0.0	0.1	1.5	0.1	0.2	0.2	1.9	0.1	0.3	12.3	0.4	5.9	0.2	4.9	0.3	0.1	7.5	0.8	0.2	16.1	5.5	20.8	0.8	0.4	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.3	1.8	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.1	4.5	0.0	1.4	0.3	7.7	0.2	0.7	0.3	3.6	0.6	0.1	1.3	16.1	0.9	0.2	20.8	0.4	0.8	5.5	0.4	1.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.3	0.2
TRIB1	"C8FW, GIG2, TRB1"	ENSG00000173334	"Tribbles pseudokinase 1"	Q96RU8	8	125430321-125438405	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 84.2;thyroid gland: 90.7"	"Cell line enhanced"	"Detected in many"		"HEL: 54.0;U-266/70: 33.1;U-266/84: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 10.8;neutrophil: 5.8;non-classical monocyte: 3.7;T-reg: 3.1"	"Group enriched"	"Detected in many"	11	"granulocytes: 10.8;monocytes: 3.7;T-cells: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063982			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA063982: AB_2685165"	"unprognostic (1.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.08e-2)"	26.7	6.5	5.9	17.6	6.5	84.2	13.3	4.3	6.1	10.4	12.4	4.4	6.6	4.9	6.2	6.7	10.9	10.9	21.0	11.1	4.3	4.0	16.6	63.5	28.9	14.6	4.2	3.9	6.4	23.6	20.9	7.2	15.5	4.5	12.1	13.3	15.0	14.5	9.1	22.3	10.4	16.9	11.3	3.1	15.9	18.5	5.6	3.1	9.2	90.7	17.6	12.1	12.4	9.0	0.2	0.5	10.8	3.7	0.0	3.1	0.1	4.0	4.6	0.6	1.3	1.3	2.6	7.3	2.6	3.7	1.9	0.6	6.2	5.4	7.4	2.5	1.9	3.1	2.0	2.6	1.7	3.2	9.7	54.0	2.0	12.0	3.4	27.0	4.9	2.5	3.9	8.1	18.4	5.7	4.7	23.5	0.2	4.3	2.5	4.2	4.5	9.0	5.1	0.9	8.0	15.9	15.5	3.9	1.4	6.5	7.1	25.7	1.8	1.3	2.9	2.1	2.8	2.1	3.3	33.1	33.0	10.3	3.8	0.1	5.0	0.0	0.9	10.8	0.0	1.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	5.8	0.0	3.7	0.3	3.1	0.1	5.9	6.5	4.3	6.1	4.3	4.0	4.2	3.9	4.5	3.1
TRIM58	BIA2	ENSG00000162722	"Tripartite motif containing 58"	Q8NG06	1	247857199-247878205	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.8;placenta: 22.4;thyroid gland: 15.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 7.9;HEL: 21.0;K-562: 11.6;PC-3: 20.2;U-2 OS: 16.5;WM-115: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023637	Uncertain					310000	310000			"HPA023637: AB_1858309"	"unprognostic (3.85e-1)"	"unprognostic (5.24e-3)"	"unprognostic (7.00e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.14e-5)"	"unprognostic (3.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.57e-2)"	0.7	0.8	1.3	1.0	4.4	24.8	0.7	0.3	3.7	0.6	1.3	0.2	0.0	0.3	0.5	0.4	0.5	1.4	0.5	0.8	1.5	3.2	0.5	0.6	3.4	0.4	2.4	1.2	1.1	0.4	0.3	0.7	22.4	6.9	1.7	1.0	1.1	0.5	0.4	0.5	1.2	0.6	0.8	1.3	5.8	0.7	4.9	0.1	0.0	15.2	0.0	0.4	1.9	0.7	3.1	0.6	3.7	0.7	1.7	0.3	1.9	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	7.9	0.0	0.0	0.0	0.8	21.0	0.0	0.0	0.0	2.8	1.6	0.0	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.0	0.0	0.1	1.3	20.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.1	0.0	0.0	16.5	0.0	0.0	3.5	0.0	0.0	0.0	5.9	21.3	2.8	0.7	1.8	0.3	0.5	0.2	3.1	0.2	0.2	0.6	1.0	0.3	0.2	3.7	1.7	0.6	0.6	0.2	1.9	1.3	4.4	0.3	3.7	1.5	3.2	2.4	1.2	6.9	0.1
TROAP	TASTIN	ENSG00000135451	"Trophinin associated protein"	Q12815	12	49323236-49331731	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.3;lymphoid tissue: 45.6;testis: 29.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044102	Uncertain									"HPA044102: AB_10963691"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (3.43e-3)"	"unprognostic (2.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.17e-2)"	0.7	1.3	0.3	17.3	0.4	26.3	2.6	0.4	0.9	2.1	6.5	0.5	0.3	5.1	0.8	2.5	11.2	0.5	3.2	1.9	0.4	0.2	1.2	1.3	2.0	6.2	0.3	0.5	0.8	0.8	0.0	0.5	4.3	0.7	0.9	5.5	0.6	2.2	0.8	0.7	4.3	5.2	1.4	0.4	5.9	4.0	29.1	0.3	45.6	0.7	7.0	10.8	1.1	4.1	2.0	0.4	0.2	0.1	2.3	10.9	0.9	26.2	20.8	27.2	19.9	0.8	2.0	20.4	12.8	12.7	38.6	22.1	46.1	20.8	18.0	6.3	9.8	21.0	21.2	12.5	22.5	14.5	29.0	25.1	33.0	14.9	0.5	18.2	27.0	0.4	1.7	25.7	17.6	21.8	15.5	31.1	15.5	34.0	33.4	28.0	12.5	31.5	17.2	22.7	23.3	9.2	9.8	17.3	11.9	15.8	30.5	9.6	25.0	13.8	6.9	9.8	26.9	19.8	34.5	16.8	18.2	22.5	9.4	20.5	10.9	0.2	0.0	0.1	0.2	0.0	0.4	2.0	2.9	3.0	0.4	1.5	0.1	0.7	0.0	2.3	0.1	0.0	10.9	0.9	0.3	0.4	0.4	0.9	0.4	0.2	0.3	0.5	0.7	0.3
TRPM2	"EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7"	ENSG00000142185	"Transient receptor potential cation channel subfamily M member 2"	O94759	21	44350163-44443081	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 16.7;NB-4: 23.7;THP-1: 29.2;U-937: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.3;plasmacytoid DC: 14.5"	"Group enriched"	"Detected in many"	8	"dendritic cells: 14.5;monocytes: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030976, HPA035260"	Enhanced		Approved	"Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA030976: AB_2673682, HPA035260: AB_2674540"	"unprognostic (3.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.55e-2)"	"prognostic favourable (9.28e-4)"	"unprognostic (6.49e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (4.39e-6)"	"unprognostic (1.40e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.88e-3)"	"prognostic favourable (7.59e-4)"	5.4	4.5	7.4	8.6	7.8	29.9	3.9	14.5	16.3	2.9	4.5	6.9	0.0	4.4	1.9	1.5	2.1	2.6	5.7	1.8	7.8	8.9	2.1	2.0	3.8	8.2	8.5	10.4	1.5	2.4	2.1	2.1	7.1	11.7	1.9	3.0	2.6	2.9	1.3	1.3	2.3	5.1	3.2	9.7	8.1	3.1	1.9	7.3	2.0	1.7	0.0	4.8	4.9	1.7	1.4	14.5	0.4	7.3	0.5	1.1	1.8	8.3	3.1	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.2	0.1	0.0	0.0	0.2	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	0.0	0.0	16.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	23.7	0.0	9.8	0.9	3.0	3.2	0.0	0.0	6.1	0.0	0.0	9.8	0.0	11.6	29.2	0.0	0.5	8.9	0.0	0.3	0.1	12.4	0.0	0.0	27.6	0.0	0.0	7.3	0.0	1.0	2.6	0.6	0.3	0.3	0.4	2.5	1.4	0.3	0.4	0.4	0.5	2.0	14.5	1.1	1.8	7.4	7.8	14.5	16.3	7.8	8.9	8.5	10.4	11.7	7.3
TSPAN32	"PHEMX, TSSC6"	ENSG00000064201	"Tetraspanin 32"	Q96QS1	11	2301997-2318200	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.3;bone marrow: 17.5;heart muscle: 11.9;lymphoid tissue: 11.5"	"Group enriched"	"Detected in some"	8	"HEL: 15.4;HL-60: 6.7;NB-4: 5.6;THP-1: 5.9;U-937: 9.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA024135	Uncertain		Approved	Nucleoplasm		37000	37000	Nucleoplasm	Nucleoplasm	"HPA024135: AB_1858409"	"unprognostic (7.50e-3)"	"unprognostic (4.88e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.10e-4)"	"unprognostic (7.72e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.35e-1)"	"unprognostic (8.13e-2)"	1.2	0.4	0.3	6.3	0.5	17.5	0.5	0.4	1.0	1.3	1.3	2.1	0.0	0.2	1.6	1.6	0.9	0.6	1.4	11.9	0.3	0.4	0.9	0.8	3.1	5.1	0.5	0.3	0.8	0.4	0.0	0.4	0.9	0.5	1.2	0.1	1.7	5.6	0.9	0.3	0.5	1.1	1.8	0.8	5.8	1.4	0.4	1.1	7.4	0.5	2.1	11.5	1.0	0.8	1.1	14.9	17.9	19.3	25.3	13.2	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	15.4	0.0	0.1	0.7	6.7	1.1	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	9.4	0.0	17.9	15.2	2.0	13.0	17.9	8.1	1.1	4.7	11.1	14.9	0.6	3.7	13.2	8.4	25.3	19.3	0.7	5.8	9.5	0.3	0.5	0.4	1.0	0.3	0.4	0.5	0.3	0.5	1.1
TYMS	"HsT422, TMS, TS, Tsase"	ENSG00000176890	"Thymidylate synthetase"	P04818	18	657604-673578	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 75.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.8"	"Group enriched"	"Detected in many"	6	"NK-cells: 6.8;T-cells: 13.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 6.7;olfactory region: 8.8"	CAB002784	Enhanced									"CAB002784: "	"unprognostic (7.58e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (5.10e-6)"	"unprognostic (1.62e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (2.47e-1)"	3.0	2.6	4.6	15.5	5.8	34.9	2.8	1.2	6.3	3.4	10.1	10.2	1.5	4.8	2.5	3.6	12.3	2.4	4.6	2.0	5.8	2.9	4.8	5.1	4.2	15.4	3.4	4.5	2.0	3.1	1.1	1.3	14.3	3.4	3.0	12.9	1.1	3.4	0.8	0.7	3.6	6.9	5.5	4.6	8.9	4.2	21.5	5.3	75.5	1.7	10.9	19.3	4.8	4.3	1.2	1.8	1.0	0.1	6.8	13.8	2.5	13.7	21.2	44.3	21.4	4.9	8.2	22.5	32.5	19.4	35.1	42.1	17.9	11.0	21.4	12.7	17.5	6.2	30.9	12.2	30.4	20.1	34.3	36.3	19.9	30.7	1.1	74.5	39.8	7.3	2.9	22.1	6.9	29.3	29.1	34.4	44.1	15.8	89.7	41.3	15.9	15.9	59.4	39.9	25.8	13.2	12.2	15.1	24.5	27.4	12.7	8.2	8.7	34.0	11.6	40.6	80.2	37.1	63.3	42.7	52.5	48.9	10.7	32.3	46.4	0.0	0.0	1.0	1.1	0.1	0.0	1.2	2.9	2.2	1.8	0.0	0.0	0.7	0.6	6.8	0.1	0.3	13.8	2.5	4.6	5.8	1.2	6.3	5.8	2.9	3.4	4.5	3.4	5.3
TYROBP	"DAP12, KARAP, PLO-SL, PLOSL"	ENSG00000011600	"TYRO protein tyrosine kinase binding protein"	O43914	19	35904401-35908295	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 267.2;bone marrow: 125.7;lymphoid tissue: 123.6"	"Group enriched"	"Detected in some"	10	"HMC-1: 116.0;THP-1: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 267.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009493, HPA041899"	Enhanced									"CAB009493: AB_638987, HPA041899: AB_10795266"	"unprognostic (7.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.39e-2)"	76.0	21.4	13.3	54.9	20.7	125.7	16.4	2.8	11.3	11.9	14.3	24.0	2.3	17.1	8.1	19.3	7.2	14.0	25.7	17.5	12.9	14.2	17.6	29.8	75.3	80.0	20.8	5.6	11.7	8.7	1.8	9.0	32.0	17.2	14.9	12.3	15.0	12.4	7.2	7.3	6.7	18.9	16.0	36.3	123.6	10.4	7.3	18.6	8.5	6.7	6.6	10.3	22.3	8.4	0.7	79.3	267.2	190.6	62.8	20.3	162.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.1	5.3	116.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	7.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.8	0.0	32.8	190.6	100.9	20.3	134.4	10.6	0.7	0.4	2.8	79.3	0.3	0.5	2.3	267.2	62.8	130.3	68.5	0.3	162.3	13.3	20.7	2.8	11.3	12.9	14.2	20.8	5.6	17.2	18.6
UBALD2	"FAM100B, MGC29814"	ENSG00000185262	"UBA like domain containing 2"	Q8IYN6	17	76265202-76271299	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 108.9"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 61.8;Karpas-707: 80.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 20.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023046	Uncertain									"HPA023046: AB_1848359"	"unprognostic (1.33e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.06e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.45e-3)"	21.0	10.1	10.7	29.6	16.4	108.9	45.6	8.6	13.2	11.2	33.1	12.3	11.4	45.9	10.4	10.4	35.0	11.6	17.3	19.9	12.3	11.4	14.4	13.4	26.6	40.0	13.1	7.2	7.9	26.5	7.8	9.0	23.1	22.6	13.7	10.3	10.5	25.9	14.3	72.1	22.1	45.7	9.1	23.5	30.0	28.5	8.0	11.1	28.7	21.4	11.3	28.5	17.8	21.8	1.7	2.7	20.3	1.3	0.9	3.3	0.5	22.6	5.1	4.7	3.7	5.3	5.2	11.2	8.4	6.2	3.2	3.8	6.0	25.3	6.0	8.9	2.1	8.5	2.1	4.7	2.5	61.8	5.5	6.7	5.7	5.5	3.7	7.7	32.9	4.5	5.7	3.5	9.1	11.0	10.4	80.5	4.1	11.6	36.8	18.1	4.3	9.0	18.0	9.7	16.6	6.0	12.8	12.1	11.6	5.9	8.2	41.4	5.9	20.5	8.1	7.3	10.6	12.1	13.3	35.8	27.3	12.2	8.4	6.4	19.8	3.7	1.3	2.2	1.6	1.0	1.3	1.7	2.8	1.7	0.5	1.3	3.3	2.6	20.3	0.9	0.7	2.7	1.8	0.5	10.7	16.4	8.6	13.2	12.3	11.4	13.1	7.2	22.6	11.1
UBE2S	E2-EPF	ENSG00000108106	"Ubiquitin conjugating enzyme E2 S"	Q16763	19	55399745-55407777	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015228, HPA057150"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB015228: , HPA057150: AB_2683351"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (9.54e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (8.00e-6)"	"unprognostic (1.42e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.08e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavourable (8.16e-8)"	"unprognostic (1.05e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	10.2	9.2	18.0	19.5	15.9	68.0	4.7	11.4	21.6	6.1	12.0	9.1	4.5	8.4	7.1	7.2	17.1	6.0	9.7	18.0	18.7	18.1	5.9	5.6	6.3	22.9	13.7	14.4	6.4	6.0	3.7	12.9	9.8	12.9	7.0	7.1	6.2	4.9	5.3	7.3	6.2	7.3	10.7	15.3	11.0	10.6	69.4	8.2	60.2	5.9	14.3	21.1	10.0	7.1	4.5	3.1	6.0	1.9	0.6	2.6	0.3	59.4	32.2	28.3	22.6	1.8	2.6	5.0	48.4	14.7	29.9	27.3	21.8	21.3	57.9	20.1	12.1	17.5	28.4	12.6	13.3	45.3	94.2	34.6	18.5	7.0	5.4	41.3	33.7	2.8	3.5	22.0	21.3	11.7	34.3	40.6	18.7	15.7	56.0	21.5	71.1	54.7	49.3	21.8	20.8	8.0	12.7	72.0	39.0	61.7	15.3	27.4	10.9	22.5	17.9	18.1	51.3	15.3	115.2	32.7	78.5	67.9	18.9	29.3	65.3	1.1	1.9	2.9	1.8	1.5	1.2	4.5	2.6	2.6	1.5	1.6	2.5	1.5	6.0	0.6	0.9	3.1	1.0	0.3	18.0	15.9	11.4	21.6	18.7	18.1	13.7	14.4	12.9	8.2
USP15	"KIAA0529, UNPH4"	ENSG00000135655	"Ubiquitin specific peptidase 15"	Q9Y4E8	12	62260338-62417431	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 68.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 68.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006237, HPA006428, HPA071014"	Approved		Enhanced	Cytosol		280000	280000	Cytosol	Cytosol	"HPA006237: , HPA006428: AB_2667588, HPA071014: AB_2686333"	"unprognostic (8.18e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (8.04e-4)"	"unprognostic (6.59e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavourable (1.58e-5)"	"unprognostic (9.28e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.26e-1)"	23.1	16.8	11.5	22.5	11.9	88.9	17.8	21.1	15.7	14.5	14.5	5.2	11.9	11.4	12.7	12.4	16.1	14.1	11.2	15.2	9.6	6.2	13.8	20.4	23.8	26.2	11.6	9.4	22.5	15.8	18.9	22.5	31.0	14.9	12.4	13.8	7.6	16.2	10.7	28.5	23.0	19.7	16.3	16.2	35.6	14.3	20.0	11.0	33.1	14.1	15.4	18.9	18.4	17.9	5.7	6.0	68.5	14.2	3.3	12.1	4.8	9.3	8.8	8.8	7.6	13.9	16.3	15.7	15.2	13.5	13.5	12.1	8.8	9.4	10.0	8.7	13.0	10.2	11.7	13.2	15.8	11.0	7.2	13.7	7.5	6.7	13.5	21.7	33.4	11.8	13.8	15.9	14.2	15.9	44.4	19.4	12.4	10.4	12.9	11.0	12.9	13.0	8.3	9.3	16.1	12.5	10.8	11.1	5.3	17.6	11.2	8.6	14.7	13.0	19.0	10.5	10.5	16.3	9.4	9.2	10.2	11.4	12.0	17.7	11.8	27.2	14.2	13.8	3.4	7.3	3.5	5.7	4.6	3.2	4.9	4.7	5.9	3.5	68.5	3.3	5.8	6.0	12.1	4.8	11.5	11.9	21.1	15.7	9.6	6.2	11.6	9.4	14.9	11.0
VAMP1	"SYB1, VAMP-1"	ENSG00000139190	"Vesicle associated membrane protein 1"	P23763	12	6462237-6470987	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.7;brain: 85.2"	"Cell line enriched"	"Detected in many"	6	"U-698: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002779, CAB016119, CAB079000"	Approved	Supported								"CAB002779: , CAB016119: AB_628309, CAB079000: "	"unprognostic (2.33e-1)"	"unprognostic (6.72e-3)"	"prognostic unfavourable (6.37e-5)"	"unprognostic (8.09e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-3)"	"prognostic unfavourable (6.97e-4)"	"unprognostic (1.22e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavourable (1.04e-11)"	"unprognostic (1.47e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.65e-2)"	3.4	6.8	10.2	13.7	12.8	38.7	4.2	9.8	53.1	5.7	8.0	11.1	1.6	4.7	8.7	5.4	3.9	5.1	5.2	4.0	14.1	25.4	3.2	4.3	5.3	24.3	33.5	10.0	3.8	2.4	1.1	3.1	2.4	85.2	8.6	8.8	4.8	6.3	7.6	4.0	4.2	7.9	7.7	31.3	12.4	5.4	3.7	8.3	3.7	7.9	0.8	23.0	5.0	4.7	5.5	2.5	13.4	1.0	2.1	7.0	2.5	0.9	3.4	1.8	2.6	5.6	6.4	2.2	1.8	3.4	1.9	5.4	1.1	3.1	9.7	0.4	4.4	2.9	2.3	1.0	2.8	7.6	5.4	1.5	10.2	1.2	2.6	3.7	3.7	4.7	0.4	2.4	1.4	1.7	0.5	2.8	4.2	1.0	4.9	4.3	9.2	1.5	5.4	3.0	1.8	1.2	1.3	0.4	0.8	3.7	1.9	1.4	0.6	1.4	2.0	0.8	2.9	1.9	1.2	2.5	1.0	66.4	3.5	7.8	0.7	6.9	1.0	13.4	6.7	0.4	5.3	5.5	5.5	6.2	1.1	1.3	5.8	4.8	5.5	2.1	0.5	2.5	7.0	2.5	10.2	12.8	9.8	53.1	14.1	25.4	33.5	10.0	85.2	8.3
VAV1	VAV	ENSG00000141968	"Vav guanine nucleotide exchange factor 1"	P15498	19	6772714-6857366	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.7;bone marrow: 25.7;lymphoid tissue: 43.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 30.9;Karpas-707: 35.3;MOLT-4: 33.5;REH: 22.2;THP-1: 26.0;U-266/84: 25.6;U-937: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001864	Enhanced		Approved	Cytosol		30000	30000	Cytosol	Cytosol	"HPA001864: AB_1858722"	"unprognostic (2.93e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.58e-2)"	"prognostic unfavourable (1.48e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.28e-1)"	5.1	3.0	3.1	19.0	5.6	25.7	2.3	0.7	2.2	1.7	3.5	4.0	0.3	2.8	1.9	2.6	2.6	2.6	3.1	3.3	2.5	3.0	2.7	2.6	8.5	25.1	5.3	1.2	2.0	1.5	5.2	1.8	4.4	3.5	3.2	3.7	2.3	5.8	1.1	0.8	1.4	10.7	2.6	8.7	37.1	2.5	1.5	4.8	43.1	2.0	1.2	20.0	6.1	2.4	9.3	10.5	25.7	22.8	11.5	14.7	10.5	0.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.8	15.2	4.6	0.0	0.0	0.0	0.0	0.0	6.4	0.5	18.3	0.0	0.0	0.0	17.8	30.9	0.0	0.0	0.0	0.0	0.0	0.6	35.3	0.0	2.5	33.5	10.2	0.0	0.0	22.2	0.0	12.0	0.6	0.0	0.0	0.0	0.0	5.1	0.0	2.2	26.0	0.0	0.0	0.4	0.0	0.0	21.2	25.6	17.2	0.0	28.1	0.0	0.9	11.5	11.9	14.7	18.8	10.5	9.3	10.7	12.7	10.5	9.2	11.8	10.6	25.7	11.5	22.8	9.0	8.5	10.5	3.1	5.6	0.7	2.2	2.5	3.0	5.3	1.2	3.5	4.8
VPREB1	"CD179A, VpreB"	ENSG00000169575	"V-set pre-B cell surrogate light chain 1"	P12018	22	22244675-22245515	"CD markers, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 8.1;bone marrow: 23.8;lymphoid tissue: 4.8"	"Group enriched"	"Detected in some"	11	"Daudi: 8.4;MOLT-4: 17.8;RPMI-8226: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 5.8;naive B-cell: 8.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 8.1"					"Not detected"	"Not detected"			HPA055886	Uncertain				"Intracellular and membrane"					"HPA055886: AB_2682956"																		0.0	0.0	0.0	2.2	0.0	23.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	1.3	0.0	4.8	0.0	0.0	1.2	0.0	0.0	8.1	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VRK1		ENSG00000100749	"Vaccinia related kinase 1"	Q99986	14	96797304-96931722	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	6.0	4.4	7.1	9.8	17.1	39.0	8.7	8.6	10.2	6.1	7.8	4.4	4.1	5.2	5.9	5.7	9.4	6.9	3.3	6.0	7.4	6.5	6.2	4.3	4.5	18.3	6.9	6.1	5.9	3.7	3.8	5.1	7.1	6.7	5.3	9.1	4.1	4.8	4.1	4.3	6.4	6.9	5.4	6.1	15.7	6.7	33.3	6.9	33.0	4.9	6.1	18.4	5.9	5.7	20.8	13.5	20.1	9.5	28.5	22.3	12.5	15.7	9.1	22.5	10.0	2.7	5.0	14.0	11.9	9.3	19.1	19.0	10.8	15.6	40.1	8.1	7.0	17.5	21.0	15.5	26.3	22.8	11.3	25.0	6.0	11.1	2.9	48.0	15.7	2.7	2.8	14.4	10.6	13.2	21.2	25.4	16.4	18.0	38.1	20.7	14.4	17.3	35.7	39.4	13.6	8.7	16.2	15.9	9.0	10.5	10.8	8.0	12.3	19.0	7.1	8.7	7.8	15.0	11.9	13.3	15.7	38.8	13.6	21.0	10.3	20.1	7.6	14.5	15.1	9.3	18.4	20.3	17.6	18.5	9.9	20.8	19.1	19.3	4.5	28.5	9.5	13.5	22.3	12.5	7.1	17.1	8.6	10.2	7.4	6.5	6.9	6.1	6.7	6.9
WAS	"IMD2, THC, WASP, WASPA"	ENSG00000015285	"Wiskott-Aldrich syndrome"	P42768	X	48676596-48691427	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.7;lymphoid tissue: 55.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.3;HMC-1: 45.7;MOLT-4: 19.4;NB-4: 21.1;RPMI-8226: 26.0;U-266/70: 24.2;U-937: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 20.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002022, CAB004290"	Enhanced		Approved	"Plasma membrane,Cytosol"		320000	320000	"Plasma membrane"	"Plasma membrane"	"CAB004290: AB_628445, HPA002022: AB_1080581"	"unprognostic (1.43e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.36e-2)"	"prognostic favourable (4.95e-4)"	"unprognostic (9.89e-2)"	"prognostic favourable (3.78e-4)"	"unprognostic (5.12e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavourable (5.58e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.71e-1)"	7.6	4.0	4.9	28.9	7.8	30.7	3.3	2.0	5.1	2.7	4.4	5.9	0.5	4.8	2.4	5.6	3.7	4.5	4.4	3.0	4.6	4.1	4.1	5.0	12.6	29.9	7.6	1.3	2.6	2.2	0.7	2.6	5.4	6.0	3.2	3.2	3.5	5.4	1.9	1.4	2.2	14.3	3.7	12.8	55.9	4.1	1.7	7.3	53.2	2.8	1.4	33.2	5.8	2.5	2.1	3.5	20.3	5.3	2.1	3.2	2.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	21.3	0.0	0.0	0.7	0.0	0.0	0.0	12.2	0.1	18.8	0.2	0.0	0.2	9.6	45.7	0.0	0.0	0.0	0.0	0.0	0.2	13.1	0.0	2.1	19.4	21.1	0.1	0.1	16.9	0.0	26.0	0.0	0.0	0.1	0.2	0.3	0.2	0.2	0.1	19.2	0.1	0.0	0.1	0.3	0.0	24.2	11.8	14.9	0.1	24.4	0.0	1.8	4.6	20.3	3.0	5.0	2.2	1.8	2.3	2.5	3.5	2.1	2.1	2.3	18.1	2.1	5.3	1.8	3.2	2.0	4.9	7.8	2.0	5.1	4.6	4.1	7.6	1.3	6.0	7.3
WDR74	FLJ10439	ENSG00000133316	"WD repeat domain 74"	Q6RFH5	11	62832342-62841809	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037795, HPA038419"	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA037795: AB_10671380, HPA038419: AB_2676006"	"unprognostic (5.52e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.29e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	14.2	13.2	12.6	19.7	13.8	77.4	14.2	14.6	21.5	12.5	12.5	10.9	8.7	10.8	14.1	10.2	16.1	15.1	12.8	12.6	12.2	11.9	15.5	19.7	10.0	18.1	15.4	16.5	17.4	20.6	9.4	8.0	11.9	13.6	12.5	11.2	8.0	16.5	9.8	42.1	19.8	10.6	11.5	9.5	18.0	13.4	23.5	16.6	16.0	20.0	19.1	16.0	12.4	14.0	39.1	44.8	15.9	34.8	26.8	16.7	11.9	16.2	19.5	7.7	12.7	6.3	8.7	23.7	9.1	9.9	19.9	13.3	28.6	19.9	28.6	26.0	7.5	21.7	23.5	18.2	15.6	18.2	17.3	14.4	21.6	24.7	18.6	28.6	9.5	8.4	20.5	12.6	42.2	9.7	31.4	8.5	9.0	31.2	27.3	45.5	31.2	26.1	27.9	13.1	49.8	14.1	9.3	17.1	19.2	10.5	21.8	29.4	15.3	22.1	6.9	11.6	14.0	26.1	22.9	21.2	29.4	34.7	12.9	17.5	15.1	8.7	34.8	3.2	11.7	16.9	14.7	18.6	12.1	11.0	29.2	39.1	16.7	14.8	15.9	26.8	11.3	44.8	13.7	11.9	12.6	13.8	14.6	21.5	12.2	11.9	15.4	16.5	13.6	16.6
WHAMM	"KIAA1971, WHAMM1, WHDC1"	ENSG00000156232	"WAS protein homolog associated with actin, golgi membranes and microtubules"	Q8TF30	15	82809628-82836108	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 44.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039690, HPA040231"	Supported		Supported	Cytosol				Cytosol	Cytosol	"HPA039690: AB_10795405, HPA040231: AB_10795361"	"unprognostic (7.98e-2)"	"prognostic favourable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (8.56e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.20e-2)"	10.6	6.6	7.9	9.8	11.7	44.5	10.1	14.0	9.5	8.7	8.8	11.2	7.7	8.8	8.5	6.7	10.2	7.3	6.6	7.4	10.1	5.3	9.5	11.4	10.7	9.6	10.7	8.0	10.9	9.3	16.7	7.9	8.9	13.9	10.1	8.2	7.6	9.3	7.5	23.3	12.0	10.6	12.0	12.3	11.9	8.3	5.5	14.3	8.3	9.6	6.6	11.0	11.1	13.1	3.2	2.4	5.0	1.6	5.8	3.2	0.9	4.0	4.1	2.6	3.9	8.4	5.9	4.4	5.7	5.7	6.2	6.2	2.7	7.4	8.8	7.1	5.2	9.0	7.9	4.5	4.1	2.9	4.5	5.0	4.7	4.0	8.6	3.6	6.0	5.8	6.2	3.0	6.2	4.4	4.5	11.6	6.2	3.1	3.0	5.2	1.1	2.5	4.4	5.6	2.4	10.8	16.4	2.5	2.0	8.7	5.8	5.8	3.9	7.7	7.0	8.3	2.9	5.5	6.4	12.6	7.1	4.3	5.9	5.0	5.2	5.0	1.6	1.3	3.2	1.1	2.9	2.6	3.1	2.4	1.0	3.2	2.9	2.9	3.6	5.8	1.1	2.4	2.4	0.9	7.9	11.7	14.0	9.5	10.1	5.3	10.7	8.0	13.9	14.3
YOD1	"DKFZp451J1719, DUBA8, OTUD2"	ENSG00000180667	"YOD1 deubiquitinase"	Q5VVQ6	1	207043849-207052980	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 44.7"	"Cell line enhanced"	"Detected in many"		"HEL: 39.4;K-562: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028400, HPA028439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		40000	40000	"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA028400: AB_10599854, HPA028439: AB_10600994"	"unprognostic (3.69e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.87e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.62e-1)"	4.5	4.6	4.0	4.0	5.3	44.7	6.6	4.8	7.5	6.1	3.9	7.6	2.6	4.1	4.0	3.1	24.5	3.7	3.5	5.0	4.0	2.2	4.5	5.2	9.4	4.2	7.1	4.4	3.5	3.6	2.5	5.1	6.3	5.1	3.4	4.0	3.4	9.7	3.0	6.5	14.9	4.8	2.7	8.5	5.2	8.4	5.6	6.9	14.3	5.8	10.0	8.2	5.8	12.3	0.5	1.3	3.9	1.5	1.2	1.8	0.9	5.3	2.8	4.5	2.7	1.6	2.1	8.8	3.5	2.7	2.7	2.7	5.4	5.5	2.8	1.4	2.1	5.9	0.0	4.3	3.0	2.2	4.8	39.4	11.6	2.5	1.5	5.1	13.9	1.5	3.4	2.2	8.4	2.3	27.4	0.0	2.3	0.0	4.5	2.8	4.3	6.4	2.3	0.2	2.0	2.7	6.0	2.3	5.2	5.8	6.7	7.6	2.4	3.6	1.1	2.3	6.1	1.9	4.6	4.5	0.2	4.2	2.7	0.0	1.5	3.9	1.2	2.0	1.1	1.5	1.5	0.4	1.7	0.9	1.3	0.5	1.4	1.8	2.9	1.2	1.0	0.7	0.8	0.9	4.0	5.3	4.8	7.5	4.0	2.2	7.1	4.4	5.1	6.9
YPEL5	CGI-127	ENSG00000119801	"Yippee like 5"	P62699	2	30146941-30160533	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 164.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042809	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA042809: AB_2678179"	"unprognostic (7.22e-3)"	"unprognostic (6.50e-3)"	"unprognostic (9.16e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.67e-3)"	29.6	32.5	39.0	20.1	38.2	164.9	32.9	34.2	52.9	31.2	34.6	20.7	38.2	19.4	28.7	40.9	35.1	25.6	30.8	26.1	38.1	39.5	40.5	29.8	31.9	30.5	35.3	32.5	30.0	23.4	24.6	26.0	48.1	36.4	33.8	22.2	33.1	28.7	47.6	27.7	26.1	29.1	36.8	30.6	29.6	27.2	31.4	18.3	34.2	39.0	20.6	28.2	40.1	25.2	21.3	35.0	72.4	31.9	12.5	21.6	30.9	10.0	5.5	12.1	5.9	34.3	33.3	10.3	14.2	44.0	8.3	12.8	4.5	10.4	5.9	9.7	28.6	5.4	2.8	14.5	11.7	26.2	5.4	3.1	2.5	7.3	29.3	1.0	7.3	34.3	29.5	15.6	20.1	15.6	4.3	10.6	22.2	5.2	3.2	7.2	6.7	6.6	1.9	16.3	5.6	27.6	19.5	4.9	14.9	7.2	7.0	17.6	7.8	5.8	20.4	22.4	8.6	6.1	3.9	25.3	9.9	7.9	16.0	2.8	9.0	41.7	19.6	43.1	13.6	21.8	13.5	21.3	16.6	15.9	18.2	17.4	16.0	14.1	72.4	12.5	31.9	35.0	21.6	30.9	39.0	38.2	34.2	52.9	38.1	39.5	35.3	32.5	36.4	18.3
ZBTB43	"FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B"	ENSG00000169155	"Zinc finger and BTB domain containing 43"	O43298	9	126805006-126838210	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 51.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016825	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA016825: AB_1858959"	"unprognostic (1.18e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.14e-1)"	"unprognostic (5.41e-3)"	"prognostic favourable (8.73e-4)"	"unprognostic (6.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.13e-2)"	6.6	6.2	7.8	4.9	12.1	51.7	6.6	10.6	13.6	5.8	5.6	9.5	3.0	5.6	6.6	5.2	10.3	5.3	5.9	9.5	7.9	5.7	5.1	9.0	9.3	6.0	8.6	7.1	7.1	5.9	9.6	9.3	8.2	8.1	5.1	6.6	7.5	7.4	4.4	34.7	14.6	6.7	6.0	8.5	5.7	7.4	15.7	9.3	5.3	6.2	7.1	10.1	5.5	7.0	6.1	5.2	10.6	6.3	9.0	10.7	4.3	4.5	3.5	6.4	5.9	5.4	7.8	6.7	6.4	6.0	4.8	4.3	8.5	3.2	6.3	3.1	6.1	13.3	5.6	6.0	6.0	6.0	3.7	4.4	10.4	3.6	7.3	6.1	8.4	9.5	15.2	7.8	19.5	3.7	7.5	14.8	7.1	4.9	5.3	3.9	5.8	6.0	4.6	20.7	5.2	5.3	5.3	5.7	5.3	6.6	6.2	5.7	5.8	3.9	3.5	5.8	5.6	6.5	5.2	15.9	11.3	2.5	7.2	5.2	4.7	10.6	6.3	5.3	10.7	6.3	10.2	6.1	5.8	6.2	5.2	5.1	6.4	7.3	3.5	9.0	4.8	2.8	8.2	4.3	7.8	12.1	10.6	13.6	7.9	5.7	8.6	7.1	8.1	9.3
ZC3H12A	"FLJ23231, MCPIP1"	ENSG00000163874	"Zinc finger CCCH-type containing 12A"	Q5D1E8	1	37474552-37484379	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.7;tongue: 56.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.4;RT4: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA032052, HPA032053"	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"				"Cytoplasmic bodies"	"Cytoplasmic bodies"	"HPA032052: AB_10603241, HPA032053: AB_2674128"	"unprognostic (2.35e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.51e-2)"	"prognostic favourable (9.67e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavourable (5.95e-5)"	"unprognostic (5.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.77e-2)"	11.7	8.4	0.8	15.0	2.9	58.7	8.2	1.3	1.3	6.4	13.3	2.9	5.6	7.0	5.0	6.9	25.2	8.1	22.6	6.3	2.1	0.7	6.7	10.7	21.0	11.3	1.8	0.7	7.1	6.8	1.0	4.6	8.1	3.8	16.1	4.2	3.0	10.9	6.3	11.8	23.1	14.1	8.5	2.6	10.9	11.0	3.4	1.1	8.3	4.0	56.9	34.8	17.0	22.2	6.1	2.6	8.9	2.1	5.5	5.5	2.3	3.7	2.7	0.3	1.7	1.4	2.1	3.1	2.7	24.4	1.7	2.3	3.0	8.5	4.2	11.6	2.6	8.2	1.1	17.5	1.0	8.6	1.7	1.1	8.9	4.7	2.0	2.2	1.8	4.4	9.0	15.2	2.7	2.0	2.1	7.0	1.6	4.5	1.7	4.0	2.1	2.4	2.5	1.1	2.5	4.4	30.2	0.8	0.5	5.4	8.7	0.6	3.0	2.5	2.0	5.3	2.9	3.8	4.1	5.6	2.0	3.1	12.0	4.7	1.0	1.8	2.1	5.8	5.4	2.1	5.5	5.2	2.2	3.3	2.6	6.1	1.3	2.5	8.9	5.5	1.9	2.5	2.8	2.3	0.8	2.9	1.3	1.3	2.1	0.7	1.8	0.7	3.8	1.1
ZDHHC18	DKFZp667O2416	ENSG00000204160	"Zinc finger DHHC-type containing 18"	Q9NUE0	1	26826710-26857602	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 86.2"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 27.0"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040234	Approved		Approved	Microtubules				Microtubules	Microtubules	"HPA040234: AB_10805709"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (5.15e-4)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (7.42e-7)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavourable (1.36e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	20.5	8.2	13.3	22.7	18.9	86.2	39.0	21.4	18.4	10.2	13.0	11.9	7.5	11.7	12.4	6.4	19.3	9.9	13.5	9.8	13.5	20.0	7.8	14.5	16.2	23.5	16.3	12.8	9.6	10.8	7.1	10.5	20.3	15.2	10.7	13.9	11.2	14.1	9.8	8.7	16.3	12.2	16.6	10.4	27.1	10.8	7.0	9.5	11.7	14.6	10.1	23.3	16.5	24.7	0.2	0.4	27.0	0.6	0.5	1.3	0.2	18.1	8.1	13.2	9.1	11.0	7.7	13.0	10.9	13.0	19.3	14.4	7.4	11.7	8.4	7.0	14.5	12.8	14.0	6.5	16.6	53.1	11.9	8.1	5.9	10.3	9.5	7.2	7.1	6.6	8.9	17.7	11.8	10.7	8.4	17.5	7.6	8.8	13.6	5.8	12.6	7.8	11.3	11.4	8.9	8.1	4.6	6.1	7.4	7.3	5.6	8.0	5.0	7.1	9.1	13.3	10.3	21.8	12.5	20.9	14.9	7.2	7.6	13.1	9.0	0.0	0.2	5.1	0.9	0.6	0.7	0.2	0.6	0.6	0.4	0.1	0.4	0.4	27.0	0.5	0.4	0.2	1.3	0.2	13.3	18.9	21.4	18.4	13.5	20.0	16.3	12.8	15.2	9.5
ZNF367	FLJ33970	ENSG00000165244	"Zinc finger protein 367"	Q7RTV3	9	96385941-96418329	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.8;lymphoid tissue: 21.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	7	"T-cells: 1.8"	"Low region specificity"	"Detected in all"							"HPA015319, HPA015785"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA015319: AB_2669185, HPA015785: AB_2217750"	"unprognostic (5.91e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.76e-3)"	"unprognostic (1.60e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.88e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.72e-1)"	"prognostic favourable (2.34e-4)"	"unprognostic (2.28e-1)"	2.7	1.2	2.1	8.9	4.6	23.8	4.4	2.9	3.9	2.2	4.9	2.9	1.7	3.2	1.3	2.1	4.5	1.3	3.0	4.6	2.5	2.1	3.3	12.0	2.6	4.7	4.4	2.0	2.2	1.8	3.9	0.6	3.7	3.8	1.4	3.8	2.1	3.2	0.6	3.9	3.9	3.2	2.6	4.3	3.4	2.4	9.6	4.3	21.5	1.3	6.5	5.0	2.1	2.5	0.1	0.2	0.1	0.2	0.1	1.8	0.7	13.2	5.5	5.4	4.8	2.1	3.0	7.3	18.5	11.0	9.3	11.1	3.4	9.4	10.1	7.9	8.8	16.3	6.2	6.7	11.0	11.0	5.4	7.3	10.5	2.8	0.0	10.2	9.0	0.5	0.4	7.5	3.8	3.4	6.7	24.7	11.7	8.8	15.6	8.4	3.7	9.0	8.0	27.3	6.1	2.6	9.0	9.6	6.6	8.1	9.8	5.6	5.1	9.1	3.0	15.3	8.7	14.0	14.0	9.6	16.2	4.1	9.2	9.0	12.8	0.0	0.0	0.1	1.2	0.0	0.8	0.0	0.8	1.2	0.2	0.1	1.1	1.3	0.0	0.1	0.2	0.1	1.8	0.7	2.1	4.6	2.9	3.9	2.5	2.1	4.4	2.0	3.8	4.3
ZNF394	"FLJ12298, ZKSCAN14, ZSCAN46"	ENSG00000160908	"Zinc finger protein 394"	Q53GI3	7	99486519-99500324	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051421, HPA054639"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA051421: AB_2681479, HPA054639: AB_2682553"	"prognostic favourable (3.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-1)"	"prognostic favourable (2.11e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"prognostic favourable (1.09e-4)"	11.3	8.3	10.0	11.5	11.8	77.5	12.2	16.4	13.2	10.8	10.9	11.7	8.8	10.7	11.0	7.7	12.2	11.2	9.3	10.4	7.9	6.2	9.4	9.5	12.6	12.2	11.2	6.6	14.3	12.0	7.9	16.2	8.4	9.7	13.0	9.1	10.1	10.1	9.0	14.8	13.6	13.5	9.1	9.1	19.1	10.9	9.5	11.0	15.6	11.4	8.8	17.5	11.9	11.6	17.6	22.3	31.6	17.0	24.3	29.3	17.0	7.7	7.7	5.2	10.9	8.1	5.6	10.3	6.6	8.8	7.7	7.5	8.1	8.5	9.2	9.5	6.8	7.5	7.0	8.4	7.6	6.7	9.2	9.1	9.1	8.9	6.5	12.9	15.9	7.3	7.3	7.5	8.0	8.7	13.0	18.5	7.0	14.5	13.3	21.2	11.6	9.2	7.6	5.7	16.1	8.3	11.1	6.2	12.9	7.7	18.7	12.4	4.8	16.1	9.1	9.3	9.4	13.4	8.2	15.2	15.9	15.0	6.6	13.1	9.8	31.6	14.3	24.1	23.1	17.0	24.2	17.6	23.6	25.0	15.6	17.2	29.3	23.1	26.3	24.3	16.7	22.3	25.2	17.0	10.0	11.8	16.4	13.2	7.9	6.2	11.2	6.6	9.7	11.0
